assays_ASI,assays_DOI,assays_ASST,assays_ASSCT,assays_CURAB,assays_CHEI,assays_ASTTY,assays_TII,assays_Ti,assays_SASI,assays_SRI,assays_VARII,assays_RELATTY,assays_Descri,assays_ASSOR,assays_ASSSUBFRA,assays_ASTI,assays_CONFSC,assays_CEI,assays_BFOR
7524,9866,A,,Intermediate,CHEMBL618647,In vivo,2113.0,50597,,1,,N,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,Kidney,1,,BAO_0000218
7525,9866,A,,Intermediate,CHEMBL618648,In vivo,2113.0,50597,,1,,N,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,Kidney,1,,BAO_0000218
7526,9866,A,,Intermediate,CHEMBL618649,In vivo,2113.0,50597,,1,,N,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,Kidney,1,,BAO_0000218
7527,9866,A,,Intermediate,CHEMBL618650,In vivo,2107.0,50597,,1,,N,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7528,9866,A,,Intermediate,CHEMBL618651,In vivo,2107.0,50597,,1,,N,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,Liver,1,,BAO_0000218
7529,9866,A,,Intermediate,CHEMBL876497,In vivo,2107.0,50597,,1,,N,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7530,9866,A,,Intermediate,CHEMBL618652,In vivo,2048.0,50597,,1,,N,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,Lung,1,,BAO_0000218
7531,9866,A,,Intermediate,CHEMBL618653,In vivo,2048.0,50597,,1,,N,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,Lung,1,,BAO_0000218
7532,9866,A,,Intermediate,CHEMBL618654,In vivo,2048.0,50597,,1,,N,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,Lung,1,,BAO_0000218
7533,6351,A,,Intermediate,CHEMBL618655,,,50597,,1,,N,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Rattus norvegicus,,,1,,BAO_0000218
7534,1465,A,,Intermediate,CHEMBL618656,,,50597,,1,,N,Compound was tested for solubility in water,Rattus norvegicus,,,1,,BAO_0000218
7535,5182,P,,Intermediate,CHEMBL618657,,,22229,,1,,U,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,,0,,BAO_0000100
7536,17847,A,,Intermediate,CHEMBL618658,,,50597,,1,,N,Solubility was determined,Rattus norvegicus,,,1,,BAO_0000218
7537,15339,A,,Intermediate,CHEMBL618659,,,50597,,1,,N,solubility in water (ug/mL) at 37 degree C.,Rattus norvegicus,,,1,,BAO_0000218
7538,5202,A,,Intermediate,CHEMBL618660,,,50597,,1,,N,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Rattus norvegicus,,,1,,BAO_0000218
7539,1088,A,,Intermediate,CHEMBL618661,,,50597,,1,,N,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Rattus norvegicus,,,1,,BAO_0000218
7540,3169,A,,Intermediate,CHEMBL873807,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
7541,5353,A,,Intermediate,CHEMBL618662,,,50597,,1,,N,Half life in Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7542,2864,A,,Intermediate,CHEMBL618663,In vivo,,50597,,1,,N,Half life period after 3 mg/kg iv administration,Rattus norvegicus,,,1,,BAO_0000218
7543,2864,A,,Intermediate,CHEMBL618664,In vivo,,50597,,1,,N,Half life period after 3 mg/kg iv administration in rat,Rattus norvegicus,,,1,,BAO_0000218
7544,2864,A,,Intermediate,CHEMBL618665,In vivo,,50597,,1,,N,Half life period after 3 mg/kg iv administration in the rat,Rattus norvegicus,,,1,,BAO_0000218
7545,6362,A,,Intermediate,CHEMBL876498,,,50597,,1,,N,Half life period in female Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7546,6249,A,,Intermediate,CHEMBL618666,,,50597,,1,,N,Half life period in rat,Rattus norvegicus,,,1,,BAO_0000218
7547,3169,A,,Intermediate,CHEMBL620440,,,50597,,1,,N,Half-life in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
7548,3169,A,,Intermediate,CHEMBL620441,,,50597,,1,,N,Half-life in rats with metabolic oxidation,Rattus norvegicus,,,1,,BAO_0000218
7549,3169,A,,Intermediate,CHEMBL620442,,,50597,,1,,N,Half-life in rats,Rattus norvegicus,,,1,,BAO_0000218
7550,17260,A,,Intermediate,CHEMBL620443,In vivo,,50597,,1,,N,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7551,17260,A,,Intermediate,CHEMBL620444,In vivo,,50597,,1,,N,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7552,17260,A,,Intermediate,CHEMBL620445,In vivo,,50597,,1,,N,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7553,17260,A,,Intermediate,CHEMBL620446,In vivo,,50597,,1,,N,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7554,2879,A,,Intermediate,CHEMBL620447,,1969.0,50597,,1,,N,Biological half-life measured in plasma of rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7555,2879,A,,Intermediate,CHEMBL621129,,1969.0,50597,,1,,N,Biological half-life measured in plasma of rat; 22-25,Rattus norvegicus,,Plasma,1,,BAO_0000218
7556,2879,A,,Intermediate,CHEMBL621130,,1969.0,50597,,1,,N,Biological half-life measured in plasma of rat; 9-16,Rattus norvegicus,,Plasma,1,,BAO_0000218
7557,3184,A,,Intermediate,CHEMBL873808,In vivo,,50597,,1,,N,Compound was evaluated for its half life when administered intravenously in rat,Rattus norvegicus,,,1,,BAO_0000218
7558,4891,A,,Intermediate,CHEMBL876598,In vivo,,50597,,1,,N,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Rattus norvegicus,,,1,,BAO_0000218
7559,429,A,,Intermediate,CHEMBL621131,In vivo,,50597,,1,,N,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7560,5656,A,,Intermediate,CHEMBL621132,In vivo,,50597,,1,,N,Half life (T1/2) after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
7561,4413,A,,Intermediate,CHEMBL621133,In vivo,,50597,,1,,N,Half life of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
7562,3598,A,,Expert,CHEMBL621312,In vivo,,50597,,1,,N,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7563,17267,A,,Intermediate,CHEMBL621313,,,50597,,1,,N,Half life of compound was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7564,4727,A,,Intermediate,CHEMBL621314,,178.0,50597,,1,,N,Half life of compound was determined in rat blood,Rattus norvegicus,,Blood,1,,BAO_0000218
7565,17651,A,,Intermediate,CHEMBL621315,In vivo,,50597,,1,,N,Half life at 1 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7566,17651,A,,Intermediate,CHEMBL621316,In vivo,,50597,,1,,N,Half life at 10 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7567,401,A,,Intermediate,CHEMBL621317,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
7568,4942,A,,Intermediate,CHEMBL621318,,,50597,,1,,N,Half life in rats in hours,Rattus norvegicus,,,1,,BAO_0000218
7569,17735,A,,Intermediate,CHEMBL621319,In vivo,,50597,,1,,N,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
7570,6056,A,,Intermediate,CHEMBL621377,In vivo,,50597,,1,,N,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7571,5213,A,,Intermediate,CHEMBL621378,,,50597,,1,,N,Half life was determined,Rattus norvegicus,,,1,,BAO_0000218
7572,6616,A,,Intermediate,CHEMBL876599,In vivo,,50597,,1,,N,Half life after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
7573,5937,A,,Intermediate,CHEMBL621379,In vivo,,50597,,1,,N,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7574,5819,A,,Intermediate,CHEMBL621380,,1969.0,50597,,1,,N,Half life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
7575,5819,A,,Intermediate,CHEMBL621381,,1969.0,50597,,1,,N,Half life in rat plasma; Not detected,Rattus norvegicus,,Plasma,1,,BAO_0000218
7576,6803,A,,Intermediate,CHEMBL618515,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
7577,17804,A,,Intermediate,CHEMBL618516,In vivo,,50597,,1,,N,Half life period of compound was determined after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
7578,17804,A,,Intermediate,CHEMBL618517,In vivo,,50597,,1,,N,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
7579,5948,A,,Intermediate,CHEMBL618518,,,50597,,1,,N,Half life period in rat,Rattus norvegicus,,,1,,BAO_0000218
7580,1916,A,,Intermediate,CHEMBL618519,In vivo,,50597,,1,,N,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,1,,BAO_0000218
7581,1916,A,,Intermediate,CHEMBL618698,In vivo,,50597,,1,,N,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,,1,,BAO_0000218
7582,1916,A,,Intermediate,CHEMBL618862,In vivo,,50597,,1,,N,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Rattus norvegicus,,,1,,BAO_0000218
7583,4890,A,,Intermediate,CHEMBL618863,In vivo,,50597,,1,,N,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7584,17764,A,,Intermediate,CHEMBL618864,In vivo,,50597,,1,,N,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
7585,4727,A,,Intermediate,CHEMBL618865,In vivo,,50597,,1,,N,Half life time in rat the dose of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7586,17509,A,,Intermediate,CHEMBL618866,In vivo,,50597,,1,,N,Half-life 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,,,1,,BAO_0000218
7587,17509,A,,Intermediate,CHEMBL618867,In vivo,,50597,,1,,N,Half-life 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,,,1,,BAO_0000218
7588,6597,A,,Intermediate,CHEMBL875828,,,50597,,1,,N,Half-life consistent with the observed metabolic steady state in rats,Rattus norvegicus,,,1,,BAO_0000218
7589,17735,A,,Intermediate,CHEMBL618868,In vivo,,50597,,1,,N,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
7590,6597,A,,Intermediate,CHEMBL618869,,,50597,,1,,N,Half-life for oxidative metabolic stability was determined using male human,Rattus norvegicus,,,1,,BAO_0000218
7591,17670,A,,Intermediate,CHEMBL618870,In vivo,,50597,,1,,N,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,1,,BAO_0000218
7592,1696,A,,Intermediate,CHEMBL618871,,1969.0,50597,,1,,N,Half-life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
7593,1742,A,,Intermediate,CHEMBL618872,,1969.0,50597,,1,,N,Half-life in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
7594,17800,A,,Intermediate,CHEMBL873816,,,50597,,1,,N,Half-life in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
7595,12923,A,,Autocuration,CHEMBL618873,,,22224,,1,,U,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,,0,,BAO_0000218
7596,11954,A,,Autocuration,CHEMBL621602,,,22224,,1,,U,Area under curve after oral dose of 0.1 mg//kg,,,,0,,BAO_0000019
7597,11954,A,,Autocuration,CHEMBL621603,,,22224,,1,,U,Area under curve after oral dose of 0.3 mg/kg,,,,0,,BAO_0000218
7598,11954,A,,Autocuration,CHEMBL621604,,,22224,,1,,U,Area under curve after oral dose of 1 mg/kg,,,,0,,BAO_0000218
7599,11954,A,,Autocuration,CHEMBL621605,,,22224,,1,,U,Area under curve after oral dose of 10 mg/kg,,,,0,,BAO_0000218
7600,11954,A,,Autocuration,CHEMBL621606,,,22224,,1,,U,Area under curve after oral dose of 23.4 mg/kg,,,,0,,BAO_0000218
7601,11954,A,,Autocuration,CHEMBL621607,,,22224,,1,,U,Area under curve after oral dose of 3 mg/kg,,,,0,,BAO_0000218
7602,11954,A,,Autocuration,CHEMBL621608,,,22224,,1,,U,Area under curve after oral dose of 3.87 mg/kg,,,,0,,BAO_0000218
7603,5237,A,,Autocuration,CHEMBL621609,,,22224,,1,,U,Area under curve was determined,,,,0,,BAO_0000019
7604,4026,A,,Autocuration,CHEMBL621610,,,22224,,1,,U,Area under curve at a dose of 10 mg/kg,,,,0,,BAO_0000218
7605,5237,A,,Intermediate,CHEMBL621611,,,50597,,1,,N,Area under curve was determined; ND=No data,Rattus norvegicus,,,1,,BAO_0000218
7606,14793,A,,Intermediate,CHEMBL621612,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,1,,BAO_0000218
7607,14793,A,,Intermediate,CHEMBL622308,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,1,,BAO_0000218
7608,14793,A,,Intermediate,CHEMBL622309,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,1,,BAO_0000218
7609,14793,A,,Intermediate,CHEMBL622310,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,,1,,BAO_0000218
7610,14793,A,,Intermediate,CHEMBL622311,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,,,1,,BAO_0000218
7611,14793,A,,Intermediate,CHEMBL622312,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Rattus norvegicus,,,1,,BAO_0000218
7612,14793,A,,Intermediate,CHEMBL622931,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,,1,,BAO_0000218
7613,14793,A,,Intermediate,CHEMBL622932,,,50597,,1,,N,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Rattus norvegicus,,,1,,BAO_0000218
7614,14793,A,,Intermediate,CHEMBL622736,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7615,14793,A,,Intermediate,CHEMBL622737,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7616,14793,A,,Intermediate,CHEMBL622738,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7617,14793,A,,Intermediate,CHEMBL622739,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7618,14793,A,,Intermediate,CHEMBL622740,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7619,14793,A,,Intermediate,CHEMBL622741,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7620,14793,A,,Intermediate,CHEMBL622742,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7621,14793,A,,Intermediate,CHEMBL622743,,1969.0,50597,,1,,N,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
7622,11637,A,,Intermediate,CHEMBL622744,,1969.0,50594,,1,,N,AUC in mice,Mus musculus,,Plasma,1,,BAO_0000218
7623,11149,A,,Autocuration,CHEMBL624134,,,22224,,1,,U,Area under curve was measured from the graph obtained from concentration Vs time,,,,0,,BAO_0000019
7624,10016,A,,Autocuration,CHEMBL624135,,,22224,,1,,U,Area under curve value of compound per hour after oral administration,,,,0,,BAO_0000019
7625,17796,A,,Intermediate,CHEMBL624136,,,50597,,1,,N,Area under curve was determined after oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
7626,17796,A,,Intermediate,CHEMBL624137,,,50597,,1,,N,Area under curve was determined after oral administration in rats; No data,Rattus norvegicus,,,1,,BAO_0000218
7627,17796,A,,Intermediate,CHEMBL624320,,,50597,,1,,N,Area under curve was determined after oral administration in rats;No data,Rattus norvegicus,,,1,,BAO_0000218
7628,12923,A,,Intermediate,CHEMBL624321,,,50588,,1,,N,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,,,1,,BAO_0000218
7629,15372,A,,Intermediate,CHEMBL624322,,,50597,,1,,N,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7630,15372,A,,Intermediate,CHEMBL624323,,,50597,,1,,N,Area under curve was determined for the compound after iv dose of 5.06 in rats,Rattus norvegicus,,,1,,BAO_0000218
7631,15372,A,,Intermediate,CHEMBL624324,,,50597,,1,,N,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7632,15372,A,,Intermediate,CHEMBL624325,,,50597,,1,,N,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7633,15372,A,,Intermediate,CHEMBL624326,,,50597,,1,,N,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7634,15372,A,,Intermediate,CHEMBL624327,,,50597,,1,,N,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7635,15372,A,,Intermediate,CHEMBL624328,,,50597,,1,,N,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
7636,14169,A,,Intermediate,CHEMBL627848,,,50588,,1,,N,Area under curve was determined in Dogs after peroral administration,Canis lupus familiaris,,,1,,BAO_0000218
7637,14169,A,,Intermediate,CHEMBL627849,,,50597,,1,,N,Area under curve was determined in Rats after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
7638,14258,A,,Intermediate,CHEMBL627850,,,50597,,1,,N,Area under curve was determined in carotid blood of rat when administered intradermally,Rattus norvegicus,,,1,,BAO_0000218
7639,14258,A,,Intermediate,CHEMBL627851,,,50597,,1,,N,Area under curve was determined in portal blood of rat when administered intradermally,Rattus norvegicus,,,1,,BAO_0000218
7640,15011,A,,Intermediate,CHEMBL627852,,,50594,,1,,N,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
7641,15011,A,,Intermediate,CHEMBL627853,,,50594,,1,,N,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
7642,15011,A,,Intermediate,CHEMBL627854,,,50594,,1,,N,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,1,,BAO_0000218
7643,15011,A,,Intermediate,CHEMBL627855,,,50594,,1,,N,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
7644,15011,A,,Intermediate,CHEMBL627856,,,50594,,1,,N,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,,,1,,BAO_0000218
7645,15011,A,,Intermediate,CHEMBL875339,,,50594,,1,,N,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
7646,15011,A,,Intermediate,CHEMBL627857,,,50594,,1,,N,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Mus musculus,,,1,,BAO_0000218
7647,11195,A,,Intermediate,CHEMBL627858,In vivo,2106.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Rattus norvegicus,,Spleen,1,,BAO_0000218
7648,10130,A,,Intermediate,CHEMBL627859,,178.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,Blood,1,,BAO_0000218
7649,10130,A,,Intermediate,CHEMBL627860,,955.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,Brain,1,,BAO_0000218
7650,10130,A,,Intermediate,CHEMBL627019,,948.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,Heart,1,,BAO_0000218
7651,10130,A,,Intermediate,CHEMBL627020,,2107.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,Liver,1,,BAO_0000218
7652,10130,A,,Intermediate,CHEMBL627021,,2048.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,Lung,1,,BAO_0000218
7653,10130,A,,Intermediate,CHEMBL627022,,2385.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7654,10130,A,,Intermediate,CHEMBL627023,,,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,1,,BAO_0000218
7655,10130,A,,Intermediate,CHEMBL627024,,2106.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,Spleen,1,,BAO_0000218
7656,10130,A,,Intermediate,CHEMBL627025,,2046.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
7657,10130,A,,Intermediate,CHEMBL627026,,2113.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
7658,10130,A,,Intermediate,CHEMBL627027,,178.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,Blood,1,,BAO_0000218
7659,10130,A,,Intermediate,CHEMBL627028,,955.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,Brain,1,,BAO_0000218
7660,10130,A,,Intermediate,CHEMBL627029,,948.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,Heart,1,,BAO_0000218
7661,10130,A,,Intermediate,CHEMBL627030,,2113.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
7662,10130,A,,Intermediate,CHEMBL627031,,2107.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,Liver,1,,BAO_0000218
7663,10130,A,,Intermediate,CHEMBL627032,,2048.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,Lung,1,,BAO_0000218
7664,10130,A,,Intermediate,CHEMBL627033,,2385.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7665,10130,A,,Intermediate,CHEMBL627034,,,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,1,,BAO_0000218
7666,10130,A,,Intermediate,CHEMBL627035,,2106.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,Spleen,1,,BAO_0000218
7667,10130,A,,Intermediate,CHEMBL627036,,2046.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
7668,10130,A,,Intermediate,CHEMBL875340,,178.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,,Blood,1,,BAO_0000218
7669,10130,A,,Intermediate,CHEMBL627037,,948.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,,Heart,1,,BAO_0000218
7670,10130,A,,Intermediate,CHEMBL627038,,2113.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
7671,10130,A,,Intermediate,CHEMBL627039,,2107.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,,Liver,1,,BAO_0000218
7672,10130,A,,Intermediate,CHEMBL627040,,2385.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7673,10130,A,,Intermediate,CHEMBL624663,,2106.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,,Spleen,1,,BAO_0000218
7674,10130,A,,Intermediate,CHEMBL625963,,2046.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
7675,10130,A,,Intermediate,CHEMBL876799,,955.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,,Brain,1,,BAO_0000218
7676,10130,A,,Intermediate,CHEMBL626133,,2048.0,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,,Lung,1,,BAO_0000218
7677,10130,A,,Intermediate,CHEMBL626134,,,50597,,1,,N,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,,,1,,BAO_0000218
7678,6295,A,,Intermediate,CHEMBL626135,,,50597,,1,,N,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7679,6296,A,,Intermediate,CHEMBL626136,,,50597,,1,,N,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7680,6296,A,,Intermediate,CHEMBL626137,,,50597,,1,,N,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Rattus norvegicus,,,1,,BAO_0000218
7681,6295,A,,Intermediate,CHEMBL626138,,,50597,,1,,N,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7682,6296,A,,Intermediate,CHEMBL626139,,,50597,,1,,N,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7683,17260,A,,Intermediate,CHEMBL626140,In vivo,,50597,,1,,N,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7684,17260,A,,Intermediate,CHEMBL626141,In vivo,,50597,,1,,N,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7685,17686,A,,Intermediate,CHEMBL626142,,,50597,,1,,N,C24h in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
7686,9866,A,,Intermediate,CHEMBL627930,In vivo,2385.0,50597,,1,,N,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7687,9866,A,,Intermediate,CHEMBL627931,In vivo,2385.0,50597,,1,,N,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7688,9866,A,,Intermediate,CHEMBL627932,In vivo,2385.0,50597,,1,,N,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
7689,9866,A,,Intermediate,CHEMBL627933,In vivo,2106.0,50597,,1,,N,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,,Spleen,1,,BAO_0000218
7690,9866,A,,Intermediate,CHEMBL627934,In vivo,2106.0,50597,,1,,N,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,,Spleen,1,,BAO_0000218
7691,9866,A,,Intermediate,CHEMBL627935,In vivo,2106.0,50597,,1,,N,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,,Spleen,1,,BAO_0000218
7692,9866,A,,Intermediate,CHEMBL627936,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,,Blood,1,,BAO_0000218
7693,9866,A,,Intermediate,CHEMBL627937,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Blood,1,,BAO_0000218
7694,9866,A,,Intermediate,CHEMBL627938,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,Blood,1,,BAO_0000218
7695,9866,A,,Intermediate,CHEMBL627939,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Blood,1,,BAO_0000218
7696,9866,A,,Intermediate,CHEMBL627940,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,Blood,1,,BAO_0000218
7697,9866,A,,Intermediate,CHEMBL627941,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,Blood,1,,BAO_0000218
7698,9866,A,,Intermediate,CHEMBL876800,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,Blood,1,,BAO_0000218
7699,9866,A,,Intermediate,CHEMBL627942,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Blood,1,,BAO_0000218
7700,9866,A,,Intermediate,CHEMBL627943,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,Blood,1,,BAO_0000218
7701,9866,A,,Intermediate,CHEMBL627944,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7702,9866,A,,Intermediate,CHEMBL627945,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7703,9866,A,,Intermediate,CHEMBL628584,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7704,9866,A,,Intermediate,CHEMBL628585,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7705,9866,A,,Intermediate,CHEMBL628586,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7706,9866,A,,Intermediate,CHEMBL628587,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7707,9866,A,,Intermediate,CHEMBL628588,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7708,9866,A,,Intermediate,CHEMBL628589,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7709,9866,A,,Intermediate,CHEMBL625304,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7710,9866,A,,Intermediate,CHEMBL625305,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7711,9866,A,,Intermediate,CHEMBL625306,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7712,9866,A,,Intermediate,CHEMBL625307,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7713,9866,A,,Intermediate,CHEMBL625308,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,Blood,1,,BAO_0000218
7714,9866,A,,Intermediate,CHEMBL627740,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7715,9866,A,,Intermediate,CHEMBL627741,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Rattus norvegicus,,Blood,1,,BAO_0000218
7716,9866,A,,Intermediate,CHEMBL627742,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,Blood,1,,BAO_0000218
7717,9866,A,,Intermediate,CHEMBL627743,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Blood,1,,BAO_0000218
7718,9866,A,,Intermediate,CHEMBL627744,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Blood,1,,BAO_0000218
7719,9866,A,,Intermediate,CHEMBL627745,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Bone,1,,BAO_0000218
7720,9866,A,,Intermediate,CHEMBL627746,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,Bone,1,,BAO_0000218
7721,9866,A,,Intermediate,CHEMBL627747,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,Bone,1,,BAO_0000218
7722,9866,A,,Intermediate,CHEMBL876810,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Bone,1,,BAO_0000218
7723,9866,A,,Intermediate,CHEMBL627748,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,Bone,1,,BAO_0000218
7724,9866,A,,Intermediate,CHEMBL627749,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,Bone,1,,BAO_0000218
7725,9866,A,,Intermediate,CHEMBL627750,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,Bone,1,,BAO_0000218
7726,9866,A,,Intermediate,CHEMBL618728,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Bone,1,,BAO_0000218
7727,9866,A,,Intermediate,CHEMBL618729,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,Bone,1,,BAO_0000218
7728,9866,A,,Intermediate,CHEMBL618730,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7729,9866,A,,Intermediate,CHEMBL618731,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7730,9866,A,,Intermediate,CHEMBL618732,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7731,9866,A,,Intermediate,CHEMBL618733,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7732,9866,A,,Intermediate,CHEMBL618734,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7733,9866,A,,Intermediate,CHEMBL618735,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7734,9866,A,,Intermediate,CHEMBL876602,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7735,9866,A,,Intermediate,CHEMBL618736,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7736,9866,A,,Intermediate,CHEMBL618737,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7737,9866,A,,Intermediate,CHEMBL618738,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7738,9866,A,,Intermediate,CHEMBL618739,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,Bone,1,,BAO_0000218
7739,9866,A,,Intermediate,CHEMBL618740,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,Bone,1,,BAO_0000218
7740,9866,A,,Intermediate,CHEMBL618741,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,Bone,1,,BAO_0000218
7741,9866,A,,Intermediate,CHEMBL618742,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Bone,1,,BAO_0000218
7742,9866,A,,Intermediate,CHEMBL618743,In vivo,10000001.0,50597,,1,,N,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Bone,1,,BAO_0000218
7743,17752,A,,Intermediate,CHEMBL618744,In vivo,1969.0,50597,,1,,N,Half-life from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
7744,5610,A,,Intermediate,CHEMBL618745,,,50597,,1,,N,Half-life in male rat,Rattus norvegicus,,,1,,BAO_0000218
7745,5939,A,,Intermediate,CHEMBL620479,In vivo,,50597,,1,,N,Half-life in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
7746,5939,A,,Intermediate,CHEMBL620480,In vivo,,50597,,1,,N,Half-life in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
7747,17771,A,,Intermediate,CHEMBL620481,In vivo,,50597,,1,,N,Half-life in rat at a dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7748,1974,A,,Intermediate,CHEMBL620482,,,50597,,1,,N,Half-life was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
7749,4239,A,,Intermediate,CHEMBL876603,,,50597,,1,,N,Half-life was measured in rat,Rattus norvegicus,,,1,,BAO_0000218
7750,6681,A,,Intermediate,CHEMBL620483,In vivo,,50597,,1,,N,Half-life period for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
7751,17752,A,,Intermediate,CHEMBL620484,In vivo,,50597,,1,,N,Half-life period in rats after intravenous administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7752,6046,A,,Intermediate,CHEMBL620485,In vivo,,50597,,1,,N,Half-life period in rat at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7753,6685,A,,Intermediate,CHEMBL620486,In vivo,,50597,,1,,N,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
7754,6685,A,,Intermediate,CHEMBL620487,In vivo,,50597,,1,,N,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,,1,,BAO_0000218
7755,6685,A,,Intermediate,CHEMBL620488,In vivo,,50597,,1,,N,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,1,,BAO_0000218
7756,4727,A,,Intermediate,CHEMBL620489,In vivo,,50597,,1,,N,Half-life time in rat the dose of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7757,1088,A,,Intermediate,CHEMBL620490,In vivo,,50597,,1,,N,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Rattus norvegicus,,,1,,BAO_0000218
7758,5610,A,,Intermediate,CHEMBL620491,In vivo,,50597,,1,,N,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7759,3032,A,,Intermediate,CHEMBL876604,In vivo,1969.0,50597,,1,,N,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,Plasma,1,,BAO_0000218
7760,5199,A,,Intermediate,CHEMBL620492,In vivo,,50597,,1,,N,Oral half life was determined,Rattus norvegicus,,,1,,BAO_0000218
7761,14941,A,,Intermediate,CHEMBL620493,In vivo,,50597,,1,,N,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,1,,BAO_0000218
7762,4408,A,,Intermediate,CHEMBL620494,In vivo,,50597,,1,,N,Pharmacokinetic property (t1/2) in rat,Rattus norvegicus,,,1,,BAO_0000218
7763,2552,A,,Intermediate,CHEMBL620495,,1969.0,50597,,1,,N,Plasma elimination half-life was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
7764,5199,A,,Intermediate,CHEMBL620496,In vivo,1969.0,50597,,1,,N,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,Plasma,1,,BAO_0000218
7765,15662,A,,Intermediate,CHEMBL620497,In vivo,1969.0,50597,,1,,N,Plasma half life was observed after intravenous administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7766,1465,A,,Intermediate,CHEMBL620498,,1969.0,50597,,1,,N,Plasma half-life was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
7767,1446,A,,Intermediate,CHEMBL620499,In vivo,1969.0,50597,,1,,N,Plasma half-life following oral administration in Fisher rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
7768,6824,A,,Intermediate,CHEMBL620500,,1969.0,50597,,1,,N,Plasma half-life in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7769,17533,A,,Intermediate,CHEMBL873809,In vivo,1969.0,50597,,1,,N,Plasmatic Half-life after intravenous administration to rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7770,5979,A,,Intermediate,CHEMBL620501,In vivo,,50597,,1,,N,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,1,,BAO_0000218
7771,4689,A,,Intermediate,CHEMBL620502,In vivo,,50597,,1,,N,Terminal half life after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
7772,4689,A,,Intermediate,CHEMBL620503,In vivo,,50597,,1,,N,Terminal half life in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7773,2463,A,,Intermediate,CHEMBL620504,In vivo,,50597,,1,,N,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,,,1,,BAO_0000218
7774,4883,A,,Intermediate,CHEMBL876605,In vivo,,50597,,1,,N,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7775,4883,A,,Intermediate,CHEMBL620505,In vivo,,50597,,1,,N,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7776,15662,A,,Intermediate,CHEMBL873811,In vivo,1969.0,50597,,1,,N,plasma half life was observed after intravenous administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7777,3598,A,,Expert,CHEMBL624016,In vivo,,50597,,1,,N,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7778,4576,A,,Intermediate,CHEMBL624017,,,50597,,1,,N,Half life of compound determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7779,4576,A,,Intermediate,CHEMBL624018,,,50597,,1,,N,Mean residence time determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7780,4576,A,,Intermediate,CHEMBL624019,,,50597,,1,,N,Plasma half life determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7781,4910,A,,Intermediate,CHEMBL624020,In vivo,955.0,50597,,1,,N,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Rattus norvegicus,,Brain,1,,BAO_0000218
7782,4891,A,,Intermediate,CHEMBL624201,In vivo,,50597,,1,,N,Compound was evaluated for pharmacokinetic parameter maximum time period,Rattus norvegicus,,,1,,BAO_0000218
7783,429,A,,Intermediate,CHEMBL872528,In vivo,,50597,,1,,N,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7784,5974,A,,Intermediate,CHEMBL624202,In vivo,,50597,,1,,N,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7785,5974,A,,Intermediate,CHEMBL624203,In vivo,,50597,,1,,N,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7786,5974,A,,Intermediate,CHEMBL624350,In vivo,,50597,,1,,N,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7787,5974,A,,Intermediate,CHEMBL621320,In vivo,,50597,,1,,N,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7788,17582,A,,Intermediate,CHEMBL621321,In vivo,,50597,,1,,N,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
7789,4026,A,,Intermediate,CHEMBL621322,,,50597,,1,,N,Maximum time (Tmax) required to reach Cmax in rats,Rattus norvegicus,,,1,,BAO_0000218
7790,4890,A,,Intermediate,CHEMBL621323,In vivo,,50597,,1,,N,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7791,6571,A,,Intermediate,CHEMBL621324,In vivo,,50597,,1,,N,Maximum time of clearance of compound in rats after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
7792,4727,A,,Intermediate,CHEMBL621325,,,50597,,1,,N,Maximum time at the dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7793,17651,A,,Intermediate,CHEMBL875837,In vivo,1969.0,50597,,1,,N,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
7794,17651,A,,Intermediate,CHEMBL621326,In vivo,1969.0,50597,,1,,N,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
7795,14465,A,,Intermediate,CHEMBL621327,In vivo,,50597,,1,,N,Tmax in Guinea pig (PO dose),Rattus norvegicus,,,1,,BAO_0000218
7796,14941,A,,Intermediate,CHEMBL621328,In vivo,,50597,,1,,N,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,1,,BAO_0000218
7797,5960,A,,Intermediate,CHEMBL621329,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Tmax) in rat,Rattus norvegicus,,,1,,BAO_0000218
7798,5022,A,,Intermediate,CHEMBL621330,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Tmax) was estimated,Rattus norvegicus,,,1,,BAO_0000218
7799,4408,A,,Intermediate,CHEMBL621331,In vivo,,50597,,1,,N,Pharmacokinetic property (Tmax) in rat,Rattus norvegicus,,,1,,BAO_0000218
7800,5983,A,,Intermediate,CHEMBL621332,In vivo,,50597,,1,,N,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,1,,BAO_0000218
7801,4689,A,,Intermediate,CHEMBL621333,In vivo,,50597,,1,,N,T max in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7802,2792,A,,Intermediate,CHEMBL621334,In vivo,,50597,,1,,N,T max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
7803,15011,A,,Intermediate,CHEMBL621335,,,50594,,1,,N,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,,,1,,BAO_0000218
7804,14180,A,,Intermediate,CHEMBL621336,,,50588,,1,,N,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Canis lupus familiaris,,,1,,BAO_0000218
7805,14180,A,,Intermediate,CHEMBL621337,,,50597,,1,,N,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Rattus norvegicus,,,1,,BAO_0000218
7806,14599,A,,Intermediate,CHEMBL621338,,,50588,,1,,N,Area under curve was measured after i.v. administration into Beagle dog.,Canis lupus familiaris,,,1,,BAO_0000218
7807,14599,A,,Intermediate,CHEMBL875838,,,50588,,1,,N,Area under curve was measured after iv administration into Beagle dog,Canis lupus familiaris,,,1,,BAO_0000218
7808,14599,A,,Intermediate,CHEMBL621339,,,50588,,1,,N,Area under curve was measured after po administration into Beagle dog,Canis lupus familiaris,,,1,,BAO_0000218
7809,14599,A,,Intermediate,CHEMBL621340,,,50588,,1,,N,Area under curve was measured after po administration into Beagle dog.,Canis lupus familiaris,,,1,,BAO_0000218
7810,15675,A,,Autocuration,CHEMBL621341,,,22224,,1,,U,Area under curve was measured at peroral dose of 3 mg/kg,,,,0,,BAO_0000218
7811,12706,A,,Autocuration,CHEMBL621342,,,22224,,1,,U,Area under curve was measured by using concentration Vs time,,,,0,,BAO_0000019
7812,12706,A,,Autocuration,CHEMBL621343,,,22224,,1,,U,Area under curve was measured by using concentration Vs time; not tested,,,,0,,BAO_0000019
7813,9750,A,,Intermediate,CHEMBL621344,,,50594,,1,,N,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Mus musculus,,,1,,BAO_0000218
7814,9750,A,,Intermediate,CHEMBL621345,,,50594,,1,,N,Area under curve(AUC) was measured in mice after oral administration.,Mus musculus,,,1,,BAO_0000218
7815,14691,A,,Autocuration,CHEMBL621346,,,22224,,1,,U,Area under curve(AUC) value of the compound,,,,0,,BAO_0000019
7816,14691,A,,Autocuration,CHEMBL621347,,,22224,,1,,U,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,,0,,BAO_0000218
7817,14691,A,,Intermediate,CHEMBL621348,,,50588,,1,,N,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,,,1,,BAO_0000218
7818,2939,A,,Autocuration,CHEMBL621349,,178.0,22224,,1,,U,Area under curve(carotid artery) was determined by the availability in blood,,,Blood,0,,BAO_0000019
7819,2939,A,,Autocuration,CHEMBL621350,,178.0,22224,,1,,U,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,Blood,0,,BAO_0000019
7820,2939,A,,Autocuration,CHEMBL875839,,178.0,22224,,1,,U,Area under curve(carotid artery) was determined by the availability in blood; No data,,,Blood,0,,BAO_0000019
7821,2939,A,,Autocuration,CHEMBL620211,,178.0,22224,,1,,U,Area under curve(portal vein) was determined by the availability in blood,,,Blood,0,,BAO_0000019
7822,2939,A,,Autocuration,CHEMBL620212,,178.0,22224,,1,,U,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,Blood,0,,BAO_0000019
7823,2939,A,,Autocuration,CHEMBL620213,,178.0,22224,,1,,U,Area under curve(portal vein) was determined by the availability in blood; No data,,,Blood,0,,BAO_0000019
7824,9552,A,,Intermediate,CHEMBL620214,,1969.0,50797,,1,,N,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,,Plasma,1,,BAO_0000218
7825,9552,A,,Intermediate,CHEMBL620215,,1969.0,50797,,1,,N,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,,Plasma,1,,BAO_0000218
7826,9552,A,,Intermediate,CHEMBL620216,,1969.0,50797,,1,,N,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Macaca mulatta,,Plasma,1,,BAO_0000218
7827,9552,A,,Intermediate,CHEMBL620888,,1969.0,50588,,1,,N,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Canis lupus familiaris,,Plasma,1,,BAO_0000218
7828,9552,A,,Intermediate,CHEMBL620889,,1969.0,50588,,1,,N,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Canis lupus familiaris,,Plasma,1,,BAO_0000218
7829,9552,A,,Autocuration,CHEMBL620890,,1969.0,22224,,1,,U,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,Plasma,0,,BAO_0000019
7830,11911,A,,Intermediate,CHEMBL620891,,1969.0,50597,,1,,N,Area under plasma time curve determined in male rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7831,16618,A,,Autocuration,CHEMBL620892,,,22224,,1,,U,Area under the MAP curve measured over 5 min.,,,,0,,BAO_0000019
7832,14387,A,,Intermediate,CHEMBL621079,,,50594,,1,,N,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Mus musculus,,,1,,BAO_0000218
7833,14387,A,,Intermediate,CHEMBL621080,,,50594,,1,,N,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Mus musculus,,,1,,BAO_0000218
7834,12836,A,,Intermediate,CHEMBL621081,,,50588,,1,,N,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Canis lupus familiaris,,,1,,BAO_0000218
7835,12836,A,,Intermediate,CHEMBL621082,,,100712,,1,,N,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Cricetinae,,,1,,BAO_0000218
7836,12836,A,,Intermediate,CHEMBL621083,,,50597,,1,,N,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
7837,14339,A,,Intermediate,CHEMBL621084,,,50588,,1,,N,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Canis lupus familiaris,,,1,,BAO_0000218
7838,14339,A,,Intermediate,CHEMBL621085,,,50588,,1,,N,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,,,1,,BAO_0000218
7839,14339,A,,Intermediate,CHEMBL621086,,,50588,,1,,N,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Canis lupus familiaris,,,1,,BAO_0000218
7840,10524,A,,Intermediate,CHEMBL621087,,,50588,,1,,N,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Canis lupus familiaris,,,1,,BAO_0000218
7841,9994,A,,Intermediate,CHEMBL622607,,,50588,,1,,N,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,,,1,,BAO_0000218
7842,11325,A,,Intermediate,CHEMBL622608,,,50588,,1,,N,Serum AUC in marmosets (IV dose),Canis lupus familiaris,,,1,,BAO_0000218
7843,12536,A,,Autocuration,CHEMBL624481,,,22224,,1,,U,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,,0,,BAO_0000019
7844,12536,A,,Autocuration,CHEMBL624482,,,22224,,1,,U,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,,0,,BAO_0000019
7845,12536,A,,Autocuration,CHEMBL624483,,,22224,,1,,U,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,,0,,BAO_0000019
7846,12536,A,,Autocuration,CHEMBL624484,,,22224,,1,,U,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,,0,,BAO_0000019
7847,12536,A,,Autocuration,CHEMBL624485,,,22224,,1,,U,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,,0,,BAO_0000019
7848,15556,A,,Intermediate,CHEMBL624486,,,50597,,1,,N,Area under the curve for fumarate salt was evaluated in F344 Rats.,Rattus norvegicus,,,1,,BAO_0000218
7849,2809,A,,Autocuration,CHEMBL624487,,,22224,,1,,U,Area under the curve for the compound was calculated.,,,,0,,BAO_0000019
7850,9511,A,,Autocuration,CHEMBL624488,,,22224,,1,,U,Area under the curve in concentration/ time,,,,0,,BAO_0000019
7851,12818,A,,Intermediate,CHEMBL624489,,,50597,,1,,N,Area under the curve administered intraintestinal in rats.,Rattus norvegicus,,,1,,BAO_0000218
7852,12818,A,,Intermediate,CHEMBL625184,,,50597,,1,,N,Area under the curve administered intravenously in rats.,Rattus norvegicus,,,1,,BAO_0000218
7853,15118,A,,Autocuration,CHEMBL625185,,,22224,,1,,U,Area under the curve during intravenous administration,,,,0,,BAO_0000019
7854,15118,A,,Autocuration,CHEMBL875954,,,22224,,1,,U,Area under the curve during intravenous administration; Not determined,,,,0,,BAO_0000019
7855,15118,A,,Autocuration,CHEMBL625186,,,22224,,1,,U,Area under the curve during systemic administration,,,,0,,BAO_0000019
7856,15118,A,,Autocuration,CHEMBL625187,,,22224,,1,,U,Area under the curve during systemic administration; Not determined,,,,0,,BAO_0000019
7857,2632,A,,Autocuration,CHEMBL625188,,,22224,,1,,U,Area under the curve was calculated for the compound.,,,,0,,BAO_0000019
7858,14346,A,,Intermediate,CHEMBL625189,,,50588,,1,,N,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
7859,14346,A,,Intermediate,CHEMBL625190,,,50588,,1,,N,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
7860,14346,A,,Intermediate,CHEMBL621733,,,50597,,1,,N,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7861,14346,A,,Intermediate,CHEMBL621734,,,50597,,1,,N,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7862,11149,A,,Intermediate,CHEMBL621735,,,50597,,1,,N,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,,1,,BAO_0000218
7863,17796,A,,Intermediate,CHEMBL621736,,1969.0,50597,,1,,N,Clearance of the drug was measured in the plasma of rat; No data,Rattus norvegicus,,Plasma,1,,BAO_0000218
7864,5247,A,,Intermediate,CHEMBL621737,,1969.0,50597,,1,,N,The pharmacokinetic parameter plasma clearance in vivo in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
7865,4727,A,,Intermediate,CHEMBL621738,,,50597,,1,,N,Plasma clearance at the dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7866,5654,A,,Intermediate,CHEMBL622806,In vivo,,50597,,1,,N,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
7867,5654,A,,Intermediate,CHEMBL623519,In vivo,,50597,,1,,N,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
7868,17260,A,,Intermediate,CHEMBL623520,In vivo,,50597,,1,,N,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
7869,17065,A,,Intermediate,CHEMBL623521,In vivo,,50597,,1,,N,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,1,,BAO_0000218
7870,17671,A,,Intermediate,CHEMBL623522,In vivo,,50597,,1,,N,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7871,6672,A,,Intermediate,CHEMBL623523,In vivo,,50597,,1,,N,Clearance rate in rat,Rattus norvegicus,,,1,,BAO_0000218
7872,6673,A,,Intermediate,CHEMBL623690,In vivo,,50597,,1,,N,Clearance rate in rat,Rattus norvegicus,,,1,,BAO_0000218
7873,5978,A,,Intermediate,CHEMBL623691,In vivo,,50597,,1,,N,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7874,5978,A,,Intermediate,CHEMBL623692,In vivo,,50597,,1,,N,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7875,5978,A,,Intermediate,CHEMBL623693,In vivo,,50597,,1,,N,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7876,5978,A,,Intermediate,CHEMBL623694,In vivo,,50597,,1,,N,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
7877,4413,A,,Intermediate,CHEMBL623695,In vivo,,50597,,1,,N,Clearance of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
7878,2661,A,,Intermediate,CHEMBL623696,In vivo,,50597,,1,,N,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
7879,2661,A,,Intermediate,CHEMBL623697,In vivo,,50597,,1,,N,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
7880,5005,A,,Intermediate,CHEMBL623698,In vivo,1969.0,22224,,1,,U,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,,Plasma,0,,BAO_0000218
7881,5005,A,,Intermediate,CHEMBL623699,In vivo,1969.0,22224,,1,,U,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Rattus norvegicus,,Plasma,0,,BAO_0000218
7882,15765,A,,Intermediate,CHEMBL623700,In vivo,,50597,,1,,N,Mean (%CV) PK parameters for CL(mL/min/kg).,Rattus norvegicus,,,1,,BAO_0000218
7883,3747,A,,Intermediate,CHEMBL623701,In vivo,,50597,,1,,N,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Rattus norvegicus,,,1,,BAO_0000218
7884,16366,A,,Intermediate,CHEMBL623702,In vivo,1969.0,50597,,1,,N,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Rattus norvegicus,,Plasma,1,,BAO_0000218
7885,4199,A,,Intermediate,CHEMBL623703,In vivo,,50597,,1,,N,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Rattus norvegicus,,,1,,BAO_0000218
7886,17267,A,,Intermediate,CHEMBL623704,In vivo,,50597,,1,,N,Plasma clearance in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
7887,6535,A,,Intermediate,CHEMBL623705,In vivo,,50597,,1,,N,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
7888,6535,A,,Intermediate,CHEMBL623706,In vivo,,50597,,1,,N,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
7889,5041,A,,Intermediate,CHEMBL623707,In vivo,,50597,,1,,N,Plasma clearance was determined,Rattus norvegicus,,,1,,BAO_0000218
7890,5960,A,,Intermediate,CHEMBL623708,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
7891,5937,A,,Intermediate,CHEMBL623709,In vivo,,50597,,1,,N,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7892,5871,A,,Intermediate,CHEMBL623710,In vivo,,50597,,1,,N,Plasma clearance in rat by iv administration,Rattus norvegicus,,,1,,BAO_0000218
7893,5874,A,,Intermediate,CHEMBL623711,In vivo,,50597,,1,,N,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7894,6504,A,,Intermediate,CHEMBL623712,In vivo,,50597,,1,,N,Plasma clearance in rat p.o.,Rattus norvegicus,,,1,,BAO_0000218
7895,6803,A,,Intermediate,CHEMBL623713,In vivo,,50597,,1,,N,Plasma clearance in rats,Rattus norvegicus,,,1,,BAO_0000218
7896,5041,A,,Intermediate,CHEMBL623714,In vivo,,50597,,1,,N,Plasma clearance was determined; ND denotes no data,Rattus norvegicus,,,1,,BAO_0000218
7897,5041,A,,Intermediate,CHEMBL623715,In vivo,,50597,,1,,N,Plasma clearance was determined; ND denotes not determined,Rattus norvegicus,,,1,,BAO_0000218
7898,1916,A,,Intermediate,CHEMBL623716,In vivo,,50597,,1,,N,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,1,,BAO_0000218
7899,5199,A,,Intermediate,CHEMBL622980,In vivo,,50597,,1,,N,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,,1,,BAO_0000218
7900,16367,A,,Intermediate,CHEMBL622981,In vivo,,50597,,1,,N,Plasma administration to rats,Rattus norvegicus,,,1,,BAO_0000218
7901,6362,A,,Intermediate,CHEMBL622982,In vivo,,50597,,1,,N,Plasma clearance of the compound in female Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
7902,15662,A,,Intermediate,CHEMBL622983,In vivo,,50597,,1,,N,Plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
7903,6215,A,,Intermediate,CHEMBL622984,In vivo,,50597,,1,,N,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7904,1466,A,,Intermediate,CHEMBL622985,In vivo,,50597,,1,,N,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
7905,15662,A,,Intermediate,CHEMBL623631,In vivo,1969.0,50597,,1,,N,plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7906,4723,A,,Intermediate,CHEMBL623632,In vivo,,50597,,1,,N,In vivo CL/F determined,Rattus norvegicus,,,1,,BAO_0000218
7907,2792,A,,Intermediate,CHEMBL623633,In vivo,1969.0,50597,,1,,N,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
7908,2792,A,,Intermediate,CHEMBL623634,In vivo,1969.0,50597,,1,,N,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
7909,5213,A,,Intermediate,CHEMBL623635,In vivo,,50597,,1,,N,Compound was tested for the lower blood clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
7910,4687,A,,Intermediate,CHEMBL621195,In vivo,,50597,,1,,N,Evaluated for the low clearance in rat (in vivo),Rattus norvegicus,,,1,,BAO_0000218
7911,3371,A,,Intermediate,CHEMBL621196,In vivo,,50597,,1,,N,Pharmacokinetic property (CLb)of the compound was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
7912,4690,A,,Intermediate,CHEMBL875287,In vivo,,50597,,1,,N,Rapid clearance after intravenous administration in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
7913,5702,A,,Intermediate,CHEMBL621197,In vivo,,50597,,1,,N,Clearance measured in rat,Rattus norvegicus,,,1,,BAO_0000218
7914,740,A,,Intermediate,CHEMBL621198,In vivo,1969.0,50597,,1,,N,Compound was evaluated for plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7915,4853,A,,Intermediate,CHEMBL621199,In vivo,1969.0,50597,,1,,N,Low plasma clearance was calculated in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7916,5789,A,,Intermediate,CHEMBL621200,In vivo,,50597,,1,,N,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,,,1,,BAO_0000218
7917,4527,A,,Intermediate,CHEMBL621201,In vivo,,50597,,1,,N,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
7918,4527,A,,Intermediate,CHEMBL621202,In vivo,,50597,,1,,N,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
7919,6518,A,,Intermediate,CHEMBL621203,In vivo,,50597,,1,,N,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7920,6518,A,,Intermediate,CHEMBL621204,In vivo,,50597,,1,,N,Plasma clearance after IV dosing at 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
7921,9866,A,,Intermediate,CHEMBL621205,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Rattus norvegicus,,Heart,1,,BAO_0000218
7922,9866,A,,Intermediate,CHEMBL621206,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Heart,1,,BAO_0000218
7923,9866,A,,Intermediate,CHEMBL621207,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,Heart,1,,BAO_0000218
7924,9866,A,,Intermediate,CHEMBL621208,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Rattus norvegicus,,Heart,1,,BAO_0000218
7925,9866,A,,Intermediate,CHEMBL621209,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Heart,1,,BAO_0000218
7926,9866,A,,Intermediate,CHEMBL876484,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,Heart,1,,BAO_0000218
7927,9866,A,,Intermediate,CHEMBL621210,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,Heart,1,,BAO_0000218
7928,9866,A,,Intermediate,CHEMBL621211,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Heart,1,,BAO_0000218
7929,9866,A,,Intermediate,CHEMBL621212,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,,Heart,1,,BAO_0000218
7930,9866,A,,Intermediate,CHEMBL621213,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7931,9866,A,,Intermediate,CHEMBL621214,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7932,9866,A,,Intermediate,CHEMBL621215,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7933,9866,A,,Intermediate,CHEMBL621216,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7934,9866,A,,Intermediate,CHEMBL621217,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7935,9866,A,,Intermediate,CHEMBL621218,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7936,9866,A,,Intermediate,CHEMBL621219,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7937,9866,A,,Intermediate,CHEMBL621220,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7938,9866,A,,Intermediate,CHEMBL621221,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7939,9866,A,,Intermediate,CHEMBL621222,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7940,9866,A,,Intermediate,CHEMBL621223,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,Heart,1,,BAO_0000218
7941,9866,A,,Intermediate,CHEMBL876485,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,,Heart,1,,BAO_0000218
7942,9866,A,,Intermediate,CHEMBL621224,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,Heart,1,,BAO_0000218
7943,9866,A,,Intermediate,CHEMBL621225,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Heart,1,,BAO_0000218
7944,9866,A,,Intermediate,CHEMBL621226,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Heart,1,,BAO_0000218
7945,9866,A,,Intermediate,CHEMBL621227,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7946,9866,A,,Intermediate,CHEMBL621228,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7947,9866,A,,Intermediate,CHEMBL621229,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7948,9866,A,,Intermediate,CHEMBL621230,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Kidney,1,,BAO_0000218
7949,9866,A,,Intermediate,CHEMBL621231,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,,Kidney,1,,BAO_0000218
7950,9866,A,,Intermediate,CHEMBL621232,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7951,9866,A,,Intermediate,CHEMBL621233,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7952,9866,A,,Intermediate,CHEMBL621234,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7953,9866,A,,Intermediate,CHEMBL621235,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,,Kidney,1,,BAO_0000218
7954,9866,A,,Intermediate,CHEMBL621236,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,Kidney,1,,BAO_0000218
7955,9866,A,,Intermediate,CHEMBL621237,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Kidney,1,,BAO_0000218
7956,9866,A,,Intermediate,CHEMBL876486,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Kidney,1,,BAO_0000218
7957,9866,A,,Intermediate,CHEMBL622436,In vivo,160.0,50597,,1,,N,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Rattus norvegicus,,Intestine,1,,BAO_0000218
7958,9866,A,,Intermediate,CHEMBL622437,In vivo,160.0,50597,,1,,N,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Intestine,1,,BAO_0000218
7959,9866,A,,Intermediate,CHEMBL622438,In vivo,160.0,50597,,1,,N,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,Intestine,1,,BAO_0000218
7960,9866,A,,Intermediate,CHEMBL622439,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Rattus norvegicus,,Liver,1,,BAO_0000218
7961,9866,A,,Intermediate,CHEMBL622440,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Liver,1,,BAO_0000218
7962,9866,A,,Intermediate,CHEMBL622441,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Liver,1,,BAO_0000218
7963,9866,A,,Intermediate,CHEMBL622442,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,,Liver,1,,BAO_0000218
7964,9866,A,,Intermediate,CHEMBL622443,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Liver,1,,BAO_0000218
7965,9866,A,,Intermediate,CHEMBL622444,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,,Liver,1,,BAO_0000218
7966,9866,A,,Intermediate,CHEMBL622445,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,Liver,1,,BAO_0000218
7967,9866,A,,Intermediate,CHEMBL622446,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,,Liver,1,,BAO_0000218
7968,9866,A,,Intermediate,CHEMBL622447,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,,Liver,1,,BAO_0000218
7969,9866,A,,Intermediate,CHEMBL622448,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Liver,1,,BAO_0000218
7970,9866,A,,Intermediate,CHEMBL622449,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,,Liver,1,,BAO_0000218
7971,9866,A,,Intermediate,CHEMBL622450,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7972,9866,A,,Intermediate,CHEMBL622451,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7973,9866,A,,Intermediate,CHEMBL622452,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Rattus norvegicus,,Liver,1,,BAO_0000218
7974,9866,A,,Intermediate,CHEMBL622453,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7975,9866,A,,Intermediate,CHEMBL622454,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Rattus norvegicus,,Liver,1,,BAO_0000218
7976,9866,A,,Intermediate,CHEMBL622455,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
7977,9866,A,,Intermediate,CHEMBL876024,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,,Liver,1,,BAO_0000218
7978,2792,A,,Intermediate,CHEMBL622456,In vivo,,50597,,1,,N,T max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
7979,15078,A,,Intermediate,CHEMBL622457,In vivo,,50597,,1,,N,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
7980,15078,A,,Intermediate,CHEMBL622458,In vivo,,50597,,1,,N,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
7981,15022,A,,Intermediate,CHEMBL622459,,,50597,,1,,N,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
7982,15022,A,,Intermediate,CHEMBL873343,,,50597,,1,,N,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
7983,15022,A,,Intermediate,CHEMBL622460,,,50597,,1,,N,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
7984,4576,A,,Intermediate,CHEMBL622461,,1969.0,50597,,1,,N,Time for maximum plasma concentration determined in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7985,6681,A,,Intermediate,CHEMBL622462,In vivo,1969.0,50597,,1,,N,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
7986,16365,A,,Intermediate,CHEMBL622463,In vivo,,50597,,1,,N,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
7987,16365,A,,Intermediate,CHEMBL622464,In vivo,,50597,,1,,N,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
7988,16365,A,,Intermediate,CHEMBL622465,In vivo,,50597,,1,,N,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7989,16365,A,,Intermediate,CHEMBL622466,In vivo,,50597,,1,,N,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
7990,16365,A,,Intermediate,CHEMBL622467,In vivo,,50597,,1,,N,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
7991,6824,A,,Intermediate,CHEMBL622468,,1969.0,50597,,1,,N,Time of maximum plasma concentration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
7992,6685,A,,Intermediate,CHEMBL876025,,1969.0,50597,,1,,N,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,Plasma,1,,BAO_0000218
7993,6685,A,,Intermediate,CHEMBL622469,,1969.0,50597,,1,,N,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,Plasma,1,,BAO_0000218
7994,6685,A,,Intermediate,CHEMBL622470,,1969.0,50597,,1,,N,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,Plasma,1,,BAO_0000218
7995,15662,A,,Intermediate,CHEMBL622471,In vivo,,50597,,1,,N,Time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
7996,1742,A,,Intermediate,CHEMBL622472,,1969.0,50597,,1,,N,Time required to reach maximum concentration in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
7997,2774,A,,Intermediate,CHEMBL622473,In vivo,1969.0,50597,,1,,N,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,,Plasma,1,,BAO_0000218
7998,5199,A,,Intermediate,CHEMBL624282,In vivo,1969.0,50597,,1,,N,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
7999,12873,A,,Intermediate,CHEMBL624283,In vivo,1969.0,50597,,1,,N,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8000,12873,A,,Intermediate,CHEMBL624284,In vivo,1969.0,50597,,1,,N,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8001,1916,A,,Intermediate,CHEMBL624285,In vivo,1969.0,50597,,1,,N,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8002,16367,A,,Intermediate,CHEMBL624286,In vivo,,50597,,1,,N,Time to reach Cmax after oral administration to rats,Rattus norvegicus,,,1,,BAO_0000218
8003,16366,A,,Intermediate,CHEMBL624287,In vivo,,50597,,1,,N,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Rattus norvegicus,,,1,,BAO_0000218
8004,216,A,,Intermediate,CHEMBL624288,,,50597,,1,,N,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Rattus norvegicus,,,1,,BAO_0000218
8005,6410,A,,Intermediate,CHEMBL624289,In vivo,1969.0,50597,,1,,N,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,Plasma,1,,BAO_0000218
8006,6410,A,,Intermediate,CHEMBL873344,In vivo,1969.0,50597,,1,,N,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8007,6215,A,,Intermediate,CHEMBL619623,In vivo,,50597,,1,,N,Tmax after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8008,3598,A,,Expert,CHEMBL621399,In vivo,,50597,,1,,N,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8009,4527,A,,Intermediate,CHEMBL621400,In vivo,,50597,,1,,N,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8010,17670,A,,Intermediate,CHEMBL621401,In vivo,,50597,,1,,N,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,1,,BAO_0000218
8011,1465,A,,Intermediate,CHEMBL621402,,,50597,,1,,N,Tmax was determined,Rattus norvegicus,,,1,,BAO_0000218
8012,2552,A,,Intermediate,CHEMBL621403,,,50597,,1,,N,Tmax was determined,Rattus norvegicus,,,1,,BAO_0000218
8013,5656,A,,Intermediate,CHEMBL621121,In vivo,,50597,,1,,N,Tmax after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8014,17764,A,,Intermediate,CHEMBL872525,In vivo,,50597,,1,,N,Tmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
8015,5610,A,,Intermediate,CHEMBL621122,,,50597,,1,,N,Tmax in male rat,Rattus norvegicus,,,1,,BAO_0000218
8016,6046,A,,Intermediate,CHEMBL621123,In vivo,,50597,,1,,N,Tmax in rat at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8017,5874,A,,Intermediate,CHEMBL621124,In vivo,,50597,,1,,N,Tmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8018,17596,A,,Intermediate,CHEMBL621125,,,50597,,1,,N,Tmax in rats,Rattus norvegicus,,,1,,BAO_0000218
8019,17804,A,,Intermediate,CHEMBL621126,In vivo,,50597,,1,,N,Tmax was measured in rats after peroral administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8020,1908,A,,Intermediate,CHEMBL621127,In vivo,,50597,,1,,N,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,,1,,BAO_0000218
8021,2959,A,,Intermediate,CHEMBL621128,In vivo,,50597,,1,,N,Tmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,1,,BAO_0000218
8022,6757,A,,Intermediate,CHEMBL618263,In vivo,,50597,,1,,N,Tmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8023,6757,A,,Intermediate,CHEMBL618264,In vivo,,50597,,1,,N,Tmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8024,6757,A,,Intermediate,CHEMBL618265,In vivo,,50597,,1,,N,Tmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8025,4186,A,,Intermediate,CHEMBL618266,In vivo,1969.0,50597,,1,,N,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,Plasma,1,,BAO_0000218
8026,15662,A,,Intermediate,CHEMBL618267,In vivo,,50597,,1,,N,time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8027,429,A,,Intermediate,CHEMBL618450,,1088.0,50597,,1,,N,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Rattus norvegicus,,Urine,1,,BAO_0000218
8028,429,A,,Intermediate,CHEMBL618451,,1088.0,50597,,1,,N,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Rattus norvegicus,,Urine,1,,BAO_0000218
8029,5546,A,,Intermediate,CHEMBL618452,,,50597,,1,,N,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,1,,BAO_0000218
8030,3173,A,,Intermediate,CHEMBL618453,,1088.0,50597,,1,,N,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Rattus norvegicus,,Urine,1,,BAO_0000218
8031,3173,A,,Intermediate,CHEMBL618454,,1088.0,50597,,1,,N,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Rattus norvegicus,,Urine,1,,BAO_0000218
8032,3173,A,,Intermediate,CHEMBL618455,,1088.0,50597,,1,,N,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Rattus norvegicus,,Urine,1,,BAO_0000218
8033,4257,A,,Intermediate,CHEMBL618456,In vivo,,50597,,1,,N,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,,,1,,BAO_0000218
8034,6011,A,,Intermediate,CHEMBL618457,In vivo,,50597,,1,,N,Compound distribution in rat tissues was determined,Rattus norvegicus,,,1,,BAO_0000218
8035,5472,A,,Intermediate,CHEMBL618458,In vivo,,50597,,1,,N,Volume of distribution was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
8036,14346,A,,Intermediate,CHEMBL618459,,,50597,,1,,N,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8037,14346,A,,Intermediate,CHEMBL876733,,,50597,,1,,N,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8038,14346,A,,Intermediate,CHEMBL618460,,,50588,,1,,N,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
8039,14346,A,,Intermediate,CHEMBL618461,,,50597,,1,,N,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8040,15469,A,,Autocuration,CHEMBL618462,,,22224,,1,,U,Area under the curve was determined after oral administration (300 uM/Kg),,,,0,,BAO_0000019
8041,14346,A,,Intermediate,CHEMBL618463,,,50597,,1,,N,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8042,14346,A,,Intermediate,CHEMBL618464,,,50597,,1,,N,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8043,14346,A,,Intermediate,CHEMBL618465,,,50597,,1,,N,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8044,14346,A,,Intermediate,CHEMBL618466,,,50597,,1,,N,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8045,14346,A,,Intermediate,CHEMBL618467,,,50597,,1,,N,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8046,15372,A,,Intermediate,CHEMBL618468,,,50597,,1,,N,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8047,12935,A,,Intermediate,CHEMBL618469,,1969.0,50588,,1,,N,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Canis lupus familiaris,,Plasma,1,,BAO_0000218
8048,12935,A,,Intermediate,CHEMBL618470,,1969.0,50588,,1,,N,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Canis lupus familiaris,,Plasma,1,,BAO_0000218
8049,14813,A,,Autocuration,CHEMBL618471,,,22224,,1,,U,Plasma drug AUC in rat (PO dose),,,,0,,BAO_0000218
8050,15792,A,,Intermediate,CHEMBL618472,,,50594,,1,,N,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Mus musculus,,,1,,BAO_0000218
8051,3579,A,,Autocuration,CHEMBL618473,,,22224,,1,,U,Area under was determined at a dose of 30 mg/kg,,,,0,,BAO_0000218
8052,12487,A,,Intermediate,CHEMBL621699,,,50506,,1,,N,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Mustela putorius furo,,,1,,BAO_0000218
8053,12487,A,,Intermediate,CHEMBL621700,,,50597,,1,,N,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Rattus norvegicus,,,1,,BAO_0000218
8054,12487,A,,Intermediate,CHEMBL621701,,,50597,,1,,N,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Rattus norvegicus,,,1,,BAO_0000218
8055,12487,A,,Intermediate,CHEMBL621702,,,50506,,1,,N,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Mustela putorius furo,,,1,,BAO_0000218
8056,12487,A,,Intermediate,CHEMBL621703,,,50588,,1,,N,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,,,1,,BAO_0000218
8057,12487,A,,Intermediate,CHEMBL621704,,,50588,,1,,N,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,,,1,,BAO_0000218
8058,12902,A,,Intermediate,CHEMBL624259,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8059,12902,A,,Intermediate,CHEMBL624260,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8060,12902,A,,Intermediate,CHEMBL624430,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8061,12902,A,,Intermediate,CHEMBL624431,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8062,12902,A,,Intermediate,CHEMBL624432,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8063,12902,A,,Intermediate,CHEMBL624433,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8064,12902,A,,Intermediate,CHEMBL624434,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8065,12902,A,,Intermediate,CHEMBL624435,,,50597,,1,,N,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Rattus norvegicus,,,1,,BAO_0000218
8066,12745,A,,Intermediate,CHEMBL618570,,,50594,,1,,N,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
8067,12745,A,,Intermediate,CHEMBL618571,,,50594,,1,,N,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,1,,BAO_0000218
8068,12745,A,,Intermediate,CHEMBL618572,,,50594,,1,,N,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
8069,12745,A,,Intermediate,CHEMBL618573,,,50594,,1,,N,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,1,,BAO_0000218
8070,12745,A,,Intermediate,CHEMBL619267,,,50594,,1,,N,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
8071,12745,A,,Intermediate,CHEMBL619431,,,50594,,1,,N,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,1,,BAO_0000218
8072,12745,A,,Intermediate,CHEMBL619432,,,50594,,1,,N,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
8073,12745,A,,Intermediate,CHEMBL619433,,,50594,,1,,N,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,,,1,,BAO_0000218
8074,13298,A,,Autocuration,CHEMBL619434,,1969.0,22224,,1,,U,AUC in mice after oral dose (50 mg/kg),,,Plasma,0,,BAO_0000218
8075,12226,A,,Intermediate,CHEMBL619435,,1977.0,50594,,1,,N,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Mus musculus,,Serum,1,,BAO_0000218
8076,12634,A,,Autocuration,CHEMBL619436,,1969.0,22224,,1,,U,AUC (0-4 hr) ug/ml/h,,,Plasma,0,,BAO_0000019
8077,14810,A,,Intermediate,CHEMBL619437,,,50597,,1,,N,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Rattus norvegicus,,,1,,BAO_0000218
8078,13889,A,,Autocuration,CHEMBL619438,,,22224,,1,,U,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,,0,,BAO_0000218
8079,10018,A,,Intermediate,CHEMBL619439,,,50594,,1,,N,Compound was evaluated for Area under curve in mice,Mus musculus,,,1,,BAO_0000218
8080,8758,A,,Intermediate,CHEMBL619440,,,50597,,1,,N,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,,,1,,BAO_0000218
8081,8758,F,,Autocuration,CHEMBL619441,,,22224,,1,,U,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,0,,BAO_0000218
8082,8758,A,,Intermediate,CHEMBL619442,,,50597,,1,,N,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,,,1,,BAO_0000218
8083,2249,A,,Autocuration,CHEMBL875156,,,22224,,1,,U,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,,0,,BAO_0000019
8084,2249,A,,Autocuration,CHEMBL619443,,,22224,,1,,U,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,,0,,BAO_0000019
8085,2249,A,,Autocuration,CHEMBL619444,,,22224,,1,,U,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,,0,,BAO_0000019
8086,2249,A,,Autocuration,CHEMBL623464,,,22224,,1,,U,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,,0,,BAO_0000019
8087,15115,A,,Intermediate,CHEMBL623465,,,50594,,1,,N,Compound was evaluated for area under curve when administered through oral route in mouse,Mus musculus,,,1,,BAO_0000218
8088,6518,A,,Intermediate,CHEMBL623466,In vivo,,50597,,1,,N,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
8089,6518,A,,Intermediate,CHEMBL623467,In vivo,,50597,,1,,N,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
8090,6249,A,,Intermediate,CHEMBL623468,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8091,2463,A,,Intermediate,CHEMBL622660,In vivo,,50597,,1,,N,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,,,1,,BAO_0000218
8092,4969,A,,Intermediate,CHEMBL622661,In vivo,,50597,,1,,N,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8093,17720,F,,Intermediate,CHEMBL622662,In vivo,,50597,,1,,N,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,1,,BAO_0000218
8094,3457,A,,Intermediate,CHEMBL622663,In vivo,,50597,,1,,N,Pharmacokinetic property (total body clearance) in rat,Rattus norvegicus,,,1,,BAO_0000218
8095,5983,A,,Intermediate,CHEMBL622664,In vivo,,50597,,1,,N,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,,,1,,BAO_0000218
8096,6295,A,,Intermediate,CHEMBL622665,,,50597,,1,,N,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8097,6296,A,,Intermediate,CHEMBL622666,,,50597,,1,,N,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8098,17686,A,,Intermediate,CHEMBL621615,In vivo,,50597,,1,,N,Cl in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8099,17764,A,,Intermediate,CHEMBL621616,In vivo,,50597,,1,,N,Clearance of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
8100,5503,A,,Intermediate,CHEMBL621617,In vivo,,50597,,1,,N,Clearance was determined,Rattus norvegicus,,,1,,BAO_0000218
8101,4368,A,,Intermediate,CHEMBL621618,In vivo,,50597,,1,,N,Clearance by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8102,6005,A,,Intermediate,CHEMBL621619,In vivo,,50597,,1,,N,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8103,5031,A,,Intermediate,CHEMBL621620,In vivo,,50597,,1,,N,Clearance rate after i.v. administration in rats,Rattus norvegicus,,,1,,BAO_0000218
8104,4890,A,,Intermediate,CHEMBL621786,In vivo,,50597,,1,,N,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8105,5182,A,,Intermediate,CHEMBL621787,In vivo,,50597,,1,,N,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,1,,BAO_0000218
8106,5979,A,,Intermediate,CHEMBL621788,In vivo,,50597,,1,,N,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,1,,BAO_0000218
8107,5656,A,,Intermediate,CHEMBL621789,In vivo,,50597,,1,,N,Clearance (Cl) after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8108,17804,A,,Intermediate,CHEMBL621790,In vivo,,50597,,1,,N,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8109,4839,A,,Intermediate,CHEMBL621791,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8110,5041,A,,Intermediate,CHEMBL621792,In vitro,,50597,,1,,N,In vitro microsome metabolism clearance in rat was determined,Rattus norvegicus,Microsomes,,1,,BAO_0000218
8111,5041,A,,Intermediate,CHEMBL621793,In vitro,,50597,,1,,N,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Rattus norvegicus,Microsomes,,1,,BAO_0000218
8112,5974,A,,Intermediate,CHEMBL621794,In vivo,,50597,,1,,N,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8113,5496,A,,Intermediate,CHEMBL621795,In vivo,1969.0,50597,,1,,N,In vivo plasma clearance was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
8114,5739,A,,Intermediate,CHEMBL621796,In vivo,,50597,,1,,N,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,1,,BAO_0000218
8115,5676,A,Hepatocyte,Intermediate,CHEMBL621797,In vivo,2107.0,50597,,1,,N,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Rattus norvegicus,,Liver,1,401.0,BAO_0000218
8116,4239,A,,Intermediate,CHEMBL621798,In vivo,,50597,,1,,N,Pharmacokinetic property (Plasma clearance) was measured in rat,Rattus norvegicus,,,1,,BAO_0000218
8117,5676,A,,Intermediate,CHEMBL621799,In vivo,,50597,,1,,N,Pharmacokinetic property (clearance) in rat i.v.,Rattus norvegicus,,,1,,BAO_0000218
8118,1918,A,,Intermediate,CHEMBL621800,In vivo,,50597,,1,,N,"Plasma Clearance was evaluated in rats, iv",Rattus norvegicus,,,1,,BAO_0000218
8119,17800,A,,Intermediate,CHEMBL621801,In vivo,,50597,,1,,N,Plasma clearance (in vivo) in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
8120,6056,A,,Intermediate,CHEMBL621802,In vivo,,50597,,1,,N,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8121,5496,A,,Intermediate,CHEMBL618596,In vivo,,50597,,1,,N,Plasma clearance was determined,Rattus norvegicus,,,1,,BAO_0000218
8122,5939,A,,Intermediate,CHEMBL618597,In vivo,,50597,,1,,N,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8123,5939,A,,Intermediate,CHEMBL618598,In vivo,,50597,,1,,N,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8124,17752,A,,Intermediate,CHEMBL618599,In vivo,,50597,,1,,N,Plasma clearance in rats,Rattus norvegicus,,,1,,BAO_0000218
8125,4576,A,,Intermediate,CHEMBL618600,In vivo,,50597,,1,,N,Plasma clearance rate determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8126,6011,A,,Intermediate,CHEMBL618601,In vivo,,50597,,1,,N,Plasma clearance was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8127,5510,A,,Intermediate,CHEMBL618602,In vivo,,50597,,1,,N,Plasma clearance was determined,Rattus norvegicus,,,1,,BAO_0000218
8128,5948,A,,Intermediate,CHEMBL618603,In vivo,,50597,,1,,N,Plasma clearance value in rat,Rattus norvegicus,,,1,,BAO_0000218
8129,6125,A,,Intermediate,CHEMBL618604,Ex vivo,2107.0,50597,,1,,N,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,,Liver,1,,BAO_0000218
8130,4839,A,,Intermediate,CHEMBL618605,In vivo,,50597,,1,,N,Clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8131,17686,A,,Intermediate,CHEMBL618606,In vivo,,50597,,1,,N,Total body clearance in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8132,6571,A,,Intermediate,CHEMBL618607,In vivo,,50597,,1,,N,Clearance of compound in rats after intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
8133,3364,A,,Intermediate,CHEMBL618608,In vivo,,50597,,1,,N,Clearance after iv administration to rats,Rattus norvegicus,,,1,,BAO_0000218
8134,13569,A,,Intermediate,CHEMBL618609,In vivo,,50597,,1,,N,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8135,13569,A,,Intermediate,CHEMBL618610,In vivo,,50597,,1,,N,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8136,13569,A,,Intermediate,CHEMBL618611,In vivo,,50597,,1,,N,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8137,13569,A,,Intermediate,CHEMBL618612,In vivo,,50597,,1,,N,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8138,13569,A,,Intermediate,CHEMBL618613,In vivo,,50597,,1,,N,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8139,13569,A,,Intermediate,CHEMBL621076,In vivo,,50597,,1,,N,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8140,13569,A,,Intermediate,CHEMBL621077,In vivo,,50597,,1,,N,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8141,17670,A,,Intermediate,CHEMBL621078,In vivo,,50597,,1,,N,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,1,,BAO_0000218
8142,5970,A,,Intermediate,CHEMBL621251,In vivo,,50597,,1,,N,Clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8143,6495,A,,Intermediate,CHEMBL621252,In vivo,,50597,,1,,N,Clearance in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8144,4590,A,,Intermediate,CHEMBL621253,In vivo,,50597,,1,,N,Clearance in rat.,Rattus norvegicus,,,1,,BAO_0000218
8145,6193,A,,Intermediate,CHEMBL621254,In vivo,,50597,,1,,N,Clearance rate following an oral dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8146,2832,A,,Intermediate,CHEMBL621255,In vivo,,50597,,1,,N,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Rattus norvegicus,,,1,,BAO_0000218
8147,1052,A,,Intermediate,CHEMBL621256,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Rattus norvegicus,,Plasma,1,,BAO_0000218
8148,9866,A,,Intermediate,CHEMBL621257,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
8149,9866,A,,Intermediate,CHEMBL621258,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,,Liver,1,,BAO_0000218
8150,9866,A,,Intermediate,CHEMBL621259,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
8151,9866,A,,Intermediate,CHEMBL621260,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,,Liver,1,,BAO_0000218
8152,9866,A,,Intermediate,CHEMBL876494,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
8153,9866,A,,Intermediate,CHEMBL621261,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,,Liver,1,,BAO_0000218
8154,9866,A,,Intermediate,CHEMBL621262,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,Liver,1,,BAO_0000218
8155,9866,A,,Intermediate,CHEMBL621263,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,,Liver,1,,BAO_0000218
8156,9866,A,,Intermediate,CHEMBL621264,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Liver,1,,BAO_0000218
8157,9866,A,,Intermediate,CHEMBL621265,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8158,9866,A,,Intermediate,CHEMBL621266,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8159,9866,A,,Intermediate,CHEMBL621267,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8160,9866,A,,Intermediate,CHEMBL621268,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8161,9866,A,,Intermediate,CHEMBL621269,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8162,9866,A,,Intermediate,CHEMBL621270,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8163,9866,A,,Intermediate,CHEMBL621271,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8164,9866,A,,Intermediate,CHEMBL621272,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8165,9866,A,,Intermediate,CHEMBL621273,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8166,9866,A,,Intermediate,CHEMBL621274,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8167,9866,A,,Intermediate,CHEMBL876495,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8168,9866,A,,Intermediate,CHEMBL621275,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8169,9866,A,,Intermediate,CHEMBL621276,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8170,9866,A,,Intermediate,CHEMBL621277,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8171,9866,A,,Intermediate,CHEMBL621278,In vivo,160.0,50597,,1,,N,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Intestine,1,,BAO_0000218
8172,9866,A,,Intermediate,CHEMBL621279,In vivo,160.0,50597,,1,,N,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,Intestine,1,,BAO_0000218
8173,9866,A,,Intermediate,CHEMBL621280,In vivo,160.0,50597,,1,,N,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Rattus norvegicus,,Intestine,1,,BAO_0000218
8174,9866,A,,Intermediate,CHEMBL621281,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,,Spleen,1,,BAO_0000218
8175,9866,A,,Intermediate,CHEMBL621282,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Rattus norvegicus,,Spleen,1,,BAO_0000218
8176,9866,A,,Intermediate,CHEMBL621283,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,,Spleen,1,,BAO_0000218
8177,9866,A,,Intermediate,CHEMBL621284,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,,Spleen,1,,BAO_0000218
8178,9866,A,,Intermediate,CHEMBL621285,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
8179,9866,A,,Intermediate,CHEMBL621286,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Spleen,1,,BAO_0000218
8180,9866,A,,Intermediate,CHEMBL623220,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,,Spleen,1,,BAO_0000218
8181,9866,A,,Intermediate,CHEMBL623221,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,,Spleen,1,,BAO_0000218
8182,9866,A,,Intermediate,CHEMBL876029,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Rattus norvegicus,,Spleen,1,,BAO_0000218
8183,9866,A,,Intermediate,CHEMBL623222,In vivo,945.0,50597,,1,,N,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,,Stomach,1,,BAO_0000218
8184,9866,A,,Intermediate,CHEMBL623223,In vivo,945.0,50597,,1,,N,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,,Stomach,1,,BAO_0000218
8185,9866,A,,Intermediate,CHEMBL621445,In vivo,945.0,50597,,1,,N,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Rattus norvegicus,,Stomach,1,,BAO_0000218
8186,13950,A,,Intermediate,CHEMBL621446,In vivo,178.0,50597,,1,,N,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
8187,13950,A,,Intermediate,CHEMBL621447,In vivo,178.0,50597,,1,,N,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
8188,13950,A,,Intermediate,CHEMBL619681,In vivo,178.0,50597,,1,,N,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
8189,13950,A,,Intermediate,CHEMBL619682,In vivo,178.0,50597,,1,,N,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
8190,13950,A,,Intermediate,CHEMBL619683,In vivo,178.0,50597,,1,,N,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
8191,13950,A,,Intermediate,CHEMBL619684,In vivo,955.0,50597,,1,,N,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Brain,1,,BAO_0000218
8192,13950,A,,Intermediate,CHEMBL619685,In vivo,955.0,50597,,1,,N,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Brain,1,,BAO_0000218
8193,13950,A,,Intermediate,CHEMBL619686,In vivo,955.0,50597,,1,,N,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Brain,1,,BAO_0000218
8194,13950,A,,Intermediate,CHEMBL619687,In vivo,955.0,50597,,1,,N,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Brain,1,,BAO_0000218
8195,13950,A,,Intermediate,CHEMBL619688,In vivo,955.0,50597,,1,,N,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Brain,1,,BAO_0000218
8196,13950,A,,Intermediate,CHEMBL619689,In vivo,948.0,50597,,1,,N,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
8197,13950,A,,Intermediate,CHEMBL619690,In vivo,948.0,50597,,1,,N,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
8198,13950,A,,Intermediate,CHEMBL619691,In vivo,948.0,50597,,1,,N,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
8199,6062,A,,Intermediate,CHEMBL619692,In vivo,,50597,,1,,N,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8200,3598,A,,Expert,CHEMBL619693,,,50597,,1,,N,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8201,1908,A,,Intermediate,CHEMBL619694,In vivo,,50597,,1,,N,Vc value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,,1,,BAO_0000218
8202,17596,A,,Intermediate,CHEMBL619695,In vivo,,50597,,1,,N,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
8203,4891,A,,Intermediate,CHEMBL619696,In vivo,,50597,,1,,N,Compound was evaluated for pharmacokinetic parameter volume of distribution,Rattus norvegicus,,,1,,BAO_0000218
8204,740,A,,Intermediate,CHEMBL619697,In vivo,,50597,,1,,N,Compound was evaluated for volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8205,16366,A,,Intermediate,CHEMBL619698,In vivo,,50597,,1,,N,Steady state volume distribution was determined; steady state(ss),Rattus norvegicus,,,1,,BAO_0000218
8206,3364,A,,Intermediate,CHEMBL619699,In vivo,,50597,,1,,N,Steady state volume of distribution after iv administration to rats,Rattus norvegicus,,,1,,BAO_0000218
8207,2552,A,,Intermediate,CHEMBL619700,In vivo,,50597,,1,,N,Steady state volume of distribution dosing at 3 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
8208,406,A,,Intermediate,CHEMBL619701,In vivo,,50597,,1,,N,The compound was evaluated for volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8209,12500,A,,Intermediate,CHEMBL619702,In vivo,,50597,,1,,N,The compound was tested for volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8210,12500,A,,Intermediate,CHEMBL620335,In vivo,,50597,,1,,N,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Rattus norvegicus,,,1,,BAO_0000218
8211,5656,A,,Intermediate,CHEMBL620336,In vivo,,50597,,1,,N,Volume distribution (VD) after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8212,17671,A,,Intermediate,CHEMBL620337,In vivo,,50597,,1,,N,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8213,1094,A,,Intermediate,CHEMBL620520,In vivo,,50597,,1,,N,Volume distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8214,5833,A,,Intermediate,CHEMBL620521,In vivo,,50597,,1,,N,Volume distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8215,5939,A,,Intermediate,CHEMBL875825,In vivo,,50597,,1,,N,Volume distribution in rat after peroral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8216,5939,A,,Intermediate,CHEMBL620522,In vivo,,50597,,1,,N,Volume distribution in rat after peroral administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8217,6005,A,,Intermediate,CHEMBL620523,In vivo,,50597,,1,,N,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8218,1696,A,,Intermediate,CHEMBL620524,In vivo,,50597,,1,,N,Volume of distribution in rat.,Rattus norvegicus,,,1,,BAO_0000218
8219,6672,A,,Intermediate,CHEMBL620525,In vivo,,50597,,1,,N,Volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8220,6673,A,,Intermediate,CHEMBL620526,In vivo,,50597,,1,,N,Volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8221,5871,A,,Intermediate,CHEMBL620527,In vivo,,50597,,1,,N,Volume of distribution in rat by iv administration,Rattus norvegicus,,,1,,BAO_0000218
8222,6803,A,,Intermediate,CHEMBL620528,In vivo,,50597,,1,,N,Volume of distribution in rats,Rattus norvegicus,,,1,,BAO_0000218
8223,5199,A,,Intermediate,CHEMBL620529,In vivo,,50597,,1,,N,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,,,1,,BAO_0000218
8224,4727,A,,Intermediate,CHEMBL620530,,,50597,,1,,N,Volume distribution at the dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8225,16367,A,,Intermediate,CHEMBL620531,In vivo,,50597,,1,,N,Steady state volume of distribution was determined,Rattus norvegicus,,,1,,BAO_0000218
8226,5005,A,,Intermediate,CHEMBL620532,In vivo,,22224,,1,,U,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,,,0,,BAO_0000218
8227,5005,A,,Intermediate,CHEMBL620533,In vivo,,22224,,1,,U,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Rattus norvegicus,,,0,,BAO_0000218
8228,5005,A,,Intermediate,CHEMBL620534,In vivo,,22224,,1,,U,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Rattus norvegicus,,,0,,BAO_0000218
8229,15765,A,,Intermediate,CHEMBL620535,In vivo,,50597,,1,,N,Mean (%CV) PK parameters for Vdss(mL/kg).,Rattus norvegicus,,,1,,BAO_0000218
8230,2792,A,,Intermediate,CHEMBL875826,In vivo,,50597,,1,,N,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
8231,2792,A,,Intermediate,CHEMBL620536,In vivo,,50597,,1,,N,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
8232,5334,A,,Intermediate,CHEMBL620537,In vivo,,50597,,1,,N,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8233,5334,A,,Intermediate,CHEMBL618526,In vivo,,50597,,1,,N,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Rattus norvegicus,,,1,,BAO_0000218
8234,5739,A,,Intermediate,CHEMBL618527,In vivo,,50597,,1,,N,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,1,,BAO_0000218
8235,5789,A,,Intermediate,CHEMBL618528,In vivo,,50597,,1,,N,Pharmacokinetic property (Vdss) in rat,Rattus norvegicus,,,1,,BAO_0000218
8236,4239,A,,Intermediate,CHEMBL618529,In vivo,,50597,,1,,N,Pharmacokinetic property (vdss) was measured in rat,Rattus norvegicus,,,1,,BAO_0000218
8237,4709,A,,Intermediate,CHEMBL618530,In vivo,,50597,,1,,N,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8238,6642,A,,Intermediate,CHEMBL618531,In vivo,,50597,,1,,N,Volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8239,5247,A,,Intermediate,CHEMBL618532,In vivo,,50597,,1,,N,The pharmacokinetic parameter volume of distribution in vivo in rats,Rattus norvegicus,,,1,,BAO_0000218
8240,17720,F,,Intermediate,CHEMBL618533,In vivo,,50597,,1,,N,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,1,,BAO_0000218
8241,17686,A,,Intermediate,CHEMBL618534,In vivo,,50597,,1,,N,Vdss in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8242,4689,A,,Intermediate,CHEMBL618535,In vivo,,50597,,1,,N,Volume distribution after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
8243,5654,A,,Intermediate,CHEMBL618536,In vivo,,50597,,1,,N,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8244,5654,A,,Intermediate,CHEMBL618537,In vivo,,50597,,1,,N,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8245,4527,A,,Intermediate,CHEMBL618538,In vivo,,50597,,1,,N,Volume distribution at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8246,4521,A,,Intermediate,CHEMBL618539,In vivo,,50597,,1,,N,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
8247,6057,A,,Intermediate,CHEMBL618540,In vivo,,50597,,1,,N,Volume distribution was calculated in rat,Rattus norvegicus,,,1,,BAO_0000218
8248,5510,A,,Intermediate,CHEMBL618541,In vivo,,50597,,1,,N,Volume distribution was determined,Rattus norvegicus,,,1,,BAO_0000218
8249,2938,A,,Intermediate,CHEMBL618542,In vivo,,50597,,1,,N,Volume of distribution after intravenous administration was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
8250,6679,A,,Intermediate,CHEMBL622544,In vivo,,50597,,1,,N,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,1,,BAO_0000218
8251,6685,A,,Intermediate,CHEMBL622545,In vivo,,50597,,1,,N,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
8252,6685,A,,Intermediate,CHEMBL622546,In vivo,,50597,,1,,N,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
8253,6685,A,,Intermediate,CHEMBL622547,In vivo,,50597,,1,,N,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,1,,BAO_0000218
8254,5145,A,,Intermediate,CHEMBL622548,In vivo,,50597,,1,,N,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8255,6467,A,,Intermediate,CHEMBL622549,In vivo,,50597,,1,,N,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8256,6467,A,,Intermediate,CHEMBL622550,In vivo,,50597,,1,,N,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,1,,BAO_0000218
8257,15115,A,,Intermediate,CHEMBL622551,,,50594,,1,,N,Compound was evaluated for area under curve when administered through oral route to mouse,Mus musculus,,,1,,BAO_0000218
8258,8758,A,,Intermediate,CHEMBL622552,,,50597,,1,,N,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,,,1,,BAO_0000218
8259,8758,A,,Intermediate,CHEMBL622553,,,50597,,1,,N,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,,,1,,BAO_0000218
8260,8267,F,,Autocuration,CHEMBL622554,In vivo,,22224,,1,,U,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,,0,,BAO_0000218
8261,8267,A,,Intermediate,CHEMBL622555,,,50588,,1,,N,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
8262,14239,A,,Intermediate,CHEMBL622556,,,50594,,1,,N,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Mus musculus,,,1,,BAO_0000218
8263,14239,A,,Intermediate,CHEMBL622557,,,50594,,1,,N,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Mus musculus,,,1,,BAO_0000218
8264,10754,A,,Intermediate,CHEMBL622558,,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Mus musculus,,Blood,1,,BAO_0000218
8265,10754,A,,Intermediate,CHEMBL622559,,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Mus musculus,,Blood,1,,BAO_0000218
8266,10754,A,,Intermediate,CHEMBL622560,,,50588,,1,,N,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Canis lupus familiaris,,,1,,BAO_0000218
8267,14681,A,,Intermediate,CHEMBL622561,,,50597,,1,,N,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,1,,BAO_0000218
8268,14681,A,,Intermediate,CHEMBL622562,,,50597,,1,,N,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Rattus norvegicus,,,1,,BAO_0000218
8269,14681,A,,Intermediate,CHEMBL622563,,,50597,,1,,N,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,1,,BAO_0000218
8270,13118,A,,Autocuration,CHEMBL622564,,,22224,,1,,U,Concentration of compound in Central nervous system,,,,0,,BAO_0000019
8271,13118,A,,Autocuration,CHEMBL622565,,,22224,,1,,U,Concentration of compound in Central nervous system; Not detectable,,,,0,,BAO_0000019
8272,13318,A,,Intermediate,CHEMBL622566,,,50594,,1,,N,"Concentration of diester in the blood, following oral administration in mice",Mus musculus,,,1,,BAO_0000218
8273,13318,A,,Intermediate,CHEMBL624515,,,50594,,1,,N,"Concentration of monoester in the blood, following oral administration in mice",Mus musculus,,,1,,BAO_0000218
8274,13318,A,,Intermediate,CHEMBL624516,,,50594,,1,,N,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Mus musculus,,,1,,BAO_0000218
8275,15692,A,,Autocuration,CHEMBL624517,,,22224,,1,,U,Evaluated for Pharmacokinetic property: Area under the curve,,,,0,,BAO_0000019
8276,14839,A,,Intermediate,CHEMBL624518,,,50594,,1,,N,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Mus musculus,,,1,,BAO_0000218
8277,14839,A,,Intermediate,CHEMBL624519,,,100710,,1,,N,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Macaca fascicularis,,,1,,BAO_0000218
8278,14839,A,,Intermediate,CHEMBL624520,,,100710,,1,,N,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,,,1,,BAO_0000218
8279,14839,A,,Intermediate,CHEMBL624521,,,100710,,1,,N,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Macaca fascicularis,,,1,,BAO_0000218
8280,14839,A,,Intermediate,CHEMBL624522,,,100710,,1,,N,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,,,1,,BAO_0000218
8281,14839,A,,Intermediate,CHEMBL624523,,,100710,,1,,N,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Macaca fascicularis,,,1,,BAO_0000218
8282,14839,A,,Intermediate,CHEMBL624409,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8283,14839,A,,Intermediate,CHEMBL624410,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8284,14839,A,,Intermediate,CHEMBL624411,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8285,14839,A,,Intermediate,CHEMBL623531,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8286,14839,A,,Intermediate,CHEMBL623532,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8287,14839,A,,Intermediate,CHEMBL623533,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8288,14839,A,,Intermediate,CHEMBL623534,,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,,,1,,BAO_0000218
8289,14839,A,,Intermediate,CHEMBL623535,,,50594,,1,,N,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8290,14839,A,,Intermediate,CHEMBL623536,,,50594,,1,,N,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8291,14839,A,,Intermediate,CHEMBL623537,,,50594,,1,,N,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8292,14839,A,,Intermediate,CHEMBL623538,,,50594,,1,,N,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8293,14839,A,,Intermediate,CHEMBL623539,,,50594,,1,,N,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8294,14839,A,,Intermediate,CHEMBL623540,,,50594,,1,,N,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,,,1,,BAO_0000218
8295,14839,A,,Intermediate,CHEMBL623541,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Mus musculus,,,1,,BAO_0000218
8296,14839,A,,Intermediate,CHEMBL623542,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,1,,BAO_0000218
8297,14839,A,,Intermediate,CHEMBL623543,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Mus musculus,,,1,,BAO_0000218
8298,14839,A,,Intermediate,CHEMBL623544,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Mus musculus,,,1,,BAO_0000218
8299,14839,A,,Intermediate,CHEMBL623545,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,1,,BAO_0000218
8300,14839,A,,Intermediate,CHEMBL623546,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Mus musculus,,,1,,BAO_0000218
8301,5408,A,,Intermediate,CHEMBL623547,In vivo,1969.0,50597,,1,,N,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8302,6827,A,,Intermediate,CHEMBL623548,In vivo,,50597,,1,,N,High i.v. clearance in Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8303,17538,A,,Intermediate,CHEMBL623549,In vitro,2107.0,50597,,1,,N,In vitro clearance in rat liver microsomes,Rattus norvegicus,Microsomes,Liver,1,,BAO_0000218
8304,6331,A,,Intermediate,CHEMBL623550,In vitro,2107.0,50597,,1,,N,Intrinsic clearance in rat liver microsomes was determined,Rattus norvegicus,Microsomes,Liver,1,,BAO_0000218
8305,5948,A,Hepatocyte,Intermediate,CHEMBL875276,In vitro,2107.0,50597,,1,,N,Intrinsic clearance in rat hepatocytes was determined,Rattus norvegicus,,Liver,1,401.0,BAO_0000218
8306,4026,A,,Intermediate,CHEMBL621872,In vivo,,50597,,1,,N,Plasma Clearance was determined,Rattus norvegicus,,,1,,BAO_0000218
8307,6647,A,,Intermediate,CHEMBL621873,In vivo,,50597,,1,,N,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
8308,1696,A,,Intermediate,CHEMBL621874,In vivo,,50597,,1,,N,Plasma clearance in rat.,Rattus norvegicus,,,1,,BAO_0000218
8309,6597,A,,Intermediate,CHEMBL621875,In vivo,,50597,,1,,N,Plasma clearance in rats,Rattus norvegicus,,,1,,BAO_0000218
8310,347,A,,Intermediate,CHEMBL621876,In vivo,,50597,,1,,N,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Rattus norvegicus,,,1,,BAO_0000218
8311,16423,A,,Intermediate,CHEMBL621877,In vivo,,50597,,1,,N,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,1,,BAO_0000218
8312,2879,A,,Intermediate,CHEMBL621878,In vivo,,50597,,1,,N,Plasma clearance was measured in rat,Rattus norvegicus,,,1,,BAO_0000218
8313,4883,A,,Intermediate,CHEMBL621879,In vivo,,50597,,1,,N,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8314,5328,A,,Intermediate,CHEMBL621880,In vivo,1969.0,50597,,1,,N,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Rattus norvegicus,,Plasma,1,,BAO_0000218
8315,5160,A,,Intermediate,CHEMBL621881,In vivo,,50597,,1,,N,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8316,17582,A,,Intermediate,CHEMBL621882,In vivo,,50597,,1,,N,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
8317,17651,A,,Intermediate,CHEMBL875283,In vivo,,50597,,1,,N,Total clearance at 1 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8318,17651,A,,Intermediate,CHEMBL621883,In vivo,,50597,,1,,N,Total clearance at 10 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8319,6596,A,,Intermediate,CHEMBL621884,In vivo,,50597,,1,,N,Clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8320,4796,A,,Intermediate,CHEMBL621885,In vivo,,50597,,1,,N,Plasma clearance rate determined in rats,Rattus norvegicus,,,1,,BAO_0000218
8321,6850,A,,Intermediate,CHEMBL621886,In vivo,,50597,,1,,N,Clearance of compound in rat was evaluated,Rattus norvegicus,,,1,,BAO_0000218
8322,5932,A,,Intermediate,CHEMBL621887,In vivo,1969.0,50597,,1,,N,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
8323,3371,A,,Intermediate,CHEMBL621888,In vivo,,50597,,1,,N,Pharmacokinetic property (blood clearance) in rat,Rattus norvegicus,,,1,,BAO_0000218
8324,2083,A,,Intermediate,CHEMBL621889,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8325,4942,A,,Intermediate,CHEMBL621890,In vivo,,50597,,1,,N,Plasma clearance in rats,Rattus norvegicus,,,1,,BAO_0000218
8326,6838,A,,Intermediate,CHEMBL621891,In vitro,2107.0,50597,,1,,N,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Rattus norvegicus,Microsomes,Liver,1,,BAO_0000218
8327,5353,A,,Intermediate,CHEMBL621892,In vivo,,50597,,1,,N,Clearance in Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8328,6641,A,,Intermediate,CHEMBL621893,In vivo,,50597,,1,,N,Clearance rat,Rattus norvegicus,,,1,,BAO_0000218
8329,6641,A,,Intermediate,CHEMBL621894,In vivo,,50597,,1,,N,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Rattus norvegicus,,,1,,BAO_0000218
8330,6641,A,,Intermediate,CHEMBL621895,In vivo,,50597,,1,,N,Clearance rat; Not determined,Rattus norvegicus,,,1,,BAO_0000218
8331,6444,A,,Intermediate,CHEMBL875284,In vivo,,50597,,1,,N,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,1,,BAO_0000218
8332,6444,A,,Intermediate,CHEMBL618699,In vivo,,50597,,1,,N,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,1,,BAO_0000218
8333,6444,A,,Intermediate,CHEMBL618700,In vivo,,50597,,1,,N,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,1,,BAO_0000218
8334,6211,A,,Intermediate,CHEMBL618701,In vivo,,50597,,1,,N,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8335,12873,A,,Intermediate,CHEMBL876600,In vivo,1969.0,50597,,1,,N,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,,Plasma,1,,BAO_0000218
8336,6570,A,,Intermediate,CHEMBL618702,In vivo,,50597,,1,,N,Clearance of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8337,3341,A,,Intermediate,CHEMBL618703,In vivo,,50597,,1,,N,Compound was evaluated for Hepatic clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8338,4891,A,,Intermediate,CHEMBL618704,In vivo,,50597,,1,,N,In vivo clearance after 5 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
8339,1094,A,,Intermediate,CHEMBL618705,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma clearance in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8340,2938,A,,Intermediate,CHEMBL618706,In vivo,,50597,,1,,N,Hepatic clearance after intravenous administration was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
8341,17853,A,,Intermediate,CHEMBL618707,In vivo,,50597,,1,,N,Lower clearance in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,1,,BAO_0000218
8342,6049,A,,Intermediate,CHEMBL618708,In vivo,1969.0,50597,,1,,N,Pharmacokinetic parameter expressed as plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8343,5789,A,,Intermediate,CHEMBL618709,In vivo,,50597,,1,,N,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,,,1,,BAO_0000218
8344,4514,A,,Intermediate,CHEMBL618710,In vivo,,50597,,1,,N,Plasma clearance in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8345,6448,A,,Intermediate,CHEMBL618711,In vivo,,50597,,1,,N,Plasma clearance (Clp) in rat,Rattus norvegicus,,,1,,BAO_0000218
8346,6062,A,,Intermediate,CHEMBL618712,In vivo,,50597,,1,,N,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8347,5710,A,,Intermediate,CHEMBL618713,In vivo,,50597,,1,,N,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Rattus norvegicus,,,1,,BAO_0000218
8348,4709,A,,Intermediate,CHEMBL618714,In vivo,,50597,,1,,N,Plasma clearance after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8349,4521,A,,Intermediate,CHEMBL618715,In vivo,,50597,,1,,N,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
8350,1742,A,,Intermediate,CHEMBL618716,In vivo,,50597,,1,,N,Plasma clearance in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8351,6057,A,,Intermediate,CHEMBL876601,In vivo,,50597,,1,,N,Plasma clearance measured in rat,Rattus norvegicus,,,1,,BAO_0000218
8352,6057,A,,Intermediate,CHEMBL618717,In vivo,,50597,,1,,N,Plasma clearance was calculated in rat,Rattus norvegicus,,,1,,BAO_0000218
8353,5145,A,,Intermediate,CHEMBL618718,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8354,5833,A,,Intermediate,CHEMBL618719,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8355,6453,A,,Intermediate,CHEMBL618720,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8356,6640,A,,Intermediate,CHEMBL618721,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8357,6305,A,,Intermediate,CHEMBL621477,In vivo,,50597,,1,,N,Plasma clearance in rats,Rattus norvegicus,,,1,,BAO_0000218
8358,6642,A,,Intermediate,CHEMBL621478,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
8359,5472,A,,Intermediate,CHEMBL621479,In vivo,,50597,,1,,N,Plasma clearance was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
8360,5472,A,,Intermediate,CHEMBL621480,In vivo,,50597,,1,,N,Plasma clearance was evaluated in rat; Not tested,Rattus norvegicus,,,1,,BAO_0000218
8361,5144,A,,Intermediate,CHEMBL621481,In vivo,,50597,,1,,N,Plasma clearance rate was determined for the compound in rat,Rattus norvegicus,,,1,,BAO_0000218
8362,6685,A,,Intermediate,CHEMBL621482,In vivo,,50597,,1,,N,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
8363,6685,A,,Intermediate,CHEMBL621483,In vivo,,50597,,1,,N,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
8364,6685,A,,Intermediate,CHEMBL621484,In vivo,,50597,,1,,N,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,1,,BAO_0000218
8365,13950,A,,Intermediate,CHEMBL621485,In vivo,948.0,50597,,1,,N,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
8366,13950,A,,Intermediate,CHEMBL621486,In vivo,948.0,50597,,1,,N,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
8367,13950,A,,Intermediate,CHEMBL621487,In vivo,160.0,50597,,1,,N,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Intestine,1,,BAO_0000218
8368,13950,A,,Intermediate,CHEMBL621488,In vivo,160.0,50597,,1,,N,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Intestine,1,,BAO_0000218
8369,13950,A,,Intermediate,CHEMBL621489,In vivo,160.0,50597,,1,,N,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Intestine,1,,BAO_0000218
8370,13950,A,,Intermediate,CHEMBL621490,In vivo,160.0,50597,,1,,N,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Intestine,1,,BAO_0000218
8371,13950,A,,Intermediate,CHEMBL621491,In vivo,160.0,50597,,1,,N,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Intestine,1,,BAO_0000218
8372,13950,A,,Intermediate,CHEMBL621492,In vivo,2113.0,50597,,1,,N,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Kidney,1,,BAO_0000218
8373,13950,A,,Intermediate,CHEMBL621493,In vivo,2113.0,50597,,1,,N,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Kidney,1,,BAO_0000218
8374,13950,A,,Intermediate,CHEMBL621494,In vivo,2113.0,50597,,1,,N,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Kidney,1,,BAO_0000218
8375,13950,A,,Intermediate,CHEMBL621495,In vivo,2113.0,50597,,1,,N,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Kidney,1,,BAO_0000218
8376,13950,A,,Intermediate,CHEMBL621496,In vivo,2113.0,50597,,1,,N,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Kidney,1,,BAO_0000218
8377,13950,A,,Intermediate,CHEMBL621497,In vivo,2107.0,50597,,1,,N,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
8378,13950,A,,Intermediate,CHEMBL621498,In vivo,2107.0,50597,,1,,N,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
8379,13950,A,,Intermediate,CHEMBL621499,In vivo,2107.0,50597,,1,,N,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
8380,13950,A,,Intermediate,CHEMBL618634,In vivo,2107.0,50597,,1,,N,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
8381,13950,A,,Intermediate,CHEMBL618635,In vivo,2107.0,50597,,1,,N,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
8382,13950,A,,Intermediate,CHEMBL618636,In vivo,2048.0,50597,,1,,N,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
8383,13950,A,,Intermediate,CHEMBL619737,In vivo,2048.0,50597,,1,,N,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
8384,13950,A,,Intermediate,CHEMBL619738,In vivo,2048.0,50597,,1,,N,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
8385,13950,A,,Intermediate,CHEMBL624329,In vivo,2048.0,50597,,1,,N,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
8386,13950,A,,Intermediate,CHEMBL624330,In vivo,2048.0,50597,,1,,N,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
8387,13950,A,,Intermediate,CHEMBL624331,In vivo,2385.0,50597,,1,,N,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8388,13950,A,,Intermediate,CHEMBL624332,In vivo,2385.0,50597,,1,,N,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8389,13950,A,,Intermediate,CHEMBL624333,In vivo,2385.0,50597,,1,,N,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8390,13950,A,,Intermediate,CHEMBL624334,In vivo,2385.0,50597,,1,,N,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8391,13950,A,,Intermediate,CHEMBL624335,In vivo,2385.0,50597,,1,,N,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8392,13950,A,,Intermediate,CHEMBL620016,In vivo,2106.0,50597,,1,,N,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Spleen,1,,BAO_0000218
8393,13950,A,,Intermediate,CHEMBL620169,In vivo,2106.0,50597,,1,,N,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Spleen,1,,BAO_0000218
8394,13950,A,,Intermediate,CHEMBL620170,In vivo,2106.0,50597,,1,,N,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Spleen,1,,BAO_0000218
8395,13950,A,,Intermediate,CHEMBL620171,In vivo,2106.0,50597,,1,,N,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Spleen,1,,BAO_0000218
8396,13950,A,,Intermediate,CHEMBL620172,In vivo,2106.0,50597,,1,,N,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Spleen,1,,BAO_0000218
8397,13950,A,,Intermediate,CHEMBL620173,In vivo,945.0,50597,,1,,N,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Stomach,1,,BAO_0000218
8398,13950,A,,Intermediate,CHEMBL620174,In vivo,945.0,50597,,1,,N,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Stomach,1,,BAO_0000218
8399,13950,A,,Intermediate,CHEMBL620175,In vivo,945.0,50597,,1,,N,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Stomach,1,,BAO_0000218
8400,13950,A,,Intermediate,CHEMBL620176,In vivo,945.0,50597,,1,,N,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Stomach,1,,BAO_0000218
8401,13950,A,,Intermediate,CHEMBL620177,In vivo,945.0,50597,,1,,N,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Stomach,1,,BAO_0000218
8402,13950,A,,Intermediate,CHEMBL620178,,2037.0,50597,,1,,N,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8403,13950,A,,Intermediate,CHEMBL620179,,2037.0,50597,,1,,N,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8404,13950,A,,Intermediate,CHEMBL620180,,,50597,,1,,N,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8405,6570,A,,Intermediate,CHEMBL620181,In vivo,,50597,,1,,N,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8406,6571,A,,Intermediate,CHEMBL620182,In vivo,,50597,,1,,N,Volume of distribution of compound in rats after intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
8407,6453,A,,Intermediate,CHEMBL620183,In vivo,,50597,,1,,N,Volume of distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8408,6444,A,,Intermediate,CHEMBL620184,In vivo,,50597,,1,,N,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,1,,BAO_0000218
8409,6444,A,,Intermediate,CHEMBL620185,In vivo,,50597,,1,,N,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,1,,BAO_0000218
8410,6444,A,,Intermediate,CHEMBL620186,In vivo,,50597,,1,,N,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,1,,BAO_0000218
8411,5353,A,,Intermediate,CHEMBL620187,In vivo,,50597,,1,,N,Volume of distribution was determined in Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8412,5334,A,,Intermediate,CHEMBL620188,In vivo,,50597,,1,,N,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8413,5334,A,,Intermediate,CHEMBL620189,In vivo,,50597,,1,,N,Volume of distribution was reported in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8414,6641,A,,Intermediate,CHEMBL620190,In vivo,,50597,,1,,N,Volumes of distribution in rat after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8415,6641,A,,Intermediate,CHEMBL620191,In vivo,,50597,,1,,N,Volumes of distribution in rat after po administration,Rattus norvegicus,,,1,,BAO_0000218
8416,6641,A,,Intermediate,CHEMBL620192,In vivo,,50597,,1,,N,Volumes of distribution in rat after po administration; Not determined,Rattus norvegicus,,,1,,BAO_0000218
8417,5676,A,,Intermediate,CHEMBL620193,In vivo,,50597,,1,,N,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,,,1,,BAO_0000218
8418,6410,A,,Intermediate,CHEMBL620194,In vivo,,50597,,1,,N,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Rattus norvegicus,,,1,,BAO_0000218
8419,17670,A,,Intermediate,CHEMBL876730,In vivo,,50597,,1,,N,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,,,1,,BAO_0000218
8420,6495,A,,Intermediate,CHEMBL620195,In vivo,,50597,,1,,N,Volume distribution in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8421,5408,A,,Intermediate,CHEMBL620196,In vivo,,50597,,1,,N,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8422,4883,A,,Intermediate,CHEMBL620197,In vivo,,50597,,1,,N,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8423,6647,A,,Intermediate,CHEMBL620198,In vivo,,50597,,1,,N,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
8424,6495,A,,Intermediate,CHEMBL620199,In vivo,,50597,,1,,N,Volume of distribution in rats,Rattus norvegicus,,,1,,BAO_0000218
8425,2661,A,,Intermediate,CHEMBL620200,In vivo,,50597,,1,,N,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
8426,2661,A,,Intermediate,CHEMBL620201,In vivo,,50597,,1,,N,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
8427,5974,A,,Intermediate,CHEMBL620202,In vivo,,50597,,1,,N,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8428,5974,A,,Intermediate,CHEMBL620203,In vivo,,50597,,1,,N,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8429,5974,A,,Intermediate,CHEMBL620204,In vivo,,50597,,1,,N,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Rattus norvegicus,,,1,,BAO_0000218
8430,5974,A,,Intermediate,CHEMBL620205,In vivo,,50597,,1,,N,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8431,5960,A,,Intermediate,CHEMBL624664,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Vss) in rat,Rattus norvegicus,,,1,,BAO_0000218
8432,5676,A,,Intermediate,CHEMBL624665,In vivo,,50597,,1,,N,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,,,1,,BAO_0000218
8433,5948,A,,Intermediate,CHEMBL624666,,,50597,,1,,N,Pharmacokinetic property (Vss) in rat,Rattus norvegicus,,,1,,BAO_0000218
8434,5979,A,,Intermediate,CHEMBL624667,In vivo,,50597,,1,,N,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,,,1,,BAO_0000218
8435,5978,A,,Intermediate,CHEMBL624668,In vivo,,50597,,1,,N,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8436,5978,A,,Intermediate,CHEMBL624669,In vivo,,50597,,1,,N,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8437,5978,A,,Intermediate,CHEMBL624670,In vivo,,50597,,1,,N,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8438,5978,A,,Intermediate,CHEMBL624671,In vivo,,50597,,1,,N,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8439,6448,A,,Intermediate,CHEMBL624672,In vivo,,50597,,1,,N,Steady state volume distribution in rat,Rattus norvegicus,,,1,,BAO_0000218
8440,12873,A,,Intermediate,CHEMBL624673,In vivo,1969.0,50597,,1,,N,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Rattus norvegicus,,Plasma,1,,BAO_0000218
8441,4576,A,,Intermediate,CHEMBL624674,In vivo,,50597,,1,,N,Steady state volume of distribution determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8442,17582,A,,Intermediate,CHEMBL624675,In vivo,,50597,,1,,N,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
8443,1466,A,,Intermediate,CHEMBL621728,In vivo,,50597,,1,,N,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
8444,5182,A,,Intermediate,CHEMBL621729,,,50597,,1,,N,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8445,5182,A,,Intermediate,CHEMBL621730,,,50597,,1,,N,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Rattus norvegicus,,,1,,BAO_0000218
8446,6535,A,,Intermediate,CHEMBL621731,In vivo,,50597,,1,,N,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
8447,6535,A,,Intermediate,CHEMBL621732,In vivo,,50597,,1,,N,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
8448,5041,A,,Intermediate,CHEMBL621908,In vivo,,50597,,1,,N,Volume in steady state distribution value was determined,Rattus norvegicus,,,1,,BAO_0000218
8449,5041,A,,Intermediate,CHEMBL875347,In vivo,,50597,,1,,N,Volume in steady state distribution value was determined; ND denotes no data,Rattus norvegicus,,,1,,BAO_0000218
8450,5041,A,,Intermediate,CHEMBL621909,In vivo,,50597,,1,,N,Volume in steady state distribution value was determined; ND denotes not determined,Rattus norvegicus,,,1,,BAO_0000218
8451,17065,A,,Intermediate,CHEMBL621910,In vivo,,50597,,1,,N,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,1,,BAO_0000218
8452,6597,A,,Intermediate,CHEMBL621911,In vivo,,50597,,1,,N,Volume of distribution at steady state was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
8453,15662,A,,Intermediate,CHEMBL621912,In vivo,,50597,,1,,N,Volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8454,6485,A,,Intermediate,CHEMBL621913,In vivo,,50597,,1,,N,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8455,17655,A,,Intermediate,CHEMBL621914,In vivo,,50597,,1,,N,Volume of distribution in steady state was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8456,6616,A,,Intermediate,CHEMBL621915,In vivo,,50597,,1,,N,Volume of distribution after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8457,1916,A,,Intermediate,CHEMBL621916,In vivo,,50597,,1,,N,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,,,1,,BAO_0000218
8458,16438,A,,Intermediate,CHEMBL621917,In vivo,2107.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,,Liver,1,,BAO_0000218
8459,16438,A,,Intermediate,CHEMBL621918,In vivo,2107.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,,Liver,1,,BAO_0000218
8460,16438,A,,Intermediate,CHEMBL621919,In vivo,2106.0,50594,,1,,N,Biodistribution of compound (oxidized form) in spleen tissue,Mus musculus,,Spleen,1,,BAO_0000218
8461,16438,A,,Intermediate,CHEMBL621920,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Mus musculus,,Spleen,1,,BAO_0000218
8462,16438,A,,Intermediate,CHEMBL621921,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Mus musculus,,Spleen,1,,BAO_0000218
8463,16438,A,,Intermediate,CHEMBL622401,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Spleen,1,,BAO_0000218
8464,16438,A,,Intermediate,CHEMBL875348,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,,Spleen,1,,BAO_0000218
8465,16438,A,,Intermediate,CHEMBL622402,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,,Spleen,1,,BAO_0000218
8466,16438,A,,Intermediate,CHEMBL622403,In vivo,178.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Mus musculus,,Blood,1,,BAO_0000218
8467,16438,A,,Intermediate,CHEMBL622404,In vivo,178.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Blood,1,,BAO_0000218
8468,16438,A,,Intermediate,CHEMBL622405,In vivo,955.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Mus musculus,,Brain,1,,BAO_0000218
8469,16438,A,,Intermediate,CHEMBL622406,In vivo,955.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,,Brain,1,,BAO_0000218
8470,16438,A,,Intermediate,CHEMBL622407,In vivo,955.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Brain,1,,BAO_0000218
8471,16438,A,,Intermediate,CHEMBL622408,In vivo,948.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Mus musculus,,Heart,1,,BAO_0000218
8472,16438,A,,Intermediate,CHEMBL622409,In vivo,948.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,,Heart,1,,BAO_0000218
8473,16438,A,,Intermediate,CHEMBL622410,In vivo,948.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Heart,1,,BAO_0000218
8474,16438,A,,Intermediate,CHEMBL622411,In vivo,2113.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Mus musculus,,Kidney,1,,BAO_0000218
8475,16438,A,,Intermediate,CHEMBL627864,In vivo,2113.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,,Kidney,1,,BAO_0000218
8476,16438,A,,Intermediate,CHEMBL627865,In vivo,2113.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Kidney,1,,BAO_0000218
8477,16438,A,,Intermediate,CHEMBL627866,In vivo,2107.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Mus musculus,,Liver,1,,BAO_0000218
8478,16438,A,,Intermediate,CHEMBL627751,In vivo,2107.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Liver,1,,BAO_0000218
8479,16438,A,,Intermediate,CHEMBL627752,In vivo,2106.0,50594,,1,,N,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Mus musculus,,Spleen,1,,BAO_0000218
8480,16438,A,,Intermediate,CHEMBL627753,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,,Spleen,1,,BAO_0000218
8481,16438,A,,Intermediate,CHEMBL627754,In vivo,2106.0,50594,,1,,N,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,,Spleen,1,,BAO_0000218
8482,12467,A,,Intermediate,CHEMBL627755,,,50594,,1,,N,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Mus musculus,,,1,,BAO_0000218
8483,17208,A,,Intermediate,CHEMBL627756,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8484,17208,A,,Intermediate,CHEMBL627757,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8485,17208,A,,Intermediate,CHEMBL627758,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8486,17208,A,,Intermediate,CHEMBL627759,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8487,17208,A,,Intermediate,CHEMBL627760,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8488,17208,A,,Intermediate,CHEMBL627761,In vivo,955.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Brain,1,,BAO_0000218
8489,17208,A,,Intermediate,CHEMBL876811,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8490,17208,A,,Intermediate,CHEMBL627762,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8491,17208,A,,Intermediate,CHEMBL627763,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8492,17208,A,,Intermediate,CHEMBL627764,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8493,17208,A,,Intermediate,CHEMBL627765,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8494,17208,A,,Intermediate,CHEMBL627766,In vivo,948.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Heart,1,,BAO_0000218
8495,17208,A,,Intermediate,CHEMBL627767,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8496,17208,A,,Intermediate,CHEMBL627768,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8497,17208,A,,Intermediate,CHEMBL628422,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8498,17208,A,,Intermediate,CHEMBL628423,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8499,5089,A,,Intermediate,CHEMBL628424,In vivo,,50597,,1,,N,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8500,5089,A,,Intermediate,CHEMBL628425,In vivo,,50597,,1,,N,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8501,4257,A,,Intermediate,CHEMBL628426,In vivo,,50597,,1,,N,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,,,1,,BAO_0000218
8502,6679,A,,Intermediate,CHEMBL628427,In vivo,,50597,,1,,N,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,1,,BAO_0000218
8503,5546,A,,Intermediate,CHEMBL626938,In vivo,,50597,,1,,N,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,1,,BAO_0000218
8504,6141,A,,Intermediate,CHEMBL626939,In vivo,,50597,,1,,N,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8505,5334,A,,Intermediate,CHEMBL626940,In vivo,,50597,,1,,N,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8506,5334,A,,Intermediate,CHEMBL626941,In vivo,,50597,,1,,N,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8507,5334,A,,Intermediate,CHEMBL626942,In vivo,,50597,,1,,N,Plasma clearance was reported in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8508,4689,A,,Intermediate,CHEMBL876812,In vivo,,50597,,1,,N,Plasma clearance after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
8509,6848,A,,Intermediate,CHEMBL626943,In vivo,,50597,,1,,N,Plasma clearance of compound in rats was evaluated,Rattus norvegicus,,,1,,BAO_0000218
8510,6848,A,,Intermediate,CHEMBL626944,In vivo,,50597,,1,,N,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Rattus norvegicus,,,1,,BAO_0000218
8511,6467,A,,Intermediate,CHEMBL626945,In vivo,,50597,,1,,N,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8512,6467,A,,Intermediate,CHEMBL626946,In vivo,,50597,,1,,N,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,1,,BAO_0000218
8513,4956,A,,Intermediate,CHEMBL626856,In vivo,,50597,,1,,N,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8514,5529,A,,Intermediate,CHEMBL626857,In vivo,,50597,,1,,N,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
8515,406,A,,Intermediate,CHEMBL626858,In vivo,1969.0,50597,,1,,N,The compound was evaluated for plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8516,17655,A,,Intermediate,CHEMBL627018,In vivo,1969.0,50597,,1,,N,Total plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8517,3293,A,,Intermediate,CHEMBL625331,In vivo,178.0,50597,,1,,N,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Rattus norvegicus,,Blood,1,,BAO_0000218
8518,4075,A,,Intermediate,CHEMBL625332,In vivo,178.0,50597,,1,,N,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Rattus norvegicus,,Blood,1,,BAO_0000218
8519,2792,A,,Intermediate,CHEMBL877590,In vivo,,50597,,1,,N,C max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
8520,2792,A,,Intermediate,CHEMBL625333,In vivo,,50597,,1,,N,C max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
8521,17594,A,,Intermediate,CHEMBL625334,In vivo,,50597,,1,,N,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8522,17594,A,,Intermediate,CHEMBL625335,In vivo,,50597,,1,,N,Cmax after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8523,4762,A,,Intermediate,CHEMBL625336,In vivo,,50597,,1,,N,Cmax of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8524,17509,A,,Intermediate,CHEMBL625337,In vivo,,50597,,1,,N,Cmax 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
8525,17509,A,,Intermediate,CHEMBL625338,In vivo,,50597,,1,,N,Cmax 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
8526,1466,A,,Intermediate,CHEMBL625339,In vivo,1969.0,50597,,1,,N,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8527,6535,A,,Intermediate,CHEMBL625340,In vivo,,50597,,1,,N,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
8528,6535,A,,Intermediate,CHEMBL625341,In vivo,,50597,,1,,N,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,,,1,,BAO_0000218
8529,3169,A,,Intermediate,CHEMBL622687,In vivo,,50597,,1,,N,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8530,6515,A,,Intermediate,CHEMBL622688,In vivo,1969.0,50597,,1,,N,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8531,11149,A,,Intermediate,CHEMBL622689,In vivo,178.0,50597,,1,,N,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Rattus norvegicus,,Blood,1,,BAO_0000218
8532,11149,A,,Intermediate,CHEMBL620295,In vivo,178.0,50597,,1,,N,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,Blood,1,,BAO_0000218
8533,17858,A,,Intermediate,CHEMBL620296,In vivo,,50597,,1,,N,Cmax after 10 mg/kg oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8534,6518,A,,Intermediate,CHEMBL620297,In vivo,,50597,,1,,N,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
8535,6518,A,,Intermediate,CHEMBL620298,In vivo,,50597,,1,,N,Cmax after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
8536,4426,A,,Intermediate,CHEMBL620299,In vivo,,50597,,1,,N,Cmax after oral administration at 20 mpk in rats,Rattus norvegicus,,,1,,BAO_0000218
8537,4426,A,,Intermediate,CHEMBL620300,In vivo,,50597,,1,,N,Cmax after oral administration at 20 mpk in rats; Not performed.,Rattus norvegicus,,,1,,BAO_0000218
8538,4426,A,,Intermediate,CHEMBL620301,In vivo,,50597,,1,,N,Cmax after oral administration at 20 mpk in rats d; Not performed.,Rattus norvegicus,,,1,,BAO_0000218
8539,5656,A,,Intermediate,CHEMBL620302,In vivo,,50597,,1,,N,Cmax after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8540,6518,A,,Intermediate,CHEMBL620303,In vivo,,50597,,1,,N,Cmax after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8541,6518,A,,Intermediate,CHEMBL620304,In vivo,,50597,,1,,N,Cmax after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8542,6113,A,,Intermediate,CHEMBL620305,In vivo,,50597,,1,,N,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
8543,17764,A,,Intermediate,CHEMBL620306,In vivo,,50597,,1,,N,Cmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
8544,4756,A,,Intermediate,CHEMBL620307,In vivo,,50597,,1,,N,Cmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
8545,4756,A,,Intermediate,CHEMBL620308,In vivo,,50597,,1,,N,Cmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
8546,6402,A,,Intermediate,CHEMBL620309,In vivo,,50597,,1,,N,Cmax by administering at 20 mg/kg p.o. in rats,Rattus norvegicus,,,1,,BAO_0000218
8547,5610,A,,Intermediate,CHEMBL620310,In vivo,,50597,,1,,N,Cmax in male rat,Rattus norvegicus,,,1,,BAO_0000218
8548,5207,A,,Intermediate,CHEMBL620311,In vivo,,50597,,1,,N,Cmax in rat,Rattus norvegicus,,,1,,BAO_0000218
8549,6011,A,,Intermediate,CHEMBL620312,In vivo,,50597,,1,,N,Cmax in rat,Rattus norvegicus,,,1,,BAO_0000218
8550,6504,A,,Intermediate,CHEMBL620313,In vivo,,50597,,1,,N,Cmax in rat,Rattus norvegicus,,,1,,BAO_0000218
8551,6046,A,,Intermediate,CHEMBL620314,In vivo,,50597,,1,,N,Cmax in rat at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8552,6504,A,,Intermediate,CHEMBL620315,In vivo,,50597,,1,,N,Cmax in rat at the dose of 1 mg/kg i.v.,Rattus norvegicus,,,1,,BAO_0000218
8553,5874,A,,Intermediate,CHEMBL620316,In vivo,,50597,,1,,N,Cmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8554,17686,A,,Intermediate,CHEMBL620317,In vivo,,50597,,1,,N,Cmax in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
8555,5836,A,,Intermediate,CHEMBL620318,In vivo,,50597,,1,,N,Cmax in rats,Rattus norvegicus,,,1,,BAO_0000218
8556,17596,A,,Intermediate,CHEMBL620319,In vivo,,50597,,1,,N,Cmax in rats,Rattus norvegicus,,,1,,BAO_0000218
8557,16423,A,,Intermediate,CHEMBL620320,In vivo,,50597,,1,,N,Cmax was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8558,17804,A,,Intermediate,CHEMBL620321,In vivo,,50597,,1,,N,Cmax was measured in rats after peroral administration at 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8559,1908,A,,Intermediate,CHEMBL620322,In vivo,,50597,,1,,N,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,,1,,BAO_0000218
8560,13950,A,,Intermediate,CHEMBL620323,,,50597,,1,,N,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8561,13950,A,,Intermediate,CHEMBL620324,,1870.0,50597,,1,,N,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Frontal cortex,1,,BAO_0000218
8562,13950,A,,Intermediate,CHEMBL620325,,1870.0,50597,,1,,N,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Frontal cortex,1,,BAO_0000218
8563,13950,A,,Intermediate,CHEMBL620326,,10000000.0,50597,,1,,N,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8564,13950,A,,Intermediate,CHEMBL620327,,10000000.0,50597,,1,,N,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8565,13950,A,,Intermediate,CHEMBL620328,,,50597,,1,,N,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8566,13950,A,,Intermediate,CHEMBL620329,,,50597,,1,,N,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8567,13950,A,,Intermediate,CHEMBL620330,,1891.0,50597,,1,,N,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Midbrain,1,,BAO_0000218
8568,13950,A,,Intermediate,CHEMBL875286,,1891.0,50597,,1,,N,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Midbrain,1,,BAO_0000218
8569,13950,A,,Intermediate,CHEMBL620331,,,50597,,1,,N,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8570,13950,A,,Intermediate,CHEMBL620332,,,50597,,1,,N,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,,1,,BAO_0000218
8571,13950,A,,Intermediate,CHEMBL620333,,2435.0,50597,,1,,N,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Striatum,1,,BAO_0000218
8572,13950,A,,Intermediate,CHEMBL620334,,2435.0,50597,,1,,N,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,,Striatum,1,,BAO_0000218
8573,16434,A,,Intermediate,CHEMBL621015,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8574,16434,A,,Intermediate,CHEMBL621016,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8575,16434,A,,Intermediate,CHEMBL621191,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8576,16434,A,,Intermediate,CHEMBL621192,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8577,16434,A,,Intermediate,CHEMBL621193,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8578,16434,A,,Intermediate,CHEMBL621194,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8579,16434,A,,Intermediate,CHEMBL624204,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8580,16434,A,,Intermediate,CHEMBL624205,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8581,16435,A,,Intermediate,CHEMBL624206,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8582,16435,A,,Intermediate,CHEMBL624207,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8583,16435,A,,Intermediate,CHEMBL624208,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8584,16435,A,,Intermediate,CHEMBL624209,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8585,16435,A,,Intermediate,CHEMBL624210,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8586,16435,A,,Intermediate,CHEMBL624211,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8587,16435,A,,Intermediate,CHEMBL624212,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8588,16435,A,,Intermediate,CHEMBL624213,,178.0,50597,,1,,N,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Blood,1,,BAO_0000218
8589,16434,A,,Intermediate,CHEMBL876611,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8590,16434,A,,Intermediate,CHEMBL624214,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8591,16434,A,,Intermediate,CHEMBL624215,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8592,16435,A,,Intermediate,CHEMBL624216,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8593,16435,A,,Intermediate,CHEMBL624217,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8594,16435,A,,Intermediate,CHEMBL624218,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8595,16435,A,,Intermediate,CHEMBL624219,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8596,16435,A,,Intermediate,CHEMBL624220,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8597,16435,A,,Intermediate,CHEMBL624221,,178.0,50597,,1,,N,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Blood,1,,BAO_0000218
8598,16434,A,,Intermediate,CHEMBL624222,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
8599,16434,A,,Intermediate,CHEMBL624223,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
8600,16434,A,,Intermediate,CHEMBL624224,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
8601,16434,A,,Intermediate,CHEMBL624225,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
8602,17764,A,,Intermediate,CHEMBL622420,In vivo,,50597,,1,,N,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
8603,5031,A,,Intermediate,CHEMBL622421,In vivo,,50597,,1,,N,Volume of steady state distribution after i.v. administration in rats,Rattus norvegicus,,,1,,BAO_0000218
8604,6215,A,,Intermediate,CHEMBL622422,In vivo,,50597,,1,,N,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8605,17671,A,,Intermediate,CHEMBL622423,In vivo,,50597,,1,,N,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8606,17752,A,,Intermediate,CHEMBL622424,In vivo,,50597,,1,,N,Vss was determined,Rattus norvegicus,,,1,,BAO_0000218
8607,6596,A,,Intermediate,CHEMBL622425,In vivo,,50597,,1,,N,Vss in rat,Rattus norvegicus,,,1,,BAO_0000218
8608,16423,A,,Intermediate,CHEMBL876612,In vivo,,50597,,1,,N,Vss was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,1,,BAO_0000218
8609,15662,A,,Intermediate,CHEMBL622426,In vivo,,50597,,1,,N,volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
8610,6062,A,,Intermediate,CHEMBL622427,In vivo,,50597,,1,,N,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8611,5874,A,,Intermediate,CHEMBL622428,In vivo,,50597,,1,,N,Pharmacokinetic (PK) parameter Vz in rat,Rattus norvegicus,,,1,,BAO_0000218
8612,4942,A,,Intermediate,CHEMBL622429,In vivo,,50597,,1,,N,Volume distribution in rats,Rattus norvegicus,,,1,,BAO_0000218
8613,17796,A,,Intermediate,CHEMBL622430,In vivo,,50597,,1,,N,Volume of distribution in rat; No data,Rattus norvegicus,,,1,,BAO_0000218
8614,4890,A,,Intermediate,CHEMBL622431,In vivo,,50597,,1,,N,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
8615,15765,A,,Intermediate,CHEMBL622432,,2116.0,50597,,1,,N,% absorption predicted from in vitro rat ileum transport studies,Rattus norvegicus,,Ileum,1,,BAO_0000218
8616,13569,A,,Intermediate,CHEMBL622433,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8617,13569,A,,Intermediate,CHEMBL622434,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8618,13569,A,,Intermediate,CHEMBL622435,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8619,13569,A,,Intermediate,CHEMBL618748,In vivo,,50597,,1,,N,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
8620,13569,A,,Intermediate,CHEMBL618749,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8621,13569,A,,Intermediate,CHEMBL618750,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8622,13569,A,,Intermediate,CHEMBL618751,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8623,13569,A,,Intermediate,CHEMBL618752,In vivo,,50597,,1,,N,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
8624,4576,A,,Intermediate,CHEMBL618753,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
8625,750,A,,Intermediate,CHEMBL618754,In vivo,1969.0,50597,,1,,N,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Rattus norvegicus,,Plasma,1,,BAO_0000218
8626,750,A,,Intermediate,CHEMBL618755,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
8627,4590,A,,Intermediate,CHEMBL618756,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
8628,1716,A,,Intermediate,CHEMBL618757,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
8629,1974,A,,Intermediate,CHEMBL618758,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
8630,4502,A,,Intermediate,CHEMBL621088,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
8631,3371,A,,Intermediate,CHEMBL621089,,,50597,,1,,N,Pharmacokinetic property (cLogP) in rat,Rattus norvegicus,,,1,,BAO_0000218
8632,9099,F,,Intermediate,CHEMBL621090,,178.0,50597,,1,,N,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,,Blood,1,,BAO_0000218
8633,9099,F,,Intermediate,CHEMBL621091,,178.0,50597,,1,,N,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,,Blood,1,,BAO_0000218
8634,4590,A,,Intermediate,CHEMBL876731,In vivo,,50597,,1,,N,Clearance in rat.,Rattus norvegicus,,,1,,BAO_0000218
8635,3184,A,,Intermediate,CHEMBL621092,In vivo,,50597,,1,,N,Compound was evaluated for its clearance when administered intravenously in rat,Rattus norvegicus,,,1,,BAO_0000218
8636,16456,A,,Intermediate,CHEMBL621093,In vivo,,50597,,1,,N,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8637,4199,A,,Intermediate,CHEMBL621094,,,50597,,1,,N,Blood: Brain distribution ratio is determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8638,4199,A,,Intermediate,CHEMBL621095,,,50597,,1,,N,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Rattus norvegicus,,,1,,BAO_0000218
8639,4199,A,,Intermediate,CHEMBL621096,,,50597,,1,,N,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Rattus norvegicus,,,1,,BAO_0000218
8640,8677,A,,Intermediate,CHEMBL621097,In vivo,2113.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Kidney,1,,BAO_0000218
8641,7449,F,,Intermediate,CHEMBL621098,,,50597,,1,,N,Percent dose excreted in 0-48 hours administered ip to male rat,Rattus norvegicus,,,1,,BAO_0000218
8642,11977,A,,Intermediate,CHEMBL621099,,2037.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8643,11977,A,,Intermediate,CHEMBL621100,,2037.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8644,11977,A,,Intermediate,CHEMBL621101,,2037.0,50597,,1,,N,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8645,11977,A,,Intermediate,CHEMBL621102,,2037.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8646,11977,A,,Intermediate,CHEMBL876732,,2037.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Cerebellum,1,,BAO_0000218
8647,11977,A,,Intermediate,CHEMBL621103,,,50597,,1,,N,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8648,11977,A,,Intermediate,CHEMBL621104,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8649,11977,A,,Intermediate,CHEMBL621105,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,1,,BAO_0000218
8650,11977,A,,Intermediate,CHEMBL621106,,,50597,,1,,N,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8651,11977,A,,Intermediate,CHEMBL621107,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8652,11977,A,,Intermediate,CHEMBL621108,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8653,11977,A,,Intermediate,CHEMBL621109,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8654,17208,A,,Intermediate,CHEMBL621110,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8655,17208,A,,Intermediate,CHEMBL621111,In vivo,2113.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Kidney,1,,BAO_0000218
8656,17208,A,,Intermediate,CHEMBL622541,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8657,17208,A,,Intermediate,CHEMBL622542,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8658,17208,A,,Intermediate,CHEMBL622543,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8659,17208,A,,Intermediate,CHEMBL624412,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8660,17208,A,,Intermediate,CHEMBL624413,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8661,17208,A,,Intermediate,CHEMBL624414,In vivo,2107.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Liver,1,,BAO_0000218
8662,17208,A,,Intermediate,CHEMBL624415,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8663,17208,A,,Intermediate,CHEMBL624416,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8664,17208,A,,Intermediate,CHEMBL624417,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8665,17208,A,,Intermediate,CHEMBL624418,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8666,17208,A,,Intermediate,CHEMBL624419,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8667,17208,A,,Intermediate,CHEMBL624420,In vivo,2048.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Lung,1,,BAO_0000218
8668,17208,A,,Intermediate,CHEMBL624421,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8669,17208,A,,Intermediate,CHEMBL624422,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8670,17208,A,,Intermediate,CHEMBL624423,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8671,17208,A,,Intermediate,CHEMBL625123,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8672,17208,A,,Intermediate,CHEMBL625124,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8673,17208,A,,Intermediate,CHEMBL625125,In vivo,2385.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Muscle tissue,1,,BAO_0000218
8674,17208,A,,Intermediate,CHEMBL625126,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8675,17208,A,,Intermediate,CHEMBL626947,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8676,17208,A,,Intermediate,CHEMBL626948,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8677,17208,A,,Intermediate,CHEMBL626949,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8678,17208,A,,Intermediate,CHEMBL626950,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8679,17208,A,,Intermediate,CHEMBL626951,In vivo,14.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Zone of skin,1,,BAO_0000218
8680,17208,A,,Intermediate,CHEMBL626952,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8681,17208,A,,Intermediate,CHEMBL626953,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8682,17208,A,,Intermediate,CHEMBL626954,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8683,17208,A,,Intermediate,CHEMBL626955,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8684,17208,A,,Intermediate,CHEMBL626956,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8685,17208,A,,Intermediate,CHEMBL626957,In vivo,2106.0,50594,,1,,N,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Spleen,1,,BAO_0000218
8686,17208,A,,Intermediate,CHEMBL626958,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8687,17208,A,,Intermediate,CHEMBL626959,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8688,17208,A,,Intermediate,CHEMBL626960,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8689,17208,A,,Intermediate,CHEMBL626961,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8690,17208,A,,Intermediate,CHEMBL627589,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8691,17208,A,,Intermediate,CHEMBL627590,In vivo,178.0,50594,,1,,N,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,,Blood,1,,BAO_0000218
8692,3132,A,,Intermediate,CHEMBL627591,,,50594,,1,,N,Time taken for EC90 was determined when tested in mouse,Mus musculus,,,1,,BAO_0000218
8693,3132,A,,Intermediate,CHEMBL627592,,,50594,,1,,N,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Mus musculus,,,1,,BAO_0000218
8694,16597,A,,Intermediate,CHEMBL627593,In vivo,,50594,,1,,N,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Mus musculus,,,1,,BAO_0000218
8695,5727,A,,Intermediate,CHEMBL627594,,,50594,,1,,N,Half life in mice,Mus musculus,,,1,,BAO_0000218
8696,5302,A,,Intermediate,CHEMBL876813,In vivo,,50594,,1,,N,Half life period in mouse after 10 mg/Kg dose,Mus musculus,,,1,,BAO_0000218
8697,5302,A,,Intermediate,CHEMBL627595,In vivo,,50594,,1,,N,Half life period in mouse after 10 mg/kg dose,Mus musculus,,,1,,BAO_0000218
8698,6348,A,,Intermediate,CHEMBL627596,In vivo,,50594,,1,,N,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Mus musculus,,,1,,BAO_0000218
8699,5964,A,,Intermediate,CHEMBL627597,In vivo,,50597,,1,,N,Cmax value at 5 mg/kg po was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
8700,6078,A,,Intermediate,CHEMBL627598,In vivo,,50597,,1,,N,Cmax value evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
8701,5206,A,,Intermediate,CHEMBL627599,In vivo,955.0,50597,,1,,N,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Rattus norvegicus,,Brain,1,,BAO_0000218
8702,2959,A,,Intermediate,CHEMBL627600,In vivo,,50597,,1,,N,Cmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,1,,BAO_0000218
8703,5964,A,,Intermediate,CHEMBL627601,In vivo,,50597,,1,,N,Cmax value at 1 mg/kg po in rat,Rattus norvegicus,,,1,,BAO_0000218
8704,5964,A,,Intermediate,CHEMBL627776,In vivo,,50597,,1,,N,Cmax value at 5 mg/kg po in rat,Rattus norvegicus,,,1,,BAO_0000218
8705,6757,A,,Intermediate,CHEMBL627777,In vivo,,50597,,1,,N,Cmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8706,6757,A,,Intermediate,CHEMBL627778,In vivo,,50597,,1,,N,Cmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8707,6757,A,,Intermediate,CHEMBL627779,In vivo,,50597,,1,,N,Cmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
8708,17617,A,,Intermediate,CHEMBL876814,In vivo,,50597,,1,,N,Cmax value in rats at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8709,1445,A,,Intermediate,CHEMBL627780,In vivo,,50597,,1,,N,Cmax value was evaluated in rats at a dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8710,6082,A,,Intermediate,CHEMBL627781,In vivo,,50597,,1,,N,Cmax value was determined after peroral administration of 20 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8711,1446,A,,Intermediate,CHEMBL627782,In vivo,,50597,,1,,N,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,,,1,,BAO_0000218
8712,5407,A,,Intermediate,CHEMBL627783,In vivo,1969.0,50597,,1,,N,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8713,2690,A,,Intermediate,CHEMBL627784,In vivo,1969.0,50597,,1,,N,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8714,2661,A,,Intermediate,CHEMBL627785,In vivo,,50597,,1,,N,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
8715,2661,A,,Intermediate,CHEMBL627786,In vivo,,50597,,1,,N,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
8716,4891,A,,Intermediate,CHEMBL627787,In vivo,1969.0,50597,,1,,N,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8717,2807,A,,Intermediate,CHEMBL627788,In vivo,1969.0,50597,,1,,N,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Rattus norvegicus,,Plasma,1,,BAO_0000218
8718,2807,A,,Intermediate,CHEMBL626579,In vivo,1969.0,50597,,1,,N,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Rattus norvegicus,,Plasma,1,,BAO_0000218
8719,2807,A,,Intermediate,CHEMBL626580,In vivo,1969.0,50597,,1,,N,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Rattus norvegicus,,Plasma,1,,BAO_0000218
8720,3634,A,,Intermediate,CHEMBL876815,In vivo,,50597,,1,,N,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8721,1881,A,,Intermediate,CHEMBL626581,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Rattus norvegicus,,Plasma,1,,BAO_0000218
8722,1881,A,,Intermediate,CHEMBL626582,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Rattus norvegicus,,Plasma,1,,BAO_0000218
8723,429,A,,Intermediate,CHEMBL626583,In vivo,,50597,,1,,N,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
8724,5974,A,,Intermediate,CHEMBL626205,In vivo,,50597,,1,,N,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8725,5974,A,,Intermediate,CHEMBL626206,In vivo,,50597,,1,,N,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8726,5974,A,,Intermediate,CHEMBL626207,In vivo,,50597,,1,,N,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8727,5974,A,,Intermediate,CHEMBL623882,In vivo,,50597,,1,,N,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
8728,17582,A,,Intermediate,CHEMBL623883,In vivo,,50597,,1,,N,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Rattus norvegicus,,,1,,BAO_0000218
8729,17582,A,,Intermediate,CHEMBL623884,In vivo,,50597,,1,,N,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
8730,3032,A,,Intermediate,CHEMBL623885,In vivo,1969.0,50597,,1,,N,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,Plasma,1,,BAO_0000218
8731,6295,A,,Intermediate,CHEMBL623886,In vivo,1969.0,50597,,1,,N,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8732,6619,A,,Intermediate,CHEMBL623887,In vivo,,50597,,1,,N,Maximal concentration in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8733,6616,A,,Intermediate,CHEMBL623888,In vivo,,50597,,1,,N,Maximal concentration after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
8734,3249,A,,Intermediate,CHEMBL623889,In vivo,1969.0,50597,,1,,N,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8735,17791,A,,Intermediate,CHEMBL623890,In vivo,1969.0,50597,,1,,N,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8736,17791,A,,Intermediate,CHEMBL623891,In vivo,1969.0,50597,,1,,N,Cmax in rat plasma after oral dose (50 mg/Kg),Rattus norvegicus,,Plasma,1,,BAO_0000218
8737,1360,A,,Intermediate,CHEMBL623892,In vivo,1969.0,50597,,1,,N,Maximal plasma concentration was determined.,Rattus norvegicus,,Plasma,1,,BAO_0000218
8738,2552,A,,Intermediate,CHEMBL623893,In vivo,1969.0,50597,,1,,N,Maximal plasma drug concentration was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
8739,6571,A,,Intermediate,CHEMBL877616,In vivo,,50597,,1,,N,Maximal concentration in rats after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8740,6570,A,,Intermediate,CHEMBL623894,In vivo,,50597,,1,,N,Maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
8741,6567,A,,Intermediate,CHEMBL623895,In vivo,1969.0,50597,,1,,N,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Rattus norvegicus,,Plasma,1,,BAO_0000218
8742,3031,A,,Intermediate,CHEMBL623896,In vivo,,50597,,1,,N,Maximum concentration of compound in rat was evaluated.,Rattus norvegicus,,,1,,BAO_0000218
8743,3436,A,,Intermediate,CHEMBL623897,In vivo,,50597,,1,,N,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8744,3436,A,,Intermediate,CHEMBL623898,In vivo,,50597,,1,,N,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8745,2083,A,,Intermediate,CHEMBL623899,In vivo,,50597,,1,,N,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,,,1,,BAO_0000218
8746,3436,A,,Intermediate,CHEMBL623900,In vivo,,50597,,1,,N,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8747,4527,A,,Intermediate,CHEMBL623901,In vivo,,50597,,1,,N,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
8748,1974,A,,Intermediate,CHEMBL623902,In vivo,,50597,,1,,N,Maximum concentration was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
8749,3307,A,,Intermediate,CHEMBL623903,In vivo,1359.0,50597,,1,,N,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,Cerebrospinal fluid,1,,BAO_0000218
8750,3307,A,,Intermediate,CHEMBL623904,In vivo,1969.0,50597,,1,,N,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8751,1916,A,,Intermediate,CHEMBL877617,In vivo,1969.0,50597,,1,,N,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8752,1500,A,,Intermediate,CHEMBL623905,In vivo,,50597,,1,,N,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8753,1500,A,,Intermediate,CHEMBL623906,In vivo,,50597,,1,,N,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
8754,4186,A,,Intermediate,CHEMBL623907,In vivo,1969.0,50597,,1,,N,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,Plasma,1,,BAO_0000218
8755,16434,A,,Intermediate,CHEMBL623908,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
8756,16434,A,,Intermediate,CHEMBL623909,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
8757,16434,A,,Intermediate,CHEMBL623910,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
8758,16434,A,,Intermediate,CHEMBL623911,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
8759,16435,A,,Intermediate,CHEMBL623912,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
8760,16435,A,,Intermediate,CHEMBL624616,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
8761,16435,A,,Intermediate,CHEMBL624617,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
8762,16435,A,,Intermediate,CHEMBL624618,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
8763,16435,A,,Intermediate,CHEMBL624619,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
8764,16435,A,,Intermediate,CHEMBL624794,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
8765,16435,A,,Intermediate,CHEMBL624795,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
8766,16435,A,,Intermediate,CHEMBL623921,,,50597,,1,,N,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
8767,16434,A,,Intermediate,CHEMBL623922,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,1,,BAO_0000218
8768,16434,A,,Intermediate,CHEMBL623923,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,1,,BAO_0000218
8769,16434,A,,Intermediate,CHEMBL623924,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,1,,BAO_0000218
8770,16435,A,,Intermediate,CHEMBL623925,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
8771,16435,A,,Intermediate,CHEMBL623926,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
8772,16435,A,,Intermediate,CHEMBL623927,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
8773,16435,A,,Intermediate,CHEMBL623928,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
8774,16435,A,,Intermediate,CHEMBL623929,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
8775,16435,A,,Intermediate,CHEMBL623930,,,50597,,1,,N,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
8776,16434,A,,Intermediate,CHEMBL623931,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8777,16434,A,,Intermediate,CHEMBL622165,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8778,16434,A,,Intermediate,CHEMBL621249,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8779,16434,A,,Intermediate,CHEMBL621250,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8780,16434,A,,Intermediate,CHEMBL621448,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8781,16434,A,,Intermediate,CHEMBL621449,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8782,16434,A,,Intermediate,CHEMBL621450,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8783,16434,A,,Intermediate,CHEMBL621451,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8784,16435,A,,Intermediate,CHEMBL621452,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8785,16435,A,,Intermediate,CHEMBL621453,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8786,16435,A,,Intermediate,CHEMBL621454,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8787,16435,A,,Intermediate,CHEMBL621455,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8788,16435,A,,Intermediate,CHEMBL621456,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8789,16435,A,,Intermediate,CHEMBL625145,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8790,16435,A,,Intermediate,CHEMBL875847,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8791,16435,A,,Intermediate,CHEMBL625146,,955.0,50597,,1,,N,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Brain,1,,BAO_0000218
8792,16434,A,,Intermediate,CHEMBL625147,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8793,16434,A,,Intermediate,CHEMBL625148,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8794,16434,A,,Intermediate,CHEMBL625149,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8795,16435,A,,Intermediate,CHEMBL625150,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8796,16435,A,,Intermediate,CHEMBL625151,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8797,16435,A,,Intermediate,CHEMBL625152,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8798,16435,A,,Intermediate,CHEMBL625153,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8799,16435,A,,Intermediate,CHEMBL625154,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8800,16435,A,,Intermediate,CHEMBL625155,,955.0,50597,,1,,N,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Brain,1,,BAO_0000218
8801,11977,A,,Intermediate,CHEMBL625156,,,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,,1,,BAO_0000218
8802,11977,A,,Intermediate,CHEMBL624354,,,50597,,1,,N,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,,1,,BAO_0000218
8803,11977,A,,Intermediate,CHEMBL624355,,10000000.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8804,11977,A,,Intermediate,CHEMBL624356,,10000000.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8805,11977,A,,Intermediate,CHEMBL624357,,10000000.0,50597,,1,,N,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8806,11977,A,,Intermediate,CHEMBL624358,,10000000.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Hippocampus,1,,BAO_0000218
8807,11977,A,,Intermediate,CHEMBL624359,,2435.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Striatum,1,,BAO_0000218
8808,11977,A,,Intermediate,CHEMBL624360,,2435.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Striatum,1,,BAO_0000218
8809,11977,A,,Intermediate,CHEMBL624361,,2435.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Striatum,1,,BAO_0000218
8810,11977,A,,Intermediate,CHEMBL624362,,2435.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Striatum,1,,BAO_0000218
8811,11977,A,,Intermediate,CHEMBL624363,,2435.0,50597,,1,,N,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Striatum,1,,BAO_0000218
8812,11977,A,,Intermediate,CHEMBL624364,In vivo,178.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Blood,1,,BAO_0000218
8813,11977,A,,Intermediate,CHEMBL624365,In vivo,178.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Blood,1,,BAO_0000218
8814,11977,A,,Intermediate,CHEMBL624366,In vivo,178.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Blood,1,,BAO_0000218
8815,11977,A,,Intermediate,CHEMBL624367,In vivo,178.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Blood,1,,BAO_0000218
8816,11977,A,,Intermediate,CHEMBL624368,In vivo,955.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Brain,1,,BAO_0000218
8817,11977,A,,Intermediate,CHEMBL624369,In vivo,955.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Brain,1,,BAO_0000218
8818,11977,A,,Intermediate,CHEMBL624370,In vivo,955.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Brain,1,,BAO_0000218
8819,11977,A,,Intermediate,CHEMBL625069,In vivo,955.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Brain,1,,BAO_0000218
8820,11977,A,,Intermediate,CHEMBL625070,In vivo,955.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Brain,1,,BAO_0000218
8821,11977,A,,Intermediate,CHEMBL626051,In vivo,948.0,50597,,1,,N,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Heart,1,,BAO_0000218
8822,11977,A,,Intermediate,CHEMBL626052,In vivo,948.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Heart,1,,BAO_0000218
8823,11977,A,,Intermediate,CHEMBL626053,In vivo,948.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Heart,1,,BAO_0000218
8824,11977,A,,Intermediate,CHEMBL626054,In vivo,948.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Heart,1,,BAO_0000218
8825,11977,A,,Intermediate,CHEMBL626055,In vivo,948.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Heart,1,,BAO_0000218
8826,11977,A,,Intermediate,CHEMBL626056,In vivo,2113.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Kidney,1,,BAO_0000218
8827,11977,A,,Intermediate,CHEMBL626057,In vivo,2113.0,50597,,1,,N,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Kidney,1,,BAO_0000218
8828,11977,A,,Intermediate,CHEMBL625193,In vivo,2113.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Kidney,1,,BAO_0000218
8829,11977,A,,Intermediate,CHEMBL625194,In vivo,2113.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Kidney,1,,BAO_0000218
8830,11977,A,,Intermediate,CHEMBL625195,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
8831,11977,A,,Intermediate,CHEMBL625196,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
8832,11977,A,,Intermediate,CHEMBL625197,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
8833,11977,A,,Intermediate,CHEMBL625198,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
8834,11977,A,,Intermediate,CHEMBL627929,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
8835,11977,A,,Intermediate,CHEMBL627074,In vivo,2048.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Lung,1,,BAO_0000218
8836,11977,A,,Intermediate,CHEMBL627075,In vivo,2048.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Lung,1,,BAO_0000218
8837,11977,A,,Intermediate,CHEMBL627076,In vivo,2048.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Lung,1,,BAO_0000218
8838,11977,A,,Intermediate,CHEMBL627077,In vivo,2048.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Lung,1,,BAO_0000218
8839,11977,A,,Intermediate,CHEMBL627078,In vivo,2048.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Lung,1,,BAO_0000218
8840,11977,A,,Intermediate,CHEMBL627079,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8841,4573,A,,Intermediate,CHEMBL873824,In vivo,,50594,,1,,N,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Mus musculus,,,1,,BAO_0000218
8842,3132,A,,Intermediate,CHEMBL627080,In vivo,1969.0,50594,,1,,N,Half life in mouse plasma was determined at dose 25 mg/kg,Mus musculus,,Plasma,1,,BAO_0000218
8843,17718,A,,Intermediate,CHEMBL627081,,,50594,,1,,N,Half life was determined,Mus musculus,,,1,,BAO_0000218
8844,17728,A,,Intermediate,CHEMBL627082,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,,,1,,BAO_0000218
8845,5961,A,,Intermediate,CHEMBL627083,In vivo,,50594,,1,,N,Half-life in male mice after 1 mg/kg intravenous dose,Mus musculus,,,1,,BAO_0000218
8847,17731,A,,Intermediate,CHEMBL627085,,1969.0,50594,,1,,N,Half life in mice plasma,Mus musculus,,Plasma,1,,BAO_0000218
8848,17592,A,,Intermediate,CHEMBL627086,,,50594,,1,,N,Half life in mouse,Mus musculus,,,1,,BAO_0000218
8849,3132,A,,Intermediate,CHEMBL627087,In vivo,1969.0,50594,,1,,N,Half life in mouse plasma at dose 25 mg/kg,Mus musculus,,Plasma,1,,BAO_0000218
8850,17729,A,,Intermediate,CHEMBL627088,In vivo,,50594,,1,,N,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Mus musculus,,,1,,BAO_0000218
8851,17729,A,,Intermediate,CHEMBL627089,In vivo,,50594,,1,,N,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Mus musculus,,,1,,BAO_0000218
8852,17729,A,,Intermediate,CHEMBL627090,In vivo,,50594,,1,,N,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Mus musculus,,,1,,BAO_0000218
8853,3277,A,,Intermediate,CHEMBL627091,In vivo,,50594,,1,,N,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Mus musculus,,,1,,BAO_0000218
8854,3760,A,,Intermediate,CHEMBL627092,In vivo,,50594,,1,,N,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Mus musculus,,,1,,BAO_0000218
8855,3760,A,,Intermediate,CHEMBL876785,In vivo,,50594,,1,,N,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Mus musculus,,,1,,BAO_0000218
8856,2862,A,,Intermediate,CHEMBL627093,In vivo,,50594,,1,,N,Half-life by iv administration in mouse,Mus musculus,,,1,,BAO_0000218
8857,2862,A,,Intermediate,CHEMBL627094,In vivo,,50594,,1,,N,Half-life by oral administration in mouse,Mus musculus,,,1,,BAO_0000218
8858,5980,A,,Intermediate,CHEMBL627095,,,50594,,1,,N,Half-life in mice,Mus musculus,,,1,,BAO_0000218
8859,6159,A,,Intermediate,CHEMBL627096,,955.0,50594,,1,,N,Half-life using mouse brain homogenate,Mus musculus,,Brain,1,,BAO_0000218
8860,6254,A,,Intermediate,CHEMBL627097,,,50594,,1,,N,Half-life was measured in mice,Mus musculus,,,1,,BAO_0000218
8861,6062,A,,Intermediate,CHEMBL627098,In vivo,,50594,,1,,N,Half-life was measured in mouse after an iv dose of 1 mg/kg,Mus musculus,,,1,,BAO_0000218
8862,1574,A,,Intermediate,CHEMBL627099,,178.0,50594,,1,,N,Half-life period was determined in mouse blood,Mus musculus,,Blood,1,,BAO_0000218
8863,56,A,,Intermediate,CHEMBL627100,,955.0,50594,,1,,N,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Mus musculus,,Brain,1,,BAO_0000218
8864,993,A,,Intermediate,CHEMBL627101,,1969.0,50594,,1,,N,Plasma half life in mouse,Mus musculus,,Plasma,1,,BAO_0000218
8865,6652,A,,Intermediate,CHEMBL627102,,,50594,,1,,N,Stability of the peptide in the presence of mouse serum,Mus musculus,,,1,,BAO_0000218
8866,17852,A,,Intermediate,CHEMBL627103,,,50594,,1,,N,Terminal half life of compound was determined in mouse,Mus musculus,,,1,,BAO_0000218
8867,2675,A,,Intermediate,CHEMBL627104,In vivo,,50594,,1,,N,Terminal half life was evaluated in mice after intravenous administration,Mus musculus,,,1,,BAO_0000218
8868,2675,A,,Intermediate,CHEMBL627105,In vivo,,50594,,1,,N,Terminal half life was evaluated in mice after oral administration,Mus musculus,,,1,,BAO_0000218
8869,499,A,,Intermediate,CHEMBL876786,,,50594,,1,,N,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Mus musculus,,,1,,BAO_0000218
8870,499,A,,Intermediate,CHEMBL873825,,,50594,,1,,N,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Mus musculus,,,1,,BAO_0000218
8871,499,A,,Intermediate,CHEMBL627106,,,50594,,1,,N,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Mus musculus,,,1,,BAO_0000218
8872,14239,A,,Intermediate,CHEMBL626336,In vivo,,50594,,1,,N,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Mus musculus,,,1,,BAO_0000218
8873,5506,A,,Intermediate,CHEMBL877462,In vivo,,50594,,1,,N,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Mus musculus,,,1,,BAO_0000218
8874,5506,A,,Intermediate,CHEMBL626337,In vivo,,50594,,1,,N,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Mus musculus,,,1,,BAO_0000218
8875,17734,A,,Intermediate,CHEMBL626338,,,50594,,1,,N,Half life after intraperitoneal administration of 100 mg/kg in mice,Mus musculus,,,1,,BAO_0000218
8876,17728,A,,Intermediate,CHEMBL626339,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Mus musculus,,,1,,BAO_0000218
8877,17728,A,,Intermediate,CHEMBL626340,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,,,1,,BAO_0000218
8878,17728,A,,Intermediate,CHEMBL625377,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Mus musculus,,,1,,BAO_0000218
8879,17728,A,,Intermediate,CHEMBL625378,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Mus musculus,,,1,,BAO_0000218
8880,17728,A,,Intermediate,CHEMBL625379,In vivo,,50594,,1,,N,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Mus musculus,,,1,,BAO_0000218
8881,14294,A,,Autocuration,CHEMBL625380,,,22224,,1,,U,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Sus scrofa,Microsomes,,0,,BAO_0000251
8882,14294,A,,Autocuration,CHEMBL625381,,,22224,,1,,U,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Sus scrofa,Microsomes,,0,,BAO_0000251
8883,6056,A,,Autocuration,CHEMBL625382,,,22224,,1,,U,Stability to porcine renal DHP-I,Sus scrofa,,,0,,BAO_0000019
8884,1317,A,,Autocuration,CHEMBL873828,In vivo,,22224,,1,,U,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Sus scrofa,,,0,,BAO_0000218
8885,1317,A,,Autocuration,CHEMBL625383,In vivo,,22224,,1,,U,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Sus scrofa,,,0,,BAO_0000218
8886,5229,A,,Autocuration,CHEMBL625384,,,22224,,1,,U,Half-life of the parent prodrug in porcine esterase solution,Sus scrofa,,,0,,BAO_0000019
8887,4231,A,,Autocuration,CHEMBL625385,,,22224,,1,,U,"First order rate constant, k was determined in in pig liver Esterase",Sus scrofa,,,0,,BAO_0000019
8888,4231,A,,Autocuration,CHEMBL625386,,2107.0,22224,,1,,U,Half life of the in pig liver Esterase,Sus scrofa,,Liver,0,,BAO_0000221
8889,5318,A,,Autocuration,CHEMBL623571,,2107.0,22224,,1,,U,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Sus scrofa,,Liver,0,,BAO_0000221
8890,5318,A,,Autocuration,CHEMBL623572,,2107.0,22224,,1,,U,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Sus scrofa,,Liver,0,,BAO_0000221
8891,5318,A,,Autocuration,CHEMBL623573,,2107.0,22224,,1,,U,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Sus scrofa,,Liver,0,,BAO_0000221
8892,3305,A,,Autocuration,CHEMBL623574,,2107.0,22224,,1,,U,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Sus scrofa,,Liver,0,,BAO_0000221
8893,3305,A,,Autocuration,CHEMBL623575,,2107.0,22224,,1,,U,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Sus scrofa,,Liver,0,,BAO_0000221
8894,2842,A,,Autocuration,CHEMBL623749,,2107.0,22224,,1,,U,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Sus scrofa,,Liver,0,,BAO_0000221
8895,2842,A,,Autocuration,CHEMBL623750,,2107.0,22224,,1,,U,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Sus scrofa,,Liver,0,,BAO_0000221
8896,889,A,,Autocuration,CHEMBL623751,In vitro,2107.0,22224,,1,,U,Half-life in vitro in pig liver,Sus scrofa,,Liver,0,,BAO_0000221
8897,1904,A,,Autocuration,CHEMBL623752,,2107.0,22224,,1,,U,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Sus scrofa,,Liver,0,,BAO_0000221
8898,4186,A,,Intermediate,CHEMBL623753,In vivo,1969.0,50597,,1,,N,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Rattus norvegicus,,Plasma,1,,BAO_0000218
8899,2774,A,,Intermediate,CHEMBL623754,In vivo,1969.0,50597,,1,,N,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,,Plasma,1,,BAO_0000218
8900,1742,A,,Intermediate,CHEMBL623755,In vivo,1969.0,50597,,1,,N,Maximum concentration in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
8901,3169,A,,Intermediate,CHEMBL623756,In vivo,,50597,,1,,N,Maximum concentration in rats,Rattus norvegicus,,,1,,BAO_0000218
8902,3169,A,,Intermediate,CHEMBL623757,In vivo,,50597,,1,,N,Maximum concentration in rats at 1-2 hours,Rattus norvegicus,,,1,,BAO_0000218
8903,2081,A,,Intermediate,CHEMBL623758,In vivo,,50597,,1,,N,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Rattus norvegicus,,,1,,BAO_0000218
8904,3307,A,,Intermediate,CHEMBL623759,In vivo,955.0,50597,,1,,N,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,,Brain,1,,BAO_0000218
8905,4727,A,,Intermediate,CHEMBL623760,In vivo,,50597,,1,,N,Maximum concentration at the dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
8906,6597,A,,Intermediate,CHEMBL623761,In vivo,,50597,,1,,N,Maximum concentration was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
8907,16365,A,,Intermediate,CHEMBL623762,In vivo,1969.0,50597,,1,,N,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8908,16365,A,,Intermediate,CHEMBL877594,In vivo,1969.0,50597,,1,,N,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8909,16365,A,,Intermediate,CHEMBL623763,In vivo,1969.0,50597,,1,,N,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8910,16365,A,,Intermediate,CHEMBL623764,In vivo,1969.0,50597,,1,,N,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8911,16365,A,,Intermediate,CHEMBL623765,In vivo,1969.0,50597,,1,,N,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8912,2591,A,,Intermediate,CHEMBL623766,In vivo,178.0,50597,,1,,N,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
8913,2591,A,,Intermediate,CHEMBL623767,In vivo,178.0,50597,,1,,N,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
8914,2591,A,,Intermediate,CHEMBL623768,In vivo,178.0,50597,,1,,N,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
8915,5978,A,,Intermediate,CHEMBL623769,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8916,5978,A,,Intermediate,CHEMBL623770,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8917,5978,A,,Intermediate,CHEMBL623771,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8918,5978,A,,Intermediate,CHEMBL623772,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8919,5978,A,,Intermediate,CHEMBL623773,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8920,5978,A,,Intermediate,CHEMBL623774,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8921,5978,A,,Intermediate,CHEMBL623775,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8922,14465,A,,Intermediate,CHEMBL623776,In vivo,,50597,,1,,N,Cmax in rat (PO dose),Rattus norvegicus,,,1,,BAO_0000218
8923,4723,A,,Intermediate,CHEMBL622191,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8924,4723,A,,Intermediate,CHEMBL622192,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8925,4576,A,,Intermediate,CHEMBL622193,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration determined in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8926,12873,A,,Intermediate,CHEMBL622194,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8927,12873,A,,Intermediate,CHEMBL622195,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
8928,6824,A,,Intermediate,CHEMBL622196,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8929,17065,A,,Intermediate,CHEMBL622197,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8930,2932,A,,Intermediate,CHEMBL622198,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Rattus norvegicus,,Plasma,1,,BAO_0000218
8931,2932,A,,Intermediate,CHEMBL622199,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Rattus norvegicus,,Plasma,1,,BAO_0000218
8932,2879,A,,Intermediate,CHEMBL622200,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration of compound was measured in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8933,2864,A,,Intermediate,CHEMBL622201,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration after 20 mg/kg oral administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
8934,16367,A,,Intermediate,CHEMBL623990,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration after oral administration to rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8935,17717,A,,Intermediate,CHEMBL623991,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,Plasma,1,,BAO_0000218
8936,17717,A,,Intermediate,CHEMBL623992,In vivo,1969.0,50597,,1,,N,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,,Plasma,1,,BAO_0000218
8937,17717,A,,Intermediate,CHEMBL623993,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,Plasma,1,,BAO_0000218
8938,17717,A,,Intermediate,CHEMBL623994,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,Plasma,1,,BAO_0000218
8939,17720,F,,Intermediate,CHEMBL623995,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8940,17720,F,,Intermediate,CHEMBL623996,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8941,17720,F,,Intermediate,CHEMBL623997,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8942,4516,A,,Intermediate,CHEMBL623998,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration dosed orally in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8943,4516,A,,Intermediate,CHEMBL623999,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration dosed orally in rats after 6 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
8944,4516,A,,Intermediate,CHEMBL624000,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Rattus norvegicus,,Plasma,1,,BAO_0000218
8945,5199,A,,Intermediate,CHEMBL624001,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
8946,17538,A,,Intermediate,CHEMBL624002,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in rat after po administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
8947,6685,A,,Intermediate,CHEMBL624003,In vivo,1969.0,50597,,1,,N,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,Plasma,1,,BAO_0000218
8948,6685,A,,Intermediate,CHEMBL624004,In vivo,1969.0,50597,,1,,N,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Rattus norvegicus,,Plasma,1,,BAO_0000218
8949,16434,A,,Intermediate,CHEMBL624005,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8950,16434,A,,Intermediate,CHEMBL624006,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8951,16434,A,,Intermediate,CHEMBL624007,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8952,16434,A,,Intermediate,CHEMBL624008,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8953,16434,A,,Intermediate,CHEMBL624009,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8954,16434,A,,Intermediate,CHEMBL874387,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8955,16434,A,,Intermediate,CHEMBL624010,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8956,16434,A,,Intermediate,CHEMBL624011,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8957,16435,A,,Intermediate,CHEMBL624012,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8958,16435,A,,Intermediate,CHEMBL624013,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8959,16435,A,,Intermediate,CHEMBL624736,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8960,16435,A,,Intermediate,CHEMBL624737,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8961,16434,A,,Intermediate,CHEMBL624738,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8962,16434,A,,Intermediate,CHEMBL624739,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8963,16434,A,,Intermediate,CHEMBL624740,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8964,16435,A,,Intermediate,CHEMBL624896,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8965,16435,A,,Intermediate,CHEMBL624897,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8966,16435,A,,Intermediate,CHEMBL624108,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8967,16435,A,,Intermediate,CHEMBL624109,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8968,16435,A,,Intermediate,CHEMBL624110,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8969,16435,A,,Intermediate,CHEMBL624111,,948.0,50597,,1,,N,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Heart,1,,BAO_0000218
8970,16435,A,,Intermediate,CHEMBL624112,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8971,16435,A,,Intermediate,CHEMBL624113,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8972,16435,A,,Intermediate,CHEMBL619709,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8973,16435,A,,Intermediate,CHEMBL619710,,948.0,50597,,1,,N,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Heart,1,,BAO_0000218
8974,16434,A,,Intermediate,CHEMBL619711,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8975,16434,A,,Intermediate,CHEMBL619712,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8976,16434,A,,Intermediate,CHEMBL619713,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8977,16434,A,,Intermediate,CHEMBL619714,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8978,16434,A,,Intermediate,CHEMBL619715,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8979,16434,A,,Intermediate,CHEMBL619716,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8980,16434,A,,Intermediate,CHEMBL619717,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8981,16434,A,,Intermediate,CHEMBL619718,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8982,16435,A,,Intermediate,CHEMBL619719,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8983,16435,A,,Intermediate,CHEMBL875329,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8984,16435,A,,Intermediate,CHEMBL619720,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8985,16435,A,,Intermediate,CHEMBL619721,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8986,16435,A,,Intermediate,CHEMBL619722,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8987,16435,A,,Intermediate,CHEMBL619723,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8988,16435,A,,Intermediate,CHEMBL619724,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8989,16435,A,,Intermediate,CHEMBL619725,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Kidney,1,,BAO_0000218
8990,16434,A,,Intermediate,CHEMBL619726,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
8991,16434,A,,Intermediate,CHEMBL619727,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
8992,16434,A,,Intermediate,CHEMBL619728,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
8993,16435,A,,Intermediate,CHEMBL619729,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
8994,11977,A,,Intermediate,CHEMBL619730,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8995,11977,A,,Intermediate,CHEMBL619731,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8996,11977,A,,Intermediate,CHEMBL619732,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8997,11977,A,,Intermediate,CHEMBL619733,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8998,11977,A,,Intermediate,CHEMBL619734,In vivo,2385.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
8999,11977,A,,Intermediate,CHEMBL619735,In vivo,14.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9000,11977,A,,Intermediate,CHEMBL875330,In vivo,14.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9001,11977,A,,Intermediate,CHEMBL628465,In vivo,14.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9002,11977,A,,Intermediate,CHEMBL628466,In vivo,14.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9003,11977,A,,Intermediate,CHEMBL628467,In vivo,14.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9004,11977,A,,Intermediate,CHEMBL628468,In vivo,2106.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Spleen,1,,BAO_0000218
9005,11977,A,,Intermediate,CHEMBL628469,In vivo,2106.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Spleen,1,,BAO_0000218
9006,11977,A,,Intermediate,CHEMBL628470,In vivo,2106.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Spleen,1,,BAO_0000218
9007,11977,A,,Intermediate,CHEMBL628471,In vivo,2106.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Spleen,1,,BAO_0000218
9008,11977,A,,Intermediate,CHEMBL628472,In vivo,2106.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Spleen,1,,BAO_0000218
9009,11977,A,,Intermediate,CHEMBL625191,In vivo,2046.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9010,11977,A,,Intermediate,CHEMBL625192,In vivo,2046.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9011,11977,A,,Intermediate,CHEMBL875337,In vivo,2046.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9012,11977,A,,Intermediate,CHEMBL626341,In vivo,2046.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9013,11977,A,,Intermediate,CHEMBL626342,In vivo,2046.0,50597,,1,,N,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9014,11977,A,,Intermediate,CHEMBL621943,In vivo,2107.0,50597,,1,,N,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,,Liver,1,,BAO_0000218
9015,3748,A,,Intermediate,CHEMBL621944,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
9016,15765,A,,Intermediate,CHEMBL621945,,,50597,,1,,N,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Rattus norvegicus,,,1,,BAO_0000218
9017,4871,A,,Intermediate,CHEMBL621946,,,50597,,1,,N,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,,,1,,BAO_0000218
9018,4871,A,,Intermediate,CHEMBL621947,,,50597,,1,,N,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,,,1,,BAO_0000218
9019,4872,A,,Intermediate,CHEMBL621948,,,50597,,1,,N,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,,,1,,BAO_0000218
9020,4872,A,,Intermediate,CHEMBL621949,,,50597,,1,,N,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,,,1,,BAO_0000218
9021,5413,A,,Intermediate,CHEMBL621950,,,50597,,1,,N,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Rattus norvegicus,,,1,,BAO_0000218
9022,5413,A,,Intermediate,CHEMBL621951,,,50597,,1,,N,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Rattus norvegicus,,,1,,BAO_0000218
9023,15272,A,,Intermediate,CHEMBL621952,In vivo,178.0,50597,,1,,N,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Rattus norvegicus,,Blood,1,,BAO_0000218
9024,4689,A,,Intermediate,CHEMBL621953,,2107.0,50597,,1,,N,Stability (%) in rat liver microsomes,Rattus norvegicus,,Liver,1,,BAO_0000218
9025,6057,A,,Intermediate,CHEMBL621954,,,50597,,1,,N,Area under curve was calculated after intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
9026,6057,A,,Intermediate,CHEMBL621955,,,50597,,1,,N,Area under the curve was calculated after iv administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9027,6057,A,,Intermediate,CHEMBL621956,,,50597,,1,,N,Area under the curve was calculated in rat after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9028,6211,A,,Intermediate,CHEMBL621957,,,50597,,1,,N,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9029,5710,A,,Intermediate,CHEMBL621958,,,50597,,1,,N,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
9030,5710,A,,Intermediate,CHEMBL621959,,,50597,,1,,N,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
9031,17853,A,,Intermediate,CHEMBL621960,,,50597,,1,,N,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,1,,BAO_0000218
9032,17853,A,,Intermediate,CHEMBL621961,,,50597,,1,,N,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Rattus norvegicus,,,1,,BAO_0000218
9033,15765,A,,Intermediate,CHEMBL621962,,,50597,,1,,N,p value of the compound,Rattus norvegicus,,,1,,BAO_0000218
9034,15765,F,,Intermediate,CHEMBL876787,,,50597,,1,,N,p value of the compound,Rattus norvegicus,,,1,,BAO_0000218
9035,15765,A,,Intermediate,CHEMBL621963,,,50597,,1,,N,p value of the compound,Rattus norvegicus,,,1,,BAO_0000218
9036,6175,A,,Intermediate,CHEMBL622637,,945.0,50597,,1,,N,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9037,6175,A,,Intermediate,CHEMBL622638,,945.0,50597,,1,,N,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9038,6175,A,,Intermediate,CHEMBL626561,,945.0,50597,,1,,N,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9039,7991,F,,Autocuration,CHEMBL626562,,,22224,,1,,U,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Oryctolagus cuniculus,,,0,,BAO_0000019
9040,429,A,,Autocuration,CHEMBL626563,,,22224,,1,,U,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Oryctolagus cuniculus,,,0,,BAO_0000218
9041,429,A,,Autocuration,CHEMBL626564,,,22224,,1,,U,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Oryctolagus cuniculus,,,0,,BAO_0000218
9042,6253,A,,Autocuration,CHEMBL626565,In vivo,,22224,,1,,U,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,0,,BAO_0000218
9043,6253,A,,Autocuration,CHEMBL626566,In vivo,,22224,,1,,U,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,,0,,BAO_0000218
9044,3615,A,,Autocuration,CHEMBL626567,In vivo,,22224,,1,,U,Clearance rate in rabbits,Oryctolagus cuniculus,,,0,,BAO_0000218
9045,4059,A,,Autocuration,CHEMBL626568,In vivo,,22224,,1,,U,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,,0,,BAO_0000218
9046,5124,A,,Autocuration,CHEMBL626569,In vivo,,22224,,1,,U,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9047,5124,A,,Autocuration,CHEMBL626570,In vivo,,22224,,1,,U,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9048,5124,A,,Autocuration,CHEMBL626571,In vivo,,22224,,1,,U,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9049,429,A,,Autocuration,CHEMBL626572,In vivo,,22224,,1,,U,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9050,4059,A,,Autocuration,CHEMBL626573,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,Plasma,0,,BAO_0000218
9051,9659,A,,Autocuration,CHEMBL626574,,2107.0,22224,,1,,U,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Oryctolagus cuniculus,Microsomes,Liver,0,,BAO_0000251
9052,9659,A,,Autocuration,CHEMBL626575,,2107.0,22224,,1,,U,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Oryctolagus cuniculus,Microsomes,Liver,0,,BAO_0000251
9053,3639,A,,Autocuration,CHEMBL626576,,,22224,,1,,U,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Oryctolagus cuniculus,,,0,,BAO_0000218
9054,3639,A,,Autocuration,CHEMBL626577,,,22224,,1,,U,Dose at which bioavailability of perorally administered compound was tested in rabbit,Oryctolagus cuniculus,,,0,,BAO_0000218
9055,3639,A,,Autocuration,CHEMBL626578,In vivo,,22224,,1,,U,The compound was tested for its bioavailability in rabbit (by oral dosage).,Oryctolagus cuniculus,,,0,,BAO_0000218
9056,5124,A,,Autocuration,CHEMBL625263,In vivo,,22224,,1,,U,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9057,5124,A,,Autocuration,CHEMBL625264,In vivo,,22224,,1,,U,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9058,5124,A,,Autocuration,CHEMBL625265,In vivo,,22224,,1,,U,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9059,14294,A,,Autocuration,CHEMBL625266,,,22224,,1,,U,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Oryctolagus cuniculus,Microsomes,,0,,BAO_0000251
9060,14294,A,,Autocuration,CHEMBL876796,,,22224,,1,,U,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Oryctolagus cuniculus,Microsomes,,0,,BAO_0000251
9061,429,A,,Autocuration,CHEMBL625267,In vivo,,22224,,1,,U,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9062,5124,A,,Autocuration,CHEMBL625268,In vivo,1969.0,22224,,1,,U,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,,Plasma,0,,BAO_0000218
9063,5124,A,,Autocuration,CHEMBL625269,In vivo,1969.0,22224,,1,,U,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,,Plasma,0,,BAO_0000218
9064,5124,A,,Autocuration,CHEMBL624689,In vivo,1969.0,22224,,1,,U,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,,Plasma,0,,BAO_0000218
9065,429,A,,Autocuration,CHEMBL624690,In vivo,,22224,,1,,U,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9066,429,A,,Autocuration,CHEMBL624691,,1088.0,22224,,1,,U,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Oryctolagus cuniculus,,Urine,0,,BAO_0000218
9067,429,A,,Autocuration,CHEMBL624692,,1088.0,22224,,1,,U,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Oryctolagus cuniculus,,Urine,0,,BAO_0000218
9068,4059,A,,Autocuration,CHEMBL624693,In vivo,,22224,,1,,U,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,,,0,,BAO_0000218
9069,4137,A,,Autocuration,CHEMBL624694,In vivo,,22224,,1,,U,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Oryctolagus cuniculus,,,0,,BAO_0000218
9070,11672,A,,Autocuration,CHEMBL877596,In vitro,,22224,,1,,U,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Oryctolagus cuniculus,,,0,,BAO_0000221
9071,12886,A,,Autocuration,CHEMBL624695,,,22224,,1,,U,Time within which only 10% of the drug was degraded,Oryctolagus cuniculus,,,0,,BAO_0000019
9072,3853,A,,Autocuration,CHEMBL624696,,2107.0,22224,,1,,U,Half life period in rabbit liver homogenate,Oryctolagus cuniculus,,Liver,0,,BAO_0000221
9073,3615,A,,Autocuration,CHEMBL624697,,,22224,,1,,U,Half life value in rabbits,Oryctolagus cuniculus,,,0,,BAO_0000019
9074,6253,A,,Autocuration,CHEMBL624698,In vivo,178.0,22224,,1,,U,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,Blood,0,,BAO_0000218
9075,6253,A,,Autocuration,CHEMBL624699,In vivo,178.0,22224,,1,,U,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,,Blood,0,,BAO_0000218
9076,6077,A,,Autocuration,CHEMBL624700,In vivo,,22224,,1,,U,Half-life period in rabbits following intravenous administration at 2 mg/kg,Oryctolagus cuniculus,,,0,,BAO_0000218
9077,17617,A,,Intermediate,CHEMBL622903,,1969.0,50597,,1,,N,AUC 0-8 hr value in rats at 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9078,17594,A,,Intermediate,CHEMBL622904,,1969.0,50597,,1,,N,AUC after administration at 2000 mg/kg/day in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9079,6149,A,,Intermediate,CHEMBL622905,,1969.0,50597,,1,,N,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9080,17260,A,,Intermediate,CHEMBL622906,,1969.0,50597,,1,,N,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9081,17260,A,,Intermediate,CHEMBL622907,,1969.0,50597,,1,,N,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9082,6644,A,,Intermediate,CHEMBL622908,,1969.0,50597,,1,,N,AUC in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
9083,6644,A,,Intermediate,CHEMBL622909,,1969.0,50597,,1,,N,AUC in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
9084,6644,A,,Intermediate,CHEMBL622910,,1969.0,50597,,1,,N,AUC in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
9085,6495,A,,Intermediate,CHEMBL622911,,955.0,50597,,1,,N,AUC in rat brain after oral administration at 10 mg/kg,Rattus norvegicus,,Brain,1,,BAO_0000218
9086,6504,A,,Intermediate,CHEMBL622912,,1969.0,50597,,1,,N,AUC in rat p.o.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9087,17686,A,,Intermediate,CHEMBL622913,,1969.0,50597,,1,,N,AUC in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9088,6495,A,,Intermediate,CHEMBL622914,,1969.0,50597,,1,,N,AUC in rat plasma after oral administration at 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9089,216,A,,Intermediate,CHEMBL622915,,1969.0,50597,,1,,N,AUC in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9090,1908,A,,Intermediate,CHEMBL622916,,1969.0,50597,,1,,N,AUC value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9091,1908,A,,Intermediate,CHEMBL622917,,1969.0,50597,,1,,N,AUC value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9092,6685,A,,Intermediate,CHEMBL622918,In vivo,1969.0,50597,,1,,N,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,Plasma,1,,BAO_0000218
9093,216,A,,Intermediate,CHEMBL622919,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Rattus norvegicus,,Plasma,1,,BAO_0000218
9094,6049,A,,Intermediate,CHEMBL622920,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was evaluated in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9095,2463,A,,Intermediate,CHEMBL622921,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9096,6679,A,,Intermediate,CHEMBL622922,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9097,6681,A,,Intermediate,CHEMBL622923,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
9098,4890,A,,Intermediate,CHEMBL877604,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9099,6410,A,,Intermediate,CHEMBL622924,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9100,6410,A,,Intermediate,CHEMBL622925,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9101,16366,A,,Intermediate,CHEMBL622926,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Rattus norvegicus,,Plasma,1,,BAO_0000218
9102,6227,A,,Intermediate,CHEMBL623625,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9103,3598,A,,Expert,CHEMBL623626,In vivo,1969.0,50597,,1,,N,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9104,1465,A,,Intermediate,CHEMBL623627,In vivo,1969.0,50597,,1,,N,Maximum plasma drug concentration was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9105,4368,A,,Intermediate,CHEMBL623628,In vivo,,50597,,1,,N,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9106,15662,A,,Intermediate,CHEMBL623629,In vivo,1969.0,50597,,1,,N,Mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9107,15662,A,,Intermediate,CHEMBL623630,In vivo,1969.0,50597,,1,,N,Mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9108,5355,A,,Intermediate,CHEMBL623804,In vivo,,50597,,1,,N,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9109,5355,A,,Intermediate,CHEMBL623805,In vivo,,50597,,1,,N,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9110,1567,A,,Intermediate,CHEMBL623806,In vivo,1969.0,50597,,1,,N,Peak oral plasma concentration was determined in rats by oral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9111,4026,A,,Intermediate,CHEMBL623807,In vivo,1969.0,50597,,1,,N,Peak plasma concentration (Cmax) was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9112,6193,A,,Intermediate,CHEMBL623808,In vivo,1969.0,50597,,1,,N,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9113,4026,A,,Intermediate,CHEMBL623809,In vivo,1969.0,50597,,1,,N,Peak plasma concentration (Cmax) in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9114,6485,A,,Intermediate,CHEMBL623810,In vivo,1969.0,50597,,1,,N,Peak plasma concentration at 1 mg/kg peroral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9115,17655,A,,Intermediate,CHEMBL623811,In vivo,1969.0,50597,,1,,N,Peak plasma concentration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9116,14941,A,,Intermediate,CHEMBL623812,In vivo,1969.0,50597,,1,,N,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,Plasma,1,,BAO_0000218
9117,5394,A,,Intermediate,CHEMBL877605,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9118,4408,A,,Intermediate,CHEMBL623813,In vivo,,50597,,1,,N,Pharmacokinetic property (Cmax) in rat,Rattus norvegicus,,,1,,BAO_0000218
9119,5983,A,,Intermediate,CHEMBL623814,In vivo,,50597,,1,,N,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,1,,BAO_0000218
9120,4878,A,,Intermediate,CHEMBL623815,In vivo,,50597,,1,,N,Cmax in rat after 3mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
9121,5862,A,,Intermediate,CHEMBL623816,In vivo,,50597,,1,,N,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
9122,4517,A,,Intermediate,CHEMBL623145,In vivo,,50597,,1,,N,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
9123,5932,A,,Intermediate,CHEMBL623146,In vivo,1969.0,50597,,1,,N,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
9124,5436,A,,Intermediate,CHEMBL623147,In vivo,1969.0,50597,,1,,N,Plasma concentration after oral administration of 100 mg/kg to rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9125,4910,A,,Intermediate,CHEMBL623042,In vivo,955.0,50597,,1,,N,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,Brain,1,,BAO_0000218
9126,4950,A,,Intermediate,CHEMBL623043,In vivo,,50597,,1,,N,Tested for the Cmax in rat at 10 mg/kg per orally,Rattus norvegicus,,,1,,BAO_0000218
9127,15078,A,,Intermediate,CHEMBL623044,In vivo,,50597,,1,,N,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9128,15078,A,,Intermediate,CHEMBL623045,In vivo,,50597,,1,,N,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9129,3360,A,,Intermediate,CHEMBL623046,In vivo,,50597,,1,,N,Bioavailability as oral Cmax in rats at 30 mins,Rattus norvegicus,,,1,,BAO_0000218
9130,3360,A,,Intermediate,CHEMBL623226,In vivo,,50597,,1,,N,Bioavailability as oral Cmax in rats at 6hr,Rattus norvegicus,,,1,,BAO_0000218
9131,15022,A,,Intermediate,CHEMBL623227,In vivo,,50597,,1,,N,The maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9132,15022,A,,Intermediate,CHEMBL623228,In vivo,,50597,,1,,N,The maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9133,15022,A,,Intermediate,CHEMBL623229,In vivo,,50597,,1,,N,The maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9134,5160,A,,Intermediate,CHEMBL623230,In vivo,1969.0,50597,,1,,N,The maximum plasma levels for the compounds were determined by LC-MS.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9135,15662,A,,Intermediate,CHEMBL623231,In vivo,1969.0,50597,,1,,N,mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9136,15662,A,,Intermediate,CHEMBL623232,In vivo,1969.0,50597,,1,,N,mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9137,4709,A,,Intermediate,CHEMBL623233,,,50597,,1,,N,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9138,3535,A,,Intermediate,CHEMBL623234,,,50597,,1,,N,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Rattus norvegicus,,,1,,BAO_0000218
9139,3535,A,,Intermediate,CHEMBL623235,,,50597,,1,,N,Concentration in plasma (portal) following oral dose in rats at 1 hr,Rattus norvegicus,,,1,,BAO_0000218
9140,3535,A,,Intermediate,CHEMBL623236,,,50597,,1,,N,Concentration in plasma (portal) following oral dose in rats at 2 hr,Rattus norvegicus,,,1,,BAO_0000218
9141,3535,A,,Intermediate,CHEMBL623237,,,50597,,1,,N,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Rattus norvegicus,,,1,,BAO_0000218
9142,3535,A,,Intermediate,CHEMBL623238,,,50597,,1,,N,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Rattus norvegicus,,,1,,BAO_0000218
9143,3535,A,,Intermediate,CHEMBL623239,,,50597,,1,,N,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Rattus norvegicus,,,1,,BAO_0000218
9144,5005,A,,Intermediate,CHEMBL623240,In vivo,1969.0,22224,,1,,U,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Rattus norvegicus,,Plasma,0,,BAO_0000218
9145,6326,A,,Intermediate,CHEMBL623241,,1898.0,50597,,1,,N,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
9146,6326,A,,Intermediate,CHEMBL623242,,1898.0,50597,,1,,N,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
9147,6326,A,,Intermediate,CHEMBL874394,,,50597,,1,,N,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Rattus norvegicus,,,1,,BAO_0000218
9148,6326,A,,Intermediate,CHEMBL623243,,,50597,,1,,N,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Rattus norvegicus,,,1,,BAO_0000218
9149,17411,A,,Intermediate,CHEMBL623244,,,50597,,1,,N,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9150,16435,A,,Intermediate,CHEMBL623245,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
9151,16435,A,,Intermediate,CHEMBL623246,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
9152,16435,A,,Intermediate,CHEMBL623247,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
9153,16435,A,,Intermediate,CHEMBL623248,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
9154,16435,A,,Intermediate,CHEMBL623249,,2113.0,50597,,1,,N,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
9155,16434,A,,Intermediate,CHEMBL625072,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9156,16434,A,,Intermediate,CHEMBL625073,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9157,16434,A,,Intermediate,CHEMBL625074,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9158,16434,A,,Intermediate,CHEMBL625075,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9159,16434,A,,Intermediate,CHEMBL625076,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9160,16434,A,,Intermediate,CHEMBL625077,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9161,16434,A,,Intermediate,CHEMBL625078,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9162,16434,A,,Intermediate,CHEMBL874395,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9163,16435,A,,Intermediate,CHEMBL625079,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9164,16435,A,,Intermediate,CHEMBL625080,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9165,16435,A,,Intermediate,CHEMBL625081,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9166,16435,A,,Intermediate,CHEMBL625082,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9167,16435,A,,Intermediate,CHEMBL625083,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9168,16435,A,,Intermediate,CHEMBL625084,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9169,16435,A,,Intermediate,CHEMBL625085,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9170,16435,A,,Intermediate,CHEMBL625086,,2107.0,50597,,1,,N,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Liver,1,,BAO_0000218
9171,16434,A,,Intermediate,CHEMBL625087,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9172,16434,A,,Intermediate,CHEMBL625088,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9173,16434,A,,Intermediate,CHEMBL622205,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9174,16435,A,,Intermediate,CHEMBL622206,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9175,16435,A,,Intermediate,CHEMBL622207,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9176,16435,A,,Intermediate,CHEMBL622366,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9177,16435,A,,Intermediate,CHEMBL622367,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9178,16435,A,,Intermediate,CHEMBL875331,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9179,16435,A,,Intermediate,CHEMBL622368,,2107.0,50597,,1,,N,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Liver,1,,BAO_0000218
9180,16434,A,,Intermediate,CHEMBL622369,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9181,16434,A,,Intermediate,CHEMBL622370,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9182,16434,A,,Intermediate,CHEMBL622371,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9183,16434,A,,Intermediate,CHEMBL622372,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9184,16434,A,,Intermediate,CHEMBL622373,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9185,16434,A,,Intermediate,CHEMBL622374,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9186,16434,A,,Intermediate,CHEMBL622375,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9187,16434,A,,Intermediate,CHEMBL622376,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9188,16435,A,,Intermediate,CHEMBL622377,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9189,16435,A,,Intermediate,CHEMBL622378,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9190,16435,A,,Intermediate,CHEMBL622379,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9191,16435,A,,Intermediate,CHEMBL622380,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9192,16435,A,,Intermediate,CHEMBL622381,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9193,16435,A,,Intermediate,CHEMBL622382,,2048.0,50597,,1,,N,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9194,16434,A,,Intermediate,CHEMBL622383,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9195,6175,A,,Intermediate,CHEMBL875332,,945.0,50597,,1,,N,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9196,6175,A,,Intermediate,CHEMBL622384,,945.0,50597,,1,,N,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9197,6175,A,,Intermediate,CHEMBL622385,,945.0,50597,,1,,N,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9198,6175,A,,Intermediate,CHEMBL622386,,945.0,50597,,1,,N,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,,Stomach,1,,BAO_0000218
9199,10839,A,,Intermediate,CHEMBL622387,,,50597,,1,,N,The compound was tested for the plasma binding in rat,Rattus norvegicus,,,1,,BAO_0000218
9200,16459,A,,Intermediate,CHEMBL622388,,,50597,,1,,N,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Rattus norvegicus,,,1,,BAO_0000218
9201,16459,A,,Intermediate,CHEMBL622389,,,50597,,1,,N,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Rattus norvegicus,,,1,,BAO_0000218
9202,16459,A,,Intermediate,CHEMBL622390,,,50597,,1,,N,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Rattus norvegicus,,,1,,BAO_0000218
9203,16459,A,,Intermediate,CHEMBL622391,,,50597,,1,,N,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
9204,16459,A,,Intermediate,CHEMBL622392,,,50597,,1,,N,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
9205,16459,A,,Intermediate,CHEMBL622393,,,50597,,1,,N,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
9206,3278,A,,Intermediate,CHEMBL622394,,,50597,,1,,N,Plasma level at 2 hr after administration of the compound,Rattus norvegicus,,,1,,BAO_0000218
9207,3278,A,,Intermediate,CHEMBL622395,,,50597,,1,,N,plasma level at 2 hr after administration of the compound,Rattus norvegicus,,,1,,BAO_0000218
9208,4684,A,,Intermediate,CHEMBL622396,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 1 min,Rattus norvegicus,,Serum,1,,BAO_0000218
9209,4684,A,,Intermediate,CHEMBL624894,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 10 min,Rattus norvegicus,,Serum,1,,BAO_0000218
9210,4684,A,,Intermediate,CHEMBL624895,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 10 mins,Rattus norvegicus,,Serum,1,,BAO_0000218
9211,4684,A,,Intermediate,CHEMBL624058,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 2 hr,Rattus norvegicus,,Serum,1,,BAO_0000218
9212,4684,A,,Intermediate,CHEMBL624059,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 3 min,Rattus norvegicus,,Serum,1,,BAO_0000218
9213,4684,A,,Intermediate,CHEMBL624060,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 3 mins,Rattus norvegicus,,Serum,1,,BAO_0000218
9214,4684,A,,Intermediate,CHEMBL624061,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 5 min,Rattus norvegicus,,Serum,1,,BAO_0000218
9215,4684,A,,Intermediate,CHEMBL624062,,1977.0,50597,,1,,N,Stability in rat serum measured as % recovery at 5 mins,Rattus norvegicus,,Serum,1,,BAO_0000218
9216,16456,A,,Intermediate,CHEMBL624063,In vivo,,50597,,1,,N,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9217,16456,A,,Intermediate,CHEMBL624064,In vivo,,50597,,1,,N,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9218,723,A,,Intermediate,CHEMBL624065,,1969.0,50597,,1,,N,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9219,723,A,,Intermediate,CHEMBL624066,,1969.0,50597,,1,,N,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9220,5160,A,,Intermediate,CHEMBL877490,In vivo,,50597,,1,,N,Half life tested in mature male rat at a dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9221,4709,A,,Intermediate,CHEMBL874442,In vivo,,50597,,1,,N,Half life after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9222,5633,A,,Intermediate,CHEMBL626890,In vivo,,50597,,1,,N,Half life period after administration (30 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
9223,5302,A,,Intermediate,CHEMBL626891,In vivo,,50597,,1,,N,Half life period in rat after 5 mg/Kg dose,Rattus norvegicus,,,1,,BAO_0000218
9224,5302,A,,Intermediate,CHEMBL626892,In vivo,,50597,,1,,N,Half life period in rat after 5 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9225,17791,A,,Intermediate,CHEMBL626893,,,50597,,1,,N,Half life period was determined,Rattus norvegicus,,,1,,BAO_0000218
9226,17791,A,,Intermediate,CHEMBL626894,,,50597,,1,,N,Half life period was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
9227,17791,A,,Intermediate,CHEMBL626895,,,50597,,1,,N,Half life period was evaluated in rat; 0.5-1.0,Rattus norvegicus,,,1,,BAO_0000218
9228,17791,A,,Intermediate,CHEMBL626896,,,50597,,1,,N,Half life period was evaluated in rat; 5.9-7.5,Rattus norvegicus,,,1,,BAO_0000218
9229,14512,A,,Intermediate,CHEMBL626897,,1969.0,50597,,1,,N,Half-life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9230,6230,A,,Intermediate,CHEMBL626898,,,50597,,1,,N,Half-life time in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
9231,3364,A,,Intermediate,CHEMBL626899,In vivo,,50597,,1,,N,Terminal half-life after iv administration to rats,Rattus norvegicus,,,1,,BAO_0000218
9232,6874,A,,Intermediate,CHEMBL626900,In vivo,,50597,,1,,N,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9233,857,A,,Intermediate,CHEMBL626901,,,50597,,1,,N,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9234,858,A,,Intermediate,CHEMBL626902,In vivo,,50597,,1,,N,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Rattus norvegicus,,,1,,BAO_0000218
9235,858,A,,Intermediate,CHEMBL626903,In vivo,,50597,,1,,N,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Rattus norvegicus,,,1,,BAO_0000218
9236,5355,A,,Intermediate,CHEMBL874443,In vivo,,50597,,1,,N,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9237,5355,A,,Intermediate,CHEMBL626904,In vivo,,50597,,1,,N,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9238,6305,A,,Intermediate,CHEMBL626905,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
9239,13501,A,,Intermediate,CHEMBL873830,In vivo,1969.0,50597,,1,,N,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9240,17594,A,,Intermediate,CHEMBL626906,In vivo,,50597,,1,,N,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9241,4186,A,,Intermediate,CHEMBL631076,In vivo,1969.0,50597,,1,,N,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,Plasma,1,,BAO_0000218
9242,2932,A,,Intermediate,CHEMBL631077,,1969.0,50597,,1,,N,Biological half-life was measured in plasma of rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9243,17065,A,,Intermediate,CHEMBL631078,In vivo,,50597,,1,,N,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,1,,BAO_0000218
9244,15765,A,,Intermediate,CHEMBL631079,In vivo,,50597,,1,,N,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Rattus norvegicus,,,1,,BAO_0000218
9245,2713,A,,Intermediate,CHEMBL631080,In vivo,,50597,,1,,N,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9246,2661,A,,Intermediate,CHEMBL631081,In vivo,,50597,,1,,N,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9247,2661,A,,Intermediate,CHEMBL631239,In vivo,,50597,,1,,N,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9248,740,A,,Intermediate,CHEMBL631240,,1969.0,50597,,1,,N,Compound was evaluated for plasma half life in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9249,6597,A,,Intermediate,CHEMBL631241,,1969.0,50597,,1,,N,AUC value at a dose of 5 mg/kg (p.o.) in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9250,2959,A,,Intermediate,CHEMBL631242,,1969.0,50597,,1,,N,AUC value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9251,17594,A,,Intermediate,CHEMBL631243,,1969.0,50597,,1,,N,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9252,17596,A,,Intermediate,CHEMBL874444,,1969.0,50597,,1,,N,AUC0-96 after administration at 50 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9253,17594,A,,Intermediate,CHEMBL631244,,1969.0,50597,,1,,N,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9254,3293,A,,Intermediate,CHEMBL631245,,,50597,,1,,N,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Rattus norvegicus,,,1,,BAO_0000218
9255,6757,A,,Intermediate,CHEMBL627162,,,50597,,1,,N,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
9256,6757,A,,Intermediate,CHEMBL627163,,,50597,,1,,N,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
9257,6757,A,,Intermediate,CHEMBL627164,,,50597,,1,,N,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,,,1,,BAO_0000218
9258,5979,A,,Intermediate,CHEMBL627165,,2113.0,50597,,1,,N,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Rattus norvegicus,,Kidney,1,,BAO_0000218
9259,5979,A,,Intermediate,CHEMBL627166,,,50597,,1,,N,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Rattus norvegicus,,,1,,BAO_0000218
9260,5979,A,,Intermediate,CHEMBL627167,,,50597,,1,,N,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Rattus norvegicus,,,1,,BAO_0000218
9261,4026,A,,Intermediate,CHEMBL627822,,,50597,,1,,N,Area under curve (AUC) at a dose of 30 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9262,5355,A,,Intermediate,CHEMBL627823,,,50597,,1,,N,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9263,5355,A,,Intermediate,CHEMBL627824,,,50597,,1,,N,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9264,5355,A,,Intermediate,CHEMBL627825,,,50597,,1,,N,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9265,5633,A,,Intermediate,CHEMBL627826,,,50597,,1,,N,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
9266,1716,A,,Intermediate,CHEMBL627827,,,50597,,1,,N,Area under curve (Pharmacokinetic property) was determined,Rattus norvegicus,,,1,,BAO_0000218
9267,1716,A,,Intermediate,CHEMBL627828,,,50597,,1,,N,Area under curve (Pharmacokinetic property) of the compound; Not determined,Rattus norvegicus,,,1,,BAO_0000218
9268,4689,A,,Intermediate,CHEMBL627829,,,50597,,1,,N,Area under curve after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
9269,4527,A,,Intermediate,CHEMBL627830,,,50597,,1,,N,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
9270,4527,A,,Intermediate,CHEMBL627831,,,50597,,1,,N,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
9271,15662,A,,Intermediate,CHEMBL627832,,,50597,,1,,N,Area under curve in male SD rats was observed after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9272,4413,A,,Intermediate,CHEMBL627833,,,50597,,1,,N,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
9273,3598,A,,Expert,CHEMBL627834,,,50597,,1,,N,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9274,3598,A,,Expert,CHEMBL628004,,,50597,,1,,N,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9275,5964,A,,Intermediate,CHEMBL628005,,,50597,,1,,N,Area under curve at 5 mg/kg po was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9276,4689,A,,Intermediate,CHEMBL628006,,,50597,,1,,N,Area under curve in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9277,4186,A,,Intermediate,CHEMBL628007,,,50597,,1,,N,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,,,1,,BAO_0000218
9278,5510,A,,Intermediate,CHEMBL625676,,,50597,,1,,N,Area under curve was determined,Rattus norvegicus,,,1,,BAO_0000218
9279,17858,A,,Intermediate,CHEMBL631309,,,50597,,1,,N,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Rattus norvegicus,,,1,,BAO_0000218
9280,17804,A,,Intermediate,CHEMBL631310,,,50597,,1,,N,Area under curve after intravenous administration at 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9281,6106,A,,Intermediate,CHEMBL631311,,,50597,,1,,N,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Rattus norvegicus,,,1,,BAO_0000218
9282,5964,A,,Intermediate,CHEMBL631312,,,50597,,1,,N,Area under curve at 4 hr in rat,Rattus norvegicus,,,1,,BAO_0000218
9283,4026,A,,Intermediate,CHEMBL631313,,,50597,,1,,N,Area under curve at a dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9284,4756,A,,Intermediate,CHEMBL631314,,,50597,,1,,N,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
9285,4756,A,,Intermediate,CHEMBL631315,,,50597,,1,,N,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
9286,5862,A,,Intermediate,CHEMBL631316,,,50597,,1,,N,Area under curve for a 2-mpk po dose in SD rats,Rattus norvegicus,,,1,,BAO_0000218
9287,5862,A,,Intermediate,CHEMBL631317,,,50597,,1,,N,Area under curve in SD rats,Rattus norvegicus,,,1,,BAO_0000218
9288,6644,A,,Intermediate,CHEMBL874471,,,50597,,1,,N,Area under curve in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9289,5871,A,,Intermediate,CHEMBL631318,,,50597,,1,,N,Area under curve in rat by po administration at 0-24 hr,Rattus norvegicus,,,1,,BAO_0000218
9290,5919,A,,Intermediate,CHEMBL631319,,1969.0,50597,,1,,N,Area under curve in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9291,5939,A,,Intermediate,CHEMBL631320,,,50597,,1,,N,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9292,5939,A,,Intermediate,CHEMBL631321,,,50597,,1,,N,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9293,10,A,,Intermediate,CHEMBL631322,,,50597,,1,,N,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,,,1,,BAO_0000218
9294,11149,A,,Intermediate,CHEMBL631323,,,50597,,1,,N,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Rattus norvegicus,,,1,,BAO_0000218
9295,5302,A,,Intermediate,CHEMBL631324,,,50597,,1,,N,Area under curve value in rat at a dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9296,17796,A,,Intermediate,CHEMBL631325,,,50597,,1,,N,Area under curve was determined after oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9297,4890,A,,Intermediate,CHEMBL631326,,,50597,,1,,N,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9298,6011,A,,Intermediate,CHEMBL631327,,,50597,,1,,N,Area under curve was determined after peroral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9299,5375,A,,Intermediate,CHEMBL631328,,,50597,,1,,N,Area under curve was determined at a dose 30 mpk administered orally.,Rattus norvegicus,,,1,,BAO_0000218
9300,17764,A,,Intermediate,CHEMBL631329,,,50597,,1,,N,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
9301,4368,A,,Intermediate,CHEMBL627217,,,50597,,1,,N,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9302,5610,A,,Intermediate,CHEMBL626352,,,50597,,1,,N,Area under curve was determined in male rat,Rattus norvegicus,,,1,,BAO_0000218
9303,5833,A,,Intermediate,CHEMBL626353,,,50597,,1,,N,Area under curve was determined in rat after PO administration,Rattus norvegicus,,,1,,BAO_0000218
9304,4257,A,,Intermediate,CHEMBL626354,,,50597,,1,,N,Area under curve was determined in rat after a 3 mg/kg of oral dose,Rattus norvegicus,,,1,,BAO_0000218
9305,5937,A,,Intermediate,CHEMBL626355,,,50597,,1,,N,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9306,5932,A,,Intermediate,CHEMBL626356,,,50597,,1,,N,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9307,5932,A,,Intermediate,CHEMBL626357,,,50597,,1,,N,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Rattus norvegicus,,,1,,BAO_0000218
9308,17411,A,,Intermediate,CHEMBL626358,,,50597,,1,,N,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9309,17411,A,,Intermediate,CHEMBL626359,,,50597,,1,,N,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9310,17771,A,,Intermediate,CHEMBL626360,,1969.0,50597,,1,,N,Peak plasma concentration in rat at a dose of 3 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9311,1628,A,,Intermediate,CHEMBL626361,,,50597,,1,,N,Plasma concentration at 2 hr in rats was evaluated.,Rattus norvegicus,,,1,,BAO_0000218
9312,1628,A,,Intermediate,CHEMBL626362,,,50597,,1,,N,Plasma concentration at 2 hr in rats was evaluated; Not available,Rattus norvegicus,,,1,,BAO_0000218
9313,17411,A,,Intermediate,CHEMBL626363,,,50597,,1,,N,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9314,4910,A,,Intermediate,CHEMBL626970,,,50597,,1,,N,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,1,,BAO_0000218
9315,4910,A,,Intermediate,CHEMBL626971,,,50597,,1,,N,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,1,,BAO_0000218
9316,4910,A,,Intermediate,CHEMBL626972,,1969.0,50597,,1,,N,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9317,4910,A,,Intermediate,CHEMBL626973,,1969.0,50597,,1,,N,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9318,4910,A,,Intermediate,CHEMBL626974,,1969.0,50597,,1,,N,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9319,4910,A,,Intermediate,CHEMBL874592,,1969.0,50597,,1,,N,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9320,5510,A,,Intermediate,CHEMBL626975,,,50597,,1,,N,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Rattus norvegicus,,,1,,BAO_0000218
9321,5510,A,,Intermediate,CHEMBL626976,,,50597,,1,,N,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Rattus norvegicus,,,1,,BAO_0000218
9322,5510,A,,Intermediate,CHEMBL626977,,,50597,,1,,N,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Rattus norvegicus,,,1,,BAO_0000218
9323,5510,A,,Intermediate,CHEMBL626978,,,50597,,1,,N,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Rattus norvegicus,,,1,,BAO_0000218
9324,16427,A,,Intermediate,CHEMBL626979,,,50597,,1,,N,PK study was carried to determine the relative absorption ranking in rat.,Rattus norvegicus,,,1,,BAO_0000218
9325,4689,A,,Intermediate,CHEMBL626980,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9326,11450,A,,Intermediate,CHEMBL626981,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9327,11450,A,,Intermediate,CHEMBL626982,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9328,11450,A,,Intermediate,CHEMBL626983,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9329,11450,A,,Intermediate,CHEMBL622522,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9330,11450,A,,Intermediate,CHEMBL622523,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9331,11450,A,,Intermediate,CHEMBL622524,,178.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
9332,11450,A,,Intermediate,CHEMBL622525,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9333,11450,A,,Intermediate,CHEMBL622526,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9334,11450,A,,Intermediate,CHEMBL619849,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9335,11450,A,,Intermediate,CHEMBL619850,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9336,11450,A,,Intermediate,CHEMBL623864,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9337,11450,A,,Intermediate,CHEMBL623865,,955.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
9338,11450,A,,Intermediate,CHEMBL623866,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9339,11450,A,,Intermediate,CHEMBL623867,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9340,11450,A,,Intermediate,CHEMBL877615,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9341,11450,A,,Intermediate,CHEMBL623868,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9342,11450,A,,Intermediate,CHEMBL623869,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9343,11450,A,,Intermediate,CHEMBL623870,,948.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
9344,16434,A,,Intermediate,CHEMBL623871,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9345,16434,A,,Intermediate,CHEMBL623872,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9346,16435,A,,Intermediate,CHEMBL622129,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9347,16435,A,,Intermediate,CHEMBL622130,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9348,16435,A,,Intermediate,CHEMBL622131,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9349,16435,A,,Intermediate,CHEMBL622132,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9350,16435,A,,Intermediate,CHEMBL622133,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9351,16435,A,,Intermediate,CHEMBL622134,,2048.0,50597,,1,,N,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Lung,1,,BAO_0000218
9352,16435,A,,Intermediate,CHEMBL622135,,2048.0,50597,,1,,N,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9353,16435,A,,Intermediate,CHEMBL622136,,2048.0,50597,,1,,N,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Lung,1,,BAO_0000218
9354,16434,A,,Intermediate,CHEMBL622137,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9355,16434,A,,Intermediate,CHEMBL622138,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9356,16434,A,,Intermediate,CHEMBL623017,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9357,16434,A,,Intermediate,CHEMBL623018,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9358,16434,A,,Intermediate,CHEMBL623019,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9359,16434,A,,Intermediate,CHEMBL623020,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9360,16434,A,,Intermediate,CHEMBL623021,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9361,16434,A,,Intermediate,CHEMBL623022,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9362,16435,A,,Intermediate,CHEMBL623023,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9363,16435,A,,Intermediate,CHEMBL623024,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9364,16435,A,,Intermediate,CHEMBL623025,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9365,16435,A,,Intermediate,CHEMBL620545,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9366,16435,A,,Intermediate,CHEMBL620546,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9367,16435,A,,Intermediate,CHEMBL620547,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9368,16435,A,,Intermediate,CHEMBL620548,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9369,16435,A,,Intermediate,CHEMBL620549,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9370,16434,A,,Intermediate,CHEMBL620550,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9371,16434,A,,Intermediate,CHEMBL620551,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9372,16434,A,,Intermediate,CHEMBL620552,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9373,16435,A,,Intermediate,CHEMBL620553,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9374,16435,A,,Intermediate,CHEMBL620554,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9375,16435,A,,Intermediate,CHEMBL875845,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9376,16435,A,,Intermediate,CHEMBL620555,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9377,16435,A,,Intermediate,CHEMBL620556,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9378,16435,A,,Intermediate,CHEMBL620557,,2385.0,50597,,1,,N,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9379,16434,A,,Intermediate,CHEMBL620558,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9380,16434,A,,Intermediate,CHEMBL620559,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9381,16434,A,,Intermediate,CHEMBL622939,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9382,16434,A,,Intermediate,CHEMBL622940,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9383,16434,A,,Intermediate,CHEMBL622941,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9384,16434,A,,Intermediate,CHEMBL622942,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9385,16434,A,,Intermediate,CHEMBL622943,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9386,16434,A,,Intermediate,CHEMBL622944,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9387,16435,A,,Intermediate,CHEMBL622945,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9388,16435,A,,Intermediate,CHEMBL622946,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9389,3341,A,,Intermediate,CHEMBL622947,,,50597,,1,,N,Compound was evaluated for terminal half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9390,3634,A,,Intermediate,CHEMBL622948,In vivo,1969.0,50597,,1,,N,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Rattus norvegicus,,Plasma,1,,BAO_0000218
9391,3634,A,,Intermediate,CHEMBL622949,In vivo,1969.0,50597,,1,,N,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Rattus norvegicus,,Plasma,1,,BAO_0000218
9392,4839,A,,Intermediate,CHEMBL622950,,,50597,,1,,N,Compound was tested for its half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9393,5005,A,,Intermediate,CHEMBL622951,In vivo,1969.0,22224,,1,,U,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Macaca mulatta,,Plasma,0,,BAO_0000218
9394,5005,A,,Intermediate,CHEMBL622952,,1969.0,22224,,1,,U,Compound was tested for its plasma half life in Sprague Dawley rats,Rattus norvegicus,,Plasma,0,,BAO_0000366
9395,5005,A,,Intermediate,CHEMBL622953,,1969.0,22224,,1,,U,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Rattus norvegicus,,Plasma,0,,BAO_0000366
9396,1094,A,,Intermediate,CHEMBL873818,,1969.0,50597,,1,,N,Compound was tested for plasma half-life period in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9397,5031,A,,Intermediate,CHEMBL622954,In vivo,,50597,,1,,N,Elimination half life after i.v. administration of compound in rats,Rattus norvegicus,,,1,,BAO_0000218
9398,6518,A,,Intermediate,CHEMBL622955,In vivo,,50597,,1,,N,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9399,6518,A,,Intermediate,CHEMBL875229,In vivo,,50597,,1,,N,Elimination half-life after IV dosing at 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9400,6518,A,,Intermediate,CHEMBL622956,In vivo,,50597,,1,,N,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9401,6518,A,,Intermediate,CHEMBL622957,In vivo,,50597,,1,,N,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9402,5408,A,,Intermediate,CHEMBL622958,In vivo,955.0,50597,,1,,N,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,,Brain,1,,BAO_0000218
9403,5408,A,,Intermediate,CHEMBL622959,In vivo,1969.0,50597,,1,,N,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9404,5408,A,,Intermediate,CHEMBL622960,In vivo,955.0,50597,,1,,N,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,,Brain,1,,BAO_0000218
9405,5408,A,,Intermediate,CHEMBL622961,In vivo,1969.0,50597,,1,,N,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9406,4687,A,,Intermediate,CHEMBL622962,In vivo,,50597,,1,,N,Evaluated for the half life in rat (in vivo),Rattus norvegicus,,,1,,BAO_0000218
9407,6640,A,,Intermediate,CHEMBL622963,,,50597,,1,,N,Hafl life in rat,Rattus norvegicus,,,1,,BAO_0000218
9408,6640,A,,Intermediate,CHEMBL622964,,,50597,,1,,N,Hafl life rat,Rattus norvegicus,,,1,,BAO_0000218
9409,6641,A,,Intermediate,CHEMBL622965,,,50597,,1,,N,Hafl life rat,Rattus norvegicus,,,1,,BAO_0000218
9410,6640,A,,Intermediate,CHEMBL622966,,,50597,,1,,N,Hafl life rat; Not determined,Rattus norvegicus,,,1,,BAO_0000218
9411,6641,A,,Intermediate,CHEMBL622967,,,50597,,1,,N,Hafl life rat; Not determined,Rattus norvegicus,,,1,,BAO_0000218
9412,17411,A,,Intermediate,CHEMBL622968,In vivo,2113.0,50597,,1,,N,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,Kidney,1,,BAO_0000218
9413,17411,A,,Intermediate,CHEMBL622969,In vivo,2107.0,50597,,1,,N,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,Liver,1,,BAO_0000218
9414,17411,A,,Intermediate,CHEMBL875327,In vivo,2048.0,50597,,1,,N,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,Lung,1,,BAO_0000218
9415,6570,A,,Intermediate,CHEMBL628638,In vivo,,50597,,1,,N,Half life in rat after 1 mg/kg i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
9416,6570,A,,Intermediate,CHEMBL628639,In vivo,,50597,,1,,N,Half life in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9417,17411,A,,Intermediate,CHEMBL625840,In vivo,,50597,,1,,N,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9418,4722,A,,Intermediate,CHEMBL625841,In vivo,,50597,,1,,N,Half life of 10 mg/kg oral dose determined in rats,Rattus norvegicus,,,1,,BAO_0000218
9419,5978,A,,Intermediate,CHEMBL625842,In vivo,,50597,,1,,N,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9420,5978,A,,Intermediate,CHEMBL625843,In vivo,,50597,,1,,N,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9421,5978,A,,Intermediate,CHEMBL625844,In vivo,,50597,,1,,N,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9422,5978,A,,Intermediate,CHEMBL873822,In vivo,,50597,,1,,N,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9423,5978,A,,Intermediate,CHEMBL625845,In vivo,,50597,,1,,N,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9424,5978,A,,Intermediate,CHEMBL627059,In vivo,,50597,,1,,N,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9425,5978,A,,Intermediate,CHEMBL627060,In vivo,,50597,,1,,N,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9426,5978,A,,Intermediate,CHEMBL627061,In vivo,,50597,,1,,N,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9427,4762,A,,Intermediate,CHEMBL627709,In vivo,,50597,,1,,N,Half life of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9428,5327,A,,Intermediate,CHEMBL627710,In vivo,,50597,,1,,N,Half life of compound determined after intravenous administration to rat,Rattus norvegicus,,,1,,BAO_0000218
9429,4847,A,,Intermediate,CHEMBL627711,,,50597,,1,,N,Half life of compound was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9430,17720,A,,Intermediate,CHEMBL627712,In vivo,1969.0,50597,,1,,N,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9431,4723,A,,Intermediate,CHEMBL627713,In vivo,,50597,,1,,N,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9432,4723,A,,Intermediate,CHEMBL627714,In vivo,,50597,,1,,N,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9433,4256,A,,Intermediate,CHEMBL627889,In vivo,,22224,,1,,U,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Macaca fascicularis,,,0,,BAO_0000218
9434,4256,A,,Intermediate,CHEMBL627890,In vivo,,22224,,1,,U,Half life determined in rat by intravenous administration,Rattus norvegicus,,,0,,BAO_0000218
9435,4722,A,,Intermediate,CHEMBL627891,In vivo,,50597,,1,,N,Half life determined in rats after iv administration,Rattus norvegicus,,,1,,BAO_0000218
9436,6535,A,,Intermediate,CHEMBL627892,In vivo,1969.0,50597,,1,,N,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,,Plasma,1,,BAO_0000218
9437,6535,A,,Intermediate,CHEMBL627893,In vivo,1969.0,50597,,1,,N,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,,Plasma,1,,BAO_0000218
9438,1435,A,,Intermediate,CHEMBL627894,,1969.0,50597,,1,,N,Half life in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9439,1435,A,,Intermediate,CHEMBL627895,,1969.0,50597,,1,,N,Half life in rat plasma was determined; NA means not applicable,Rattus norvegicus,,Plasma,1,,BAO_0000218
9440,5206,A,,Intermediate,CHEMBL627896,,,50597,,1,,N,Half life in rat was tested,Rattus norvegicus,,,1,,BAO_0000218
9441,6080,A,,Intermediate,CHEMBL627897,,1969.0,50597,,1,,N,Half life measured in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9442,4449,A,,Intermediate,CHEMBL627898,,,50597,,1,,N,Half life recorded in rats,Rattus norvegicus,,,1,,BAO_0000218
9443,6057,A,,Intermediate,CHEMBL627899,,,50597,,1,,N,Half life was calculated,Rattus norvegicus,,,1,,BAO_0000218
9444,6057,A,,Intermediate,CHEMBL873823,,,50597,,1,,N,Half life was calculated in rat,Rattus norvegicus,,,1,,BAO_0000218
9445,3747,A,,Intermediate,CHEMBL627900,,,50597,,1,,N,Half life was determined,Rattus norvegicus,,,1,,BAO_0000218
9446,17858,A,,Intermediate,CHEMBL627901,In vivo,,50597,,1,,N,Half life after 10 mg/kg oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9447,16365,A,,Intermediate,CHEMBL627902,In vivo,,50597,,1,,N,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9448,16365,A,,Intermediate,CHEMBL627903,In vivo,,50597,,1,,N,Half life after administering orally a dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9449,5031,A,,Intermediate,CHEMBL627904,,,50597,,1,,N,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9450,4722,A,,Intermediate,CHEMBL627905,,,50597,,1,,N,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Rattus norvegicus,,,1,,BAO_0000218
9451,6078,A,,Intermediate,CHEMBL627906,,,50597,,1,,N,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9452,6078,A,,Intermediate,CHEMBL627907,,,50597,,1,,N,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9453,6078,A,,Intermediate,CHEMBL876783,,,50597,,1,,N,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9454,6078,A,,Intermediate,CHEMBL627908,,,50597,,1,,N,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Rattus norvegicus,,,1,,BAO_0000218
9455,17065,A,,Intermediate,CHEMBL627909,,,50597,,1,,N,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,,,1,,BAO_0000218
9456,1353,A,,Intermediate,CHEMBL627910,,,50597,,1,,N,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Rattus norvegicus,,,1,,BAO_0000218
9457,1353,A,,Intermediate,CHEMBL627911,,,50597,,1,,N,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Rattus norvegicus,,,1,,BAO_0000218
9458,1353,A,,Intermediate,CHEMBL627912,,,50597,,1,,N,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Rattus norvegicus,,,1,,BAO_0000218
9459,1353,A,,Intermediate,CHEMBL627913,,,50597,,1,,N,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Rattus norvegicus,,,1,,BAO_0000218
9460,1353,A,,Intermediate,CHEMBL627914,,,50597,,1,,N,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Rattus norvegicus,,,1,,BAO_0000218
9461,16423,A,,Intermediate,CHEMBL627915,,,50597,,1,,N,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,1,,BAO_0000218
9462,16423,A,,Intermediate,CHEMBL627916,,,50597,,1,,N,Area under the curve was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9463,6062,A,,Intermediate,CHEMBL627917,,,50597,,1,,N,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9464,6056,A,,Intermediate,CHEMBL627918,,,50597,,1,,N,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9465,5182,A,,Intermediate,CHEMBL627919,,,50597,,1,,N,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Rattus norvegicus,,,1,,BAO_0000218
9466,6410,A,,Intermediate,CHEMBL627920,,,50597,,1,,N,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9467,6410,A,,Intermediate,CHEMBL627921,,,50597,,1,,N,Area under the curve was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9468,4723,A,,Intermediate,CHEMBL627922,,,50597,,1,,N,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9469,4723,A,,Intermediate,CHEMBL876784,,,50597,,1,,N,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9470,4723,A,,Intermediate,CHEMBL627923,,,50597,,1,,N,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9471,4723,A,,Intermediate,CHEMBL626208,,,50597,,1,,N,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9472,4723,A,,Intermediate,CHEMBL626209,,,50597,,1,,N,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9473,4723,A,,Intermediate,CHEMBL626210,,,50597,,1,,N,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
9474,2463,A,,Intermediate,CHEMBL627994,,1969.0,50597,,1,,N,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9475,4709,A,,Intermediate,CHEMBL627995,,,50597,,1,,N,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9476,4075,A,,Intermediate,CHEMBL627996,,,50597,,1,,N,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Rattus norvegicus,,,1,,BAO_0000218
9477,5394,A,,Intermediate,CHEMBL627997,,,50597,,1,,N,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Rattus norvegicus,,,1,,BAO_0000218
9478,2661,A,,Intermediate,CHEMBL627998,,,50597,,1,,N,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9479,2661,A,,Intermediate,CHEMBL628640,,,50597,,1,,N,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9480,2661,A,,Intermediate,CHEMBL628641,,,50597,,1,,N,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9481,2661,A,,Intermediate,CHEMBL628642,,,50597,,1,,N,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
9482,17791,A,,Intermediate,CHEMBL628643,,,50597,,1,,N,Compound was evaluated for area under the curve expressed as (h*ug/ml),Rattus norvegicus,,,1,,BAO_0000218
9483,2591,A,,Intermediate,CHEMBL628644,,,50597,,1,,N,Compound was tested for area under curve in rat,Rattus norvegicus,,,1,,BAO_0000218
9484,6567,A,,Intermediate,CHEMBL628645,,,50597,,1,,N,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Rattus norvegicus,,,1,,BAO_0000218
9485,6211,A,,Intermediate,CHEMBL628646,,,50597,,1,,N,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9486,5529,A,,Intermediate,CHEMBL628647,,,50597,,1,,N,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
9487,5408,A,,Intermediate,CHEMBL628648,,,50597,,1,,N,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,,,1,,BAO_0000218
9488,5408,A,,Intermediate,CHEMBL625358,,,50597,,1,,N,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,1,,BAO_0000218
9489,5408,A,,Intermediate,CHEMBL625359,,,50597,,1,,N,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,,,1,,BAO_0000218
9490,5408,A,,Intermediate,CHEMBL625360,,,50597,,1,,N,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,,,1,,BAO_0000218
9491,429,A,,Intermediate,CHEMBL625361,,,50597,,1,,N,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Rattus norvegicus,,,1,,BAO_0000218
9492,429,A,,Intermediate,CHEMBL625362,,,50597,,1,,N,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Rattus norvegicus,,,1,,BAO_0000218
9493,429,A,,Intermediate,CHEMBL625363,,,50597,,1,,N,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Rattus norvegicus,,,1,,BAO_0000218
9494,4796,A,,Intermediate,CHEMBL625364,,,50597,,1,,N,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,,,1,,BAO_0000218
9495,5974,A,,Intermediate,CHEMBL625365,,,50597,,1,,N,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9496,5974,A,,Intermediate,CHEMBL625366,,,50597,,1,,N,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9497,5974,A,,Intermediate,CHEMBL625367,,,50597,,1,,N,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9498,11450,A,,Intermediate,CHEMBL625368,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9499,11450,A,,Intermediate,CHEMBL625369,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9500,11450,A,,Intermediate,CHEMBL625370,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9501,11450,A,,Intermediate,CHEMBL625371,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9502,11450,A,,Intermediate,CHEMBL625372,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9503,11450,A,,Intermediate,CHEMBL625373,,2113.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
9504,11450,A,,Intermediate,CHEMBL625374,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9505,11450,A,,Intermediate,CHEMBL877593,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9506,11450,A,,Intermediate,CHEMBL625375,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9507,11450,A,,Intermediate,CHEMBL625376,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9508,11450,A,,Intermediate,CHEMBL621973,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9509,11450,A,,Intermediate,CHEMBL621974,,2107.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
9510,11450,A,,Intermediate,CHEMBL621975,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9511,11450,A,,Intermediate,CHEMBL622166,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9512,11450,A,,Intermediate,CHEMBL622167,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9513,11450,A,,Intermediate,CHEMBL622168,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9514,11450,A,,Intermediate,CHEMBL622169,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9515,11450,A,,Intermediate,CHEMBL622170,,2048.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
9516,11450,A,,Intermediate,CHEMBL622171,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9517,11450,A,,Intermediate,CHEMBL622172,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9518,11450,A,,Intermediate,CHEMBL622173,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9519,11450,A,,Intermediate,CHEMBL622174,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9520,11450,A,,Intermediate,CHEMBL622175,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9521,11450,A,,Intermediate,CHEMBL622176,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9522,11450,A,,Intermediate,CHEMBL622177,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9523,11450,A,,Intermediate,CHEMBL622178,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9524,11450,A,,Intermediate,CHEMBL622179,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9525,11450,A,,Intermediate,CHEMBL622180,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9526,16435,A,,Intermediate,CHEMBL622181,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9527,16435,A,,Intermediate,CHEMBL622182,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9528,16435,A,,Intermediate,CHEMBL622183,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9529,16435,A,,Intermediate,CHEMBL622184,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9530,16435,A,,Intermediate,CHEMBL622185,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9531,16435,A,,Intermediate,CHEMBL622186,,,50597,,1,,N,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9532,16434,A,,Intermediate,CHEMBL622187,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9533,16434,A,,Intermediate,CHEMBL625002,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9534,16434,A,,Intermediate,CHEMBL622090,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9535,16435,A,,Intermediate,CHEMBL622091,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9536,16435,A,,Intermediate,CHEMBL622092,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9537,16435,A,,Intermediate,CHEMBL622093,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9538,16435,A,,Intermediate,CHEMBL622094,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9539,16435,A,,Intermediate,CHEMBL622095,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9540,16435,A,,Intermediate,CHEMBL622264,,,50597,,1,,N,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9541,16434,A,,Intermediate,CHEMBL622265,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9542,16434,A,,Intermediate,CHEMBL622266,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9543,16434,A,,Intermediate,CHEMBL622267,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9544,16434,A,,Intermediate,CHEMBL622268,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9545,16434,A,,Intermediate,CHEMBL622269,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9546,16434,A,,Intermediate,CHEMBL625071,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9547,16434,A,,Intermediate,CHEMBL621621,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9548,16434,A,,Intermediate,CHEMBL621622,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9549,16435,A,,Intermediate,CHEMBL621623,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9550,16435,A,,Intermediate,CHEMBL621624,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9551,16435,A,,Intermediate,CHEMBL621625,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9552,16435,A,,Intermediate,CHEMBL621626,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9553,16435,A,,Intermediate,CHEMBL621627,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9554,16435,A,,Intermediate,CHEMBL621628,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9555,16435,A,,Intermediate,CHEMBL875328,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9556,16435,A,,Intermediate,CHEMBL621629,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,Spleen,1,,BAO_0000218
9557,16434,A,,Intermediate,CHEMBL621630,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9558,16434,A,,Intermediate,CHEMBL621631,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9559,16434,A,,Intermediate,CHEMBL621632,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9560,16435,A,,Intermediate,CHEMBL621633,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9561,16435,A,,Intermediate,CHEMBL621634,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9562,16435,A,,Intermediate,CHEMBL621635,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9563,16435,A,,Intermediate,CHEMBL621636,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9564,16435,A,,Intermediate,CHEMBL621637,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9565,16435,A,,Intermediate,CHEMBL621638,,2106.0,50597,,1,,N,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
9566,16434,A,,Intermediate,CHEMBL618883,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9567,16434,A,,Intermediate,CHEMBL618884,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9568,16434,A,,Intermediate,CHEMBL628627,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9569,16434,A,,Intermediate,CHEMBL628628,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9570,16434,A,,Intermediate,CHEMBL628629,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9571,16365,A,,Intermediate,CHEMBL628630,In vivo,,50597,,1,,N,Half life after administering orally a dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9572,16365,A,,Intermediate,CHEMBL628631,In vivo,,50597,,1,,N,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9573,16365,A,,Intermediate,CHEMBL628632,In vivo,,50597,,1,,N,Half life after administering intravenously a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9574,526,A,,Intermediate,CHEMBL628633,In vivo,,50597,,1,,N,Half life after oral dosing in rats,Rattus norvegicus,,,1,,BAO_0000218
9575,16365,A,,Intermediate,CHEMBL628634,In vivo,,50597,,1,,N,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9576,4368,A,,Intermediate,CHEMBL627789,In vivo,,50597,,1,,N,Half life by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9577,3371,A,,Intermediate,CHEMBL627790,,,50597,,1,,N,Half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9578,6448,A,,Intermediate,CHEMBL627791,,,50597,,1,,N,Half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9579,6453,A,,Intermediate,CHEMBL627792,,,50597,,1,,N,Half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9580,4353,A,,Intermediate,CHEMBL627793,In vivo,,50597,,1,,N,Half life in rat after intravenous administration of the compound,Rattus norvegicus,,,1,,BAO_0000218
9581,4353,A,,Intermediate,CHEMBL627794,In vivo,1969.0,50597,,1,,N,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,,Plasma,1,,BAO_0000218
9582,4353,A,,Intermediate,CHEMBL627795,In vivo,,50597,,1,,N,Half life in rat after po administration of the compound,Rattus norvegicus,,,1,,BAO_0000218
9583,4353,A,,Intermediate,CHEMBL627796,In vivo,,50597,,1,,N,Half life in rat after po administration of the compound; ND means Not determined,Rattus norvegicus,,,1,,BAO_0000218
9584,4353,A,,Intermediate,CHEMBL875335,In vivo,1969.0,50597,,1,,N,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Rattus norvegicus,,Plasma,1,,BAO_0000218
9585,4353,A,,Intermediate,CHEMBL627797,In vivo,1969.0,50597,,1,,N,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,,Plasma,1,,BAO_0000218
9586,5789,A,,Intermediate,CHEMBL627798,In vivo,,50597,,1,,N,Half life in rat i.v.,Rattus norvegicus,,,1,,BAO_0000218
9587,17686,A,,Intermediate,CHEMBL627799,In vivo,,50597,,1,,N,Half life in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
9588,6495,A,,Intermediate,CHEMBL627800,,,50597,,1,,N,Half life in rats,Rattus norvegicus,,,1,,BAO_0000218
9589,484,A,,Intermediate,CHEMBL627801,In vivo,,50597,,1,,N,Half life in rats after intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
9590,6467,A,,Intermediate,CHEMBL627802,In vivo,,50597,,1,,N,Half life in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
9591,6642,A,,Expert,CHEMBL627803,,,50597,,1,,N,Half life in rat,Rattus norvegicus,,,1,,BAO_0000218
9592,16367,A,,Intermediate,CHEMBL873820,In vivo,,50597,,1,,N,Half life was evaluated after intravenous administration to rats,Rattus norvegicus,,,1,,BAO_0000218
9593,1369,A,,Intermediate,CHEMBL627804,,,50597,,1,,N,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Rattus norvegicus,,,1,,BAO_0000218
9594,5472,A,,Intermediate,CHEMBL627805,,,50597,,1,,N,Half life was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
9595,6049,A,,Intermediate,CHEMBL627806,,,50597,,1,,N,Half life was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
9596,5472,A,,Intermediate,CHEMBL627107,,,50597,,1,,N,Half life was evaluated in rat; Not tested,Rattus norvegicus,,,1,,BAO_0000218
9597,16366,A,,Intermediate,CHEMBL627108,In vivo,,50597,,1,,N,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Rattus norvegicus,,,1,,BAO_0000218
9598,11149,A,,Intermediate,CHEMBL627109,In vivo,,50597,,1,,N,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,,,1,,BAO_0000218
9599,11149,A,,Intermediate,CHEMBL627110,In vivo,178.0,50597,,1,,N,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Rattus norvegicus,,Blood,1,,BAO_0000218
9600,2891,A,,Intermediate,CHEMBL627111,In vivo,,22224,,1,,U,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,,,0,,BAO_0000218
9601,2891,A,,Intermediate,CHEMBL627112,In vivo,,22224,,1,,U,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,,,0,,BAO_0000218
9602,2891,A,,Intermediate,CHEMBL627113,In vivo,,22224,,1,,U,Half life was measured in rat at dose of 30 mg/kg by iv administration,Rattus norvegicus,,,0,,BAO_0000218
9603,2891,A,,Intermediate,CHEMBL627114,In vivo,,22224,,1,,U,Half life was measured in rat at dose of 30 mg/kg by po administration,Rattus norvegicus,,,0,,BAO_0000218
9604,4026,A,,Intermediate,CHEMBL627115,,,50597,,1,,N,Half life (t1/2) was determined,Rattus norvegicus,,,1,,BAO_0000218
9605,4527,A,,Intermediate,CHEMBL627116,,,50597,,1,,N,Half life period at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
9606,4527,A,,Intermediate,CHEMBL627117,In vivo,,50597,,1,,N,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Rattus norvegicus,,,1,,BAO_0000218
9607,5503,A,,Intermediate,CHEMBL627118,,,50597,,1,,N,Half life period was determined,Rattus norvegicus,,,1,,BAO_0000218
9608,4426,A,,Intermediate,CHEMBL627119,In vivo,,50597,,1,,N,Half life period after intravenous administration at 20 mpk in rats,Rattus norvegicus,,,1,,BAO_0000218
9609,4426,A,,Intermediate,CHEMBL627120,In vivo,,50597,,1,,N,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Rattus norvegicus,,,1,,BAO_0000218
9610,6109,A,,Intermediate,CHEMBL626922,In vivo,,50597,,1,,N,Half life period after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9611,5654,A,,Intermediate,CHEMBL626923,In vivo,,50597,,1,,N,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9612,5654,A,,Intermediate,CHEMBL626924,In vivo,,50597,,1,,N,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9613,4755,A,,Intermediate,CHEMBL626925,,1969.0,50597,,1,,N,Half life period in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,,Plasma,1,,BAO_0000218
9614,5862,A,,Intermediate,CHEMBL626926,,,50597,,1,,N,Half life period in SD rats,Rattus norvegicus,,,1,,BAO_0000218
9615,1515,A,,Intermediate,CHEMBL626927,,1969.0,50597,,1,,N,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Rattus norvegicus,,Plasma,1,,BAO_0000218
9616,1515,A,,Intermediate,CHEMBL626928,,1969.0,50597,,1,,N,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,,Plasma,1,,BAO_0000218
9617,1515,A,,Intermediate,CHEMBL626929,,1969.0,50597,,1,,N,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,Plasma,1,,BAO_0000218
9618,1515,A,,Intermediate,CHEMBL626930,,1969.0,50597,,1,,N,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,Plasma,1,,BAO_0000218
9619,5960,A,,Intermediate,CHEMBL626931,,,50597,,1,,N,Half life period in rat,Rattus norvegicus,,,1,,BAO_0000218
9620,6103,A,,Intermediate,CHEMBL626932,,,50597,,1,,N,Half life period in rat,Rattus norvegicus,,,1,,BAO_0000218
9621,6317,A,,Intermediate,CHEMBL626933,,,50597,,1,,N,Half life period in rat,Rattus norvegicus,,,1,,BAO_0000218
9622,6644,A,,Intermediate,CHEMBL873826,In vivo,,50597,,1,,N,Half life period in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9623,6644,A,,Intermediate,CHEMBL626934,In vivo,,50597,,1,,N,Half life period in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9624,6644,A,,Intermediate,CHEMBL626935,In vivo,,50597,,1,,N,Half life period in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9625,6644,A,,Intermediate,CHEMBL626936,In vivo,,50597,,1,,N,Half life period in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9626,5974,A,,Intermediate,CHEMBL626937,,,50597,,1,,N,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
9627,6295,A,,Intermediate,CHEMBL625906,,,50597,,1,,N,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9628,6296,A,,Intermediate,CHEMBL625907,,,50597,,1,,N,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9629,16427,A,,Intermediate,CHEMBL625908,,,50597,,1,,N,PK study was carried to determine AUC (area under curve) value in rat,Rattus norvegicus,,,1,,BAO_0000218
9630,16367,A,,Intermediate,CHEMBL625909,,,50597,,1,,N,Pharmacokinetic parameter AUC after intravenous administration to rats,Rattus norvegicus,,,1,,BAO_0000218
9631,16367,A,,Intermediate,CHEMBL625910,,,50597,,1,,N,Pharmacokinetic parameter AUC after oral administration to rats,Rattus norvegicus,,,1,,BAO_0000218
9632,16365,A,,Intermediate,CHEMBL625911,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9633,16365,A,,Intermediate,CHEMBL625912,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9634,16365,A,,Intermediate,CHEMBL626538,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9635,16365,A,,Intermediate,CHEMBL876794,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Rattus norvegicus,,,1,,BAO_0000218
9636,16365,A,,Intermediate,CHEMBL626539,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Rattus norvegicus,,,1,,BAO_0000218
9637,16365,A,,Intermediate,CHEMBL626540,,,50597,,1,,N,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
9638,5394,A,,Intermediate,CHEMBL626541,,,50597,,1,,N,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9639,5394,A,,Intermediate,CHEMBL626542,,,50597,,1,,N,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9640,2792,A,,Intermediate,CHEMBL626543,,,50597,,1,,N,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
9641,2792,A,,Intermediate,CHEMBL626544,,,50597,,1,,N,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
9642,2792,A,,Intermediate,CHEMBL626545,,,50597,,1,,N,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
9643,2792,A,,Intermediate,CHEMBL626546,,,50597,,1,,N,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
9644,5334,A,,Intermediate,CHEMBL626547,,,50597,,1,,N,Pharmacokinetic parameter area under curve was reported,Rattus norvegicus,,,1,,BAO_0000218
9645,4408,A,,Intermediate,CHEMBL626548,,,50597,,1,,N,Pharmacokinetic property (AUC) in rat,Rattus norvegicus,,,1,,BAO_0000218
9646,5983,A,,Intermediate,CHEMBL626549,,,50597,,1,,N,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,,,1,,BAO_0000218
9647,4397,A,,Intermediate,CHEMBL626550,,,50597,,1,,N,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Rattus norvegicus,,,1,,BAO_0000218
9648,4397,A,,Intermediate,CHEMBL626551,,,50597,,1,,N,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Rattus norvegicus,,,1,,BAO_0000218
9649,5491,A,,Intermediate,CHEMBL623777,,,50597,,1,,N,Pharmacokinetic property was determined,Rattus norvegicus,,,1,,BAO_0000218
9650,5491,A,,Intermediate,CHEMBL623778,,,50597,,1,,N,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9651,5491,A,,Intermediate,CHEMBL623779,,,50597,,1,,N,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Rattus norvegicus,,,1,,BAO_0000218
9652,4199,A,,Intermediate,CHEMBL623780,,1969.0,50597,,1,,N,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9653,4199,A,,Intermediate,CHEMBL622015,,1969.0,50597,,1,,N,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9654,4199,A,,Intermediate,CHEMBL622016,,1969.0,50597,,1,,N,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9655,5173,A,,Intermediate,CHEMBL622017,,,50597,,1,,N,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Rattus norvegicus,,,1,,BAO_0000218
9656,5173,A,,Intermediate,CHEMBL622018,,,50597,,1,,N,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Rattus norvegicus,,,1,,BAO_0000218
9657,5173,A,,Intermediate,CHEMBL622019,,,50597,,1,,N,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Rattus norvegicus,,,1,,BAO_0000218
9658,5173,A,,Intermediate,CHEMBL622020,,,50597,,1,,N,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Rattus norvegicus,,,1,,BAO_0000218
9659,16366,A,,Intermediate,CHEMBL622021,,,50597,,1,,N,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Rattus norvegicus,,,1,,BAO_0000218
9660,16366,A,,Intermediate,CHEMBL622022,,,50597,,1,,N,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Rattus norvegicus,,,1,,BAO_0000218
9661,5327,A,,Intermediate,CHEMBL622023,,,50597,,1,,N,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9662,6681,A,,Intermediate,CHEMBL622024,,,50597,,1,,N,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
9663,12873,A,,Intermediate,CHEMBL622693,,,50597,,1,,N,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Rattus norvegicus,,,1,,BAO_0000218
9664,12873,A,,Intermediate,CHEMBL622694,,,50597,,1,,N,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Rattus norvegicus,,,1,,BAO_0000218
9665,6685,A,,Intermediate,CHEMBL622695,,,50597,,1,,N,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9666,6685,A,,Intermediate,CHEMBL622696,,,50597,,1,,N,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,,,1,,BAO_0000218
9667,6685,A,,Intermediate,CHEMBL622697,,,50597,,1,,N,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,,,1,,BAO_0000218
9668,6619,A,,Intermediate,CHEMBL622874,,,50597,,1,,N,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Rattus norvegicus,,,1,,BAO_0000218
9669,6619,A,,Intermediate,CHEMBL622875,,,50597,,1,,N,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Rattus norvegicus,,,1,,BAO_0000218
9670,10363,A,,Intermediate,CHEMBL622876,,,50597,,1,,N,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,,,1,,BAO_0000218
9671,4796,A,,Intermediate,CHEMBL622877,,,50597,,1,,N,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,,,1,,BAO_0000218
9672,4910,A,,Intermediate,CHEMBL622878,,,50597,,1,,N,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,,1,,BAO_0000218
9673,4910,A,,Intermediate,CHEMBL622879,,1969.0,50597,,1,,N,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9674,4839,A,,Intermediate,CHEMBL877602,,,50597,,1,,N,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Rattus norvegicus,,,1,,BAO_0000218
9675,15078,A,,Intermediate,CHEMBL622880,,,50597,,1,,N,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9676,15078,A,,Intermediate,CHEMBL622881,,,50597,,1,,N,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9677,15078,A,,Intermediate,CHEMBL622882,,,50597,,1,,N,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9678,15078,A,,Intermediate,CHEMBL622883,,,50597,,1,,N,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9679,11450,A,,Intermediate,CHEMBL622884,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9680,11450,A,,Intermediate,CHEMBL622885,,2046.0,50597,,1,,N,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9681,8151,A,,Intermediate,CHEMBL622886,,,50597,,1,,N,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,1,,BAO_0000218
9682,8151,A,,Intermediate,CHEMBL622887,,,50597,,1,,N,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
9683,8151,A,,Intermediate,CHEMBL622888,,1088.0,50597,,1,,N,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,,Urine,1,,BAO_0000218
9684,8677,A,,Intermediate,CHEMBL622889,In vivo,178.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Blood,1,,BAO_0000218
9685,8677,A,,Intermediate,CHEMBL622890,In vivo,178.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Blood,1,,BAO_0000218
9686,8677,A,,Intermediate,CHEMBL622891,In vivo,178.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Blood,1,,BAO_0000218
9687,8677,A,,Intermediate,CHEMBL877603,In vivo,178.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Blood,1,,BAO_0000218
9688,8677,A,,Intermediate,CHEMBL622892,In vivo,955.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Brain,1,,BAO_0000218
9689,8677,A,,Intermediate,CHEMBL622893,In vivo,955.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Brain,1,,BAO_0000218
9690,8677,A,,Intermediate,CHEMBL622894,In vivo,955.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Brain,1,,BAO_0000218
9691,8677,A,,Intermediate,CHEMBL622895,In vivo,955.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Brain,1,,BAO_0000218
9692,8677,A,,Intermediate,CHEMBL622896,In vivo,955.0,50597,,1,,N,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
9693,8677,A,,Intermediate,CHEMBL622897,In vivo,948.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Heart,1,,BAO_0000218
9694,8677,A,,Intermediate,CHEMBL622898,In vivo,948.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Heart,1,,BAO_0000218
9695,8677,A,,Intermediate,CHEMBL622899,In vivo,948.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Heart,1,,BAO_0000218
9696,8677,A,,Intermediate,CHEMBL622900,In vivo,2113.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Kidney,1,,BAO_0000218
9697,8677,A,,Intermediate,CHEMBL624114,In vivo,2113.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Kidney,1,,BAO_0000218
9698,8677,A,,Intermediate,CHEMBL624115,In vivo,2113.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Kidney,1,,BAO_0000218
9699,8677,A,,Intermediate,CHEMBL624116,In vivo,2113.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Kidney,1,,BAO_0000218
9700,8677,A,,Intermediate,CHEMBL624117,In vivo,2107.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Liver,1,,BAO_0000218
9701,8677,A,,Intermediate,CHEMBL624118,In vivo,2107.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Liver,1,,BAO_0000218
9702,8677,A,,Intermediate,CHEMBL624119,In vivo,2107.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Liver,1,,BAO_0000218
9703,8677,A,,Intermediate,CHEMBL624120,In vivo,2107.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Liver,1,,BAO_0000218
9704,8677,A,,Intermediate,CHEMBL624121,In vivo,2048.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Lung,1,,BAO_0000218
9705,8677,A,,Intermediate,CHEMBL624122,In vivo,2048.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Lung,1,,BAO_0000218
9706,8677,A,,Intermediate,CHEMBL624123,In vivo,2048.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Lung,1,,BAO_0000218
9707,8677,A,,Intermediate,CHEMBL624124,In vivo,2048.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Lung,1,,BAO_0000218
9708,8677,A,,Intermediate,CHEMBL624125,In vivo,2385.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9709,8677,A,,Intermediate,CHEMBL624126,In vivo,2385.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9710,8677,A,,Intermediate,CHEMBL624127,In vivo,2385.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9711,8677,A,,Intermediate,CHEMBL624128,In vivo,2385.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9712,8677,A,,Intermediate,CHEMBL624129,In vivo,14.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9713,8677,A,,Intermediate,CHEMBL624130,In vivo,14.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9714,8677,A,,Intermediate,CHEMBL622340,In vivo,14.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9715,8677,A,,Intermediate,CHEMBL622341,In vivo,14.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Zone of skin,1,,BAO_0000218
9716,8677,A,,Intermediate,CHEMBL622342,In vivo,160.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Intestine,1,,BAO_0000218
9717,8677,A,,Intermediate,CHEMBL622343,In vivo,160.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Intestine,1,,BAO_0000218
9718,8677,A,,Intermediate,CHEMBL622344,In vivo,160.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Intestine,1,,BAO_0000218
9719,8677,A,,Intermediate,CHEMBL622345,In vivo,160.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Intestine,1,,BAO_0000218
9720,8677,A,,Intermediate,CHEMBL622346,In vivo,2106.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Spleen,1,,BAO_0000218
9721,8677,A,,Intermediate,CHEMBL622347,In vivo,2106.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Spleen,1,,BAO_0000218
9722,8677,A,,Intermediate,CHEMBL622348,In vivo,2106.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Spleen,1,,BAO_0000218
9723,8677,A,,Intermediate,CHEMBL622349,In vivo,2106.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Spleen,1,,BAO_0000218
9724,16434,A,,Intermediate,CHEMBL622350,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9725,16434,A,,Intermediate,CHEMBL622351,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9726,16434,A,,Intermediate,CHEMBL622352,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9727,16435,A,,Intermediate,CHEMBL622353,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9728,16435,A,,Intermediate,CHEMBL622354,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9729,16435,A,,Intermediate,CHEMBL622355,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9730,16435,A,,Intermediate,CHEMBL622356,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9731,16435,A,,Intermediate,CHEMBL622357,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9732,16435,A,,Intermediate,CHEMBL622358,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,,,1,,BAO_0000218
9733,16435,A,,Intermediate,CHEMBL622359,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9734,16435,A,,Intermediate,CHEMBL874393,,,50597,,1,,N,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9735,16434,A,,Intermediate,CHEMBL622872,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9736,16434,A,,Intermediate,CHEMBL622873,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9737,16434,A,,Intermediate,CHEMBL623047,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9738,16435,A,,Intermediate,CHEMBL623048,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9739,16435,A,,Intermediate,CHEMBL623049,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9740,16435,A,,Intermediate,CHEMBL623050,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9741,16435,A,,Intermediate,CHEMBL623051,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9742,16435,A,,Intermediate,CHEMBL623052,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9743,16435,A,,Intermediate,CHEMBL626343,,,50597,,1,,N,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9744,16434,A,,Intermediate,CHEMBL626344,,,50597,,1,,N,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,,,1,,BAO_0000218
9745,16434,A,,Intermediate,CHEMBL626345,,,50597,,1,,N,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,,,1,,BAO_0000218
9746,16434,A,,Intermediate,CHEMBL626346,,,50597,,1,,N,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,,,1,,BAO_0000218
9747,16434,A,,Intermediate,CHEMBL626347,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9748,16434,A,,Intermediate,CHEMBL626348,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9749,16434,A,,Intermediate,CHEMBL626349,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9750,16435,F,,Intermediate,CHEMBL626350,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9751,16435,A,,Intermediate,CHEMBL626351,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9752,16435,A,,Intermediate,CHEMBL627650,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9753,16435,F,,Intermediate,CHEMBL627651,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,,,1,,BAO_0000218
9754,16435,A,,Intermediate,CHEMBL627652,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,,,1,,BAO_0000218
9755,16435,A,,Intermediate,CHEMBL627653,,,50597,,1,,N,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,,,1,,BAO_0000218
9756,13091,A,,Intermediate,CHEMBL627654,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9757,13091,A,,Intermediate,CHEMBL627835,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9758,13091,A,,Intermediate,CHEMBL627836,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9759,13091,A,,Intermediate,CHEMBL627837,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9760,13091,A,,Intermediate,CHEMBL627838,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9761,13091,A,,Intermediate,CHEMBL875338,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9762,13091,A,,Intermediate,CHEMBL627839,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9763,13091,A,,Intermediate,CHEMBL627840,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9764,13091,A,,Intermediate,CHEMBL627841,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9765,13091,A,,Intermediate,CHEMBL627842,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9766,13091,A,,Intermediate,CHEMBL627843,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9767,13091,A,,Intermediate,CHEMBL627844,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9768,13091,A,,Intermediate,CHEMBL627845,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9769,5874,A,,Intermediate,CHEMBL627846,In vivo,,50597,,1,,N,Half life period in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9770,1515,A,,Intermediate,CHEMBL627847,,1969.0,50597,,1,,N,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Rattus norvegicus,,Plasma,1,,BAO_0000218
9771,1515,A,,Intermediate,CHEMBL873821,,1969.0,50597,,1,,N,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,,Plasma,1,,BAO_0000218
9772,1515,A,,Intermediate,CHEMBL626079,,1969.0,50597,,1,,N,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,Plasma,1,,BAO_0000218
9773,1515,A,,Intermediate,CHEMBL626080,,1969.0,50597,,1,,N,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,,Plasma,1,,BAO_0000218
9774,5491,A,,Intermediate,CHEMBL626081,,1969.0,50597,,1,,N,Half life period was evaluated in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9775,5491,A,,Intermediate,CHEMBL875344,,1969.0,50597,,1,,N,Half life period was evaluated in rat plasma; Not tested,Rattus norvegicus,,Plasma,1,,BAO_0000218
9776,1918,A,,Intermediate,CHEMBL626082,,,50597,,1,,N,Half life period was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
9777,1918,A,,Intermediate,CHEMBL626250,In vivo,,50597,,1,,N,"Half life period was evaluated in rats, iv",Rattus norvegicus,,,1,,BAO_0000218
9778,6113,A,,Intermediate,CHEMBL626251,In vivo,,50597,,1,,N,Half life period after intravenous administration at 5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
9779,5546,A,,Intermediate,CHEMBL626252,In vivo,,50597,,1,,N,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,,,1,,BAO_0000218
9780,5553,A,,Intermediate,CHEMBL626253,In vivo,,50597,,1,,N,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9781,4188,A,,Intermediate,CHEMBL626254,,1969.0,50597,,1,,N,Half life stability of compound was evaluated in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9782,6215,A,,Intermediate,CHEMBL626255,In vivo,,50597,,1,,N,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9783,6141,A,,Intermediate,CHEMBL626256,In vivo,,50597,,1,,N,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9784,5182,A,,Intermediate,CHEMBL626257,In vivo,,50597,,1,,N,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,1,,BAO_0000218
9785,5182,A,,Intermediate,CHEMBL626258,In vivo,,50597,,1,,N,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Rattus norvegicus,,,1,,BAO_0000218
9786,5710,A,,Intermediate,CHEMBL626259,In vivo,,50597,,1,,N,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Rattus norvegicus,,,1,,BAO_0000218
9787,5789,A,,Intermediate,CHEMBL626260,In vivo,,50597,,1,,N,Half in rat i.v.,Rattus norvegicus,,,1,,BAO_0000218
9788,6011,A,,Intermediate,CHEMBL875345,In vivo,,50597,,1,,N,Half period in rat after intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
9789,17594,A,,Intermediate,CHEMBL626261,In vivo,,50597,,1,,N,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9790,12357,A,,Intermediate,CHEMBL626262,In vitro,2107.0,50597,,1,,N,Half-life measured in in vitro Cathepsin B assay in rat liver,Rattus norvegicus,,Liver,1,,BAO_0000218
9791,5210,A,,Intermediate,CHEMBL626263,,,50597,,1,,N,Half-life of compound was determined in rats,Rattus norvegicus,,,1,,BAO_0000218
9792,17596,A,,Intermediate,CHEMBL625270,In vivo,,50597,,1,,N,Half-life at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
9793,6672,A,,Intermediate,CHEMBL625271,,,50597,,1,,N,Half-life determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9794,6673,A,,Intermediate,CHEMBL625272,,,50597,,1,,N,Half-life determined in rat,Rattus norvegicus,,,1,,BAO_0000218
9795,4910,A,,Intermediate,CHEMBL625273,In vivo,955.0,50597,,1,,N,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,Brain,1,,BAO_0000218
9796,3741,A,,Intermediate,CHEMBL625274,,1969.0,50597,,1,,N,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Rattus norvegicus,,Plasma,1,,BAO_0000218
9797,17671,A,,Intermediate,CHEMBL625275,In vivo,,50597,,1,,N,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9798,4910,A,,Intermediate,CHEMBL625276,In vivo,1969.0,50597,,1,,N,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
9799,17537,A,,Intermediate,CHEMBL625277,,1969.0,50597,,1,,N,Half-life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9800,4965,A,,Intermediate,CHEMBL625278,,1969.0,50597,,1,,N,Half-life in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9801,17537,A,,Intermediate,CHEMBL625279,,1969.0,50597,,1,,N,Half-life in rat plasma; Not tested,Rattus norvegicus,,Plasma,1,,BAO_0000218
9802,6124,A,,Intermediate,CHEMBL625280,,1977.0,50597,,1,,N,Half-life in rat serum,Rattus norvegicus,,Serum,1,,BAO_0000218
9803,6124,A,,Intermediate,CHEMBL876797,,1977.0,50597,,1,,N,Half-life in rat serum; na is not available,Rattus norvegicus,,Serum,1,,BAO_0000218
9804,6078,A,,Intermediate,CHEMBL625281,,,50597,,1,,N,Half-life was calculated in rat,Rattus norvegicus,,,1,,BAO_0000218
9805,17668,A,,Intermediate,CHEMBL873827,,1969.0,50597,,1,,N,Half-life was calculated in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9806,3185,A,,Intermediate,CHEMBL625282,,,50597,,1,,N,Half-life was determined,Rattus norvegicus,,,1,,BAO_0000218
9807,4883,A,,Intermediate,CHEMBL625283,,,50597,,1,,N,Half-life was determined,Rattus norvegicus,,,1,,BAO_0000218
9808,2959,A,,Intermediate,CHEMBL625284,In vivo,,50597,,1,,N,Half-life after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,,,1,,BAO_0000218
9809,4029,A,,Intermediate,CHEMBL625285,In vivo,,50597,,1,,N,Half-life after administration of 3.2 mg/kg intravenously in male rat,Rattus norvegicus,,,1,,BAO_0000218
9810,4029,A,,Intermediate,CHEMBL625286,In vivo,,50597,,1,,N,Half-life after intravenous administration in female rat,Rattus norvegicus,,,1,,BAO_0000218
9811,4029,A,,Intermediate,CHEMBL625287,In vivo,,50597,,1,,N,Half-life after intravenous administration in male rat,Rattus norvegicus,,,1,,BAO_0000218
9812,6180,A,,Intermediate,CHEMBL625288,In vivo,,50597,,1,,N,Half-life after intravenous dose in rat,Rattus norvegicus,,,1,,BAO_0000218
9813,1557,A,,Intermediate,CHEMBL625289,,2107.0,50597,,1,,N,Half-life in a rat liver homogenate preparation,Rattus norvegicus,,Liver,1,,BAO_0000218
9814,12500,A,,Intermediate,CHEMBL625290,,1969.0,50597,,1,,N,Half-life in plasma of rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9815,12500,A,,Intermediate,CHEMBL876798,,1969.0,50597,,1,,N,Half-life in plasma of rat at dose of 3-10 mgkg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9816,5064,A,,Intermediate,CHEMBL625291,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9817,5145,A,,Intermediate,CHEMBL625292,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9818,5147,A,,Intermediate,CHEMBL625293,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9819,5833,A,,Intermediate,CHEMBL622832,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9820,6596,A,,Intermediate,CHEMBL622833,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9821,17655,A,,Intermediate,CHEMBL622834,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
9822,6495,A,,Intermediate,CHEMBL622835,In vivo,,50597,,1,,N,Half-life in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9823,17538,A,,Intermediate,CHEMBL622836,In vivo,,50597,,1,,N,Half-life in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9824,17538,A,,Intermediate,CHEMBL622837,In vivo,,50597,,1,,N,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,,,1,,BAO_0000218
9825,10,A,,Intermediate,CHEMBL622838,In vivo,,50597,,1,,N,Half-life in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,,,1,,BAO_0000218
9826,17669,A,,Intermediate,CHEMBL622839,,955.0,50597,,1,,N,Half-life in rat brain homogenate,Rattus norvegicus,,Brain,1,,BAO_0000218
9827,17065,A,,Intermediate,CHEMBL622840,,1969.0,50597,,1,,N,Half-life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9828,4333,A,,Intermediate,CHEMBL622841,,,50597,,1,,N,Half-life in rats,Rattus norvegicus,,,1,,BAO_0000218
9829,6827,A,,Intermediate,CHEMBL622842,,,50597,,1,,N,Half-life in Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9830,889,A,,Intermediate,CHEMBL622843,In vitro,1969.0,50597,,1,,N,Half-life in vitro in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
9831,889,A,,Intermediate,CHEMBL622844,In vitro,1969.0,50597,,1,,N,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
9832,3747,A,,Intermediate,CHEMBL622845,,,50597,,1,,N,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Rattus norvegicus,,,1,,BAO_0000218
9833,15022,A,,Intermediate,CHEMBL622846,,,50597,,1,,N,The area under the curve of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9834,15022,A,,Intermediate,CHEMBL622847,,,50597,,1,,N,The area under the curve of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9835,15022,A,,Intermediate,CHEMBL622848,,,50597,,1,,N,The area under the curve of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
9836,3360,A,,Intermediate,CHEMBL622849,In vivo,,50597,,1,,N,Bioavailability as oral AUC in rats,Rattus norvegicus,,,1,,BAO_0000218
9837,5334,A,,Intermediate,CHEMBL622850,,1969.0,50597,,1,,N,The plasma concentration versus time curve (AUC) was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9838,17411,A,,Intermediate,CHEMBL876807,,,50597,,1,,N,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9839,17411,A,,Intermediate,CHEMBL622851,,,50597,,1,,N,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9840,17411,A,,Intermediate,CHEMBL622852,,,50597,,1,,N,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9841,6570,A,,Intermediate,CHEMBL622853,,,50597,,1,,N,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Rattus norvegicus,,,1,,BAO_0000218
9842,6570,A,,Intermediate,CHEMBL622854,,,50597,,1,,N,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Rattus norvegicus,,,1,,BAO_0000218
9843,17411,A,,Intermediate,CHEMBL622855,,,50597,,1,,N,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9844,14941,A,,Intermediate,CHEMBL622856,,1969.0,50597,,1,,N,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,Plasma,1,,BAO_0000218
9845,14941,A,,Intermediate,CHEMBL622857,,1969.0,50597,,1,,N,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,Plasma,1,,BAO_0000218
9846,17538,A,,Intermediate,CHEMBL622858,,1969.0,50597,,1,,N,AUC in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9847,17752,A,,Intermediate,CHEMBL622859,,1969.0,50597,,1,,N,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9848,17509,A,,Intermediate,CHEMBL622860,,,50597,,1,,N,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9849,17509,A,,Intermediate,CHEMBL622861,,,50597,,1,,N,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9850,17509,A,,Intermediate,CHEMBL622862,,,50597,,1,,N,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9851,17509,A,,Intermediate,CHEMBL622863,,,50597,,1,,N,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9852,17509,A,,Intermediate,CHEMBL623817,,,50597,,1,,N,Area under curve value 6 hr after po administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9853,17717,A,,Intermediate,CHEMBL623818,,,50597,,1,,N,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,1,,BAO_0000218
9854,17717,A,,Intermediate,CHEMBL623819,,,50597,,1,,N,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,,,1,,BAO_0000218
9855,17717,A,,Intermediate,CHEMBL623820,,,50597,,1,,N,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,1,,BAO_0000218
9856,17717,A,,Intermediate,CHEMBL623821,,,50597,,1,,N,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,,1,,BAO_0000218
9857,6642,A,,Intermediate,CHEMBL623822,,1969.0,50597,,1,,N,AUC normalized for dose (AUCN) in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9858,6640,A,,Intermediate,CHEMBL623823,,,50597,,1,,N,Area under curve in rat after p.o. administration,Rattus norvegicus,,,1,,BAO_0000218
9859,6641,A,,Intermediate,CHEMBL623824,,,50597,,1,,N,Area under curve in rat after p.o. administration,Rattus norvegicus,,,1,,BAO_0000218
9860,6641,A,,Intermediate,CHEMBL623825,,,50597,,1,,N,Area under curve in rat after p.o. administration; Not determined,Rattus norvegicus,,,1,,BAO_0000218
9861,6641,A,,Intermediate,CHEMBL622070,,,50597,,1,,N,Area under curve in rat after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9862,3603,A,,Intermediate,CHEMBL622071,,,50597,,1,,N,Area under curve (carotid artery) value of the compound,Rattus norvegicus,,,1,,BAO_0000218
9863,3550,A,,Intermediate,CHEMBL622072,,,50597,,1,,N,Bioavailability expressed as the area under curve of rat carotid artery,Rattus norvegicus,,,1,,BAO_0000218
9864,15662,A,,Intermediate,CHEMBL622073,,,50597,,1,,N,Area under curve in male SD rats was observed after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
9865,17720,A,,Intermediate,CHEMBL622074,,,50597,,1,,N,Area under curve of the compound was determined,Rattus norvegicus,,,1,,BAO_0000218
9866,5407,A,,Intermediate,CHEMBL622075,,,50597,,1,,N,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Rattus norvegicus,,,1,,BAO_0000218
9867,17752,A,,Intermediate,CHEMBL622076,,1969.0,50597,,1,,N,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9868,17752,A,,Intermediate,CHEMBL622077,,1969.0,50597,,1,,N,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
9869,3603,A,,Intermediate,CHEMBL622078,,,50597,,1,,N,Area under curve (portal vein) value of the compound,Rattus norvegicus,,,1,,BAO_0000218
9870,3550,A,,Intermediate,CHEMBL622079,,,50597,,1,,N,Bioavailability expressed as the area under curve of rat portal vein,Rattus norvegicus,,,1,,BAO_0000218
9871,17655,A,,Intermediate,CHEMBL622080,,1969.0,50597,,1,,N,Area Under plasma concentration time curve in rat upon peroral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
9872,17582,A,,Intermediate,CHEMBL877612,,,50597,,1,,N,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9873,17582,A,,Intermediate,CHEMBL622081,,,50597,,1,,N,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
9874,17791,A,,Intermediate,CHEMBL622082,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats,Rattus norvegicus,,,1,,BAO_0000218
9875,17791,A,,Intermediate,CHEMBL622083,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats after iv administration,Rattus norvegicus,,,1,,BAO_0000218
9876,17791,A,,Intermediate,CHEMBL622084,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats; 30-80,Rattus norvegicus,,,1,,BAO_0000218
9877,17791,A,,Intermediate,CHEMBL622085,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats; 50-60,Rattus norvegicus,,,1,,BAO_0000218
9878,17791,A,,Intermediate,CHEMBL622086,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats; no data,Rattus norvegicus,,,1,,BAO_0000218
9879,17791,A,,Intermediate,CHEMBL622087,,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats; peptide,Rattus norvegicus,,,1,,BAO_0000218
9880,7768,A,,Intermediate,CHEMBL622088,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Rattus norvegicus,,Blood,1,,BAO_0000218
9881,7768,A,,Intermediate,CHEMBL622089,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Rattus norvegicus,,Blood,1,,BAO_0000218
9882,7768,A,,Intermediate,CHEMBL623685,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Rattus norvegicus,,Blood,1,,BAO_0000218
9883,7768,A,,Intermediate,CHEMBL623686,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Rattus norvegicus,,Blood,1,,BAO_0000218
9884,8677,A,,Intermediate,CHEMBL623687,In vivo,945.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Stomach,1,,BAO_0000218
9885,8677,A,,Intermediate,CHEMBL623688,In vivo,945.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Stomach,1,,BAO_0000218
9886,8677,A,,Intermediate,CHEMBL623689,In vivo,945.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Stomach,1,,BAO_0000218
9887,8677,A,,Intermediate,CHEMBL622485,In vivo,945.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Stomach,1,,BAO_0000218
9888,8677,A,,Intermediate,CHEMBL622486,In vivo,2046.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9889,8677,A,,Intermediate,CHEMBL877613,In vivo,2046.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9890,8677,A,,Intermediate,CHEMBL622487,In vivo,2046.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9891,8677,A,,Intermediate,CHEMBL622488,In vivo,2046.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
9892,8677,A,,Intermediate,CHEMBL622489,In vivo,948.0,50597,,1,,N,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,,Heart,1,,BAO_0000218
9893,6899,A,,Intermediate,CHEMBL622490,,1088.0,50597,,1,,N,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,Urine,1,,BAO_0000218
9894,6899,A,,Intermediate,CHEMBL622491,,1088.0,50597,,1,,N,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,,Urine,1,,BAO_0000218
9895,6899,A,,Intermediate,CHEMBL622492,,2107.0,50597,,1,,N,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Rattus norvegicus,,Liver,1,,BAO_0000218
9896,6899,A,,Intermediate,CHEMBL622493,,1088.0,50597,,1,,N,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,Urine,1,,BAO_0000218
9897,6899,A,,Intermediate,CHEMBL622494,,1088.0,50597,,1,,N,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,,Urine,1,,BAO_0000218
9898,8677,A,,Intermediate,CHEMBL622495,,2385.0,50597,,1,,N,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9899,6899,A,,Intermediate,CHEMBL622496,,,50597,,1,,N,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Rattus norvegicus,,,1,,BAO_0000218
9900,6899,A,,Intermediate,CHEMBL622497,,1088.0,50597,,1,,N,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,,Urine,1,,BAO_0000218
9901,2189,A,,Intermediate,CHEMBL622498,,,50597,,1,,N,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Rattus norvegicus,,,1,,BAO_0000218
9902,2189,A,,Intermediate,CHEMBL624918,,1088.0,50597,,1,,N,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Rattus norvegicus,,Urine,1,,BAO_0000218
9903,2189,A,,Intermediate,CHEMBL624919,,1088.0,50597,,1,,N,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Rattus norvegicus,,Urine,1,,BAO_0000218
9904,10839,A,,Intermediate,CHEMBL624920,In vivo,178.0,50597,,1,,N,Biodistribution of compound in rat blood after 5 min of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
9905,10839,A,,Intermediate,CHEMBL624921,In vivo,178.0,50597,,1,,N,Biodistribution of compound in rat blood after 5 min of administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
9906,10839,A,,Intermediate,CHEMBL624922,In vivo,955.0,50597,,1,,N,Biodistribution of compound in rat brain after 5 min of administration,Rattus norvegicus,,Brain,1,,BAO_0000218
9907,10839,A,,Intermediate,CHEMBL624923,In vivo,948.0,50597,,1,,N,Biodistribution of compound in rat heart after 5 min of administration,Rattus norvegicus,,Heart,1,,BAO_0000218
9908,10839,A,,Intermediate,CHEMBL624924,In vivo,948.0,50597,,1,,N,Biodistribution of compound in rat heart after 5 min of administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
9909,10839,A,,Intermediate,CHEMBL624925,In vivo,2113.0,50597,,1,,N,Biodistribution of compound in rat kidney after 5 min of administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
9910,10839,A,,Intermediate,CHEMBL624926,In vivo,2113.0,50597,,1,,N,Biodistribution of compound in rat kidney after 5 min of administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
9911,10839,A,,Intermediate,CHEMBL624927,In vivo,2107.0,50597,,1,,N,Biodistribution of compound in rat liver after 5 min of administration,Rattus norvegicus,,Liver,1,,BAO_0000218
9912,10839,A,,Intermediate,CHEMBL874402,In vivo,2107.0,50597,,1,,N,Biodistribution of compound in rat liver after 5 min of administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
9913,10839,A,,Intermediate,CHEMBL624928,In vivo,2048.0,50597,,1,,N,Biodistribution of compound in rat lung after 5 min of administration,Rattus norvegicus,,Lung,1,,BAO_0000218
9914,10839,A,,Intermediate,CHEMBL624929,In vivo,2048.0,50597,,1,,N,Biodistribution of compound in rat lung after 5 min of administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
9915,10839,A,,Intermediate,CHEMBL624930,In vivo,2385.0,50597,,1,,N,Biodistribution of compound in rat muscle after 5 min of administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9916,10839,A,,Intermediate,CHEMBL624931,In vivo,2385.0,50597,,1,,N,Biodistribution of compound in rat muscle after 5 min of administration.,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9917,4043,A,,Intermediate,CHEMBL624932,,948.0,50597,,1,,N,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Heart,1,,BAO_0000218
9918,4043,A,,Intermediate,CHEMBL624933,,948.0,50597,,1,,N,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Heart,1,,BAO_0000218
9919,4043,A,,Intermediate,CHEMBL624934,,2107.0,50597,,1,,N,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Liver,1,,BAO_0000218
9920,4043,A,,Intermediate,CHEMBL624935,,2107.0,50597,,1,,N,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Liver,1,,BAO_0000218
9921,4043,A,,Intermediate,CHEMBL624936,,,50597,,1,,N,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,1,,BAO_0000218
9922,4043,A,,Intermediate,CHEMBL624937,,,50597,,1,,N,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,1,,BAO_0000218
9923,4043,A,,Intermediate,CHEMBL624938,,2106.0,50597,,1,,N,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Spleen,1,,BAO_0000218
9924,4043,A,,Intermediate,CHEMBL624939,,2106.0,50597,,1,,N,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,Spleen,1,,BAO_0000218
9925,4043,A,,Intermediate,CHEMBL624940,,,50597,,1,,N,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,1,,BAO_0000218
9926,4043,A,,Intermediate,CHEMBL874403,,,50597,,1,,N,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,,,1,,BAO_0000218
9927,1446,A,,Intermediate,CHEMBL624941,,,50597,,1,,N,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Rattus norvegicus,,,1,,BAO_0000218
9928,9971,A,,Intermediate,CHEMBL624942,,1088.0,50597,,1,,N,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Rattus norvegicus,,Urine,1,,BAO_0000218
9929,9971,A,,Intermediate,CHEMBL624943,,1088.0,50597,,1,,N,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Rattus norvegicus,,Urine,1,,BAO_0000218
9930,5765,A,,Intermediate,CHEMBL624944,In vivo,,50597,,1,,N,% Bioavailability after 1 day of the drug administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9931,5765,A,,Intermediate,CHEMBL624945,In vivo,,50597,,1,,N,% Bioavailability after 4 day of the drug administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9932,4257,A,,Intermediate,CHEMBL624946,In vivo,,50597,,1,,N,Absolute bioavailability was evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
9933,13091,A,,Intermediate,CHEMBL624947,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9934,13091,A,,Intermediate,CHEMBL624948,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9935,13091,A,,Intermediate,CHEMBL624949,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9936,13091,A,,Intermediate,CHEMBL622025,,2113.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Rattus norvegicus,,Kidney,1,,BAO_0000218
9937,13091,A,,Intermediate,CHEMBL622026,,2113.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Rattus norvegicus,,Kidney,1,,BAO_0000218
9938,13091,A,,Intermediate,CHEMBL622027,,2113.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Rattus norvegicus,,Kidney,1,,BAO_0000218
9939,13091,A,,Intermediate,CHEMBL622028,,2113.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Rattus norvegicus,,Kidney,1,,BAO_0000218
9940,13091,A,,Intermediate,CHEMBL622029,,2107.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Rattus norvegicus,,Liver,1,,BAO_0000218
9941,13091,A,,Intermediate,CHEMBL622208,,2107.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Rattus norvegicus,,Liver,1,,BAO_0000218
9942,13091,A,,Intermediate,CHEMBL622209,,2107.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Rattus norvegicus,,Liver,1,,BAO_0000218
9943,13091,A,,Intermediate,CHEMBL622210,,2107.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Rattus norvegicus,,Liver,1,,BAO_0000218
9944,13091,A,,Intermediate,CHEMBL622211,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9945,13091,A,,Intermediate,CHEMBL622212,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9946,13091,A,,Intermediate,CHEMBL622213,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9947,13091,A,,Intermediate,CHEMBL874404,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9948,13091,A,,Intermediate,CHEMBL620452,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9949,13091,A,,Intermediate,CHEMBL620453,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9950,13091,A,,Intermediate,CHEMBL620454,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9951,13091,A,,Intermediate,CHEMBL624067,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9952,13091,A,,Intermediate,CHEMBL624068,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9953,13091,A,,Intermediate,CHEMBL624069,,992.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Rattus norvegicus,,Female gonad,1,,BAO_0000218
9954,13091,A,,Intermediate,CHEMBL624070,,992.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Rattus norvegicus,,Female gonad,1,,BAO_0000218
9955,13091,A,,Intermediate,CHEMBL624071,,992.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Rattus norvegicus,,Female gonad,1,,BAO_0000218
9956,13091,A,,Intermediate,CHEMBL624072,,995.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Rattus norvegicus,,Uterus,1,,BAO_0000218
9957,13091,A,,Intermediate,CHEMBL624073,,995.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Rattus norvegicus,,Uterus,1,,BAO_0000218
9958,13091,A,,Intermediate,CHEMBL624788,,995.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Rattus norvegicus,,Uterus,1,,BAO_0000218
9959,13091,A,,Intermediate,CHEMBL624789,,995.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Rattus norvegicus,,Uterus,1,,BAO_0000218
9960,13091,A,,Intermediate,CHEMBL624790,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Rattus norvegicus,,,1,,BAO_0000218
9961,13091,A,,Intermediate,CHEMBL624791,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Rattus norvegicus,,,1,,BAO_0000218
9962,13091,A,,Intermediate,CHEMBL624792,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9963,13091,A,,Intermediate,CHEMBL624793,,,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Rattus norvegicus,,,1,,BAO_0000218
9964,13091,A,,Intermediate,CHEMBL877491,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9965,13091,A,,Intermediate,CHEMBL624957,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9966,13091,A,,Intermediate,CHEMBL624958,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9967,13091,A,,Intermediate,CHEMBL624959,,2385.0,50597,,1,,N,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
9968,11977,A,,Intermediate,CHEMBL624960,,,50597,,1,,N,Dissociation constant was determined,Rattus norvegicus,,,1,,BAO_0000218
9969,14941,A,,Intermediate,CHEMBL624961,,,50597,,1,,N,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,,,1,,BAO_0000218
9970,15078,A,,Intermediate,CHEMBL624962,,,50597,,1,,N,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9971,15078,A,,Intermediate,CHEMBL624963,,,50597,,1,,N,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
9972,4755,A,,Intermediate,CHEMBL624964,,,50597,,1,,N,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,,,1,,BAO_0000218
9973,589,A,,Intermediate,CHEMBL624965,,,50597,,1,,N,LogP value was evaluated in the in situ rat gut perfusion assay,Rattus norvegicus,,,1,,BAO_0000218
9974,17582,A,,Intermediate,CHEMBL624966,In vivo,,50597,,1,,N,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
9975,5031,A,,Intermediate,CHEMBL624967,In vivo,,50597,,1,,N,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Rattus norvegicus,,,1,,BAO_0000218
9976,17764,A,,Intermediate,CHEMBL624968,In vivo,,50597,,1,,N,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
9977,17720,A,,Intermediate,CHEMBL624969,,,50597,,1,,N,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,,1,,BAO_0000218
9978,2862,F,,Expert,CHEMBL624970,,,50597,,1,,N,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Rattus norvegicus,,,1,,BAO_0000218
9979,16423,A,,Intermediate,CHEMBL624971,,,50597,,1,,N,Half-life was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,,,1,,BAO_0000218
9980,16423,A,,Intermediate,CHEMBL624972,In vivo,,50597,,1,,N,Half-life was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9981,6005,A,,Intermediate,CHEMBL624973,In vivo,,50597,,1,,N,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9982,2938,A,,Intermediate,CHEMBL624974,,1969.0,50597,,1,,N,Half-life was evaluated in plasma of rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
9983,6410,A,,Intermediate,CHEMBL624975,In vivo,,50597,,1,,N,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9984,6410,A,,Intermediate,CHEMBL877492,In vivo,,50597,,1,,N,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9985,6062,A,,Intermediate,CHEMBL624976,In vivo,,50597,,1,,N,Half-life was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9986,6571,A,,Intermediate,CHEMBL624977,In vivo,,50597,,1,,N,Half-life period of compound in rats after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
9987,3136,A,,Intermediate,CHEMBL626848,,1969.0,50597,,1,,N,Half-life period of compound was measured in rat plasma.,Rattus norvegicus,,Plasma,1,,BAO_0000218
9988,3136,A,,Intermediate,CHEMBL626849,,1969.0,50597,,1,,N,Half-life period of compound was measured in rat plasma; ND is not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9989,3136,A,,Intermediate,CHEMBL626850,,1969.0,50597,,1,,N,Half-life period of compound was measured in rat plasma; not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
9990,4521,A,,Intermediate,CHEMBL626851,In vivo,,50597,,1,,N,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
9991,5871,A,,Intermediate,CHEMBL626852,In vivo,,50597,,1,,N,Half-life period in rat by iv administration,Rattus norvegicus,,,1,,BAO_0000218
9992,6077,A,,Intermediate,CHEMBL626853,In vivo,,50597,,1,,N,Half-life period in rats following intravenous administration at 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
9993,6679,A,,Intermediate,CHEMBL626854,In vivo,,50597,,1,,N,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,1,,BAO_0000218
9994,5144,A,,Intermediate,CHEMBL627486,,,50597,,1,,N,Half-life period was determined for the compound in rat,Rattus norvegicus,,,1,,BAO_0000218
9995,4498,A,,Intermediate,CHEMBL627487,In vivo,,50597,,1,,N,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,,,1,,BAO_0000218
9996,4498,A,,Intermediate,CHEMBL627488,In vivo,,50597,,1,,N,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,,,1,,BAO_0000218
9997,1908,A,,Intermediate,CHEMBL627489,In vivo,,50597,,1,,N,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,,,1,,BAO_0000218
9998,6211,A,,Intermediate,CHEMBL627490,In vivo,,50597,,1,,N,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
9999,5529,A,,Intermediate,CHEMBL873829,In vivo,,50597,,1,,N,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10000,6444,A,,Intermediate,CHEMBL627655,In vivo,,50597,,1,,N,Half-life was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,,,1,,BAO_0000218
10001,6444,A,,Intermediate,CHEMBL625994,In vivo,,50597,,1,,N,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,,,1,,BAO_0000218
10002,6444,A,,Intermediate,CHEMBL625995,In vivo,,50597,,1,,N,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,,,1,,BAO_0000218
10003,5207,A,,Intermediate,CHEMBL625996,,,50597,,1,,N,Half-life in rat,Rattus norvegicus,,,1,,BAO_0000218
10004,530,A,,Intermediate,CHEMBL625850,In vitro,1969.0,50597,,1,,N,In vitro half life in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
10005,1116,A,,Intermediate,CHEMBL625851,In vitro,1969.0,50597,,1,,N,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Rattus norvegicus,,Plasma,1,,BAO_0000218
10006,3219,A,,Intermediate,CHEMBL625852,In vitro,,50597,,1,,N,In vitro half life in rat,Rattus norvegicus,,,1,,BAO_0000218
10007,6109,A,,Intermediate,CHEMBL625853,In vivo,,50597,,1,,N,In vivo half life period after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
10008,17582,A,,Intermediate,CHEMBL625854,In vivo,,50597,,1,,N,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
10009,17582,A,,Intermediate,CHEMBL874450,In vivo,,50597,,1,,N,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
10010,5974,A,,Intermediate,CHEMBL625855,In vivo,,50597,,1,,N,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10011,5974,A,,Intermediate,CHEMBL625856,In vivo,,50597,,1,,N,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10012,5974,A,,Intermediate,CHEMBL625857,In vivo,,50597,,1,,N,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10013,5974,A,,Intermediate,CHEMBL873831,In vivo,,50597,,1,,N,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10014,17853,A,,Intermediate,CHEMBL625858,In vivo,,50597,,1,,N,Longer half-life in rat (i.v.) at 0.5 mpk,Rattus norvegicus,,,1,,BAO_0000218
10015,17853,A,,Intermediate,CHEMBL625859,In vivo,,50597,,1,,N,Longer half-life in rat (p.o.) at 2.0 mpk,Rattus norvegicus,,,1,,BAO_0000218
10016,3457,A,,Intermediate,CHEMBL625860,,,50597,,1,,N,Pharmacokinetic property (half life) in rat,Rattus norvegicus,,,1,,BAO_0000218
10017,2792,A,,Intermediate,CHEMBL625861,In vivo,,50597,,1,,N,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
10018,2792,A,,Intermediate,CHEMBL625862,In vivo,,50597,,1,,N,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
10019,2792,A,,Intermediate,CHEMBL625863,In vivo,,50597,,1,,N,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
10020,2792,A,,Intermediate,CHEMBL625864,In vivo,,50597,,1,,N,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,,,1,,BAO_0000218
10021,5739,A,,Intermediate,CHEMBL625865,In vivo,,50597,,1,,N,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,,,1,,BAO_0000218
10022,15765,A,,Intermediate,CHEMBL625866,In vivo,,50597,,1,,N,Pharmacokinetic half time was determined intravenously in rats.,Rattus norvegicus,,,1,,BAO_0000218
10023,6567,A,,Intermediate,CHEMBL625867,In vivo,1969.0,50597,,1,,N,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Rattus norvegicus,,Plasma,1,,BAO_0000218
10024,2448,A,,Intermediate,CHEMBL625868,,1969.0,50597,,1,,N,Plasma half life of hydrolysis of the compound,Rattus norvegicus,,Plasma,1,,BAO_0000218
10025,5423,A,,Intermediate,CHEMBL625869,In vivo,1969.0,50597,,1,,N,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10026,4853,A,,Intermediate,CHEMBL874451,,1969.0,50597,,1,,N,Plasma half life period was calculated in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10027,4514,A,,Intermediate,CHEMBL625870,,1969.0,50597,,1,,N,Plasma half-life in Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10028,4514,A,,Intermediate,CHEMBL625871,,1969.0,50597,,1,,N,Plasma half-life in Sprague-Dawley rats; Not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
10029,1500,A,,Intermediate,CHEMBL625872,,1969.0,50597,,1,,N,Plasma half-life in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10030,1500,A,,Intermediate,CHEMBL625873,,1969.0,50597,,1,,N,Plasma half-life in rats; <MQL,Rattus norvegicus,,Plasma,1,,BAO_0000218
10031,5334,A,,Intermediate,CHEMBL625874,,1969.0,50597,,1,,N,Plasma half-life period (0-8 h) was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
10032,5334,A,,Intermediate,CHEMBL625875,,1969.0,50597,,1,,N,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10033,5334,A,,Intermediate,CHEMBL625876,In vivo,1969.0,50597,,1,,N,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10034,5334,A,,Intermediate,CHEMBL631258,In vivo,1969.0,50597,,1,,N,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10035,4956,A,,Intermediate,CHEMBL631259,,1969.0,50597,,1,,N,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Rattus norvegicus,,Plasma,1,,BAO_0000218
10036,4956,A,,Intermediate,CHEMBL631260,,1969.0,50597,,1,,N,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
10037,7768,A,,Intermediate,CHEMBL631261,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Rattus norvegicus,,Blood,1,,BAO_0000218
10038,7768,A,,Intermediate,CHEMBL631262,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Rattus norvegicus,,Blood,1,,BAO_0000218
10039,7768,A,,Intermediate,CHEMBL631263,,178.0,50597,,1,,N,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Rattus norvegicus,,Blood,1,,BAO_0000218
10040,7768,A,,Intermediate,CHEMBL631264,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Rattus norvegicus,,,1,,BAO_0000218
10041,7768,A,,Intermediate,CHEMBL631265,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Rattus norvegicus,,,1,,BAO_0000218
10042,7768,A,,Intermediate,CHEMBL631266,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Rattus norvegicus,,,1,,BAO_0000218
10043,7768,A,,Intermediate,CHEMBL631267,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Rattus norvegicus,,,1,,BAO_0000218
10044,7768,A,,Intermediate,CHEMBL631268,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Rattus norvegicus,,,1,,BAO_0000218
10045,7768,A,,Intermediate,CHEMBL631269,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Rattus norvegicus,,,1,,BAO_0000218
10046,7768,A,,Intermediate,CHEMBL631270,,,50597,,1,,N,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Rattus norvegicus,,,1,,BAO_0000218
10047,7768,A,,Intermediate,CHEMBL631271,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,,Heart,1,,BAO_0000218
10048,7768,A,,Intermediate,CHEMBL631272,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Rattus norvegicus,,Heart,1,,BAO_0000218
10049,7768,A,,Intermediate,CHEMBL631273,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Rattus norvegicus,,Heart,1,,BAO_0000218
10050,7768,A,,Intermediate,CHEMBL631274,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Rattus norvegicus,,Heart,1,,BAO_0000218
10051,7768,A,,Intermediate,CHEMBL631275,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Rattus norvegicus,,Heart,1,,BAO_0000218
10052,7768,A,,Intermediate,CHEMBL626984,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Rattus norvegicus,,Heart,1,,BAO_0000218
10053,7768,A,,Intermediate,CHEMBL626985,,948.0,50597,,1,,N,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Rattus norvegicus,,Heart,1,,BAO_0000218
10054,7768,A,,Intermediate,CHEMBL626986,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,,Liver,1,,BAO_0000218
10055,7768,A,,Intermediate,CHEMBL626987,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Rattus norvegicus,,Liver,1,,BAO_0000218
10056,7768,A,,Intermediate,CHEMBL626988,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Rattus norvegicus,,Liver,1,,BAO_0000218
10057,7768,A,,Intermediate,CHEMBL626989,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Rattus norvegicus,,Liver,1,,BAO_0000218
10058,7768,A,,Intermediate,CHEMBL626990,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Rattus norvegicus,,Liver,1,,BAO_0000218
10059,7768,A,,Intermediate,CHEMBL626991,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Rattus norvegicus,,Liver,1,,BAO_0000218
10060,7768,A,,Intermediate,CHEMBL626992,,2107.0,50597,,1,,N,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Rattus norvegicus,,Liver,1,,BAO_0000218
10061,7768,A,,Intermediate,CHEMBL626993,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Rattus norvegicus,,Lung,1,,BAO_0000218
10062,7768,A,,Intermediate,CHEMBL874593,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Rattus norvegicus,,Lung,1,,BAO_0000218
10063,7768,A,,Intermediate,CHEMBL626994,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Rattus norvegicus,,Lung,1,,BAO_0000218
10064,7768,A,,Intermediate,CHEMBL626995,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Rattus norvegicus,,Lung,1,,BAO_0000218
10065,7768,A,,Intermediate,CHEMBL626190,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Rattus norvegicus,,Lung,1,,BAO_0000218
10066,7768,A,,Intermediate,CHEMBL626191,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Rattus norvegicus,,Lung,1,,BAO_0000218
10067,7768,A,,Intermediate,CHEMBL626364,,2048.0,50597,,1,,N,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Rattus norvegicus,,Lung,1,,BAO_0000218
10068,7768,A,,Intermediate,CHEMBL626365,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10069,7768,A,,Intermediate,CHEMBL626366,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10070,7768,A,,Intermediate,CHEMBL626367,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10071,7768,A,,Intermediate,CHEMBL626368,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10072,7768,A,,Intermediate,CHEMBL626369,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10073,7768,A,,Intermediate,CHEMBL626370,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10074,4498,A,,Intermediate,CHEMBL626371,In vivo,,50597,,1,,N,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,,,1,,BAO_0000218
10075,4498,A,,Intermediate,CHEMBL626372,In vivo,,50597,,1,,N,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,,,1,,BAO_0000218
10076,3603,A,,Intermediate,CHEMBL626373,In vivo,,50597,,1,,N,Bioavailability after a dose of 10 mg/kg p.o.,Rattus norvegicus,,,1,,BAO_0000218
10077,6215,A,,Intermediate,CHEMBL626374,In vivo,,50597,,1,,N,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10078,5710,A,,Intermediate,CHEMBL626375,In vivo,,50597,,1,,N,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Rattus norvegicus,,,1,,BAO_0000218
10079,5710,A,,Intermediate,CHEMBL626376,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10080,5676,A,,Intermediate,CHEMBL626377,In vivo,,50597,,1,,N,Bioavailability in rat po was determined,Rattus norvegicus,,,1,,BAO_0000218
10081,17667,A,,Intermediate,CHEMBL626378,In vivo,,50597,,1,,N,Bioavailability of compound at 10 mg/kg in rat after oral administration,Rattus norvegicus,,,1,,BAO_0000218
10082,17667,A,,Intermediate,CHEMBL626379,In vivo,,50597,,1,,N,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
10083,6848,A,,Intermediate,CHEMBL626380,In vivo,,50597,,1,,N,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10084,6848,A,,Intermediate,CHEMBL626381,In vivo,,50597,,1,,N,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10085,17267,A,,Intermediate,CHEMBL626382,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10086,6362,A,,Intermediate,CHEMBL626383,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley) (female),Rattus norvegicus,,,1,,BAO_0000218
10087,17671,A,,Intermediate,CHEMBL874652,In vivo,,50597,,1,,N,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10088,17671,A,,Intermediate,CHEMBL626384,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10089,4333,A,,Intermediate,CHEMBL626385,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Rattus norvegicus,,,1,,BAO_0000218
10090,6077,A,,Intermediate,CHEMBL626386,In vivo,,50597,,1,,N,Bioavailability in rat at an oral dose of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10091,3278,A,,Intermediate,CHEMBL626387,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10092,5964,A,,Intermediate,CHEMBL626388,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10093,4884,A,,Intermediate,CHEMBL626389,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10094,4905,A,,Intermediate,CHEMBL626390,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10095,4884,A,,Intermediate,CHEMBL626391,In vivo,,50597,,1,,N,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Rattus norvegicus,,,1,,BAO_0000218
10096,6850,A,,Intermediate,CHEMBL626392,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10097,2864,A,,Intermediate,CHEMBL626393,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10098,5780,A,,Intermediate,CHEMBL623026,In vivo,,50597,,1,,N,Bioavailability was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10099,1465,A,,Intermediate,CHEMBL623027,In vivo,,50597,,1,,N,Bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10100,5199,A,,Intermediate,CHEMBL623028,In vivo,,50597,,1,,N,Bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10101,5765,A,,Intermediate,CHEMBL623029,In vivo,,50597,,1,,N,Bioavailability in rat after 1 day dosing,Rattus norvegicus,,,1,,BAO_0000218
10102,5765,A,,Intermediate,CHEMBL623030,In vivo,,50597,,1,,N,Bioavailability in rat after 4 day dosing,Rattus norvegicus,,,1,,BAO_0000218
10103,6518,A,,Intermediate,CHEMBL623031,In vivo,,50597,,1,,N,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
10104,6518,A,,Intermediate,CHEMBL623032,In vivo,,50597,,1,,N,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,,,1,,BAO_0000218
10105,6518,A,,Intermediate,CHEMBL623033,In vivo,,50597,,1,,N,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10106,6518,A,,Intermediate,CHEMBL623034,In vivo,,50597,,1,,N,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10107,2083,A,,Intermediate,CHEMBL623035,In vivo,,50597,,1,,N,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,,,1,,BAO_0000218
10108,17260,A,,Intermediate,CHEMBL623036,In vivo,,50597,,1,,N,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,,,1,,BAO_0000218
10109,4956,A,,Intermediate,CHEMBL623037,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10110,4368,A,,Intermediate,CHEMBL623038,In vivo,,50597,,1,,N,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10111,17752,A,,Intermediate,CHEMBL874385,In vivo,1969.0,50597,,1,,N,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
10112,1446,A,,Intermediate,CHEMBL623039,In vivo,,50597,,1,,N,Bioavailability in rat (Fisher) (fasted),Rattus norvegicus,,,1,,BAO_0000218
10113,2891,A,,Intermediate,CHEMBL623040,In vivo,,22224,,1,,U,Bioavailability in monkey after po administration of 10 mg/kg dose,Primates,,,0,,BAO_0000218
10114,2891,A,,Intermediate,CHEMBL623041,In vivo,,22224,,1,,U,Oral bioavailability in monkey (dose 10 mg/kg),Primates,,,0,,BAO_0000218
10115,6672,A,,Intermediate,CHEMBL623741,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10116,6673,A,,Intermediate,CHEMBL623742,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10117,17655,A,,Intermediate,CHEMBL623743,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10118,17796,A,,Intermediate,CHEMBL623744,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10119,17853,A,,Intermediate,CHEMBL623745,In vivo,,50597,,1,,N,Bioavailability in rat (dose 2.0 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10120,4521,A,,Intermediate,CHEMBL623746,In vivo,,50597,,1,,N,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10121,4940,A,,Intermediate,CHEMBL623747,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 5 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10122,2891,A,,Intermediate,CHEMBL623748,In vivo,,22224,,1,,U,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,,,0,,BAO_0000218
10123,2891,A,,Intermediate,CHEMBL623916,In vivo,,22224,,1,,U,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,,,0,,BAO_0000218
10124,4521,A,,Intermediate,CHEMBL623917,In vivo,,50597,,1,,N,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
10125,17686,A,,Intermediate,CHEMBL623918,In vivo,,50597,,1,,N,Bioavailability in rat (dose 2 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10126,17796,A,,Intermediate,CHEMBL874386,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10127,17796,A,,Intermediate,CHEMBL623919,In vivo,1969.0,50597,,1,,N,Bioavailability in rat; Only traces detected in rat plasma,Rattus norvegicus,,Plasma,1,,BAO_0000218
10128,5064,A,,Intermediate,CHEMBL623920,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10129,5147,A,,Intermediate,CHEMBL623148,In vivo,,50597,,1,,N,Bioavailability upon oral administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10130,1916,A,,Intermediate,CHEMBL623149,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10131,6049,A,,Intermediate,CHEMBL623150,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10132,1445,A,,Intermediate,CHEMBL623151,In vivo,,50597,,1,,N,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Rattus norvegicus,,,1,,BAO_0000218
10133,1445,A,,Intermediate,CHEMBL623152,In vivo,,50597,,1,,N,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Rattus norvegicus,,,1,,BAO_0000218
10134,2862,F,,Expert,CHEMBL623153,,,50597,,1,,N,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Rattus norvegicus,,,1,,BAO_0000218
10135,2862,F,,Expert,CHEMBL623154,,,50597,,1,,N,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Rattus norvegicus,,,1,,BAO_0000218
10136,4194,A,,Intermediate,CHEMBL623155,,,50597,,1,,N,In vitro and metabolic stability was determined,Rattus norvegicus,,,1,,BAO_0000218
10137,4194,A,,Intermediate,CHEMBL623156,,,50597,,1,,N,In vitro metabolic stability in rat hepatocytes,Rattus norvegicus,,,1,,BAO_0000218
10138,5486,A,,Intermediate,CHEMBL623157,,,50597,,1,,N,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Rattus norvegicus,,,1,,BAO_0000218
10139,17582,A,Hepatocyte,Intermediate,CHEMBL623158,In vitro,2107.0,50597,,1,,N,Metabolic rate for compound was observed in rat hepatocytes,Rattus norvegicus,,Liver,1,401.0,BAO_0000218
10140,5600,A,,Intermediate,CHEMBL623159,,,50597,,1,,N,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Rattus norvegicus,,,1,,BAO_0000218
10141,14294,A,,Intermediate,CHEMBL874390,,,50597,,1,,N,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Rattus norvegicus,,,1,,BAO_0000218
10142,14294,A,,Intermediate,CHEMBL623160,,,50597,,1,,N,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Rattus norvegicus,,,1,,BAO_0000218
10143,14294,A,,Intermediate,CHEMBL623161,,,50597,,1,,N,Metabolism of compound in rat S9 microsomes; Trace,Rattus norvegicus,,,1,,BAO_0000218
10144,17847,A,,Intermediate,CHEMBL623162,,,50597,,1,,N,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Rattus norvegicus,,,1,,BAO_0000218
10145,11020,A,,Intermediate,CHEMBL623163,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10146,11020,A,,Intermediate,CHEMBL623164,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10147,11020,A,,Intermediate,CHEMBL623165,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Rattus norvegicus,,,1,,BAO_0000218
10148,11020,A,,Intermediate,CHEMBL623166,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,1,,BAO_0000218
10149,11020,A,,Intermediate,CHEMBL624983,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Rattus norvegicus,,,1,,BAO_0000218
10150,11020,A,,Intermediate,CHEMBL624984,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Rattus norvegicus,,,1,,BAO_0000218
10151,11020,A,,Intermediate,CHEMBL624985,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10152,11020,A,,Intermediate,CHEMBL622970,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10153,11020,A,,Intermediate,CHEMBL622971,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10154,11020,A,,Intermediate,CHEMBL622972,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10155,11020,A,,Intermediate,CHEMBL622973,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10156,11020,A,,Intermediate,CHEMBL622974,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10157,11020,A,,Intermediate,CHEMBL622975,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10158,11020,A,,Intermediate,CHEMBL622976,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10159,11020,A,,Intermediate,CHEMBL622977,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Rattus norvegicus,,,1,,BAO_0000218
10160,11020,A,,Intermediate,CHEMBL624351,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10161,11020,A,,Intermediate,CHEMBL624352,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10162,11020,A,,Intermediate,CHEMBL624353,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,1,,BAO_0000218
10163,11020,A,,Intermediate,CHEMBL622397,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,1,,BAO_0000218
10164,11020,A,,Intermediate,CHEMBL622398,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,,,1,,BAO_0000218
10165,11020,A,,Intermediate,CHEMBL622399,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,,,1,,BAO_0000218
10166,11020,A,,Intermediate,CHEMBL622400,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,1,,BAO_0000218
10167,11020,A,,Intermediate,CHEMBL628428,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10168,11020,A,,Intermediate,CHEMBL628590,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10169,11020,A,,Intermediate,CHEMBL628591,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10170,11020,A,,Intermediate,CHEMBL628592,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10171,11020,A,,Intermediate,CHEMBL628593,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10172,11020,A,,Intermediate,CHEMBL875333,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10173,11020,A,,Intermediate,CHEMBL628594,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10174,4969,A,,Intermediate,CHEMBL628595,,1969.0,50597,,1,,N,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
10175,6737,A,,Intermediate,CHEMBL628596,,1969.0,50597,,1,,N,Stability in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
10176,6737,A,,Intermediate,CHEMBL628597,,1969.0,50597,,1,,N,Stability in rat plasma was determined; ND= no data,Rattus norvegicus,,Plasma,1,,BAO_0000218
10177,5089,A,,Intermediate,CHEMBL628598,,1969.0,50597,,1,,N,Tested for plasma half life period in rat (0-8 hr),Rattus norvegicus,,Plasma,1,,BAO_0000218
10178,5089,A,,Intermediate,CHEMBL628599,,1969.0,50597,,1,,N,Tested for plasma half life period in rat (0-8 hr); Not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
10179,1466,A,,Intermediate,CHEMBL628600,In vivo,,50597,,1,,N,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
10180,1466,A,,Intermediate,CHEMBL628601,In vivo,,50597,,1,,N,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
10181,4950,A,,Intermediate,CHEMBL628602,,,50597,,1,,N,Tested for the half life in rat,Rattus norvegicus,,,1,,BAO_0000218
10182,2412,A,,Intermediate,CHEMBL628603,In vitro,,50597,,1,,N,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Rattus norvegicus,,,1,,BAO_0000218
10183,2412,A,,Intermediate,CHEMBL628604,In vitro,,50597,,1,,N,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Rattus norvegicus,,,1,,BAO_0000218
10184,2412,A,,Intermediate,CHEMBL628605,In vitro,,50597,,1,,N,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Rattus norvegicus,,,1,,BAO_0000218
10185,2412,A,,Intermediate,CHEMBL628606,In vitro,,50597,,1,,N,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Rattus norvegicus,,,1,,BAO_0000218
10186,2412,A,,Intermediate,CHEMBL628607,In vitro,,50597,,1,,N,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Rattus norvegicus,,,1,,BAO_0000218
10187,15022,A,,Intermediate,CHEMBL628608,,,50597,,1,,N,The biological half life the compound was measured at the dose of 100 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
10188,15022,A,,Intermediate,CHEMBL628609,,,50597,,1,,N,The biological half life the compound was measured at the dose of 30 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
10189,406,A,,Intermediate,CHEMBL628610,,1969.0,50597,,1,,N,The compound was evaluated for plasma half life period in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10190,15078,A,,Intermediate,CHEMBL873819,In vivo,,50597,,1,,N,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
10191,15078,A,,Intermediate,CHEMBL628611,In vivo,,50597,,1,,N,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
10192,5247,A,,Intermediate,CHEMBL628612,In vivo,,50597,,1,,N,The pharmacokinetic parameter half-life period in vivo in rats,Rattus norvegicus,,,1,,BAO_0000218
10193,5041,A,,Intermediate,CHEMBL628613,In vivo,,50597,,1,,N,"The pharmacokinetic property, Half-life was determined",Rattus norvegicus,,,1,,BAO_0000218
10194,5041,A,,Intermediate,CHEMBL628614,In vivo,,50597,,1,,N,"The pharmacokinetic property, Half-life in rat in vivo",Rattus norvegicus,,,1,,BAO_0000218
10195,5041,A,,Intermediate,CHEMBL628615,In vivo,,50597,,1,,N,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Rattus norvegicus,,,1,,BAO_0000218
10196,5041,A,,Intermediate,CHEMBL628616,In vivo,,50597,,1,,N,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Rattus norvegicus,,,1,,BAO_0000218
10197,3918,A,,Intermediate,CHEMBL627924,,1969.0,50597,,1,,N,The plasma half life period in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10198,2906,A,,Intermediate,CHEMBL627925,,2107.0,50597,,1,,N,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Rattus norvegicus,,Liver,1,,BAO_0000218
10199,6467,A,,Intermediate,CHEMBL627926,In vivo,,50597,,1,,N,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,,,1,,BAO_0000218
10200,5510,A,,Intermediate,CHEMBL627927,,,50597,,1,,N,t1/2 (apparent elimination)of the compound was determined,Rattus norvegicus,,,1,,BAO_0000218
10201,3788,A,,Intermediate,CHEMBL627928,,,50597,,1,,N,t1/2 value in rat,Rattus norvegicus,,,1,,BAO_0000218
10202,17796,A,,Intermediate,CHEMBL627539,,,50597,,1,,N,Half life in rat,Rattus norvegicus,,,1,,BAO_0000218
10203,12873,A,,Intermediate,CHEMBL876790,In vivo,1969.0,50597,,1,,N,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,,Plasma,1,,BAO_0000218
10204,5983,A,,Intermediate,CHEMBL858186,In vivo,,50597,,1,,N,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,,,1,,BAO_0000218
10205,15765,A,,Intermediate,CHEMBL627540,,,50597,,1,,N,Half-life period in fasted rats,Rattus norvegicus,,,1,,BAO_0000218
10206,2661,A,,Intermediate,CHEMBL627541,In vivo,,50597,,1,,N,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
10207,2661,A,,Intermediate,CHEMBL627715,In vivo,,50597,,1,,N,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
10208,429,A,,Intermediate,CHEMBL627716,In vivo,,50597,,1,,N,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10209,17655,A,,Intermediate,CHEMBL627717,,,50597,,1,,N,Maximum time required to achieve Cmax was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10210,17717,A,,Intermediate,CHEMBL627718,In vivo,,50597,,1,,N,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,1,,BAO_0000218
10211,17717,A,,Intermediate,CHEMBL627719,In vivo,,50597,,1,,N,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,,,1,,BAO_0000218
10212,17717,A,,Intermediate,CHEMBL627720,In vivo,,50597,,1,,N,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,,,1,,BAO_0000218
10213,6570,A,,Intermediate,CHEMBL627721,In vivo,,50597,,1,,N,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10214,6570,A,,Intermediate,CHEMBL627722,In vivo,,50597,,1,,N,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Rattus norvegicus,,,1,,BAO_0000218
10215,5978,A,,Intermediate,CHEMBL627723,In vivo,,50597,,1,,N,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10216,5978,A,,Intermediate,CHEMBL626058,In vivo,,50597,,1,,N,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10217,5978,A,,Intermediate,CHEMBL626059,In vivo,,50597,,1,,N,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10218,5978,A,,Intermediate,CHEMBL626060,In vivo,,50597,,1,,N,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10219,17720,A,,Intermediate,CHEMBL626061,In vivo,1969.0,50597,,1,,N,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
10220,4723,A,,Intermediate,CHEMBL876791,In vivo,,50597,,1,,N,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
10221,4723,A,,Intermediate,CHEMBL626062,In vivo,,50597,,1,,N,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,,,1,,BAO_0000218
10222,4756,A,,Intermediate,CHEMBL626063,In vivo,,50597,,1,,N,Tmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
10223,4756,A,,Intermediate,CHEMBL626064,In vivo,,50597,,1,,N,Tmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
10224,17720,A,,Intermediate,CHEMBL626065,In vivo,1969.0,50597,,1,,N,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
10225,17720,A,,Intermediate,CHEMBL626066,In vivo,1969.0,50597,,1,,N,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
10226,1466,A,,Intermediate,CHEMBL626067,In vivo,,50597,,1,,N,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
10227,7449,F,,Intermediate,CHEMBL626068,,,50597,,1,,N,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Rattus norvegicus,,,1,,BAO_0000218
10228,7449,F,,Intermediate,CHEMBL626069,,,50597,,1,,N,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Rattus norvegicus,,,1,,BAO_0000218
10229,7449,F,,Intermediate,CHEMBL626070,,,50597,,1,,N,Percent total excretion of 3-methoxyacetaminophen glucuronide,Rattus norvegicus,,,1,,BAO_0000218
10230,7449,F,,Intermediate,CHEMBL626071,,,50597,,1,,N,Percent total excretion of N-methoxyacetaminophen glucuronide,Rattus norvegicus,,,1,,BAO_0000218
10231,7449,F,,Intermediate,CHEMBL626072,,,50597,,1,,N,Percent total excretion of N-methoxyacetaminophen sulfate,Rattus norvegicus,,,1,,BAO_0000218
10232,7449,F,,Intermediate,CHEMBL626073,,,50597,,1,,N,Percent total excretion of acetaminophen,Rattus norvegicus,,,1,,BAO_0000218
10233,7768,A,,Intermediate,CHEMBL626741,,2046.0,50597,,1,,N,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
10234,17655,A,,Intermediate,CHEMBL626742,,,50597,,1,,N,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Rattus norvegicus,,,1,,BAO_0000218
10235,17735,A,,Intermediate,CHEMBL626743,,,50597,,1,,N,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Rattus norvegicus,,,1,,BAO_0000218
10236,5960,A,,Intermediate,CHEMBL876792,,,50597,,1,,N,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Rattus norvegicus,,,1,,BAO_0000218
10237,17735,A,,Intermediate,CHEMBL626744,,,50597,,1,,N,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,,,1,,BAO_0000218
10238,7116,A,,Intermediate,CHEMBL626745,,,50597,,1,,N,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,,,1,,BAO_0000218
10239,4878,A,,Intermediate,CHEMBL626746,In vivo,1969.0,50597,,1,,N,AUC in rat after 3mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
10240,5939,A,,Intermediate,CHEMBL626747,,,50597,,1,,N,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10241,5939,A,,Intermediate,CHEMBL626748,,,50597,,1,,N,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10242,16367,A,,Intermediate,CHEMBL626749,,,50597,,1,,N,Bioavailability administered orally at a dose of 10 mg/kg to rats,Rattus norvegicus,,,1,,BAO_0000218
10243,16366,A,,Intermediate,CHEMBL626750,,,50597,,1,,N,Oral Bioavailability was determined,Rattus norvegicus,,,1,,BAO_0000218
10244,4426,A,,Intermediate,CHEMBL626751,,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10245,4426,A,,Intermediate,CHEMBL626913,,,50597,,1,,N,Oral bioavailability in rat; Not performed.,Rattus norvegicus,,,1,,BAO_0000218
10246,5041,A,,Intermediate,CHEMBL626914,,,50597,,1,,N,Bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10247,5041,A,,Intermediate,CHEMBL626915,,,50597,,1,,N,Bioavailability was determined; ND denotes no data,Rattus norvegicus,,,1,,BAO_0000218
10248,1500,A,,Intermediate,CHEMBL626916,,,50597,,1,,N,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10249,1500,A,,Intermediate,CHEMBL626917,,,50597,,1,,N,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10250,17409,A,,Intermediate,CHEMBL626918,,,50597,,1,,N,Binding towards rat plasma protein at 10 uM,Rattus norvegicus,,,1,,BAO_0000218
10251,17409,A,,Intermediate,CHEMBL626919,,,50597,,1,,N,Binding towards rat plasma protein at 100 uM,Rattus norvegicus,,,1,,BAO_0000218
10252,2959,A,,Intermediate,CHEMBL626920,In vivo,,50597,,1,,N,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10253,13501,A,,Intermediate,CHEMBL621976,In vivo,,50597,,1,,N,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,,,1,,BAO_0000218
10254,6567,A,,Intermediate,CHEMBL877599,In vivo,,50597,,1,,N,Bioavailability in rat after 5 mg/kg oral gavage,Rattus norvegicus,,,1,,BAO_0000218
10255,6571,A,,Intermediate,CHEMBL621977,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10256,6715,A,,Intermediate,CHEMBL621978,In vivo,,50597,,1,,N,Bioavailability in rat (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10257,6715,A,,Intermediate,CHEMBL621979,In vivo,,50597,,1,,N,Bioavailability in rat (dose 3 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10258,2932,A,,Intermediate,CHEMBL621980,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10259,4171,A,,Intermediate,CHEMBL621981,In vivo,,50597,,1,,N,Bioavailability of the compound in rats after administration of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10260,17509,A,,Intermediate,CHEMBL621982,In vivo,,50597,,1,,N,Bioavailability after administration of 10 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10261,17509,A,,Intermediate,CHEMBL882953,In vivo,,50597,,1,,N,Bioavailability after administration of 2 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10262,4527,A,,Intermediate,CHEMBL621983,In vivo,,50597,,1,,N,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
10263,4026,A,,Intermediate,CHEMBL621984,In vivo,,50597,,1,,N,Bioavailability in dogs was determined; high,Rattus norvegicus,,,1,,BAO_0000218
10264,6659,A,,Intermediate,CHEMBL621985,In vivo,,50597,,1,,N,Bioavailability in monkey after intravenous administration at 1 mpk,Rattus norvegicus,,,1,,BAO_0000218
10265,6659,A,,Intermediate,CHEMBL621986,In vivo,,50597,,1,,N,Bioavailability in monkey after peroral administration at 10 mpk,Rattus norvegicus,,,1,,BAO_0000218
10266,6659,A,,Intermediate,CHEMBL621987,In vivo,,50597,,1,,N,Bioavailability in rat after intravenous administration at 1 mpk,Rattus norvegicus,,,1,,BAO_0000218
10267,6659,F,,Intermediate,CHEMBL877600,In vivo,,50597,,1,,N,Bioavailability in rat after intravenous administration at 2 mpk,Rattus norvegicus,,,1,,BAO_0000218
10268,6659,A,,Intermediate,CHEMBL621988,In vivo,,50597,,1,,N,Bioavailability in rat after peroral administration at 30 mpk,Rattus norvegicus,,,1,,BAO_0000218
10269,6659,F,,Intermediate,CHEMBL621989,In vivo,,50597,,1,,N,Bioavailability in rat after peroral administration at at 100 mpk,Rattus norvegicus,,,1,,BAO_0000218
10270,6597,A,,Intermediate,CHEMBL621990,In vivo,,50597,,1,,N,Bioavailability in rats was evaluated,Rattus norvegicus,,,1,,BAO_0000218
10271,1202,A,,Intermediate,CHEMBL621991,In vivo,,50597,,1,,N,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Rattus norvegicus,,,1,,BAO_0000218
10272,1202,A,,Intermediate,CHEMBL621992,In vivo,,50597,,1,,N,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Rattus norvegicus,,,1,,BAO_0000218
10273,1202,A,,Intermediate,CHEMBL621993,In vivo,,50597,,1,,N,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Rattus norvegicus,,,1,,BAO_0000218
10274,1202,A,,Intermediate,CHEMBL621994,In vivo,,50597,,1,,N,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Rattus norvegicus,,,1,,BAO_0000218
10275,5207,A,,Intermediate,CHEMBL621995,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10276,5970,A,,Intermediate,CHEMBL621996,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10277,17538,A,,Intermediate,CHEMBL621997,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10278,17538,A,,Intermediate,CHEMBL621998,In vivo,,50597,,1,,N,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,,,1,,BAO_0000218
10279,1466,A,,Intermediate,CHEMBL621999,In vivo,,50597,,1,,N,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,,,1,,BAO_0000218
10280,2879,A,,Intermediate,CHEMBL622000,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10281,2879,A,,Intermediate,CHEMBL622001,In vivo,,50597,,1,,N,Bioavailability was measured in rat after oral administration; 2-4,Rattus norvegicus,,,1,,BAO_0000218
10282,2879,A,,Intermediate,CHEMBL622002,In vivo,,50597,,1,,N,Bioavailability was measured in rat after oral administration; 3-7,Rattus norvegicus,,,1,,BAO_0000218
10283,3777,A,,Intermediate,CHEMBL622003,In vivo,,50597,,1,,N,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,,,1,,BAO_0000218
10284,3777,A,,Intermediate,CHEMBL877601,In vivo,,50597,,1,,N,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,,,1,,BAO_0000218
10285,3777,A,,Intermediate,CHEMBL624871,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10286,3777,A,,Intermediate,CHEMBL622004,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10287,5423,A,,Intermediate,CHEMBL882954,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10288,16365,A,,Intermediate,CHEMBL622005,In vivo,,50597,,1,,N,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Rattus norvegicus,,,1,,BAO_0000218
10289,16365,A,,Intermediate,CHEMBL622006,In vivo,,50597,,1,,N,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Rattus norvegicus,,,1,,BAO_0000218
10290,4239,A,,Intermediate,CHEMBL622007,In vivo,,50597,,1,,N,Bioavailability was measured in rat,Rattus norvegicus,,,1,,BAO_0000218
10291,5438,A,,Intermediate,CHEMBL622008,In vivo,,50597,,1,,N,Bioavailability was reported,Rattus norvegicus,,,1,,BAO_0000218
10292,5334,A,,Intermediate,CHEMBL622009,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10293,5334,A,,Intermediate,CHEMBL622010,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10294,4199,A,,Intermediate,CHEMBL622011,In vivo,,50597,,1,,N,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,,,1,,BAO_0000218
10295,4199,A,,Intermediate,CHEMBL622012,In vivo,,50597,,1,,N,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Rattus norvegicus,,,1,,BAO_0000218
10296,4199,A,,Intermediate,CHEMBL622013,In vivo,,50597,,1,,N,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Rattus norvegicus,,,1,,BAO_0000218
10297,4890,A,,Intermediate,CHEMBL622014,In vivo,,50597,,1,,N,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
10298,2792,A,,Intermediate,CHEMBL624749,In vivo,,50597,,1,,N,Bioavailability was determined at 3 mg/kg po dose in rats,Rattus norvegicus,,,1,,BAO_0000218
10299,5529,A,,Intermediate,CHEMBL624750,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10300,6685,A,,Intermediate,CHEMBL624751,In vivo,,50597,,1,,N,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
10301,6685,A,,Intermediate,CHEMBL624752,In vivo,,50597,,1,,N,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
10302,6685,A,,Intermediate,CHEMBL624753,In vivo,,50597,,1,,N,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,,,1,,BAO_0000218
10303,6005,A,,Intermediate,CHEMBL624754,In vivo,,50597,,1,,N,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10304,6410,A,,Intermediate,CHEMBL624755,In vivo,,50597,,1,,N,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,,1,,BAO_0000218
10305,6410,A,,Intermediate,CHEMBL624756,In vivo,,50597,,1,,N,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10306,6103,A,,Intermediate,CHEMBL624757,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10307,6410,A,,Intermediate,CHEMBL624758,In vivo,,50597,,1,,N,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,,,1,,BAO_0000218
10308,6410,A,,Intermediate,CHEMBL622270,In vivo,,50597,,1,,N,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10309,5353,A,,Intermediate,CHEMBL622271,In vivo,,50597,,1,,N,Bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,1,,BAO_0000218
10310,4727,A,,Intermediate,CHEMBL622272,In vivo,,50597,,1,,N,Bioavailability in rat at the dose of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10311,17804,A,,Intermediate,CHEMBL622273,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10312,5809,A,,Intermediate,CHEMBL622274,In vivo,,50597,,1,,N,Bioavailability in rat (cannulated) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10313,17804,A,,Intermediate,CHEMBL622275,In vivo,,50597,,1,,N,Bioavailability value of compound in rats was determined after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10314,3634,A,,Intermediate,CHEMBL622276,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10315,3341,A,,Intermediate,CHEMBL622277,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10316,2690,A,,Intermediate,CHEMBL622278,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10317,3184,A,,Intermediate,CHEMBL622279,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10318,740,A,,Intermediate,CHEMBL622280,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10319,1806,A,,Intermediate,CHEMBL624083,In vivo,,50597,,1,,N,Compound was evaluated for oral bioavailability in rats; 15-27 %,Rattus norvegicus,,,1,,BAO_0000218
10320,4891,A,,Intermediate,CHEMBL624084,In vivo,,50597,,1,,N,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Rattus norvegicus,,,1,,BAO_0000218
10321,3634,A,,Intermediate,CHEMBL624085,In vivo,,50597,,1,,N,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Rattus norvegicus,,,1,,BAO_0000218
10322,64,A,,Intermediate,CHEMBL624086,In vivo,,50597,,1,,N,Compound was tested for bioavailability in rats,Rattus norvegicus,,,1,,BAO_0000218
10323,4839,A,,Intermediate,CHEMBL624087,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10324,1094,A,,Intermediate,CHEMBL624088,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10325,5005,A,,Intermediate,CHEMBL624089,In vivo,,22224,,1,,U,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Macaca mulatta,,,0,,BAO_0000218
10326,5005,A,,Intermediate,CHEMBL624090,In vivo,,22224,,1,,U,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,,,0,,BAO_0000218
10327,4687,A,,Intermediate,CHEMBL624091,In vivo,,50597,,1,,N,Evaluated for the bioavailability in rat (in vivo),Rattus norvegicus,,,1,,BAO_0000218
10328,17804,A,,Intermediate,CHEMBL624092,In vivo,,50597,,1,,N,F value of compound in rats was determined after peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10329,5974,A,,Intermediate,CHEMBL624093,In vivo,,50597,,1,,N,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10330,5974,A,,Intermediate,CHEMBL624094,In vivo,,50597,,1,,N,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10331,5974,A,,Intermediate,CHEMBL624095,In vivo,,50597,,1,,N,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10332,5974,A,,Intermediate,CHEMBL624096,In vivo,,50597,,1,,N,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10333,1088,A,,Intermediate,CHEMBL624097,In vivo,,50597,,1,,N,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Rattus norvegicus,,,1,,BAO_0000218
10334,1742,A,,Intermediate,CHEMBL624098,In vivo,,50597,,1,,N,Maximum fall in carotid flow in rat,Rattus norvegicus,,,1,,BAO_0000218
10335,4689,A,,Intermediate,CHEMBL874392,In vivo,,50597,,1,,N,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
10336,2463,A,,Intermediate,CHEMBL624099,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10337,5654,A,,Intermediate,CHEMBL624100,In vivo,,50597,,1,,N,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10338,5654,A,,Intermediate,CHEMBL624101,In vivo,,50597,,1,,N,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10339,6874,A,,Intermediate,CHEMBL624102,In vivo,,50597,,1,,N,Oral bioavailability in rat (male Wistar),Rattus norvegicus,,,1,,BAO_0000218
10340,5633,A,,Intermediate,CHEMBL624103,In vivo,,50597,,1,,N,Oral bioavailability after administration (30 mg/kg) in rat; good,Rattus norvegicus,,,1,,BAO_0000218
10341,5496,A,,Intermediate,CHEMBL624104,In vivo,,50597,,1,,N,Oral bioavailability at the dose of 2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10342,2358,A,,Intermediate,CHEMBL624105,In vivo,,50597,,1,,N,Oral bioavailability determined in rats,Rattus norvegicus,,,1,,BAO_0000218
10343,16456,A,,Intermediate,CHEMBL624106,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10344,5302,A,,Intermediate,CHEMBL624107,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10345,5302,A,,Intermediate,CHEMBL623943,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10346,5302,A,,Intermediate,CHEMBL623944,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10347,11020,A,,Intermediate,CHEMBL623945,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10348,11020,A,,Intermediate,CHEMBL623946,,,50597,,1,,N,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,,,1,,BAO_0000218
10349,11020,A,,Intermediate,CHEMBL623947,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10350,11020,A,,Intermediate,CHEMBL623948,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10351,11020,A,,Intermediate,CHEMBL623949,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Rattus norvegicus,,,1,,BAO_0000218
10352,11020,A,,Intermediate,CHEMBL623950,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Rattus norvegicus,,,1,,BAO_0000218
10353,11020,A,,Intermediate,CHEMBL874398,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Rattus norvegicus,,,1,,BAO_0000218
10354,11020,A,,Intermediate,CHEMBL623951,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Rattus norvegicus,,,1,,BAO_0000218
10355,11020,A,,Intermediate,CHEMBL623952,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10356,11020,A,,Intermediate,CHEMBL623953,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10357,11020,A,,Intermediate,CHEMBL623954,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10358,11020,A,,Intermediate,CHEMBL623955,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10359,11020,A,,Intermediate,CHEMBL623956,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10360,11020,A,,Intermediate,CHEMBL627807,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10361,11020,A,,Intermediate,CHEMBL627808,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10362,11020,A,,Intermediate,CHEMBL627809,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Rattus norvegicus,,,1,,BAO_0000218
10363,11020,A,,Intermediate,CHEMBL627810,,,50597,,1,,N,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Rattus norvegicus,,,1,,BAO_0000218
10364,11020,A,,Intermediate,CHEMBL627811,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Rattus norvegicus,,,1,,BAO_0000218
10365,11020,A,,Intermediate,CHEMBL627812,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Rattus norvegicus,,,1,,BAO_0000218
10366,11020,A,,Intermediate,CHEMBL627813,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Rattus norvegicus,,,1,,BAO_0000218
10367,11020,A,,Intermediate,CHEMBL627814,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Rattus norvegicus,,,1,,BAO_0000218
10368,11020,A,,Intermediate,CHEMBL875336,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Rattus norvegicus,,,1,,BAO_0000218
10369,11020,A,,Intermediate,CHEMBL627815,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Rattus norvegicus,,,1,,BAO_0000218
10370,11020,A,,Intermediate,CHEMBL627816,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Rattus norvegicus,,,1,,BAO_0000218
10371,11020,A,,Intermediate,CHEMBL627817,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Rattus norvegicus,,,1,,BAO_0000218
10372,11020,A,,Intermediate,CHEMBL627818,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Rattus norvegicus,,,1,,BAO_0000218
10373,11020,A,,Intermediate,CHEMBL627819,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Rattus norvegicus,,,1,,BAO_0000218
10374,11020,A,,Intermediate,CHEMBL627820,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Rattus norvegicus,,,1,,BAO_0000218
10375,11020,A,,Intermediate,CHEMBL627821,,,50597,,1,,N,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Rattus norvegicus,,,1,,BAO_0000218
10376,11020,A,,Intermediate,CHEMBL628464,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10377,11020,A,,Intermediate,CHEMBL626239,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,,,1,,BAO_0000218
10378,11020,A,,Intermediate,CHEMBL626240,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,,,1,,BAO_0000218
10379,11020,A,,Intermediate,CHEMBL626241,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,,,1,,BAO_0000218
10380,11020,A,,Intermediate,CHEMBL626242,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,,,1,,BAO_0000218
10381,11020,A,,Intermediate,CHEMBL626243,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,,,1,,BAO_0000218
10382,11020,A,,Intermediate,CHEMBL626244,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,,,1,,BAO_0000218
10383,11020,A,,Intermediate,CHEMBL626907,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10384,11020,A,,Intermediate,CHEMBL626908,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10385,11020,A,,Intermediate,CHEMBL626909,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10386,11020,A,,Intermediate,CHEMBL626910,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,,,1,,BAO_0000218
10387,7449,F,,Intermediate,CHEMBL875342,,,50597,,1,,N,Percent total excretion of acetaminophen cysteine conjugate,Rattus norvegicus,,,1,,BAO_0000218
10388,7449,F,,Intermediate,CHEMBL626911,,,50597,,1,,N,Percent total excretion of acetaminophen glucuronide,Rattus norvegicus,,,1,,BAO_0000218
10389,7449,F,,Intermediate,CHEMBL626912,,,50597,,1,,N,Percent total excretion of acetaminophen sulfate,Rattus norvegicus,,,1,,BAO_0000218
10390,7449,F,,Intermediate,CHEMBL627065,,,50597,,1,,N,Percent total excretion of acetaminophen-mercapturic acid,Rattus norvegicus,,,1,,BAO_0000218
10391,3172,A,,Intermediate,CHEMBL627066,,1088.0,50597,,1,,N,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Rattus norvegicus,,Urine,1,,BAO_0000218
10392,16456,A,,Intermediate,CHEMBL627067,In vivo,,50597,,1,,N,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10393,10839,A,,Autocuration,CHEMBL627068,In vivo,2385.0,22224,,1,,U,Biodistribution of compound in rat muscle after 5 min of administration,ratrat,,Muscle tissue,0,,BAO_0000218
10394,10839,A,,Autocuration,CHEMBL627069,In vivo,2385.0,22224,,1,,U,Biodistribution of compound in rat muscle after 5 min of administration.,ratrat,,Muscle tissue,0,,BAO_0000218
10395,5334,A,,Autocuration,CHEMBL627070,In vivo,,22224,,1,,U,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10396,5334,A,,Autocuration,CHEMBL627071,In vivo,,22224,,1,,U,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10397,5334,A,,Autocuration,CHEMBL627072,In vivo,,22224,,1,,U,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10398,5334,A,,Autocuration,CHEMBL627073,In vivo,,22224,,1,,U,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10399,5334,A,,Autocuration,CHEMBL625387,In vivo,,22224,,1,,U,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10400,5334,A,,Autocuration,CHEMBL625388,In vivo,,22224,,1,,U,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,,0,,BAO_0000218
10401,5334,A,,Autocuration,CHEMBL625389,In vivo,1969.0,22224,,1,,U,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,,Plasma,0,,BAO_0000218
10402,5334,A,,Autocuration,CHEMBL875343,In vivo,1969.0,22224,,1,,U,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,,Plasma,0,,BAO_0000218
10403,1735,A,,Intermediate,CHEMBL876795,,,50497,,1,,N,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Serpentes,,,1,,BAO_0000218
10404,1469,A,,Intermediate,CHEMBL626552,,,50497,,1,,N,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Serpentes,,,1,,BAO_0000218
10405,1336,A,,Intermediate,CHEMBL626553,,,50497,,1,,N,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Serpentes,,,1,,BAO_0000218
10406,12403,A,,Autocuration,CHEMBL626554,,1969.0,22224,,1,,U,The human biological plasma half life of the compound,Homo sapiens,,Plasma,0,,BAO_0000366
10407,8151,A,,Intermediate,CHEMBL626555,,1088.0,50597,,1,,N,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,,Urine,1,,BAO_0000218
10408,8004,A,,Intermediate,CHEMBL626556,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,,,1,,BAO_0000218
10409,8004,A,,Intermediate,CHEMBL626557,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10410,8004,A,,Intermediate,CHEMBL626558,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,,,1,,BAO_0000218
10411,8004,A,,Intermediate,CHEMBL626559,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10412,8004,A,,Intermediate,CHEMBL626560,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10413,8004,A,,Intermediate,CHEMBL876803,,,50597,,1,,N,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10414,8004,A,,Intermediate,CHEMBL627964,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,,,1,,BAO_0000218
10415,8004,A,,Intermediate,CHEMBL627965,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10416,8004,A,,Intermediate,CHEMBL627966,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,,,1,,BAO_0000218
10417,8004,A,,Intermediate,CHEMBL627967,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10418,8004,A,,Intermediate,CHEMBL627968,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10419,8004,A,,Intermediate,CHEMBL627969,,,50597,,1,,N,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10420,8004,A,,Intermediate,CHEMBL627970,,,50597,,1,,N,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,,,1,,BAO_0000218
10421,8004,A,,Intermediate,CHEMBL627971,,178.0,50597,,1,,N,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Rattus norvegicus,,Blood,1,,BAO_0000218
10422,8004,A,,Intermediate,CHEMBL627972,,178.0,50597,,1,,N,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Rattus norvegicus,,Blood,1,,BAO_0000218
10423,15917,B,,Expert,CHEMBL856029,,,180,,1,,D,Dissociation constant against binding to human cyclophilin A,Homo sapiens,,,9,,BAO_0000357
10424,12396,B,,Expert,CHEMBL627973,,,11591,,1,,H,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Bos taurus,,,8,,BAO_0000019
10425,7065,A,,Autocuration,CHEMBL627974,,,22224,,1,,U,-Log C was determined by performing the electroshock minimum test,,,,0,,BAO_0000019
10426,7065,A,,Autocuration,CHEMBL627975,,,22224,,1,,U,-Log C was determined by performing the foot shock test,,,,0,,BAO_0000019
10427,7065,A,,Autocuration,CHEMBL627976,,,22224,,1,,U,-Log C was determined by performing the incl screen test,,,,0,,BAO_0000019
10428,7065,A,,Autocuration,CHEMBL627977,,,22224,,1,,U,-Log C was determined by performing the maximum electroshock test,,,,0,,BAO_0000019
10429,7065,A,,Autocuration,CHEMBL627978,,,22224,,1,,U,-Log C was determined by performing the pentylenetetrazole test,,,,0,,BAO_0000019
10430,12415,A,,Autocuration,CHEMBL627979,,,22224,,1,,U,Tested for experimental arotinoid inhibitory dose,,,,0,,BAO_0000019
10431,10256,A,,Autocuration,CHEMBL876804,,,22224,,1,,U,Negative log transformed activity,,,,0,,BAO_0000019
10432,7991,A,,Autocuration,CHEMBL627980,,,22224,,1,,U,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,,0,,BAO_0000019
10433,14342,A,,Intermediate,CHEMBL627981,,,50512,,1,,N,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Cavia porcellus,,,1,,BAO_0000218
10434,14342,A,,Intermediate,CHEMBL627982,,,50512,,1,,N,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Cavia porcellus,,,1,,BAO_0000218
10435,14342,A,,Intermediate,CHEMBL627983,,,50512,,1,,N,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Cavia porcellus,,,1,,BAO_0000218
10436,14342,A,,Intermediate,CHEMBL627984,,2116.0,50512,,1,,N,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Cavia porcellus,,Ileum,1,,BAO_0000218
10437,6047,P,,Autocuration,CHEMBL627985,,,22229,,1,,U,Solubility in water was determined; values expressed as -log,,,,0,,BAO_0000100
10438,17269,A,,Autocuration,CHEMBL627986,,,22224,,1,,U,Ratio of Kcat to that of Km was determined,,,,0,,BAO_0000019
10439,10026,A,,Autocuration,CHEMBL627987,,,22224,,1,,U,Observed first order rate constant,,,,0,,BAO_0000019
10440,14583,A,,Autocuration,CHEMBL627988,,,22224,,1,,U,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,,0,,BAO_0000019
10441,2661,A,,Intermediate,CHEMBL627989,In vivo,,50597,,1,,N,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,,,1,,BAO_0000218
10442,2661,A,,Intermediate,CHEMBL627990,In vivo,,50597,,1,,N,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
10443,4029,A,,Intermediate,CHEMBL876805,In vivo,,50597,,1,,N,Oral Bioavailability after administration of 10 mg/kg in male rat,Rattus norvegicus,,,1,,BAO_0000218
10444,17735,A,,Intermediate,CHEMBL627991,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10445,4576,A,,Intermediate,CHEMBL627992,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10446,17582,A,,Intermediate,CHEMBL627993,In vivo,,50597,,1,,N,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,,,1,,BAO_0000218
10447,17651,A,,Intermediate,CHEMBL622817,In vivo,,50597,,1,,N,Oral bioavailability at 1 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10448,17651,A,,Intermediate,CHEMBL622818,In vivo,,50597,,1,,N,Oral bioavailability at 10 mg/kg was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10449,17670,A,,Intermediate,CHEMBL622819,In vivo,,50597,,1,,N,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Rattus norvegicus,,,1,,BAO_0000218
10450,5045,A,,Intermediate,CHEMBL872267,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10451,1696,A,,Intermediate,CHEMBL622820,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10452,17764,A,,Intermediate,CHEMBL622821,In vivo,,50597,,1,,N,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,,,1,,BAO_0000218
10453,6448,A,,Intermediate,CHEMBL622822,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10454,6596,A,,Intermediate,CHEMBL622823,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10455,17547,A,,Intermediate,CHEMBL622824,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10456,17771,A,,Intermediate,CHEMBL622825,In vivo,,50597,,1,,N,Oral bioavailability in rat at a dose of 3 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10457,6495,A,,Intermediate,CHEMBL622901,In vivo,,50597,,1,,N,Oral bioavailability in rat after oral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10458,4558,A,,Intermediate,CHEMBL622902,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10459,17596,A,,Intermediate,CHEMBL621844,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10460,6827,A,,Intermediate,CHEMBL621845,In vivo,,50597,,1,,N,Oral bioavailability in Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
10461,4026,A,,Intermediate,CHEMBL621846,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10462,10,A,,Intermediate,CHEMBL621847,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10463,17717,A,,Intermediate,CHEMBL877609,In vivo,,50597,,1,,N,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,1,,BAO_0000218
10464,17717,A,,Intermediate,CHEMBL621848,In vivo,,50597,,1,,N,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10465,17717,A,,Intermediate,CHEMBL621849,In vivo,,50597,,1,,N,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,1,,BAO_0000218
10466,17717,A,,Intermediate,CHEMBL622030,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10467,4796,A,,Intermediate,CHEMBL622031,In vivo,,50597,,1,,N,Percent oral bioavailability determined in rats,Rattus norvegicus,,,1,,BAO_0000218
10468,4883,A,,Intermediate,CHEMBL622032,In vivo,,50597,,1,,N,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10469,2137,A,,Intermediate,CHEMBL622033,In vivo,,50597,,1,,N,The compound was evaluated for bioavailability in rats; 32-51,Rattus norvegicus,,,1,,BAO_0000218
10470,2959,A,,Intermediate,CHEMBL622034,In vivo,,50597,,1,,N,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10471,1361,A,,Intermediate,CHEMBL622035,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10472,4727,A,,Intermediate,CHEMBL882966,In vivo,,50597,,1,,N,Bioavailability percent in rat at the dose of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10473,16423,A,,Intermediate,CHEMBL622036,In vivo,,50597,,1,,N,Bioavailability was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,,,1,,BAO_0000218
10474,5206,A,,Intermediate,CHEMBL622037,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10475,6448,A,,Intermediate,CHEMBL622038,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10476,17723,A,,Intermediate,CHEMBL622039,In vivo,,50597,,1,,N,Bioavailability in rats,Rattus norvegicus,,,1,,BAO_0000218
10477,17738,A,,Intermediate,CHEMBL622040,In vivo,178.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,Blood,1,,BAO_0000218
10478,17738,A,,Intermediate,CHEMBL622041,In vivo,178.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Blood,1,,BAO_0000218
10479,17738,A,,Intermediate,CHEMBL622042,In vivo,178.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Blood,1,,BAO_0000218
10480,17738,A,,Intermediate,CHEMBL622043,In vivo,178.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Blood,1,,BAO_0000218
10481,17738,A,,Intermediate,CHEMBL622044,In vivo,178.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Blood,1,,BAO_0000218
10482,17738,A,,Intermediate,CHEMBL622045,In vivo,10000001.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Bone,1,,BAO_0000218
10483,17738,A,,Intermediate,CHEMBL622046,In vivo,10000001.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Bone,1,,BAO_0000218
10484,17738,A,,Intermediate,CHEMBL622047,In vivo,10000001.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Bone,1,,BAO_0000218
10485,17738,A,,Intermediate,CHEMBL877610,In vivo,10000001.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Bone,1,,BAO_0000218
10486,17738,A,,Intermediate,CHEMBL622048,In vivo,955.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Brain,1,,BAO_0000218
10487,17738,A,,Intermediate,CHEMBL622049,In vivo,955.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Brain,1,,BAO_0000218
10488,17738,A,,Intermediate,CHEMBL622050,In vivo,955.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Brain,1,,BAO_0000218
10489,17738,A,,Intermediate,CHEMBL622051,In vivo,955.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Brain,1,,BAO_0000218
10490,17738,A,,Intermediate,CHEMBL622052,In vivo,,50597,,1,,N,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,,1,,BAO_0000218
10491,17738,A,,Intermediate,CHEMBL622053,In vivo,,50597,,1,,N,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,,1,,BAO_0000218
10492,17738,A,,Intermediate,CHEMBL622054,In vivo,,50597,,1,,N,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,,1,,BAO_0000218
10493,17738,A,,Intermediate,CHEMBL622055,In vivo,,50597,,1,,N,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,,1,,BAO_0000218
10494,5237,A,,Intermediate,CHEMBL622056,In vivo,,50597,,1,,N,Oral bioavailability in rats was determined; High,Rattus norvegicus,,,1,,BAO_0000218
10495,5503,A,,Intermediate,CHEMBL622057,In vivo,,50597,,1,,N,Oral bioavailability in the rat was determined,Rattus norvegicus,,,1,,BAO_0000218
10496,15765,A,,Intermediate,CHEMBL628008,In vivo,,50597,,1,,N,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Rattus norvegicus,,,1,,BAO_0000218
10497,15660,A,,Intermediate,CHEMBL622058,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10498,5978,A,,Intermediate,CHEMBL622059,In vivo,,50597,,1,,N,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10499,5978,A,,Intermediate,CHEMBL622060,In vivo,,50597,,1,,N,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10500,5978,A,,Intermediate,CHEMBL622061,In vivo,,50597,,1,,N,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10501,5978,A,,Intermediate,CHEMBL622062,In vivo,,50597,,1,,N,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,,,1,,BAO_0000218
10502,5656,A,,Intermediate,CHEMBL622063,In vivo,,50597,,1,,N,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Rattus norvegicus,,,1,,BAO_0000218
10503,3598,A,,Expert,CHEMBL877611,In vivo,,50597,,1,,N,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10504,4216,A,,Intermediate,CHEMBL622064,In vivo,,50597,,1,,N,Oral bioavailability of compound in Sprague Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
10505,17839,A,,Intermediate,CHEMBL622065,In vivo,,50597,,1,,N,Oral bioavailability of compound in rat,Rattus norvegicus,,,1,,BAO_0000218
10506,6570,A,,Intermediate,CHEMBL622066,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10507,5334,A,,Intermediate,CHEMBL622067,In vivo,,50597,,1,,N,Oral bioavailability of compound in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
10508,6886,A,,Intermediate,CHEMBL622068,In vivo,,50597,,1,,N,Oral bioavailability of compound in rats,Rattus norvegicus,,,1,,BAO_0000218
10509,5210,A,,Intermediate,CHEMBL622069,In vivo,,50597,,1,,N,Oral bioavailability of compound was determined in rats,Rattus norvegicus,,,1,,BAO_0000218
10510,4170,A,,Intermediate,CHEMBL624796,In vivo,,50597,,1,,N,Oral bioavailability at a dose of 30 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10511,6028,A,,Intermediate,CHEMBL624797,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10512,6028,A,,Intermediate,CHEMBL623053,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10513,6078,A,,Intermediate,CHEMBL623054,In vivo,,50597,,1,,N,Oral bioavailability evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
10514,6168,A,,Intermediate,CHEMBL623055,In vivo,,50597,,1,,N,Oral bioavailability in fasted rat,Rattus norvegicus,,,1,,BAO_0000218
10515,6168,A,,Intermediate,CHEMBL623056,In vivo,,50597,,1,,N,Oral bioavailability in fed rat,Rattus norvegicus,,,1,,BAO_0000218
10516,5160,A,,Intermediate,CHEMBL623057,In vivo,,50597,,1,,N,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10517,6057,A,,Intermediate,CHEMBL623058,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10518,6535,A,,Intermediate,CHEMBL623059,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10519,6535,A,,Intermediate,CHEMBL623060,In vivo,,50597,,1,,N,Oral bioavailability in rat after administration of 10 mg/kg po,Rattus norvegicus,,,1,,BAO_0000218
10520,4194,A,,Intermediate,CHEMBL623061,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10521,6230,A,,Intermediate,CHEMBL623062,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10522,6619,A,,Intermediate,CHEMBL623063,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10523,17607,A,,Intermediate,CHEMBL623064,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10524,4942,A,,Intermediate,CHEMBL623065,In vivo,,50597,,1,,N,Oral bioavailability in ratrs,Rattus norvegicus,,,1,,BAO_0000218
10525,4942,A,,Intermediate,CHEMBL623066,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10526,6646,A,,Intermediate,CHEMBL623067,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10527,5237,A,,Intermediate,CHEMBL623068,In vivo,,50597,,1,,N,Oral bioavailability in rats was determined; High,Rattus norvegicus,,,1,,BAO_0000218
10528,6646,A,,Intermediate,CHEMBL623069,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10529,4449,A,,Intermediate,CHEMBL623070,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10530,6057,A,,Intermediate,CHEMBL623071,In vivo,,50597,,1,,N,Oral bioavailability was calculated in rat,Rattus norvegicus,,,1,,BAO_0000218
10531,2552,A,,Intermediate,CHEMBL623072,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10532,5496,A,,Intermediate,CHEMBL623073,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10533,6484,A,,Intermediate,CHEMBL623074,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10534,6485,A,,Intermediate,CHEMBL623075,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10535,6616,A,,Intermediate,CHEMBL623076,In vivo,,50597,,1,,N,Oral bioavailability after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
10536,4969,A,,Intermediate,CHEMBL623077,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10537,5862,A,,Intermediate,CHEMBL623078,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,1,,BAO_0000218
10538,4514,A,,Intermediate,CHEMBL623079,In vivo,,50597,,1,,N,Oral bioavailability in Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
10539,4514,A,,Intermediate,CHEMBL623080,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10540,4514,A,,Intermediate,CHEMBL623081,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10541,5546,A,,Intermediate,CHEMBL623082,In vivo,,50597,,1,,N,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Rattus norvegicus,,,1,,BAO_0000218
10542,6168,A,,Intermediate,CHEMBL874400,In vivo,,50597,,1,,N,Oral bioavailability in fasted rat,Rattus norvegicus,,,1,,BAO_0000218
10543,6168,A,,Intermediate,CHEMBL623083,In vivo,,50597,,1,,N,Oral bioavailability in fed rat,Rattus norvegicus,,,1,,BAO_0000218
10544,3624,A,,Intermediate,CHEMBL623084,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10545,5213,A,,Intermediate,CHEMBL623085,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10546,5496,A,,Intermediate,CHEMBL623086,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10547,5553,A,,Intermediate,CHEMBL623087,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10548,5833,A,,Intermediate,CHEMBL623088,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10549,5836,A,,Intermediate,CHEMBL623089,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10550,5865,A,,Intermediate,CHEMBL623090,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10551,5960,A,,Intermediate,CHEMBL623091,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10552,6249,A,,Intermediate,CHEMBL623092,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10553,6448,A,,Intermediate,CHEMBL623093,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10554,6453,A,,Intermediate,CHEMBL874401,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10555,6640,A,,Intermediate,CHEMBL623094,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10556,17607,A,,Intermediate,CHEMBL623095,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10557,5939,A,,Intermediate,CHEMBL623096,In vivo,,50597,,1,,N,Oral bioavailability in rat after peroral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10558,5939,A,,Intermediate,CHEMBL624913,In vivo,,50597,,1,,N,Oral bioavailability in rat after peroral administration at 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10559,6281,A,,Intermediate,CHEMBL624914,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10560,5874,A,,Intermediate,CHEMBL624915,In vivo,,50597,,1,,N,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10561,5213,A,,Intermediate,CHEMBL624916,In vivo,,50597,,1,,N,Oral bioavailability in rat; Not measured,Rattus norvegicus,,,1,,BAO_0000218
10562,4964,A,,Intermediate,CHEMBL624917,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10563,11020,A,,Intermediate,CHEMBL625157,,,50597,,1,,N,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,,,1,,BAO_0000218
10564,6251,A,,Intermediate,CHEMBL625158,,2107.0,50597,,1,,N,In vitro metabolic potential in rat liver microsomes,Rattus norvegicus,,Liver,1,,BAO_0000218
10565,1568,A,,Intermediate,CHEMBL625159,In vivo,,50597,,1,,N,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Rattus norvegicus,,,1,,BAO_0000218
10566,3032,A,,Intermediate,CHEMBL625160,In vivo,,50597,,1,,N,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,,,1,,BAO_0000218
10567,3748,A,,Intermediate,CHEMBL625161,In vivo,,50597,,1,,N,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Rattus norvegicus,,,1,,BAO_0000218
10568,401,A,,Intermediate,CHEMBL625162,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10569,6512,A,,Intermediate,CHEMBL625163,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10570,17617,A,,Intermediate,CHEMBL625164,In vivo,,50597,,1,,N,Oral bioavailability in rats at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10571,6679,A,,Intermediate,CHEMBL625165,In vivo,,50597,,1,,N,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,,,1,,BAO_0000218
10572,6742,A,,Intermediate,CHEMBL625166,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10573,589,A,,Intermediate,CHEMBL625167,,,50597,,1,,N,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Rattus norvegicus,,,1,,BAO_0000218
10574,589,A,,Intermediate,CHEMBL625168,,,50597,,1,,N,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Rattus norvegicus,,,1,,BAO_0000218
10575,3185,A,,Intermediate,CHEMBL625169,In vivo,,50597,,1,,N,Plasma clearance of the compound,Rattus norvegicus,,,1,,BAO_0000218
10576,17596,A,,Intermediate,CHEMBL626264,In vivo,,50597,,1,,N,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,,,1,,BAO_0000218
10577,2713,A,,Intermediate,CHEMBL626265,In vivo,,50597,,1,,N,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10578,12500,A,,Intermediate,CHEMBL626266,In vivo,1969.0,50597,,1,,N,The compound was tested for plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10579,12500,A,,Intermediate,CHEMBL626267,In vivo,1969.0,50597,,1,,N,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Rattus norvegicus,,Plasma,1,,BAO_0000218
10580,2713,A,,Intermediate,CHEMBL626268,,,50597,,1,,N,Plasma concentration upon oral administration of 1 mg/Kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10581,1446,A,,Intermediate,CHEMBL626269,,,50597,,1,,N,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Rattus norvegicus,,,1,,BAO_0000218
10582,6227,A,,Intermediate,CHEMBL626270,,,50597,,1,,N,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Rattus norvegicus,,,1,,BAO_0000218
10583,4709,A,,Intermediate,CHEMBL626271,,,50597,,1,,N,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10584,5510,A,,Intermediate,CHEMBL626272,,,50597,,1,,N,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Rattus norvegicus,,,1,,BAO_0000218
10585,5510,A,,Intermediate,CHEMBL626273,,,50597,,1,,N,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,,,1,,BAO_0000218
10586,5510,A,,Intermediate,CHEMBL875346,,,50597,,1,,N,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,,,1,,BAO_0000218
10587,5510,A,,Intermediate,CHEMBL626274,,,50597,,1,,N,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Rattus norvegicus,,,1,,BAO_0000218
10588,4514,A,,Intermediate,CHEMBL626275,,,50597,,1,,N,Compound was tested for protein binding in rat plasma,Rattus norvegicus,,,1,,BAO_0000218
10589,2713,A,,Intermediate,CHEMBL624646,,,50597,,1,,N,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Rattus norvegicus,,,1,,BAO_0000218
10590,2713,A,,Intermediate,CHEMBL624647,,,50597,,1,,N,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Rattus norvegicus,,,1,,BAO_0000218
10591,5340,A,,Intermediate,CHEMBL624648,,2107.0,50597,,1,,N,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Rattus norvegicus,,Liver,1,,BAO_0000218
10592,12058,A,,Intermediate,CHEMBL624649,,,50597,,1,,N,Area under curve ratio was determined (po/iv) in rat,Rattus norvegicus,,,1,,BAO_0000218
10593,11195,A,,Intermediate,CHEMBL624650,,,50597,,1,,N,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
10594,11195,A,,Intermediate,CHEMBL624651,,,50597,,1,,N,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
10595,11195,A,,Intermediate,CHEMBL624652,,,50597,,1,,N,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Rattus norvegicus,,,1,,BAO_0000218
10596,6495,A,,Intermediate,CHEMBL624653,,,50597,,1,,N,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10597,6078,A,,Intermediate,CHEMBL624654,,,50597,,1,,N,Ratio of AUCbrain to AUCplasma,Rattus norvegicus,,,1,,BAO_0000218
10598,5656,A,,Intermediate,CHEMBL624655,,,50597,,1,,N,Ratio of brain to plasma,Rattus norvegicus,,,1,,BAO_0000218
10599,4910,A,,Intermediate,CHEMBL624656,,,50597,,1,,N,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Rattus norvegicus,,,1,,BAO_0000218
10600,4910,A,,Intermediate,CHEMBL624657,,,50597,,1,,N,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,,,1,,BAO_0000218
10601,4910,A,,Intermediate,CHEMBL624658,,,50597,,1,,N,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,,,1,,BAO_0000218
10602,10130,A,,Intermediate,CHEMBL624659,,,50597,,1,,N,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,1,,BAO_0000218
10603,10130,A,,Intermediate,CHEMBL624660,,,50597,,1,,N,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,1,,BAO_0000218
10604,10130,A,,Intermediate,CHEMBL624661,,,50597,,1,,N,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,,,1,,BAO_0000218
10605,5213,A,,Intermediate,CHEMBL624662,,,50597,,1,,N,Steady state brain :blood ratio was determined,Rattus norvegicus,,,1,,BAO_0000218
10606,4910,A,,Intermediate,CHEMBL625199,,,50597,,1,,N,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,1,,BAO_0000218
10607,4910,A,,Intermediate,CHEMBL625200,,,50597,,1,,N,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,,,1,,BAO_0000218
10608,4910,A,,Intermediate,CHEMBL625201,,,50597,,1,,N,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,,,1,,BAO_0000218
10609,4910,A,,Intermediate,CHEMBL625202,,,50597,,1,,N,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,,,1,,BAO_0000218
10610,2083,A,,Intermediate,CHEMBL625203,,,50597,,1,,N,Percentage recovery after 3h incubation with rat hapatocytes was determined,Rattus norvegicus,,,1,,BAO_0000218
10611,2082,A,,Intermediate,CHEMBL625204,,,50597,,1,,N,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,,,1,,BAO_0000218
10612,2082,A,,Intermediate,CHEMBL625205,,,50597,,1,,N,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,,,1,,BAO_0000218
10613,6351,A,,Intermediate,CHEMBL625206,,,50597,,1,,N,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
10614,14583,A,,Autocuration,CHEMBL625207,,,22224,,1,,U,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,,0,,BAO_0000019
10615,14583,A,,Autocuration,CHEMBL625208,,,22224,,1,,U,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,,0,,BAO_0000019
10616,4608,A,Caco-2,Intermediate,CHEMBL625209,,,50587,,1,,N,In vivo absorption in Caco-2 cell line monolayers was determined,Homo sapiens,,,1,495.0,BAO_0000218
10617,13668,P,,Autocuration,CHEMBL625210,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
10618,5669,A,,Intermediate,CHEMBL625211,,,50597,,1,,N,Area under curve was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
10619,5669,A,,Intermediate,CHEMBL625212,,,50797,,1,,N,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,1,,BAO_0000218
10620,5669,A,,Intermediate,CHEMBL625213,,,50597,,1,,N,Area under curve was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
10621,5669,A,,Intermediate,CHEMBL625214,,,50597,,1,,N,Area under curve was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
10622,5669,A,,Intermediate,CHEMBL874542,,,50597,,1,,N,Area under curve was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
10623,6472,P,,Autocuration,CHEMBL625215,,,22229,,1,,U,Calculated partition coefficient (clogP) (AlogP),,,,0,,BAO_0000100
10624,15106,A,,Autocuration,CHEMBL625216,,,22224,,1,,U,Activated partial thromboplastin time measured,,,,0,,BAO_0000019
10625,15207,P,,Autocuration,CHEMBL625217,,,22224,,1,,U,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,,0,,BAO_0000100
10626,15207,P,,Autocuration,CHEMBL625218,,,22224,,1,,U,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,,0,,BAO_0000100
10627,13941,A,,Intermediate,CHEMBL622864,,1969.0,50588,,1,,N,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
10628,13941,A,,Intermediate,CHEMBL622865,,1969.0,50597,,1,,N,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10629,13941,A,,Intermediate,CHEMBL622866,,1969.0,50597,,1,,N,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10630,13941,A,,Intermediate,CHEMBL622867,,1969.0,50588,,1,,N,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
10631,15240,A,,Intermediate,CHEMBL876808,,1969.0,50512,,1,,N,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,Plasma,1,,BAO_0000218
10632,10655,A,,Autocuration,CHEMBL627725,,955.0,22224,,1,,U,AUC in brain,,,Brain,0,,BAO_0000019
10633,10655,A,,Autocuration,CHEMBL627726,,1977.0,22224,,1,,U,AUC in serum,,,Serum,0,,BAO_0000019
10634,6504,A,,Autocuration,CHEMBL627727,,1969.0,22224,,1,,U,AUC was determined,,,Plasma,0,,BAO_0000019
10635,10615,A,,Autocuration,CHEMBL627728,,1969.0,22224,,1,,U,AUC of the compound.,,,Plasma,0,,BAO_0000019
10636,10353,A,,Autocuration,CHEMBL627729,,1969.0,22224,,1,,U,AUC value (0-4 hr),,,Plasma,0,,BAO_0000019
10637,14907,A,,Autocuration,CHEMBL627730,,1969.0,22224,,1,,U,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,Plasma,0,,BAO_0000019
10638,14907,A,,Autocuration,CHEMBL627731,,1969.0,22224,,1,,U,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,Plasma,0,,BAO_0000019
10639,14907,A,,Autocuration,CHEMBL627732,,1969.0,22224,,1,,U,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,Plasma,0,,BAO_0000019
10640,14907,A,,Autocuration,CHEMBL627733,,1969.0,22224,,1,,U,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,Plasma,0,,BAO_0000019
10641,16359,A,,Intermediate,CHEMBL627734,,1969.0,50597,,1,,N,AUC(area under curve) was determined after intravenous administration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10642,16359,A,,Intermediate,CHEMBL627735,,1969.0,50597,,1,,N,AUC(area under curve) was determined after oral administration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10643,15240,A,,Intermediate,CHEMBL627736,,1969.0,50512,,1,,N,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,Plasma,1,,BAO_0000218
10644,15240,A,,Intermediate,CHEMBL876809,,1969.0,50597,,1,,N,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10645,15469,A,,Autocuration,CHEMBL627737,,,22224,,1,,U,Area Under Curve after oral dosing of 100 uM/Kg,,,,0,,BAO_0000019
10646,15469,A,,Autocuration,CHEMBL627738,,,22224,,1,,U,Area Under Curve after oral dosing of 30 uM/Kg,,,,0,,BAO_0000019
10647,13520,A,,Autocuration,CHEMBL627739,,,22224,,1,,U,Area Under Curve was measured by ploting the graph between concentration verses time,,,,0,,BAO_0000019
10648,17025,A,,Intermediate,CHEMBL626143,,,50588,,1,,N,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,,,1,,BAO_0000218
10649,17025,A,,Autocuration,CHEMBL626144,,,22224,,1,,U,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Simiiformes,,,0,,BAO_0000218
10650,17025,A,,Intermediate,CHEMBL626145,,,50592,,1,,N,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,,,1,,BAO_0000218
10651,17025,A,,Intermediate,CHEMBL626146,,,50597,,1,,N,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,,,1,,BAO_0000218
10652,12032,A,,Intermediate,CHEMBL626147,,178.0,50597,,1,,N,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Rattus norvegicus,,Blood,1,,BAO_0000218
10653,10291,A,,Autocuration,CHEMBL626148,,,22224,,1,,U,Area under curve (AUC) was determined,,,,0,,BAO_0000019
10654,5767,A,,Autocuration,CHEMBL626149,,,22224,,1,,U,Area under curve (AUC) following ip administration at 1 mg/kg,,,,0,,BAO_0000218
10655,1434,A,,Autocuration,CHEMBL626150,,,22224,,1,,U,Area under curve (AUC) was determined; ND is Not determined,,,,0,,BAO_0000019
10656,14925,A,,Intermediate,CHEMBL626151,,,50588,,1,,N,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Canis lupus familiaris,,,1,,BAO_0000218
10657,14925,A,,Intermediate,CHEMBL626152,,,50588,,1,,N,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,,,1,,BAO_0000218
10658,14925,A,,Intermediate,CHEMBL626153,,,50588,,1,,N,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,,,1,,BAO_0000218
10659,1434,A,,Autocuration,CHEMBL626154,,,22224,,1,,U,Area under curve (AUR) was determined,,,,0,,BAO_0000019
10660,11883,A,,Autocuration,CHEMBL626155,,,22224,,1,,U,Area under curve at 1 uM/dg administered intravenously,,,,0,,BAO_0000019
10661,11883,A,,Autocuration,CHEMBL626156,,,22224,,1,,U,Area under curve at 10 uM/dg administered perorally,,,,0,,BAO_0000019
10662,11883,A,,Autocuration,CHEMBL626157,,,22224,,1,,U,Area under curve at 2 uM/dg administered intravenously,,,,0,,BAO_0000019
10663,11883,A,,Autocuration,CHEMBL626158,,,22224,,1,,U,Area under curve at 20 uM/dg administered perorally,,,,0,,BAO_0000019
10664,15233,A,,Intermediate,CHEMBL626159,,,50588,,1,,N,Area under curve at a peroral dose of 3 mg/kg in dog,Canis lupus familiaris,,,1,,BAO_0000218
10665,15233,A,,Intermediate,CHEMBL626160,,,50597,,1,,N,Area under curve at a peroral dose of 3 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10666,15233,A,,Intermediate,CHEMBL626161,,,50588,,1,,N,Area under curve at an iv dose of 1 mg/kg in dog,Canis lupus familiaris,,,1,,BAO_0000218
10667,15233,A,,Intermediate,CHEMBL626162,,,50597,,1,,N,Area under curve at an iv dose of 1 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10668,12978,A,,Autocuration,CHEMBL626163,,,22224,,1,,U,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,,0,,BAO_0000019
10669,12978,A,,Autocuration,CHEMBL626164,,,22224,,1,,U,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,,0,,BAO_0000019
10670,11355,A,,Intermediate,CHEMBL626165,,,50594,,1,,N,Area under curve measured as conc vs time after intravenous administration to mice.,Mus musculus,,,1,,BAO_0000218
10671,11355,A,,Intermediate,CHEMBL626166,,,50594,,1,,N,Area under curve measured as conc vs time after peroral administration to mice.,Mus musculus,,,1,,BAO_0000218
10672,12923,A,,Intermediate,CHEMBL626167,,,50588,,1,,N,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,,,1,,BAO_0000218
10673,12923,A,,Intermediate,CHEMBL626168,,,50588,,1,,N,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,,,1,,BAO_0000218
10674,12923,A,,Intermediate,CHEMBL877463,,,50588,,1,,N,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Canis lupus familiaris,,,1,,BAO_0000218
10675,12923,A,,Intermediate,CHEMBL626169,,,50588,,1,,N,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,,,1,,BAO_0000218
10676,17738,A,,Intermediate,CHEMBL626170,In vivo,948.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Heart,1,,BAO_0000218
10677,17738,A,,Intermediate,CHEMBL626171,In vivo,948.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Heart,1,,BAO_0000218
10678,17738,A,,Intermediate,CHEMBL626172,In vivo,948.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Heart,1,,BAO_0000218
10679,17738,A,,Intermediate,CHEMBL626173,In vivo,948.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Heart,1,,BAO_0000218
10680,17738,A,,Intermediate,CHEMBL626174,In vivo,2113.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
10681,17738,A,,Intermediate,CHEMBL626175,In vivo,2113.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
10682,17738,A,,Intermediate,CHEMBL626176,In vivo,2113.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
10683,17738,A,,Intermediate,CHEMBL626177,In vivo,2113.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
10684,17738,A,,Intermediate,CHEMBL622499,In vivo,2113.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
10685,17738,A,,Intermediate,CHEMBL622500,In vivo,2107.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,,Liver,1,,BAO_0000218
10686,17738,A,,Intermediate,CHEMBL622501,In vivo,2107.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Liver,1,,BAO_0000218
10687,17738,A,,Intermediate,CHEMBL622502,In vivo,2107.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Liver,1,,BAO_0000218
10688,17738,A,,Intermediate,CHEMBL622503,In vivo,2107.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Liver,1,,BAO_0000218
10689,17738,A,,Intermediate,CHEMBL877614,In vivo,2107.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Liver,1,,BAO_0000218
10690,17738,A,,Intermediate,CHEMBL624839,In vivo,2048.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Lung,1,,BAO_0000218
10691,17738,A,,Intermediate,CHEMBL624840,In vivo,2048.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Lung,1,,BAO_0000218
10692,17738,A,,Intermediate,CHEMBL624841,In vivo,2048.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Lung,1,,BAO_0000218
10693,17738,A,,Intermediate,CHEMBL624842,In vivo,2048.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Lung,1,,BAO_0000218
10694,17738,A,,Intermediate,CHEMBL624843,In vivo,2385.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10695,17738,A,,Intermediate,CHEMBL624844,In vivo,2385.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10696,17738,A,,Intermediate,CHEMBL624845,In vivo,2385.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10697,17738,A,,Intermediate,CHEMBL621904,In vivo,2385.0,50597,,1,,N,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10698,11195,A,,Intermediate,CHEMBL621905,In vivo,178.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Rattus norvegicus,,Blood,1,,BAO_0000218
10699,11195,A,,Intermediate,CHEMBL874382,In vivo,178.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Rattus norvegicus,,Blood,1,,BAO_0000218
10700,11195,A,,Intermediate,CHEMBL621906,In vivo,178.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Rattus norvegicus,,Blood,1,,BAO_0000218
10701,11195,A,,Intermediate,CHEMBL621907,In vivo,955.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Rattus norvegicus,,Brain,1,,BAO_0000218
10702,11195,A,,Intermediate,CHEMBL622096,In vivo,955.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Rattus norvegicus,,Brain,1,,BAO_0000218
10703,11195,A,,Intermediate,CHEMBL622097,In vivo,955.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Rattus norvegicus,,Brain,1,,BAO_0000218
10704,11195,A,,Intermediate,CHEMBL622098,In vivo,948.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Rattus norvegicus,,Heart,1,,BAO_0000218
10705,11195,A,,Intermediate,CHEMBL622099,In vivo,948.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Rattus norvegicus,,Heart,1,,BAO_0000218
10706,11195,A,,Intermediate,CHEMBL622100,In vivo,948.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Rattus norvegicus,,Heart,1,,BAO_0000218
10707,11195,A,,Intermediate,CHEMBL622101,In vivo,2113.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
10708,11195,A,,Intermediate,CHEMBL622102,In vivo,2113.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
10709,11195,A,,Intermediate,CHEMBL622103,In vivo,2113.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
10710,11195,A,,Intermediate,CHEMBL622104,In vivo,2107.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Rattus norvegicus,,Liver,1,,BAO_0000218
10711,11195,A,,Intermediate,CHEMBL622105,In vivo,2107.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Rattus norvegicus,,Liver,1,,BAO_0000218
10712,11195,A,,Intermediate,CHEMBL622106,In vivo,2107.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Rattus norvegicus,,Liver,1,,BAO_0000218
10713,11195,A,,Intermediate,CHEMBL622107,In vivo,2048.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Rattus norvegicus,,Lung,1,,BAO_0000218
10714,11195,A,,Intermediate,CHEMBL622108,In vivo,2048.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Rattus norvegicus,,Lung,1,,BAO_0000218
10715,11195,A,,Intermediate,CHEMBL622109,In vivo,2048.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Rattus norvegicus,,Lung,1,,BAO_0000218
10716,11195,A,,Intermediate,CHEMBL622110,In vivo,2385.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10717,11195,A,,Intermediate,CHEMBL622111,In vivo,2385.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10718,11195,A,,Intermediate,CHEMBL874383,In vivo,2385.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
10719,11195,A,,Intermediate,CHEMBL622112,In vivo,14.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
10720,11195,A,,Intermediate,CHEMBL622113,In vivo,14.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
10721,11195,A,,Intermediate,CHEMBL622114,In vivo,14.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
10722,11195,A,,Intermediate,CHEMBL622115,In vivo,2106.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Rattus norvegicus,,Spleen,1,,BAO_0000218
10723,11195,A,,Intermediate,CHEMBL622116,In vivo,2106.0,50597,,1,,N,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Rattus norvegicus,,Spleen,1,,BAO_0000218
10724,6193,A,,Intermediate,CHEMBL622117,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10725,6803,A,,Intermediate,CHEMBL622118,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10726,6647,A,,Intermediate,CHEMBL622119,In vivo,,50597,,1,,N,Oral bioavailability in rats at 6 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10727,6647,A,,Intermediate,CHEMBL622120,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 6 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10728,6647,A,,Intermediate,CHEMBL622121,In vivo,,50597,,1,,N,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Rattus norvegicus,,,1,,BAO_0000218
10729,6640,A,,Intermediate,CHEMBL622122,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10730,6641,A,,Intermediate,CHEMBL622123,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10731,6641,A,,Intermediate,CHEMBL622124,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10732,6642,A,,Intermediate,CHEMBL622125,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10733,5472,A,,Intermediate,CHEMBL622126,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10734,6141,A,,Intermediate,CHEMBL620455,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10735,4390,A,,Intermediate,CHEMBL620456,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10736,5472,A,,Intermediate,CHEMBL620457,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10737,5472,A,,Intermediate,CHEMBL620458,In vivo,,50597,,1,,N,Oral bioavailability was evaluated; Not tested,Rattus norvegicus,,,1,,BAO_0000218
10738,5438,A,,Intermediate,CHEMBL620459,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10739,4883,A,,Intermediate,CHEMBL620460,In vivo,,50597,,1,,N,Oral bioavailability in rat by oral dosing,Rattus norvegicus,,,1,,BAO_0000218
10740,1908,A,,Intermediate,CHEMBL620461,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10741,4853,A,,Intermediate,CHEMBL620462,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,1,,BAO_0000218
10742,4853,A,,Intermediate,CHEMBL620463,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10743,4853,A,,Intermediate,CHEMBL620464,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10744,4853,A,,Intermediate,CHEMBL620465,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10745,4853,A,,Intermediate,CHEMBL620466,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10746,4853,A,,Intermediate,CHEMBL620467,In vivo,,50597,,1,,N,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10747,4853,A,,Intermediate,CHEMBL620468,In vivo,,50597,,1,,N,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10748,12873,A,,Intermediate,CHEMBL620469,In vivo,,50597,,1,,N,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Rattus norvegicus,,,1,,BAO_0000218
10749,12873,A,,Intermediate,CHEMBL620470,In vivo,,50597,,1,,N,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Rattus norvegicus,,,1,,BAO_0000218
10750,3169,A,,Intermediate,CHEMBL620471,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10751,6305,A,,Intermediate,CHEMBL620472,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10752,4762,A,,Intermediate,CHEMBL620473,In vivo,,50597,,1,,N,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,,,1,,BAO_0000218
10753,17847,A,,Intermediate,CHEMBL620474,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10754,6211,A,,Intermediate,CHEMBL620475,In vivo,,50597,,1,,N,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10755,6011,A,,Intermediate,CHEMBL620476,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10756,6317,A,,Intermediate,CHEMBL620477,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10757,6644,A,,Intermediate,CHEMBL620478,In vivo,,50597,,1,,N,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
10758,6644,A,,Intermediate,CHEMBL618768,In vivo,,50597,,1,,N,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
10759,6644,A,,Intermediate,CHEMBL618769,In vivo,,50597,,1,,N,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
10760,6644,A,,Intermediate,CHEMBL618770,In vivo,,50597,,1,,N,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
10761,6113,A,,Intermediate,CHEMBL618771,In vivo,,50597,,1,,N,Oral bioavailability (dose 20 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10762,5937,A,,Intermediate,CHEMBL618772,In vivo,,50597,,1,,N,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10763,5711,A,,Intermediate,CHEMBL618773,In vivo,,50597,,1,,N,Oral bioavailability in rat at 10 mg/kg of the compound,Rattus norvegicus,,,1,,BAO_0000218
10764,17717,A,,Intermediate,CHEMBL875842,In vivo,,50597,,1,,N,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,1,,BAO_0000218
10765,17717,A,,Intermediate,CHEMBL618774,In vivo,,50597,,1,,N,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,,,1,,BAO_0000218
10766,17717,A,,Intermediate,CHEMBL618775,In vivo,,50597,,1,,N,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,,,1,,BAO_0000218
10767,17717,A,,Intermediate,CHEMBL618776,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10768,4722,A,,Intermediate,CHEMBL618777,In vivo,,50597,,1,,N,Percent bioavailability (F) in rats after iv administration,Rattus norvegicus,,,1,,BAO_0000218
10769,4722,A,,Intermediate,CHEMBL618778,In vivo,,50597,,1,,N,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10770,4353,A,,Intermediate,CHEMBL618779,In vivo,,50597,,1,,N,Bioavailability in rat (dose 5 uM/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10771,15662,A,,Intermediate,CHEMBL618780,In vivo,,50597,,1,,N,Oral bioavailability,Rattus norvegicus,,,1,,BAO_0000218
10772,4756,A,,Intermediate,CHEMBL618781,In vivo,,50597,,1,,N,Bioavailability in rat (dose 2 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10773,4756,A,,Intermediate,CHEMBL618782,In vivo,,50597,,1,,N,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
10774,3436,A,,Intermediate,CHEMBL618783,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,,,1,,BAO_0000218
10775,17800,A,,Intermediate,CHEMBL618784,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10776,15762,A,,Intermediate,CHEMBL618785,In vivo,,50597,,1,,N,Percent oral bioavailability evaluated in rat,Rattus norvegicus,,,1,,BAO_0000218
10777,5089,A,,Intermediate,CHEMBL618786,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10778,5089,A,,Intermediate,CHEMBL618787,In vivo,,50597,,1,,N,Percent oral bioavailability in rat; Not determined,Rattus norvegicus,,,1,,BAO_0000218
10779,3185,A,,Intermediate,CHEMBL618788,In vivo,,50597,,1,,N,Oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10780,5145,A,,Intermediate,CHEMBL618789,In vivo,,50597,,1,,N,Bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10781,3457,A,,Intermediate,CHEMBL618790,In vivo,,50597,,1,,N,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Rattus norvegicus,,,1,,BAO_0000218
10782,3457,A,,Intermediate,CHEMBL618791,In vivo,,50597,,1,,N,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Rattus norvegicus,,,1,,BAO_0000218
10783,5983,A,,Intermediate,CHEMBL875843,In vivo,,50597,,1,,N,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10784,5739,A,,Intermediate,CHEMBL618792,In vivo,,50597,,1,,N,Oral bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,,,1,,BAO_0000218
10785,3579,A,,Intermediate,CHEMBL623395,In vivo,,50597,,1,,N,Cmax at a dose of 30 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10786,17788,A,,Autocuration,CHEMBL623396,In vivo,,22224,,1,,U,Cmax in monkeys at a dose of 1 mg/kg,Simiiformes,,,0,,BAO_0000218
10787,14956,A,,Intermediate,CHEMBL623397,In vivo,,50597,,1,,N,Cmax in rat,Rattus norvegicus,,,1,,BAO_0000218
10788,17788,A,,Intermediate,CHEMBL623398,In vivo,,50597,,1,,N,Cmax in rats at a dose of 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
10789,9750,A,,Intermediate,CHEMBL623399,In vivo,,50594,,1,,N,Cmax was measured in mice after an oral dose of 50 mg/kg.,Mus musculus,,,1,,BAO_0000218
10790,12767,A,,Autocuration,CHEMBL623400,In vivo,,22224,,1,,U,"Cmax value at a dose of 12.7 uM/kg, po",,,,0,,BAO_0000218
10791,12767,A,,Autocuration,CHEMBL623401,In vivo,,22224,,1,,U,"Cmax value at a dose of 6.3 uM/kg, iv",,,,0,,BAO_0000218
10792,12767,A,,Autocuration,CHEMBL623402,In vivo,,22224,,1,,U,"Cmax value at a dose of 7.1 uM/kg, iv",,,,0,,BAO_0000218
10793,12703,A,,Autocuration,CHEMBL623403,In vivo,,22224,,1,,U,Cmax value of compound was determined after 1 hr,,,,0,,BAO_0000218
10794,15778,A,,Autocuration,CHEMBL623404,In vivo,,22224,,1,,U,Cmax value of the compound,,,,0,,BAO_0000218
10795,12818,A,,Intermediate,CHEMBL625997,In vivo,,50597,,1,,N,Cmax value administered intraintestinal in rats.,Rattus norvegicus,,,1,,BAO_0000218
10796,14964,A,,Intermediate,CHEMBL625998,In vivo,,50597,,1,,N,Cmax value administered perorally was determined in rat; Not determined,Rattus norvegicus,,,1,,BAO_0000218
10797,15808,A,,Autocuration,CHEMBL625999,In vivo,,22224,,1,,U,Cmax value at the dose of 2.3 mg/kg,,,,0,,BAO_0000218
10798,15808,A,,Autocuration,CHEMBL626000,In vivo,,22224,,1,,U,Cmax value at the dose of 5 mg/kg,,,,0,,BAO_0000218
10799,15778,A,,Autocuration,CHEMBL626001,In vivo,,22224,,1,,U,Cmax value in the period of 8 hr after dosing. ,,,,0,,BAO_0000218
10800,3715,A,,Autocuration,CHEMBL626002,In vivo,,22224,,1,,U,Cmax value at a oral dose of 20 mg/kg; Not tested,,,,0,,BAO_0000218
10801,3715,A,,Autocuration,CHEMBL626003,In vivo,,22224,,1,,U,Cmax value at a oral dose of 20 mg/kg,,,,0,,BAO_0000218
10802,1446,A,,Intermediate,CHEMBL626004,In vivo,,50597,,1,,N,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,,,1,,BAO_0000218
10803,15240,A,,Intermediate,CHEMBL626005,In vivo,,50512,,1,,N,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,1,,BAO_0000218
10804,15240,A,,Intermediate,CHEMBL626006,In vivo,,50597,,1,,N,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,,,1,,BAO_0000218
10805,14810,A,,Intermediate,CHEMBL626007,In vivo,1969.0,50597,,1,,N,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Rattus norvegicus,,Plasma,1,,BAO_0000218
10806,14239,A,,Intermediate,CHEMBL626008,In vivo,1969.0,50594,,1,,N,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Mus musculus,,Plasma,1,,BAO_0000218
10807,12555,A,,Intermediate,CHEMBL626009,In vivo,2107.0,50588,,1,,N,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Canis lupus familiaris,,Liver,1,,BAO_0000218
10808,10754,A,,Intermediate,CHEMBL626010,In vivo,,50588,,1,,N,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Canis lupus familiaris,,,1,,BAO_0000218
10809,10754,A,,Intermediate,CHEMBL626011,In vivo,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Mus musculus,,Blood,1,,BAO_0000218
10810,10754,A,,Intermediate,CHEMBL626012,In vivo,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Mus musculus,,Blood,1,,BAO_0000218
10811,10754,A,,Intermediate,CHEMBL626013,In vivo,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Mus musculus,,Blood,1,,BAO_0000218
10812,10754,A,,Intermediate,CHEMBL626014,In vivo,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Mus musculus,,Blood,1,,BAO_0000218
10813,10754,A,,Intermediate,CHEMBL877496,In vivo,178.0,50594,,1,,N,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Mus musculus,,Blood,1,,BAO_0000218
10814,14600,F,,Intermediate,CHEMBL626015,In vivo,,50588,,1,,N,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
10815,14600,F,,Intermediate,CHEMBL626016,In vivo,,50588,,1,,N,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
10816,14600,F,,Intermediate,CHEMBL626017,In vivo,,50588,,1,,N,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
10817,13543,A,,Intermediate,CHEMBL626018,In vivo,1969.0,50588,,1,,N,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,,Plasma,1,,BAO_0000218
10818,13543,A,,Intermediate,CHEMBL626692,In vivo,1969.0,50588,,1,,N,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,,Plasma,1,,BAO_0000218
10819,13543,A,,Intermediate,CHEMBL626693,In vivo,1969.0,50597,,1,,N,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
10820,13543,A,,Autocuration,CHEMBL626694,In vivo,1969.0,22224,,1,,U,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,,Plasma,0,,BAO_0000218
10821,14600,A,,Intermediate,CHEMBL626695,In vivo,178.0,50588,,1,,N,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,Blood,1,,BAO_0000218
10822,14600,A,,Intermediate,CHEMBL626696,In vivo,178.0,50588,,1,,N,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,Blood,1,,BAO_0000218
10823,14600,A,,Intermediate,CHEMBL626697,In vivo,178.0,50588,,1,,N,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,Blood,1,,BAO_0000218
10824,14600,A,,Intermediate,CHEMBL626859,In vivo,178.0,50588,,1,,N,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Canis lupus familiaris,,Blood,1,,BAO_0000218
10825,14600,A,,Intermediate,CHEMBL626860,In vivo,178.0,50588,,1,,N,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,Blood,1,,BAO_0000218
10826,14600,A,,Intermediate,CHEMBL626861,In vivo,178.0,50588,,1,,N,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,,Blood,1,,BAO_0000218
10827,14681,A,,Intermediate,CHEMBL626296,In vivo,,50597,,1,,N,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,,,1,,BAO_0000218
10828,15905,A,,Autocuration,CHEMBL626297,In vivo,,22224,,1,,U,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,,0,,BAO_0000218
10829,15905,A,,Autocuration,CHEMBL626298,In vivo,1969.0,22224,,1,,U,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,Plasma,0,,BAO_0000218
10830,13304,A,,Intermediate,CHEMBL626299,In vivo,1969.0,50597,,1,,N,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Rattus norvegicus,,Plasma,1,,BAO_0000218
10831,15137,A,,Intermediate,CHEMBL626300,In vivo,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10832,15137,A,,Intermediate,CHEMBL626301,In vivo,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10833,15137,A,,Intermediate,CHEMBL626962,In vivo,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10834,15137,A,,Intermediate,CHEMBL626963,In vivo,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10835,15137,A,,Intermediate,CHEMBL626964,In vivo,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
10836,14839,A,,Intermediate,CHEMBL626965,In vivo,1969.0,100710,,1,,N,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Macaca fascicularis,,Plasma,1,,BAO_0000218
10837,14839,A,,Intermediate,CHEMBL626966,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10838,14839,A,,Intermediate,CHEMBL626967,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10839,14839,A,,Intermediate,CHEMBL626968,In vivo,1969.0,100710,,1,,N,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Macaca fascicularis,,Plasma,1,,BAO_0000218
10840,8418,A,,Intermediate,CHEMBL626969,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Rattus norvegicus,,Heart,1,,BAO_0000218
10841,8418,A,,Intermediate,CHEMBL627126,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Rattus norvegicus,,Heart,1,,BAO_0000218
10842,8418,A,,Intermediate,CHEMBL631276,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Rattus norvegicus,,Heart,1,,BAO_0000218
10843,8418,A,,Intermediate,CHEMBL631277,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Rattus norvegicus,,Heart,1,,BAO_0000218
10844,8418,A,,Intermediate,CHEMBL631278,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Rattus norvegicus,,Heart,1,,BAO_0000218
10845,8418,A,,Intermediate,CHEMBL874457,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Rattus norvegicus,,Heart,1,,BAO_0000218
10846,8418,A,,Intermediate,CHEMBL631279,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Rattus norvegicus,,Heart,1,,BAO_0000218
10847,8418,A,,Intermediate,CHEMBL631280,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Rattus norvegicus,,Heart,1,,BAO_0000218
10848,8418,A,,Intermediate,CHEMBL631281,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Rattus norvegicus,,Heart,1,,BAO_0000218
10849,8418,A,,Intermediate,CHEMBL631968,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Rattus norvegicus,,Heart,1,,BAO_0000218
10850,8418,A,,Intermediate,CHEMBL631969,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Rattus norvegicus,,Heart,1,,BAO_0000218
10851,8418,A,,Intermediate,CHEMBL631970,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Rattus norvegicus,,Heart,1,,BAO_0000218
10852,8418,A,,Intermediate,CHEMBL631971,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Rattus norvegicus,,Heart,1,,BAO_0000218
10853,8418,A,,Intermediate,CHEMBL631972,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Rattus norvegicus,,Heart,1,,BAO_0000218
10854,8418,A,,Intermediate,CHEMBL630435,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Rattus norvegicus,,Heart,1,,BAO_0000218
10855,8418,A,,Intermediate,CHEMBL630436,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Rattus norvegicus,,Heart,1,,BAO_0000218
10856,8418,A,,Intermediate,CHEMBL630437,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Rattus norvegicus,,Heart,1,,BAO_0000218
10857,8418,A,,Intermediate,CHEMBL630438,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Rattus norvegicus,,Heart,1,,BAO_0000218
10858,8418,A,,Intermediate,CHEMBL630439,,948.0,50597,,1,,N,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Rattus norvegicus,,Heart,1,,BAO_0000218
10859,8418,A,,Intermediate,CHEMBL630440,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Rattus norvegicus,,Kidney,1,,BAO_0000218
10860,8418,A,,Intermediate,CHEMBL630441,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Rattus norvegicus,,Kidney,1,,BAO_0000218
10861,8418,A,,Intermediate,CHEMBL630442,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Rattus norvegicus,,Kidney,1,,BAO_0000218
10862,8418,A,,Intermediate,CHEMBL625234,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Rattus norvegicus,,Kidney,1,,BAO_0000218
10863,8418,A,,Intermediate,CHEMBL625235,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Rattus norvegicus,,Kidney,1,,BAO_0000218
10864,8418,A,,Intermediate,CHEMBL625236,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Rattus norvegicus,,Kidney,1,,BAO_0000218
10865,8418,A,,Intermediate,CHEMBL625237,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Rattus norvegicus,,Kidney,1,,BAO_0000218
10866,8418,A,,Intermediate,CHEMBL626125,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Rattus norvegicus,,Kidney,1,,BAO_0000218
10867,8418,A,,Intermediate,CHEMBL626126,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Rattus norvegicus,,Kidney,1,,BAO_0000218
10868,8418,A,,Intermediate,CHEMBL626127,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Rattus norvegicus,,Kidney,1,,BAO_0000218
10869,8418,A,,Intermediate,CHEMBL626128,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Rattus norvegicus,,Kidney,1,,BAO_0000218
10870,8418,A,,Intermediate,CHEMBL626129,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Rattus norvegicus,,Kidney,1,,BAO_0000218
10871,8418,A,,Intermediate,CHEMBL626130,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Rattus norvegicus,,Kidney,1,,BAO_0000218
10872,8418,A,,Intermediate,CHEMBL626131,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Rattus norvegicus,,Kidney,1,,BAO_0000218
10873,8418,A,,Intermediate,CHEMBL626132,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Rattus norvegicus,,Kidney,1,,BAO_0000218
10874,8418,A,,Intermediate,CHEMBL626752,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Rattus norvegicus,,Kidney,1,,BAO_0000218
10875,8418,A,,Intermediate,CHEMBL626753,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Rattus norvegicus,,Kidney,1,,BAO_0000218
10876,8418,A,,Intermediate,CHEMBL626754,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Rattus norvegicus,,Kidney,1,,BAO_0000218
10877,8418,A,,Intermediate,CHEMBL626755,,2113.0,50597,,1,,N,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Rattus norvegicus,,Kidney,1,,BAO_0000218
10878,8418,A,,Intermediate,CHEMBL626756,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Rattus norvegicus,,Liver,1,,BAO_0000218
10879,8418,A,,Intermediate,CHEMBL626757,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Rattus norvegicus,,Liver,1,,BAO_0000218
10880,8418,A,,Intermediate,CHEMBL626758,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Rattus norvegicus,,Liver,1,,BAO_0000218
10881,8418,A,,Intermediate,CHEMBL626759,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Rattus norvegicus,,Liver,1,,BAO_0000218
10882,8418,A,,Intermediate,CHEMBL626760,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Rattus norvegicus,,Liver,1,,BAO_0000218
10883,6996,A,,Intermediate,CHEMBL626394,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10884,6996,A,,Intermediate,CHEMBL626395,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
10885,6996,A,,Intermediate,CHEMBL626396,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10886,6996,A,,Intermediate,CHEMBL626397,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10887,6996,A,,Intermediate,CHEMBL626398,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
10888,6996,A,,Intermediate,CHEMBL626399,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10889,6996,A,,Intermediate,CHEMBL874653,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
10890,6996,A,,Intermediate,CHEMBL626400,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10891,6996,A,,Intermediate,CHEMBL626401,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10892,6996,A,,Intermediate,CHEMBL626402,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
10893,6996,A,,Intermediate,CHEMBL626403,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
10894,6996,A,,Intermediate,CHEMBL626404,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10895,6996,A,,Intermediate,CHEMBL626405,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
10896,6996,A,,Intermediate,CHEMBL625529,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10897,6996,A,,Intermediate,CHEMBL625530,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10898,6996,A,,Intermediate,CHEMBL625531,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
10899,6996,A,,Intermediate,CHEMBL625532,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
10900,6996,A,,Intermediate,CHEMBL625533,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10901,6996,A,,Intermediate,CHEMBL875474,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
10902,6996,A,,Intermediate,CHEMBL625534,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10903,6996,A,,Intermediate,CHEMBL625535,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10904,6996,A,,Intermediate,CHEMBL625536,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
10905,6996,A,,Intermediate,CHEMBL625537,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
10906,6996,A,,Intermediate,CHEMBL625538,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10907,6996,A,,Intermediate,CHEMBL625539,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
10908,6996,A,,Intermediate,CHEMBL625540,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10909,6996,A,,Intermediate,CHEMBL625541,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10910,6996,A,,Intermediate,CHEMBL625542,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
10911,6996,A,,Intermediate,CHEMBL625543,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
10912,6996,A,,Intermediate,CHEMBL625544,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
10913,6996,A,,Intermediate,CHEMBL625545,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
10914,6996,A,,Intermediate,CHEMBL625546,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10915,6996,A,,Intermediate,CHEMBL625547,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
10916,6996,A,,Intermediate,CHEMBL625548,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10917,6996,A,,Intermediate,CHEMBL625549,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10918,6996,A,,Intermediate,CHEMBL625550,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10919,6996,A,,Intermediate,CHEMBL625551,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10920,6996,A,,Intermediate,CHEMBL875475,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10921,6996,A,,Intermediate,CHEMBL625552,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10922,6996,A,,Intermediate,CHEMBL625553,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10923,6996,A,,Intermediate,CHEMBL625554,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10924,6996,A,,Intermediate,CHEMBL625555,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
10925,6996,A,,Intermediate,CHEMBL625556,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10926,6996,A,,Intermediate,CHEMBL624986,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
10927,6996,A,,Intermediate,CHEMBL624987,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10928,6996,A,,Intermediate,CHEMBL624988,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
10929,9025,A,,Intermediate,CHEMBL624989,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Canis lupus familiaris,,Artery,1,,BAO_0000218
10930,9025,A,,Intermediate,CHEMBL624990,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Canis lupus familiaris,,Artery,1,,BAO_0000218
10931,9025,A,,Intermediate,CHEMBL874391,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Canis lupus familiaris,,Artery,1,,BAO_0000218
10932,9025,A,,Intermediate,CHEMBL624991,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Canis lupus familiaris,,Artery,1,,BAO_0000218
10933,9025,A,,Intermediate,CHEMBL624992,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Canis lupus familiaris,,Artery,1,,BAO_0000218
10934,9025,A,,Intermediate,CHEMBL624993,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Canis lupus familiaris,,Artery,1,,BAO_0000218
10935,9025,A,,Intermediate,CHEMBL624994,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Canis lupus familiaris,,Artery,1,,BAO_0000218
10936,9025,A,,Intermediate,CHEMBL624995,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Canis lupus familiaris,,Artery,1,,BAO_0000218
10937,9025,A,,Intermediate,CHEMBL624996,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Canis lupus familiaris,,Artery,1,,BAO_0000218
10938,9025,A,,Intermediate,CHEMBL624997,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Canis lupus familiaris,,Artery,1,,BAO_0000218
10939,9025,A,,Intermediate,CHEMBL624998,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Canis lupus familiaris,,Artery,1,,BAO_0000218
10940,9025,A,,Intermediate,CHEMBL624999,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Canis lupus familiaris,,Artery,1,,BAO_0000218
10941,9025,A,,Intermediate,CHEMBL882955,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Canis lupus familiaris,,Artery,1,,BAO_0000218
10942,9025,A,,Intermediate,CHEMBL625000,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Canis lupus familiaris,,Artery,1,,BAO_0000218
10943,9025,A,,Intermediate,CHEMBL625001,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Canis lupus familiaris,,Artery,1,,BAO_0000218
10944,9025,A,,Intermediate,CHEMBL625089,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Canis lupus familiaris,,Artery,1,,BAO_0000218
10945,9025,A,,Intermediate,CHEMBL625090,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Canis lupus familiaris,,Artery,1,,BAO_0000218
10946,9025,A,,Intermediate,CHEMBL625091,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Canis lupus familiaris,,Artery,1,,BAO_0000218
10947,9025,A,,Intermediate,CHEMBL625092,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Canis lupus familiaris,,Artery,1,,BAO_0000218
10948,9025,A,,Intermediate,CHEMBL625093,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Canis lupus familiaris,,Artery,1,,BAO_0000218
10949,9025,A,,Intermediate,CHEMBL625094,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Canis lupus familiaris,,Artery,1,,BAO_0000218
10950,9025,A,,Intermediate,CHEMBL625095,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Canis lupus familiaris,,Artery,1,,BAO_0000218
10951,2249,A,,Intermediate,CHEMBL625096,In vivo,,50588,,1,,N,Compound was evaluated for its bioavailability in the dogs,Canis lupus familiaris,,,1,,BAO_0000218
10952,2249,A,,Intermediate,CHEMBL625097,In vivo,,50597,,1,,N,Compound was evaluated for its bioavailability in the rats,Rattus norvegicus,,,1,,BAO_0000218
10953,17515,A,,Autocuration,CHEMBL882956,In vivo,,22224,,1,,U,Compound was evaluated for oral bioavailability,,,,0,,BAO_0000218
10954,14541,A,,Intermediate,CHEMBL625098,In vivo,,50597,,1,,N,Compound was evaluated for percentage of Oral bioavailability in rats,Rattus norvegicus,,,1,,BAO_0000218
10955,12797,A,,Autocuration,CHEMBL625099,In vivo,,22224,,1,,U,Bioavailability in guinea pig,Cavia porcellus,,,0,,BAO_0000218
10956,12797,A,,Intermediate,CHEMBL625100,In vivo,,50597,,1,,N,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10957,12797,A,,Intermediate,CHEMBL625101,In vivo,,50588,,1,,N,Compound was evaluated for the oral bioavailability in dog,Canis lupus familiaris,,,1,,BAO_0000218
10958,12797,A,,Intermediate,CHEMBL874396,In vivo,,50597,,1,,N,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10959,11727,F,,Autocuration,CHEMBL625102,In vivo,,22224,,1,,U,Bioavailability in dog (dosed i.v.),Canis lupus familiaris,,,0,,BAO_0000218
10960,13249,A,,Intermediate,CHEMBL625103,In vivo,,50588,,1,,N,Compound was tested for in vivo bioavailability in dog,Canis lupus familiaris,,,1,,BAO_0000218
10961,13249,A,,Intermediate,CHEMBL625104,In vivo,,100712,,1,,N,Compound was tested for in vivo bioavailability in hamsters,Cricetinae,,,1,,BAO_0000218
10962,13249,A,,Autocuration,CHEMBL625105,In vivo,,22224,,1,,U,Compound was tested for in vivo bioavailability in monkey,Simiiformes,,,0,,BAO_0000218
10963,13249,A,,Intermediate,CHEMBL625106,In vivo,,50597,,1,,N,Compound was tested for in vivo bioavailability in rat,Rattus norvegicus,,,1,,BAO_0000218
10964,9552,A,,Autocuration,CHEMBL625107,In vivo,,22224,,1,,U,Oral bioavailability in mouse,Mus musculus,,,0,,BAO_0000218
10965,9552,A,,Intermediate,CHEMBL625108,In vivo,,50594,,1,,N,Compound was tested for percent of oral bioavailability in mice; 56-74,Mus musculus,,,1,,BAO_0000218
10966,14839,A,,Autocuration,CHEMBL625109,In vivo,,22224,,1,,U,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Mus musculus,,,0,,BAO_0000218
10967,14839,A,,Autocuration,CHEMBL625110,In vivo,,22224,,1,,U,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Macaca fascicularis,,,0,,BAO_0000218
10968,14839,A,,Autocuration,CHEMBL625111,In vivo,,22224,,1,,U,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Macaca fascicularis,,,0,,BAO_0000218
10969,14839,A,,Intermediate,CHEMBL625112,In vivo,,50594,,1,,N,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Mus musculus,,,1,,BAO_0000218
10970,14839,A,,Intermediate,CHEMBL875334,In vivo,,50594,,1,,N,Oral bioavailability in nude mice,Mus musculus,,,1,,BAO_0000218
10971,11219,A,,Autocuration,CHEMBL628617,In vivo,,22224,,1,,U,Bioavailability in monkey (i.d. dosing),Primates,,,0,,BAO_0000218
10972,9552,A,,Autocuration,CHEMBL628618,In vivo,,22224,,1,,U,Bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
10973,11732,A,,Autocuration,CHEMBL628619,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,,0,,BAO_0000218
10974,11732,A,,Autocuration,CHEMBL628620,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,,0,,BAO_0000218
10975,14839,A,,Intermediate,CHEMBL628621,In vivo,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,1,,BAO_0000218
10976,14839,A,,Intermediate,CHEMBL628622,In vivo,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,1,,BAO_0000218
10977,14839,A,,Intermediate,CHEMBL628623,In vivo,,100710,,1,,N,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,,,1,,BAO_0000218
10978,14839,A,,Intermediate,CHEMBL628624,In vivo,1969.0,100710,,1,,N,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Macaca fascicularis,,Plasma,1,,BAO_0000218
10979,14839,A,,Intermediate,CHEMBL628625,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10980,14839,A,,Intermediate,CHEMBL628626,In vivo,1969.0,100710,,1,,N,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Macaca fascicularis,,Plasma,1,,BAO_0000218
10981,14839,A,,Intermediate,CHEMBL627041,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10982,14839,A,,Intermediate,CHEMBL627042,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10983,14839,A,,Intermediate,CHEMBL627043,In vivo,1969.0,50594,,1,,N,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,,Plasma,1,,BAO_0000218
10984,13932,A,,Autocuration,CHEMBL627044,In vivo,1969.0,22224,,1,,U,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,Plasma,0,,BAO_0000218
10985,11637,A,,Intermediate,CHEMBL627045,In vivo,1969.0,50594,,1,,N,Cmax in mouse plasma,Mus musculus,,Plasma,1,,BAO_0000218
10986,11637,A,,Autocuration,CHEMBL627046,In vivo,1969.0,22224,,1,,U,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,Plasma,0,,BAO_0000218
10987,13960,A,,Intermediate,CHEMBL627047,In vivo,1969.0,50597,,1,,N,Maximal plasma concentration in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10988,15905,A,,Intermediate,CHEMBL627048,In vivo,1969.0,50597,,1,,N,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
10989,14062,A,,Intermediate,CHEMBL627049,In vivo,,50597,,1,,N,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10990,14062,A,,Intermediate,CHEMBL627050,In vivo,,50597,,1,,N,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10991,14062,A,,Intermediate,CHEMBL627051,In vivo,,50597,,1,,N,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10992,14062,A,,Intermediate,CHEMBL627052,In vivo,,50597,,1,,N,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10993,14062,A,,Intermediate,CHEMBL627053,In vivo,,50597,,1,,N,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10994,14062,A,,Intermediate,CHEMBL627054,In vivo,,50597,,1,,N,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
10995,15011,A,,Intermediate,CHEMBL627055,In vivo,,50594,,1,,N,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
10996,15011,A,,Intermediate,CHEMBL627056,In vivo,,50594,,1,,N,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
10997,15011,A,,Intermediate,CHEMBL627057,In vivo,,50594,,1,,N,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,1,,BAO_0000218
10998,15011,A,,Intermediate,CHEMBL627058,In vivo,,50594,,1,,N,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
10999,15011,A,,Intermediate,CHEMBL626211,In vivo,,50594,,1,,N,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,,,1,,BAO_0000218
11000,10291,A,,Autocuration,CHEMBL626212,In vivo,,22224,,1,,U,Maximum Concentration of the compound.,,,,0,,BAO_0000218
11001,14599,A,,Intermediate,CHEMBL626213,In vivo,,50588,,1,,N,Maximum Concentration was measured after iv administration into Beagle dog,Canis lupus familiaris,,,1,,BAO_0000218
11002,14599,A,,Intermediate,CHEMBL626214,In vivo,,50588,,1,,N,Maximum Concentration was measured after iv administration into Beagle dog.,Canis lupus familiaris,,,1,,BAO_0000218
11003,14599,A,,Intermediate,CHEMBL626215,In vivo,,50588,,1,,N,Maximum Concentration was measured after po administration into Beagle dog,Canis lupus familiaris,,,1,,BAO_0000218
11004,14599,A,,Intermediate,CHEMBL626216,In vivo,,50588,,1,,N,Maximum Concentration was measured after po administration into Beagle dog.,Canis lupus familiaris,,,1,,BAO_0000218
11005,12767,A,,Autocuration,CHEMBL626217,In vivo,178.0,22224,,1,,U,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,Blood,0,,BAO_0000218
11006,12767,A,,Autocuration,CHEMBL626218,In vivo,178.0,22224,,1,,U,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,Blood,0,,BAO_0000218
11007,12767,A,,Autocuration,CHEMBL626219,In vivo,178.0,22224,,1,,U,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,Blood,0,,BAO_0000218
11008,12767,A,,Autocuration,CHEMBL626220,In vivo,178.0,22224,,1,,U,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,Blood,0,,BAO_0000218
11009,12767,A,,Autocuration,CHEMBL626221,In vivo,178.0,22224,,1,,U,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,Blood,0,,BAO_0000218
11010,12767,A,,Autocuration,CHEMBL626222,In vivo,178.0,22224,,1,,U,Maximum blood level reached at dose of 10.6 uM/kg orally,,,Blood,0,,BAO_0000218
11011,14706,A,,Intermediate,CHEMBL626223,In vivo,,50512,,1,,N,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Cavia porcellus,,,1,,BAO_0000218
11012,14706,A,,Intermediate,CHEMBL626224,In vivo,,50512,,1,,N,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Cavia porcellus,,,1,,BAO_0000218
11013,14793,A,,Intermediate,CHEMBL626225,In vivo,955.0,50597,,1,,N,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,Brain,1,,BAO_0000218
11014,14793,A,,Intermediate,CHEMBL626226,In vivo,955.0,50597,,1,,N,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,Brain,1,,BAO_0000218
11015,14793,A,,Intermediate,CHEMBL626227,In vivo,955.0,50597,,1,,N,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,,Brain,1,,BAO_0000218
11016,14793,A,,Intermediate,CHEMBL626228,In vivo,955.0,50597,,1,,N,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,,Brain,1,,BAO_0000218
11017,14793,A,,Intermediate,CHEMBL626229,In vivo,,50597,,1,,N,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11018,14793,A,,Intermediate,CHEMBL626921,In vivo,,50597,,1,,N,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11019,14793,A,,Intermediate,CHEMBL876793,In vivo,,50597,,1,,N,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11020,14793,A,,Intermediate,CHEMBL625309,In vivo,,50597,,1,,N,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11021,10524,A,,Intermediate,CHEMBL625310,In vivo,,50278,,1,,N,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Bacillus subtilis,,,1,,BAO_0000218
11022,11871,A,,Autocuration,CHEMBL625311,In vivo,,22224,,1,,U,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Simiiformes,,,0,,BAO_0000218
11023,11871,A,,Intermediate,CHEMBL625312,In vivo,,50597,,1,,N,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11024,3437,A,,Autocuration,CHEMBL625313,In vivo,,22224,,1,,U,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,,0,,BAO_0000218
11025,12038,A,,Intermediate,CHEMBL625314,In vivo,,50594,,1,,N,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Mus musculus,,,1,,BAO_0000218
11026,12038,A,,Intermediate,CHEMBL625315,In vivo,,50597,,1,,N,Maximum concentration in male rats after iv administration of 20 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11027,8418,A,,Intermediate,CHEMBL625316,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Rattus norvegicus,,Liver,1,,BAO_0000218
11028,8418,A,,Intermediate,CHEMBL625317,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Rattus norvegicus,,Liver,1,,BAO_0000218
11029,8418,A,,Intermediate,CHEMBL625318,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Rattus norvegicus,,Liver,1,,BAO_0000218
11030,8418,A,,Intermediate,CHEMBL625319,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Rattus norvegicus,,Liver,1,,BAO_0000218
11031,8418,A,,Intermediate,CHEMBL625320,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Rattus norvegicus,,Liver,1,,BAO_0000218
11032,8418,A,,Intermediate,CHEMBL625321,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Rattus norvegicus,,Liver,1,,BAO_0000218
11033,8418,A,,Intermediate,CHEMBL625322,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Rattus norvegicus,,Liver,1,,BAO_0000218
11034,8418,A,,Intermediate,CHEMBL876801,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Rattus norvegicus,,Liver,1,,BAO_0000218
11035,8418,A,,Intermediate,CHEMBL625323,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Rattus norvegicus,,Liver,1,,BAO_0000218
11036,8418,A,,Intermediate,CHEMBL625324,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Rattus norvegicus,,Liver,1,,BAO_0000218
11037,8418,A,,Intermediate,CHEMBL625325,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Rattus norvegicus,,Liver,1,,BAO_0000218
11038,8418,A,,Intermediate,CHEMBL625326,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Rattus norvegicus,,Liver,1,,BAO_0000218
11039,8418,A,,Intermediate,CHEMBL625327,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Rattus norvegicus,,Liver,1,,BAO_0000218
11040,8418,A,,Intermediate,CHEMBL625328,,2107.0,50597,,1,,N,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Rattus norvegicus,,Liver,1,,BAO_0000218
11041,8418,A,,Intermediate,CHEMBL625329,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Rattus norvegicus,,Lung,1,,BAO_0000218
11042,8418,A,,Intermediate,CHEMBL625330,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Rattus norvegicus,,Lung,1,,BAO_0000218
11043,8418,A,,Intermediate,CHEMBL627774,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Rattus norvegicus,,Lung,1,,BAO_0000218
11044,8418,A,,Intermediate,CHEMBL627775,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Rattus norvegicus,,Lung,1,,BAO_0000218
11045,8418,A,,Intermediate,CHEMBL627949,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Rattus norvegicus,,Lung,1,,BAO_0000218
11046,8418,A,,Intermediate,CHEMBL627950,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Rattus norvegicus,,Lung,1,,BAO_0000218
11047,8418,A,,Intermediate,CHEMBL627951,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Rattus norvegicus,,Lung,1,,BAO_0000218
11048,8418,A,,Intermediate,CHEMBL627952,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Rattus norvegicus,,Lung,1,,BAO_0000218
11049,8418,A,,Intermediate,CHEMBL627953,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Rattus norvegicus,,Lung,1,,BAO_0000218
11050,8418,A,,Intermediate,CHEMBL627954,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Rattus norvegicus,,Lung,1,,BAO_0000218
11051,8418,A,,Intermediate,CHEMBL627955,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Rattus norvegicus,,Lung,1,,BAO_0000218
11052,8418,A,,Intermediate,CHEMBL627956,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Rattus norvegicus,,Lung,1,,BAO_0000218
11053,8418,A,,Intermediate,CHEMBL876802,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Rattus norvegicus,,Lung,1,,BAO_0000218
11054,8418,A,,Intermediate,CHEMBL627957,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Rattus norvegicus,,Lung,1,,BAO_0000218
11055,8418,A,,Intermediate,CHEMBL627958,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Rattus norvegicus,,Lung,1,,BAO_0000218
11056,8418,A,,Intermediate,CHEMBL627959,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Rattus norvegicus,,Lung,1,,BAO_0000218
11057,8418,A,,Intermediate,CHEMBL627960,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Rattus norvegicus,,Lung,1,,BAO_0000218
11058,8418,A,,Intermediate,CHEMBL627961,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Rattus norvegicus,,Lung,1,,BAO_0000218
11059,8418,A,,Intermediate,CHEMBL627962,,2048.0,50597,,1,,N,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Rattus norvegicus,,Lung,1,,BAO_0000218
11060,9796,A,,Intermediate,CHEMBL627963,,,50597,,1,,N,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,,1,,BAO_0000218
11061,9796,A,,Intermediate,CHEMBL624759,,,50597,,1,,N,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,1,,BAO_0000218
11062,9796,A,,Intermediate,CHEMBL624760,,,50597,,1,,N,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,1,,BAO_0000218
11063,9796,A,,Intermediate,CHEMBL624761,,,50597,,1,,N,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,1,,BAO_0000218
11064,9796,A,,Intermediate,CHEMBL877607,,,50597,,1,,N,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,,1,,BAO_0000218
11065,9796,A,,Intermediate,CHEMBL624762,,2107.0,50597,,1,,N,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,Liver,1,,BAO_0000218
11066,9796,A,,Intermediate,CHEMBL624763,,2107.0,50597,,1,,N,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Liver,1,,BAO_0000218
11067,9796,A,,Intermediate,CHEMBL624764,,2107.0,50597,,1,,N,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Liver,1,,BAO_0000218
11068,9796,A,,Intermediate,CHEMBL624765,,2107.0,50597,,1,,N,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Liver,1,,BAO_0000218
11069,9796,A,,Intermediate,CHEMBL624766,,2107.0,50597,,1,,N,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Liver,1,,BAO_0000218
11070,6996,A,,Intermediate,CHEMBL624767,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11071,6996,A,,Intermediate,CHEMBL624768,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
11072,6996,A,,Intermediate,CHEMBL624769,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11073,6996,A,,Intermediate,CHEMBL624770,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11074,6996,A,,Intermediate,CHEMBL624771,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
11075,6996,A,,Intermediate,CHEMBL624772,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11076,6996,A,,Intermediate,CHEMBL624773,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
11077,6996,A,,Intermediate,CHEMBL624774,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11078,6996,A,,Intermediate,CHEMBL624775,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11079,6996,A,,Intermediate,CHEMBL624776,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
11080,6996,A,,Intermediate,CHEMBL624777,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
11081,6996,A,,Intermediate,CHEMBL624778,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11082,6996,A,,Intermediate,CHEMBL624779,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
11083,6996,A,,Intermediate,CHEMBL624780,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
11084,6996,A,,Intermediate,CHEMBL624781,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
11085,6996,A,,Intermediate,CHEMBL877608,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11086,6996,A,,Intermediate,CHEMBL624782,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11087,6996,A,,Intermediate,CHEMBL624783,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11088,6996,A,,Intermediate,CHEMBL624784,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
11089,6996,A,,Intermediate,CHEMBL624785,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11090,6996,A,,Intermediate,CHEMBL624786,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11091,6996,A,,Intermediate,CHEMBL624787,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
11092,6996,A,,Intermediate,CHEMBL628676,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11093,6996,A,,Intermediate,CHEMBL621842,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
11094,6996,A,,Intermediate,CHEMBL621843,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11095,6996,A,,Intermediate,CHEMBL623873,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11096,6996,A,,Intermediate,CHEMBL623874,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
11097,6996,A,,Intermediate,CHEMBL623875,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
11098,6996,A,,Intermediate,CHEMBL623876,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
11099,6996,A,,Intermediate,CHEMBL623877,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
11100,6996,A,,Intermediate,CHEMBL623878,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11101,6996,A,,Intermediate,CHEMBL623879,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
11102,6996,A,,Intermediate,CHEMBL623880,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11103,6996,A,,Intermediate,CHEMBL623881,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11104,6996,A,,Intermediate,CHEMBL623957,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11105,6996,A,,Intermediate,CHEMBL623958,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11106,6996,A,,Intermediate,CHEMBL623959,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11107,6996,A,,Intermediate,CHEMBL623960,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11108,6996,A,,Intermediate,CHEMBL623961,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11109,6996,A,,Intermediate,CHEMBL623962,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11110,6996,A,,Intermediate,CHEMBL624676,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
11111,6996,A,,Intermediate,CHEMBL624677,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11112,6996,A,,Intermediate,CHEMBL624678,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
11113,6996,A,,Intermediate,CHEMBL624679,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11114,6996,A,,Intermediate,CHEMBL624680,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11115,11732,A,,Autocuration,CHEMBL624849,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,,0,,BAO_0000218
11116,11732,A,,Autocuration,CHEMBL624850,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,,0,,BAO_0000218
11117,11732,A,,Autocuration,CHEMBL874399,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,,0,,BAO_0000218
11118,11732,A,,Autocuration,CHEMBL624851,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,,0,,BAO_0000218
11119,11732,A,,Autocuration,CHEMBL624852,In vivo,,22224,,1,,U,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,,0,,BAO_0000218
11120,13359,A,,Autocuration,CHEMBL624853,In vivo,,22224,,1,,U,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,,,0,,BAO_0000218
11121,16618,A,,Autocuration,CHEMBL624854,In vivo,,22224,,1,,U,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,,,0,,BAO_0000218
11122,13960,A,,Autocuration,CHEMBL624855,In vivo,,22224,,1,,U,Oral bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
11123,13917,A,,Autocuration,CHEMBL624856,In vivo,,22224,,1,,U,Oral bioavailability in rats was determined in vivo,Rattus norvegicus,,,0,,BAO_0000218
11124,14266,A,,Autocuration,CHEMBL882957,In vivo,,22224,,1,,U,Oral bioavailability in dog,Canis lupus familiaris,,,0,,BAO_0000218
11125,12359,A,,Autocuration,CHEMBL624857,In vivo,,22224,,1,,U,Oral bioavailability of compound in monkey,Simiiformes,,,0,,BAO_0000218
11126,12359,A,,Intermediate,CHEMBL622202,In vivo,,50597,,1,,N,Oral bioavailability of compound in rat,Rattus norvegicus,,,1,,BAO_0000218
11127,12359,A,,Autocuration,CHEMBL622203,In vivo,,22224,,1,,U,Bioavailability in rat of PMEA prodrug,Rattus norvegicus,,,0,,BAO_0000218
11128,12359,A,,Intermediate,CHEMBL625522,In vivo,,50597,,1,,N,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Rattus norvegicus,,,1,,BAO_0000218
11129,10791,A,,Autocuration,CHEMBL622868,In vivo,,22224,,1,,U,Serum conc at 3 hours following 25 mg/kg dose,Macaca mulatta,,,0,,BAO_0000218
11130,10791,A,,Autocuration,CHEMBL622869,In vivo,1088.0,22224,,1,,U,Urine conc 0-5 hours following 25 mg/kg dose,Macaca mulatta,,Urine,0,,BAO_0000218
11131,10791,A,,Autocuration,CHEMBL622870,In vivo,1088.0,22224,,1,,U,Urine conc 0-24 hours following 25 mg/kg dose,Macaca mulatta,,Urine,0,,BAO_0000218
11132,138,A,,Autocuration,CHEMBL622871,In vivo,,22224,,1,,U,Oral bioavailability in African green monkeys; 20-25,Chlorocebus aethiops,,,0,,BAO_0000218
11133,14521,A,,Intermediate,CHEMBL620560,In vivo,,100710,,1,,N,Oral bioavailability in cynomolgus monkey.,Macaca fascicularis,,,1,,BAO_0000218
11134,13953,A,,Autocuration,CHEMBL620561,In vivo,,22224,,1,,U,Oral bioavailability in dog,Canis lupus familiaris,,,0,,BAO_0000218
11135,12836,A,,Intermediate,CHEMBL620562,In vivo,,50588,,1,,N,Oral bioavailability in dog at 10 mg/kg oral dose,Canis lupus familiaris,,,1,,BAO_0000218
11136,12836,A,,Intermediate,CHEMBL620563,In vivo,,100712,,1,,N,Oral bioavailability in hamster at 10 mg/kg oral dose,Cricetinae,,,1,,BAO_0000218
11137,12836,A,,Intermediate,CHEMBL620564,In vivo,,50597,,1,,N,Oral bioavailability in rat at 10 mg/kg oral dose,Rattus norvegicus,,,1,,BAO_0000218
11138,14521,A,,Autocuration,CHEMBL872265,In vivo,,22224,,1,,U,Oral bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
11139,13953,A,,Autocuration,CHEMBL620565,In vivo,,22224,,1,,U,Oral bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
11140,6799,A,,Autocuration,CHEMBL620566,In vivo,,22224,,1,,U,Oral bioavailability,Eutheria,,,0,,BAO_0000218
11141,11311,A,,Autocuration,CHEMBL620567,In vivo,,22224,,1,,U,Oral bioavailability was determined; range 49-102%,,,,0,,BAO_0000218
11142,4013,A,,Intermediate,CHEMBL620568,In vivo,,50588,,1,,N,Oral bioavailability was determined in dogs,Canis lupus familiaris,,,1,,BAO_0000218
11143,4013,A,,Autocuration,CHEMBL620569,In vivo,,22224,,1,,U,Oral bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
11144,17591,A,,Autocuration,CHEMBL620570,In vivo,,22224,,1,,U,Oral bioavailability,Eutheria,,,0,,BAO_0000218
11145,17591,A,,Autocuration,CHEMBL620571,In vivo,,22224,,1,,U,Oral bioavailability was determined; Not orally available,,,,0,,BAO_0000218
11146,15011,A,,Intermediate,CHEMBL620572,In vivo,,50594,,1,,N,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,,,1,,BAO_0000218
11147,15011,A,,Autocuration,CHEMBL620573,In vivo,,22224,,1,,U,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Mus musculus,,,0,,BAO_0000218
11148,15011,A,,Autocuration,CHEMBL620574,In vivo,,22224,,1,,U,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Mus musculus,,,0,,BAO_0000218
11149,9552,A,,Autocuration,CHEMBL620575,In vivo,,22224,,1,,U,Oral bioavailability in Rhesus monkey,Macaca mulatta,,,0,,BAO_0000218
11150,9552,A,,Autocuration,CHEMBL620576,In vivo,,22224,,1,,U,Oral bioavailability in dog (female mongrel),Canis lupus familiaris,,,0,,BAO_0000218
11151,3639,A,,Autocuration,CHEMBL875846,In vivo,,22224,,1,,U,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,,0,,BAO_0000218
11152,13397,A,,Autocuration,CHEMBL620577,In vivo,,22224,,1,,U,Oral bioavailability in dog,Canis lupus familiaris,,,0,,BAO_0000218
11153,3031,A,,Autocuration,CHEMBL620578,In vivo,,22224,,1,,U,Percentage Bioavailability was evaluated.,,,,0,,BAO_0000218
11154,12818,A,,Autocuration,CHEMBL620579,In vivo,,22224,,1,,U,Bioavailability in rat administered i.d.,Rattus norvegicus,,,0,,BAO_0000218
11155,4847,A,,Autocuration,CHEMBL621248,In vivo,,22224,,1,,U,Bioavailability,Eutheria,,,0,,BAO_0000218
11156,12421,A,,Autocuration,CHEMBL625390,In vivo,,22224,,1,,U,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,,,0,,BAO_0000218
11157,11966,A,,Autocuration,CHEMBL625391,In vivo,,22224,,1,,U,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Rattus norvegicus,,,0,,BAO_0000218
11158,11218,A,,Autocuration,CHEMBL872266,In vivo,,22224,,1,,U,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Primates,,,0,,BAO_0000218
11159,13129,A,,Autocuration,CHEMBL625392,In vivo,,22224,,1,,U,Oral bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,,,0,,BAO_0000218
11160,12350,A,,Intermediate,CHEMBL625393,In vivo,,50597,,1,,N,The oral bioavailability was measured on rats after oral administration,Rattus norvegicus,,,1,,BAO_0000218
11161,2231,A,,Intermediate,CHEMBL625394,In vivo,,50597,,1,,N,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11162,2231,A,,Intermediate,CHEMBL625395,In vivo,,50797,,1,,N,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,,,1,,BAO_0000218
11163,12187,A,,Autocuration,CHEMBL625396,In vivo,,22224,,1,,U,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,,,0,,BAO_0000218
11164,12421,A,,Autocuration,CHEMBL625397,In vivo,,22224,,1,,U,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,,,0,,BAO_0000218
11165,13256,A,,Intermediate,CHEMBL625398,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11166,13256,A,,Intermediate,CHEMBL625399,In vivo,178.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Blood,1,,BAO_0000218
11167,13256,A,,Intermediate,CHEMBL626074,In vivo,2037.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Cerebellum,1,,BAO_0000218
11168,13256,A,,Intermediate,CHEMBL626075,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11169,2231,A,,Intermediate,CHEMBL626076,In vivo,1969.0,50597,,1,,N,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11170,2231,A,,Intermediate,CHEMBL626077,In vivo,1969.0,50797,,1,,N,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,,Plasma,1,,BAO_0000218
11171,12178,A,,Intermediate,CHEMBL626078,In vivo,178.0,50597,,1,,N,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Rattus norvegicus,,Blood,1,,BAO_0000218
11172,12178,A,,Autocuration,CHEMBL625846,In vivo,178.0,22224,,1,,U,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,Blood,0,,BAO_0000218
11173,12178,A,,Autocuration,CHEMBL625847,In vivo,178.0,22224,,1,,U,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,Blood,0,,BAO_0000218
11174,15633,A,,Expert,CHEMBL625848,In vivo,,50597,,1,,N,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11175,14258,A,,Intermediate,CHEMBL625849,In vivo,1969.0,50597,,1,,N,Maximum concentration of compound in plasma administered orally to rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
11176,14224,A,,Intermediate,CHEMBL626023,In vivo,1969.0,50588,,1,,N,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Canis lupus familiaris,,Plasma,1,,BAO_0000218
11177,14224,A,,Intermediate,CHEMBL626024,In vivo,1969.0,50588,,1,,N,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Canis lupus familiaris,,Plasma,1,,BAO_0000218
11178,14224,A,,Intermediate,CHEMBL626025,In vivo,1969.0,50588,,1,,N,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Canis lupus familiaris,,Plasma,1,,BAO_0000218
11179,5566,A,,Autocuration,CHEMBL626026,In vivo,,22224,,1,,U,Maximum concentration after 10 mg/kg by oral administration,,,,0,,BAO_0000218
11180,16935,A,,Autocuration,CHEMBL626027,In vivo,,22224,,1,,U,Maximum concentration at a dose of 1.5 mg/kg,,,,0,,BAO_0000218
11181,16935,A,,Autocuration,CHEMBL626028,In vivo,,22224,,1,,U,Maximum concentration at a dose of 2.0 mg/kg,,,,0,,BAO_0000218
11182,14224,A,,Intermediate,CHEMBL626029,In vivo,1969.0,50588,,1,,N,Maximum concentration in dog plasma,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11183,12536,A,,Autocuration,CHEMBL626030,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,Plasma,0,,BAO_0000218
11184,12536,A,,Autocuration,CHEMBL626031,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,Plasma,0,,BAO_0000218
11185,12536,A,,Autocuration,CHEMBL626032,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,Plasma,0,,BAO_0000218
11186,12536,A,,Autocuration,CHEMBL626033,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,Plasma,0,,BAO_0000218
11187,12536,A,,Autocuration,CHEMBL626034,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,Plasma,0,,BAO_0000218
11188,9994,A,,Intermediate,CHEMBL626035,In vivo,1969.0,50588,,1,,N,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,,Plasma,1,,BAO_0000218
11189,1434,A,,Autocuration,CHEMBL626036,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma at Tmax,,,Plasma,0,,BAO_0000218
11190,12836,A,,Expert,CHEMBL626037,In vivo,1969.0,50588,,1,,N,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11191,12836,A,,Intermediate,CHEMBL626038,In vivo,1969.0,100712,,1,,N,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Cricetinae,,Plasma,1,,BAO_0000218
11192,12836,A,,Intermediate,CHEMBL626039,In vivo,1969.0,50597,,1,,N,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11193,12545,A,,Intermediate,CHEMBL626040,In vivo,1969.0,50597,,1,,N,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11194,13856,A,,Intermediate,CHEMBL626041,In vivo,1969.0,50592,,1,,N,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Oryctolagus cuniculus,,Plasma,1,,BAO_0000218
11195,3550,A,,Autocuration,CHEMBL626042,In vivo,,22224,,1,,U,Maximum concentration was calculated,,,,0,,BAO_0000218
11196,2632,A,,Autocuration,CHEMBL626043,In vivo,,22224,,1,,U,Maximum concentration was calculated.,,,,0,,BAO_0000218
11197,5566,A,,Autocuration,CHEMBL626044,In vivo,,22224,,1,,U,Maximum concentration at a peroral dose of 10 mg/kg,,,,0,,BAO_0000218
11198,11883,A,,Autocuration,CHEMBL626045,In vivo,,22224,,1,,U,Maximum concentration of the drug at 10 uM/dg administered perorally,,,,0,,BAO_0000218
11199,11883,A,,Autocuration,CHEMBL626046,In vivo,,22224,,1,,U,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,,0,,BAO_0000218
11200,14122,A,,Intermediate,CHEMBL626047,In vivo,1969.0,50588,,1,,N,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Canis lupus familiaris,,Plasma,1,,BAO_0000218
11201,14122,A,,Intermediate,CHEMBL626048,In vivo,1969.0,100712,,1,,N,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Cricetinae,,Plasma,1,,BAO_0000218
11202,14122,A,,Intermediate,CHEMBL626049,In vivo,1969.0,50597,,1,,N,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Rattus norvegicus,,Plasma,1,,BAO_0000218
11203,12542,A,,Intermediate,CHEMBL626050,In vivo,1969.0,50597,,1,,N,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11204,12542,A,,Intermediate,CHEMBL874541,In vivo,1969.0,50588,,1,,N,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11205,12542,A,,Intermediate,CHEMBL622826,In vivo,1969.0,100712,,1,,N,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Cricetinae,,Plasma,1,,BAO_0000218
11206,12542,A,,Intermediate,CHEMBL622827,In vivo,1969.0,100712,,1,,N,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Cricetinae,,Plasma,1,,BAO_0000218
11207,12542,A,,Intermediate,CHEMBL622828,In vivo,1969.0,50597,,1,,N,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11208,14080,A,,Intermediate,CHEMBL622829,In vivo,1969.0,50597,,1,,N,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Rattus norvegicus,,Plasma,1,,BAO_0000218
11209,11911,A,,Intermediate,CHEMBL876806,In vivo,,50597,,1,,N,Maximum concentration reached following intravenous administration in male rat,Rattus norvegicus,,,1,,BAO_0000218
11210,13204,A,,Intermediate,CHEMBL622830,In vivo,,50588,,1,,N,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Canis lupus familiaris,,,1,,BAO_0000218
11211,13204,A,,Intermediate,CHEMBL622831,In vivo,,50597,,1,,N,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Rattus norvegicus,,,1,,BAO_0000218
11212,14346,A,,Intermediate,CHEMBL626794,In vivo,,50588,,1,,N,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
11213,14346,A,,Intermediate,CHEMBL626795,In vivo,,50597,,1,,N,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
11214,14346,A,,Intermediate,CHEMBL626796,In vivo,,50597,,1,,N,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
11215,14346,A,,Intermediate,CHEMBL626797,In vivo,,50597,,1,,N,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
11216,14127,A,,Intermediate,CHEMBL626798,In vivo,,50597,,1,,N,Maximum drug concentration is determined after oral dosing in rats.,Rattus norvegicus,,,1,,BAO_0000218
11217,14339,A,,Intermediate,CHEMBL626799,In vivo,,50588,,1,,N,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,,,1,,BAO_0000218
11218,14339,A,,Intermediate,CHEMBL626800,In vivo,,50588,,1,,N,Maximum observed concentration in oral (5 mg/kg) fed dogs,Canis lupus familiaris,,,1,,BAO_0000218
11219,13494,A,,Autocuration,CHEMBL626801,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration,,,Plasma,0,,BAO_0000218
11220,14925,A,,Intermediate,CHEMBL876816,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Rattus norvegicus,,Plasma,1,,BAO_0000218
11221,14474,A,,Intermediate,CHEMBL626802,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
11222,14474,A,,Intermediate,CHEMBL626803,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11223,13917,A,,Autocuration,CHEMBL626804,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration following oral administration of 30 umol/kg,,,Plasma,0,,BAO_0000218
11224,9796,A,,Intermediate,CHEMBL626805,,1969.0,50597,,1,,N,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11225,9796,A,,Intermediate,CHEMBL626309,,1969.0,50597,,1,,N,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11226,9796,A,,Intermediate,CHEMBL626310,,1969.0,50597,,1,,N,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11227,9796,A,,Intermediate,CHEMBL626311,,1969.0,50597,,1,,N,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11228,9796,A,,Intermediate,CHEMBL626312,,1969.0,50597,,1,,N,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11229,9796,A,,Intermediate,CHEMBL626313,,995.0,50597,,1,,N,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Uterus,1,,BAO_0000218
11230,9796,A,,Intermediate,CHEMBL626314,,995.0,50597,,1,,N,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,,Uterus,1,,BAO_0000218
11231,9796,A,,Intermediate,CHEMBL626315,,995.0,50597,,1,,N,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Uterus,1,,BAO_0000218
11232,9796,A,,Intermediate,CHEMBL626316,,995.0,50597,,1,,N,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Uterus,1,,BAO_0000218
11233,9796,A,,Intermediate,CHEMBL626317,,995.0,50597,,1,,N,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,,Uterus,1,,BAO_0000218
11234,8363,A,,Intermediate,CHEMBL626318,,,50597,,1,,N,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11235,8363,A,,Intermediate,CHEMBL626319,,,50597,,1,,N,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11236,8363,A,,Intermediate,CHEMBL626320,,,50597,,1,,N,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11237,8363,A,,Intermediate,CHEMBL875053,,,50597,,1,,N,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11238,8363,A,,Intermediate,CHEMBL626321,,,50597,,1,,N,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11239,8363,A,,Intermediate,CHEMBL626322,,,50597,,1,,N,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11240,8363,A,,Intermediate,CHEMBL626323,,,50597,,1,,N,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11241,8363,A,,Intermediate,CHEMBL626324,,,50597,,1,,N,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11242,8363,A,,Intermediate,CHEMBL626325,,,50597,,1,,N,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11243,8363,A,,Intermediate,CHEMBL626326,,,50597,,1,,N,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11244,8363,A,,Intermediate,CHEMBL626327,,,50597,,1,,N,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,,,1,,BAO_0000218
11245,8363,A,,Intermediate,CHEMBL626328,,,50597,,1,,N,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,,,1,,BAO_0000218
11246,8684,A,,Intermediate,CHEMBL626329,,178.0,50597,,1,,N,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11247,8684,A,,Intermediate,CHEMBL626330,,178.0,50597,,1,,N,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11248,8684,A,,Intermediate,CHEMBL626331,,178.0,50597,,1,,N,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11249,8684,A,,Intermediate,CHEMBL626332,,178.0,50597,,1,,N,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11250,8684,A,,Intermediate,CHEMBL626333,,178.0,50597,,1,,N,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11251,8684,A,,Intermediate,CHEMBL626334,,178.0,50597,,1,,N,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11252,8684,A,,Intermediate,CHEMBL626335,,178.0,50597,,1,,N,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11253,8684,A,,Intermediate,CHEMBL624798,,178.0,50597,,1,,N,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Blood,1,,BAO_0000218
11254,8684,A,,Intermediate,CHEMBL624799,,955.0,50597,,1,,N,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11255,8684,A,,Intermediate,CHEMBL624800,,955.0,50597,,1,,N,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11256,8684,A,,Intermediate,CHEMBL624801,,955.0,50597,,1,,N,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11257,8684,A,,Intermediate,CHEMBL624802,,955.0,50597,,1,,N,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11258,8684,A,,Intermediate,CHEMBL624803,,955.0,50597,,1,,N,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11259,8684,A,,Intermediate,CHEMBL624804,,955.0,50597,,1,,N,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11260,8684,A,,Intermediate,CHEMBL624805,,955.0,50597,,1,,N,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11261,8684,A,,Intermediate,CHEMBL624806,,955.0,50597,,1,,N,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Rattus norvegicus,,Brain,1,,BAO_0000218
11262,8684,A,,Intermediate,CHEMBL624807,,,50597,,1,,N,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11263,8684,A,,Intermediate,CHEMBL624808,,,50597,,1,,N,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11264,8684,A,,Intermediate,CHEMBL624809,,,50597,,1,,N,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11265,8684,A,,Intermediate,CHEMBL624810,,,50597,,1,,N,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11266,8684,A,,Intermediate,CHEMBL877618,,,50597,,1,,N,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11267,8684,A,,Intermediate,CHEMBL624811,,,50597,,1,,N,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11268,8684,A,,Intermediate,CHEMBL624812,,,50597,,1,,N,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11269,8684,A,,Intermediate,CHEMBL624813,,,50597,,1,,N,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11270,8684,A,,Intermediate,CHEMBL624814,,,50597,,1,,N,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11271,8684,A,,Intermediate,CHEMBL624815,,,50597,,1,,N,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11272,8684,A,,Intermediate,CHEMBL624816,,,50597,,1,,N,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11273,8684,A,,Intermediate,CHEMBL624817,,,50597,,1,,N,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11274,6996,A,,Intermediate,CHEMBL624818,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11275,6996,A,,Intermediate,CHEMBL624819,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
11276,6996,A,,Intermediate,CHEMBL624820,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11277,6996,A,,Intermediate,CHEMBL624821,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11278,6996,A,,Intermediate,CHEMBL624822,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
11279,6996,A,,Intermediate,CHEMBL624823,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
11280,15599,A,,Intermediate,CHEMBL624824,,,50212,,1,,N,Observed diffusion coefficient in organic solvent for Escherichia coli,Escherichia coli,,,1,,BAO_0000218
11281,9614,A,,Intermediate,CHEMBL624825,,178.0,50597,,1,,N,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,Blood,1,,BAO_0000218
11282,9614,A,,Intermediate,CHEMBL624826,,178.0,50597,,1,,N,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11283,9614,A,,Intermediate,CHEMBL876817,,2081.0,50597,,1,,N,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,Cardiac atrium,1,,BAO_0000218
11284,9614,A,,Intermediate,CHEMBL624827,,2081.0,50597,,1,,N,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,Cardiac atrium,1,,BAO_0000218
11285,9614,A,,Intermediate,CHEMBL624828,,,50597,,1,,N,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,1,,BAO_0000218
11286,9614,A,,Intermediate,CHEMBL624829,,,50597,,1,,N,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,1,,BAO_0000218
11287,9614,A,,Intermediate,CHEMBL624830,,2107.0,50597,,1,,N,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,Liver,1,,BAO_0000218
11288,9614,A,,Intermediate,CHEMBL624831,,2107.0,50597,,1,,N,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
11289,9614,A,,Intermediate,CHEMBL624832,,2081.0,50597,,1,,N,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,Cardiac atrium,1,,BAO_0000218
11290,9614,A,,Intermediate,CHEMBL624833,,2081.0,50597,,1,,N,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,Cardiac atrium,1,,BAO_0000218
11291,9614,A,,Intermediate,CHEMBL624834,,,50597,,1,,N,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,,1,,BAO_0000218
11292,9614,A,,Intermediate,CHEMBL624835,,,50597,,1,,N,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,,1,,BAO_0000218
11293,9614,A,,Intermediate,CHEMBL624836,,2106.0,50597,,1,,N,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,,Spleen,1,,BAO_0000218
11294,9614,A,,Intermediate,CHEMBL624837,,2106.0,50597,,1,,N,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,,Spleen,1,,BAO_0000218
11295,9071,A,,Intermediate,CHEMBL624838,,178.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Blood,1,,BAO_0000218
11296,9071,A,,Intermediate,CHEMBL622188,,178.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Rattus norvegicus,,Blood,1,,BAO_0000218
11297,9071,A,,Intermediate,CHEMBL622189,,948.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Heart,1,,BAO_0000218
11298,9071,A,,Intermediate,CHEMBL622190,,948.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Rattus norvegicus,,Heart,1,,BAO_0000218
11299,9071,A,,Intermediate,CHEMBL625170,,948.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Rattus norvegicus,,Heart,1,,BAO_0000218
11300,9071,A,,Intermediate,CHEMBL625171,,2113.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
11301,9071,A,,Intermediate,CHEMBL625172,,2113.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
11302,9071,A,,Intermediate,CHEMBL625173,,2113.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Rattus norvegicus,,Kidney,1,,BAO_0000218
11303,9071,A,,Intermediate,CHEMBL625174,,2107.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11304,9071,A,,Intermediate,CHEMBL625175,,2107.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11305,9071,A,,Intermediate,CHEMBL625176,,2107.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Rattus norvegicus,,Liver,1,,BAO_0000218
11306,9071,A,,Intermediate,CHEMBL625177,,2048.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11307,9071,A,,Intermediate,CHEMBL625178,,2048.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11308,9071,A,,Intermediate,CHEMBL625179,,2048.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Rattus norvegicus,,Lung,1,,BAO_0000218
11309,9071,A,,Intermediate,CHEMBL625180,,2048.0,50597,,1,,N,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11310,10677,A,,Autocuration,CHEMBL625181,,,22224,,1,,U,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,,0,,BAO_0000218
11311,9750,A,,Intermediate,CHEMBL625182,,1088.0,50594,,1,,N,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Mus musculus,,Urine,1,,BAO_0000218
11312,8319,A,,Intermediate,CHEMBL625183,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11313,8319,A,,Intermediate,CHEMBL875848,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11314,8319,A,,Intermediate,CHEMBL622260,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11315,8319,A,,Intermediate,CHEMBL622261,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11316,8319,A,,Intermediate,CHEMBL622262,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11317,8319,A,,Intermediate,CHEMBL622263,,2113.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11318,8319,A,,Intermediate,CHEMBL622418,,2113.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11319,8319,A,,Intermediate,CHEMBL622419,,2107.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,Liver,1,,BAO_0000218
11320,13256,A,,Intermediate,CHEMBL623388,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11321,13256,A,,Intermediate,CHEMBL623389,In vivo,2107.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Liver,1,,BAO_0000218
11322,13256,A,,Intermediate,CHEMBL623390,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11323,13256,A,,Intermediate,CHEMBL623391,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11324,13256,A,,Intermediate,CHEMBL623392,In vivo,178.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Blood,1,,BAO_0000218
11325,13256,A,,Intermediate,CHEMBL623393,In vivo,2037.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Cerebellum,1,,BAO_0000218
11326,13256,A,,Intermediate,CHEMBL623394,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11327,13256,A,,Intermediate,CHEMBL618885,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11328,13256,A,,Intermediate,CHEMBL618886,In vivo,2107.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Liver,1,,BAO_0000218
11329,13256,A,,Intermediate,CHEMBL618887,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11330,13256,A,,Intermediate,CHEMBL619535,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11331,13256,A,,Intermediate,CHEMBL619536,In vivo,178.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Blood,1,,BAO_0000218
11332,13256,A,,Intermediate,CHEMBL619537,In vivo,2037.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Cerebellum,1,,BAO_0000218
11333,13256,A,,Intermediate,CHEMBL619705,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11334,13256,A,,Intermediate,CHEMBL619706,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11335,13256,A,,Intermediate,CHEMBL619707,In vivo,2107.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Liver,1,,BAO_0000218
11336,13256,A,,Intermediate,CHEMBL619708,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11337,13256,A,,Intermediate,CHEMBL625219,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11338,13256,A,,Intermediate,CHEMBL625220,In vivo,178.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Blood,1,,BAO_0000218
11339,13256,A,,Intermediate,CHEMBL625221,In vivo,2037.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Cerebellum,1,,BAO_0000218
11340,13256,A,,Intermediate,CHEMBL625222,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11341,13256,A,,Intermediate,CHEMBL625223,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11342,13256,A,,Intermediate,CHEMBL625224,In vivo,2107.0,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,Liver,1,,BAO_0000218
11343,13256,A,,Intermediate,CHEMBL625225,In vivo,,50594,,1,,N,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,,,1,,BAO_0000218
11344,8829,A,,Intermediate,CHEMBL625226,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 24 hours of iv administration,Rattus norvegicus,,Blood,1,,BAO_0000218
11345,8829,A,,Intermediate,CHEMBL625227,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
11346,8829,A,,Intermediate,CHEMBL625228,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 30 minutes of iv administration,Rattus norvegicus,,Blood,1,,BAO_0000218
11347,8829,A,,Intermediate,CHEMBL875354,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
11348,8829,A,,Intermediate,CHEMBL625229,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 5 minutes of iv administration,Rattus norvegicus,,Blood,1,,BAO_0000218
11349,8829,A,,Intermediate,CHEMBL625230,In vivo,178.0,50597,,1,,N,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,Blood,1,,BAO_0000218
11350,8829,A,,Intermediate,CHEMBL625231,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 24 hours of iv administration,Rattus norvegicus,,Heart,1,,BAO_0000218
11351,8829,A,,Intermediate,CHEMBL625900,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
11352,8829,A,,Intermediate,CHEMBL625901,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 30 minutes of iv administration,Rattus norvegicus,,Heart,1,,BAO_0000218
11353,8829,A,,Intermediate,CHEMBL625902,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
11354,8829,A,,Intermediate,CHEMBL625903,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 5 minutes of iv administration,Rattus norvegicus,,Heart,1,,BAO_0000218
11355,8829,A,,Intermediate,CHEMBL625904,In vivo,948.0,50597,,1,,N,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,Heart,1,,BAO_0000218
11356,8829,A,,Intermediate,CHEMBL625905,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 24 hours of iv administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11357,8829,A,,Intermediate,CHEMBL627861,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
11358,8829,A,,Intermediate,CHEMBL627862,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11359,8829,A,,Intermediate,CHEMBL627863,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
11360,8829,A,,Intermediate,CHEMBL627769,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11361,13249,A,,Intermediate,CHEMBL627770,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11362,13622,A,,Intermediate,CHEMBL627771,In vivo,,100710,,1,,N,Cmax in cynomolgus monkey (PO dose),Macaca fascicularis,,,1,,BAO_0000218
11363,13622,A,,Intermediate,CHEMBL627772,In vivo,,50597,,1,,N,Cmax in rat (PO dose),Rattus norvegicus,,,1,,BAO_0000218
11364,13622,A,,Intermediate,CHEMBL627773,In vivo,,50597,,1,,N,Cmax in rat (PO dose),Rattus norvegicus,,,1,,BAO_0000218
11365,13494,A,,Intermediate,CHEMBL621922,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11366,12170,A,,Intermediate,CHEMBL621923,In vivo,1969.0,50597,,1,,N,Cmax in rat plasma after oral dose (10 mg/kg),Rattus norvegicus,,Plasma,1,,BAO_0000218
11367,12170,A,,Autocuration,CHEMBL621924,In vivo,1969.0,22224,,1,,U,Cmax in plasma after oral dose (10 mg/kg),,,Plasma,0,,BAO_0000218
11368,17025,A,,Intermediate,CHEMBL621925,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11369,17025,A,,Autocuration,CHEMBL621926,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Simiiformes,,Plasma,0,,BAO_0000218
11370,17025,A,,Intermediate,CHEMBL621927,In vivo,1969.0,50592,,1,,N,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,,Plasma,1,,BAO_0000218
11371,17025,A,,Intermediate,CHEMBL621928,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,,Plasma,1,,BAO_0000218
11372,14187,A,,Intermediate,CHEMBL621929,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11373,14816,A,,Intermediate,CHEMBL621930,In vivo,1969.0,50594,,1,,N,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Mus musculus,,Plasma,1,,BAO_0000218
11374,17820,A,,Intermediate,CHEMBL621931,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration after oral dosing in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11375,14380,A,,Autocuration,CHEMBL621932,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11376,14380,A,,Autocuration,CHEMBL621933,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11377,14691,A,,Intermediate,CHEMBL621934,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11378,14691,A,,Intermediate,CHEMBL621935,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11379,13375,A,,Intermediate,CHEMBL621936,In vivo,1969.0,50597,,1,,N,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11380,6236,A,,Autocuration,CHEMBL621937,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was determined,,,Plasma,0,,BAO_0000218
11381,14380,A,,Autocuration,CHEMBL621938,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11382,14380,A,,Autocuration,CHEMBL621939,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11383,14380,A,,Autocuration,CHEMBL621940,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11384,14380,A,,Autocuration,CHEMBL621941,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11385,14380,A,,Autocuration,CHEMBL621942,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11386,14380,A,,Autocuration,CHEMBL626178,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11387,14380,A,,Autocuration,CHEMBL626179,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11388,14380,A,,Autocuration,CHEMBL626180,In vivo,1969.0,22224,,1,,U,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,Plasma,0,,BAO_0000218
11389,13622,A,,Intermediate,CHEMBL626181,In vivo,1969.0,50597,,1,,N,Plasma Cmax in rat (PO dose),Rattus norvegicus,,Plasma,1,,BAO_0000218
11390,15372,A,,Intermediate,CHEMBL626182,In vivo,,50597,,1,,N,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
11391,15372,A,,Intermediate,CHEMBL626183,In vivo,,50597,,1,,N,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
11392,15372,A,,Intermediate,CHEMBL626184,In vivo,,50597,,1,,N,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
11393,15372,A,,Intermediate,CHEMBL626185,In vivo,,50597,,1,,N,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,,,1,,BAO_0000218
11394,14925,A,,Intermediate,CHEMBL626186,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11395,14925,A,,Intermediate,CHEMBL877589,In vivo,1969.0,50588,,1,,N,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11396,11883,A,,Autocuration,CHEMBL626187,In vivo,,22224,,1,,U,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,,0,,BAO_0000218
11397,11883,A,,Autocuration,CHEMBL626188,In vivo,,22224,,1,,U,Maximum concentration of the drug at 20 uM/dg administered perorally,,,,0,,BAO_0000218
11398,13391,A,,Autocuration,CHEMBL626189,In vivo,,22224,,1,,U,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,,0,,BAO_0000218
11399,13391,A,,Autocuration,CHEMBL626855,In vivo,178.0,22224,,1,,U,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11400,13391,A,,Autocuration,CHEMBL623781,In vivo,178.0,22224,,1,,U,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11401,13391,A,,Autocuration,CHEMBL623782,In vivo,178.0,22224,,1,,U,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11402,16360,A,,Intermediate,CHEMBL623783,In vivo,1969.0,50597,,1,,N,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11403,3673,A,,Intermediate,CHEMBL623784,In vivo,1969.0,50588,,1,,N,Cmax in dog plasma after 1mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11404,14431,A,,Intermediate,CHEMBL623785,In vivo,1969.0,50588,,1,,N,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11405,14431,A,,Intermediate,CHEMBL623786,In vivo,1969.0,50597,,1,,N,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11406,14964,A,,Intermediate,CHEMBL623787,In vivo,,50597,,1,,N,Oral maximum concentration in rat,Rattus norvegicus,,,1,,BAO_0000218
11407,14964,A,,Intermediate,CHEMBL623788,In vivo,,50597,,1,,N,Oral maximum concentration in rat,Rattus norvegicus,,,1,,BAO_0000218
11408,14209,A,,Intermediate,CHEMBL623789,In vivo,1969.0,50594,,1,,N,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Mus musculus,,Plasma,1,,BAO_0000218
11409,11355,A,,Intermediate,CHEMBL623790,In vivo,178.0,50594,,1,,N,Peak concentration in blood after intravenous administration to mice,Mus musculus,,Blood,1,,BAO_0000218
11410,11355,A,,Intermediate,CHEMBL623791,In vivo,178.0,50594,,1,,N,Peak concentration in blood after peroral administration to mice,Mus musculus,,Blood,1,,BAO_0000218
11411,11966,A,,Intermediate,CHEMBL623792,In vivo,1969.0,50597,,1,,N,Peak concentration in rat plasma was determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
11412,8918,A,,Autocuration,CHEMBL623793,In vivo,1969.0,22224,,1,,U,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,,Plasma,0,,BAO_0000218
11413,8918,A,,Intermediate,CHEMBL623794,In vivo,1969.0,50594,,1,,N,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,,Plasma,1,,BAO_0000218
11414,8918,A,,Intermediate,CHEMBL623795,In vivo,1969.0,50597,,1,,N,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11415,8684,A,,Intermediate,CHEMBL623796,,,50597,,1,,N,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11416,8684,A,,Intermediate,CHEMBL623797,,,50597,,1,,N,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11417,8684,A,,Intermediate,CHEMBL623798,,,50597,,1,,N,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11418,8684,A,,Intermediate,CHEMBL623799,,,50597,,1,,N,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11419,8684,A,,Intermediate,CHEMBL624490,,160.0,50597,,1,,N,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11420,8684,A,,Intermediate,CHEMBL624491,,160.0,50597,,1,,N,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11421,8684,A,,Intermediate,CHEMBL624492,,160.0,50597,,1,,N,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11422,8684,A,,Intermediate,CHEMBL624493,,160.0,50597,,1,,N,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11423,8684,A,,Intermediate,CHEMBL877595,,160.0,50597,,1,,N,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11424,8684,A,,Intermediate,CHEMBL624494,,160.0,50597,,1,,N,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11425,8684,A,,Intermediate,CHEMBL624495,,160.0,50597,,1,,N,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11426,8684,A,,Intermediate,CHEMBL624681,,160.0,50597,,1,,N,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Intestine,1,,BAO_0000218
11427,8684,A,,Intermediate,CHEMBL624682,,,50597,,1,,N,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11428,8684,A,,Intermediate,CHEMBL624683,,,50597,,1,,N,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11429,8684,A,,Intermediate,CHEMBL624684,,,50597,,1,,N,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11430,8684,A,,Intermediate,CHEMBL624685,,,50597,,1,,N,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11431,8684,A,,Intermediate,CHEMBL624686,,,50597,,1,,N,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11432,8684,A,,Intermediate,CHEMBL624687,,,50597,,1,,N,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11433,8684,A,,Intermediate,CHEMBL624688,,,50597,,1,,N,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11434,8684,A,,Intermediate,CHEMBL627161,,,50597,,1,,N,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11435,8684,A,,Intermediate,CHEMBL622127,,,50597,,1,,N,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11436,8684,A,,Intermediate,CHEMBL622128,,,50597,,1,,N,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11437,8684,A,,Intermediate,CHEMBL874384,,,50597,,1,,N,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11438,8684,A,,Intermediate,CHEMBL624898,,,50597,,1,,N,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11439,8684,A,,Intermediate,CHEMBL624899,,,50597,,1,,N,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11440,8684,A,,Intermediate,CHEMBL624900,,,50597,,1,,N,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11441,8684,A,,Intermediate,CHEMBL624901,,,50597,,1,,N,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11442,8684,A,,Intermediate,CHEMBL624902,,,50597,,1,,N,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11443,8684,A,,Intermediate,CHEMBL624903,,,50597,,1,,N,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11444,8684,A,,Intermediate,CHEMBL624904,,,50597,,1,,N,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11445,8684,A,,Intermediate,CHEMBL624905,,,50597,,1,,N,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11446,8684,A,,Intermediate,CHEMBL624906,,,50597,,1,,N,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11447,8684,A,,Intermediate,CHEMBL624907,,,50597,,1,,N,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11448,8684,A,,Intermediate,CHEMBL624908,,,50597,,1,,N,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11449,8684,A,,Intermediate,CHEMBL624909,,,50597,,1,,N,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11450,8684,A,,Intermediate,CHEMBL624910,,,50597,,1,,N,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11451,8684,A,,Intermediate,CHEMBL624911,,2385.0,50597,,1,,N,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11452,8684,A,,Intermediate,CHEMBL874388,,2385.0,50597,,1,,N,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11453,8684,A,,Intermediate,CHEMBL624912,,2385.0,50597,,1,,N,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11454,8684,A,,Intermediate,CHEMBL622930,,2385.0,50597,,1,,N,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11455,8684,A,,Intermediate,CHEMBL623121,,2385.0,50597,,1,,N,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11456,8684,A,,Intermediate,CHEMBL623122,,2385.0,50597,,1,,N,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11457,8684,A,,Intermediate,CHEMBL623123,,2385.0,50597,,1,,N,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11458,8684,A,,Intermediate,CHEMBL623124,,2385.0,50597,,1,,N,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11459,8684,A,,Intermediate,CHEMBL623125,,,50597,,1,,N,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11460,8684,A,,Intermediate,CHEMBL623126,,,50597,,1,,N,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11461,8684,A,,Intermediate,CHEMBL623127,,,50597,,1,,N,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11462,8684,A,,Intermediate,CHEMBL623128,,,50597,,1,,N,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11463,8684,A,,Intermediate,CHEMBL623129,,,50597,,1,,N,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11464,8684,A,,Intermediate,CHEMBL623130,,,50597,,1,,N,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11465,8684,A,,Intermediate,CHEMBL623131,,,50597,,1,,N,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11466,8684,A,,Intermediate,CHEMBL623132,,,50597,,1,,N,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11467,8319,A,,Intermediate,CHEMBL623133,,2107.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,Liver,1,,BAO_0000218
11468,8319,A,,Intermediate,CHEMBL623134,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11469,8319,A,,Intermediate,CHEMBL874389,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11470,8319,A,,Intermediate,CHEMBL623135,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11471,8319,A,,Intermediate,CHEMBL623136,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11472,8319,A,,Intermediate,CHEMBL623137,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11473,8319,A,,Intermediate,CHEMBL623138,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11474,8319,A,,Intermediate,CHEMBL623139,,2113.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11475,8319,A,,Intermediate,CHEMBL623140,,2113.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11476,8319,A,,Intermediate,CHEMBL623141,,2107.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,Liver,1,,BAO_0000218
11477,8319,A,,Intermediate,CHEMBL623142,,2107.0,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,Liver,1,,BAO_0000218
11478,8319,A,,Intermediate,CHEMBL623143,,,50597,,1,,N,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11479,14571,A,,Intermediate,CHEMBL623144,,1088.0,50594,,1,,N,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Mus musculus,,Urine,1,,BAO_0000218
11480,14571,A,,Intermediate,CHEMBL623405,,1088.0,50597,,1,,N,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Rattus norvegicus,,Urine,1,,BAO_0000218
11481,8319,A,,Intermediate,CHEMBL624074,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11482,8319,A,,Intermediate,CHEMBL624075,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11483,8319,A,,Intermediate,CHEMBL624076,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11484,8319,A,,Intermediate,CHEMBL624077,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11485,8319,A,,Intermediate,CHEMBL624078,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11486,8319,A,,Intermediate,CHEMBL624079,,2113.0,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11487,8319,A,,Intermediate,CHEMBL624261,,2113.0,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11488,8319,A,,Intermediate,CHEMBL624262,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11489,8319,A,,Intermediate,CHEMBL624263,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11490,8319,A,,Intermediate,CHEMBL624264,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11491,8319,A,,Intermediate,CHEMBL624265,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11492,8319,A,,Intermediate,CHEMBL624266,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11493,8319,A,,Intermediate,CHEMBL624267,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11494,8319,A,,Intermediate,CHEMBL624268,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11495,8319,A,,Intermediate,CHEMBL875227,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11496,8319,A,,Intermediate,CHEMBL624269,,2113.0,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11497,8319,A,,Intermediate,CHEMBL624270,,2113.0,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
11498,8319,A,,Intermediate,CHEMBL624271,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,,,1,,BAO_0000218
11499,8319,A,,Intermediate,CHEMBL624272,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11500,8319,A,,Intermediate,CHEMBL624273,,,50597,,1,,N,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,,,1,,BAO_0000218
11501,12064,A,,Intermediate,CHEMBL624274,,1088.0,50597,,1,,N,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Rattus norvegicus,,Urine,1,,BAO_0000218
11502,12064,A,,Intermediate,CHEMBL624275,,1088.0,50597,,1,,N,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Rattus norvegicus,,Urine,1,,BAO_0000218
11503,12064,A,,Intermediate,CHEMBL624276,,1088.0,50597,,1,,N,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Rattus norvegicus,,Urine,1,,BAO_0000218
11504,12038,A,,Intermediate,CHEMBL624277,,1088.0,50597,,1,,N,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Rattus norvegicus,,Urine,1,,BAO_0000218
11505,14314,A,,Autocuration,CHEMBL624278,,,22224,,1,,U,% dose converted to 2-amino-5-chlorophenyl sulfate,,,,0,,BAO_0000019
11506,14314,A,,Autocuration,CHEMBL624279,,,22224,,1,,U,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,,0,,BAO_0000019
11507,11488,A,,Intermediate,CHEMBL624280,,1988.0,50597,,1,,N,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,Feces,1,,BAO_0000218
11508,11488,A,,Intermediate,CHEMBL624281,,1988.0,50597,,1,,N,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,Feces,1,,BAO_0000218
11509,11488,A,,Intermediate,CHEMBL622933,,1988.0,50597,,1,,N,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,Feces,1,,BAO_0000218
11510,11488,A,,Intermediate,CHEMBL622934,,1988.0,50597,,1,,N,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,Feces,1,,BAO_0000218
11511,8829,A,,Intermediate,CHEMBL622935,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
11512,8829,A,,Intermediate,CHEMBL622936,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 5 minutes of iv administration,Rattus norvegicus,,Liver,1,,BAO_0000218
11513,8829,A,,Intermediate,CHEMBL875228,In vivo,2107.0,50597,,1,,N,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,Liver,1,,BAO_0000218
11514,8829,A,,Intermediate,CHEMBL622937,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 24 hours of iv administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11515,8829,A,,Intermediate,CHEMBL622938,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
11516,8829,A,,Intermediate,CHEMBL619736,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 30 minutes of iv administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11517,8829,A,,Intermediate,CHEMBL625117,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
11518,8829,A,,Intermediate,CHEMBL625118,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 5 minutes of iv administration,Rattus norvegicus,,Lung,1,,BAO_0000218
11519,8829,A,,Intermediate,CHEMBL625119,In vivo,2048.0,50597,,1,,N,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,,Lung,1,,BAO_0000218
11520,14972,A,,Intermediate,CHEMBL625120,In vivo,2037.0,50597,,1,,N,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Rattus norvegicus,,Cerebellum,1,,BAO_0000218
11521,14972,A,,Intermediate,CHEMBL625121,In vivo,,50597,,1,,N,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Rattus norvegicus,,,1,,BAO_0000218
11522,14972,A,,Intermediate,CHEMBL625122,In vivo,10000006.0,50597,,1,,N,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Rattus norvegicus,,Thalamus,1,,BAO_0000218
11523,14608,A,,Intermediate,CHEMBL622204,In vivo,178.0,50597,,1,,N,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Blood,1,,BAO_0000218
11524,14608,A,,Intermediate,CHEMBL877503,In vivo,178.0,50597,,1,,N,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Blood,1,,BAO_0000218
11525,14608,A,,Intermediate,CHEMBL627127,In vivo,178.0,50597,,1,,N,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Blood,1,,BAO_0000218
11526,14608,A,,Autocuration,CHEMBL627128,In vivo,10000000.0,22224,,1,,U,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,Hippocampus,0,,BAO_0000218
11527,14608,A,,Autocuration,CHEMBL627129,In vivo,10000000.0,22224,,1,,U,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,Hippocampus,0,,BAO_0000218
11528,14608,A,,Autocuration,CHEMBL627130,In vivo,10000000.0,22224,,1,,U,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,Hippocampus,0,,BAO_0000218
11529,14608,A,,Intermediate,CHEMBL627131,In vivo,955.0,50597,,1,,N,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Brain,1,,BAO_0000218
11530,14608,A,,Intermediate,CHEMBL627132,In vivo,955.0,50597,,1,,N,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Brain,1,,BAO_0000218
11531,14608,A,,Intermediate,CHEMBL627133,In vivo,955.0,50597,,1,,N,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Brain,1,,BAO_0000218
11532,14608,A,,Intermediate,CHEMBL627134,In vivo,2037.0,50597,,1,,N,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
11533,14608,A,,Intermediate,CHEMBL627135,In vivo,2037.0,50597,,1,,N,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
11534,14608,A,,Intermediate,CHEMBL627136,In vivo,2037.0,50597,,1,,N,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
11535,14608,A,,Intermediate,CHEMBL628435,In vivo,,50597,,1,,N,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,,1,,BAO_0000218
11536,14608,A,,Intermediate,CHEMBL628436,In vivo,,50597,,1,,N,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,,1,,BAO_0000218
11537,14608,A,,Intermediate,CHEMBL628437,In vivo,,50597,,1,,N,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,,1,,BAO_0000218
11538,14608,A,,Intermediate,CHEMBL628438,In vivo,948.0,50597,,1,,N,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Heart,1,,BAO_0000218
11539,14608,A,,Intermediate,CHEMBL628439,In vivo,948.0,50597,,1,,N,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Heart,1,,BAO_0000218
11540,14608,A,,Intermediate,CHEMBL628440,In vivo,948.0,50597,,1,,N,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Heart,1,,BAO_0000218
11541,14608,A,,Intermediate,CHEMBL628441,In vivo,10000000.0,50597,,1,,N,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
11542,14608,A,,Intermediate,CHEMBL628442,In vivo,10000000.0,50597,,1,,N,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
11543,14608,A,,Intermediate,CHEMBL628443,In vivo,10000000.0,50597,,1,,N,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
11544,14608,A,,Intermediate,CHEMBL628444,In vivo,2113.0,50597,,1,,N,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
11545,14608,A,,Intermediate,CHEMBL628445,In vivo,2113.0,50597,,1,,N,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
11546,14608,A,,Intermediate,CHEMBL877504,In vivo,2113.0,50597,,1,,N,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Kidney,1,,BAO_0000218
11547,14608,A,,Intermediate,CHEMBL628446,In vivo,2107.0,50597,,1,,N,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Liver,1,,BAO_0000218
11548,14608,A,,Intermediate,CHEMBL626874,In vivo,2107.0,50597,,1,,N,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Liver,1,,BAO_0000218
11549,14608,A,,Intermediate,CHEMBL626875,In vivo,2107.0,50597,,1,,N,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Liver,1,,BAO_0000218
11550,14608,A,,Intermediate,CHEMBL626876,In vivo,2048.0,50597,,1,,N,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Lung,1,,BAO_0000218
11551,14608,A,,Intermediate,CHEMBL626877,In vivo,2048.0,50597,,1,,N,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Lung,1,,BAO_0000218
11552,14608,A,,Intermediate,CHEMBL626878,In vivo,2048.0,50597,,1,,N,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Lung,1,,BAO_0000218
11553,14608,A,,Intermediate,CHEMBL626879,In vivo,2385.0,50597,,1,,N,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11554,8918,A,,Autocuration,CHEMBL626880,In vivo,1969.0,22224,,1,,U,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,,Plasma,0,,BAO_0000218
11555,8918,A,,Intermediate,CHEMBL626881,In vivo,1969.0,50594,,1,,N,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,,Plasma,1,,BAO_0000218
11556,8918,A,,Intermediate,CHEMBL626882,In vivo,1969.0,50597,,1,,N,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11557,14470,A,,Intermediate,CHEMBL626883,In vivo,1969.0,50588,,1,,N,Peak plasma concentration was measured in dogs,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11558,14393,A,,Intermediate,CHEMBL626884,In vivo,,50597,,1,,N,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
11559,14886,A,,Intermediate,CHEMBL626885,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11560,14886,A,,Intermediate,CHEMBL626886,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11561,14886,A,,Intermediate,CHEMBL626887,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11562,14393,A,,Intermediate,CHEMBL626888,In vivo,,50597,,1,,N,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
11563,13465,A,,Intermediate,CHEMBL626889,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Canis lupus familiaris,,,1,,BAO_0000218
11564,13465,A,,Autocuration,CHEMBL626761,In vivo,,22224,,1,,U,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Simiiformes,,,0,,BAO_0000218
11565,13465,A,,Intermediate,CHEMBL626762,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Canis lupus familiaris,,,1,,BAO_0000218
11566,13465,A,,Intermediate,CHEMBL626763,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Canis lupus familiaris,,,1,,BAO_0000218
11567,13465,A,,Intermediate,CHEMBL626764,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Rattus norvegicus,,,1,,BAO_0000218
11568,13465,A,,Intermediate,CHEMBL626765,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Rattus norvegicus,,,1,,BAO_0000218
11569,13465,A,,Intermediate,CHEMBL626766,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Canis lupus familiaris,,,1,,BAO_0000218
11570,13465,A,,Intermediate,CHEMBL626767,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Rattus norvegicus,,,1,,BAO_0000218
11571,13465,A,,Intermediate,CHEMBL626768,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Rattus norvegicus,,,1,,BAO_0000218
11572,13465,A,,Intermediate,CHEMBL626769,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Canis lupus familiaris,,,1,,BAO_0000218
11573,13465,A,,Intermediate,CHEMBL874463,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Canis lupus familiaris,,,1,,BAO_0000218
11574,13465,A,,Autocuration,CHEMBL626770,In vivo,,22224,,1,,U,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Simiiformes,,,0,,BAO_0000218
11575,13465,A,,Autocuration,CHEMBL626771,In vivo,,22224,,1,,U,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Simiiformes,,,0,,BAO_0000218
11576,13465,A,,Intermediate,CHEMBL626772,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Rattus norvegicus,,,1,,BAO_0000218
11577,14731,A,,Intermediate,CHEMBL626773,In vivo,,100710,,1,,N,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,,,1,,BAO_0000218
11578,14731,A,,Intermediate,CHEMBL626774,In vivo,,50594,,1,,N,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Mus musculus,,,1,,BAO_0000218
11579,13376,A,,Intermediate,CHEMBL626775,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
11580,13376,A,,Intermediate,CHEMBL626776,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
11581,14443,A,,Intermediate,CHEMBL626777,In vivo,,50597,,1,,N,Maximum concentration (Cmax) in rat when administered orally,Rattus norvegicus,,,1,,BAO_0000218
11582,13465,A,,Autocuration,CHEMBL626778,In vivo,1969.0,22224,,1,,U,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Simiiformes,,Plasma,0,,BAO_0000218
11583,16359,A,,Autocuration,CHEMBL626779,In vivo,,22224,,1,,U,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Rattus norvegicus,,,0,,BAO_0000218
11584,16359,A,,Autocuration,CHEMBL626780,In vivo,,22224,,1,,U,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Rattus norvegicus,,,0,,BAO_0000218
11585,15618,A,,Autocuration,CHEMBL626781,In vivo,1969.0,22224,,1,,U,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,Plasma,0,,BAO_0000218
11586,14554,A,,Intermediate,CHEMBL632164,In vivo,,50597,,1,,N,Pharmacokinetic profile Cmax was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
11587,11537,A,,Intermediate,CHEMBL632165,In vivo,,50588,,1,,N,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Canis lupus familiaris,,,1,,BAO_0000218
11588,11537,A,,Intermediate,CHEMBL632166,In vivo,,50594,,1,,N,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Mus musculus,,,1,,BAO_0000218
11589,11537,A,,Intermediate,CHEMBL632167,In vivo,,50588,,1,,N,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Canis lupus familiaris,,,1,,BAO_0000218
11590,11537,A,,Intermediate,CHEMBL632168,In vivo,,50594,,1,,N,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Mus musculus,,,1,,BAO_0000218
11591,2021,A,,Autocuration,CHEMBL632169,In vivo,1969.0,22224,,1,,U,Cmax in rat plasma,Rattus norvegicus,,Plasma,0,,BAO_0000218
11592,5932,A,,Intermediate,CHEMBL632170,In vivo,1969.0,50588,,1,,N,Cmax in dog plasma after 30mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11593,5932,A,,Intermediate,CHEMBL632171,In vivo,1969.0,50597,,1,,N,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11594,17320,A,,Intermediate,CHEMBL632172,In vivo,1969.0,50597,,1,,N,Plasma level in rats at 30 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
11595,15831,A,,Intermediate,CHEMBL632173,In vivo,1969.0,50594,,1,,N,Tested for maximum plasma concentration in mice,Mus musculus,,Plasma,1,,BAO_0000218
11596,15078,A,,Intermediate,CHEMBL632174,In vivo,,50597,,1,,N,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
11597,14941,A,,Intermediate,CHEMBL632175,In vivo,,50597,,1,,N,The Cmax values in female wistar rats.,Rattus norvegicus,,,1,,BAO_0000218
11598,15343,A,,Intermediate,CHEMBL632176,In vivo,1969.0,50588,,1,,N,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11599,15343,A,,Intermediate,CHEMBL632177,In vivo,1969.0,50597,,1,,N,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
11600,14856,A,,Intermediate,CHEMBL632178,In vivo,1969.0,50597,,1,,N,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11601,13129,A,,Intermediate,CHEMBL632179,In vivo,,50597,,1,,N,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,,,1,,BAO_0000218
11602,13098,A,,Intermediate,CHEMBL632180,In vivo,178.0,50597,,1,,N,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
11603,13098,A,,Intermediate,CHEMBL632181,In vivo,178.0,50597,,1,,N,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
11604,13098,A,,Intermediate,CHEMBL632182,In vivo,178.0,50597,,1,,N,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
11605,15478,A,,Autocuration,CHEMBL632183,In vivo,178.0,22224,,1,,U,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Mus musculus,,Blood,0,,BAO_0000218
11606,15341,A,,Intermediate,CHEMBL632184,In vivo,,50588,,1,,N,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Canis lupus familiaris,,,1,,BAO_0000218
11607,15341,A,,Intermediate,CHEMBL874470,In vivo,,50597,,1,,N,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Rattus norvegicus,,,1,,BAO_0000218
11608,8684,A,,Intermediate,CHEMBL631302,,,50597,,1,,N,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11609,8684,A,,Intermediate,CHEMBL631303,,,50597,,1,,N,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11610,8684,A,,Intermediate,CHEMBL631304,,,50597,,1,,N,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11611,8684,A,,Intermediate,CHEMBL631305,,,50597,,1,,N,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11612,8684,A,,Intermediate,CHEMBL631306,,,50597,,1,,N,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11613,8684,A,,Intermediate,CHEMBL631307,,,50597,,1,,N,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11614,8684,A,,Intermediate,CHEMBL631308,,,50597,,1,,N,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11615,8684,A,,Intermediate,CHEMBL625557,,,50597,,1,,N,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,,1,,BAO_0000218
11616,8684,A,,Intermediate,CHEMBL625558,,2106.0,50597,,1,,N,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11617,8684,A,,Intermediate,CHEMBL625559,,2106.0,50597,,1,,N,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11618,8684,A,,Intermediate,CHEMBL625560,,2106.0,50597,,1,,N,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11619,8684,A,,Intermediate,CHEMBL625561,,2106.0,50597,,1,,N,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11620,8684,A,,Intermediate,CHEMBL625562,,2106.0,50597,,1,,N,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11621,8684,A,,Intermediate,CHEMBL875320,,2106.0,50597,,1,,N,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11622,8684,A,,Intermediate,CHEMBL625563,,2106.0,50597,,1,,N,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11623,8684,A,,Intermediate,CHEMBL625564,,2106.0,50597,,1,,N,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Spleen,1,,BAO_0000218
11624,8684,A,,Intermediate,CHEMBL625565,,995.0,50597,,1,,N,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11625,8684,A,,Intermediate,CHEMBL625566,,995.0,50597,,1,,N,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11626,8684,A,,Intermediate,CHEMBL625567,,995.0,50597,,1,,N,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11627,8684,A,,Intermediate,CHEMBL625568,,995.0,50597,,1,,N,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11628,8684,A,,Intermediate,CHEMBL628217,,995.0,50597,,1,,N,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11629,8684,A,,Intermediate,CHEMBL628218,,995.0,50597,,1,,N,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11630,8684,A,,Intermediate,CHEMBL628219,,995.0,50597,,1,,N,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11631,8684,A,,Intermediate,CHEMBL628220,,995.0,50597,,1,,N,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,,Uterus,1,,BAO_0000218
11632,8926,A,,Autocuration,CHEMBL628221,,,22224,,1,,U,Distribution in the blood after 120 min of intravenous administration,,,,0,,BAO_0000019
11633,8926,A,,Autocuration,CHEMBL628222,,,22224,,1,,U,Distribution in the blood after 15 min of intravenous administration,,,,0,,BAO_0000019
11634,8926,A,,Autocuration,CHEMBL628223,,,22224,,1,,U,Distribution in the blood after 30 min of intravenous administration,,,,0,,BAO_0000019
11635,8926,A,,Autocuration,CHEMBL628224,,,22224,,1,,U,Distribution in the blood after 5 min of intravenous administration,,,,0,,BAO_0000019
11636,8926,A,,Autocuration,CHEMBL628225,,,22224,,1,,U,Distribution in the blood after 60 min of intravenous administration,,,,0,,BAO_0000019
11637,8926,A,,Autocuration,CHEMBL628226,,,22224,,1,,U,Distribution in the blood after 90 min of intravenous administration,,,,0,,BAO_0000019
11638,8926,A,,Autocuration,CHEMBL628227,,,22224,,1,,U,Distribution in the bone after 120 min of intravenous administration,,,,0,,BAO_0000019
11639,8926,A,,Autocuration,CHEMBL875481,,,22224,,1,,U,Distribution in the bone after 15 min of intravenous administration,,,,0,,BAO_0000019
11640,8926,A,,Autocuration,CHEMBL628228,,,22224,,1,,U,Distribution in the bone after 30 min of intravenous administration,,,,0,,BAO_0000019
11641,8926,A,,Autocuration,CHEMBL628229,,,22224,,1,,U,Distribution in the bone after 5 min of intravenous administration,,,,0,,BAO_0000019
11642,8926,A,,Autocuration,CHEMBL628230,,,22224,,1,,U,Distribution in the bone after 60 min of intravenous administration,,,,0,,BAO_0000019
11643,8926,A,,Autocuration,CHEMBL628231,,,22224,,1,,U,Distribution in the bone after 90 min of intravenous administration,,,,0,,BAO_0000019
11644,8926,A,,Autocuration,CHEMBL628232,,,22224,,1,,U,Distribution in the heart after 120 min of intravenous administration,,,,0,,BAO_0000019
11645,8926,A,,Autocuration,CHEMBL628233,,,22224,,1,,U,Distribution in the heart after 15 min of intravenous administration,,,,0,,BAO_0000019
11646,8926,A,,Autocuration,CHEMBL628234,,,22224,,1,,U,Distribution in the heart after 30 min of intravenous administration,,,,0,,BAO_0000019
11647,8926,A,,Autocuration,CHEMBL628235,,,22224,,1,,U,Distribution in the heart after 5 min of intravenous administration,,,,0,,BAO_0000019
11648,8926,A,,Autocuration,CHEMBL628236,,,22224,,1,,U,Distribution in the heart after 60 min of intravenous administration,,,,0,,BAO_0000019
11649,8926,A,,Autocuration,CHEMBL628237,,,22224,,1,,U,Distribution in the heart after 90 min of intravenous administration,,,,0,,BAO_0000019
11650,8926,A,,Autocuration,CHEMBL628238,,,22224,,1,,U,Distribution in the kidneys after 120 min of intravenous administration,,,,0,,BAO_0000019
11651,8926,A,,Autocuration,CHEMBL628239,,,22224,,1,,U,Distribution in the kidneys after 15 min of intravenous administration,,,,0,,BAO_0000019
11652,8926,A,,Autocuration,CHEMBL628240,,,22224,,1,,U,Distribution in the kidneys after 30 min of intravenous administration,,,,0,,BAO_0000019
11653,8926,A,,Autocuration,CHEMBL628241,,,22224,,1,,U,Distribution in the kidneys after 5 min of intravenous administration,,,,0,,BAO_0000019
11654,8926,A,,Autocuration,CHEMBL628242,,,22224,,1,,U,Distribution in the kidneys after 60 min of intravenous administration,,,,0,,BAO_0000019
11655,8926,A,,Autocuration,CHEMBL875482,,,22224,,1,,U,Distribution in the kidneys after 90 min of intravenous administration,,,,0,,BAO_0000019
11656,8926,A,,Autocuration,CHEMBL628243,,,22224,,1,,U,Distribution in the liver after 120 min of intravenous administration,,,,0,,BAO_0000019
11657,8926,A,,Autocuration,CHEMBL628244,,,22224,,1,,U,Distribution in the liver after 15 min of intravenous administration,,,,0,,BAO_0000019
11658,8926,A,,Autocuration,CHEMBL628245,,,22224,,1,,U,Distribution in the liver after 30 min of intravenous administration,,,,0,,BAO_0000019
11659,8926,A,,Autocuration,CHEMBL628246,,,22224,,1,,U,Distribution in the liver after 5 min of intravenous administration,,,,0,,BAO_0000019
11660,8926,A,,Autocuration,CHEMBL628247,,,22224,,1,,U,Distribution in the liver after 60 min of intravenous administration,,,,0,,BAO_0000019
11661,8926,A,,Autocuration,CHEMBL628248,,,22224,,1,,U,Distribution in the liver after 90 min of intravenous administration,,,,0,,BAO_0000019
11662,8926,A,,Autocuration,CHEMBL628249,,,22224,,1,,U,Distribution in the lung after 120 min of intravenous administration,,,,0,,BAO_0000019
11663,14839,A,,Intermediate,CHEMBL625452,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,1,,BAO_0000218
11664,14839,A,,Intermediate,CHEMBL625453,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,1,,BAO_0000218
11665,14839,A,,Intermediate,CHEMBL625454,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,,,1,,BAO_0000218
11666,14839,A,,Intermediate,CHEMBL623844,,,50594,,1,,N,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,,,1,,BAO_0000218
11667,12178,A,,Intermediate,CHEMBL623845,,,50597,,1,,N,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,,,1,,BAO_0000218
11668,12178,A,,Intermediate,CHEMBL623846,,,50597,,1,,N,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,,,1,,BAO_0000218
11669,12178,A,,Autocuration,CHEMBL623847,,,22224,,1,,U,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,,0,,BAO_0000218
11670,12186,A,,Intermediate,CHEMBL623848,,,100710,,1,,N,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,1,,BAO_0000218
11671,12186,A,,Intermediate,CHEMBL623849,,,100710,,1,,N,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,1,,BAO_0000218
11672,12186,A,,Intermediate,CHEMBL623850,,,100710,,1,,N,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,1,,BAO_0000218
11673,12186,A,,Intermediate,CHEMBL623851,,,100710,,1,,N,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,1,,BAO_0000218
11674,12187,A,,Autocuration,CHEMBL623852,,,22224,,1,,U,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,0,,BAO_0000218
11675,12187,A,,Intermediate,CHEMBL624551,,,50506,,1,,N,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,,,1,,BAO_0000218
11676,12187,A,,Intermediate,CHEMBL624552,,,50506,,1,,N,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,,,1,,BAO_0000218
11677,12187,A,,Autocuration,CHEMBL624553,,,22224,,1,,U,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,0,,BAO_0000218
11678,12187,A,,Autocuration,CHEMBL624554,,,22224,,1,,U,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Simiiformes,,,0,,BAO_0000218
11679,12187,A,,Intermediate,CHEMBL624555,,,50597,,1,,N,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
11680,12187,A,,Intermediate,CHEMBL624741,,,50597,,1,,N,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,1,,BAO_0000218
11681,14122,A,,Intermediate,CHEMBL624742,,,50588,,1,,N,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,1,,BAO_0000218
11682,14122,A,,Intermediate,CHEMBL624743,,,100712,,1,,N,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,1,,BAO_0000218
11683,14122,A,,Intermediate,CHEMBL877606,,,50597,,1,,N,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,,,1,,BAO_0000218
11684,13391,A,,Autocuration,CHEMBL624744,,,22224,,1,,U,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,,0,,BAO_0000218
11685,13391,A,,Autocuration,CHEMBL624745,,178.0,22224,,1,,U,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11686,13391,A,,Autocuration,CHEMBL624746,,178.0,22224,,1,,U,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11687,13391,A,,Autocuration,CHEMBL624747,,178.0,22224,,1,,U,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,Blood,0,,BAO_0000218
11688,16360,A,,Autocuration,CHEMBL624748,,,22224,,1,,U,Oral absorption expressed as Area under curve was determined,,,,0,,BAO_0000019
11689,3673,A,,Intermediate,CHEMBL622504,,,50588,,1,,N,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Canis lupus familiaris,,,1,,BAO_0000218
11690,14122,A,,Intermediate,CHEMBL622505,,,50588,,1,,N,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,1,,BAO_0000218
11691,14122,A,,Intermediate,CHEMBL622506,,,100712,,1,,N,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,1,,BAO_0000218
11692,14122,A,,Intermediate,CHEMBL622507,,,100712,,1,,N,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,,,1,,BAO_0000218
11693,14122,A,,Intermediate,CHEMBL622508,,,50597,,1,,N,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,,,1,,BAO_0000218
11694,13889,A,,Autocuration,CHEMBL622509,,,22224,,1,,U,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,,0,,BAO_0000019
11695,14393,A,,Intermediate,CHEMBL622510,,,50597,,1,,N,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
11696,17279,A,,Intermediate,CHEMBL622511,,,50597,,1,,N,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Rattus norvegicus,,,1,,BAO_0000218
11697,14548,A,,Intermediate,CHEMBL622512,,,100710,,1,,N,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,,,1,,BAO_0000218
11698,14548,A,,Intermediate,CHEMBL622513,,,100710,,1,,N,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,,,1,,BAO_0000218
11699,14548,A,,Intermediate,CHEMBL622514,,,100710,,1,,N,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Macaca fascicularis,,,1,,BAO_0000218
11700,14548,A,,Intermediate,CHEMBL622515,,,50588,,1,,N,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,,,1,,BAO_0000218
11701,14548,A,,Intermediate,CHEMBL622516,,,50588,,1,,N,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Canis lupus familiaris,,,1,,BAO_0000218
11702,14548,A,,Intermediate,CHEMBL622517,,,50597,,1,,N,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
11703,14548,A,,Intermediate,CHEMBL622518,,,50597,,1,,N,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
11704,14548,A,,Intermediate,CHEMBL622519,,,50597,,1,,N,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
11705,14608,A,,Intermediate,CHEMBL622520,In vivo,2385.0,50597,,1,,N,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11706,14608,A,,Intermediate,CHEMBL622521,In vivo,2385.0,50597,,1,,N,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11707,14608,A,,Intermediate,CHEMBL625113,In vivo,14.0,50594,,1,,N,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Mus musculus,,Zone of skin,1,,BAO_0000218
11708,14608,A,,Intermediate,CHEMBL625114,In vivo,14.0,50597,,1,,N,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
11709,14608,A,,Intermediate,CHEMBL874397,In vivo,14.0,50597,,1,,N,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
11710,14608,A,,Intermediate,CHEMBL625115,In vivo,2106.0,50597,,1,,N,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
11711,14608,A,,Intermediate,CHEMBL625116,In vivo,2106.0,50597,,1,,N,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
11712,14608,A,,Intermediate,CHEMBL623932,In vivo,2106.0,50597,,1,,N,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Spleen,1,,BAO_0000218
11713,14608,A,,Intermediate,CHEMBL623933,In vivo,2435.0,50597,,1,,N,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Striatum,1,,BAO_0000218
11714,14608,A,,Intermediate,CHEMBL623934,In vivo,2435.0,50597,,1,,N,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Striatum,1,,BAO_0000218
11715,14608,A,,Intermediate,CHEMBL623935,In vivo,2435.0,50597,,1,,N,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Striatum,1,,BAO_0000218
11716,14608,A,,Intermediate,CHEMBL623936,In vivo,2046.0,50597,,1,,N,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
11717,14608,A,,Intermediate,CHEMBL623937,In vivo,2046.0,50597,,1,,N,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
11718,14608,A,,Intermediate,CHEMBL623938,In vivo,2046.0,50597,,1,,N,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
11719,15383,A,,Intermediate,CHEMBL623939,,,50594,,1,,N,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,1,,BAO_0000218
11720,15383,A,,Intermediate,CHEMBL623940,,,50594,,1,,N,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,,1,,BAO_0000218
11721,15383,A,,Intermediate,CHEMBL623941,,,50594,,1,,N,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,1,,BAO_0000218
11722,15383,A,,Intermediate,CHEMBL627216,,,50594,,1,,N,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,1,,BAO_0000218
11723,15383,A,,Intermediate,CHEMBL623942,,,50594,,1,,N,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,1,,BAO_0000218
11724,15383,A,,Intermediate,CHEMBL618793,,955.0,50594,,1,,N,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,Brain,1,,BAO_0000218
11725,15383,A,,Intermediate,CHEMBL618794,,955.0,50594,,1,,N,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,Brain,1,,BAO_0000218
11726,15383,A,,Intermediate,CHEMBL618795,,955.0,50594,,1,,N,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,Brain,1,,BAO_0000218
11727,15383,A,,Intermediate,CHEMBL618796,,,50594,,1,,N,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,1,,BAO_0000218
11728,15383,A,,Intermediate,CHEMBL618797,,,50594,,1,,N,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,1,,BAO_0000218
11729,15383,A,,Intermediate,CHEMBL618798,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,,Kidney,1,,BAO_0000218
11730,15383,A,,Intermediate,CHEMBL618799,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,Kidney,1,,BAO_0000218
11731,15383,A,,Intermediate,CHEMBL618800,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,Kidney,1,,BAO_0000218
11732,15383,A,,Intermediate,CHEMBL618801,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,Kidney,1,,BAO_0000218
11733,15383,A,,Intermediate,CHEMBL618802,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,Kidney,1,,BAO_0000218
11734,15383,A,,Intermediate,CHEMBL618803,,2113.0,50594,,1,,N,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,Kidney,1,,BAO_0000218
11735,15383,A,,Intermediate,CHEMBL618804,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,,Liver,1,,BAO_0000218
11736,15383,A,,Intermediate,CHEMBL618805,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,Liver,1,,BAO_0000218
11737,15383,A,,Intermediate,CHEMBL618806,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,Liver,1,,BAO_0000218
11738,15383,A,,Intermediate,CHEMBL618807,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,Liver,1,,BAO_0000218
11739,15383,A,,Intermediate,CHEMBL618808,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,Liver,1,,BAO_0000218
11740,15383,A,,Intermediate,CHEMBL618809,,2107.0,50594,,1,,N,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,Liver,1,,BAO_0000218
11741,15383,A,,Intermediate,CHEMBL618810,,2385.0,50594,,1,,N,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,Muscle tissue,1,,BAO_0000218
11742,15383,A,,Intermediate,CHEMBL618811,,2385.0,50594,,1,,N,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,,Muscle tissue,1,,BAO_0000218
11743,15383,A,,Intermediate,CHEMBL875844,,2385.0,50594,,1,,N,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,Muscle tissue,1,,BAO_0000218
11744,15383,A,,Intermediate,CHEMBL618812,,2385.0,50594,,1,,N,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,Muscle tissue,1,,BAO_0000218
11745,15383,A,,Intermediate,CHEMBL618813,,2385.0,50594,,1,,N,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,Muscle tissue,1,,BAO_0000218
11746,15383,A,,Intermediate,CHEMBL618814,,,50594,,1,,N,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,1,,BAO_0000218
11747,15383,A,,Intermediate,CHEMBL618815,,,50594,,1,,N,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,1,,BAO_0000218
11748,15383,A,,Intermediate,CHEMBL618816,,,50594,,1,,N,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,1,,BAO_0000218
11749,15383,A,,Intermediate,CHEMBL618817,,,50594,,1,,N,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,1,,BAO_0000218
11750,15383,A,,Intermediate,CHEMBL620544,,,50594,,1,,N,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,1,,BAO_0000218
11751,15341,A,,Intermediate,CHEMBL626230,In vivo,,50597,,1,,N,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Rattus norvegicus,,,1,,BAO_0000218
11752,15341,A,,Intermediate,CHEMBL626231,In vivo,,50597,,1,,N,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,,,1,,BAO_0000218
11753,15341,A,,Intermediate,CHEMBL626232,In vivo,,50597,,1,,N,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Rattus norvegicus,,,1,,BAO_0000218
11754,14906,A,,Intermediate,CHEMBL626233,In vivo,1969.0,50588,,1,,N,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11755,14906,A,,Intermediate,CHEMBL626234,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11756,14906,A,,Intermediate,CHEMBL875341,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11757,14215,A,,Intermediate,CHEMBL626235,In vivo,1969.0,50587,,1,,N,The maximum plasma concentration (100 mg/kg) administered orally in human,Homo sapiens,,Plasma,1,,BAO_0000218
11758,14215,A,,Autocuration,CHEMBL626236,In vivo,1969.0,22224,,1,,U,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Callithrix,,Plasma,0,,BAO_0000218
11759,14215,A,,Autocuration,CHEMBL626237,In vivo,1969.0,22224,,1,,U,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Simiiformes,,Plasma,0,,BAO_0000218
11760,14215,A,,Intermediate,CHEMBL626238,In vivo,1969.0,50588,,1,,N,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11761,14215,A,,Intermediate,CHEMBL622412,In vivo,1969.0,50587,,1,,N,The maximum plasma concentration (200 mg/kg) administered orally in human,Homo sapiens,,Plasma,1,,BAO_0000218
11762,14215,A,,Intermediate,CHEMBL623114,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11763,14215,A,,Autocuration,CHEMBL623115,In vivo,1969.0,22224,,1,,U,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Callithrix,,Plasma,0,,BAO_0000218
11764,14215,A,,Autocuration,CHEMBL623116,In vivo,1969.0,22224,,1,,U,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Simiiformes,,Plasma,0,,BAO_0000218
11765,14215,A,,Autocuration,CHEMBL623117,In vivo,1969.0,22224,,1,,U,The maximum plasma concentration (30 mg/kg) administered orally in dog,Canis lupus familiaris,,Plasma,0,,BAO_0000218
11766,14215,A,,Intermediate,CHEMBL623118,In vivo,1969.0,50587,,1,,N,The maximum plasma concentration (400 mg/kg) administered orally in human,Homo sapiens,,Plasma,1,,BAO_0000218
11767,14215,A,,Intermediate,CHEMBL623119,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11768,14215,A,,Intermediate,CHEMBL623120,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration (50 mg/kg) administered orally in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11769,14215,A,,Intermediate,CHEMBL623286,In vivo,1969.0,50587,,1,,N,The maximum plasma concentration (800 mg/kg) administered orally in human,Homo sapiens,,Plasma,1,,BAO_0000218
11770,14067,A,,Intermediate,CHEMBL623287,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration was measured on rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
11771,12350,A,,Intermediate,CHEMBL623288,In vivo,1969.0,50597,,1,,N,The maximum plasma concentration was measured on rats after oral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
11772,14813,A,,Intermediate,CHEMBL623289,In vivo,1969.0,50597,,1,,N,Plasma drug Cmax in rat (PO dose),Rattus norvegicus,,Plasma,1,,BAO_0000218
11773,12536,A,,Autocuration,CHEMBL623290,In vivo,,22224,,1,,U,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,,0,,BAO_0000218
11774,14169,A,,Intermediate,CHEMBL623291,In vivo,1969.0,50588,,1,,N,maximum Plasma concentration in Dog was determined after Peroral administration,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11775,14169,A,,Intermediate,CHEMBL623292,In vivo,1969.0,50597,,1,,N,maximum Plasma concentration in Rats was determined after Peroral administration,Rattus norvegicus,,Plasma,1,,BAO_0000218
11776,15604,A,,Intermediate,CHEMBL623293,In vivo,1969.0,50588,,1,,N,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
11777,15604,A,,Autocuration,CHEMBL623294,In vivo,1969.0,22224,,1,,U,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,,Plasma,0,,BAO_0000218
11778,15604,A,,Intermediate,CHEMBL623295,In vivo,1969.0,50597,,1,,N,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
11779,14387,A,,Intermediate,CHEMBL623296,In vivo,,50594,,1,,N,maximum concentration was measured when administered through oral route in mice,Mus musculus,,,1,,BAO_0000218
11780,15115,A,,Intermediate,CHEMBL875349,,,50594,,1,,N,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Mus musculus,,,1,,BAO_0000218
11781,15115,A,,Autocuration,CHEMBL623297,,,22224,,1,,U,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Simiiformes,,,0,,BAO_0000019
11782,15115,A,,Autocuration,CHEMBL623298,,,22224,,1,,U,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Simiiformes,,,0,,BAO_0000019
11783,15115,A,,Autocuration,CHEMBL623299,,,22224,,1,,U,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Simiiformes,,,0,,BAO_0000019
11784,16359,A,,Intermediate,CHEMBL623300,,,50597,,1,,N,Pharmacokinetic parameter was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
11785,12829,A,,Intermediate,CHEMBL623301,,,50594,,1,,N,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,,,1,,BAO_0000218
11786,12829,A,,Intermediate,CHEMBL623302,,,50594,,1,,N,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Mus musculus,,,1,,BAO_0000218
11787,12829,A,,Intermediate,CHEMBL623303,,,50594,,1,,N,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,,,1,,BAO_0000218
11788,12829,A,,Intermediate,CHEMBL623304,,,50594,,1,,N,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Mus musculus,,,1,,BAO_0000218
11789,12829,A,,Intermediate,CHEMBL623305,,,50594,,1,,N,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Mus musculus,,,1,,BAO_0000218
11790,15137,A,,Intermediate,CHEMBL623306,,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11791,15137,A,,Intermediate,CHEMBL623307,,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11792,15137,A,,Intermediate,CHEMBL623308,,1969.0,50597,,1,,N,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,,Plasma,1,,BAO_0000218
11793,15137,A,,Intermediate,CHEMBL623309,,1969.0,50594,,1,,N,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Mus musculus,,Plasma,1,,BAO_0000218
11794,13509,A,,Intermediate,CHEMBL623310,,,50594,,1,,N,Plasma Concentration after 120 min of oral administration to mice,Mus musculus,,,1,,BAO_0000218
11795,13509,A,,Intermediate,CHEMBL623311,,,50594,,1,,N,Plasma Concentration after 30 min of oral administration to mice,Mus musculus,,,1,,BAO_0000218
11796,13509,A,,Intermediate,CHEMBL623312,,,100710,,1,,N,Plasma Concentration after 60 min of oral administration to mice,Macaca fascicularis,,,1,,BAO_0000218
11797,13509,A,,Intermediate,CHEMBL875350,,,50594,,1,,N,Plasma Concentration after 60 min of oral administration to mice; Not determined,Mus musculus,,,1,,BAO_0000218
11798,13509,A,,Intermediate,CHEMBL628635,,,50594,,1,,N,Plasma Concentration after 90 min of oral administration to mice,Mus musculus,,,1,,BAO_0000218
11799,12064,A,,Intermediate,CHEMBL628636,,,50597,,1,,N,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11800,12064,A,,Intermediate,CHEMBL628637,,,50597,,1,,N,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11801,12064,A,,Intermediate,CHEMBL628058,,,50597,,1,,N,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
11802,10677,A,,Intermediate,CHEMBL628059,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Rattus norvegicus,,,1,,BAO_0000218
11803,10677,A,,Intermediate,CHEMBL628060,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Rattus norvegicus,,,1,,BAO_0000218
11804,8926,A,,Autocuration,CHEMBL628061,,,22224,,1,,U,Distribution in the lung after 15 min of intravenous administration,,,,0,,BAO_0000019
11805,8926,A,,Autocuration,CHEMBL628062,,,22224,,1,,U,Distribution in the lung after 30 min of intravenous administration,,,,0,,BAO_0000019
11806,8926,A,,Autocuration,CHEMBL628063,,,22224,,1,,U,Distribution in the lung after 5 min of intravenous administration,,,,0,,BAO_0000019
11807,8926,A,,Autocuration,CHEMBL628064,,,22224,,1,,U,Distribution in the lung after 60 min of intravenous administration,,,,0,,BAO_0000019
11808,8926,A,,Autocuration,CHEMBL628065,,,22224,,1,,U,Distribution in the lung after 90 min of intravenous administration,,,,0,,BAO_0000019
11809,8926,A,,Autocuration,CHEMBL628066,,2385.0,22224,,1,,U,Distribution in the muscle after 120 min of intravenous administration,,,Muscle tissue,0,,BAO_0000019
11810,8926,A,,Autocuration,CHEMBL628067,,2385.0,22224,,1,,U,Distribution in the muscle after 15 min of intravenous administration,,,Muscle tissue,0,,BAO_0000019
11811,8926,A,,Intermediate,CHEMBL874646,,2385.0,50594,,1,,N,Distribution in the muscle after 30 min of intravenous administration,Mus musculus,,Muscle tissue,1,,BAO_0000218
11812,8926,A,,Autocuration,CHEMBL628068,,2385.0,22224,,1,,U,Distribution in the muscle after 5 min of intravenous administration,,,Muscle tissue,0,,BAO_0000019
11813,8926,A,,Autocuration,CHEMBL628069,,2385.0,22224,,1,,U,Distribution in the muscle after 60 min of intravenous administration,,,Muscle tissue,0,,BAO_0000019
11814,8926,A,,Autocuration,CHEMBL628070,,2385.0,22224,,1,,U,Distribution in the muscle after 90 min of intravenous administration,,,Muscle tissue,0,,BAO_0000019
11815,8926,A,,Autocuration,CHEMBL628071,,2106.0,22224,,1,,U,Distribution in the spleen after 120 min of intravenous administration,,,Spleen,0,,BAO_0000019
11816,8926,A,,Autocuration,CHEMBL628072,,2106.0,22224,,1,,U,Distribution in the spleen after 15 min of intravenous administration,,,Spleen,0,,BAO_0000019
11817,8926,A,,Autocuration,CHEMBL628073,,2106.0,22224,,1,,U,Distribution in the spleen after 30 min of intravenous administration,,,Spleen,0,,BAO_0000019
11818,8926,A,,Autocuration,CHEMBL628074,,2106.0,22224,,1,,U,Distribution in the spleen after 5 min of intravenous administration,,,Spleen,0,,BAO_0000019
11819,8926,A,,Autocuration,CHEMBL628075,,2106.0,22224,,1,,U,Distribution in the spleen after 60 min of intravenous administration,,,Spleen,0,,BAO_0000019
11820,8926,A,,Autocuration,CHEMBL628076,,2106.0,22224,,1,,U,Distribution in the spleen after 90 min of intravenous administration,,,Spleen,0,,BAO_0000019
11821,7570,A,,Intermediate,CHEMBL628077,,1235.0,50597,,1,,N,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,,Adrenal cortex,1,,BAO_0000218
11822,7570,A,,Intermediate,CHEMBL628078,,178.0,50597,,1,,N,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,,Blood,1,,BAO_0000218
11823,7570,A,,Intermediate,CHEMBL628079,,2107.0,50597,,1,,N,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,,Liver,1,,BAO_0000218
11824,7570,A,,Intermediate,CHEMBL628080,,992.0,50597,,1,,N,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,,Female gonad,1,,BAO_0000218
11825,7570,A,,Intermediate,CHEMBL628081,,2046.0,50597,,1,,N,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
11826,7570,A,,Intermediate,CHEMBL628082,,1235.0,50597,,1,,N,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,,Adrenal cortex,1,,BAO_0000218
11827,7570,A,,Intermediate,CHEMBL874647,,178.0,50597,,1,,N,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,,Blood,1,,BAO_0000218
11828,7570,A,,Intermediate,CHEMBL626406,,2107.0,50597,,1,,N,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,,Liver,1,,BAO_0000218
11829,7570,A,,Intermediate,CHEMBL626407,,992.0,50597,,1,,N,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,,Female gonad,1,,BAO_0000218
11830,7570,A,,Intermediate,CHEMBL626408,,2046.0,50597,,1,,N,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
11831,8608,A,,Intermediate,CHEMBL626409,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Rattus norvegicus,,Blood,1,,BAO_0000218
11832,8608,A,,Intermediate,CHEMBL626410,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Rattus norvegicus,,Blood,1,,BAO_0000218
11833,8608,A,,Intermediate,CHEMBL626411,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Rattus norvegicus,,Blood,1,,BAO_0000218
11834,8608,A,,Intermediate,CHEMBL626412,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Rattus norvegicus,,Blood,1,,BAO_0000218
11835,8608,A,,Intermediate,CHEMBL626413,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Rattus norvegicus,,Blood,1,,BAO_0000218
11836,8608,A,,Intermediate,CHEMBL626414,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Rattus norvegicus,,Blood,1,,BAO_0000218
11837,8608,A,,Intermediate,CHEMBL626415,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Rattus norvegicus,,Blood,1,,BAO_0000218
11838,8608,A,,Intermediate,CHEMBL626416,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Rattus norvegicus,,Blood,1,,BAO_0000218
11839,8608,A,,Intermediate,CHEMBL627062,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Rattus norvegicus,,Blood,1,,BAO_0000218
11840,8608,A,,Intermediate,CHEMBL627063,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Rattus norvegicus,,Blood,1,,BAO_0000218
11841,8608,A,,Intermediate,CHEMBL627064,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Rattus norvegicus,,Blood,1,,BAO_0000218
11842,8608,A,,Intermediate,CHEMBL627227,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Rattus norvegicus,,Blood,1,,BAO_0000218
11843,8608,A,,Intermediate,CHEMBL627228,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Rattus norvegicus,,Blood,1,,BAO_0000218
11844,8608,A,,Intermediate,CHEMBL627229,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Rattus norvegicus,,Blood,1,,BAO_0000218
11845,8608,A,,Intermediate,CHEMBL625792,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Rattus norvegicus,,Blood,1,,BAO_0000218
11846,8608,A,,Intermediate,CHEMBL625793,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Rattus norvegicus,,Blood,1,,BAO_0000218
11847,8608,A,,Intermediate,CHEMBL625794,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Rattus norvegicus,,Blood,1,,BAO_0000218
11848,8608,A,,Intermediate,CHEMBL625795,,178.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Rattus norvegicus,,Blood,1,,BAO_0000218
11849,13792,A,,Intermediate,CHEMBL625796,,,50594,,1,,N,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Mus musculus,,,1,,BAO_0000218
11850,13376,A,,Intermediate,CHEMBL625797,,,50588,,1,,N,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
11851,13376,A,,Intermediate,CHEMBL625798,,,50588,,1,,N,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
11852,14380,A,,Autocuration,CHEMBL875613,,,22224,,1,,U,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11853,14380,A,,Autocuration,CHEMBL625799,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11854,14380,A,,Autocuration,CHEMBL625800,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11855,14380,A,,Autocuration,CHEMBL625801,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11856,14380,A,,Autocuration,CHEMBL625802,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11857,14380,A,,Autocuration,CHEMBL625803,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11858,14380,A,,Autocuration,CHEMBL625804,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,,0,,BAO_0000019
11859,14380,A,,Autocuration,CHEMBL622530,,,22224,,1,,U,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,,0,,BAO_0000218
11860,13701,A,,Intermediate,CHEMBL622531,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Mus musculus,,,1,,BAO_0000218
11861,13701,A,,Intermediate,CHEMBL622532,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11862,13701,A,,Intermediate,CHEMBL623176,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11863,13701,A,,Intermediate,CHEMBL623177,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11864,13701,A,,Intermediate,CHEMBL623178,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11865,13701,A,,Intermediate,CHEMBL623179,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,,,1,,BAO_0000218
11866,13701,A,,Intermediate,CHEMBL623180,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11867,13701,A,,Intermediate,CHEMBL623181,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11868,13701,A,,Intermediate,CHEMBL624131,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11869,13701,A,,Intermediate,CHEMBL624132,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11870,13701,A,,Intermediate,CHEMBL624133,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11871,13701,A,,Intermediate,CHEMBL624846,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Mus musculus,,,1,,BAO_0000218
11872,13701,A,,Intermediate,CHEMBL624847,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11873,13701,A,,Intermediate,CHEMBL624848,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11874,13701,A,,Intermediate,CHEMBL625012,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11875,13701,A,,Intermediate,CHEMBL625013,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11876,13701,A,,Intermediate,CHEMBL625014,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,,,1,,BAO_0000218
11877,13701,A,,Intermediate,CHEMBL625015,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Mus musculus,,,1,,BAO_0000218
11878,13701,A,,Intermediate,CHEMBL625016,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11879,13701,A,,Intermediate,CHEMBL625017,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Mus musculus,,,1,,BAO_0000218
11880,13701,A,,Intermediate,CHEMBL625018,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11881,13701,A,,Intermediate,CHEMBL625019,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11882,13701,A,,Intermediate,CHEMBL625020,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
11883,13701,A,,Intermediate,CHEMBL625021,,,50594,,1,,N,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Mus musculus,,,1,,BAO_0000218
11884,14393,A,,Intermediate,CHEMBL625022,,,50597,,1,,N,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
11885,14731,A,,Intermediate,CHEMBL625023,,,50594,,1,,N,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Mus musculus,,,1,,BAO_0000218
11886,14731,A,,Intermediate,CHEMBL625024,,,100710,,1,,N,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Macaca fascicularis,,,1,,BAO_0000218
11887,14731,A,,Intermediate,CHEMBL627626,,,100710,,1,,N,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,,,1,,BAO_0000218
11888,13758,A,,Autocuration,CHEMBL627627,,955.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,Brain,0,,BAO_0000218
11889,13758,A,,Autocuration,CHEMBL627628,,1977.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,Serum,0,,BAO_0000218
11890,13758,A,,Autocuration,CHEMBL627629,,955.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,Brain,0,,BAO_0000218
11891,13758,A,,Autocuration,CHEMBL627630,,1977.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,Serum,0,,BAO_0000218
11892,16359,A,,Autocuration,CHEMBL627631,,,22224,,1,,U,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,,0,,BAO_0000019
11893,16359,A,,Autocuration,CHEMBL629515,,,22224,,1,,U,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,,0,,BAO_0000218
11894,15383,A,,Intermediate,CHEMBL629516,,2106.0,50594,,1,,N,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,Spleen,1,,BAO_0000218
11895,15383,A,,Intermediate,CHEMBL629517,,2106.0,50594,,1,,N,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,Spleen,1,,BAO_0000218
11896,15383,A,,Intermediate,CHEMBL629518,,2106.0,50594,,1,,N,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,Spleen,1,,BAO_0000218
11897,15383,A,,Intermediate,CHEMBL877499,,,50594,,1,,N,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,,,1,,BAO_0000218
11898,15383,A,,Intermediate,CHEMBL629519,,,50594,,1,,N,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,,,1,,BAO_0000218
11899,15383,A,,Intermediate,CHEMBL629520,,,50594,,1,,N,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,,,1,,BAO_0000218
11900,15383,A,,Intermediate,CHEMBL629521,,,50594,,1,,N,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,,,1,,BAO_0000218
11901,14439,A,,Intermediate,CHEMBL629522,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Mus musculus,,,1,,BAO_0000218
11902,14439,A,,Intermediate,CHEMBL629523,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Mus musculus,,,1,,BAO_0000218
11903,14439,A,,Intermediate,CHEMBL629524,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,1,,BAO_0000218
11904,14439,A,,Intermediate,CHEMBL629525,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Mus musculus,,,1,,BAO_0000218
11905,14439,A,,Intermediate,CHEMBL629526,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Mus musculus,,,1,,BAO_0000218
11906,14439,A,,Intermediate,CHEMBL629527,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Mus musculus,,,1,,BAO_0000218
11907,14439,A,,Intermediate,CHEMBL629528,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,1,,BAO_0000218
11908,14439,A,,Intermediate,CHEMBL629529,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Mus musculus,,,1,,BAO_0000218
11909,14439,A,,Intermediate,CHEMBL629530,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Mus musculus,,,1,,BAO_0000218
11910,14439,A,,Intermediate,CHEMBL629531,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Mus musculus,,,1,,BAO_0000218
11911,14439,A,,Intermediate,CHEMBL628656,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Mus musculus,,,1,,BAO_0000218
11912,14439,A,,Intermediate,CHEMBL628657,,,50594,,1,,N,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Mus musculus,,,1,,BAO_0000218
11913,13751,A,,Intermediate,CHEMBL628658,In vivo,,50597,,1,,N,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11914,13751,A,,Intermediate,CHEMBL628659,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11915,13751,A,,Intermediate,CHEMBL877500,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11916,13751,A,,Intermediate,CHEMBL628660,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11917,13751,A,,Intermediate,CHEMBL628661,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11918,13751,A,,Intermediate,CHEMBL628662,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11919,13751,A,,Intermediate,CHEMBL628663,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11920,13751,A,,Intermediate,CHEMBL628664,In vivo,,50597,,1,,N,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
11921,13751,A,,Intermediate,CHEMBL628665,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11922,13751,A,,Intermediate,CHEMBL628666,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11923,13751,A,,Intermediate,CHEMBL628667,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11924,13751,A,,Intermediate,CHEMBL628668,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11925,13751,A,,Intermediate,CHEMBL628669,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11926,13751,A,,Intermediate,CHEMBL628670,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11927,13751,A,,Intermediate,CHEMBL628671,In vivo,178.0,50597,,1,,N,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Blood,1,,BAO_0000218
11928,13751,A,,Intermediate,CHEMBL628672,In vivo,10000001.0,50597,,1,,N,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Bone,1,,BAO_0000218
11929,13751,A,,Intermediate,CHEMBL630300,In vivo,10000001.0,50597,,1,,N,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Bone,1,,BAO_0000218
11930,13751,A,,Intermediate,CHEMBL629787,In vivo,10000001.0,50597,,1,,N,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Bone,1,,BAO_0000218
11931,13751,A,,Intermediate,CHEMBL629788,In vivo,10000001.0,50597,,1,,N,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Bone,1,,BAO_0000218
11932,13751,A,,Intermediate,CHEMBL629789,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11933,13751,A,,Intermediate,CHEMBL629790,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11934,13751,A,,Intermediate,CHEMBL629791,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11935,13751,A,,Intermediate,CHEMBL629792,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11936,13751,A,,Intermediate,CHEMBL629793,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11937,13751,A,,Intermediate,CHEMBL629794,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
11938,10677,A,,Intermediate,CHEMBL874459,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Rattus norvegicus,,,1,,BAO_0000218
11939,10677,A,,Intermediate,CHEMBL629795,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Rattus norvegicus,,,1,,BAO_0000218
11940,10677,A,,Intermediate,CHEMBL629796,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Rattus norvegicus,,,1,,BAO_0000218
11941,10677,A,,Intermediate,CHEMBL629797,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Rattus norvegicus,,,1,,BAO_0000218
11942,10677,A,,Intermediate,CHEMBL629798,,,50597,,1,,N,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Rattus norvegicus,,,1,,BAO_0000218
11943,10911,A,,Intermediate,CHEMBL629799,In vivo,2369.0,50597,,1,,N,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Adrenal gland,1,,BAO_0000218
11944,10911,A,,Intermediate,CHEMBL629800,In vivo,2369.0,50597,,1,,N,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Adrenal gland,1,,BAO_0000218
11945,10911,A,,Intermediate,CHEMBL629801,In vivo,2369.0,50597,,1,,N,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Adrenal gland,1,,BAO_0000218
11946,10911,A,,Intermediate,CHEMBL629802,In vivo,2369.0,50597,,1,,N,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Rattus norvegicus,,Adrenal gland,1,,BAO_0000218
11947,10911,A,,Intermediate,CHEMBL629803,In vivo,2369.0,50597,,1,,N,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Adrenal gland,1,,BAO_0000218
11948,10911,A,,Intermediate,CHEMBL629804,In vivo,178.0,50597,,1,,N,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Blood,1,,BAO_0000218
11949,10911,A,,Intermediate,CHEMBL629805,In vivo,178.0,50597,,1,,N,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Blood,1,,BAO_0000218
11950,10911,A,,Intermediate,CHEMBL629806,In vivo,178.0,50597,,1,,N,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,Blood,1,,BAO_0000218
11951,10911,A,,Intermediate,CHEMBL629807,In vivo,178.0,50597,,1,,N,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Blood,1,,BAO_0000218
11952,10911,A,,Intermediate,CHEMBL629808,In vivo,178.0,50597,,1,,N,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Blood,1,,BAO_0000218
11953,10911,A,,Intermediate,CHEMBL629809,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11954,10911,A,,Intermediate,CHEMBL629810,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11955,10911,A,,Intermediate,CHEMBL629811,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11956,10911,A,,Intermediate,CHEMBL629812,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11957,10911,A,,Intermediate,CHEMBL629813,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11958,10911,A,,Intermediate,CHEMBL874460,In vivo,955.0,50597,,1,,N,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Brain,1,,BAO_0000218
11959,10911,A,,Intermediate,CHEMBL629814,In vivo,,50597,,1,,N,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,,1,,BAO_0000218
11960,10911,A,,Intermediate,CHEMBL629815,In vivo,,50597,,1,,N,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,1,,BAO_0000218
11961,10911,A,,Intermediate,CHEMBL629816,In vivo,,50597,,1,,N,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,1,,BAO_0000218
11962,10911,A,,Intermediate,CHEMBL629817,In vivo,,50597,,1,,N,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,,1,,BAO_0000218
11963,10911,A,,Intermediate,CHEMBL626643,In vivo,2113.0,50597,,1,,N,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Kidney,1,,BAO_0000218
11964,10911,A,,Intermediate,CHEMBL626644,In vivo,2113.0,50597,,1,,N,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Kidney,1,,BAO_0000218
11965,10911,A,,Intermediate,CHEMBL626806,In vivo,2113.0,50597,,1,,N,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Kidney,1,,BAO_0000218
11966,10911,A,,Intermediate,CHEMBL626807,In vivo,2113.0,50597,,1,,N,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Kidney,1,,BAO_0000218
11967,10911,A,,Intermediate,CHEMBL627261,In vivo,2107.0,50597,,1,,N,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Liver,1,,BAO_0000218
11968,10911,A,,Intermediate,CHEMBL627262,In vivo,2107.0,50597,,1,,N,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Liver,1,,BAO_0000218
11969,10911,A,,Intermediate,CHEMBL627263,In vivo,2107.0,50597,,1,,N,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Liver,1,,BAO_0000218
11970,10911,A,,Intermediate,CHEMBL627264,In vivo,2107.0,50597,,1,,N,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Liver,1,,BAO_0000218
11971,10911,A,,Intermediate,CHEMBL627265,In vivo,2048.0,50597,,1,,N,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Lung,1,,BAO_0000218
11972,10911,A,,Intermediate,CHEMBL627266,In vivo,2048.0,50597,,1,,N,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Lung,1,,BAO_0000218
11973,10911,A,,Intermediate,CHEMBL627267,In vivo,2048.0,50597,,1,,N,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Lung,1,,BAO_0000218
11974,10911,A,,Intermediate,CHEMBL627268,In vivo,2048.0,50597,,1,,N,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Lung,1,,BAO_0000218
11975,10911,A,,Intermediate,CHEMBL627269,In vivo,2385.0,50597,,1,,N,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11976,10911,A,,Intermediate,CHEMBL627270,In vivo,2385.0,50597,,1,,N,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
11977,8608,A,,Intermediate,CHEMBL627271,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Rattus norvegicus,,,1,,BAO_0000218
11978,8608,A,,Intermediate,CHEMBL627946,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Rattus norvegicus,,,1,,BAO_0000218
11979,8608,A,,Intermediate,CHEMBL875472,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Rattus norvegicus,,,1,,BAO_0000218
11980,8608,A,,Intermediate,CHEMBL627947,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Rattus norvegicus,,,1,,BAO_0000218
11981,8608,A,,Intermediate,CHEMBL627948,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Rattus norvegicus,,,1,,BAO_0000218
11982,8608,A,,Intermediate,CHEMBL628113,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Rattus norvegicus,,,1,,BAO_0000218
11983,8608,A,,Intermediate,CHEMBL628114,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Rattus norvegicus,,,1,,BAO_0000218
11984,8608,A,,Intermediate,CHEMBL628115,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Rattus norvegicus,,,1,,BAO_0000218
11985,8608,A,,Intermediate,CHEMBL628116,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Rattus norvegicus,,,1,,BAO_0000218
11986,8608,A,,Intermediate,CHEMBL628117,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Rattus norvegicus,,,1,,BAO_0000218
11987,8608,A,,Intermediate,CHEMBL628118,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Rattus norvegicus,,,1,,BAO_0000218
11988,8608,A,,Intermediate,CHEMBL628119,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Rattus norvegicus,,,1,,BAO_0000218
11989,8608,A,,Intermediate,CHEMBL628120,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Rattus norvegicus,,,1,,BAO_0000218
11990,8608,A,,Intermediate,CHEMBL628121,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Rattus norvegicus,,,1,,BAO_0000218
11991,8608,A,,Intermediate,CHEMBL628122,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Rattus norvegicus,,,1,,BAO_0000218
11992,8608,A,,Intermediate,CHEMBL627297,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Rattus norvegicus,,,1,,BAO_0000218
11993,8608,A,,Intermediate,CHEMBL627298,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Rattus norvegicus,,,1,,BAO_0000218
11994,8608,A,,Intermediate,CHEMBL627299,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Rattus norvegicus,,,1,,BAO_0000218
11995,8608,A,,Intermediate,CHEMBL627300,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Rattus norvegicus,,,1,,BAO_0000218
11996,8608,A,,Intermediate,CHEMBL627301,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Rattus norvegicus,,,1,,BAO_0000218
11997,8608,A,,Intermediate,CHEMBL627302,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Rattus norvegicus,,,1,,BAO_0000218
11998,8608,A,,Intermediate,CHEMBL627303,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Rattus norvegicus,,,1,,BAO_0000218
11999,8608,A,,Intermediate,CHEMBL627304,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Rattus norvegicus,,,1,,BAO_0000218
12000,8608,A,,Intermediate,CHEMBL627305,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Rattus norvegicus,,,1,,BAO_0000218
12001,8608,A,,Intermediate,CHEMBL627306,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,,,1,,BAO_0000218
12002,8608,A,,Intermediate,CHEMBL623982,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Rattus norvegicus,,,1,,BAO_0000218
12003,8608,A,,Intermediate,CHEMBL623983,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Rattus norvegicus,,,1,,BAO_0000218
12004,8608,A,,Intermediate,CHEMBL623984,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Rattus norvegicus,,,1,,BAO_0000218
12005,8608,A,,Intermediate,CHEMBL623985,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Rattus norvegicus,,,1,,BAO_0000218
12006,8608,A,,Intermediate,CHEMBL623986,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Rattus norvegicus,,,1,,BAO_0000218
12007,8608,A,,Intermediate,CHEMBL623987,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Rattus norvegicus,,,1,,BAO_0000218
12008,8608,A,,Intermediate,CHEMBL623988,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Rattus norvegicus,,,1,,BAO_0000218
12009,8608,A,,Intermediate,CHEMBL623989,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Rattus norvegicus,,,1,,BAO_0000218
12010,8608,A,,Intermediate,CHEMBL622215,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Rattus norvegicus,,,1,,BAO_0000218
12011,8608,A,,Intermediate,CHEMBL622216,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Rattus norvegicus,,,1,,BAO_0000218
12012,8608,A,,Intermediate,CHEMBL877481,,,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Rattus norvegicus,,,1,,BAO_0000218
12013,16359,A,,Autocuration,CHEMBL622217,,,22224,,1,,U,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,,0,,BAO_0000218
12014,13701,A,,Intermediate,CHEMBL622218,,,50594,,1,,N,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,,,1,,BAO_0000218
12015,14554,A,,Intermediate,CHEMBL622219,,,50597,,1,,N,Pharmacokinetic profile AUC was evaluated in rats,Rattus norvegicus,,,1,,BAO_0000218
12016,6241,A,,Autocuration,CHEMBL622220,,,22224,,1,,U,Pharmacokinetic property (Area under curve),,,,0,,BAO_0000019
12017,11537,A,,Intermediate,CHEMBL622221,,,50588,,1,,N,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Canis lupus familiaris,,,1,,BAO_0000218
12018,11537,A,,Intermediate,CHEMBL622222,,,50594,,1,,N,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Mus musculus,,,1,,BAO_0000218
12019,11537,A,,Intermediate,CHEMBL622223,,,50588,,1,,N,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Canis lupus familiaris,,,1,,BAO_0000218
12020,11537,A,,Intermediate,CHEMBL622224,,,50594,,1,,N,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Mus musculus,,,1,,BAO_0000218
12021,13118,A,,Autocuration,CHEMBL622225,,,22224,,1,,U,Plasma concentration (AUC) was determined,,,,0,,BAO_0000019
12022,13118,A,,Autocuration,CHEMBL622226,,,22224,,1,,U,Plasma concentration (AUC) was determined; Not detectable,,,,0,,BAO_0000019
12023,9562,A,,Intermediate,CHEMBL624154,,,50512,,1,,N,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Cavia porcellus,,,1,,BAO_0000218
12024,10363,A,,Intermediate,CHEMBL624155,,,50597,,1,,N,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12025,10363,A,,Intermediate,CHEMBL624156,,,50597,,1,,N,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,,,1,,BAO_0000218
12026,10363,A,,Intermediate,CHEMBL624157,,,50597,,1,,N,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12027,10363,A,,Intermediate,CHEMBL624158,,,50597,,1,,N,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12028,12504,A,,Intermediate,CHEMBL624159,,,50597,,1,,N,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,,,1,,BAO_0000218
12029,12504,A,,Intermediate,CHEMBL624160,,,50597,,1,,N,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,,,1,,BAO_0000218
12030,12504,A,,Intermediate,CHEMBL624161,,,50597,,1,,N,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,,,1,,BAO_0000218
12031,12504,A,,Intermediate,CHEMBL624162,,,50597,,1,,N,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,,,1,,BAO_0000218
12032,13317,A,,Intermediate,CHEMBL624163,,,50588,,1,,N,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Canis lupus familiaris,,,1,,BAO_0000218
12033,15078,A,,Intermediate,CHEMBL624164,,,50597,,1,,N,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
12034,14941,A,,Intermediate,CHEMBL624165,,,50597,,1,,N,The AUC(0-infinity) values in female wistar rats.,Rattus norvegicus,,,1,,BAO_0000218
12035,15078,A,,Intermediate,CHEMBL624166,,,50597,,1,,N,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
12036,15078,A,,Intermediate,CHEMBL624167,,,50597,,1,,N,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Rattus norvegicus,,,1,,BAO_0000218
12037,14941,A,,Intermediate,CHEMBL624168,,,50597,,1,,N,The AUC(0-t)values in female wistar rats.,Rattus norvegicus,,,1,,BAO_0000218
12038,14067,A,,Intermediate,CHEMBL624169,,,50597,,1,,N,The Area under the concentration time curve of compound was measured on rats,Rattus norvegicus,,,1,,BAO_0000218
12039,14215,A,,Intermediate,CHEMBL624170,,,50587,,1,,N,The area under curve (100 mg/kg) administered orally in humans,Homo sapiens,,,1,,BAO_0000218
12040,14215,A,,Autocuration,CHEMBL624171,,,22224,,1,,U,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Callithrix,,,0,,BAO_0000218
12041,14215,A,,Autocuration,CHEMBL624172,,,22224,,1,,U,The area under curve (12.5 mg/kg) administered intravenously in monkey,Simiiformes,,,0,,BAO_0000218
12042,14215,A,,Intermediate,CHEMBL624173,,,50588,,1,,N,The area under curve (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,,,1,,BAO_0000218
12043,14215,A,,Intermediate,CHEMBL877488,,,50587,,1,,N,The area under curve (200 mg/kg) administered orally in humans,Homo sapiens,,,1,,BAO_0000218
12044,14215,A,,Intermediate,CHEMBL624174,,,50597,,1,,N,The area under curve (25 mg/kg) administered intravenously in rat,Rattus norvegicus,,,1,,BAO_0000218
12045,14215,A,,Autocuration,CHEMBL624175,,,22224,,1,,U,The area under curve (25 mg/kg) administered orally in marmoset,Callithrix,,,0,,BAO_0000218
12046,14215,A,,Autocuration,CHEMBL624176,,,22224,,1,,U,The area under curve (25 mg/kg) administered orally in monkey,Simiiformes,,,0,,BAO_0000218
12047,14215,A,,Intermediate,CHEMBL624177,,,50588,,1,,N,The area under curve (30 mg/kg) administered orally in dog,Canis lupus familiaris,,,1,,BAO_0000218
12048,14215,A,,Intermediate,CHEMBL624178,,,50587,,1,,N,The area under curve (400 mg/kg) administered orally in humans,Homo sapiens,,,1,,BAO_0000218
12049,14215,A,,Intermediate,CHEMBL624179,,,50597,,1,,N,The area under curve (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,,,1,,BAO_0000218
12050,14215,A,,Intermediate,CHEMBL627689,,,50597,,1,,N,The area under curve (50 mg/kg) administered orally in rat,Rattus norvegicus,,,1,,BAO_0000218
12051,14215,A,,Intermediate,CHEMBL627690,,,50587,,1,,N,The area under curve (800 mg/kg) administered orally in humans,Homo sapiens,,,1,,BAO_0000218
12052,11324,A,,Autocuration,CHEMBL627691,,,22224,,1,,U,The compound was evaluated for area under the curve,,,,0,,BAO_0000019
12053,11324,A,,Autocuration,CHEMBL627692,,,22224,,1,,U,The compound was evaluated for area under the curve in marmosets,Callithrix,,,0,,BAO_0000019
12054,11324,A,,Autocuration,CHEMBL627693,,,22224,,1,,U,The compound was evaluated for area under the curve in marmosets,Callithrix,,,0,,BAO_0000019
12055,13875,A,,Intermediate,CHEMBL627694,,,50597,,1,,N,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,1,,BAO_0000218
12056,13875,A,,Intermediate,CHEMBL627695,,,50597,,1,,N,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,1,,BAO_0000218
12057,13875,A,,Autocuration,CHEMBL627696,,,22224,,1,,U,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,,0,,BAO_0000218
12058,13875,A,,Intermediate,CHEMBL627697,,,50597,,1,,N,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,1,,BAO_0000218
12059,13875,A,,Intermediate,CHEMBL627698,,,50597,,1,,N,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,1,,BAO_0000218
12060,13875,A,,Intermediate,CHEMBL627699,,,50597,,1,,N,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,,,1,,BAO_0000218
12061,13807,A,,Intermediate,CHEMBL627700,,,50597,,1,,N,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Rattus norvegicus,,,1,,BAO_0000218
12062,14127,A,,Intermediate,CHEMBL627701,,,50597,,1,,N,Total drug exposure is determined after oral dosing in rats.,Rattus norvegicus,,,1,,BAO_0000218
12063,15116,A,,Autocuration,CHEMBL627702,,,22224,,1,,U,Total drug exposure (5 mg/kg) when administered intravenously,,,,0,,BAO_0000218
12064,15116,A,,Autocuration,CHEMBL627703,,,22224,,1,,U,Total drug exposure (5 mg/kg) when administered orally,,,,0,,BAO_0000218
12065,15604,A,,Autocuration,CHEMBL626873,,,22224,,1,,U,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,,,0,,BAO_0000218
12066,15604,A,,Intermediate,CHEMBL629583,,,50597,,1,,N,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
12067,15604,A,,Intermediate,CHEMBL629584,,,50588,,1,,N,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,,,1,,BAO_0000218
12068,15604,A,,Intermediate,CHEMBL629585,,,50588,,1,,N,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,,,1,,BAO_0000218
12069,13751,A,,Intermediate,CHEMBL629586,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
12070,13751,A,,Intermediate,CHEMBL629587,In vivo,955.0,50597,,1,,N,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Brain,1,,BAO_0000218
12071,13751,A,,Intermediate,CHEMBL629588,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12072,13751,A,,Intermediate,CHEMBL629589,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12073,13751,A,,Intermediate,CHEMBL629590,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12074,13751,A,,Intermediate,CHEMBL629591,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12075,13751,A,,Intermediate,CHEMBL629592,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12076,13751,A,,Intermediate,CHEMBL629593,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12077,13751,A,,Intermediate,CHEMBL629594,In vivo,,50597,,1,,N,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12078,13751,A,,Intermediate,CHEMBL629595,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12079,13751,A,,Intermediate,CHEMBL630290,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12080,13751,A,,Intermediate,CHEMBL627137,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12081,13751,A,,Intermediate,CHEMBL627138,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12082,13751,A,,Intermediate,CHEMBL627139,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12083,13751,A,,Intermediate,CHEMBL627140,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12084,13751,A,,Intermediate,CHEMBL627141,In vivo,948.0,50597,,1,,N,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Heart,1,,BAO_0000218
12085,13751,A,,Intermediate,CHEMBL627142,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12086,13751,A,,Intermediate,CHEMBL627143,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12087,13751,A,,Intermediate,CHEMBL874449,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12088,13751,A,,Intermediate,CHEMBL627144,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12089,13751,A,,Intermediate,CHEMBL627145,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12090,13751,A,,Intermediate,CHEMBL627146,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12091,13751,A,,Intermediate,CHEMBL627147,In vivo,2113.0,50597,,1,,N,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Kidney,1,,BAO_0000218
12092,13751,A,,Intermediate,CHEMBL627148,In vivo,2107.0,50597,,1,,N,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12093,13751,A,,Intermediate,CHEMBL627149,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12094,13751,A,,Intermediate,CHEMBL632160,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12095,13751,A,,Intermediate,CHEMBL632161,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12096,13751,A,,Intermediate,CHEMBL632162,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12097,13751,A,,Intermediate,CHEMBL632163,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12098,13751,A,,Intermediate,CHEMBL874469,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12099,13751,A,,Intermediate,CHEMBL627182,In vivo,2048.0,50597,,1,,N,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Lung,1,,BAO_0000218
12100,13751,A,,Intermediate,CHEMBL627183,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12101,13751,A,,Intermediate,CHEMBL627184,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12102,13751,A,,Intermediate,CHEMBL627185,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12103,13751,A,,Intermediate,CHEMBL627186,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12104,13751,A,,Intermediate,CHEMBL627187,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12105,13751,A,,Intermediate,CHEMBL627188,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12106,13751,A,,Intermediate,CHEMBL627189,In vivo,2385.0,50597,,1,,N,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12107,13751,A,,Intermediate,CHEMBL627190,In vivo,,50597,,1,,N,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,,1,,BAO_0000218
12108,13751,A,,Intermediate,CHEMBL627191,In vivo,2107.0,50597,,1,,N,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12109,13751,A,,Intermediate,CHEMBL627192,In vivo,2107.0,50597,,1,,N,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12110,13751,A,,Intermediate,CHEMBL627193,In vivo,2107.0,50597,,1,,N,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12111,10911,A,,Intermediate,CHEMBL874590,In vivo,2385.0,50597,,1,,N,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12112,10911,A,,Intermediate,CHEMBL627194,In vivo,2385.0,50597,,1,,N,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12113,10911,A,,Intermediate,CHEMBL627195,In vivo,2385.0,50597,,1,,N,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12114,10911,A,,Intermediate,CHEMBL627196,In vivo,992.0,50597,,1,,N,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Female gonad,1,,BAO_0000218
12115,10911,A,,Intermediate,CHEMBL627197,In vivo,992.0,50597,,1,,N,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Female gonad,1,,BAO_0000218
12116,10911,A,,Intermediate,CHEMBL627198,In vivo,992.0,50597,,1,,N,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Female gonad,1,,BAO_0000218
12117,10911,A,,Intermediate,CHEMBL627199,In vivo,992.0,50597,,1,,N,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Rattus norvegicus,,Female gonad,1,,BAO_0000218
12118,10911,A,,Intermediate,CHEMBL627200,In vivo,992.0,50597,,1,,N,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Female gonad,1,,BAO_0000218
12119,10911,A,,Intermediate,CHEMBL627201,In vivo,1969.0,50597,,1,,N,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Plasma,1,,BAO_0000218
12120,10911,A,,Intermediate,CHEMBL627202,In vivo,1969.0,50597,,1,,N,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Plasma,1,,BAO_0000218
12121,10911,A,,Intermediate,CHEMBL627203,In vivo,1969.0,50597,,1,,N,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Plasma,1,,BAO_0000218
12122,10911,A,,Intermediate,CHEMBL627204,In vivo,1969.0,50597,,1,,N,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Plasma,1,,BAO_0000218
12123,10911,A,,Intermediate,CHEMBL627205,In vivo,2106.0,50597,,1,,N,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Spleen,1,,BAO_0000218
12124,10911,A,,Intermediate,CHEMBL627206,In vivo,2106.0,50597,,1,,N,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Spleen,1,,BAO_0000218
12125,10911,A,,Intermediate,CHEMBL627207,In vivo,2106.0,50597,,1,,N,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Spleen,1,,BAO_0000218
12126,10911,A,,Intermediate,CHEMBL627208,In vivo,2106.0,50597,,1,,N,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Spleen,1,,BAO_0000218
12127,10911,A,,Intermediate,CHEMBL627209,In vivo,2046.0,50597,,1,,N,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12128,10911,A,,Intermediate,CHEMBL627210,In vivo,2046.0,50597,,1,,N,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12129,10911,A,,Intermediate,CHEMBL627211,In vivo,2046.0,50597,,1,,N,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12130,10911,A,,Intermediate,CHEMBL627212,In vivo,2046.0,50597,,1,,N,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12131,10911,A,,Intermediate,CHEMBL627213,In vivo,995.0,50597,,1,,N,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,,Uterus,1,,BAO_0000218
12132,10911,A,,Intermediate,CHEMBL626599,In vivo,995.0,50597,,1,,N,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Uterus,1,,BAO_0000218
12133,10911,A,,Intermediate,CHEMBL626600,In vivo,995.0,50597,,1,,N,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Uterus,1,,BAO_0000218
12134,10911,A,,Intermediate,CHEMBL626601,In vivo,995.0,50597,,1,,N,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,,Uterus,1,,BAO_0000218
12135,8081,A,,Autocuration,CHEMBL627484,,,22224,,1,,U,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,,0,,BAO_0000019
12136,17248,A,,Intermediate,CHEMBL627485,,1969.0,100710,,1,,N,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Macaca fascicularis,,Plasma,1,,BAO_0000218
12137,17248,A,,Intermediate,CHEMBL628147,,1969.0,100710,,1,,N,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Macaca fascicularis,,Plasma,1,,BAO_0000218
12138,17248,A,,Intermediate,CHEMBL628148,,1969.0,100710,,1,,N,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Macaca fascicularis,,Plasma,1,,BAO_0000218
12139,17248,A,,Intermediate,CHEMBL628149,,1969.0,50588,,1,,N,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Canis lupus familiaris,,Plasma,1,,BAO_0000218
12140,17248,A,,Intermediate,CHEMBL628150,,1969.0,50588,,1,,N,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12141,17248,A,,Intermediate,CHEMBL628318,,1969.0,50588,,1,,N,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12142,17248,A,,Intermediate,CHEMBL628319,,1969.0,50588,,1,,N,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12143,15592,A,,Intermediate,CHEMBL875609,,,50588,,1,,N,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,,,1,,BAO_0000218
12144,7040,A,,Autocuration,CHEMBL628320,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,,0,,BAO_0000019
12145,7040,A,,Autocuration,CHEMBL628321,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,,0,,BAO_0000019
12146,7040,A,,Autocuration,CHEMBL628322,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,,0,,BAO_0000019
12147,7040,A,,Autocuration,CHEMBL628323,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,,0,,BAO_0000019
12148,7040,A,,Autocuration,CHEMBL628324,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,,0,,BAO_0000019
12149,7040,A,,Autocuration,CHEMBL628325,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,,0,,BAO_0000019
12150,7040,A,,Autocuration,CHEMBL628326,,,22224,,1,,U,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,,0,,BAO_0000019
12151,9614,A,,Intermediate,CHEMBL628327,,1236.0,50588,,1,,N,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12152,9614,A,,Intermediate,CHEMBL628328,,1236.0,50588,,1,,N,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12153,9614,A,,Intermediate,CHEMBL628329,,178.0,50588,,1,,N,"Concentration of compound in blood of dog 1, after administering intravenously",Canis lupus familiaris,,Blood,1,,BAO_0000218
12154,8608,A,,Intermediate,CHEMBL628330,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Rattus norvegicus,,Liver,1,,BAO_0000218
12155,8608,A,,Intermediate,CHEMBL628331,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Rattus norvegicus,,Liver,1,,BAO_0000218
12156,8608,A,,Intermediate,CHEMBL628332,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Rattus norvegicus,,Liver,1,,BAO_0000218
12157,8608,A,,Intermediate,CHEMBL628333,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Rattus norvegicus,,Liver,1,,BAO_0000218
12158,8608,A,,Intermediate,CHEMBL628334,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Rattus norvegicus,,Liver,1,,BAO_0000218
12159,8608,A,,Intermediate,CHEMBL628335,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Rattus norvegicus,,Liver,1,,BAO_0000218
12160,8608,A,,Intermediate,CHEMBL628336,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Rattus norvegicus,,Liver,1,,BAO_0000218
12161,8608,A,,Intermediate,CHEMBL628337,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,,Liver,1,,BAO_0000218
12162,8608,A,,Intermediate,CHEMBL628338,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Rattus norvegicus,,Liver,1,,BAO_0000218
12163,8608,A,,Intermediate,CHEMBL875610,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Rattus norvegicus,,Liver,1,,BAO_0000218
12164,8608,A,,Intermediate,CHEMBL628339,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Rattus norvegicus,,Liver,1,,BAO_0000218
12165,8608,A,,Intermediate,CHEMBL628340,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Rattus norvegicus,,Liver,1,,BAO_0000218
12166,8608,A,,Intermediate,CHEMBL628341,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Rattus norvegicus,,Liver,1,,BAO_0000218
12167,8608,A,,Intermediate,CHEMBL622214,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Rattus norvegicus,,Liver,1,,BAO_0000218
12168,8608,A,,Intermediate,CHEMBL623167,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Rattus norvegicus,,Liver,1,,BAO_0000218
12169,8608,A,,Intermediate,CHEMBL623168,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Rattus norvegicus,,Liver,1,,BAO_0000218
12170,8608,A,,Intermediate,CHEMBL623169,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Rattus norvegicus,,Liver,1,,BAO_0000218
12171,8608,A,,Intermediate,CHEMBL623170,,2107.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Rattus norvegicus,,Liver,1,,BAO_0000218
12172,8608,A,,Intermediate,CHEMBL627224,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Rattus norvegicus,,Lung,1,,BAO_0000218
12173,8608,A,,Intermediate,CHEMBL875634,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Rattus norvegicus,,Lung,1,,BAO_0000218
12174,8608,A,,Intermediate,CHEMBL627225,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Rattus norvegicus,,Lung,1,,BAO_0000218
12175,8608,A,,Intermediate,CHEMBL627226,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Rattus norvegicus,,Lung,1,,BAO_0000218
12176,8608,A,,Intermediate,CHEMBL626083,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Rattus norvegicus,,Lung,1,,BAO_0000218
12177,8608,A,,Intermediate,CHEMBL626084,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Rattus norvegicus,,Lung,1,,BAO_0000218
12178,8608,A,,Intermediate,CHEMBL626085,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Rattus norvegicus,,Lung,1,,BAO_0000218
12179,8608,A,,Intermediate,CHEMBL626086,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Rattus norvegicus,,Lung,1,,BAO_0000218
12180,8608,A,,Intermediate,CHEMBL626087,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Rattus norvegicus,,Lung,1,,BAO_0000218
12181,8608,A,,Intermediate,CHEMBL626088,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Rattus norvegicus,,Lung,1,,BAO_0000218
12182,8608,A,,Intermediate,CHEMBL626089,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Rattus norvegicus,,Lung,1,,BAO_0000218
12183,8608,A,,Intermediate,CHEMBL626090,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Rattus norvegicus,,Lung,1,,BAO_0000218
12184,8608,A,,Intermediate,CHEMBL626091,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Rattus norvegicus,,Lung,1,,BAO_0000218
12185,8608,A,,Intermediate,CHEMBL626092,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Rattus norvegicus,,Lung,1,,BAO_0000218
12186,8608,A,,Intermediate,CHEMBL626093,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Rattus norvegicus,,Lung,1,,BAO_0000218
12187,8608,A,,Intermediate,CHEMBL626094,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Rattus norvegicus,,Lung,1,,BAO_0000218
12188,8608,A,,Intermediate,CHEMBL626095,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Rattus norvegicus,,Lung,1,,BAO_0000218
12189,8608,A,,Intermediate,CHEMBL626096,,2048.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Rattus norvegicus,,Lung,1,,BAO_0000218
12190,15604,A,,Autocuration,CHEMBL626097,,,22224,,1,,U,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,,,0,,BAO_0000218
12191,15604,A,,Intermediate,CHEMBL626098,,,50597,,1,,N,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
12192,1806,A,,Autocuration,CHEMBL626099,,1969.0,22224,,1,,U,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,Plasma,0,,BAO_0000218
12193,1806,A,,Autocuration,CHEMBL626100,,1969.0,22224,,1,,U,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,Plasma,0,,BAO_0000218
12194,17237,A,,Intermediate,CHEMBL626101,,1969.0,50588,,1,,N,AUC 0-inf in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12195,17237,A,,Intermediate,CHEMBL626102,,1969.0,50512,,1,,N,AUC 0-inf in guinea pig,Cavia porcellus,,Plasma,1,,BAO_0000218
12196,17237,A,,Intermediate,CHEMBL626103,,1969.0,50588,,1,,N,AUC 0-t in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12197,17237,A,,Intermediate,CHEMBL628391,,1969.0,50512,,1,,N,AUC 0-t in guinea pig,Cavia porcellus,,Plasma,1,,BAO_0000218
12198,15194,A,,Intermediate,CHEMBL628392,,,50597,,1,,N,The compound was tested for brain to plasma partition in rat,Rattus norvegicus,,,1,,BAO_0000218
12199,15194,A,,Intermediate,CHEMBL628393,,,50597,,1,,N,The compound was tested for brain to plasma partition in rat.,Rattus norvegicus,,,1,,BAO_0000218
12200,8787,A,,Autocuration,CHEMBL628394,,178.0,22224,,1,,U,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,Blood,0,,BAO_0000019
12201,17025,A,,Intermediate,CHEMBL628395,,,50588,,1,,N,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,1,,BAO_0000218
12202,17025,A,,Autocuration,CHEMBL628396,,,22224,,1,,U,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,0,,BAO_0000218
12203,17025,A,,Intermediate,CHEMBL628397,,,50592,,1,,N,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,1,,BAO_0000218
12204,17025,A,,Intermediate,CHEMBL628398,,,50597,,1,,N,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,1,,BAO_0000218
12205,4236,A,,Intermediate,CHEMBL628399,,,50797,,1,,N,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,,,1,,BAO_0000218
12206,15343,A,,Intermediate,CHEMBL628400,,,50588,,1,,N,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,,,1,,BAO_0000218
12207,15343,A,,Intermediate,CHEMBL874907,,,50597,,1,,N,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
12208,17720,A,,Autocuration,CHEMBL628401,,,22224,,1,,U,Area under curve of the compound was determined,,,,0,,BAO_0000019
12209,17788,A,,Autocuration,CHEMBL628402,,1969.0,22224,,1,,U,AUC in monkeys at a dose of 1 mg/kg,Simiiformes,,Plasma,0,,BAO_0000218
12210,17788,A,,Intermediate,CHEMBL628403,,1969.0,50597,,1,,N,AUC in rats at a dose of 1 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
12211,8778,A,,Autocuration,CHEMBL628404,,,22224,,1,,U,Compound was evaluated for the overall absorbance loss at pH of 2,,,,0,,BAO_0000019
12212,8778,A,,Autocuration,CHEMBL628405,,,22224,,1,,U,Compound was evaluated for the overall absorbance loss at pH of 4,,,,0,,BAO_0000019
12213,8778,A,,Autocuration,CHEMBL628406,,,22224,,1,,U,Compound was evaluated for the overall absorbance loss at pH of 7,,,,0,,BAO_0000019
12214,2249,A,,Intermediate,CHEMBL628407,,,50597,,1,,N,Compound was evaluated for its absorption in the rats,Rattus norvegicus,,,1,,BAO_0000218
12215,8881,A,,Intermediate,CHEMBL628408,,1088.0,50597,,1,,N,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,,Urine,1,,BAO_0000218
12216,8881,A,,Intermediate,CHEMBL629171,,1088.0,50597,,1,,N,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Rattus norvegicus,,Urine,1,,BAO_0000218
12217,8881,A,,Intermediate,CHEMBL629172,,1088.0,50597,,1,,N,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,,Urine,1,,BAO_0000218
12218,8881,A,,Intermediate,CHEMBL629173,,1088.0,50597,,1,,N,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Rattus norvegicus,,Urine,1,,BAO_0000218
12219,15286,A,,Intermediate,CHEMBL629174,,,50597,,1,,N,In vitro percent permeability into rat ileum,Rattus norvegicus,,,1,,BAO_0000218
12220,15286,A,,Intermediate,CHEMBL629175,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 10-17,Rattus norvegicus,,,1,,BAO_0000218
12221,15286,A,,Intermediate,CHEMBL629176,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 10-18,Rattus norvegicus,,,1,,BAO_0000218
12222,15286,A,,Intermediate,CHEMBL629177,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 10-19,Rattus norvegicus,,,1,,BAO_0000218
12223,15286,A,,Intermediate,CHEMBL629178,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 12-15,Rattus norvegicus,,,1,,BAO_0000218
12224,15286,A,,Intermediate,CHEMBL631869,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 13-19,Rattus norvegicus,,,1,,BAO_0000218
12225,15286,A,,Intermediate,CHEMBL631870,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 14-17,Rattus norvegicus,,,1,,BAO_0000218
12226,15286,A,,Intermediate,CHEMBL631871,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 15-18,Rattus norvegicus,,,1,,BAO_0000218
12227,15286,A,,Intermediate,CHEMBL631872,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 2-5,Rattus norvegicus,,,1,,BAO_0000218
12228,15286,A,,Autocuration,CHEMBL875775,,2116.0,22224,,1,,U,In vitro percent permeability into rat ileum; Range is 23-42,,,Ileum,0,,BAO_0000221
12229,15286,A,,Intermediate,CHEMBL631873,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 28-36,Rattus norvegicus,,,1,,BAO_0000218
12230,15286,A,,Intermediate,CHEMBL631874,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 29-35,Rattus norvegicus,,,1,,BAO_0000218
12231,15286,A,,Intermediate,CHEMBL631875,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 46-66,Rattus norvegicus,,,1,,BAO_0000218
12232,15286,A,,Intermediate,CHEMBL631876,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 50-68,Rattus norvegicus,,,1,,BAO_0000218
12233,15286,A,,Intermediate,CHEMBL631877,,,50597,,1,,N,In vitro percent permeability into rat ileum; Range is 78-81,Rattus norvegicus,,,1,,BAO_0000218
12234,15286,A,,Intermediate,CHEMBL631878,,,50597,,1,,N,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Rattus norvegicus,,,1,,BAO_0000218
12235,15286,A,,Intermediate,CHEMBL631879,,,50597,,1,,N,In vitro percent permeability into rat ileum; nd indicates not detected,Rattus norvegicus,,,1,,BAO_0000218
12236,15286,A,,Intermediate,CHEMBL631880,,,50597,,1,,N,In vitro percent permeability into rat ileum; nt indicates not detected,Rattus norvegicus,,,1,,BAO_0000218
12237,15286,A,,Intermediate,CHEMBL631881,,,50597,,1,,N,In vitro percent permeability into rat ileum; nt indicates not tested,Rattus norvegicus,,,1,,BAO_0000218
12238,13770,A,,Intermediate,CHEMBL631882,,,50597,,1,,N,Compound was tested for oral absorption in bile-duct cannulated rats,Rattus norvegicus,,,1,,BAO_0000218
12239,13770,A,,Intermediate,CHEMBL630749,,,50597,,1,,N,Compound was tested for oral absorption in bile-duct cannulated rats.,Rattus norvegicus,,,1,,BAO_0000218
12240,5202,A,,Intermediate,CHEMBL630750,,,50587,,1,,N,Oral absorption using Caco-2 cell monolayers.,Homo sapiens,,,1,,BAO_0000218
12241,14920,A,,Intermediate,CHEMBL630253,,,50587,,1,,N,Percent of the drug absorbed after administration to humans was determined,Homo sapiens,,,1,,BAO_0000218
12242,14103,A,,Intermediate,CHEMBL630254,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12243,14103,A,,Intermediate,CHEMBL630255,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12244,14103,A,,Intermediate,CHEMBL630256,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12245,13751,A,,Intermediate,CHEMBL875781,In vivo,2107.0,50597,,1,,N,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12246,13751,A,,Intermediate,CHEMBL630257,In vivo,2107.0,50597,,1,,N,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12247,13751,A,,Intermediate,CHEMBL630258,In vivo,2107.0,50597,,1,,N,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,,Liver,1,,BAO_0000218
12248,15807,A,,Intermediate,CHEMBL630259,,,50597,,1,,N,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,,1,,BAO_0000218
12249,15807,A,,Intermediate,CHEMBL630260,,2435.0,50597,,1,,N,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,Striatum,1,,BAO_0000218
12250,15807,A,,Intermediate,CHEMBL630261,,2435.0,50597,,1,,N,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,,Striatum,1,,BAO_0000218
12251,14950,A,,Intermediate,CHEMBL630262,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Rattus norvegicus,,,1,,BAO_0000218
12252,14950,A,,Intermediate,CHEMBL630263,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Rattus norvegicus,,,1,,BAO_0000218
12253,14950,A,,Intermediate,CHEMBL630264,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Rattus norvegicus,,,1,,BAO_0000218
12254,14950,A,,Intermediate,CHEMBL630265,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Rattus norvegicus,,,1,,BAO_0000218
12255,14950,A,,Intermediate,CHEMBL630266,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Rattus norvegicus,,,1,,BAO_0000218
12256,14950,A,,Intermediate,CHEMBL630267,,2113.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Rattus norvegicus,,Kidney,1,,BAO_0000218
12257,14950,A,,Intermediate,CHEMBL630268,,2113.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Rattus norvegicus,,Kidney,1,,BAO_0000218
12258,14950,A,,Intermediate,CHEMBL630269,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Rattus norvegicus,,,1,,BAO_0000218
12259,14950,A,,Intermediate,CHEMBL630270,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Rattus norvegicus,,,1,,BAO_0000218
12260,14950,A,,Intermediate,CHEMBL630141,,2048.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Rattus norvegicus,,Lung,1,,BAO_0000218
12261,14950,A,,Intermediate,CHEMBL630142,,2048.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Rattus norvegicus,,Lung,1,,BAO_0000218
12262,14950,A,,Intermediate,CHEMBL630143,,2385.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12263,14950,A,,Intermediate,CHEMBL630144,,2385.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12264,14950,A,,Intermediate,CHEMBL630145,,2367.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Rattus norvegicus,,Prostate gland,1,,BAO_0000218
12265,14950,A,,Intermediate,CHEMBL630146,,2367.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Rattus norvegicus,,Prostate gland,1,,BAO_0000218
12266,14950,A,,Intermediate,CHEMBL630147,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Rattus norvegicus,,,1,,BAO_0000218
12267,14950,A,,Intermediate,CHEMBL630148,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Rattus norvegicus,,,1,,BAO_0000218
12268,14950,A,,Intermediate,CHEMBL630149,,,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Rattus norvegicus,,,1,,BAO_0000218
12269,14950,A,,Intermediate,CHEMBL630150,,2106.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Rattus norvegicus,,Spleen,1,,BAO_0000218
12270,14950,A,,Intermediate,CHEMBL630151,,2106.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Rattus norvegicus,,Spleen,1,,BAO_0000218
12271,14950,A,,Intermediate,CHEMBL632031,,2046.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12272,14950,A,,Intermediate,CHEMBL632032,,2046.0,50597,,1,,N,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12273,14950,A,,Intermediate,CHEMBL632033,,,50597,,1,,N,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Rattus norvegicus,,,1,,BAO_0000218
12274,14950,A,,Intermediate,CHEMBL632034,,,50597,,1,,N,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Rattus norvegicus,,,1,,BAO_0000218
12275,14950,A,,Intermediate,CHEMBL632035,,2385.0,50597,,1,,N,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12276,14950,A,,Intermediate,CHEMBL632036,,,50597,,1,,N,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Rattus norvegicus,,,1,,BAO_0000218
12277,14950,A,,Intermediate,CHEMBL632037,,2046.0,50597,,1,,N,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12278,8631,A,,Intermediate,CHEMBL632038,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12279,8631,A,,Intermediate,CHEMBL632039,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12280,8631,A,,Intermediate,CHEMBL632040,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12281,8631,A,,Intermediate,CHEMBL632041,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12282,9614,A,,Intermediate,CHEMBL632042,,178.0,50588,,1,,N,"Concentration of compound in blood of dog 2, after administering intravenously",Canis lupus familiaris,,Blood,1,,BAO_0000218
12283,9614,A,,Intermediate,CHEMBL632043,,,50588,,1,,N,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Canis lupus familiaris,,,1,,BAO_0000218
12284,9614,A,,Intermediate,CHEMBL632044,,,50588,,1,,N,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Canis lupus familiaris,,,1,,BAO_0000218
12285,9614,A,,Intermediate,CHEMBL632045,,2107.0,50588,,1,,N,"Concentration of compound in liver of dog 1, after administering intravenously",Canis lupus familiaris,,Liver,1,,BAO_0000218
12286,9614,A,,Intermediate,CHEMBL632046,,2107.0,50588,,1,,N,"Concentration of compound in liver of dog 2, after administering intravenously",Canis lupus familiaris,,Liver,1,,BAO_0000218
12287,9614,A,,Intermediate,CHEMBL632047,,2048.0,50588,,1,,N,"Concentration of compound in lung of dog 1, after administering intravenously",Canis lupus familiaris,,Lung,1,,BAO_0000218
12288,9614,A,,Intermediate,CHEMBL632048,,2048.0,50588,,1,,N,"Concentration of compound in lung of dog 2, after administering intravenously",Canis lupus familiaris,,Lung,1,,BAO_0000218
12289,9614,A,,Intermediate,CHEMBL632049,,2385.0,50588,,1,,N,"Concentration of compound in muscle of dog 1, after administering intravenously",Canis lupus familiaris,,Muscle tissue,1,,BAO_0000218
12290,9614,A,,Intermediate,CHEMBL876418,,2385.0,50588,,1,,N,"Concentration of compound in muscle of dog 2, after administering intravenously",Canis lupus familiaris,,Muscle tissue,1,,BAO_0000218
12291,9614,A,,Intermediate,CHEMBL632050,,2106.0,50588,,1,,N,"Concentration of compound in spleen of dog 1,after administering intravenously",Canis lupus familiaris,,Spleen,1,,BAO_0000218
12292,9614,A,,Intermediate,CHEMBL632051,,2106.0,50588,,1,,N,"Concentration of compound in spleen of dog 2, after administering intravenously",Canis lupus familiaris,,Spleen,1,,BAO_0000218
12293,10353,F,,Autocuration,CHEMBL632052,,,22224,,1,,U,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,,0,,BAO_0000218
12294,10353,F,,Autocuration,CHEMBL632053,,,22224,,1,,U,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,,0,,BAO_0000218
12295,10353,A,,Autocuration,CHEMBL632054,,,22224,,1,,U,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,0,,BAO_0000218
12296,10353,F,,Autocuration,CHEMBL632055,,,22224,,1,,U,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,0,,BAO_0000218
12297,10353,F,,Autocuration,CHEMBL631181,,,22224,,1,,U,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,,0,,BAO_0000218
12298,9196,A,,Autocuration,CHEMBL631182,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,,0,,BAO_0000218
12299,9196,A,,Autocuration,CHEMBL631183,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,0,,BAO_0000218
12300,9196,A,,Autocuration,CHEMBL631184,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12301,9196,A,,Autocuration,CHEMBL629774,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12302,9196,A,,Autocuration,CHEMBL629775,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12303,9196,A,,Autocuration,CHEMBL876549,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12304,9196,A,,Autocuration,CHEMBL628172,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12305,9196,A,,Autocuration,CHEMBL628173,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12306,9196,A,,Autocuration,CHEMBL628174,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,,0,,BAO_0000218
12307,9196,A,,Autocuration,CHEMBL628175,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,,0,,BAO_0000218
12308,9196,A,,Autocuration,CHEMBL628176,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12309,9196,A,,Autocuration,CHEMBL628177,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12310,9196,A,,Autocuration,CHEMBL628178,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12311,9196,A,,Autocuration,CHEMBL628179,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12312,9196,A,,Autocuration,CHEMBL628180,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,0,,BAO_0000218
12313,9196,A,,Autocuration,CHEMBL628181,,,22224,,1,,U,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,,0,,BAO_0000218
12314,9196,A,,Autocuration,CHEMBL628182,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12315,9196,A,,Autocuration,CHEMBL628183,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12316,9196,A,,Autocuration,CHEMBL628184,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,,0,,BAO_0000218
12317,9196,A,,Autocuration,CHEMBL628185,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12318,9196,A,,Autocuration,CHEMBL875617,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12319,9196,A,,Autocuration,CHEMBL628186,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,0,,BAO_0000218
12320,9196,A,,Autocuration,CHEMBL628187,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12321,9196,A,,Autocuration,CHEMBL628188,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12322,9196,A,,Autocuration,CHEMBL628189,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12323,9196,A,,Autocuration,CHEMBL628190,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,,0,,BAO_0000218
12324,9196,A,,Autocuration,CHEMBL628191,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12325,9196,A,,Autocuration,CHEMBL626513,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,,0,,BAO_0000218
12326,8608,A,,Intermediate,CHEMBL626514,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12327,8608,A,,Intermediate,CHEMBL626515,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12328,8608,A,,Intermediate,CHEMBL626516,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12329,8608,A,,Intermediate,CHEMBL626517,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12330,8608,A,,Intermediate,CHEMBL626518,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12331,8608,A,,Intermediate,CHEMBL626519,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12332,8608,A,,Intermediate,CHEMBL626520,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12333,8608,A,,Intermediate,CHEMBL626521,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12334,8608,A,,Intermediate,CHEMBL626522,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12335,8608,A,,Intermediate,CHEMBL626523,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12336,8608,A,,Intermediate,CHEMBL626524,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12337,8608,A,,Intermediate,CHEMBL626688,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12338,8608,A,,Intermediate,CHEMBL626689,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12339,8608,A,,Intermediate,CHEMBL626690,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12340,8608,A,,Intermediate,CHEMBL626691,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12341,8608,A,,Intermediate,CHEMBL627319,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12342,8608,A,,Intermediate,CHEMBL624052,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12343,8608,A,,Intermediate,CHEMBL624053,,2046.0,50597,,1,,N,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12344,8085,A,,Intermediate,CHEMBL624054,,,50597,,1,,N,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,1,,BAO_0000218
12345,8085,A,,Intermediate,CHEMBL624055,,,50597,,1,,N,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,1,,BAO_0000218
12346,8085,A,,Intermediate,CHEMBL624056,,,50597,,1,,N,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,,1,,BAO_0000218
12347,8085,A,,Intermediate,CHEMBL624057,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12348,8085,A,,Intermediate,CHEMBL622281,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12349,8085,A,,Intermediate,CHEMBL622282,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12350,8085,A,,Intermediate,CHEMBL622283,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12351,8085,A,,Intermediate,CHEMBL622284,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12352,8085,A,,Intermediate,CHEMBL622285,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12353,8085,A,,Intermediate,CHEMBL622286,,995.0,50597,,1,,N,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,,Uterus,1,,BAO_0000218
12354,7657,P,,Autocuration,CHEMBL622287,,,22224,,1,,U,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,,0,,BAO_0000100
12355,8935,A,,Intermediate,CHEMBL622288,,,50594,,1,,N,Partition coefficient (logD7.4),Mus musculus,,,1,,BAO_0000218
12356,13792,A,,Intermediate,CHEMBL622289,,,50594,,1,,N,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,,,1,,BAO_0000218
12357,13792,A,,Intermediate,CHEMBL622290,,955.0,50594,,1,,N,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,,Brain,1,,BAO_0000218
12358,13792,A,,Intermediate,CHEMBL622291,,,50594,,1,,N,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,,,1,,BAO_0000218
12359,13792,A,,Intermediate,CHEMBL622292,,955.0,50594,,1,,N,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Mus musculus,,Brain,1,,BAO_0000218
12360,13792,A,,Intermediate,CHEMBL622293,,,50594,,1,,N,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,,,1,,BAO_0000218
12361,13792,A,,Intermediate,CHEMBL622294,,955.0,50594,,1,,N,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,,Brain,1,,BAO_0000218
12362,13792,A,,Intermediate,CHEMBL622295,,,50594,,1,,N,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,,,1,,BAO_0000218
12363,13792,A,,Intermediate,CHEMBL622296,,955.0,50597,,1,,N,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Rattus norvegicus,,Brain,1,,BAO_0000218
12364,14103,A,,Intermediate,CHEMBL874409,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12365,14103,A,,Intermediate,CHEMBL622297,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12366,14103,A,,Intermediate,CHEMBL622298,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12367,14103,A,,Intermediate,CHEMBL622299,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12368,14103,A,,Intermediate,CHEMBL622300,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12369,14103,A,,Intermediate,CHEMBL622301,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12370,14103,A,,Intermediate,CHEMBL622302,,1969.0,50597,,1,,N,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12371,14103,A,,Intermediate,CHEMBL622303,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12372,14103,A,,Intermediate,CHEMBL622304,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12373,14103,A,,Intermediate,CHEMBL622305,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12374,14103,A,,Intermediate,CHEMBL622306,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12375,14103,A,,Intermediate,CHEMBL626864,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12376,14103,A,,Intermediate,CHEMBL626865,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12377,14103,A,,Intermediate,CHEMBL626866,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12378,14103,A,,Intermediate,CHEMBL626867,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12379,14103,A,,Intermediate,CHEMBL626868,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12380,14103,A,,Intermediate,CHEMBL626869,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12381,14103,A,,Intermediate,CHEMBL626870,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12382,14103,A,,Intermediate,CHEMBL626871,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12383,14103,A,,Intermediate,CHEMBL626872,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12384,14103,A,,Intermediate,CHEMBL632185,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12385,14103,A,,Intermediate,CHEMBL632186,,1969.0,50597,,1,,N,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
12386,12904,A,,Autocuration,CHEMBL629310,,,22224,,1,,U,Amount of acetic acid produced by the compound,,,,0,,BAO_0000019
12387,12904,A,,Autocuration,CHEMBL629311,,,22224,,1,,U,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,,0,,BAO_0000019
12388,9663,A,,Intermediate,CHEMBL629312,,,50597,,1,,N,Log of (Cbrain/Cblood) in rats,Rattus norvegicus,,,1,,BAO_0000218
12389,7652,A,,Autocuration,CHEMBL629313,,,22224,,1,,U,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,0,,BAO_0000221
12390,7652,A,,Autocuration,CHEMBL629314,,,22224,,1,,U,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,0,,BAO_0000221
12391,7652,A,,Autocuration,CHEMBL629315,,,22224,,1,,U,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,0,,BAO_0000221
12392,7652,B,,Autocuration,CHEMBL629316,,,22224,,1,,U,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,,0,,BAO_0000219
12393,7652,A,,Autocuration,CHEMBL629317,,,22224,,1,,U,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,0,,BAO_0000221
12394,7652,A,,Autocuration,CHEMBL629318,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,0,,BAO_0000019
12395,7652,A,,Autocuration,CHEMBL877497,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12396,7652,A,,Autocuration,CHEMBL629319,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,,0,,BAO_0000019
12397,7652,A,,Autocuration,CHEMBL629320,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12398,7652,A,,Autocuration,CHEMBL629496,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12399,7652,A,,Autocuration,CHEMBL629497,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12400,7652,A,,Autocuration,CHEMBL629498,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,,0,,BAO_0000019
12401,7652,A,,Autocuration,CHEMBL629499,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12402,7652,A,,Autocuration,CHEMBL629500,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,0,,BAO_0000019
12403,7652,A,,Autocuration,CHEMBL629501,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,,0,,BAO_0000019
12404,7652,A,,Autocuration,CHEMBL629502,,,22224,,1,,U,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,,0,,BAO_0000019
12405,8267,F,,Autocuration,CHEMBL629503,In vivo,,22224,,1,,U,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,,0,,BAO_0000218
12406,8267,A,,Intermediate,CHEMBL629504,,,50588,,1,,N,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
12407,14479,A,,Autocuration,CHEMBL629505,,,22224,,1,,U,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,,0,,BAO_0000019
12408,17515,A,,Autocuration,CHEMBL629506,,,22224,,1,,U,Compound was evaluated for total body clearance,,,,0,,BAO_0000019
12409,17515,A,,Autocuration,CHEMBL629507,,,22224,,1,,U,Compound was evaluated for volume of distribution at steady state,,,,0,,BAO_0000019
12410,8142,A,,Autocuration,CHEMBL877498,,,22224,,1,,U,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,,0,,BAO_0000019
12411,14849,A,,Autocuration,CHEMBL629508,,,22224,,1,,U,Percentage of the diamine which is monoprotonated at pH 7.4,,,,0,,BAO_0000019
12412,7653,A,,Autocuration,CHEMBL629509,,,22224,,1,,U,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,,0,,BAO_0000019
12413,8631,A,,Intermediate,CHEMBL629510,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12414,8631,A,,Intermediate,CHEMBL629511,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12415,8631,A,,Intermediate,CHEMBL629512,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12416,8631,A,,Intermediate,CHEMBL629513,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12417,8631,A,,Intermediate,CHEMBL629514,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12418,8631,A,,Intermediate,CHEMBL628447,,178.0,50597,,1,,N,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12419,8631,A,,Intermediate,CHEMBL628448,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12420,8631,A,,Intermediate,CHEMBL628449,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12421,8631,A,,Intermediate,CHEMBL631119,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12422,8631,A,,Intermediate,CHEMBL631120,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12423,8631,A,,Intermediate,CHEMBL631121,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12424,8631,A,,Intermediate,CHEMBL874458,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Rattus norvegicus,,Blood,1,,BAO_0000218
12425,8631,A,,Intermediate,CHEMBL631122,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12426,8631,A,,Intermediate,CHEMBL631123,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12427,8631,A,,Intermediate,CHEMBL631124,,178.0,50597,,1,,N,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12428,8631,A,,Intermediate,CHEMBL631125,,178.0,50597,,1,,N,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12429,8631,A,,Intermediate,CHEMBL631290,,178.0,50597,,1,,N,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12430,8631,A,,Intermediate,CHEMBL631291,,178.0,50597,,1,,N,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12431,8631,A,,Intermediate,CHEMBL631292,,178.0,50597,,1,,N,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12432,8631,A,,Intermediate,CHEMBL631293,,178.0,50597,,1,,N,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12433,8631,A,,Intermediate,CHEMBL631294,,178.0,50597,,1,,N,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12434,8631,A,,Intermediate,CHEMBL631295,,178.0,50597,,1,,N,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12435,8631,A,,Intermediate,CHEMBL631296,,178.0,50597,,1,,N,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12436,8631,A,,Intermediate,CHEMBL631297,,178.0,50597,,1,,N,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,,Blood,1,,BAO_0000218
12437,10263,A,,Autocuration,CHEMBL631298,,,22224,,1,,U,Maximum biodistribution (Bmax) was determined.,,,,0,,BAO_0000218
12438,12364,A,,Intermediate,CHEMBL631299,,,50594,,1,,N,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,1,,BAO_0000218
12439,12364,A,,Intermediate,CHEMBL631300,,,50594,,1,,N,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,1,,BAO_0000218
12440,12364,A,,Intermediate,CHEMBL631301,,,50594,,1,,N,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,1,,BAO_0000218
12441,12364,A,,Intermediate,CHEMBL630291,,,50594,,1,,N,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Mus musculus,,,1,,BAO_0000218
12442,14793,A,,Autocuration,CHEMBL630292,,,22224,,1,,U,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,0,,BAO_0000218
12443,14793,A,,Autocuration,CHEMBL630293,,,22224,,1,,U,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,,0,,BAO_0000218
12444,14793,A,,Autocuration,CHEMBL630294,,,22224,,1,,U,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,,0,,BAO_0000218
12445,14793,A,,Autocuration,CHEMBL630295,,,22224,,1,,U,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,,0,,BAO_0000218
12446,14793,A,,Autocuration,CHEMBL630296,,,22224,,1,,U,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,,0,,BAO_0000218
12447,14793,A,,Autocuration,CHEMBL626782,,,22224,,1,,U,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,,0,,BAO_0000218
12448,14793,A,,Autocuration,CHEMBL626783,,,22224,,1,,U,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,,0,,BAO_0000218
12449,14793,A,,Autocuration,CHEMBL626784,,,22224,,1,,U,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,0,,BAO_0000218
12450,14793,A,,Autocuration,CHEMBL626785,,,22224,,1,,U,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,,0,,BAO_0000218
12451,14793,A,,Autocuration,CHEMBL626786,,,22224,,1,,U,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,,0,,BAO_0000218
12452,9196,A,,Autocuration,CHEMBL626787,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12453,9196,A,,Autocuration,CHEMBL626788,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,0,,BAO_0000218
12454,9196,A,,Autocuration,CHEMBL625927,,,22224,,1,,U,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12455,8374,A,,Intermediate,CHEMBL625928,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12456,8374,A,,Intermediate,CHEMBL625929,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12457,8374,A,,Intermediate,CHEMBL625930,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,,Blood,1,,BAO_0000218
12458,8374,A,,Intermediate,CHEMBL625931,,178.0,50597,,1,,N,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Rattus norvegicus,,Blood,1,,BAO_0000218
12459,8374,A,,Intermediate,CHEMBL627230,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Rattus norvegicus,,Blood,1,,BAO_0000218
12460,8374,A,,Intermediate,CHEMBL627231,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12461,8374,A,,Intermediate,CHEMBL627232,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12462,8374,A,,Intermediate,CHEMBL627233,,178.0,50597,,1,,N,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,,Blood,1,,BAO_0000218
12463,8374,A,,Intermediate,CHEMBL875470,,178.0,50597,,1,,N,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12464,8374,A,,Intermediate,CHEMBL627234,,178.0,50597,,1,,N,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12465,8374,A,,Intermediate,CHEMBL627235,,178.0,50597,,1,,N,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12466,8374,A,,Intermediate,CHEMBL627236,,178.0,50597,,1,,N,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12467,8374,A,,Intermediate,CHEMBL627237,,178.0,50597,,1,,N,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12468,8374,A,,Intermediate,CHEMBL627238,,178.0,50597,,1,,N,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12469,8374,A,,Intermediate,CHEMBL627239,,178.0,50597,,1,,N,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12470,8374,A,,Intermediate,CHEMBL627240,,178.0,50597,,1,,N,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12471,8374,A,,Intermediate,CHEMBL627241,,178.0,50597,,1,,N,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12472,8374,A,,Intermediate,CHEMBL627242,,178.0,50597,,1,,N,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12473,8374,A,,Intermediate,CHEMBL627243,,178.0,50597,,1,,N,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12474,8374,A,,Intermediate,CHEMBL627244,,178.0,50597,,1,,N,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12475,8374,A,,Intermediate,CHEMBL627245,,178.0,50597,,1,,N,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12476,8374,A,,Intermediate,CHEMBL627246,,178.0,50597,,1,,N,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12477,8374,A,,Intermediate,CHEMBL627247,,178.0,50597,,1,,N,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12478,8374,A,,Intermediate,CHEMBL627248,,178.0,50597,,1,,N,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12479,8374,A,,Intermediate,CHEMBL627249,,178.0,50597,,1,,N,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12480,8374,A,,Intermediate,CHEMBL625569,,178.0,50597,,1,,N,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12481,8374,A,,Intermediate,CHEMBL625570,,178.0,50597,,1,,N,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12482,8374,A,,Intermediate,CHEMBL625571,,178.0,50597,,1,,N,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12483,8374,A,,Intermediate,CHEMBL625572,,178.0,50597,,1,,N,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12484,8374,A,,Intermediate,CHEMBL625573,,178.0,50597,,1,,N,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12485,8374,A,,Intermediate,CHEMBL625574,,178.0,50597,,1,,N,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Rattus norvegicus,,Blood,1,,BAO_0000218
12486,8374,A,,Intermediate,CHEMBL626245,,178.0,50597,,1,,N,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,,Blood,1,,BAO_0000218
12487,8374,A,,Intermediate,CHEMBL626246,,178.0,50597,,1,,N,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12488,9196,A,,Autocuration,CHEMBL626247,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12489,9196,A,,Autocuration,CHEMBL626248,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12490,9196,A,,Autocuration,CHEMBL626249,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,0,,BAO_0000218
12491,9196,A,,Autocuration,CHEMBL626420,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12492,9196,A,,Autocuration,CHEMBL626421,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,0,,BAO_0000218
12493,9196,A,,Autocuration,CHEMBL626422,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12494,9196,A,,Autocuration,CHEMBL626423,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12495,9196,A,,Autocuration,CHEMBL626424,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12496,12023,A,,Intermediate,CHEMBL626425,,,50588,,1,,N,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Canis lupus familiaris,,,1,,BAO_0000218
12497,12023,A,,Intermediate,CHEMBL875476,,,50597,,1,,N,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Rattus norvegicus,,,1,,BAO_0000218
12498,12023,A,,Intermediate,CHEMBL626426,,,100710,,1,,N,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Macaca fascicularis,,,1,,BAO_0000218
12499,10580,P,,Autocuration,CHEMBL626427,,,22224,,1,,U,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,0,,BAO_0000100
12500,10580,P,,Autocuration,CHEMBL626428,,,22224,,1,,U,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,0,,BAO_0000100
12501,16032,A,,Autocuration,CHEMBL626429,,,22224,,1,,U,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,,0,,BAO_0000019
12502,16032,A,,Autocuration,CHEMBL625025,,1088.0,22224,,1,,U,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,Urine,0,,BAO_0000019
12503,8594,A,,Intermediate,CHEMBL625026,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12504,8594,A,,Intermediate,CHEMBL625027,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12505,8594,A,,Intermediate,CHEMBL874410,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12506,8594,A,,Intermediate,CHEMBL625028,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12507,8594,A,,Intermediate,CHEMBL625029,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12508,8594,A,,Intermediate,CHEMBL625030,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12509,8594,A,,Intermediate,CHEMBL625031,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12510,8594,A,,Intermediate,CHEMBL625032,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12511,8594,A,,Intermediate,CHEMBL625033,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12512,8594,A,,Intermediate,CHEMBL625034,,178.0,50597,,1,,N,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12513,8594,A,,Intermediate,CHEMBL624872,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12514,8594,A,,Intermediate,CHEMBL624873,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12515,8594,A,,Intermediate,CHEMBL624874,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12516,8594,A,,Intermediate,CHEMBL624875,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12517,8594,A,,Intermediate,CHEMBL624876,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12518,8594,A,,Intermediate,CHEMBL624877,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12519,8594,A,,Intermediate,CHEMBL624878,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12520,8594,A,,Intermediate,CHEMBL624879,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12521,8594,A,,Intermediate,CHEMBL624880,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12522,8594,A,,Intermediate,CHEMBL624881,,948.0,50597,,1,,N,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12523,8594,A,,Intermediate,CHEMBL624882,,948.0,50597,,1,,N,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Rattus norvegicus,,Heart,1,,BAO_0000218
12524,8594,A,,Intermediate,CHEMBL624883,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12525,8594,A,,Intermediate,CHEMBL624884,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12526,8594,A,,Intermediate,CHEMBL624885,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12527,8594,A,,Intermediate,CHEMBL624886,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12528,8594,A,,Intermediate,CHEMBL624887,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12529,8594,A,,Intermediate,CHEMBL624888,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12530,8594,A,,Intermediate,CHEMBL624889,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12531,8594,A,,Intermediate,CHEMBL624890,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12532,8594,A,,Intermediate,CHEMBL621964,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12533,8594,A,,Intermediate,CHEMBL621965,,2113.0,50597,,1,,N,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12534,8594,A,,Intermediate,CHEMBL621966,,2107.0,50597,,1,,N,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12535,8594,A,,Intermediate,CHEMBL621967,,2107.0,50597,,1,,N,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12536,8594,A,,Intermediate,CHEMBL622164,,2107.0,50597,,1,,N,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12537,7653,A,,Autocuration,CHEMBL623097,,,22224,,1,,U,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,,0,,BAO_0000019
12538,7653,A,,Autocuration,CHEMBL623098,,,22224,,1,,U,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,,0,,BAO_0000019
12539,7653,A,,Autocuration,CHEMBL623099,,,22224,,1,,U,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,,0,,BAO_0000019
12540,7653,A,,Autocuration,CHEMBL623100,,,22224,,1,,U,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,,0,,BAO_0000019
12541,9104,A,,Intermediate,CHEMBL628673,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Rattus norvegicus,,,1,,BAO_0000218
12542,9104,A,,Intermediate,CHEMBL628674,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Rattus norvegicus,,,1,,BAO_0000218
12543,9104,A,,Intermediate,CHEMBL628675,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Rattus norvegicus,,,1,,BAO_0000218
12544,9104,A,,Intermediate,CHEMBL627644,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,,,1,,BAO_0000218
12545,9104,A,,Intermediate,CHEMBL627645,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Rattus norvegicus,,,1,,BAO_0000218
12546,9104,A,,Intermediate,CHEMBL627646,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Rattus norvegicus,,,1,,BAO_0000218
12547,9104,A,,Intermediate,CHEMBL627647,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,,,1,,BAO_0000218
12548,9104,A,,Intermediate,CHEMBL627648,,,50597,,1,,N,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Rattus norvegicus,,,1,,BAO_0000218
12549,12902,A,,Intermediate,CHEMBL627649,,,50597,,1,,N,Free level in rat plasma,Rattus norvegicus,,,1,,BAO_0000218
12550,6614,A,,Autocuration,CHEMBL628313,,,22224,,1,,U,Level reaching in blood plasma of rat or human was determined,,,,0,,BAO_0000019
12551,9663,A,,Intermediate,CHEMBL628314,,,50597,,1,,N,Log (Cbrain/Cblood) in rats,Rattus norvegicus,,,1,,BAO_0000218
12552,17658,A,,Autocuration,CHEMBL628315,,,22224,,1,,U,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,,0,,BAO_0000019
12553,17658,A,,Autocuration,CHEMBL628316,,,22224,,1,,U,Mean percentage of compound transport through membrane; expressed as membrane transport,,,,0,,BAO_0000019
12554,14314,A,,Autocuration,CHEMBL628317,,,22224,,1,,U,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,,0,,BAO_0000218
12555,7385,A,,Autocuration,CHEMBL628473,,,22224,,1,,U,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,,0,,BAO_0000019
12556,7385,A,,Autocuration,CHEMBL628474,,,22224,,1,,U,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,,0,,BAO_0000019
12557,7385,A,,Autocuration,CHEMBL628475,,,22224,,1,,U,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,,0,,BAO_0000019
12558,1329,A,,Autocuration,CHEMBL628476,,,22224,,1,,U,Net water uptake by a carrier mediated transport (%cm) mechanism,,,,0,,BAO_0000019
12559,12187,A,,Autocuration,CHEMBL628477,,,22224,,1,,U,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,0,,BAO_0000218
12560,12187,A,,Intermediate,CHEMBL628478,,,50506,,1,,N,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,,,1,,BAO_0000218
12561,12187,A,,Intermediate,CHEMBL628479,,,50506,,1,,N,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,,,1,,BAO_0000218
12562,12187,A,,Autocuration,CHEMBL628480,,,22224,,1,,U,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,0,,BAO_0000218
12563,12187,A,,Autocuration,CHEMBL628481,,,22224,,1,,U,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Simiiformes,,,0,,BAO_0000218
12564,12187,A,,Intermediate,CHEMBL628482,,,50597,,1,,N,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
12565,12187,A,,Intermediate,CHEMBL628483,,,50597,,1,,N,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,1,,BAO_0000218
12566,9278,A,,Intermediate,CHEMBL628484,,1969.0,50597,,1,,N,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,,Plasma,1,,BAO_0000218
12567,9278,A,,Intermediate,CHEMBL628485,,1969.0,50597,,1,,N,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,Plasma,1,,BAO_0000218
12568,9278,A,,Intermediate,CHEMBL628486,,1969.0,100710,,1,,N,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Macaca fascicularis,,Plasma,1,,BAO_0000218
12569,9278,A,,Intermediate,CHEMBL628487,,1969.0,50587,,1,,N,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Homo sapiens,,Plasma,1,,BAO_0000218
12570,9278,A,,Intermediate,CHEMBL628488,,1969.0,50597,,1,,N,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,,Plasma,1,,BAO_0000218
12571,9278,A,,Intermediate,CHEMBL628489,,1969.0,50597,,1,,N,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,Plasma,1,,BAO_0000218
12572,9278,A,,Intermediate,CHEMBL628490,,1969.0,50597,,1,,N,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,,Plasma,1,,BAO_0000218
12573,12186,A,,Intermediate,CHEMBL628491,,,100710,,1,,N,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,1,,BAO_0000218
12574,12186,A,,Intermediate,CHEMBL877507,,,100710,,1,,N,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,,,1,,BAO_0000218
12575,12186,A,,Autocuration,CHEMBL628492,,,22224,,1,,U,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,0,,BAO_0000218
12576,12041,A,,Autocuration,CHEMBL628493,,,22224,,1,,U,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Simiiformes,,,0,,BAO_0000019
12577,12041,A,,Autocuration,CHEMBL628494,,,22224,,1,,U,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Simiiformes,,,0,,BAO_0000019
12578,12041,A,,Autocuration,CHEMBL628495,,,22224,,1,,U,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Simiiformes,,,0,,BAO_0000019
12579,6737,A,,Intermediate,CHEMBL628496,,,50587,,1,,N,Permeability in Caco-2 assay at 10E-6,Homo sapiens,,,1,,BAO_0000218
12580,13758,A,,Autocuration,CHEMBL628497,,955.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,Brain,0,,BAO_0000218
12581,13758,A,,Autocuration,CHEMBL628498,,955.0,22224,,1,,U,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,Brain,0,,BAO_0000218
12582,5676,A,,Autocuration,CHEMBL628499,,,22224,,1,,U,Plasma protein binding was determined,,,,0,,BAO_0000019
12583,14793,A,,Autocuration,CHEMBL627656,,,22224,,1,,U,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,,0,,BAO_0000218
12584,14793,A,,Autocuration,CHEMBL627657,,,22224,,1,,U,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,0,,BAO_0000218
12585,14793,A,,Autocuration,CHEMBL626808,,,22224,,1,,U,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,,0,,BAO_0000218
12586,14793,A,,Autocuration,CHEMBL626809,,,22224,,1,,U,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,,0,,BAO_0000218
12587,14793,A,,Autocuration,CHEMBL626810,,,22224,,1,,U,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,,0,,BAO_0000218
12588,14793,A,,Autocuration,CHEMBL626811,,,22224,,1,,U,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,0,,BAO_0000218
12589,14793,A,,Autocuration,CHEMBL874465,,,22224,,1,,U,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,,0,,BAO_0000218
12590,14793,A,,Autocuration,CHEMBL626812,,,22224,,1,,U,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,,0,,BAO_0000218
12591,14793,A,,Autocuration,CHEMBL626813,,,22224,,1,,U,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,,0,,BAO_0000218
12592,14793,A,,Autocuration,CHEMBL626814,,,22224,,1,,U,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,,0,,BAO_0000218
12593,14000,A,,Autocuration,CHEMBL626815,,,22224,,1,,U,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,,0,,BAO_0000019
12594,5948,A,,Autocuration,CHEMBL628566,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
12595,13824,P,,Autocuration,CHEMBL628567,,,22229,,1,,U,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,0,,BAO_0000100
12596,10778,P,,Autocuration,CHEMBL628568,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12597,17237,A,,Intermediate,CHEMBL628569,In vivo,,50588,,1,,N,C max in dog,Canis lupus familiaris,,,1,,BAO_0000218
12598,17237,A,,Intermediate,CHEMBL628570,In vivo,,50512,,1,,N,C max in guinea pig,Cavia porcellus,,,1,,BAO_0000218
12599,2809,A,,Autocuration,CHEMBL628571,In vivo,,22224,,1,,U,C max value was evaluated,,,,0,,BAO_0000218
12600,11954,A,,Autocuration,CHEMBL628572,In vivo,,22224,,1,,U,Cmax value after oral dose of 0.1 mg//kg,,,,0,,BAO_0000218
12601,11954,A,,Autocuration,CHEMBL628573,In vivo,,22224,,1,,U,Cmax value after oral dose of 0.3 mg/kg,,,,0,,BAO_0000218
12602,11954,A,,Autocuration,CHEMBL628574,In vivo,,22224,,1,,U,Cmax value after oral dose of 1 mg/kg,,,,0,,BAO_0000218
12603,11954,A,,Autocuration,CHEMBL628575,In vivo,,22224,,1,,U,Cmax value after oral dose of 10 mg/kg,,,,0,,BAO_0000218
12604,11954,A,,Autocuration,CHEMBL628576,In vivo,,22224,,1,,U,Cmax value after oral dose of 23.4 mg/kg,,,,0,,BAO_0000218
12605,11954,A,,Autocuration,CHEMBL628577,In vivo,,22224,,1,,U,Cmax value after oral dose of 3 mg/kg,,,,0,,BAO_0000218
12606,11954,A,,Autocuration,CHEMBL628578,In vivo,,22224,,1,,U,Cmax value after oral dose of 3.87 mg/kg,,,,0,,BAO_0000218
12607,12768,A,,Intermediate,CHEMBL874466,In vivo,,50588,,1,,N,Cmax value in female Beagle dogs,Canis lupus familiaris,,,1,,BAO_0000218
12608,12768,A,,Intermediate,CHEMBL628579,In vivo,,50597,,1,,N,Cmax value in male rats,Rattus norvegicus,,,1,,BAO_0000218
12609,12780,A,,Intermediate,CHEMBL628580,In vivo,1969.0,50597,,1,,N,Cmax value in rat plasma when administered 20 mg/kg perorally,Rattus norvegicus,,Plasma,1,,BAO_0000218
12610,15592,A,,Intermediate,CHEMBL628581,In vivo,1969.0,50588,,1,,N,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12611,15592,A,,Intermediate,CHEMBL628582,In vivo,1969.0,50588,,1,,N,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12612,17025,A,,Intermediate,CHEMBL628583,,,50588,,1,,N,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,1,,BAO_0000218
12613,17025,A,,Autocuration,CHEMBL625782,,,22224,,1,,U,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,0,,BAO_0000218
12614,17025,A,,Intermediate,CHEMBL625783,,,50592,,1,,N,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,1,,BAO_0000218
12615,17025,A,,Intermediate,CHEMBL625784,,,50597,,1,,N,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,1,,BAO_0000218
12616,4236,A,,Intermediate,CHEMBL625785,,1969.0,50797,,1,,N,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,,Plasma,1,,BAO_0000218
12617,15791,A,,Intermediate,CHEMBL625786,,,50597,,1,,N,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12618,11149,A,,Autocuration,CHEMBL874467,,,22224,,1,,U,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,,0,,BAO_0000019
12619,15592,A,,Intermediate,CHEMBL625787,,,50588,,1,,N,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,,,1,,BAO_0000218
12620,15778,A,,Intermediate,CHEMBL625964,,,50677,,1,,N,cytotoxicity against HIV protease enzyme.,Human immunodeficiency virus,,,1,,BAO_0000218
12621,12745,A,,Intermediate,CHEMBL625965,,,50594,,1,,N,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
12622,12745,A,,Intermediate,CHEMBL625966,,,50594,,1,,N,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Mus musculus,,,1,,BAO_0000218
12623,13941,A,,Intermediate,CHEMBL625967,In vivo,1969.0,50588,,1,,N,The plasma clearance in dog.,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12624,13941,A,,Intermediate,CHEMBL625968,In vivo,1969.0,50597,,1,,N,The plasma clearance in rat.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12625,16449,A,,Intermediate,CHEMBL625969,In vivo,1969.0,50597,,1,,N,Clearance from plasma in male Sprague-Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12626,16449,A,,Intermediate,CHEMBL625970,In vivo,1969.0,100710,,1,,N,Clearance from plasma in male cynomolgus monkeys,Macaca fascicularis,,Plasma,1,,BAO_0000218
12627,14224,A,,Intermediate,CHEMBL625971,In vivo,1969.0,50588,,1,,N,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Canis lupus familiaris,,Plasma,1,,BAO_0000218
12628,14224,A,,Intermediate,CHEMBL625972,In vivo,1969.0,50588,,1,,N,Clearance of compound in dog plasma,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12629,14224,A,,Intermediate,CHEMBL625973,In vivo,1969.0,50587,,1,,N,Clearance of compound in human plasma,Homo sapiens,,Plasma,1,,BAO_0000218
12630,14317,A,,Intermediate,CHEMBL625974,In vivo,,50588,,1,,N,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Canis lupus familiaris,,,1,,BAO_0000218
12631,14317,A,,Intermediate,CHEMBL625975,In vivo,,50588,,1,,N,Clearance of compound when administered intravenously as an individual dose to a single dog.,Canis lupus familiaris,,,1,,BAO_0000218
12632,14224,A,,Intermediate,CHEMBL625976,In vivo,1969.0,50588,,1,,N,"Clearance (10 mg/kg, intravenously) in dog plasma",Canis lupus familiaris,,Plasma,1,,BAO_0000218
12633,17237,A,,Intermediate,CHEMBL625977,In vivo,,50588,,1,,N,Clearance value in dog,Canis lupus familiaris,,,1,,BAO_0000218
12634,17237,A,,Intermediate,CHEMBL625978,In vivo,,50512,,1,,N,Clearance value in guinea pig,Cavia porcellus,,,1,,BAO_0000218
12635,14187,A,,Intermediate,CHEMBL874468,In vivo,,50597,,1,,N,Clearance values in rats after iv administration.,Rattus norvegicus,,,1,,BAO_0000218
12636,4806,A,,Autocuration,CHEMBL625421,In vivo,1969.0,22224,,1,,U,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,Plasma,0,,BAO_0000218
12637,15025,A,,Intermediate,CHEMBL625422,In vivo,,50592,,1,,N,In vivo clearance (5 mg/kg) was determined in rabbits,Oryctolagus cuniculus,,,1,,BAO_0000218
12638,13197,A,,Intermediate,CHEMBL625423,In vivo,,50597,,1,,N,Plasma Clearance rate was determined for the compound in rats,Rattus norvegicus,,,1,,BAO_0000218
12639,13197,A,,Autocuration,CHEMBL625424,In vivo,,22224,,1,,U,Plasma Clearance rate was determined for the compound in squirrel monkeys,Saimiri,,,0,,BAO_0000218
12640,13960,A,,Intermediate,CHEMBL625425,In vivo,,50597,,1,,N,Plasma clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
12641,17820,A,,Autocuration,CHEMBL625426,In vivo,,22224,,1,,U,Plasma clearance of the compound,,,,0,,BAO_0000218
12642,14706,A,,Intermediate,CHEMBL625427,In vivo,,50512,,1,,N,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Cavia porcellus,,,1,,BAO_0000218
12643,14706,A,,Intermediate,CHEMBL625428,In vivo,,50512,,1,,N,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Cavia porcellus,,,1,,BAO_0000218
12644,6504,A,,Autocuration,CHEMBL625429,In vivo,,22224,,1,,U,Plasma clearance was determined,,,,0,,BAO_0000218
12645,14925,A,,Intermediate,CHEMBL625430,In vivo,,50588,,1,,N,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Canis lupus familiaris,,,1,,BAO_0000218
12646,13197,A,,Intermediate,CHEMBL625431,In vivo,,50597,,1,,N,Plasma clearance rate was determined for the compound in rats,Rattus norvegicus,,,1,,BAO_0000218
12647,13197,A,,Autocuration,CHEMBL627307,In vivo,,22224,,1,,U,Plasma clearance rate was determined for the compound in squirrel monkeys,Saimiri,,,0,,BAO_0000218
12648,3437,A,,Autocuration,CHEMBL627308,In vivo,,22224,,1,,U,Slow clearance (CL) was determined,,,,0,,BAO_0000218
12649,9196,A,,Autocuration,CHEMBL627309,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12650,9196,A,,Autocuration,CHEMBL627310,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,0,,BAO_0000218
12651,9196,A,,Autocuration,CHEMBL627311,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,0,,BAO_0000218
12652,9196,A,,Autocuration,CHEMBL627312,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12653,9196,A,,Autocuration,CHEMBL627313,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,0,,BAO_0000218
12654,9196,A,,Autocuration,CHEMBL627314,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12655,9196,A,,Autocuration,CHEMBL627315,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12656,9196,A,,Autocuration,CHEMBL627316,,,22224,,1,,U,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12657,9196,A,,Autocuration,CHEMBL627317,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,0,,BAO_0000218
12658,9196,A,,Autocuration,CHEMBL627318,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12659,9196,A,,Autocuration,CHEMBL627999,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,0,,BAO_0000218
12660,9196,A,,Autocuration,CHEMBL628000,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,0,,BAO_0000218
12661,9196,A,,Autocuration,CHEMBL628001,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,0,,BAO_0000218
12662,9196,A,,Autocuration,CHEMBL628002,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12663,9196,A,,Autocuration,CHEMBL625610,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12664,9196,A,,Autocuration,CHEMBL625611,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12665,9196,A,,Autocuration,CHEMBL625612,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,0,,BAO_0000218
12666,9196,A,,Autocuration,CHEMBL625613,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,0,,BAO_0000218
12667,9196,A,,Autocuration,CHEMBL875479,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,0,,BAO_0000218
12668,9196,A,,Autocuration,CHEMBL625614,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,0,,BAO_0000218
12669,9196,A,,Autocuration,CHEMBL625615,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,0,,BAO_0000218
12670,9196,A,,Autocuration,CHEMBL626302,,,22224,,1,,U,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,0,,BAO_0000218
12671,8374,A,,Intermediate,CHEMBL626303,,178.0,50597,,1,,N,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12672,8374,A,,Intermediate,CHEMBL627420,,178.0,50597,,1,,N,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,,Blood,1,,BAO_0000218
12673,13477,A,,Intermediate,CHEMBL627421,,,50597,,1,,N,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,1,,BAO_0000218
12674,13477,A,,Intermediate,CHEMBL625695,,,50597,,1,,N,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,1,,BAO_0000218
12675,13477,A,,Intermediate,CHEMBL625696,,,50597,,1,,N,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Rattus norvegicus,,,1,,BAO_0000218
12676,10009,A,,Intermediate,CHEMBL875606,,955.0,50594,,1,,N,Distribution of compound in mice brain was measured after 1 hr,Mus musculus,,Brain,1,,BAO_0000218
12677,10009,A,,Intermediate,CHEMBL625697,,955.0,50594,,1,,N,Distribution of compound in mice brain was measured after 24 hr r,Mus musculus,,Brain,1,,BAO_0000218
12678,10009,A,,Intermediate,CHEMBL625698,,955.0,50594,,1,,N,Distribution of compound in mice brain was measured after 2 hr,Mus musculus,,Brain,1,,BAO_0000218
12679,10009,A,,Intermediate,CHEMBL625699,,955.0,50594,,1,,N,Distribution of compound in mice brain was measured after 3 hr,Mus musculus,,Brain,1,,BAO_0000218
12680,10009,A,,Intermediate,CHEMBL625700,,955.0,50594,,1,,N,Distribution of compound in mice brain was measured after 6 hr,Mus musculus,,Brain,1,,BAO_0000218
12681,10009,A,,Intermediate,CHEMBL625701,,,50594,,1,,N,Distribution of compound in mice liver was measured after 1 hr,Mus musculus,,,1,,BAO_0000218
12682,10009,A,,Intermediate,CHEMBL625702,,,50594,,1,,N,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Mus musculus,,,1,,BAO_0000218
12683,10009,A,,Intermediate,CHEMBL625703,,,50594,,1,,N,Distribution of compound in mice liver was measured after 2 hr,Mus musculus,,,1,,BAO_0000218
12684,10009,A,,Intermediate,CHEMBL625704,,,50594,,1,,N,Distribution of compound in mice liver was measured after 3 hr,Mus musculus,,,1,,BAO_0000218
12685,10009,A,,Intermediate,CHEMBL625705,,,50594,,1,,N,Distribution of compound in mice liver was measured after 6 hr,Mus musculus,,,1,,BAO_0000218
12686,8170,A,,Intermediate,CHEMBL625706,,1236.0,50588,,1,,N,Distribution in dog adrenal medulla 30 min after administration.,Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12687,8170,A,,Intermediate,CHEMBL625707,,1236.0,50588,,1,,N,Distribution in dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12688,8170,A,,Intermediate,CHEMBL625708,,,50588,,1,,N,Distribution in female dog Ovary 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12689,8170,A,,Intermediate,CHEMBL625709,,,50588,,1,,N,Distribution in female dog Ovary 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12690,8170,A,,Intermediate,CHEMBL624180,,,50588,,1,,N,Distribution in female dog adipose 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12691,8170,A,,Intermediate,CHEMBL624181,,,50588,,1,,N,Distribution in female dog adipose 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12692,8170,A,,Intermediate,CHEMBL624182,,1235.0,50588,,1,,N,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,,Adrenal cortex,1,,BAO_0000218
12693,8170,A,,Intermediate,CHEMBL624183,,1235.0,50588,,1,,N,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,,Adrenal cortex,1,,BAO_0000218
12694,8594,A,,Intermediate,CHEMBL624184,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12695,8594,A,,Intermediate,CHEMBL877489,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12696,8594,A,,Intermediate,CHEMBL624185,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12697,8594,A,,Intermediate,CHEMBL624186,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12698,8594,A,,Intermediate,CHEMBL624187,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12699,8594,A,,Intermediate,CHEMBL624188,,2107.0,50597,,1,,N,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12700,8594,A,,Intermediate,CHEMBL624189,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12701,8594,A,,Intermediate,CHEMBL624190,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12702,8594,A,,Intermediate,CHEMBL624191,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12703,8594,A,,Intermediate,CHEMBL624192,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12704,8594,A,,Intermediate,CHEMBL624193,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12705,8594,A,,Intermediate,CHEMBL624194,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12706,8594,A,,Intermediate,CHEMBL624891,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12707,8594,A,,Intermediate,CHEMBL624892,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12708,8594,A,,Intermediate,CHEMBL624893,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12709,8594,A,,Intermediate,CHEMBL627632,,2048.0,50597,,1,,N,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12710,8594,A,,Intermediate,CHEMBL627633,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12711,8594,A,,Intermediate,CHEMBL627634,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12712,8594,A,,Intermediate,CHEMBL627635,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12713,8594,A,,Intermediate,CHEMBL627636,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12714,8594,A,,Intermediate,CHEMBL626816,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12715,8594,A,,Intermediate,CHEMBL626817,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12716,8594,A,,Intermediate,CHEMBL626818,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12717,8594,A,,Intermediate,CHEMBL626819,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12718,8594,A,,Intermediate,CHEMBL626820,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12719,8594,A,,Intermediate,CHEMBL626821,,,50597,,1,,N,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12720,8594,A,,Intermediate,CHEMBL626822,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12721,8594,A,,Intermediate,CHEMBL626823,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12722,8594,A,,Intermediate,CHEMBL626824,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12723,8594,A,,Intermediate,CHEMBL626825,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12724,8594,A,,Intermediate,CHEMBL626826,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12725,8594,A,,Intermediate,CHEMBL626827,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12726,8594,A,,Intermediate,CHEMBL626828,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12727,8594,A,,Intermediate,CHEMBL626829,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12728,8594,A,,Intermediate,CHEMBL626830,,2046.0,50597,,1,,N,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12729,8594,A,,Intermediate,CHEMBL627150,,,50597,,1,,N,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12730,8594,A,,Intermediate,CHEMBL627151,,,50597,,1,,N,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12731,8594,A,,Intermediate,CHEMBL627152,,,50597,,1,,N,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,,,1,,BAO_0000218
12732,8594,A,,Intermediate,CHEMBL627153,,,50597,,1,,N,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12733,12904,A,,Autocuration,CHEMBL627154,,,22224,,1,,U,Rate of acetate production by the compound was determined,,,,0,,BAO_0000019
12734,12904,A,,Autocuration,CHEMBL627155,,,22224,,1,,U,Rate of acetate production by the compound was determined; Not determined,,,,0,,BAO_0000019
12735,3730,A,,Autocuration,CHEMBL627156,,,22224,,1,,U,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,,0,,BAO_0000019
12736,3627,A,,Autocuration,CHEMBL627157,,,22224,,1,,U,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,,0,,BAO_0000019
12737,13799,A,,Intermediate,CHEMBL627158,,,50592,,1,,N,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,,,1,,BAO_0000218
12738,13799,A,,Intermediate,CHEMBL627159,,1969.0,50592,,1,,N,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,,Plasma,1,,BAO_0000218
12739,13799,A,,Intermediate,CHEMBL627160,,,50594,,1,,N,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Mus musculus,,,1,,BAO_0000218
12740,13799,A,,Intermediate,CHEMBL628540,,,50597,,1,,N,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,,1,,BAO_0000218
12741,13799,A,,Intermediate,CHEMBL628541,,1969.0,50597,,1,,N,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,Plasma,1,,BAO_0000218
12742,13799,A,,Intermediate,CHEMBL628542,,1969.0,50597,,1,,N,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,,Plasma,1,,BAO_0000218
12743,6629,P,,Autocuration,CHEMBL628543,,,22229,,1,,U,Solubility after at a pH 1.2,,,,0,,BAO_0000100
12744,6629,P,,Autocuration,CHEMBL628544,,,22229,,1,,U,Solubility after at pH 1.2,,,,0,,BAO_0000100
12745,6629,P,,Autocuration,CHEMBL628545,,,22229,,1,,U,Solubility after injection of water,,,,0,,BAO_0000100
12746,14000,A,,Autocuration,CHEMBL628546,,,22224,,1,,U,Statistical significance of IC 50 values; Expressed as R value,,,,0,,BAO_0000019
12747,8267,A,,Autocuration,CHEMBL874455,,,22224,,1,,U,Systemic availability with respect to methyldopa was determined,,,,0,,BAO_0000019
12748,13799,A,,Intermediate,CHEMBL628547,,,50597,,1,,N,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,,,1,,BAO_0000218
12749,13799,A,,Intermediate,CHEMBL628548,,1969.0,50597,,1,,N,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,,Plasma,1,,BAO_0000218
12750,7132,A,,Intermediate,CHEMBL628549,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12751,7132,A,,Intermediate,CHEMBL628550,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12752,7132,A,,Intermediate,CHEMBL628551,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12753,7132,A,,Intermediate,CHEMBL628552,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12754,7132,A,,Intermediate,CHEMBL628553,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12755,7132,A,,Intermediate,CHEMBL628554,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12756,7132,A,,Intermediate,CHEMBL628555,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12757,7132,A,,Intermediate,CHEMBL628556,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12758,7132,A,,Intermediate,CHEMBL628557,,2113.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Kidney,1,,BAO_0000218
12759,7132,A,,Intermediate,CHEMBL628558,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12760,7132,A,,Intermediate,CHEMBL628559,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12761,7132,A,,Intermediate,CHEMBL628560,,1988.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12762,7132,A,,Intermediate,CHEMBL874456,,1088.0,50592,,1,,N,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12763,7132,A,,Intermediate,CHEMBL628561,,1988.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12764,7132,A,,Intermediate,CHEMBL628562,,1988.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12765,7132,A,,Intermediate,CHEMBL628563,,1088.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12766,7132,A,,Intermediate,CHEMBL628564,,1088.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12767,7132,A,,Intermediate,CHEMBL628565,,1088.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12768,7132,A,,Intermediate,CHEMBL631248,,1088.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12769,7132,A,,Intermediate,CHEMBL631249,,1088.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
12770,7132,A,,Intermediate,CHEMBL627214,,2113.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Kidney,1,,BAO_0000218
12771,7132,A,,Intermediate,CHEMBL874591,,1988.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12772,7132,A,,Intermediate,CHEMBL627215,,1988.0,50592,,1,,N,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12773,7132,A,,Intermediate,CHEMBL625471,,1988.0,50592,,1,,N,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Oryctolagus cuniculus,,Feces,1,,BAO_0000218
12774,7132,A,,Intermediate,CHEMBL625472,,,50592,,1,,N,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Oryctolagus cuniculus,,,1,,BAO_0000218
12775,7132,A,,Intermediate,CHEMBL625473,,,50592,,1,,N,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,,,1,,BAO_0000218
12776,13317,A,,Intermediate,CHEMBL625474,In vivo,,50588,,1,,N,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Canis lupus familiaris,,,1,,BAO_0000218
12777,15341,A,,Intermediate,CHEMBL625475,In vivo,,50588,,1,,N,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Canis lupus familiaris,,,1,,BAO_0000218
12778,15341,A,,Intermediate,CHEMBL625476,In vivo,,50597,,1,,N,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Rattus norvegicus,,,1,,BAO_0000218
12779,15341,A,,Intermediate,CHEMBL625477,In vivo,,50597,,1,,N,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Rattus norvegicus,,,1,,BAO_0000218
12780,15341,A,,Intermediate,CHEMBL625478,In vivo,,50597,,1,,N,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,,,1,,BAO_0000218
12781,12801,A,,Intermediate,CHEMBL625479,In vitro,,50597,,1,,N,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,,esophageal tunica muscularis mucosae,1,,BAO_0000218
12782,12801,A,,Intermediate,CHEMBL625480,In vitro,,50597,,1,,N,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,,esophageal tunica muscularis mucosae,1,,BAO_0000218
12783,14856,A,,Intermediate,CHEMBL625481,In vivo,1969.0,50597,,1,,N,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Rattus norvegicus,,Plasma,1,,BAO_0000218
12784,14062,A,,Intermediate,CHEMBL625482,In vivo,,50597,,1,,N,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
12785,14062,A,,Intermediate,CHEMBL625483,In vivo,,50597,,1,,N,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
12786,14062,A,,Intermediate,CHEMBL625484,In vivo,,50597,,1,,N,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
12787,14062,A,,Intermediate,CHEMBL625485,In vivo,,50597,,1,,N,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
12788,14346,A,,Intermediate,CHEMBL625486,In vivo,1969.0,50588,,1,,N,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12789,14346,A,,Intermediate,CHEMBL625487,In vivo,1969.0,50597,,1,,N,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12790,14346,A,,Intermediate,CHEMBL625488,In vivo,1969.0,50597,,1,,N,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12791,14346,A,,Intermediate,CHEMBL625489,In vivo,1969.0,50597,,1,,N,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12792,14346,A,,Intermediate,CHEMBL625490,In vivo,1969.0,50597,,1,,N,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12793,14346,A,,Intermediate,CHEMBL625491,In vivo,1969.0,50588,,1,,N,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,,Plasma,1,,BAO_0000218
12794,14346,A,,Intermediate,CHEMBL625492,In vivo,1969.0,50597,,1,,N,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
12795,15711,A,,Intermediate,CHEMBL625493,In vivo,1969.0,50587,,1,,N,plasma clearance in human,Homo sapiens,,Plasma,1,,BAO_0000218
12796,14886,A,,Intermediate,CHEMBL625494,In vivo,,50597,,1,,N,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12797,14886,A,,Intermediate,CHEMBL625495,In vivo,,50597,,1,,N,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12798,14886,A,,Intermediate,CHEMBL625496,In vivo,,50597,,1,,N,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
12799,4115,P,,Autocuration,CHEMBL625497,,,22229,,1,,U,1-Octanol/water partition coefficient measured at 7.4,,,,0,,BAO_0000100
12800,13733,P,,Autocuration,CHEMBL625498,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12801,12102,A,,Autocuration,CHEMBL625499,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
12802,12676,P,,Autocuration,CHEMBL625500,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12803,13733,P,,Autocuration,CHEMBL625501,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12804,13740,P,,Autocuration,CHEMBL625502,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12805,12766,P,,Autocuration,CHEMBL625503,,,22229,,1,,U,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,,0,,BAO_0000100
12806,2764,P,,Autocuration,CHEMBL625504,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12807,12355,P,,Autocuration,CHEMBL625505,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12808,11314,P,,Autocuration,CHEMBL625506,,,22229,,1,,U,Calculated partition coefficient of the compound,,,,0,,BAO_0000100
12809,12706,A,,Autocuration,CHEMBL625507,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
12810,12645,P,,Autocuration,CHEMBL625508,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12811,13668,P,,Autocuration,CHEMBL625509,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12812,12819,P,,Autocuration,CHEMBL625510,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12813,13668,P,,Autocuration,CHEMBL883125,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12814,13017,P,,Autocuration,CHEMBL625511,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12815,2448,A,,Autocuration,CHEMBL874650,,,22224,,1,,U,Partition coefficient of the compound,,,,0,,BAO_0000019
12816,11526,A,,Autocuration,CHEMBL625512,,,22224,,1,,U,Partition coefficient of the compound,,,,0,,BAO_0000019
12817,12426,A,,Autocuration,CHEMBL625513,,,22224,,1,,U,Partition coefficient of compound was determined,,,,0,,BAO_0000019
12818,2448,A,,Autocuration,CHEMBL625514,,,22224,,1,,U,Partition coefficient was determined,,,,0,,BAO_0000019
12819,12001,P,,Autocuration,CHEMBL625515,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12820,12426,P,,Autocuration,CHEMBL625516,,,22229,,1,,U,partition coefficient of compound was determined,,,,0,,BAO_0000100
12821,13204,A,,Intermediate,CHEMBL625517,In vivo,,50588,,1,,N,The total body administered intravenously in dog,Canis lupus familiaris,,,1,,BAO_0000218
12822,13204,A,,Intermediate,CHEMBL625518,In vivo,,50597,,1,,N,The total body administered intravenously in rats,Rattus norvegicus,,,1,,BAO_0000218
12823,13889,A,,Intermediate,CHEMBL625519,,,50594,,1,,N,Time taken for the administration to female NIH mice weighing 25-30 g.,Mus musculus,,,1,,BAO_0000218
12824,13889,A,,Autocuration,CHEMBL625520,,,22224,,1,,U,Time taken for the administration,,,,0,,BAO_0000019
12825,17025,A,,Intermediate,CHEMBL874651,In vivo,,50588,,1,,N,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,,,1,,BAO_0000218
12826,17025,A,,Autocuration,CHEMBL625521,In vivo,,22224,,1,,U,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,,,0,,BAO_0000218
12827,17025,A,,Intermediate,CHEMBL623171,In vivo,,50592,,1,,N,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,,,1,,BAO_0000218
12828,17025,A,,Intermediate,CHEMBL623853,In vivo,,50597,,1,,N,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,,,1,,BAO_0000218
12829,15067,A,,Autocuration,CHEMBL623854,,,22224,,1,,U,Plasma clearance for the compound was determined.,,,,0,,BAO_0000019
12830,3091,P,,Autocuration,CHEMBL874405,,,22224,,1,,U,CLog P value of the compound,,,,0,,BAO_0000100
12831,15592,P,,Autocuration,CHEMBL623855,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12832,14738,P,,Autocuration,CHEMBL623856,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12833,14738,P,,Autocuration,CHEMBL623857,,,22224,,1,,U,ClogP value of the compound; nd ='no data',,,,0,,BAO_0000100
12834,14738,P,,Autocuration,CHEMBL623858,,,22224,,1,,U,ClogP value of the compound; nd ='not determined',,,,0,,BAO_0000100
12835,6076,P,,Autocuration,CHEMBL623859,,,22224,,1,,U,CLog P was determined,,,,0,,BAO_0000100
12836,17840,P,,Autocuration,CHEMBL839829,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12837,13589,A,,Autocuration,CHEMBL623860,,,22224,,1,,U,CLogP was calculated,,,,0,,BAO_0000019
12838,17655,A,,Autocuration,CHEMBL623861,,,22224,,1,,U,CLogP value was determined,,,,0,,BAO_0000019
12839,5867,A,,Autocuration,CHEMBL623862,,,22224,,1,,U,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,,0,,BAO_0000019
12840,5867,P,,Autocuration,CHEMBL874406,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12841,10783,P,,Autocuration,CHEMBL623863,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12842,14849,P,,Autocuration,CHEMBL624021,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12843,8170,A,,Intermediate,CHEMBL624022,,1236.0,50588,,1,,N,Distribution in female dog adrenal medulla 24 hours after administration.,Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12844,8170,A,,Intermediate,CHEMBL624023,,1236.0,50588,,1,,N,Distribution in female dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,,Adrenal medulla,1,,BAO_0000218
12845,8170,A,,Intermediate,CHEMBL624024,,,50588,,1,,N,Distribution in female dog bile 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12846,8170,A,,Intermediate,CHEMBL624025,,,50588,,1,,N,Distribution in female dog bile 72 hr after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12847,8170,A,,Intermediate,CHEMBL624026,,,50588,,1,,N,Distribution in female dog blood 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12848,8170,A,,Intermediate,CHEMBL624027,,,50588,,1,,N,Distribution in female dog blood 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12849,8170,A,,Intermediate,CHEMBL624028,,,50588,,1,,N,Distribution in female dog heart 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12850,8170,A,,Intermediate,CHEMBL624029,,,50588,,1,,N,Distribution in female dog heart 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12851,8170,A,,Intermediate,CHEMBL624030,,,50588,,1,,N,Distribution in female dog kidney 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12852,8170,A,,Intermediate,CHEMBL624031,,,50588,,1,,N,Distribution in female dog kidney 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12853,8170,A,,Intermediate,CHEMBL624032,,160.0,50588,,1,,N,Distribution in female dog large intestine 24 hours after administration.,Canis lupus familiaris,,Intestine,1,,BAO_0000218
12854,8170,A,,Intermediate,CHEMBL874407,,160.0,50588,,1,,N,Distribution in female dog large intestine 72 hours after administration.,Canis lupus familiaris,,Intestine,1,,BAO_0000218
12855,8170,A,,Intermediate,CHEMBL624033,,,50588,,1,,N,Distribution in female dog liver 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12856,8170,A,,Intermediate,CHEMBL624034,,,50588,,1,,N,Distribution in female dog liver 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12857,8170,A,,Intermediate,CHEMBL624035,,,50588,,1,,N,Distribution in female dog lung 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12858,8170,A,,Intermediate,CHEMBL624036,,,50588,,1,,N,Distribution in female dog lung 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12859,8170,A,,Intermediate,CHEMBL624037,,2385.0,50588,,1,,N,Distribution in female dog muscle 24 hours after administration.,Canis lupus familiaris,,Muscle tissue,1,,BAO_0000218
12860,8170,A,,Intermediate,CHEMBL624038,,2385.0,50588,,1,,N,Distribution in female dog muscle 72 hours after administration.,Canis lupus familiaris,,Muscle tissue,1,,BAO_0000218
12861,8170,A,,Intermediate,CHEMBL624039,,,50588,,1,,N,Distribution in female dog pancreas 24 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12862,8170,A,,Intermediate,CHEMBL624040,,,50588,,1,,N,Distribution in female dog pancreas 72 hours after administration.,Canis lupus familiaris,,,1,,BAO_0000218
12863,8170,A,,Intermediate,CHEMBL624041,,160.0,50588,,1,,N,Distribution in female dog small intestine 24 hours after administration.,Canis lupus familiaris,,Intestine,1,,BAO_0000218
12864,8170,A,,Intermediate,CHEMBL624042,,160.0,50588,,1,,N,Distribution in female dog small intestine 72 hours after administration.,Canis lupus familiaris,,Intestine,1,,BAO_0000218
12865,8170,A,,Intermediate,CHEMBL624043,,2106.0,50588,,1,,N,Distribution in female dog spleen 24 hours after administration.,Canis lupus familiaris,,Spleen,1,,BAO_0000218
12866,8170,A,,Intermediate,CHEMBL624044,,2106.0,50588,,1,,N,Distribution in female dog spleen 72 hours after administration.,Canis lupus familiaris,,Spleen,1,,BAO_0000218
12867,8170,A,,Intermediate,CHEMBL624045,,945.0,50588,,1,,N,Distribution in female dog stomach 24 hours after administration.,Canis lupus familiaris,,Stomach,1,,BAO_0000218
12868,8170,A,,Intermediate,CHEMBL624046,,945.0,50588,,1,,N,Distribution in female dog stomach 72 hours after administration.,Canis lupus familiaris,,Stomach,1,,BAO_0000218
12869,8170,A,,Intermediate,CHEMBL624047,,2046.0,50588,,1,,N,Distribution in female dog thyroid 24 hours after administration.,Canis lupus familiaris,,Thyroid gland,1,,BAO_0000218
12870,8170,A,,Intermediate,CHEMBL624048,,2046.0,50588,,1,,N,Distribution in female dog thyroid 72 hours after administration.,Canis lupus familiaris,,Thyroid gland,1,,BAO_0000218
12871,8170,A,,Intermediate,CHEMBL874408,,1088.0,50588,,1,,N,Distribution in female dog urine 24 hours after administration.,Canis lupus familiaris,,Urine,1,,BAO_0000218
12872,8170,A,,Intermediate,CHEMBL624049,,1088.0,50588,,1,,N,Distribution in female dog urine 72 hr after administration.,Canis lupus familiaris,,Urine,1,,BAO_0000218
12873,14283,A,,Autocuration,CHEMBL624050,,1969.0,22224,,1,,U,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,Plasma,0,,BAO_0000218
12874,5623,A,,Autocuration,CHEMBL624051,,,22224,,1,,U,Plasma concentration at 7 hr after intravenous dosing,,,,0,,BAO_0000019
12875,13477,A,,Intermediate,CHEMBL623278,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12876,13477,A,,Intermediate,CHEMBL623279,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12877,13477,A,,Intermediate,CHEMBL623280,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12878,13477,A,,Intermediate,CHEMBL623963,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12879,13477,A,,Intermediate,CHEMBL623964,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12880,13477,A,,Intermediate,CHEMBL623965,,,50597,,1,,N,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12881,13477,A,,Intermediate,CHEMBL623966,,,50597,,1,,N,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Rattus norvegicus,,,1,,BAO_0000218
12882,13477,A,,Intermediate,CHEMBL874415,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Rattus norvegicus,,,1,,BAO_0000218
12883,13477,A,,Intermediate,CHEMBL623967,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Rattus norvegicus,,,1,,BAO_0000218
12884,13477,A,,Intermediate,CHEMBL623968,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Rattus norvegicus,,,1,,BAO_0000218
12885,13477,A,,Intermediate,CHEMBL623969,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Rattus norvegicus,,,1,,BAO_0000218
12886,13477,A,,Intermediate,CHEMBL628409,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Rattus norvegicus,,,1,,BAO_0000218
12887,13477,A,,Intermediate,CHEMBL628410,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Rattus norvegicus,,,1,,BAO_0000218
12888,13477,A,,Intermediate,CHEMBL628411,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Rattus norvegicus,,,1,,BAO_0000218
12889,13477,A,,Intermediate,CHEMBL628412,,,50597,,1,,N,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Rattus norvegicus,,,1,,BAO_0000218
12890,12553,A,,Autocuration,CHEMBL628413,,,22224,,1,,U,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,,0,,BAO_0000019
12891,14548,A,,Autocuration,CHEMBL628414,,1969.0,22224,,1,,U,The concentration in plasmat; Not determined,,,Plasma,0,,BAO_0000019
12892,14393,A,,Intermediate,CHEMBL628415,,,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in blood,Rattus norvegicus,,,1,,BAO_0000218
12893,14393,A,,Intermediate,CHEMBL628416,,,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Rattus norvegicus,,,1,,BAO_0000218
12894,14393,A,,Intermediate,CHEMBL628417,,,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in heart,Rattus norvegicus,,,1,,BAO_0000218
12895,14393,A,,Intermediate,CHEMBL874908,,2107.0,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in liver,Rattus norvegicus,,Liver,1,,BAO_0000218
12896,14393,A,,Intermediate,CHEMBL628418,,,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in plasma,Rattus norvegicus,,,1,,BAO_0000218
12897,14393,A,,Intermediate,CHEMBL628419,,2385.0,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
12898,14393,A,,Intermediate,CHEMBL628420,,,50597,,1,,N,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Rattus norvegicus,,,1,,BAO_0000218
12899,1629,A,,Autocuration,CHEMBL628421,,,22224,,1,,U,Water solubility at 37 degree C.,,,,0,,BAO_0000019
12900,8194,P,,Autocuration,CHEMBL626726,,,22229,,1,,U,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,0,,BAO_0000100
12901,8194,P,,Autocuration,CHEMBL626727,,,22229,,1,,U,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,0,,BAO_0000100
12902,8594,A,,Intermediate,CHEMBL626728,,178.0,50597,,1,,N,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12903,8594,A,,Intermediate,CHEMBL626729,,178.0,50597,,1,,N,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12904,8594,A,,Intermediate,CHEMBL626730,,178.0,50597,,1,,N,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12905,8594,A,,Intermediate,CHEMBL626731,,178.0,50597,,1,,N,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12906,8594,A,,Intermediate,CHEMBL626732,,178.0,50597,,1,,N,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Blood,1,,BAO_0000218
12907,8594,A,,Intermediate,CHEMBL626733,,948.0,50597,,1,,N,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12908,8594,A,,Intermediate,CHEMBL626734,,948.0,50597,,1,,N,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12909,8594,A,,Intermediate,CHEMBL626735,,948.0,50597,,1,,N,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12910,8594,A,,Intermediate,CHEMBL874909,,948.0,50597,,1,,N,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12911,8594,A,,Intermediate,CHEMBL626736,,948.0,50597,,1,,N,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Heart,1,,BAO_0000218
12912,8594,A,,Intermediate,CHEMBL626737,,2113.0,50597,,1,,N,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12913,8594,A,,Intermediate,CHEMBL630999,,2113.0,50597,,1,,N,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12914,8594,A,,Intermediate,CHEMBL631000,,2113.0,50597,,1,,N,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12915,8594,A,,Intermediate,CHEMBL631001,,2113.0,50597,,1,,N,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12916,8594,A,,Intermediate,CHEMBL631002,,2113.0,50597,,1,,N,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Kidney,1,,BAO_0000218
12917,8594,A,,Intermediate,CHEMBL631003,,2107.0,50597,,1,,N,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12918,8594,A,,Intermediate,CHEMBL631004,,2107.0,50597,,1,,N,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12919,8594,A,,Intermediate,CHEMBL631005,,2107.0,50597,,1,,N,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12920,8594,A,,Intermediate,CHEMBL631006,,2107.0,50597,,1,,N,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12921,8594,A,,Intermediate,CHEMBL631007,,2107.0,50597,,1,,N,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Liver,1,,BAO_0000218
12922,8594,A,,Intermediate,CHEMBL631008,,2048.0,50597,,1,,N,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12923,8594,A,,Intermediate,CHEMBL631009,,2048.0,50597,,1,,N,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12924,8594,A,,Intermediate,CHEMBL631010,,2048.0,50597,,1,,N,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12925,8594,A,,Intermediate,CHEMBL631011,,2048.0,50597,,1,,N,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12926,8594,A,,Intermediate,CHEMBL631012,,2048.0,50597,,1,,N,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Lung,1,,BAO_0000218
12927,8594,A,,Intermediate,CHEMBL630271,,2046.0,50597,,1,,N,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12928,8594,A,,Intermediate,CHEMBL630272,,2046.0,50597,,1,,N,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12929,8594,A,,Intermediate,CHEMBL630273,,2046.0,50597,,1,,N,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12930,8594,A,,Intermediate,CHEMBL630274,,2046.0,50597,,1,,N,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12931,8594,A,,Intermediate,CHEMBL630275,,2046.0,50597,,1,,N,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
12932,8594,A,,Intermediate,CHEMBL875782,,,50597,,1,,N,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12933,8594,A,,Intermediate,CHEMBL630276,,,50597,,1,,N,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12934,8594,A,,Intermediate,CHEMBL630277,,,50597,,1,,N,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12935,8594,A,,Intermediate,CHEMBL630278,,,50597,,1,,N,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12936,8594,A,,Intermediate,CHEMBL630279,,,50597,,1,,N,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,,,1,,BAO_0000218
12937,8151,A,,Autocuration,CHEMBL630280,,,22224,,1,,U,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,,0,,BAO_0000019
12938,8151,A,,Autocuration,CHEMBL630281,,,22224,,1,,U,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,0,,BAO_0000019
12939,7132,A,,Intermediate,CHEMBL630282,,,50592,,1,,N,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,,,1,,BAO_0000218
12940,7132,A,,Intermediate,CHEMBL630283,,,50592,,1,,N,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Oryctolagus cuniculus,,,1,,BAO_0000218
12941,5797,A,,Autocuration,CHEMBL630284,,,22224,,1,,U,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,,0,,BAO_0000019
12942,7849,A,,Autocuration,CHEMBL630285,,,22224,,1,,U,Alkylating activity was determined,,,,0,,BAO_0000019
12943,14220,A,,Autocuration,CHEMBL630286,,,22224,,1,,U,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,Microsomes,,0,,BAO_0000251
12944,8650,A,,Intermediate,CHEMBL630069,,,50592,,1,,N,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Oryctolagus cuniculus,,,1,,BAO_0000218
12945,8650,A,,Intermediate,CHEMBL630070,,,50592,,1,,N,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Oryctolagus cuniculus,,,1,,BAO_0000218
12946,8650,A,,Intermediate,CHEMBL630071,,,50592,,1,,N,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Oryctolagus cuniculus,,,1,,BAO_0000218
12947,8650,A,,Intermediate,CHEMBL630072,,,50592,,1,,N,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Oryctolagus cuniculus,,,1,,BAO_0000218
12948,8650,A,,Intermediate,CHEMBL875110,,,50592,,1,,N,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Oryctolagus cuniculus,,,1,,BAO_0000218
12949,7116,A,,Intermediate,CHEMBL630073,,,50597,,1,,N,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,,,1,,BAO_0000218
12950,14131,A,,Autocuration,CHEMBL630074,,,22224,,1,,U,Compound was tested for inactivation kinetic values,,,,0,,BAO_0000019
12951,7415,A,,Autocuration,CHEMBL630075,In vivo,,22224,,1,,U,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,,0,,BAO_0000218
12952,13178,A,,Autocuration,CHEMBL630076,,,22224,,1,,U,Dissociation rate calculated from the first-order equation using the t1/2 value,,,,0,,BAO_0000019
12953,8815,P,,Autocuration,CHEMBL630077,,,22229,,1,,U,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,,0,,BAO_0000100
12954,1450,P,,Autocuration,CHEMBL630078,,,22229,,1,,U,Aqueous solubility was measured,,,,0,,BAO_0000100
12955,1450,P,,Autocuration,CHEMBL630079,,,22229,,1,,U,Aqueous solubility was measured at a pH 4,,,,0,,BAO_0000100
12956,1450,P,,Autocuration,CHEMBL630080,,,22229,,1,,U,Aqueous solubility (pH 7),,,,0,,BAO_0000100
12957,1450,P,,Autocuration,CHEMBL630081,,,22229,,1,,U,Aqueous solubility was measured at a pH 9,,,,0,,BAO_0000100
12958,12711,A,,Autocuration,CHEMBL630082,,,22224,,1,,U,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,,0,,BAO_0000019
12959,12711,A,,Autocuration,CHEMBL630083,,,22224,,1,,U,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,0,,BAO_0000019
12960,12711,A,,Autocuration,CHEMBL630084,,,22224,,1,,U,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,0,,BAO_0000019
12961,15032,P,,Autocuration,CHEMBL629198,,,22229,,1,,U,Aqueous solubility of the compound,,,,0,,BAO_0000100
12962,9964,P,,Autocuration,CHEMBL629199,,,22229,,1,,U,Aqueous solubility at 37 degree Celsius at pH 7.38,,,,0,,BAO_0000100
12963,14962,P,,Autocuration,CHEMBL629200,,,22229,,1,,U,Aqueous solubility in pH 7.4 phosphate buffer,,,,0,,BAO_0000100
12964,12487,A,,Intermediate,CHEMBL629201,,,50588,,1,,N,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,,,1,,BAO_0000218
12965,12487,A,,Intermediate,CHEMBL629202,,,50588,,1,,N,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,,,1,,BAO_0000218
12966,10026,A,,Intermediate,CHEMBL875111,,,50587,,1,,N,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,1,,BAO_0000218
12967,10026,A,,Intermediate,CHEMBL629203,,,50587,,1,,N,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,1,,BAO_0000218
12968,10026,A,,Intermediate,CHEMBL629204,,,50587,,1,,N,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,1,,BAO_0000218
12969,10026,A,,Intermediate,CHEMBL629205,,,50587,,1,,N,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,1,,BAO_0000218
12970,10026,A,,Intermediate,CHEMBL629206,,,50587,,1,,N,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,,,1,,BAO_0000218
12971,10026,A,,Autocuration,CHEMBL631185,,,22224,,1,,U,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,,0,,BAO_0000019
12972,7415,A,,Intermediate,CHEMBL631186,,,50597,,1,,N,Compound was evaluated for the average bile flow rat in rats,Rattus norvegicus,,,1,,BAO_0000218
12973,17025,A,,Intermediate,CHEMBL631187,,,50592,,1,,N,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,,,1,,BAO_0000218
12974,17025,A,,Intermediate,CHEMBL631188,,,50592,,1,,N,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,,,1,,BAO_0000218
12975,10184,A,,Autocuration,CHEMBL876419,,,22224,,1,,U,Average half life period was determined,,,,0,,BAO_0000019
12976,10184,A,,Autocuration,CHEMBL631189,,,22224,,1,,U,Average half life period was determined,,,,0,,BAO_0000019
12977,8613,A,,Intermediate,CHEMBL631190,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12978,8613,A,,Intermediate,CHEMBL631191,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12979,8613,A,,Intermediate,CHEMBL631192,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12980,8613,A,,Intermediate,CHEMBL632400,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12981,8613,A,,Intermediate,CHEMBL630564,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12982,8613,A,,Intermediate,CHEMBL630565,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12983,8613,A,,Intermediate,CHEMBL630566,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12984,8613,A,,Intermediate,CHEMBL631229,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12985,8613,A,,Intermediate,CHEMBL631230,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
12986,6030,P,,Autocuration,CHEMBL876428,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12987,6147,P,,Autocuration,CHEMBL631231,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12988,14556,P,,Autocuration,CHEMBL631232,,,22229,,1,,U,Calculated partition coefficient (clogP) (MacLogP),,,,0,,BAO_0000100
12989,768,A,,Autocuration,CHEMBL631233,,,22224,,1,,U,Hydrophilicity was determined,,,,0,,BAO_0000019
12990,14452,P,,Autocuration,CHEMBL631234,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12991,5237,A,,Autocuration,CHEMBL883126,,,22224,,1,,U,Increased absorption was determined,,,,0,,BAO_0000019
12992,14378,P,,Autocuration,CHEMBL631235,,,22224,,1,,U,Lipophilicity value was evaluated,,,,0,,BAO_0000100
12993,14418,P,,Autocuration,CHEMBL631236,,,22224,,1,,U,Log P value of the compound.,,,,0,,BAO_0000100
12994,5249,A,,Autocuration,CHEMBL631237,,,22224,,1,,U,Partition coefficient of compound was determined,,,,0,,BAO_0000019
12995,14621,P,,Autocuration,CHEMBL631238,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12996,12542,P,,Autocuration,CHEMBL876429,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
12997,12542,A,,Autocuration,CHEMBL631414,,,22224,,1,,U,Partition coefficient was measured by medchem software; Not calculated,,,,0,,BAO_0000019
12998,12542,P,,Autocuration,CHEMBL631415,,,22224,,1,,U,Partition coefficient was measured by octanol-water using standard shake-flask method,,,,0,,BAO_0000100
12999,15462,P,,Autocuration,CHEMBL631416,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13000,14884,A,,Autocuration,CHEMBL631417,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
13001,16526,P,,Autocuration,CHEMBL631418,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13002,13693,P,,Autocuration,CHEMBL631419,,,22229,,1,,U,The Octanol/Water partition coefficient CLogP,,,,0,,BAO_0000100
13003,13693,A,,Autocuration,CHEMBL631420,,,22224,,1,,U,The pharmacokinetic parameter C Log p was reported,,,,0,,BAO_0000019
13004,13779,P,,Autocuration,CHEMBL631421,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13005,14772,P,,Autocuration,CHEMBL631422,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13006,14393,P,,Autocuration,CHEMBL631423,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13007,14793,A,,Intermediate,CHEMBL876430,In vivo,1969.0,50597,,1,,N,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
13008,14793,A,,Intermediate,CHEMBL631424,In vivo,1969.0,50597,,1,,N,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
13009,13744,A,,Intermediate,CHEMBL631425,In vivo,1969.0,50588,,1,,N,Compound was administered intravenously in dog to evaluate plasma clearance values,Canis lupus familiaris,,Plasma,1,,BAO_0000218
13010,13744,A,,Autocuration,CHEMBL631426,In vivo,1969.0,22224,,1,,U,Compound was administered intravenously in monkey to evaluate plasma clearance values,Simiiformes,,Plasma,0,,BAO_0000218
13011,13744,A,,Intermediate,CHEMBL631427,In vivo,1969.0,50594,,1,,N,Compound was administered intravenously in mouse to evaluate plasma clearance values,Mus musculus,,Plasma,1,,BAO_0000218
13012,13207,A,,Intermediate,CHEMBL631428,In vivo,1969.0,50588,,1,,N,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Canis lupus familiaris,,Plasma,1,,BAO_0000218
13013,5669,A,,Intermediate,CHEMBL631429,In vitro,2107.0,50797,,1,,N,Intrinsic clearance in Rhesus liver microsome,Macaca mulatta,Microsomes,Liver,1,,BAO_0000218
13014,5669,A,,Intermediate,CHEMBL631430,In vitro,2107.0,50588,,1,,N,Intrinsic clearance in dog liver microsome,Canis lupus familiaris,Microsomes,Liver,1,,BAO_0000218
13015,5669,A,,Intermediate,CHEMBL631431,In vitro,2107.0,50597,,1,,N,Intrinsic clearance in rat liver microsome,Rattus norvegicus,Microsomes,Liver,1,,BAO_0000218
13016,4853,A,,Intermediate,CHEMBL631432,In vivo,1969.0,50797,,1,,N,Low plasma clearance was calculated in rhesus monkey,Macaca mulatta,,Plasma,1,,BAO_0000218
13017,16452,A,,Intermediate,CHEMBL631433,In vivo,,50588,,1,,N,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Canis lupus familiaris,,,1,,BAO_0000218
13018,11954,A,,Autocuration,CHEMBL631434,In vivo,,22224,,1,,U,Plasma clearance after intravenous dose of 0.3 mg/kg,,,,0,,BAO_0000218
13019,11954,A,,Autocuration,CHEMBL631435,In vivo,,22224,,1,,U,Plasma clearance after intravenous dose of 1 mg/kg,,,,0,,BAO_0000218
13020,11954,A,,Autocuration,CHEMBL631436,In vivo,,22224,,1,,U,Plasma clearance after intravenous dose of 3 mg/kg,,,,0,,BAO_0000218
13021,11954,A,,Autocuration,CHEMBL631437,In vivo,,22224,,1,,U,Plasma clearance after intravenous dose of 3.87 mg/kg,,,,0,,BAO_0000218
13022,5669,A,,Intermediate,CHEMBL631438,In vivo,,50597,,1,,N,Plasma clearance after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
13023,5669,A,,Intermediate,CHEMBL876431,In vivo,,50797,,1,,N,Plasma clearance after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,1,,BAO_0000218
13024,5669,A,,Intermediate,CHEMBL631439,In vivo,,50588,,1,,N,Plasma clearance after peroral administration at 10 mpk in dog,Canis lupus familiaris,,,1,,BAO_0000218
13025,13662,A,,Intermediate,CHEMBL631440,In vivo,,50597,,1,,N,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Rattus norvegicus,,,1,,BAO_0000218
13026,8272,A,,Autocuration,CHEMBL631441,,,22224,,1,,U,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,,0,,BAO_0000019
13027,13410,A,,Autocuration,CHEMBL631442,,,22224,,1,,U,Critical Micellar concentration was determined,,,,0,,BAO_0000019
13028,13410,A,,Autocuration,CHEMBL626525,,,22224,,1,,U,Critical Micellar concentration of the compound. was determined,,,,0,,BAO_0000019
13029,12628,A,,Autocuration,CHEMBL627168,,,22224,,1,,U,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,,0,,BAO_0000019
13030,9675,A,,Autocuration,CHEMBL875618,,,22224,,1,,U,Critical micellar concentration was measured in water by the dye solubilization method,,,,0,,BAO_0000019
13031,12628,B,,Autocuration,CHEMBL626612,,,22224,,1,,U,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,,0,,BAO_0000019
13032,12766,A,,Autocuration,CHEMBL626613,,,22224,,1,,U,CMR value (relative to BAY K 8644),,,,0,,BAO_0000019
13033,7849,A,,Autocuration,CHEMBL626614,,,22224,,1,,U,Carbamoylating activity was determined,,,,0,,BAO_0000019
13034,12187,A,,Autocuration,CHEMBL626615,,,22224,,1,,U,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,,,0,,BAO_0000218
13035,2040,A,,Autocuration,CHEMBL626616,,,22224,,1,,U,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,,0,,BAO_0000019
13036,2040,A,,Autocuration,CHEMBL626617,,,22224,,1,,U,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,,0,,BAO_0000019
13037,14180,A,,Intermediate,CHEMBL626618,In vivo,1969.0,50588,,1,,N,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Canis lupus familiaris,,Plasma,1,,BAO_0000218
13038,14180,A,,Intermediate,CHEMBL626619,In vivo,1969.0,50597,,1,,N,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Rattus norvegicus,,Plasma,1,,BAO_0000218
13039,14474,A,,Intermediate,CHEMBL626620,In vivo,,50588,,1,,N,"Clearance rate at 0.46 mg/kg, iv, in dogs",Canis lupus familiaris,,,1,,BAO_0000218
13040,14474,A,,Intermediate,CHEMBL626621,In vivo,,50597,,1,,N,"Clearance rate at 5.5 mg/kg, iv, in rat",Rattus norvegicus,,,1,,BAO_0000218
13041,14548,A,,Intermediate,CHEMBL626622,In vivo,,100710,,1,,N,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,,,1,,BAO_0000218
13042,14548,A,,Intermediate,CHEMBL626623,In vivo,,100710,,1,,N,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,,,1,,BAO_0000218
13043,14548,A,,Intermediate,CHEMBL626624,In vivo,,50588,,1,,N,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,,,1,,BAO_0000218
13044,14548,A,,Intermediate,CHEMBL626625,In vivo,,50597,,1,,N,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
13045,6125,A,,Intermediate,CHEMBL626626,Ex vivo,2107.0,50597,,1,,N,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,,Liver,1,,BAO_0000218
13046,6874,A,,Autocuration,CHEMBL626627,In vivo,,22224,,1,,U,Tested for the total clearance of the compound,,,,0,,BAO_0000218
13047,15343,A,,Intermediate,CHEMBL626628,In vivo,,50588,,1,,N,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Canis lupus familiaris,,,1,,BAO_0000218
13048,6236,A,,Autocuration,CHEMBL626629,In vivo,,22224,,1,,U,Total body clearance was determined,,,,0,,BAO_0000218
13049,11510,A,,Intermediate,CHEMBL626630,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13050,11510,A,,Intermediate,CHEMBL626631,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13051,8194,P,,Autocuration,CHEMBL626632,,,22229,,1,,U,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,0,,BAO_0000100
13052,8194,P,,Autocuration,CHEMBL626633,,,22229,,1,,U,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,0,,BAO_0000100
13053,8194,P,,Autocuration,CHEMBL626634,,,22229,,1,,U,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,,0,,BAO_0000100
13054,8194,P,,Autocuration,CHEMBL626635,,,22229,,1,,U,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,0,,BAO_0000100
13055,8194,P,,Autocuration,CHEMBL626636,,,22229,,1,,U,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,0,,BAO_0000100
13056,8194,P,,Autocuration,CHEMBL626637,,,22229,,1,,U,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,0,,BAO_0000100
13057,13273,A,,Intermediate,CHEMBL626638,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13058,13273,A,,Intermediate,CHEMBL626639,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Pneumocystis carinii,,,1,,BAO_0000218
13059,13273,A,,Intermediate,CHEMBL626640,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Pneumocystis carinii,,,1,,BAO_0000218
13060,13273,A,,Intermediate,CHEMBL626641,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Pneumocystis carinii,,,1,,BAO_0000218
13061,13273,A,,Intermediate,CHEMBL627272,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Pneumocystis carinii,,,1,,BAO_0000218
13062,13273,A,,Intermediate,CHEMBL627273,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Pneumocystis carinii,,,1,,BAO_0000218
13063,13273,A,,Intermediate,CHEMBL627441,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13064,13273,A,,Intermediate,CHEMBL628355,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13065,13273,A,,Intermediate,CHEMBL628356,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13066,13273,A,,Intermediate,CHEMBL628357,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13067,13273,A,,Intermediate,CHEMBL628358,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13068,13273,A,,Intermediate,CHEMBL622307,,,50339,,1,,N,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Pneumocystis carinii,,,1,,BAO_0000218
13069,13118,A,,Autocuration,CHEMBL622527,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,,0,,BAO_0000019
13070,13118,A,,Autocuration,CHEMBL622528,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,,0,,BAO_0000019
13071,13118,A,,Autocuration,CHEMBL622529,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,,0,,BAO_0000019
13072,13118,A,,Autocuration,CHEMBL622992,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,,0,,BAO_0000019
13073,13118,A,,Autocuration,CHEMBL622993,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,,0,,BAO_0000019
13074,13118,A,,Autocuration,CHEMBL622994,,,22224,,1,,U,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,,0,,BAO_0000019
13075,10633,A,,Intermediate,CHEMBL622995,,,50597,,1,,N,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Rattus norvegicus,,,1,,BAO_0000218
13076,10633,A,,Intermediate,CHEMBL622996,,,50597,,1,,N,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Rattus norvegicus,,,1,,BAO_0000218
13077,10633,A,,Intermediate,CHEMBL622997,,,50597,,1,,N,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Rattus norvegicus,,,1,,BAO_0000218
13078,10633,A,,Intermediate,CHEMBL622998,,,50597,,1,,N,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Rattus norvegicus,,,1,,BAO_0000218
13079,5767,A,,Autocuration,CHEMBL622999,,,22224,,1,,U,Cp max following ip administration at 1 mg/kg,,,,0,,BAO_0000218
13080,3302,A,,Autocuration,CHEMBL623000,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma was reported at 0.5 hour,,,Plasma,0,,BAO_0000218
13081,3302,A,,Autocuration,CHEMBL623001,In vivo,1969.0,22224,,1,,U,Maximum concentration in plasma was reported at 2 hour,,,Plasma,0,,BAO_0000218
13082,12467,A,,Intermediate,CHEMBL623002,,,50594,,1,,N,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Mus musculus,,,1,,BAO_0000218
13083,11778,P,,Autocuration,CHEMBL623003,,,22229,,1,,U,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,,0,,BAO_0000100
13084,4321,A,,Autocuration,CHEMBL623004,,,22224,,1,,U,Steady state concentration was evaluated,,,,0,,BAO_0000019
13085,14884,A,,Autocuration,CHEMBL623005,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
13086,15234,A,,Autocuration,CHEMBL623006,,,22224,,1,,U,Partition coefficient (logD7.4),,,,0,,BAO_0000019
13087,14198,A,,Intermediate,CHEMBL623007,In vivo,2107.0,50597,,1,,N,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,Liver,1,,BAO_0000218
13088,14198,A,,Intermediate,CHEMBL623008,In vivo,10000001.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,Bone,1,,BAO_0000218
13089,14198,A,,Intermediate,CHEMBL876654,In vivo,2037.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13090,14198,A,,Intermediate,CHEMBL623009,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13091,14198,A,,Intermediate,CHEMBL623010,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13092,14198,A,,Intermediate,CHEMBL623011,In vivo,948.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,Heart,1,,BAO_0000218
13093,14198,A,,Intermediate,CHEMBL623012,In vivo,160.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,Intestine,1,,BAO_0000218
13094,8151,A,,Autocuration,CHEMBL623013,,,22224,,1,,U,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,0,,BAO_0000019
13095,8151,A,,Autocuration,CHEMBL623014,,,22224,,1,,U,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,0,,BAO_0000019
13096,8151,A,,Autocuration,CHEMBL623015,,1088.0,22224,,1,,U,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,Urine,0,,BAO_0000019
13097,8151,A,,Autocuration,CHEMBL623016,,1088.0,22224,,1,,U,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,Urine,0,,BAO_0000019
13098,8151,A,,Autocuration,CHEMBL624858,,1088.0,22224,,1,,U,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,Urine,0,,BAO_0000019
13099,8151,A,,Intermediate,CHEMBL624859,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Rattus norvegicus,,,1,,BAO_0000218
13100,8151,A,,Intermediate,CHEMBL624860,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
13101,8151,A,,Intermediate,CHEMBL624861,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,1,,BAO_0000218
13102,8151,A,,Intermediate,CHEMBL624862,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Rattus norvegicus,,,1,,BAO_0000218
13103,8151,A,,Intermediate,CHEMBL624863,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Rattus norvegicus,,,1,,BAO_0000218
13104,8151,A,,Intermediate,CHEMBL876655,,,50597,,1,,N,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,,,1,,BAO_0000218
13105,6996,A,,Intermediate,CHEMBL624864,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,,,1,,BAO_0000218
13106,6996,A,,Intermediate,CHEMBL624865,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,,,1,,BAO_0000218
13107,6996,A,,Intermediate,CHEMBL624866,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,1,,BAO_0000218
13108,6996,F,,Expert,CHEMBL624867,,,50588,,1,,N,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
13109,6996,A,,Intermediate,CHEMBL624868,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,,,1,,BAO_0000218
13110,6996,A,,Intermediate,CHEMBL628450,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Canis lupus familiaris,,,1,,BAO_0000218
13111,6996,A,,Intermediate,CHEMBL628451,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,,,1,,BAO_0000218
13112,6996,A,,Intermediate,CHEMBL628452,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,,,1,,BAO_0000218
13113,6996,A,,Intermediate,CHEMBL628453,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,1,,BAO_0000218
13114,6996,A,,Intermediate,CHEMBL628454,,,50588,,1,,N,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
13115,6996,A,,Intermediate,CHEMBL628455,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,,,1,,BAO_0000218
13116,6996,A,,Intermediate,CHEMBL628456,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,,,1,,BAO_0000218
13117,6996,A,,Intermediate,CHEMBL628457,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,,,1,,BAO_0000218
13118,6996,A,,Intermediate,CHEMBL877505,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Canis lupus familiaris,,,1,,BAO_0000218
13119,6996,A,,Intermediate,CHEMBL628458,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Canis lupus familiaris,,,1,,BAO_0000218
13120,6996,A,,Intermediate,CHEMBL628459,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,,,1,,BAO_0000218
13121,6996,A,,Intermediate,CHEMBL628460,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,,,1,,BAO_0000218
13122,6996,A,,Intermediate,CHEMBL628461,,,50588,,1,,N,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,,,1,,BAO_0000218
13123,6996,B,,Autocuration,CHEMBL628462,,,22224,,1,,U,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,,0,,BAO_0000218
13124,6996,A,,Intermediate,CHEMBL628463,,,50588,,1,,N,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Canis lupus familiaris,,,1,,BAO_0000218
13125,6996,F,,Expert,CHEMBL625666,,,50597,,1,,N,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Rattus norvegicus,,,1,,BAO_0000218
13126,6996,B,,Autocuration,CHEMBL625667,,,22224,,1,,U,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,0,,BAO_0000218
13127,6996,A,,Expert,CHEMBL625668,,,50597,,1,,N,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,,,1,,BAO_0000218
13128,6996,A,,Intermediate,CHEMBL625669,,,50597,,1,,N,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,,,1,,BAO_0000218
13129,7114,A,,Autocuration,CHEMBL625670,,,22224,,1,,U,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,,0,,BAO_0000019
13130,7114,A,,Intermediate,CHEMBL625671,,,50597,,1,,N,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,,,1,,BAO_0000218
13131,8613,A,,Intermediate,CHEMBL625672,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Human herpesvirus 1,,,1,,BAO_0000218
13132,8613,A,,Intermediate,CHEMBL625673,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Human herpesvirus 1,,,1,,BAO_0000218
13133,8613,A,,Intermediate,CHEMBL625674,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Human herpesvirus 1,,,1,,BAO_0000218
13134,8613,A,,Intermediate,CHEMBL625675,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Human herpesvirus 1,,,1,,BAO_0000218
13135,8613,A,,Intermediate,CHEMBL627637,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Human herpesvirus 1,,,1,,BAO_0000218
13136,8613,A,,Intermediate,CHEMBL627638,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Human herpesvirus 1,,,1,,BAO_0000218
13137,8613,A,,Intermediate,CHEMBL627639,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Human herpesvirus 1,,,1,,BAO_0000218
13138,8613,A,,Intermediate,CHEMBL627640,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Human herpesvirus 1,,,1,,BAO_0000218
13139,8613,A,,Intermediate,CHEMBL627641,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Human herpesvirus 1,,,1,,BAO_0000218
13140,8613,A,,Intermediate,CHEMBL627642,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,,,1,,BAO_0000218
13141,8613,A,,Intermediate,CHEMBL877506,,,50602,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,,,1,,BAO_0000218
13142,8613,A,,Intermediate,CHEMBL627275,,,50594,,1,,N,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Mus musculus,,,1,,BAO_0000218
13143,11219,A,,Intermediate,CHEMBL627643,,,50506,,1,,N,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Mustela putorius furo,,,1,,BAO_0000218
13144,11219,A,,Intermediate,CHEMBL631246,,,50506,,1,,N,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,,,1,,BAO_0000218
13145,11219,A,,Intermediate,CHEMBL631247,,,50506,,1,,N,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,,,1,,BAO_0000218
13146,11219,A,,Intermediate,CHEMBL629532,,,50506,,1,,N,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,,,1,,BAO_0000218
13147,11219,A,,Intermediate,CHEMBL629533,,,50506,,1,,N,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Mustela putorius furo,,,1,,BAO_0000218
13148,11219,A,,Intermediate,CHEMBL629534,,,50506,,1,,N,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,,,1,,BAO_0000218
13149,11219,A,,Intermediate,CHEMBL629535,,,50506,,1,,N,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Mustela putorius furo,,,1,,BAO_0000218
13150,14837,A,,Autocuration,CHEMBL625932,,,22224,,1,,U,Pharmacokinetic parameter :drug bound to plasma was reported,,,,0,,BAO_0000019
13151,14837,A,,Autocuration,CHEMBL625933,,,22224,,1,,U,compound was evaluated for drug bound in plasma,,,,0,,BAO_0000019
13152,15343,A,,Intermediate,CHEMBL625934,,,50597,,1,,N,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,,,1,,BAO_0000218
13153,13761,A,,Autocuration,CHEMBL625935,,,22224,,1,,U,Bioavailability,Eutheria,,,0,,BAO_0000218
13154,14810,A,,Intermediate,CHEMBL625936,,,50597,,1,,N,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Rattus norvegicus,,,1,,BAO_0000218
13155,14810,A,,Intermediate,CHEMBL625937,,,50597,,1,,N,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Rattus norvegicus,,,1,,BAO_0000218
13156,13249,A,,Intermediate,CHEMBL625938,,,50588,,1,,N,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,,,1,,BAO_0000218
13157,9267,A,,Intermediate,CHEMBL625939,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13158,9267,A,,Intermediate,CHEMBL625940,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13159,9267,A,,Intermediate,CHEMBL874464,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13160,9267,A,,Intermediate,CHEMBL625941,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13161,9267,A,,Intermediate,CHEMBL625942,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13162,9267,A,,Intermediate,CHEMBL625943,,1970.0,50597,,1,,N,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Rattus norvegicus,,Bile,1,,BAO_0000218
13163,15549,A,,Intermediate,CHEMBL625944,,1977.0,50587,,1,,N,In vitro protein binding in human serum at 5 ug/ml,Homo sapiens,,Serum,1,,BAO_0000218
13164,10929,A,,Autocuration,CHEMBL625945,,,22224,,1,,U,Serum protein binding ability was measured,,,,0,,BAO_0000019
13165,15444,A,,Autocuration,CHEMBL625946,,,22224,,1,,U,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,,0,,BAO_0000019
13166,12860,A,,Autocuration,CHEMBL625947,In vivo,,22224,,1,,U,Oral bioavailability in dog,Canis lupus familiaris,,,0,,BAO_0000218
13167,12170,A,,Intermediate,CHEMBL625948,In vivo,,50597,,1,,N,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,1,,BAO_0000218
13168,15173,A,,Autocuration,CHEMBL625949,In vivo,,22224,,1,,U,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,,0,,BAO_0000218
13169,15173,A,,Autocuration,CHEMBL625950,In vivo,,22224,,1,,U,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,,0,,BAO_0000218
13170,15173,A,,Autocuration,CHEMBL625951,In vivo,,22224,,1,,U,Oral bioavailability (dose 15 mg/kg i.v.),Eutheria,,,0,,BAO_0000218
13171,15173,A,,Autocuration,CHEMBL625952,In vivo,,22224,,1,,U,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,,0,,BAO_0000218
13172,15173,A,,Autocuration,CHEMBL625953,In vivo,,22224,,1,,U,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,,0,,BAO_0000218
13173,15173,A,,Autocuration,CHEMBL625954,In vivo,,22224,,1,,U,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,,0,,BAO_0000218
13174,15173,A,,Autocuration,CHEMBL882959,In vivo,,22224,,1,,U,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,,0,,BAO_0000218
13175,11767,A,,Intermediate,CHEMBL625955,In vivo,,50588,,1,,N,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Canis lupus familiaris,,,1,,BAO_0000218
13176,11219,A,,Autocuration,CHEMBL625956,In vivo,,22224,,1,,U,Bioavailability in ferret,Mustela putorius furo,,,0,,BAO_0000218
13177,12186,A,,Intermediate,CHEMBL625957,In vivo,,100710,,1,,N,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,,,1,,BAO_0000218
13178,11510,A,,Intermediate,CHEMBL625958,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13179,11510,A,,Intermediate,CHEMBL625959,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13180,11510,A,,Intermediate,CHEMBL626642,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13181,11510,A,,Intermediate,CHEMBL631330,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13182,11510,A,,Intermediate,CHEMBL631331,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13183,11510,A,,Intermediate,CHEMBL631332,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,1,,BAO_0000218
13184,11510,A,,Intermediate,CHEMBL631333,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13185,11510,A,,Intermediate,CHEMBL632018,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13186,11510,A,,Intermediate,CHEMBL632019,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13187,11510,A,,Intermediate,CHEMBL632020,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13188,11510,A,,Intermediate,CHEMBL632021,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13189,11510,A,,Intermediate,CHEMBL632022,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13190,11510,A,,Intermediate,CHEMBL632023,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13191,11510,A,,Intermediate,CHEMBL632024,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13192,11510,A,,Intermediate,CHEMBL874472,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13193,11510,A,,Intermediate,CHEMBL632025,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13194,11510,A,,Intermediate,CHEMBL632026,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13195,11510,A,,Intermediate,CHEMBL632027,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13196,11510,A,,Intermediate,CHEMBL632028,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13197,11510,A,,Intermediate,CHEMBL626430,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13198,11510,A,,Intermediate,CHEMBL626431,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13199,11510,A,,Intermediate,CHEMBL626432,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13200,11510,A,,Intermediate,CHEMBL626433,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13201,11510,A,,Intermediate,CHEMBL626434,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13202,11510,A,,Intermediate,CHEMBL627280,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13203,11510,A,,Intermediate,CHEMBL627281,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13204,11510,A,,Intermediate,CHEMBL627282,,,50597,,1,,N,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13205,7199,A,,Autocuration,CHEMBL627283,,,22224,,1,,U,Total body clearance was measured at given dose,,,,0,,BAO_0000019
13206,7199,A,,Autocuration,CHEMBL627284,,,22224,,1,,U,Total body clearance was measured at given dose.,,,,0,,BAO_0000218
13207,7095,A,,Intermediate,CHEMBL627285,,,50597,,1,,N,Metabolic clearance from the body in rat,Rattus norvegicus,,,1,,BAO_0000218
13208,7095,A,,Autocuration,CHEMBL627286,In vivo,,22224,,1,,U,Renal clearance from the body,,,,0,,BAO_0000218
13209,7095,A,,Intermediate,CHEMBL875477,In vivo,,50597,,1,,N,Renal clearance from the body in rat,Rattus norvegicus,,,1,,BAO_0000218
13210,12528,A,,Intermediate,CHEMBL627287,In vivo,,50597,,1,,N,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
13211,12528,A,,Intermediate,CHEMBL627288,In vivo,,50588,,1,,N,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Canis lupus familiaris,,,1,,BAO_0000218
13212,7095,A,,Intermediate,CHEMBL627289,,,50597,,1,,N,Total clearance from the body in rat,Rattus norvegicus,,,1,,BAO_0000218
13213,14223,A,,Intermediate,CHEMBL627290,In vivo,1969.0,50597,,1,,N,Clearance into cortex from rat plasma or PBS,Rattus norvegicus,,Plasma,1,,BAO_0000218
13214,13569,A,,Autocuration,CHEMBL627291,In vivo,,22224,,1,,U,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,,0,,BAO_0000218
13215,13569,A,,Autocuration,CHEMBL627292,In vivo,,22224,,1,,U,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,,0,,BAO_0000218
13216,13569,A,,Autocuration,CHEMBL627293,In vivo,,22224,,1,,U,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,,0,,BAO_0000218
13217,13569,A,,Autocuration,CHEMBL627294,In vivo,,22224,,1,,U,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,,0,,BAO_0000218
13218,13569,A,,Autocuration,CHEMBL875478,In vivo,,22224,,1,,U,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,,0,,BAO_0000218
13219,13979,A,,Autocuration,CHEMBL627295,In vivo,,22224,,1,,U,Clearance was determined,,,,0,,BAO_0000218
13220,14315,A,,Intermediate,CHEMBL627296,In vivo,,50594,,1,,N,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Mus musculus,,,1,,BAO_0000218
13221,14315,A,,Intermediate,CHEMBL626119,In vivo,,50592,,1,,N,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Oryctolagus cuniculus,,,1,,BAO_0000218
13222,14315,A,,Intermediate,CHEMBL626120,In vivo,,50597,,1,,N,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Rattus norvegicus,,,1,,BAO_0000218
13223,12174,A,,Intermediate,CHEMBL626121,In vivo,,50597,,1,,N,Clearance in rat after iv dose (100 ug/kg),Rattus norvegicus,,,1,,BAO_0000218
13224,12797,A,,Autocuration,CHEMBL626122,In vivo,,22224,,1,,U,Clearance in guinea pig,Cavia porcellus,,,0,,BAO_0000218
13225,12797,A,,Intermediate,CHEMBL626123,In vivo,,50597,,1,,N,Compound was evaluated for clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
13226,12797,A,,Intermediate,CHEMBL623456,In vivo,,50588,,1,,N,Compound was evaluated for the clearance in dog,Canis lupus familiaris,,,1,,BAO_0000218
13227,12797,A,,Intermediate,CHEMBL623457,In vivo,,50597,,1,,N,Compound was evaluated for the clearance in rat,Rattus norvegicus,,,1,,BAO_0000218
13228,11500,A,,Intermediate,CHEMBL623458,In vivo,,50597,,1,,N,Compound was tested in vivo for clearance after iv administration in the rat,Rattus norvegicus,,,1,,BAO_0000218
13229,15173,A,,Autocuration,CHEMBL623459,In vivo,,22224,,1,,U,IV clearance determined at an iv dose of 14 mg/kg,,,,0,,BAO_0000218
13230,15173,A,,Autocuration,CHEMBL875484,In vivo,,22224,,1,,U,IV clearance determined at an iv dose of 15.2 mg/kg,,,,0,,BAO_0000218
13231,15173,A,,Autocuration,CHEMBL623460,In vivo,,22224,,1,,U,IV clearance determined at an iv dose of 15 mg/kg,,,,0,,BAO_0000218
13232,15173,A,,Autocuration,CHEMBL623461,In vivo,,22224,,1,,U,IV clearance determined at an peroral dose of 30 mg/kg.,,,,0,,BAO_0000218
13233,15173,A,,Autocuration,CHEMBL623462,In vivo,,22224,,1,,U,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,,0,,BAO_0000218
13234,15173,A,,Autocuration,CHEMBL627386,In vivo,,22224,,1,,U,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,,0,,BAO_0000218
13235,14198,A,,Intermediate,CHEMBL627387,In vivo,2113.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,Kidney,1,,BAO_0000218
13236,14198,A,,Intermediate,CHEMBL627388,In vivo,2107.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,Liver,1,,BAO_0000218
13237,14198,A,,Intermediate,CHEMBL627389,In vivo,2048.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,Lung,1,,BAO_0000218
13238,14198,A,,Intermediate,CHEMBL627390,In vivo,2385.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13239,14198,A,,Intermediate,CHEMBL627391,In vivo,1969.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13240,14198,A,,Intermediate,CHEMBL627392,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13241,14198,A,,Intermediate,CHEMBL627393,In vivo,2106.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,Spleen,1,,BAO_0000218
13242,14198,A,,Intermediate,CHEMBL627394,In vivo,3126.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,Trachea,1,,BAO_0000218
13243,14198,A,,Intermediate,CHEMBL627395,In vivo,10000001.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,Bone,1,,BAO_0000218
13244,14198,A,,Intermediate,CHEMBL875485,In vivo,2037.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13245,14198,A,,Intermediate,CHEMBL627396,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13246,14198,A,,Intermediate,CHEMBL627397,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13247,14198,A,,Intermediate,CHEMBL627398,In vivo,948.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,Heart,1,,BAO_0000218
13248,14198,A,,Intermediate,CHEMBL627399,In vivo,10000001.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Rattus norvegicus,,Bone,1,,BAO_0000218
13249,14198,A,,Intermediate,CHEMBL627400,In vivo,2113.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,Kidney,1,,BAO_0000218
13250,14198,A,,Intermediate,CHEMBL627401,In vivo,2107.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,Liver,1,,BAO_0000218
13251,14198,A,,Intermediate,CHEMBL627402,In vivo,2048.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,Lung,1,,BAO_0000218
13252,14198,A,,Intermediate,CHEMBL627403,In vivo,2385.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13253,14198,A,,Intermediate,CHEMBL627404,In vivo,1969.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13254,14198,A,,Intermediate,CHEMBL623101,In vivo,,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13255,14198,A,,Intermediate,CHEMBL877480,In vivo,2106.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,Spleen,1,,BAO_0000218
13256,14198,A,,Intermediate,CHEMBL623102,In vivo,3126.0,50597,,1,,N,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,Trachea,1,,BAO_0000218
13257,14198,A,,Intermediate,CHEMBL623103,In vivo,10000001.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,Bone,1,,BAO_0000218
13258,14198,A,,Intermediate,CHEMBL623104,In vivo,2037.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13259,14198,A,,Intermediate,CHEMBL623105,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13260,14198,A,,Intermediate,CHEMBL623106,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13261,14198,A,,Intermediate,CHEMBL623107,In vivo,948.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,Heart,1,,BAO_0000218
13262,14198,A,,Intermediate,CHEMBL623108,In vivo,160.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,Intestine,1,,BAO_0000218
13263,14198,A,,Intermediate,CHEMBL623109,In vivo,2113.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,Kidney,1,,BAO_0000218
13264,14198,A,,Intermediate,CHEMBL623110,In vivo,2107.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,,Liver,1,,BAO_0000218
13265,14198,A,,Intermediate,CHEMBL623111,In vivo,2048.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,Lung,1,,BAO_0000218
13266,14198,A,,Intermediate,CHEMBL625060,In vivo,2385.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13267,14198,A,,Intermediate,CHEMBL625061,In vivo,1969.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13268,14198,A,,Intermediate,CHEMBL625062,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13269,14198,A,,Intermediate,CHEMBL625063,In vivo,2106.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,Spleen,1,,BAO_0000218
13270,14198,A,,Intermediate,CHEMBL625064,In vivo,3126.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,Trachea,1,,BAO_0000218
13271,14198,A,,Intermediate,CHEMBL625065,In vivo,10000001.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,,Bone,1,,BAO_0000218
13272,14198,A,,Intermediate,CHEMBL625066,In vivo,2037.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13273,14198,A,,Intermediate,CHEMBL625067,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13274,14198,A,,Intermediate,CHEMBL625068,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13275,14198,A,,Intermediate,CHEMBL622159,In vivo,948.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,,Heart,1,,BAO_0000218
13276,14198,A,,Intermediate,CHEMBL622160,In vivo,160.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,,Intestine,1,,BAO_0000218
13277,14198,A,,Intermediate,CHEMBL622161,In vivo,2113.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,,Kidney,1,,BAO_0000218
13278,14198,A,,Intermediate,CHEMBL622162,In vivo,2048.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,,Lung,1,,BAO_0000218
13279,14198,A,,Intermediate,CHEMBL622163,In vivo,2385.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13280,14198,A,,Intermediate,CHEMBL622313,In vivo,1969.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13281,14198,A,,Intermediate,CHEMBL622314,In vivo,,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,,,1,,BAO_0000218
13282,14198,A,,Intermediate,CHEMBL622315,In vivo,2106.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,,Spleen,1,,BAO_0000218
13283,14198,A,,Intermediate,CHEMBL622316,In vivo,3126.0,50597,,1,,N,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,,Trachea,1,,BAO_0000218
13284,15599,A,,Intermediate,CHEMBL877486,,,50212,,1,,N,Normal diffusion coefficient in water for Escherichia coli,Escherichia coli,,,1,,BAO_0000218
13285,8204,A,,Autocuration,CHEMBL622317,,,22224,,1,,U,Average max percent decrease in RVR (renal vascular resistance) was determined,,,,0,,BAO_0000019
13286,8204,A,,Autocuration,CHEMBL622318,,,22224,,1,,U,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,,0,,BAO_0000019
13287,6154,A,,Autocuration,CHEMBL622319,,,22224,,1,,U,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,,0,,BAO_0000019
13288,6154,A,,Autocuration,CHEMBL622320,,,22224,,1,,U,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,,0,,BAO_0000019
13289,6154,A,,Autocuration,CHEMBL622321,,,22224,,1,,U,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,,0,,BAO_0000019
13290,6154,A,,Autocuration,CHEMBL622322,,,22224,,1,,U,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,,0,,BAO_0000019
13291,7114,A,,Autocuration,CHEMBL622323,,,22224,,1,,U,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,,0,,BAO_0000019
13292,7114,A,,Intermediate,CHEMBL622324,,,50597,,1,,N,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,,,1,,BAO_0000218
13293,8133,A,,Intermediate,CHEMBL622325,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13294,8133,A,,Intermediate,CHEMBL622326,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13295,8133,A,,Intermediate,CHEMBL877487,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13296,8133,A,,Intermediate,CHEMBL622327,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13297,8133,A,,Intermediate,CHEMBL622328,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13298,8133,A,,Intermediate,CHEMBL622329,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13299,8133,A,,Intermediate,CHEMBL622330,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13300,8133,A,,Intermediate,CHEMBL622331,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13301,8133,A,,Intermediate,CHEMBL622332,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13302,8133,A,,Intermediate,CHEMBL622333,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13303,8133,A,,Autocuration,CHEMBL627658,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13304,8133,A,,Autocuration,CHEMBL630428,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13305,8133,A,,Autocuration,CHEMBL630429,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13306,8133,A,,Autocuration,CHEMBL630430,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13307,8133,A,,Autocuration,CHEMBL630431,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13308,8133,A,,Intermediate,CHEMBL630432,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13309,8133,A,,Intermediate,CHEMBL630433,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13310,8133,A,,Intermediate,CHEMBL630434,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13311,8133,A,,Intermediate,CHEMBL629372,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13312,8133,A,,Intermediate,CHEMBL629553,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13313,8133,A,,Intermediate,CHEMBL629554,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13314,8133,A,,Intermediate,CHEMBL874447,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13315,8133,A,,Intermediate,CHEMBL629555,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13316,8133,A,,Intermediate,CHEMBL629556,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13317,8133,A,,Intermediate,CHEMBL629557,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13318,8133,A,,Intermediate,CHEMBL629558,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13319,8133,A,,Intermediate,CHEMBL629559,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13320,8133,A,,Intermediate,CHEMBL629560,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13321,8133,A,,Intermediate,CHEMBL629561,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13322,8133,A,,Intermediate,CHEMBL629562,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13323,8133,A,,Intermediate,CHEMBL629563,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13324,8133,A,,Intermediate,CHEMBL629564,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13325,8133,A,,Intermediate,CHEMBL629565,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13326,8133,A,,Intermediate,CHEMBL629566,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13327,8133,A,,Intermediate,CHEMBL629567,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13328,8133,A,,Intermediate,CHEMBL629568,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13329,8133,A,,Intermediate,CHEMBL629569,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13330,8133,A,,Intermediate,CHEMBL629570,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13331,8133,A,,Autocuration,CHEMBL629571,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13332,12170,A,,Autocuration,CHEMBL629572,In vivo,,22224,,1,,U,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,0,,BAO_0000218
13333,12170,A,,Autocuration,CHEMBL629573,In vivo,,22224,,1,,U,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,,,0,,BAO_0000218
13334,4985,A,,Autocuration,CHEMBL629574,In vivo,,22224,,1,,U,Bioavailability (dose 20 mg/kg),Eutheria,,,0,,BAO_0000218
13335,15145,A,,Autocuration,CHEMBL629575,In vivo,,22224,,1,,U,Bioavailability in dog,Canis lupus familiaris,,,0,,BAO_0000218
13336,14080,A,,Autocuration,CHEMBL874448,In vivo,,22224,,1,,U,Bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,,,0,,BAO_0000218
13337,11219,A,,Autocuration,CHEMBL629576,In vivo,,22224,,1,,U,Bioavailability in monkey (dose 10 mg/kg i.d.),Primates,,,0,,BAO_0000218
13338,15145,A,,Autocuration,CHEMBL629577,In vivo,,22224,,1,,U,Bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
13339,15145,A,,Autocuration,CHEMBL629578,In vivo,,22224,,1,,U,Bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
13340,1202,A,,Autocuration,CHEMBL629579,In vivo,,22224,,1,,U,Bioavailability in dog (dose 3.0 mg/kg p.o.),Canis lupus familiaris,,,0,,BAO_0000218
13341,1202,A,,Autocuration,CHEMBL882958,In vivo,,22224,,1,,U,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Canis lupus familiaris,,,0,,BAO_0000218
13342,1202,A,,Intermediate,CHEMBL629580,In vivo,,50505,,1,,N,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Pan troglodytes,,,1,,BAO_0000218
13343,4026,A,,Autocuration,CHEMBL629581,In vivo,,22224,,1,,U,Bioavailability,Eutheria,,,0,,BAO_0000218
13344,1492,A,,Autocuration,CHEMBL629582,In vivo,,22224,,1,,U,Bioavailability in squirrel monkey,Saimiri,,,0,,BAO_0000218
13345,12793,A,,Intermediate,CHEMBL628522,In vivo,,50588,,1,,N,Bioavailability was evaluated in dog,Canis lupus familiaris,,,1,,BAO_0000218
13346,12793,A,,Intermediate,CHEMBL625432,In vivo,,100712,,1,,N,Bioavailability was evaluated in hamster,Cricetinae,,,1,,BAO_0000218
13347,12793,A,,Autocuration,CHEMBL625433,In vivo,,22224,,1,,U,Bioavailability in rat,Rattus norvegicus,,,0,,BAO_0000218
13348,14793,A,,Intermediate,CHEMBL625434,In vivo,1969.0,50597,,1,,N,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,,Plasma,1,,BAO_0000218
13349,14793,A,,Intermediate,CHEMBL625435,In vivo,1969.0,50597,,1,,N,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Rattus norvegicus,,Plasma,1,,BAO_0000218
13350,14793,A,,Autocuration,CHEMBL625436,In vivo,,22224,,1,,U,Bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,,,0,,BAO_0000218
13351,14731,A,,Intermediate,CHEMBL874588,In vivo,,100710,,1,,N,Bioavailability was measured in cynomolgus monkeys.,Macaca fascicularis,,,1,,BAO_0000218
13352,14731,A,,Intermediate,CHEMBL625437,In vivo,,50594,,1,,N,Bioavailability was measured in nude mice.,Mus musculus,,,1,,BAO_0000218
13353,12187,A,,Autocuration,CHEMBL625438,In vivo,,22224,,1,,U,Bioavailability in ferret (dose 10 mg/kg i.d.),Mustela putorius furo,,,0,,BAO_0000218
13354,12187,A,,Autocuration,CHEMBL625439,In vivo,,22224,,1,,U,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Simiiformes,,,0,,BAO_0000218
13355,12187,A,,Autocuration,CHEMBL625440,In vivo,,22224,,1,,U,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Simiiformes,,,0,,BAO_0000218
13356,12187,A,,Autocuration,CHEMBL625441,In vivo,,22224,,1,,U,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Simiiformes,,,0,,BAO_0000218
13357,12187,A,,Autocuration,CHEMBL625442,In vivo,,22224,,1,,U,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,,,0,,BAO_0000218
13358,12187,A,,Intermediate,CHEMBL625443,In vivo,,50597,,1,,N,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,,,1,,BAO_0000218
13359,17431,A,,Autocuration,CHEMBL625444,In vivo,,22224,,1,,U,Bioavailability was determined; extremely poor,,,,0,,BAO_0000218
13360,13318,A,,Intermediate,CHEMBL625445,In vivo,,50594,,1,,N,% bioavailability in mice after oral administration of prodrug,Mus musculus,,,1,,BAO_0000218
13361,9025,A,,Intermediate,CHEMBL625446,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Canis lupus familiaris,,,1,,BAO_0000218
13362,9025,A,,Intermediate,CHEMBL882960,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Canis lupus familiaris,,,1,,BAO_0000218
13363,9025,A,,Intermediate,CHEMBL625447,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Canis lupus familiaris,,,1,,BAO_0000218
13364,9025,A,,Intermediate,CHEMBL625448,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Canis lupus familiaris,,,1,,BAO_0000218
13365,9025,A,,Intermediate,CHEMBL625449,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Canis lupus familiaris,,,1,,BAO_0000218
13366,9025,A,,Intermediate,CHEMBL874589,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Canis lupus familiaris,,,1,,BAO_0000218
13367,9025,A,,Intermediate,CHEMBL625450,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Canis lupus familiaris,,,1,,BAO_0000218
13368,9025,A,,Intermediate,CHEMBL625451,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Canis lupus familiaris,,,1,,BAO_0000218
13369,9025,A,,Intermediate,CHEMBL626584,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Canis lupus familiaris,,,1,,BAO_0000218
13370,9025,A,,Intermediate,CHEMBL626585,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Canis lupus familiaris,,,1,,BAO_0000218
13371,9025,A,,Intermediate,CHEMBL626586,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Canis lupus familiaris,,,1,,BAO_0000218
13372,9025,A,,Intermediate,CHEMBL626587,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Canis lupus familiaris,,,1,,BAO_0000218
13373,9025,A,,Intermediate,CHEMBL626588,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Canis lupus familiaris,,,1,,BAO_0000218
13374,9025,A,,Intermediate,CHEMBL626589,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Canis lupus familiaris,,,1,,BAO_0000218
13375,9025,A,,Intermediate,CHEMBL626590,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Canis lupus familiaris,,,1,,BAO_0000218
13376,9025,A,,Intermediate,CHEMBL626591,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Canis lupus familiaris,,,1,,BAO_0000218
13377,9025,A,,Intermediate,CHEMBL627181,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Canis lupus familiaris,,,1,,BAO_0000218
13378,9025,A,,Intermediate,CHEMBL628083,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Canis lupus familiaris,,,1,,BAO_0000218
13379,15173,A,,Autocuration,CHEMBL628084,In vivo,,22224,,1,,U,IV clearance determined at an peroral dose of 15 mg/kg.,,,,0,,BAO_0000218
13380,7732,F,,Expert,CHEMBL628085,In vivo,,50064,,1,,N,Mouse oral clearance was measured against Hymenolepiasis nana.,Hymenolepis nana,,,1,,BAO_0000218
13381,7732,F,,Expert,CHEMBL628086,In vivo,,50545,,1,,N,Mouse oral clearance was measured against Nematospiroides dubius,Heligmosomoides polygyrus,,,1,,BAO_0000218
13382,7732,F,,Autocuration,CHEMBL628087,In vivo,,22224,,1,,U,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,,0,,BAO_0000218
13383,7732,A,,Intermediate,CHEMBL628088,In vivo,,50594,,1,,N,Mouse oral clearance was measured against N. nana; NT is Not Tested,Mus musculus,,,1,,BAO_0000218
13384,7732,B,,Autocuration,CHEMBL628089,In vivo,,22224,,1,,U,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,,0,,BAO_0000218
13385,8328,A,,Autocuration,CHEMBL628090,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13386,8328,A,,Autocuration,CHEMBL628091,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13387,8328,A,,Autocuration,CHEMBL628092,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13388,8328,A,,Autocuration,CHEMBL628093,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13389,8328,A,,Autocuration,CHEMBL875607,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13390,8328,A,,Autocuration,CHEMBL625710,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13391,8328,A,,Autocuration,CHEMBL625711,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13392,8328,A,,Autocuration,CHEMBL625712,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13393,8328,A,,Autocuration,CHEMBL625713,In vivo,,22224,,1,,U,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,,0,,BAO_0000218
13394,13376,A,,Intermediate,CHEMBL625714,In vivo,,50588,,1,,N,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Canis lupus familiaris,,,1,,BAO_0000218
13395,13477,A,,Intermediate,CHEMBL625715,In vivo,,50797,,1,,N,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Macaca mulatta,,,1,,BAO_0000218
13396,13477,A,,Intermediate,CHEMBL625716,In vivo,,50597,,1,,N,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Rattus norvegicus,,,1,,BAO_0000218
13397,13477,A,,Intermediate,CHEMBL625717,In vivo,,50597,,1,,N,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Rattus norvegicus,,,1,,BAO_0000218
13398,13313,A,,Intermediate,CHEMBL625718,In vivo,,50597,,1,,N,Plasma clearance was determined for the compound in rats,Rattus norvegicus,,,1,,BAO_0000218
13399,12504,A,,Intermediate,CHEMBL625719,In vivo,,50597,,1,,N,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,,,1,,BAO_0000218
13400,12504,A,,Intermediate,CHEMBL625720,In vivo,,50597,,1,,N,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,,,1,,BAO_0000218
13401,12504,A,,Intermediate,CHEMBL625721,In vivo,,50597,,1,,N,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,,,1,,BAO_0000218
13402,12504,A,,Intermediate,CHEMBL625722,In vivo,,50597,,1,,N,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,,,1,,BAO_0000218
13403,13129,A,,Intermediate,CHEMBL625723,In vivo,,50597,,1,,N,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,,,1,,BAO_0000218
13404,7732,A,,Intermediate,CHEMBL625724,In vivo,,50545,,1,,N,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Heligmosomoides polygyrus,,,1,,BAO_0000218
13405,7732,A,,Intermediate,CHEMBL625725,In vivo,,50545,,1,,N,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Heligmosomoides polygyrus,,,1,,BAO_0000218
13406,7732,A,,Intermediate,CHEMBL625726,In vivo,,50545,,1,,N,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Heligmosomoides polygyrus,,,1,,BAO_0000218
13407,7732,A,,Intermediate,CHEMBL875608,In vivo,,50545,,1,,N,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Heligmosomoides polygyrus,,,1,,BAO_0000218
13408,7732,A,,Intermediate,CHEMBL625727,In vivo,,50545,,1,,N,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Heligmosomoides polygyrus,,,1,,BAO_0000218
13409,9278,A,,Autocuration,CHEMBL625728,In vivo,1088.0,22224,,1,,U,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,,Urine,0,,BAO_0000218
13410,9278,A,,Autocuration,CHEMBL625729,In vivo,,22224,,1,,U,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,,,0,,BAO_0000218
13411,9278,A,,Autocuration,CHEMBL625730,In vivo,,22224,,1,,U,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,,,0,,BAO_0000218
13412,9278,A,,Autocuration,CHEMBL625731,In vivo,1088.0,22224,,1,,U,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,,Urine,0,,BAO_0000218
13413,9278,A,,Autocuration,CHEMBL626417,In vivo,1088.0,22224,,1,,U,Urinary clearance was determined in rat at 25 mg/kg os dosage,Rattus norvegicus,,Urine,0,,BAO_0000218
13414,9278,A,,Intermediate,CHEMBL626418,In vivo,1088.0,50587,,1,,N,Urinary clearance was determined at 100 mg/kg oral dosage in human,Homo sapiens,,Urine,1,,BAO_0000218
13415,9278,A,,Intermediate,CHEMBL626419,In vivo,1088.0,50588,,1,,N,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Canis lupus familiaris,,Urine,1,,BAO_0000218
13416,5932,A,,Intermediate,CHEMBL626592,In vivo,1969.0,50588,,1,,N,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Canis lupus familiaris,,Plasma,1,,BAO_0000218
13417,5932,A,,Intermediate,CHEMBL626593,In vivo,1969.0,50597,,1,,N,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,,Plasma,1,,BAO_0000218
13418,5182,A,,Intermediate,CHEMBL626594,In vivo,,50597,,1,,N,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,,,1,,BAO_0000218
13419,10499,A,,Intermediate,CHEMBL625035,In vivo,,50588,,1,,N,Clearance rate in dogs,Canis lupus familiaris,,,1,,BAO_0000218
13420,6051,A,,Autocuration,CHEMBL625036,In vitro,,22224,,1,,U,Compound was measured for intrinsic clearance,,,,0,,BAO_0000019
13421,17508,P,,Autocuration,CHEMBL625037,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13422,6228,P,,Autocuration,CHEMBL625038,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13423,6231,P,,Autocuration,CHEMBL625039,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13424,17740,P,,Autocuration,CHEMBL625040,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13425,6495,P,,Autocuration,CHEMBL625041,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13426,2171,P,,Autocuration,CHEMBL625042,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13427,3255,A,,Autocuration,CHEMBL874411,,,22224,,1,,U,Partition coefficient of the compound,,,,0,,BAO_0000019
13428,6821,A,,Autocuration,CHEMBL625043,,,22224,,1,,U,Permeability,,,,0,,BAO_0000019
13429,2685,P,,Autocuration,CHEMBL625044,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13430,17584,A,,Autocuration,CHEMBL625045,,,22224,,1,,U,Partition coefficient (logD),,,,0,,BAO_0000019
13431,13824,P,,Autocuration,CHEMBL625046,,,22229,,1,,U,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,0,,BAO_0000100
13432,13824,P,,Autocuration,CHEMBL625047,,,22229,,1,,U,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,0,,BAO_0000100
13433,16479,P,,Autocuration,CHEMBL625048,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13434,11997,P,,Autocuration,CHEMBL625049,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13435,2988,P,,Autocuration,CHEMBL625050,,,22229,,1,,U,Calculated logarithm of partition coefficient (P) was determined,,,,0,,BAO_0000100
13436,931,P,,Autocuration,CHEMBL625051,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13437,4381,P,,Autocuration,CHEMBL874412,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13438,4397,P,,Autocuration,CHEMBL625052,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13439,5889,P,,Autocuration,CHEMBL625053,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13440,6154,A,,Autocuration,CHEMBL623250,,,22224,,1,,U,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,,0,,BAO_0000019
13441,6154,A,,Autocuration,CHEMBL623251,,,22224,,1,,U,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,,0,,BAO_0000019
13442,6154,A,,Autocuration,CHEMBL623252,,,22224,,1,,U,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,,0,,BAO_0000019
13443,6154,A,,Autocuration,CHEMBL623253,,,22224,,1,,U,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,,0,,BAO_0000019
13444,6154,A,,Autocuration,CHEMBL623254,,,22224,,1,,U,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,,0,,BAO_0000019
13445,6154,A,,Autocuration,CHEMBL623255,,,22224,,1,,U,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,,0,,BAO_0000019
13446,6887,A,,Autocuration,CHEMBL626831,,,22224,,1,,U,Percent degradation of compound at a pH of 1 over a 18 hr period,,,,0,,BAO_0000019
13447,6887,A,,Autocuration,CHEMBL877494,,,22224,,1,,U,Percent degradation of compound at pH of 1 over an 18 hr period,,,,0,,BAO_0000019
13448,14116,A,,Autocuration,CHEMBL626832,,,22224,,1,,U,Delta Logarithm of Partition Coefficient value was determined.,,,,0,,BAO_0000019
13449,11137,A,,Autocuration,CHEMBL626833,,,22224,,1,,U,Delta logPoct-cyc,,,,0,,BAO_0000019
13450,7230,P,,Autocuration,CHEMBL626834,,,22224,,1,,U,Lipophilicity estimated on reversed phase TLC,,,,0,,BAO_0000100
13451,15741,A,,Autocuration,CHEMBL626835,,,22224,,1,,U,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,,0,,BAO_0000019
13452,9663,A,,Autocuration,CHEMBL626836,,,22224,,1,,U,Delta logPoct-cyc,,,,0,,BAO_0000019
13453,9663,P,,Autocuration,CHEMBL626837,,,22229,,1,,U,Change in logarithm of partition coefficient of the compound,,,,0,,BAO_0000100
13454,13807,A,,Autocuration,CHEMBL626838,,,22224,,1,,U,Delta logD (pH 6.5),,,,0,,BAO_0000019
13455,13807,P,,Autocuration,CHEMBL626839,,,22224,,1,,U,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,,0,,BAO_0000100
13456,17425,A,,Autocuration,CHEMBL626840,,,22224,,1,,U,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,,0,,BAO_0000019
13457,12143,A,,Autocuration,CHEMBL626841,,,22224,,1,,U,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,,0,,BAO_0000019
13458,12608,A,,Autocuration,CHEMBL626842,,,22224,,1,,U,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,,0,,BAO_0000219
13459,12608,A,,Autocuration,CHEMBL626843,,,22224,,1,,U,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,,0,,BAO_0000219
13460,8649,A,,Intermediate,CHEMBL626844,,,50597,,1,,N,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Rattus norvegicus,,,1,,BAO_0000218
13461,8649,A,,Intermediate,CHEMBL877495,,,50597,,1,,N,Amount of deuterium retained was reported after normal workup in rats,Rattus norvegicus,,,1,,BAO_0000218
13462,8649,A,,Intermediate,CHEMBL626845,,,50597,,1,,N,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Rattus norvegicus,,,1,,BAO_0000218
13463,8649,A,,Intermediate,CHEMBL626846,,,50597,,1,,N,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Rattus norvegicus,,,1,,BAO_0000218
13464,8649,A,,Intermediate,CHEMBL626847,,,50597,,1,,N,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,,,1,,BAO_0000218
13465,8649,A,,Intermediate,CHEMBL628677,,,50597,,1,,N,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,,,1,,BAO_0000218
13466,8649,A,,Intermediate,CHEMBL628678,,,50597,,1,,N,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Rattus norvegicus,,,1,,BAO_0000218
13467,9659,A,,Autocuration,CHEMBL628679,,,22224,,1,,U,Compound was subjected to electrochemical oxidation,,,,0,,BAO_0000019
13468,9659,A,,Autocuration,CHEMBL628680,,,22224,,1,,U,Compound was subjected to photochemical oxidation,,,,0,,BAO_0000019
13469,9659,A,,Autocuration,CHEMBL628681,,,22224,,1,,U,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,,0,,BAO_0000019
13470,9659,A,,Autocuration,CHEMBL628682,,,22224,,1,,U,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,,0,,BAO_0000019
13471,9659,A,,Autocuration,CHEMBL628683,,,22224,,1,,U,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,,0,,BAO_0000019
13472,9607,A,,Intermediate,CHEMBL628684,,,50597,,1,,N,Percent diffusion through fuzzy rat skin after 48 h of incubation,Rattus norvegicus,,,1,,BAO_0000218
13473,7057,P,,Autocuration,CHEMBL877501,,,22229,,1,,U,Dissociation constant (pKa),,,,0,,BAO_0000100
13474,7057,P,,Autocuration,CHEMBL628685,,,22224,,1,,U,Dissociation constant value of the compound; ND means not determined.,,,,0,,BAO_0000100
13475,7911,A,,Intermediate,CHEMBL628686,,178.0,50597,,1,,N,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,Blood,1,,BAO_0000218
13476,7911,A,,Intermediate,CHEMBL628687,,178.0,50597,,1,,N,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,Blood,1,,BAO_0000218
13477,7911,A,,Intermediate,CHEMBL628688,,,50597,,1,,N,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Rattus norvegicus,,,1,,BAO_0000218
13478,7911,A,,Intermediate,CHEMBL628689,,,50597,,1,,N,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,,1,,BAO_0000218
13479,7911,A,,Intermediate,CHEMBL628690,,2107.0,50597,,1,,N,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Rattus norvegicus,,Liver,1,,BAO_0000218
13480,7911,A,,Intermediate,CHEMBL629363,,2107.0,50597,,1,,N,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,,Liver,1,,BAO_0000218
13481,7911,A,,Intermediate,CHEMBL629364,,2106.0,50597,,1,,N,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Rattus norvegicus,,Spleen,1,,BAO_0000218
13482,7911,A,,Intermediate,CHEMBL629365,,2106.0,50597,,1,,N,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,Spleen,1,,BAO_0000218
13483,7911,A,,Intermediate,CHEMBL629366,,,50597,,1,,N,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,,1,,BAO_0000218
13484,7911,A,,Intermediate,CHEMBL629367,,1088.0,50597,,1,,N,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Rattus norvegicus,,Urine,1,,BAO_0000218
13485,7911,A,,Intermediate,CHEMBL629368,,1988.0,50597,,1,,N,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,,Feces,1,,BAO_0000218
13486,7911,A,,Intermediate,CHEMBL877502,,1088.0,50597,,1,,N,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,,Urine,1,,BAO_0000218
13487,13792,A,,Intermediate,CHEMBL629369,,2037.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Mus musculus,,Cerebellum,1,,BAO_0000218
13488,13792,A,,Intermediate,CHEMBL629370,,955.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Mus musculus,,Brain,1,,BAO_0000218
13489,8133,A,,Autocuration,CHEMBL629371,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13490,8133,A,,Autocuration,CHEMBL626276,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13491,8133,A,,Autocuration,CHEMBL626277,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13492,8133,A,,Autocuration,CHEMBL631250,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13493,8133,A,,Intermediate,CHEMBL631251,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13494,8133,A,,Intermediate,CHEMBL631252,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13495,8133,A,,Intermediate,CHEMBL631253,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13496,8133,A,,Intermediate,CHEMBL631254,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13497,8133,A,,Intermediate,CHEMBL631255,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13498,8133,A,,Intermediate,CHEMBL631256,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13499,8133,A,,Intermediate,CHEMBL631257,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13500,8133,A,,Intermediate,CHEMBL628009,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13501,8133,A,,Intermediate,CHEMBL628010,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13502,8133,A,,Intermediate,CHEMBL628011,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13503,8133,A,,Intermediate,CHEMBL628012,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13504,8133,A,,Intermediate,CHEMBL628013,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13505,8133,A,,Intermediate,CHEMBL628014,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13506,8133,A,,Intermediate,CHEMBL628015,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13507,8133,A,,Intermediate,CHEMBL628016,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13508,8133,A,,Intermediate,CHEMBL874461,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13509,8133,A,,Intermediate,CHEMBL628017,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13510,8133,A,,Intermediate,CHEMBL628018,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13511,8133,A,,Intermediate,CHEMBL628019,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13512,8133,A,,Intermediate,CHEMBL628020,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13513,8133,A,,Intermediate,CHEMBL628021,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13514,8133,A,,Intermediate,CHEMBL628022,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13515,8133,A,,Intermediate,CHEMBL628023,,1088.0,50588,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,,Urine,1,,BAO_0000218
13516,8133,A,,Autocuration,CHEMBL628024,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13517,8133,A,,Autocuration,CHEMBL628025,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13518,8133,A,,Autocuration,CHEMBL628026,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13519,8133,A,,Autocuration,CHEMBL628027,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13520,8133,A,,Autocuration,CHEMBL628028,,1088.0,22224,,1,,U,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,,Urine,0,,BAO_0000218
13521,8133,A,,Intermediate,CHEMBL628029,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13522,8133,A,,Intermediate,CHEMBL628030,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13523,8133,A,,Intermediate,CHEMBL628031,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13524,8133,A,,Intermediate,CHEMBL628032,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13525,8133,A,,Intermediate,CHEMBL628033,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13526,8133,A,,Intermediate,CHEMBL628034,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13527,8133,A,,Intermediate,CHEMBL628035,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13528,8133,A,,Intermediate,CHEMBL628036,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13529,8133,A,,Intermediate,CHEMBL874462,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13530,9025,A,,Intermediate,CHEMBL628037,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Canis lupus familiaris,,,1,,BAO_0000218
13531,9025,A,,Intermediate,CHEMBL628123,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Canis lupus familiaris,,,1,,BAO_0000218
13532,9025,A,,Intermediate,CHEMBL628124,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Canis lupus familiaris,,,1,,BAO_0000218
13533,9025,A,,Intermediate,CHEMBL628125,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Canis lupus familiaris,,,1,,BAO_0000218
13534,9025,A,,Intermediate,CHEMBL628126,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Canis lupus familiaris,,,1,,BAO_0000218
13535,9025,A,,Intermediate,CHEMBL628127,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Canis lupus familiaris,,,1,,BAO_0000218
13536,9025,A,,Intermediate,CHEMBL628128,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Canis lupus familiaris,,,1,,BAO_0000218
13537,9025,A,,Intermediate,CHEMBL628129,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Canis lupus familiaris,,,1,,BAO_0000218
13538,9025,A,,Intermediate,CHEMBL628130,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Canis lupus familiaris,,,1,,BAO_0000218
13539,9025,A,,Intermediate,CHEMBL628131,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Canis lupus familiaris,,,1,,BAO_0000218
13540,9025,A,,Intermediate,CHEMBL628132,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Canis lupus familiaris,,,1,,BAO_0000218
13541,9025,A,,Intermediate,CHEMBL628133,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Canis lupus familiaris,,,1,,BAO_0000218
13542,9025,A,,Intermediate,CHEMBL628134,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Canis lupus familiaris,,,1,,BAO_0000218
13543,9025,A,,Intermediate,CHEMBL628135,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Canis lupus familiaris,,,1,,BAO_0000218
13544,9025,A,,Intermediate,CHEMBL628136,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Canis lupus familiaris,,,1,,BAO_0000218
13545,9025,A,,Intermediate,CHEMBL628137,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Canis lupus familiaris,,,1,,BAO_0000218
13546,9025,A,,Intermediate,CHEMBL628138,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Canis lupus familiaris,,,1,,BAO_0000218
13547,9025,A,,Intermediate,CHEMBL628139,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Canis lupus familiaris,,,1,,BAO_0000218
13548,9025,A,,Intermediate,CHEMBL628140,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Canis lupus familiaris,,,1,,BAO_0000218
13549,9025,A,,Intermediate,CHEMBL628141,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Canis lupus familiaris,,,1,,BAO_0000218
13550,9025,A,,Intermediate,CHEMBL628142,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Canis lupus familiaris,,,1,,BAO_0000218
13551,9025,A,,Intermediate,CHEMBL628143,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Canis lupus familiaris,,,1,,BAO_0000218
13552,9025,A,,Intermediate,CHEMBL628144,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Canis lupus familiaris,,,1,,BAO_0000218
13553,9025,A,,Intermediate,CHEMBL628145,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Canis lupus familiaris,,,1,,BAO_0000218
13554,9025,A,,Intermediate,CHEMBL628146,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Canis lupus familiaris,,,1,,BAO_0000218
13555,9025,A,,Intermediate,CHEMBL625355,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Canis lupus familiaris,,,1,,BAO_0000218
13556,9025,A,,Intermediate,CHEMBL625356,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Canis lupus familiaris,,,1,,BAO_0000218
13557,9025,A,,Intermediate,CHEMBL625357,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Canis lupus familiaris,,,1,,BAO_0000218
13558,9025,A,,Intermediate,CHEMBL625527,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Canis lupus familiaris,,,1,,BAO_0000218
13559,9025,A,,Intermediate,CHEMBL875473,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Canis lupus familiaris,,,1,,BAO_0000218
13560,9025,A,,Intermediate,CHEMBL625528,In vivo,,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Canis lupus familiaris,,,1,,BAO_0000218
13561,9025,A,,Intermediate,CHEMBL626304,In vivo,,50597,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Rattus norvegicus,,,1,,BAO_0000218
13562,9025,A,,Intermediate,CHEMBL624138,In vivo,1637.0,50588,,1,,N,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Canis lupus familiaris,,Artery,1,,BAO_0000218
13563,6448,P,,Autocuration,CHEMBL624139,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13564,17221,P,,Autocuration,CHEMBL624140,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13565,6545,P,,Autocuration,CHEMBL624141,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13566,577,P,,Autocuration,CHEMBL624142,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13567,6285,P,,Autocuration,CHEMBL624143,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13568,6500,P,,Autocuration,CHEMBL624144,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13569,6716,P,,Autocuration,CHEMBL624145,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13570,13658,P,,Autocuration,CHEMBL624146,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13571,6549,P,,Autocuration,CHEMBL624147,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13572,14685,P,,Autocuration,CHEMBL883123,,,22229,,1,,U,Calculated partition coefficient (clogP) (MacLogP),,,,0,,BAO_0000100
13573,6893,A,,Autocuration,CHEMBL624148,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
13574,3687,A,,Autocuration,CHEMBL874416,,,22224,,1,,U,Kinetic parameter was determined,,,,0,,BAO_0000019
13575,4207,P,,Autocuration,CHEMBL624149,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13576,4626,P,,Autocuration,CHEMBL624150,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13577,1021,P,,Autocuration,CHEMBL624151,,,22224,,1,,U,Lipophilicity was determined,,,,0,,BAO_0000100
13578,3777,P,,Autocuration,CHEMBL624152,,,22224,,1,,U,Lipophilicity was determined,,,,0,,BAO_0000100
13579,17533,P,,Autocuration,CHEMBL622139,,,22224,,1,,U,Lipophilicity was determined,,,,0,,BAO_0000100
13580,6524,P,,Autocuration,CHEMBL622140,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13581,17533,P,,Autocuration,CHEMBL622141,,,22224,,1,,U,Lipophilicity was determined,,,,0,,BAO_0000100
13582,6480,P,,Autocuration,CHEMBL622142,,,22224,,1,,U,Lipophilicity in octanol-water,,,,0,,BAO_0000100
13583,17606,P,,Autocuration,CHEMBL622143,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13584,6863,P,,Autocuration,CHEMBL622144,,,22229,,1,,U,Octanol-water partition coefficient was determined,,,,0,,BAO_0000100
13585,1356,A,,Autocuration,CHEMBL877473,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
13586,3326,P,,Autocuration,CHEMBL622145,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13587,1356,A,,Autocuration,CHEMBL622146,,,22224,,1,,U,Partition coefficient was determined; ND means not determined,,,,0,,BAO_0000019
13588,12984,P,,Autocuration,CHEMBL622147,,,22229,,1,,U,Calculated partition coefficient (clogP),,,,0,,BAO_0000100
13589,17363,A,,Autocuration,CHEMBL622148,,,22224,,1,,U,Partition coefficient of the compound,,,,0,,BAO_0000019
13590,6827,A,,Autocuration,CHEMBL883124,,,22224,,1,,U,Permeability was determined,,,,0,,BAO_0000019
13591,261,P,,Autocuration,CHEMBL622149,,,22229,,1,,U,The compound was evaluated for the partition coefficient,,,,0,,BAO_0000100
13592,2685,A,,Autocuration,CHEMBL622150,,,22224,,1,,U,Partition coefficient (logP),,,,0,,BAO_0000019
13593,414,P,,Autocuration,CHEMBL622151,,,22224,,1,,U,The lipophilicity was reported,,,,0,,BAO_0000100
13594,15769,P,,Autocuration,CHEMBL622152,,,22229,,1,,U,logarithm of the octanol-water partition coefficient for the compound,,,,0,,BAO_0000100
13595,17248,A,,Autocuration,CHEMBL622153,,,22224,,1,,U,Clogp value was determined,,,,0,,BAO_0000019
13596,16935,A,,Autocuration,CHEMBL877474,In vivo,,22224,,1,,U,Clp at a dose of 1.5 mg/kg,,,,0,,BAO_0000218
13597,16935,A,,Autocuration,CHEMBL622154,In vivo,,22224,,1,,U,Clp at a dose of 2.0 mg/kg,,,,0,,BAO_0000218
13598,14832,A,,Autocuration,CHEMBL622155,In vivo,1969.0,22224,,1,,U,"Clp, plasma clearance at a dose of 10 mg/kg",,,Plasma,0,,BAO_0000218
13599,14832,A,,Autocuration,CHEMBL622156,In vivo,1969.0,22224,,1,,U,"Clp, plasma clearance at a dose of 50 mg/kg",,,Plasma,0,,BAO_0000218
13600,2399,A,,Intermediate,CHEMBL622157,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma clearance in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
13601,2399,A,,Intermediate,CHEMBL622158,In vivo,1969.0,50597,,1,,N,Compound was tested for plasma clearance in rat; Not determined,Rattus norvegicus,,Plasma,1,,BAO_0000218
13602,6227,A,,Intermediate,CHEMBL622807,In vivo,,50597,,1,,N,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
13603,6227,A,,Intermediate,CHEMBL622808,In vivo,,50797,,1,,N,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Macaca mulatta,,,1,,BAO_0000218
13604,5623,A,,Autocuration,CHEMBL622809,In vivo,,22224,,1,,U,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,,0,,BAO_0000218
13605,4854,A,,Autocuration,CHEMBL622810,In vivo,,22224,,1,,U,Plasma clearance determined,,,,0,,BAO_0000218
13606,4493,A,,Intermediate,CHEMBL876653,In vivo,,100712,,1,,N,Plasma clearance after iv administration at 3 mg/kg in hamster,Cricetinae,,,1,,BAO_0000218
13607,4493,A,,Intermediate,CHEMBL622811,In vivo,,100712,,1,,N,Plasma clearance after iv administration at 4 mg/kg in hamster,Cricetinae,,,1,,BAO_0000218
13608,14956,A,,Intermediate,CHEMBL622986,In vivo,,50597,,1,,N,Rate of clearance in rat was determined,Rattus norvegicus,,,1,,BAO_0000218
13609,15372,A,,Intermediate,CHEMBL622987,In vivo,1969.0,50597,,1,,N,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13610,15372,A,,Intermediate,CHEMBL622988,In vivo,1969.0,50597,,1,,N,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13611,15372,A,,Intermediate,CHEMBL622989,In vivo,1969.0,50597,,1,,N,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13612,15372,A,,Intermediate,CHEMBL622990,In vivo,1969.0,50597,,1,,N,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,,Plasma,1,,BAO_0000218
13613,15604,A,,Autocuration,CHEMBL622991,In vivo,1969.0,22224,,1,,U,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,,Plasma,0,,BAO_0000218
13614,15604,A,,Intermediate,CHEMBL622227,In vivo,1969.0,50597,,1,,N,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,,Plasma,1,,BAO_0000218
13615,15604,A,,Intermediate,CHEMBL622228,In vivo,1969.0,50588,,1,,N,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,,Plasma,1,,BAO_0000218
13616,14964,A,,Intermediate,CHEMBL622229,In vivo,,50597,,1,,N,Clpl value in rat,Rattus norvegicus,,,1,,BAO_0000218
13617,15240,A,,Intermediate,CHEMBL622230,In vivo,,50512,,1,,N,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,,,1,,BAO_0000218
13618,16449,A,,Intermediate,CHEMBL622231,In vivo,,50597,,1,,N,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Rattus norvegicus,,,1,,BAO_0000218
13619,16449,A,,Intermediate,CHEMBL622232,In vivo,,100710,,1,,N,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Macaca fascicularis,,,1,,BAO_0000218
13620,12902,A,,Autocuration,CHEMBL622233,In vivo,,22224,,1,,U,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,,0,,BAO_0000218
13621,12902,A,,Autocuration,CHEMBL622234,In vivo,,22224,,1,,U,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,,0,,BAO_0000218
13622,12902,A,,Autocuration,CHEMBL622235,In vivo,,22224,,1,,U,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,,0,,BAO_0000218
13623,12902,A,,Autocuration,CHEMBL622236,In vivo,,22224,,1,,U,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,,0,,BAO_0000218
13624,12902,A,,Autocuration,CHEMBL622237,In vivo,,22224,,1,,U,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,,0,,BAO_0000218
13625,12902,A,,Autocuration,CHEMBL877482,In vivo,,22224,,1,,U,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,,0,,BAO_0000218
13626,12902,A,,Autocuration,CHEMBL622238,In vivo,,22224,,1,,U,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,,0,,BAO_0000218
13627,12902,A,,Autocuration,CHEMBL622239,In vivo,,22224,,1,,U,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,,0,,BAO_0000218
13628,11149,A,,Autocuration,CHEMBL622240,In vivo,178.0,22224,,1,,U,Cmax was calculated as maximum concentration reached in the blood,,,Blood,0,,BAO_0000218
13629,11149,A,,Autocuration,CHEMBL622241,In vivo,178.0,22224,,1,,U,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,Blood,0,,BAO_0000218
13630,5669,A,,Intermediate,CHEMBL631013,In vivo,,50597,,1,,N,Cmax was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
13631,5669,A,,Intermediate,CHEMBL631014,In vivo,,50797,,1,,N,Cmax was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,,,1,,BAO_0000218
13632,5669,A,,Intermediate,CHEMBL631015,In vivo,,50588,,1,,N,Cmax was determine after peroral administration at 10 mpk in dog,Canis lupus familiaris,,,1,,BAO_0000218
13633,5669,A,,Intermediate,CHEMBL631016,In vivo,,50597,,1,,N,Cmax was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
13634,5669,A,,Intermediate,CHEMBL631017,In vivo,,50597,,1,,N,Cmax was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
13635,5669,A,,Intermediate,CHEMBL631018,In vivo,,50597,,1,,N,Cmax was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,,,1,,BAO_0000218
13636,4236,A,,Autocuration,CHEMBL631019,In vivo,,22224,,1,,U,Cmax was determined,,,,0,,BAO_0000218
13637,13792,A,,Intermediate,CHEMBL875761,,955.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Mus musculus,,Brain,1,,BAO_0000218
13638,13792,A,,Intermediate,CHEMBL631020,,955.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Mus musculus,,Brain,1,,BAO_0000218
13639,13792,A,,Intermediate,CHEMBL631669,,955.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Mus musculus,,Brain,1,,BAO_0000218
13640,13792,A,,Intermediate,CHEMBL631670,,955.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Mus musculus,,Brain,1,,BAO_0000218
13641,13792,A,,Intermediate,CHEMBL631671,,2435.0,50594,,1,,N,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Mus musculus,,Striatum,1,,BAO_0000218
13642,8418,A,,Intermediate,CHEMBL631672,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Rattus norvegicus,,Blood,1,,BAO_0000218
13643,8418,A,,Intermediate,CHEMBL631673,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Rattus norvegicus,,Blood,1,,BAO_0000218
13644,8418,A,,Intermediate,CHEMBL631856,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Rattus norvegicus,,Blood,1,,BAO_0000218
13645,8418,A,,Intermediate,CHEMBL631857,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Rattus norvegicus,,Blood,1,,BAO_0000218
13646,8418,A,,Intermediate,CHEMBL631858,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Rattus norvegicus,,Blood,1,,BAO_0000218
13647,8418,A,,Intermediate,CHEMBL631859,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Rattus norvegicus,,Blood,1,,BAO_0000218
13648,8418,A,,Intermediate,CHEMBL631860,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Rattus norvegicus,,Blood,1,,BAO_0000218
13649,8418,A,,Intermediate,CHEMBL631861,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Rattus norvegicus,,Blood,1,,BAO_0000218
13650,8418,A,,Intermediate,CHEMBL631862,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Rattus norvegicus,,Blood,1,,BAO_0000218
13651,8418,A,,Intermediate,CHEMBL631863,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Rattus norvegicus,,Blood,1,,BAO_0000218
13652,8418,A,,Intermediate,CHEMBL631864,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Rattus norvegicus,,Blood,1,,BAO_0000218
13653,8418,A,,Intermediate,CHEMBL631865,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Rattus norvegicus,,Blood,1,,BAO_0000218
13654,8418,A,,Intermediate,CHEMBL631866,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Rattus norvegicus,,Blood,1,,BAO_0000218
13655,8418,A,,Intermediate,CHEMBL629360,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Rattus norvegicus,,Blood,1,,BAO_0000218
13656,8418,A,,Intermediate,CHEMBL629361,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,,Blood,1,,BAO_0000218
13657,8418,A,,Intermediate,CHEMBL629362,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Rattus norvegicus,,Blood,1,,BAO_0000218
13658,8418,A,,Intermediate,CHEMBL630740,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Rattus norvegicus,,Blood,1,,BAO_0000218
13659,8418,A,,Intermediate,CHEMBL630741,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Rattus norvegicus,,Blood,1,,BAO_0000218
13660,8418,A,,Intermediate,CHEMBL630742,,178.0,50597,,1,,N,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Rattus norvegicus,,Blood,1,,BAO_0000218
13661,8418,A,,Intermediate,CHEMBL630743,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Rattus norvegicus,,,1,,BAO_0000218
13662,8418,A,,Intermediate,CHEMBL630744,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Rattus norvegicus,,,1,,BAO_0000218
13663,8418,A,,Intermediate,CHEMBL630745,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Rattus norvegicus,,,1,,BAO_0000218
13664,8418,A,,Intermediate,CHEMBL630746,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,1,,BAO_0000218
13665,8418,A,,Intermediate,CHEMBL630747,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Rattus norvegicus,,,1,,BAO_0000218
13666,8418,A,,Intermediate,CHEMBL630748,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Rattus norvegicus,,,1,,BAO_0000218
13667,8418,A,,Intermediate,CHEMBL632056,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Rattus norvegicus,,,1,,BAO_0000218
13668,8418,A,,Intermediate,CHEMBL632057,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,1,,BAO_0000218
13669,8418,A,,Intermediate,CHEMBL632058,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Rattus norvegicus,,,1,,BAO_0000218
13670,8418,A,,Intermediate,CHEMBL632059,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,,,1,,BAO_0000218
13671,8418,A,,Intermediate,CHEMBL632060,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Rattus norvegicus,,,1,,BAO_0000218
13672,8418,A,,Intermediate,CHEMBL632061,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,,,1,,BAO_0000218
13673,8418,A,,Intermediate,CHEMBL629207,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Rattus norvegicus,,,1,,BAO_0000218
13674,8418,A,,Intermediate,CHEMBL629208,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Rattus norvegicus,,,1,,BAO_0000218
13675,8418,A,,Intermediate,CHEMBL629209,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Rattus norvegicus,,,1,,BAO_0000218
13676,8418,A,,Intermediate,CHEMBL629210,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Rattus norvegicus,,,1,,BAO_0000218
13677,8418,A,,Intermediate,CHEMBL629211,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,,,1,,BAO_0000218
13678,8418,A,,Intermediate,CHEMBL629212,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,,,1,,BAO_0000218
13679,8418,A,,Intermediate,CHEMBL629213,,,50597,,1,,N,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Rattus norvegicus,,,1,,BAO_0000218
13680,8133,A,,Intermediate,CHEMBL629214,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13681,8133,A,,Intermediate,CHEMBL629215,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13682,8133,A,,Intermediate,CHEMBL635154,,1088.0,50597,,1,,N,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Rattus norvegicus,,Urine,1,,BAO_0000218
13683,6996,A,,Intermediate,CHEMBL629216,,,50597,,1,,N,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13684,6996,A,,Intermediate,CHEMBL629217,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
13685,6996,A,,Intermediate,CHEMBL629218,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13686,6996,A,,Intermediate,CHEMBL629219,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13687,6996,A,,Intermediate,CHEMBL629220,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
13688,6996,A,,Intermediate,CHEMBL629221,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
13689,6996,A,,Intermediate,CHEMBL631127,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13690,6996,A,,Intermediate,CHEMBL631128,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
13691,6996,A,,Intermediate,CHEMBL631129,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13692,6996,A,,Intermediate,CHEMBL631130,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13693,6996,A,,Intermediate,CHEMBL631131,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
13694,6996,A,,Intermediate,CHEMBL631132,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
13695,6996,A,,Intermediate,CHEMBL631133,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13696,6996,A,,Intermediate,CHEMBL631134,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
13697,6996,A,,Intermediate,CHEMBL875120,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13698,6996,A,,Intermediate,CHEMBL631135,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13699,6996,A,,Intermediate,CHEMBL631136,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
13700,6996,A,,Intermediate,CHEMBL631137,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
13701,6996,A,,Intermediate,CHEMBL631138,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13702,6996,A,,Intermediate,CHEMBL631139,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,,,1,,BAO_0000218
13703,6996,A,,Intermediate,CHEMBL631140,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13704,6996,A,,Intermediate,CHEMBL631141,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13705,6996,A,,Intermediate,CHEMBL631142,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,,,1,,BAO_0000218
13706,6996,A,,Intermediate,CHEMBL631143,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,,,1,,BAO_0000218
13707,6996,A,,Intermediate,CHEMBL631144,,,50597,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,,,1,,BAO_0000218
13708,6996,A,,Intermediate,CHEMBL631145,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
13709,6996,A,,Intermediate,CHEMBL631146,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13710,6996,A,,Intermediate,CHEMBL631147,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
13711,6996,A,,Intermediate,CHEMBL631148,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13712,6996,A,,Intermediate,CHEMBL631149,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13713,6996,A,,Intermediate,CHEMBL631150,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13714,6996,A,,Intermediate,CHEMBL631151,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13715,6996,A,,Intermediate,CHEMBL631152,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13716,6996,A,,Intermediate,CHEMBL631443,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13717,6996,A,,Intermediate,CHEMBL631444,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13718,6996,A,,Intermediate,CHEMBL631445,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13719,6996,A,,Intermediate,CHEMBL631446,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,,,1,,BAO_0000218
13720,6996,A,,Intermediate,CHEMBL631447,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13721,6996,A,,Intermediate,CHEMBL631448,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13722,6996,A,,Intermediate,CHEMBL631449,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,,,1,,BAO_0000218
13723,6996,A,,Intermediate,CHEMBL631450,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13724,6996,A,,Intermediate,CHEMBL629724,,,50588,,1,,N,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,,,1,,BAO_0000218
13725,9716,A,,Intermediate,CHEMBL629725,In vivo,14.0,50594,,1,,N,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Zone of skin,1,,BAO_0000218
13726,9716,A,,Intermediate,CHEMBL629726,In vivo,14.0,50594,,1,,N,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Zone of skin,1,,BAO_0000218
13727,9716,A,,Intermediate,CHEMBL629727,In vivo,2106.0,50594,,1,,N,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Spleen,1,,BAO_0000218
13728,9716,A,,Intermediate,CHEMBL630404,In vivo,2106.0,50594,,1,,N,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Spleen,1,,BAO_0000218
13729,9716,A,,Intermediate,CHEMBL630405,In vivo,2106.0,50594,,1,,N,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Spleen,1,,BAO_0000218
13730,9716,A,,Intermediate,CHEMBL630406,In vivo,2106.0,50594,,1,,N,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Spleen,1,,BAO_0000218
13731,9716,A,,Intermediate,CHEMBL630407,In vivo,945.0,50594,,1,,N,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Stomach,1,,BAO_0000218
13732,9716,A,,Intermediate,CHEMBL630573,In vivo,945.0,50594,,1,,N,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Stomach,1,,BAO_0000218
13733,9716,A,,Intermediate,CHEMBL630574,In vivo,945.0,50594,,1,,N,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Stomach,1,,BAO_0000218
13734,9716,A,,Intermediate,CHEMBL630575,In vivo,945.0,50594,,1,,N,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,Stomach,1,,BAO_0000218
13735,9716,A,,Intermediate,CHEMBL630576,In vivo,,50594,,1,,N,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,1,,BAO_0000218
13736,9716,A,,Intermediate,CHEMBL630577,In vivo,,50594,,1,,N,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,1,,BAO_0000218
13737,9716,A,,Intermediate,CHEMBL630578,In vivo,,50594,,1,,N,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,1,,BAO_0000218
13738,9716,A,,Intermediate,CHEMBL630579,In vivo,,50594,,1,,N,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,,,1,,BAO_0000218
13739,12192,A,,Intermediate,CHEMBL630580,,2113.0,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Mus musculus,,Kidney,1,,BAO_0000218
13740,12192,A,,Intermediate,CHEMBL630581,,2113.0,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Mus musculus,,Kidney,1,,BAO_0000218
13741,12192,A,,Intermediate,CHEMBL630582,,2113.0,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Mus musculus,,Kidney,1,,BAO_0000218
13742,12192,A,,Intermediate,CHEMBL630583,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Mus musculus,,,1,,BAO_0000218
13743,12192,A,,Intermediate,CHEMBL630584,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Mus musculus,,,1,,BAO_0000218
13744,12192,A,,Intermediate,CHEMBL630585,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Mus musculus,,,1,,BAO_0000218
13745,12192,A,,Intermediate,CHEMBL630586,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Mus musculus,,,1,,BAO_0000218
13746,12192,A,,Intermediate,CHEMBL630587,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Mus musculus,,,1,,BAO_0000218
13747,12192,A,,Intermediate,CHEMBL630588,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Mus musculus,,,1,,BAO_0000218
13748,12192,A,,Intermediate,CHEMBL630589,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Mus musculus,,,1,,BAO_0000218
13749,12192,A,,Intermediate,CHEMBL630590,,,50594,,1,,N,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Mus musculus,,,1,,BAO_0000218
13750,12192,A,,Autocuration,CHEMBL630591,,1988.0,22224,,1,,U,Removal of 238-Plutonium(IV) in feces at 24 h,,,Feces,0,,BAO_0000019
13751,12192,A,,Autocuration,CHEMBL630592,,1988.0,22224,,1,,U,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,Feces,0,,BAO_0000019
13752,12192,A,,Autocuration,CHEMBL630593,,,22224,,1,,U,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,,0,,BAO_0000019
13753,12192,A,,Autocuration,CHEMBL630594,,,22224,,1,,U,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,,0,,BAO_0000019
13754,12192,A,,Autocuration,CHEMBL630595,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,Urine,0,,BAO_0000019
13755,12192,A,,Autocuration,CHEMBL630596,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,Urine,0,,BAO_0000019
13756,12192,A,,Autocuration,CHEMBL630597,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,Urine,0,,BAO_0000019
13757,12192,A,,Autocuration,CHEMBL630598,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,Urine,0,,BAO_0000019
13758,12192,A,,Autocuration,CHEMBL630599,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,Urine,0,,BAO_0000019
13759,12192,A,,Autocuration,CHEMBL630600,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,Urine,0,,BAO_0000019
13760,12192,A,,Autocuration,CHEMBL630601,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,Urine,0,,BAO_0000019
13761,12192,A,,Autocuration,CHEMBL630602,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,Urine,0,,BAO_0000019
13762,12192,A,,Autocuration,CHEMBL630603,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,Urine,0,,BAO_0000019
13763,12192,A,,Autocuration,CHEMBL630604,,1088.0,22224,,1,,U,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,Urine,0,,BAO_0000019
13764,12017,A,,Intermediate,CHEMBL624869,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
13765,12017,A,,Intermediate,CHEMBL624870,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
13766,12017,A,,Intermediate,CHEMBL623189,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Blood,1,,BAO_0000218
13767,12017,A,,Intermediate,CHEMBL623190,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
13768,12017,A,,Intermediate,CHEMBL623191,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
13769,12017,A,,Intermediate,CHEMBL623192,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13770,12017,A,,Intermediate,CHEMBL623193,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13771,12017,A,,Intermediate,CHEMBL623194,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,1,,BAO_0000218
13772,12017,A,,Intermediate,CHEMBL623195,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13773,12017,A,,Intermediate,CHEMBL623196,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13774,11836,A,,Intermediate,CHEMBL623197,,,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,,,1,,BAO_0000218
13775,11836,A,,Intermediate,CHEMBL623198,,,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,1,,BAO_0000218
13776,11836,A,,Intermediate,CHEMBL623199,,,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,,1,,BAO_0000218
13777,11836,A,,Intermediate,CHEMBL623200,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13778,11836,A,,Intermediate,CHEMBL623201,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13779,11836,A,,Intermediate,CHEMBL623202,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13780,11836,A,,Intermediate,CHEMBL623203,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13781,11836,A,,Intermediate,CHEMBL623204,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13782,11836,A,,Intermediate,CHEMBL623205,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13783,11836,A,,Intermediate,CHEMBL623206,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13784,11836,A,,Intermediate,CHEMBL623207,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13785,11836,A,,Intermediate,CHEMBL623208,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13786,11836,A,,Intermediate,CHEMBL623209,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13787,11836,A,,Intermediate,CHEMBL623210,,2385.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13788,11836,A,,Intermediate,CHEMBL623211,,,50597,,1,,N,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,,,1,,BAO_0000218
13789,11836,A,,Intermediate,CHEMBL623212,,995.0,50597,,1,,N,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,,Uterus,1,,BAO_0000218
13790,12640,A,,Autocuration,CHEMBL623213,,,22224,,1,,U,Tested in vitro for intrinsic activity relative to quinpirole,,,,0,,BAO_0000019
13791,14218,A,,Autocuration,CHEMBL623214,,,22224,,1,,U,"Relative ion enhancement, determined in pulsed ultrafiltration",,,,0,,BAO_0000019
13792,11296,A,,Autocuration,CHEMBL623215,,,22224,,1,,U,% ionization at the pH 7.4 at 37 degree Centigrade,,,,0,,BAO_0000019
13793,10929,A,,Autocuration,CHEMBL623216,,,22224,,1,,U,Percentage ionization was measured,,,,0,,BAO_0000019
13794,13841,A,,Intermediate,CHEMBL623217,,,50591,,1,,N,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Bos taurus,,,1,,BAO_0000218
13795,10431,A,,Autocuration,CHEMBL623218,,,22224,,1,,U,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,,0,,BAO_0000019
13796,10431,A,,Autocuration,CHEMBL623913,,,22224,,1,,U,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,,0,,BAO_0000019
13797,10431,A,,Autocuration,CHEMBL623914,,,22224,,1,,U,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,,0,,BAO_0000019
13798,8826,P,,Autocuration,CHEMBL623915,,,22229,,1,,U,Compound was evaluated for the partition coefficient in octanol/water,,,,0,,BAO_0000100
13799,8826,P,,Autocuration,CHEMBL624080,,,22229,,1,,U,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,,0,,BAO_0000100
13800,9884,A,,Autocuration,CHEMBL624081,,,22224,,1,,U,Equilibrium constant measured by the pulse radiolysis at pH 7,,,,0,,BAO_0000019
13801,9827,A,,Intermediate,CHEMBL624082,,,50587,,1,,N,In vitro hydrolytic rate constant determined in human blood,Homo sapiens,,,1,,BAO_0000218
13802,10009,A,,Intermediate,CHEMBL625054,,,50587,,1,,N,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Homo sapiens,,,1,,BAO_0000218
13803,10009,A,,Autocuration,CHEMBL877485,,,22224,,1,,U,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,,0,,BAO_0000019
13804,10009,A,,Intermediate,CHEMBL625055,,,50594,,1,,N,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Mus musculus,,,1,,BAO_0000218
13805,10009,A,,Intermediate,CHEMBL625056,,,50594,,1,,N,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Mus musculus,,,1,,BAO_0000218
13806,10009,A,,Intermediate,CHEMBL625057,,,50587,,1,,N,In vitro oxidation of compound in presence of human plasma,Homo sapiens,,,1,,BAO_0000218
13807,10009,A,,Autocuration,CHEMBL625058,,,22224,,1,,U,In vitro oxidation of compound in presence of hydrogen peroxide,,,,0,,BAO_0000019
13808,10009,A,,Intermediate,CHEMBL625059,,,50594,,1,,N,In vitro oxidation of compound in presence of mouse brain homogenate,Mus musculus,,,1,,BAO_0000218
13809,10009,A,,Intermediate,CHEMBL629536,,,50594,,1,,N,In vitro oxidation of compound in presence of mouse liver homogenate,Mus musculus,,,1,,BAO_0000218
13810,11510,A,,Intermediate,CHEMBL629537,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13811,11510,A,,Intermediate,CHEMBL629538,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13812,11510,A,,Intermediate,CHEMBL629539,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13813,11510,A,,Intermediate,CHEMBL874445,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13814,11510,A,,Intermediate,CHEMBL629540,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13815,11510,A,,Intermediate,CHEMBL629541,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13816,11510,A,,Intermediate,CHEMBL629542,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13817,11510,A,,Intermediate,CHEMBL630243,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,1,,BAO_0000218
13818,11510,A,,Intermediate,CHEMBL630244,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13819,11510,A,,Intermediate,CHEMBL630245,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13820,11510,A,,Intermediate,CHEMBL630246,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13821,11510,A,,Intermediate,CHEMBL630247,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13822,11510,A,,Intermediate,CHEMBL630248,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13823,13100,A,,Intermediate,CHEMBL630249,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood at 240 minutes after dose administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
13824,13100,A,,Intermediate,CHEMBL630250,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood at 30 minutes after dose administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
13825,13100,A,,Intermediate,CHEMBL630251,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood at 360 minutes after dose administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
13826,13100,A,,Intermediate,CHEMBL630252,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood at 3 hr after dose administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
13827,13100,A,,Intermediate,CHEMBL630408,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood at 60 minutes after dose administration.,Rattus norvegicus,,Blood,1,,BAO_0000218
13828,13100,A,,Intermediate,CHEMBL630409,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13829,13100,A,,Intermediate,CHEMBL874446,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13830,13100,A,,Intermediate,CHEMBL630410,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13831,13100,A,,Intermediate,CHEMBL630411,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13832,13100,A,,Intermediate,CHEMBL630412,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13833,13100,A,,Intermediate,CHEMBL630413,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13834,13100,A,,Intermediate,CHEMBL630414,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 3 hr after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13835,13100,A,,Intermediate,CHEMBL630415,In vivo,2037.0,50597,,1,,N,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
13836,13100,A,,Intermediate,CHEMBL630416,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 120 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13837,13100,A,,Intermediate,CHEMBL630417,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 1440 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13838,13100,A,,Intermediate,CHEMBL630418,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 15 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13839,13100,A,,Intermediate,CHEMBL630419,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 240 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13840,13100,A,,Intermediate,CHEMBL630420,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 30 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13841,13100,A,,Intermediate,CHEMBL630421,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 360 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13842,13100,A,,Intermediate,CHEMBL630422,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 3 hr after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13843,13100,A,,Intermediate,CHEMBL630423,In vivo,,50597,,1,,N,Biodistribution in rat cortex at 60 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
13844,13100,A,,Intermediate,CHEMBL630424,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 120 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13845,13100,A,,Intermediate,CHEMBL630425,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 15 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13846,13100,A,,Intermediate,CHEMBL629462,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 240 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13847,13100,A,,Intermediate,CHEMBL630426,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 30 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13848,13100,A,,Intermediate,CHEMBL630427,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 360 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13849,13100,A,,Intermediate,CHEMBL625877,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 3 hr after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13850,13100,A,,Intermediate,CHEMBL625878,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart at 60 minutes after dose administration.,Rattus norvegicus,,Heart,1,,BAO_0000218
13851,13100,A,,Intermediate,CHEMBL625879,In vivo,10000000.0,50597,,1,,N,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
13852,13100,A,,Intermediate,CHEMBL625880,In vivo,10000000.0,50597,,1,,N,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
13853,13100,A,,Intermediate,CHEMBL625881,In vivo,10000000.0,50597,,1,,N,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
13854,13100,A,,Intermediate,CHEMBL625882,In vivo,10000000.0,50597,,1,,N,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
13855,13100,A,,Intermediate,CHEMBL625883,In vivo,10000000.0,50597,,1,,N,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
13856,13100,A,,Intermediate,CHEMBL625884,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 120 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13857,13100,A,,Intermediate,CHEMBL625885,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 1440 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13858,13100,A,,Intermediate,CHEMBL628649,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 15 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13859,13100,A,,Intermediate,CHEMBL628650,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 240 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13860,13100,A,,Intermediate,CHEMBL628651,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 30 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13861,13100,A,,Intermediate,CHEMBL628652,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 360 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13862,13100,A,,Intermediate,CHEMBL628653,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney at 60 minutes after dose administration.,Rattus norvegicus,,Kidney,1,,BAO_0000218
13863,13100,A,,Intermediate,CHEMBL628654,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 120 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13864,13100,A,,Intermediate,CHEMBL628655,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 1440 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13865,13100,A,,Intermediate,CHEMBL625238,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 15 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13866,13100,A,,Intermediate,CHEMBL625239,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 240 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13867,13100,A,,Intermediate,CHEMBL625240,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 30 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13868,13100,A,,Intermediate,CHEMBL625241,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 360 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13869,13100,A,,Intermediate,CHEMBL625242,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver at 60 minutes after dose administration.,Rattus norvegicus,,Liver,1,,BAO_0000218
13870,13100,A,,Intermediate,CHEMBL874587,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 120 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13871,13100,A,,Intermediate,CHEMBL625405,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 1440 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13872,13100,A,,Intermediate,CHEMBL625406,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 15 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13873,13100,A,,Intermediate,CHEMBL625407,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 240 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13874,13100,A,,Intermediate,CHEMBL625408,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 30 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13875,13100,A,,Intermediate,CHEMBL625409,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 360 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
13876,12361,A,,Intermediate,CHEMBL625410,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13877,12361,A,,Intermediate,CHEMBL625411,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13878,12361,A,,Intermediate,CHEMBL625412,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13879,12361,A,,Intermediate,CHEMBL625413,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13880,12361,A,,Intermediate,CHEMBL625414,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13881,12361,A,,Intermediate,CHEMBL625415,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13882,12361,A,,Intermediate,CHEMBL625416,,1515.0,50597,,1,,N,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,,Thoracic aorta,1,,BAO_0000218
13883,12712,A,,Intermediate,CHEMBL625417,,1088.0,50597,,1,,N,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Rattus norvegicus,,Urine,1,,BAO_0000218
13884,7415,A,,Intermediate,CHEMBL625418,,1988.0,50597,,1,,N,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Rattus norvegicus,,Feces,1,,BAO_0000218
13885,7415,A,,Intermediate,CHEMBL625419,,1088.0,50597,,1,,N,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Rattus norvegicus,,Urine,1,,BAO_0000218
13886,7415,A,,Intermediate,CHEMBL625420,,,50597,,1,,N,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
13887,7415,A,,Intermediate,CHEMBL626996,,,50597,,1,,N,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Rattus norvegicus,,,1,,BAO_0000218
13888,7415,A,,Intermediate,CHEMBL626997,,1988.0,50597,,1,,N,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Rattus norvegicus,,Feces,1,,BAO_0000218
13889,7415,A,,Intermediate,CHEMBL626998,,1088.0,50597,,1,,N,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Rattus norvegicus,,Urine,1,,BAO_0000218
13890,7415,A,,Intermediate,CHEMBL626999,,,50597,,1,,N,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Rattus norvegicus,,,1,,BAO_0000218
13891,8050,A,,Intermediate,CHEMBL627000,,,50594,,1,,N,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Mus musculus,,,1,,BAO_0000218
13892,8050,A,,Intermediate,CHEMBL627001,,,50594,,1,,N,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Mus musculus,,,1,,BAO_0000218
13893,8050,A,,Intermediate,CHEMBL627002,,,50594,,1,,N,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Mus musculus,,,1,,BAO_0000218
13894,8050,A,,Intermediate,CHEMBL627003,,,50594,,1,,N,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Mus musculus,,,1,,BAO_0000218
13895,8050,A,,Intermediate,CHEMBL627004,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Mus musculus,,Urine,1,,BAO_0000218
13896,8050,A,,Intermediate,CHEMBL627005,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Mus musculus,,Urine,1,,BAO_0000218
13897,8050,A,,Intermediate,CHEMBL874594,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Mus musculus,,Urine,1,,BAO_0000218
13898,8050,A,,Intermediate,CHEMBL627006,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Mus musculus,,Urine,1,,BAO_0000218
13899,8050,A,,Intermediate,CHEMBL627007,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Mus musculus,,Urine,1,,BAO_0000218
13900,8050,A,,Intermediate,CHEMBL627884,,1088.0,50594,,1,,N,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Mus musculus,,Urine,1,,BAO_0000218
13901,8050,A,,Intermediate,CHEMBL627885,,1088.0,50594,,1,,N,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Mus musculus,,Urine,1,,BAO_0000218
13902,8050,A,,Intermediate,CHEMBL627886,,1088.0,50594,,1,,N,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Mus musculus,,Urine,1,,BAO_0000218
13903,8050,A,,Intermediate,CHEMBL627887,,1088.0,50594,,1,,N,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Mus musculus,,Urine,1,,BAO_0000218
13904,8050,A,,Intermediate,CHEMBL627888,,1088.0,50594,,1,,N,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Mus musculus,,Urine,1,,BAO_0000218
13905,8050,A,,Intermediate,CHEMBL628057,,1088.0,50594,,1,,N,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Mus musculus,,Urine,1,,BAO_0000218
13906,8050,A,,Intermediate,CHEMBL627405,,1088.0,50594,,1,,N,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Mus musculus,,Urine,1,,BAO_0000218
13907,12582,A,,Intermediate,CHEMBL627406,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13908,12582,A,,Intermediate,CHEMBL627407,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13909,12582,A,,Intermediate,CHEMBL627408,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13910,12582,A,,Intermediate,CHEMBL627409,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13911,12582,A,,Intermediate,CHEMBL875486,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13912,12582,A,,Intermediate,CHEMBL627410,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13913,12582,A,,Intermediate,CHEMBL627411,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13914,12582,A,,Intermediate,CHEMBL627412,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13915,12582,A,,Intermediate,CHEMBL627413,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13916,12582,A,,Intermediate,CHEMBL627414,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13917,12582,A,,Intermediate,CHEMBL627415,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13918,12582,A,,Intermediate,CHEMBL627416,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13919,12582,A,,Intermediate,CHEMBL627417,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13920,12582,A,,Intermediate,CHEMBL627418,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13921,12582,A,,Intermediate,CHEMBL627419,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13922,12582,A,,Intermediate,CHEMBL627320,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13923,12582,A,,Intermediate,CHEMBL627321,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
13924,12017,A,,Intermediate,CHEMBL627322,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
13925,12017,A,,Intermediate,CHEMBL627323,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
13926,12017,A,,Intermediate,CHEMBL627491,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Kidney,1,,BAO_0000218
13927,12017,A,,Intermediate,CHEMBL627492,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
13928,12017,A,,Intermediate,CHEMBL627493,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
13929,12017,A,,Intermediate,CHEMBL627494,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
13930,12017,A,,Intermediate,CHEMBL627495,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
13931,12017,A,,Intermediate,CHEMBL627496,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Liver,1,,BAO_0000218
13932,12017,A,,Intermediate,CHEMBL627497,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
13933,12017,A,,Intermediate,CHEMBL627498,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
13934,12017,A,,Intermediate,CHEMBL627499,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
13935,12017,A,,Intermediate,CHEMBL627500,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
13936,12017,A,,Intermediate,CHEMBL627501,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Lung,1,,BAO_0000218
13937,12017,A,,Intermediate,CHEMBL625616,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
13938,12017,A,,Intermediate,CHEMBL625617,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
13939,12017,A,,Intermediate,CHEMBL625618,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13940,12017,A,,Intermediate,CHEMBL625619,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13941,12017,A,,Intermediate,CHEMBL625620,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13942,12017,A,,Intermediate,CHEMBL625621,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13943,12017,A,,Intermediate,CHEMBL625622,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
13944,12017,A,,Intermediate,CHEMBL625788,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
13945,12017,A,,Intermediate,CHEMBL625789,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
13946,12017,A,,Intermediate,CHEMBL625790,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Spleen,1,,BAO_0000218
13947,12017,A,,Intermediate,CHEMBL625791,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
13948,12017,A,,Intermediate,CHEMBL622334,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
13949,12017,A,,Intermediate,CHEMBL622335,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
13950,12017,A,,Intermediate,CHEMBL622336,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
13951,12017,A,,Intermediate,CHEMBL622337,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
13952,12017,A,,Intermediate,CHEMBL622338,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
13953,12017,A,,Intermediate,CHEMBL622339,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
13954,12017,A,,Intermediate,CHEMBL624153,In vivo,,50597,,1,,N,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13955,12017,A,,Intermediate,CHEMBL628430,In vivo,,50597,,1,,N,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13956,12017,A,,Intermediate,CHEMBL628431,In vivo,,50597,,1,,N,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,1,,BAO_0000218
13957,12017,A,,Intermediate,CHEMBL628432,In vivo,,50597,,1,,N,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13958,12017,A,,Intermediate,CHEMBL628433,In vivo,,50597,,1,,N,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
13959,12017,A,,Intermediate,CHEMBL628434,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
13960,12017,A,,Intermediate,CHEMBL626789,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
13961,12017,A,,Intermediate,CHEMBL626790,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Rattus norvegicus,,Spleen,1,,BAO_0000218
13962,12017,A,,Intermediate,CHEMBL626791,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
13963,12017,A,,Intermediate,CHEMBL626792,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
13964,12017,A,,Intermediate,CHEMBL626793,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
13965,11510,A,,Intermediate,CHEMBL627436,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13966,11510,A,,Intermediate,CHEMBL627437,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13967,11510,A,,Intermediate,CHEMBL627438,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13968,11510,A,,Intermediate,CHEMBL627439,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13969,11510,A,,Intermediate,CHEMBL627440,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13970,11510,A,,Intermediate,CHEMBL627602,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13971,11510,A,,Intermediate,CHEMBL627603,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13972,11510,A,,Intermediate,CHEMBL627604,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13973,11510,A,,Intermediate,CHEMBL627605,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13974,11510,A,,Intermediate,CHEMBL627606,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13975,11510,A,,Intermediate,CHEMBL627607,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13976,11510,A,,Intermediate,CHEMBL627608,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13977,11510,A,,Intermediate,CHEMBL627609,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13978,11510,A,,Intermediate,CHEMBL627610,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13979,11510,A,,Intermediate,CHEMBL627611,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13980,11510,A,,Intermediate,CHEMBL627612,,,50597,,1,,N,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
13981,8362,P,,Autocuration,CHEMBL627613,,,22229,,1,,U,Octanol:water partition coefficient is evaluated,,,,0,,BAO_0000100
13982,8257,P,,Autocuration,CHEMBL627614,,,22224,,1,,U,Partition coefficient in 1-octanol/water system,,,,0,,BAO_0000100
13983,8257,P,,Autocuration,CHEMBL627615,,,22224,,1,,U,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,,0,,BAO_0000100
13984,9468,P,,Autocuration,CHEMBL627616,,,22224,,1,,U,Partition coefficient in octanol/water system was determined,,,,0,,BAO_0000100
13985,9468,P,,Autocuration,CHEMBL627617,,,22224,,1,,U,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,,0,,BAO_0000100
13986,10568,A,,Autocuration,CHEMBL627618,,,22224,,1,,U,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,,0,,BAO_0000019
13987,10568,A,,Autocuration,CHEMBL627619,,,22224,,1,,U,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,,0,,BAO_0000019
13988,15359,A,,Autocuration,CHEMBL627620,,,22224,,1,,U,Pseudo-first-order rate constant of the compound,,,,0,,BAO_0000019
13989,15359,A,,Autocuration,CHEMBL627621,,,22224,,1,,U,Pseudo-first-order rate constant with 1-min time point,,,,0,,BAO_0000019
13990,15359,A,,Autocuration,CHEMBL627622,,,22224,,1,,U,Pseudo-first-order rate constant without 1-min time point,,,,0,,BAO_0000019
13991,10431,A,,Autocuration,CHEMBL627623,,,22224,,1,,U,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,,0,,BAO_0000019
13992,10431,A,,Autocuration,CHEMBL627624,,,22224,,1,,U,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,,0,,BAO_0000019
13993,10431,A,,Autocuration,CHEMBL627625,,,22224,,1,,U,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,,0,,BAO_0000019
13994,15704,A,,Autocuration,CHEMBL628523,,,22224,,1,,U,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,,0,,BAO_0000019
13995,15287,A,,Autocuration,CHEMBL628524,,,22224,,1,,U,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,,0,,BAO_0000019
13996,7516,A,,Autocuration,CHEMBL628525,,,22224,,1,,U,The efflux rate constant of the compound,,,,0,,BAO_0000019
13997,12973,A,,Autocuration,CHEMBL625732,,,22224,,1,,U,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,0,,BAO_0000019
13998,12973,A,,Autocuration,CHEMBL625733,,,22224,,1,,U,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,0,,BAO_0000019
13999,12973,F,,Autocuration,CHEMBL625734,,,22224,,1,,U,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,0,,BAO_0000019
14000,12973,A,,Autocuration,CHEMBL625913,,,22224,,1,,U,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,,0,,BAO_0000019
14001,8696,A,,Autocuration,CHEMBL625914,,,22224,,1,,U,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,,0,,BAO_0000019
14002,15052,A,,Autocuration,CHEMBL625915,,,22224,,1,,U,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,,0,,BAO_0000019
14003,15052,A,,Autocuration,CHEMBL625916,,,22224,,1,,U,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,,0,,BAO_0000019
14004,10503,A,,Autocuration,CHEMBL625917,,,22224,,1,,U,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,,0,,BAO_0000019
14005,8354,A,,Autocuration,CHEMBL625918,,,22224,,1,,U,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14006,8354,A,,Autocuration,CHEMBL625919,,,22224,,1,,U,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14007,8354,A,,Autocuration,CHEMBL625920,,,22224,,1,,U,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14008,8354,A,,Autocuration,CHEMBL874453,,,22224,,1,,U,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14009,8354,A,,Autocuration,CHEMBL625921,,,22224,,1,,U,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14010,10503,A,,Autocuration,CHEMBL625922,,,22224,,1,,U,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,,0,,BAO_0000019
14011,8354,A,,Autocuration,CHEMBL625923,,,22224,,1,,U,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14012,8354,A,,Autocuration,CHEMBL625924,,,22224,,1,,U,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14013,8354,A,,Autocuration,CHEMBL625925,,,22224,,1,,U,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14014,8354,A,,Autocuration,CHEMBL625926,,,22224,,1,,U,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14015,13100,A,,Intermediate,CHEMBL627704,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung at 60 minutes after dose administration.,Rattus norvegicus,,Lung,1,,BAO_0000218
14016,13100,A,,Intermediate,CHEMBL627705,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14017,13100,A,,Intermediate,CHEMBL627706,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14018,13100,A,,Intermediate,CHEMBL627707,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14019,13100,A,,Intermediate,CHEMBL627708,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14020,13100,A,,Intermediate,CHEMBL628361,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14021,13100,A,,Intermediate,CHEMBL628362,In vivo,,50597,,1,,N,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Rattus norvegicus,,,1,,BAO_0000218
14022,13100,A,,Intermediate,CHEMBL628363,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 120 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14023,13100,A,,Intermediate,CHEMBL628364,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 1440 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14024,13100,A,,Intermediate,CHEMBL628365,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 15 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14025,13100,A,,Intermediate,CHEMBL874454,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 240 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14026,13100,A,,Intermediate,CHEMBL628531,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 30 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14027,13100,A,,Intermediate,CHEMBL628532,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 360 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14028,13100,A,,Intermediate,CHEMBL628533,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 3 hr after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14029,13100,A,,Intermediate,CHEMBL628534,In vivo,2435.0,50597,,1,,N,Biodistribution in rat striatum at 60 minutes after dose administration.,Rattus norvegicus,,Striatum,1,,BAO_0000218
14030,13100,A,,Intermediate,CHEMBL628535,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 120 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14031,13100,A,,Intermediate,CHEMBL628536,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14032,13100,A,,Intermediate,CHEMBL628537,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 15 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14033,13100,A,,Intermediate,CHEMBL628538,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 240 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14034,13100,A,,Intermediate,CHEMBL628539,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 30 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14035,13100,A,,Intermediate,CHEMBL630297,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 360 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14036,13100,A,,Intermediate,CHEMBL630298,In vivo,2046.0,50597,,1,,N,Biodistribution in rat thyroid at 60 minutes after dose administration.,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14037,13100,A,,Intermediate,CHEMBL630299,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14038,13100,A,,Intermediate,CHEMBL628094,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14039,13100,A,,Intermediate,CHEMBL628095,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14040,13100,A,,Intermediate,CHEMBL874648,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14041,13100,A,,Intermediate,CHEMBL628096,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14042,13100,A,,Intermediate,CHEMBL628097,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14043,13100,A,,Intermediate,CHEMBL628098,In vivo,955.0,50597,,1,,N,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Rattus norvegicus,,Brain,1,,BAO_0000218
14044,13331,A,,Autocuration,CHEMBL628099,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,,0,,BAO_0000019
14045,13331,A,,Autocuration,CHEMBL628100,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,0,,BAO_0000019
14046,13331,A,,Autocuration,CHEMBL628101,,,22224,,1,,U,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,,0,,BAO_0000019
14047,13331,A,,Autocuration,CHEMBL628102,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,,0,,BAO_0000019
14048,13331,A,,Autocuration,CHEMBL628103,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,,0,,BAO_0000019
14049,13331,A,,Autocuration,CHEMBL628104,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,0,,BAO_0000019
14050,13331,A,,Autocuration,CHEMBL628105,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,,0,,BAO_0000019
14051,13331,A,,Autocuration,CHEMBL628106,,,22224,,1,,U,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,,0,,BAO_0000019
14052,10086,A,,Intermediate,CHEMBL628107,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14053,10086,F,,Autocuration,CHEMBL628108,,1088.0,22224,,1,,U,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,Urine,0,,BAO_0000218
14054,10086,A,,Intermediate,CHEMBL628109,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14055,10086,F,,Autocuration,CHEMBL625299,,1088.0,22224,,1,,U,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,Urine,0,,BAO_0000218
14056,10086,A,,Intermediate,CHEMBL625300,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14057,10086,A,,Intermediate,CHEMBL625301,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14058,10086,A,,Intermediate,CHEMBL625302,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14059,10086,A,,Intermediate,CHEMBL874649,,1088.0,50597,,1,,N,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Rattus norvegicus,,Urine,1,,BAO_0000218
14060,13248,A,,Intermediate,CHEMBL625303,,,50597,,1,,N,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Rattus norvegicus,,,1,,BAO_0000218
14061,13248,A,,Intermediate,CHEMBL625463,,,50597,,1,,N,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Rattus norvegicus,,,1,,BAO_0000218
14062,14527,A,,Intermediate,CHEMBL625464,,2107.0,50587,,1,,N,In vitro metabolism in human liver microsomes,Homo sapiens,,Liver,1,,BAO_0000218
14063,3008,A,,Intermediate,CHEMBL625465,,,50587,,1,,N,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Homo sapiens,,,1,,BAO_0000218
14064,12582,A,,Intermediate,CHEMBL625466,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14065,12582,A,,Intermediate,CHEMBL625467,,1088.0,50588,,1,,N,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14066,12582,A,,Intermediate,CHEMBL625468,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14067,12582,A,,Intermediate,CHEMBL625469,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14068,12582,A,,Intermediate,CHEMBL625470,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14069,12582,A,,Intermediate,CHEMBL632418,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14070,12582,A,,Intermediate,CHEMBL627250,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14071,12582,A,,Intermediate,CHEMBL627251,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14072,12582,A,,Intermediate,CHEMBL627252,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14073,12582,A,,Intermediate,CHEMBL627253,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14074,12582,A,,Intermediate,CHEMBL627254,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14075,12582,A,,Intermediate,CHEMBL875471,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14076,12582,A,,Intermediate,CHEMBL627255,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14077,12582,A,,Intermediate,CHEMBL627256,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14078,12582,A,,Intermediate,CHEMBL627257,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14079,12582,A,,Intermediate,CHEMBL627258,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14080,12582,A,,Intermediate,CHEMBL627259,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14081,12582,A,,Intermediate,CHEMBL627260,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14082,12582,A,,Intermediate,CHEMBL623256,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14083,12582,A,,Intermediate,CHEMBL874413,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14084,12582,A,,Intermediate,CHEMBL623257,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14085,12582,A,,Intermediate,CHEMBL623258,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14086,12582,A,,Intermediate,CHEMBL623259,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14087,12582,A,,Intermediate,CHEMBL623260,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14088,12582,A,,Intermediate,CHEMBL623261,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14089,12582,A,,Intermediate,CHEMBL623262,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14090,12582,A,,Intermediate,CHEMBL623263,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14091,12582,A,,Intermediate,CHEMBL623264,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14092,12582,A,,Intermediate,CHEMBL623265,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14093,12582,A,,Intermediate,CHEMBL623266,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14094,12582,A,,Intermediate,CHEMBL623267,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14095,12582,A,,Intermediate,CHEMBL623268,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14096,12582,A,,Intermediate,CHEMBL623269,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14097,12582,A,,Intermediate,CHEMBL623270,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14098,12582,A,,Intermediate,CHEMBL623271,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14099,12582,A,,Intermediate,CHEMBL623272,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14100,12582,A,,Intermediate,CHEMBL623273,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14101,12582,A,,Intermediate,CHEMBL623274,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14102,12582,A,,Intermediate,CHEMBL874414,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14103,12582,A,,Intermediate,CHEMBL623275,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14104,12582,A,,Intermediate,CHEMBL629150,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14105,12582,A,,Intermediate,CHEMBL623276,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14106,12582,A,,Intermediate,CHEMBL623277,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14107,12582,A,,Intermediate,CHEMBL623112,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14108,12582,A,,Intermediate,CHEMBL623113,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14109,12582,A,,Intermediate,CHEMBL623800,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14110,12582,A,,Intermediate,CHEMBL623801,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14111,12017,A,,Intermediate,CHEMBL623802,In vivo,2106.0,50597,,1,,N,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,,Spleen,1,,BAO_0000218
14112,12017,A,,Intermediate,CHEMBL623803,In vivo,995.0,50597,,1,,N,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Uterus,1,,BAO_0000218
14113,12017,A,,Intermediate,CHEMBL623970,In vivo,995.0,50597,,1,,N,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Uterus,1,,BAO_0000218
14114,12017,A,,Intermediate,CHEMBL623971,In vivo,995.0,50597,,1,,N,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Uterus,1,,BAO_0000218
14115,14045,A,,Intermediate,CHEMBL623972,In vivo,178.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,,Blood,1,,BAO_0000218
14116,14045,A,,Intermediate,CHEMBL623973,In vivo,178.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,,Blood,1,,BAO_0000218
14117,14045,A,,Intermediate,CHEMBL623974,In vivo,178.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,,Blood,1,,BAO_0000218
14118,14045,A,,Intermediate,CHEMBL623975,In vivo,178.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,,Blood,1,,BAO_0000218
14119,14045,A,,Intermediate,CHEMBL623976,In vivo,955.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Rattus norvegicus,,Brain,1,,BAO_0000218
14120,14045,A,,Intermediate,CHEMBL623977,In vivo,955.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Rattus norvegicus,,Brain,1,,BAO_0000218
14121,14045,A,,Intermediate,CHEMBL623978,In vivo,955.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Rattus norvegicus,,Brain,1,,BAO_0000218
14122,14045,A,,Intermediate,CHEMBL623979,In vivo,955.0,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Rattus norvegicus,,Brain,1,,BAO_0000218
14123,14045,A,,Intermediate,CHEMBL623980,In vivo,,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,,,1,,BAO_0000218
14124,14045,A,,Intermediate,CHEMBL623981,In vivo,,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,,,1,,BAO_0000218
14125,14045,A,,Intermediate,CHEMBL626278,In vivo,,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,,,1,,BAO_0000218
14126,14045,A,,Intermediate,CHEMBL626279,In vivo,,50597,,1,,N,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,,,1,,BAO_0000218
14127,14045,A,,Intermediate,CHEMBL626280,In vivo,,50594,,1,,N,Biodistribution in mice bladder plus excreted urine was determined,Mus musculus,,,1,,BAO_0000218
14128,14045,A,,Intermediate,CHEMBL626281,,,50594,,1,,N,"Percentage biodistribution in mouse blood, 10 minutes post injection",Mus musculus,,,1,,BAO_0000218
14129,14045,A,,Intermediate,CHEMBL626282,,,50594,,1,,N,"Percentage biodistribution in mouse blood, 30 minutes post injection",Mus musculus,,,1,,BAO_0000218
14130,14045,A,,Intermediate,CHEMBL626283,,,50594,,1,,N,"Percentage biodistribution in mouse blood, 5 minutes post injection",Mus musculus,,,1,,BAO_0000218
14131,14045,A,,Intermediate,CHEMBL626284,,,50594,,1,,N,"Percentage biodistribution in mouse blood, 60 minutes post injection",Mus musculus,,,1,,BAO_0000218
14132,14045,A,,Intermediate,CHEMBL626285,,955.0,50594,,1,,N,"Percentage biodistribution in mouse brain, 10 minutes post injection",Mus musculus,,Brain,1,,BAO_0000218
14133,14045,A,,Intermediate,CHEMBL626286,,955.0,50594,,1,,N,"Percentage biodistribution in mouse brain, 30 minutes post injection",Mus musculus,,Brain,1,,BAO_0000218
14134,14045,A,,Intermediate,CHEMBL626287,,955.0,50594,,1,,N,"Percentage biodistribution in mouse brain, 5 minutes post injection",Mus musculus,,Brain,1,,BAO_0000218
14135,14045,A,,Intermediate,CHEMBL626288,,955.0,50594,,1,,N,"Percentage biodistribution in mouse brain, 60 minutes post injection",Mus musculus,,Brain,1,,BAO_0000218
14136,14045,A,,Intermediate,CHEMBL626289,,,50594,,1,,N,"Percentage biodistribution in mouse heart, 10 minutes post injection",Mus musculus,,,1,,BAO_0000218
14137,14045,A,,Intermediate,CHEMBL626290,,,50594,,1,,N,"Percentage biodistribution in mouse heart, 30 minutes post injection",Mus musculus,,,1,,BAO_0000218
14138,14045,A,,Intermediate,CHEMBL626291,,,50594,,1,,N,"Percentage biodistribution in mouse heart, 5 minutes post injection",Mus musculus,,,1,,BAO_0000218
14139,14045,A,,Intermediate,CHEMBL839888,,,50594,,1,,N,"Percentage biodistribution in mouse heart, 60 minutes post injection",Mus musculus,,,1,,BAO_0000218
14140,14045,A,,Intermediate,CHEMBL626292,,160.0,50594,,1,,N,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Mus musculus,,Intestine,1,,BAO_0000218
14141,14045,A,,Intermediate,CHEMBL626293,,160.0,50594,,1,,N,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Mus musculus,,Intestine,1,,BAO_0000218
14142,14045,A,,Intermediate,CHEMBL626294,,160.0,50594,,1,,N,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Mus musculus,,Intestine,1,,BAO_0000218
14143,14045,A,,Intermediate,CHEMBL626295,,160.0,50594,,1,,N,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Mus musculus,,Intestine,1,,BAO_0000218
14144,14045,A,,Intermediate,CHEMBL627659,,2107.0,50594,,1,,N,"Percentage biodistribution in mouse liver, 10 minutes post injection",Mus musculus,,Liver,1,,BAO_0000218
14145,14045,A,,Intermediate,CHEMBL627660,,2107.0,50594,,1,,N,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Mus musculus,,Liver,1,,BAO_0000218
14146,14045,A,,Intermediate,CHEMBL627661,,2107.0,50594,,1,,N,"Percentage biodistribution in mouse liver, 5 minutes post injection",Mus musculus,,Liver,1,,BAO_0000218
14147,14045,A,,Intermediate,CHEMBL627662,In vivo,2107.0,50594,,1,,N,Biodistribution in mice liver at 60 minutes of post injection,Mus musculus,,Liver,1,,BAO_0000218
14148,14045,A,,Intermediate,CHEMBL627663,In vivo,2048.0,50594,,1,,N,Biodistribution in mice lungs at 10 min of post injection,Mus musculus,,Lung,1,,BAO_0000218
14149,14045,A,,Intermediate,CHEMBL627664,,,50594,,1,,N,"Percentage biodistribution in mouse lung, 30 minutes post injection",Mus musculus,,,1,,BAO_0000218
14150,14045,A,,Intermediate,CHEMBL627665,,,50594,,1,,N,"Percentage biodistribution in mousee lung, 5 minutes post injection",Mus musculus,,,1,,BAO_0000218
14151,14045,A,,Intermediate,CHEMBL627666,In vivo,2048.0,50594,,1,,N,Biodistribution in mice lungs at 60 min of post injection,Mus musculus,,Lung,1,,BAO_0000218
14152,14045,A,,Intermediate,CHEMBL627667,,2106.0,50594,,1,,N,Percentage biodistribution in mouse spleen,Mus musculus,,Spleen,1,,BAO_0000218
14153,14045,A,,Intermediate,CHEMBL627668,,945.0,50594,,1,,N,Percentage biodistribution in mouse stomach,Mus musculus,,Stomach,1,,BAO_0000218
14154,11745,A,,Intermediate,CHEMBL627669,,1088.0,50594,,1,,N,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Mus musculus,,Urine,1,,BAO_0000218
14155,13257,A,,Autocuration,CHEMBL627670,In vivo,1255.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,Urinary bladder,0,,BAO_0000218
14156,13257,A,,Autocuration,CHEMBL627671,In vivo,178.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,Blood,0,,BAO_0000218
14157,13257,A,,Autocuration,CHEMBL627672,In vivo,1474.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,Bone element,0,,BAO_0000218
14158,13257,A,,Autocuration,CHEMBL627673,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,,0,,BAO_0000218
14159,13257,A,,Autocuration,CHEMBL627674,In vivo,2113.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,Kidney,0,,BAO_0000218
14160,13257,A,,Autocuration,CHEMBL627675,In vivo,2107.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,Liver,0,,BAO_0000218
14161,13257,A,,Autocuration,CHEMBL627676,In vivo,2048.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,Lung,0,,BAO_0000218
14162,13257,A,,Autocuration,CHEMBL627677,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,Muscle tissue,0,,BAO_0000218
14163,8354,A,,Autocuration,CHEMBL627678,,,22224,,1,,U,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
14164,7095,A,,Intermediate,CHEMBL627679,,1977.0,50597,,1,,N,Affinity for protein binding expressed as association constant in fresh rat serum,Rattus norvegicus,,Serum,1,,BAO_0000218
14165,12185,A,,Autocuration,CHEMBL627680,,,22224,,1,,U,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,0,,BAO_0000019
14166,12185,A,,Autocuration,CHEMBL627681,,,22224,,1,,U,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,0,,BAO_0000019
14167,12185,A,,Autocuration,CHEMBL627682,,,22224,,1,,U,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,0,,BAO_0000019
14168,12185,A,,Autocuration,CHEMBL627683,,,22224,,1,,U,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,0,,BAO_0000019
14169,12686,A,,Autocuration,CHEMBL627684,,,22224,,1,,U,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,,0,,BAO_0000019
14170,12686,A,,Autocuration,CHEMBL874441,,,22224,,1,,U,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,0,,BAO_0000019
14171,12686,A,,Autocuration,CHEMBL627685,,,22224,,1,,U,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,,0,,BAO_0000019
14172,12686,A,,Autocuration,CHEMBL627686,,,22224,,1,,U,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,0,,BAO_0000019
14173,8057,A,,Autocuration,CHEMBL627687,,,22224,,1,,U,Apparent rate constant Koff for inactivation of dTMP synthase.,,,,0,,BAO_0000019
14174,15778,A,,Autocuration,CHEMBL627688,,,22224,,1,,U,The irreversible inhibitor activity by second order rate equation.,,,,0,,BAO_0000019
14175,12375,A,,Intermediate,CHEMBL628038,,,50597,,1,,N,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
14176,12375,A,,Intermediate,CHEMBL628039,,,50597,,1,,N,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Rattus norvegicus,,,1,,BAO_0000218
14177,12375,A,,Intermediate,CHEMBL628040,,,50597,,1,,N,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Rattus norvegicus,,,1,,BAO_0000218
14178,13588,A,,Autocuration,CHEMBL628041,,,22224,,1,,U,Dissociation rate calculated from the first-order equation using t1/2 value,,,,0,,BAO_0000019
14179,15039,A,,Autocuration,CHEMBL630226,,,22224,,1,,U,The compound was tested for Binding constant against DNA,,,,0,,BAO_0000019
14180,9500,A,,Autocuration,CHEMBL628042,,,22224,,1,,U,First order rate constant for cyclization of the compound,,,,0,,BAO_0000019
14181,10014,A,,Autocuration,CHEMBL625232,,,22224,,1,,U,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,0,,BAO_0000019
14182,10014,A,,Autocuration,CHEMBL625233,,,22224,,1,,U,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,0,,BAO_0000019
14183,568,A,,Autocuration,CHEMBL625979,,,22224,,1,,U,Hydrolysis rate constant was determined,,,,0,,BAO_0000019
14184,10026,A,,Autocuration,CHEMBL625980,,,22224,,1,,U,Observed first order rate constant,,,,0,,BAO_0000019
14185,10281,A,,Autocuration,CHEMBL625981,,,22224,,1,,U,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,0,,BAO_0000019
14186,10281,A,,Autocuration,CHEMBL625982,,,22224,,1,,U,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,0,,BAO_0000019
14187,9680,A,,Autocuration,CHEMBL625983,,,22224,,1,,U,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,,0,,BAO_0000019
14188,13028,A,,Autocuration,CHEMBL625984,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14189,13028,A,,Autocuration,CHEMBL625985,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14190,13028,A,,Autocuration,CHEMBL625986,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14191,13028,A,,Autocuration,CHEMBL625987,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14192,13028,A,,Autocuration,CHEMBL625988,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14193,13028,A,,Autocuration,CHEMBL625989,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14194,13028,A,,Autocuration,CHEMBL625990,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14195,13028,A,,Autocuration,CHEMBL625991,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14196,13028,A,,Autocuration,CHEMBL625992,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14197,13028,A,,Autocuration,CHEMBL625993,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14198,13028,A,,Autocuration,CHEMBL631973,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14199,13028,A,,Autocuration,CHEMBL632143,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14200,13028,A,,Autocuration,CHEMBL632144,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14201,13028,A,,Autocuration,CHEMBL632145,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14202,13028,A,,Autocuration,CHEMBL632146,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14203,13028,A,,Autocuration,CHEMBL632147,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14204,13028,A,,Autocuration,CHEMBL632148,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14205,13028,A,,Autocuration,CHEMBL632149,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14206,13028,A,,Autocuration,CHEMBL632150,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14207,13028,A,,Autocuration,CHEMBL632151,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14208,3008,A,,Intermediate,CHEMBL632152,,,50587,,1,,N,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Homo sapiens,,,1,,BAO_0000218
14209,4509,A,,Intermediate,CHEMBL632153,,,50587,,1,,N,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,,,1,,BAO_0000218
14210,4509,A,,Intermediate,CHEMBL632154,,,50587,,1,,N,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,,,1,,BAO_0000218
14211,8613,A,,Intermediate,CHEMBL632155,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14212,8613,A,,Intermediate,CHEMBL632156,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,1,,BAO_0000218
14213,8613,A,,Intermediate,CHEMBL632157,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14214,8613,A,,Intermediate,CHEMBL632158,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14215,8613,A,,Intermediate,CHEMBL632159,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,1,,BAO_0000218
14216,8613,A,,Intermediate,CHEMBL626305,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14217,8613,A,,Intermediate,CHEMBL626306,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Human herpesvirus 1,,,1,,BAO_0000218
14218,8613,A,,Intermediate,CHEMBL626307,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14219,8613,A,,Intermediate,CHEMBL626308,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14220,8613,A,,Intermediate,CHEMBL626479,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14221,8613,A,,Intermediate,CHEMBL626480,,,50602,,1,,N,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Human herpesvirus 1,,,1,,BAO_0000218
14222,6021,P,,Autocuration,CHEMBL626481,,,22229,,1,,U,Calculated partition coefficient (clogP) (MlogP),,,,0,,BAO_0000100
14223,9348,A,,Autocuration,CHEMBL626482,,,22224,,1,,U,Equipotent potent ratio relative to carbachol (nicotinic activity),,,,0,,BAO_0000019
14224,15592,A,,Intermediate,CHEMBL626483,,,50588,,1,,N,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Canis lupus familiaris,,,1,,BAO_0000218
14225,15592,A,,Intermediate,CHEMBL626484,,,50588,,1,,N,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Canis lupus familiaris,,,1,,BAO_0000218
14226,15592,P,,Autocuration,CHEMBL626485,,,22229,,1,,U,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,,0,,BAO_0000100
14227,15592,P,,Autocuration,CHEMBL626486,,,22229,,1,,U,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,,0,,BAO_0000100
14228,15592,P,,Autocuration,CHEMBL626487,,,22229,,1,,U,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,,0,,BAO_0000100
14229,15592,A,,Intermediate,CHEMBL626488,In vivo,1969.0,50588,,1,,N,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,,Plasma,1,,BAO_0000218
14230,7095,A,,Intermediate,CHEMBL626489,,1977.0,50597,,1,,N,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Rattus norvegicus,,Serum,1,,BAO_0000218
14231,16618,A,,Autocuration,CHEMBL626490,,,22224,,1,,U,Area under the MAP curve measured over 5 min; ND means Not determined,,,,0,,BAO_0000019
14232,16835,P,,Autocuration,CHEMBL626491,,,22224,,1,,U,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,,0,,BAO_0000100
14233,15284,P,,Autocuration,CHEMBL626492,,,22229,,1,,U,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,,0,,BAO_0000100
14234,15750,A,,Autocuration,CHEMBL626493,,,22224,,1,,U,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,,0,,BAO_0000019
14235,16618,A,,Intermediate,CHEMBL626494,In vivo,,50597,,1,,N,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,,,1,,BAO_0000218
14236,16618,A,,Autocuration,CHEMBL626495,In vivo,,22224,,1,,U,Half life after oral tested,,,,0,,BAO_0000218
14237,15812,A,,Intermediate,CHEMBL626496,,1969.0,50597,,1,,N,Half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,,Plasma,1,,BAO_0000218
14238,16618,A,,Intermediate,CHEMBL626497,In vivo,,50597,,1,,N,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,,,1,,BAO_0000218
14239,16618,A,,Autocuration,CHEMBL626498,In vivo,,22224,,1,,U,Oral bioavailability after oral tested,,,,0,,BAO_0000218
14240,13098,A,,Intermediate,CHEMBL626499,,,50597,,1,,N,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Rattus norvegicus,,,1,,BAO_0000218
14241,13098,A,,Intermediate,CHEMBL626500,,,50597,,1,,N,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Rattus norvegicus,,,1,,BAO_0000218
14242,15812,A,,Intermediate,CHEMBL626501,,1969.0,50597,,1,,N,half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,,Plasma,1,,BAO_0000218
14243,15812,A,,Intermediate,CHEMBL626502,,1969.0,50597,,1,,N,half life was determined in plasma of rat; NT means not tested,Rattus norvegicus,,Plasma,1,,BAO_0000218
14244,11510,A,,Intermediate,CHEMBL626503,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Rattus norvegicus,,,1,,BAO_0000218
14245,11510,A,,Intermediate,CHEMBL626504,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Rattus norvegicus,,,1,,BAO_0000218
14246,11510,A,,Intermediate,CHEMBL626505,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Rattus norvegicus,,,1,,BAO_0000218
14247,11510,A,,Intermediate,CHEMBL626506,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Rattus norvegicus,,,1,,BAO_0000218
14248,11510,A,,Intermediate,CHEMBL626507,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Rattus norvegicus,,,1,,BAO_0000218
14249,11510,A,,Intermediate,CHEMBL626508,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Rattus norvegicus,,,1,,BAO_0000218
14250,11510,A,,Intermediate,CHEMBL626509,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Rattus norvegicus,,,1,,BAO_0000218
14251,11510,A,,Intermediate,CHEMBL875480,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Rattus norvegicus,,,1,,BAO_0000218
14252,11510,A,,Intermediate,CHEMBL626510,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Rattus norvegicus,,,1,,BAO_0000218
14253,11510,A,,Intermediate,CHEMBL626511,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Rattus norvegicus,,,1,,BAO_0000218
14254,11510,A,,Intermediate,CHEMBL626512,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Rattus norvegicus,,,1,,BAO_0000218
14255,11510,A,,Intermediate,CHEMBL628208,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Rattus norvegicus,,,1,,BAO_0000218
14256,11510,A,,Intermediate,CHEMBL628209,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Rattus norvegicus,,,1,,BAO_0000218
14257,11510,A,,Intermediate,CHEMBL628210,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Rattus norvegicus,,,1,,BAO_0000218
14258,11510,A,,Intermediate,CHEMBL628211,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Rattus norvegicus,,,1,,BAO_0000218
14259,11510,A,,Intermediate,CHEMBL628212,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Rattus norvegicus,,,1,,BAO_0000218
14260,11510,A,,Intermediate,CHEMBL628213,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Rattus norvegicus,,,1,,BAO_0000218
14261,12582,A,,Intermediate,CHEMBL628214,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14262,12582,A,,Intermediate,CHEMBL628215,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14263,12582,A,,Intermediate,CHEMBL628216,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14264,12582,A,,Intermediate,CHEMBL626595,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14265,12582,A,,Intermediate,CHEMBL626596,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14266,12582,A,,Intermediate,CHEMBL626597,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14267,12582,A,,Intermediate,CHEMBL626598,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14268,12582,A,,Intermediate,CHEMBL622242,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14269,12582,A,,Intermediate,CHEMBL622243,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14270,12582,A,,Intermediate,CHEMBL622244,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14271,12582,A,,Intermediate,CHEMBL622245,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14272,12582,A,,Intermediate,CHEMBL622246,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14273,12582,A,,Intermediate,CHEMBL622247,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14274,12582,A,,Intermediate,CHEMBL622248,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14275,12582,A,,Intermediate,CHEMBL877483,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14276,12582,A,,Intermediate,CHEMBL622249,,1088.0,50597,,1,,N,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14277,12582,A,,Intermediate,CHEMBL622250,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14278,12582,A,,Intermediate,CHEMBL622251,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14279,12582,A,,Intermediate,CHEMBL622252,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14280,12582,A,,Intermediate,CHEMBL622253,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14281,12582,A,,Intermediate,CHEMBL622254,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14282,12582,A,,Intermediate,CHEMBL622255,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14283,12582,A,,Intermediate,CHEMBL622256,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14284,12582,A,,Intermediate,CHEMBL622257,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14285,12582,A,,Intermediate,CHEMBL622258,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14286,12582,A,,Intermediate,CHEMBL622259,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14287,12582,A,,Intermediate,CHEMBL622927,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14288,12582,A,,Intermediate,CHEMBL622928,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14289,12582,A,,Intermediate,CHEMBL622929,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14290,12582,A,,Intermediate,CHEMBL623182,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14291,12582,A,,Intermediate,CHEMBL623183,,1088.0,50588,,1,,N,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14292,12582,A,,Intermediate,CHEMBL623184,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14293,12582,A,,Intermediate,CHEMBL623185,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14294,12582,A,,Intermediate,CHEMBL877484,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14295,12582,A,,Intermediate,CHEMBL627274,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14296,12582,A,,Intermediate,CHEMBL623186,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14297,12582,A,,Intermediate,CHEMBL623187,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14298,12582,A,,Intermediate,CHEMBL623188,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14299,12582,A,,Intermediate,CHEMBL628055,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14300,12582,A,,Intermediate,CHEMBL628056,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14301,12582,A,,Intermediate,CHEMBL628200,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14302,12582,A,,Intermediate,CHEMBL628201,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14303,12582,A,,Intermediate,CHEMBL628202,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14304,12582,A,,Intermediate,CHEMBL628203,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14305,12582,A,,Intermediate,CHEMBL628204,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14306,12582,A,,Intermediate,CHEMBL628205,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14307,12582,A,,Intermediate,CHEMBL628206,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14308,13257,A,,Autocuration,CHEMBL628207,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,Prostate gland,0,,BAO_0000218
14309,13257,A,,Autocuration,CHEMBL627220,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,Prostate gland,0,,BAO_0000218
14310,13257,A,,Autocuration,CHEMBL627221,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,Muscle tissue,0,,BAO_0000218
14311,13257,A,,Autocuration,CHEMBL627222,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,Prostate gland,0,,BAO_0000218
14312,13257,A,,Autocuration,CHEMBL627223,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,,0,,BAO_0000218
14313,13257,A,,Autocuration,CHEMBL632062,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,Muscle tissue,0,,BAO_0000218
14314,13257,A,,Autocuration,CHEMBL632063,In vivo,2106.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,Spleen,0,,BAO_0000218
14315,13257,A,,Autocuration,CHEMBL632064,In vivo,1255.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,Urinary bladder,0,,BAO_0000218
14316,13257,A,,Autocuration,CHEMBL632065,In vivo,178.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,Blood,0,,BAO_0000218
14317,13257,A,,Autocuration,CHEMBL632066,In vivo,1474.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,Bone element,0,,BAO_0000218
14318,13257,A,,Autocuration,CHEMBL632067,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,,0,,BAO_0000218
14319,13257,A,,Autocuration,CHEMBL629188,In vivo,2113.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,Kidney,0,,BAO_0000218
14320,13257,A,,Autocuration,CHEMBL629189,In vivo,2107.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,Liver,0,,BAO_0000218
14321,13257,A,,Autocuration,CHEMBL629190,In vivo,2048.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,Lung,0,,BAO_0000218
14322,13257,A,,Autocuration,CHEMBL629191,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,Muscle tissue,0,,BAO_0000218
14323,13257,A,,Autocuration,CHEMBL629192,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,Prostate gland,0,,BAO_0000218
14324,13257,A,,Autocuration,CHEMBL629193,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,Muscle tissue,0,,BAO_0000218
14325,13257,A,,Autocuration,CHEMBL629194,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,Prostate gland,0,,BAO_0000218
14326,13257,A,,Autocuration,CHEMBL629195,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,,0,,BAO_0000218
14327,13257,A,,Autocuration,CHEMBL629373,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,Muscle tissue,0,,BAO_0000218
14328,13257,A,,Autocuration,CHEMBL629374,In vivo,2106.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,Spleen,0,,BAO_0000218
14329,13257,A,,Autocuration,CHEMBL629375,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,Prostate gland,0,,BAO_0000218
14330,13257,A,,Autocuration,CHEMBL629376,In vivo,1255.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,Urinary bladder,0,,BAO_0000218
14331,13257,A,,Autocuration,CHEMBL629377,In vivo,178.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,Blood,0,,BAO_0000218
14332,13257,A,,Autocuration,CHEMBL629378,In vivo,1474.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,Bone element,0,,BAO_0000218
14333,13257,A,,Autocuration,CHEMBL629379,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,,0,,BAO_0000218
14334,13257,A,,Autocuration,CHEMBL629151,In vivo,2113.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,Kidney,0,,BAO_0000218
14335,13257,A,,Autocuration,CHEMBL629152,In vivo,2107.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,Liver,0,,BAO_0000218
14336,13257,A,,Autocuration,CHEMBL629153,In vivo,2048.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,Lung,0,,BAO_0000218
14337,13257,A,,Autocuration,CHEMBL629154,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,Muscle tissue,0,,BAO_0000218
14338,13257,A,,Autocuration,CHEMBL629155,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,Prostate gland,0,,BAO_0000218
14339,13257,A,,Autocuration,CHEMBL629156,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,Prostate gland,0,,BAO_0000218
14340,13257,A,,Autocuration,CHEMBL629157,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,Muscle tissue,0,,BAO_0000218
14341,13257,A,,Autocuration,CHEMBL629158,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,Prostate gland,0,,BAO_0000218
14342,13257,A,,Autocuration,CHEMBL629159,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,,0,,BAO_0000218
14343,13257,A,,Autocuration,CHEMBL629160,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,Muscle tissue,0,,BAO_0000218
14344,13257,A,,Autocuration,CHEMBL629161,In vivo,2106.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,Spleen,0,,BAO_0000218
14345,13257,A,,Autocuration,CHEMBL629162,In vivo,1255.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,Urinary bladder,0,,BAO_0000218
14346,13257,A,,Autocuration,CHEMBL629163,In vivo,178.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,Blood,0,,BAO_0000218
14347,13257,A,,Autocuration,CHEMBL629164,In vivo,1474.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,Bone element,0,,BAO_0000218
14348,13257,A,,Autocuration,CHEMBL629165,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,,0,,BAO_0000218
14349,13257,A,,Autocuration,CHEMBL629166,In vivo,2107.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,Liver,0,,BAO_0000218
14350,13257,A,,Autocuration,CHEMBL629167,In vivo,2048.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,Lung,0,,BAO_0000218
14351,13257,A,,Autocuration,CHEMBL629168,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,Muscle tissue,0,,BAO_0000218
14352,2193,A,,Autocuration,CHEMBL629169,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,,0,,BAO_0000019
14353,2193,A,,Autocuration,CHEMBL629170,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,,0,,BAO_0000019
14354,2193,A,,Autocuration,CHEMBL631153,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,,0,,BAO_0000019
14355,2193,A,,Autocuration,CHEMBL875121,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,,0,,BAO_0000019
14356,2193,A,,Autocuration,CHEMBL631154,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,,0,,BAO_0000019
14357,2193,A,,Autocuration,CHEMBL631155,,,22224,,1,,U,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,,0,,BAO_0000019
14358,568,A,,Autocuration,CHEMBL631156,,,22224,,1,,U,Hydrolysis rate constant was determined,,,,0,,BAO_0000019
14359,9680,A,,Autocuration,CHEMBL631157,,,22224,,1,,U,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,,0,,BAO_0000019
14360,9680,A,,Autocuration,CHEMBL631158,,,22224,,1,,U,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,0,,BAO_0000019
14361,9680,A,,Autocuration,CHEMBL631159,,,22224,,1,,U,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,0,,BAO_0000019
14362,10026,A,,Autocuration,CHEMBL631160,,,22224,,1,,U,Observed second order rate constant,,,,0,,BAO_0000019
14363,10281,A,,Autocuration,CHEMBL631161,,,22224,,1,,U,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,0,,BAO_0000019
14364,10014,A,,Autocuration,CHEMBL631162,,,22224,,1,,U,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,0,,BAO_0000019
14365,10014,A,,Autocuration,CHEMBL630313,,,22224,,1,,U,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,0,,BAO_0000019
14366,9680,A,,Autocuration,CHEMBL630314,,,22224,,1,,U,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,0,,BAO_0000019
14367,9680,A,,Autocuration,CHEMBL630315,,,22224,,1,,U,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,0,,BAO_0000019
14368,13028,A,,Autocuration,CHEMBL630316,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14369,13028,A,,Autocuration,CHEMBL630986,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14370,13028,A,,Autocuration,CHEMBL630987,,,22224,,1,,U,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14371,13028,A,,Autocuration,CHEMBL630988,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14372,13028,A,,Autocuration,CHEMBL630989,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14373,13028,A,,Autocuration,CHEMBL630990,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14374,13028,A,,Autocuration,CHEMBL630991,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14375,13028,A,,Autocuration,CHEMBL630992,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14376,13028,A,,Autocuration,CHEMBL630993,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14377,13028,A,,Autocuration,CHEMBL630994,,,22224,,1,,U,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,0,,BAO_0000019
14378,10014,A,,Intermediate,CHEMBL630995,,,50597,,1,,N,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Rattus norvegicus,,,1,,BAO_0000218
14379,9962,A,,Autocuration,CHEMBL629252,,,22224,,1,,U,Association constant for compound at 31 degree C was determined,,,,0,,BAO_0000019
14380,12029,A,,Autocuration,CHEMBL629253,,,22224,,1,,U,Calculated antagonist equilibrium dissociation constant of the compound,,,,0,,BAO_0000019
14381,12029,A,,Autocuration,CHEMBL629944,,,22224,,1,,U,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,,0,,BAO_0000019
14382,10583,A,,Intermediate,CHEMBL629945,,3126.0,50512,,1,,N,Dissociation constants vs LTE4 on guinea pig trachea,Cavia porcellus,,Trachea,1,,BAO_0000218
14383,568,A,,Autocuration,CHEMBL629946,,,22224,,1,,U,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,,0,,BAO_0000019
14384,568,A,,Autocuration,CHEMBL629947,,,22224,,1,,U,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,,0,,BAO_0000019
14385,568,A,,Autocuration,CHEMBL629948,,,22224,,1,,U,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,,0,,BAO_0000019
14386,568,A,,Autocuration,CHEMBL856024,,,22224,,1,,U,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,,0,,BAO_0000019
14387,7493,A,,Autocuration,CHEMBL629949,,,22224,,1,,U,Affinity constant KD value was derived from TMP,,,,0,,BAO_0000019
14388,8371,A,,Autocuration,CHEMBL629950,,,22224,,1,,U,Apparent dissociation (binding) rate constant was evaluated,,,,0,,BAO_0000019
14389,13114,P,,Autocuration,CHEMBL630127,,,22224,,1,,U,Dissociation constant (KD) of the compound,,,,0,,BAO_0000100
14390,15515,P,,Autocuration,CHEMBL630128,,,22224,,1,,U,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,,0,,BAO_0000100
14391,522,P,,Autocuration,CHEMBL630129,,,22224,,1,,U,Dissociation constant from ESR titration experiments,,,,0,,BAO_0000100
14392,13888,,,Autocuration,CHEMBL630130,,,22224,,1,,U,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,0,,BAO_0000019
14393,2616,P,,Autocuration,CHEMBL875234,,,22224,,1,,U,Dissociation constant was evaluated.,,,,0,,BAO_0000100
14394,3798,P,,Autocuration,CHEMBL630131,,,22224,,1,,U,Dissociation constant was reported,,,,0,,BAO_0000100
14395,8731,A,,Intermediate,CHEMBL630132,,,50597,,1,,N,Dissociation constant was determined in rat pituitary cells.,Rattus norvegicus,,,1,,BAO_0000218
14396,11892,A,,Autocuration,CHEMBL630133,,,22224,,1,,U,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,,0,,BAO_0000019
14397,11892,A,,Autocuration,CHEMBL630134,,,22224,,1,,U,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,,0,,BAO_0000019
14398,2582,A,,Autocuration,CHEMBL630135,,,22224,,1,,U,Equilibrium dissociation constant of the compound,,,,0,,BAO_0000019
14399,11892,A,,Autocuration,CHEMBL630136,,,22224,,1,,U,Equilibrium dissociation constant was determined,,,,0,,BAO_0000019
14400,13396,A,,Autocuration,CHEMBL630137,,,22224,,1,,U,Kinetic constant KD was evaluated,,,,0,,BAO_0000019
14401,603,A,,Autocuration,CHEMBL630138,,,22224,,1,,U,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,,0,,BAO_0000019
14402,15673,A,,Autocuration,CHEMBL630139,,,22224,,1,,U,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,,0,,BAO_0000019
14403,10368,A,,Autocuration,CHEMBL630140,,,22224,,1,,U,Rate constant for hydrolysis in aqueous acetone.,,,,0,,BAO_0000019
14404,14228,A,,Autocuration,CHEMBL875235,,,22224,,1,,U,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,,0,,BAO_0000019
14405,11510,A,,Intermediate,CHEMBL876439,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Rattus norvegicus,,,1,,BAO_0000218
14406,11510,A,,Intermediate,CHEMBL630605,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Rattus norvegicus,,,1,,BAO_0000218
14407,11510,A,,Intermediate,CHEMBL630606,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Rattus norvegicus,,,1,,BAO_0000218
14408,11510,A,,Intermediate,CHEMBL630607,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Rattus norvegicus,,,1,,BAO_0000218
14409,11510,A,,Intermediate,CHEMBL630608,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Rattus norvegicus,,,1,,BAO_0000218
14410,11510,A,,Intermediate,CHEMBL630609,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Rattus norvegicus,,,1,,BAO_0000218
14411,11510,A,,Intermediate,CHEMBL630610,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Rattus norvegicus,,,1,,BAO_0000218
14412,11510,A,,Intermediate,CHEMBL630611,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Rattus norvegicus,,,1,,BAO_0000218
14413,11510,A,,Intermediate,CHEMBL629552,,,50597,,1,,N,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Rattus norvegicus,,,1,,BAO_0000218
14414,11510,A,,Intermediate,CHEMBL629733,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14415,11510,A,,Intermediate,CHEMBL629734,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14416,11510,A,,Intermediate,CHEMBL629735,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14417,11510,A,,Intermediate,CHEMBL629736,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14418,11510,A,,Intermediate,CHEMBL629737,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14419,11510,A,,Intermediate,CHEMBL629738,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14420,11510,A,,Intermediate,CHEMBL629739,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14421,11510,A,,Intermediate,CHEMBL629740,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,,,1,,BAO_0000218
14422,11510,A,,Intermediate,CHEMBL629741,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14423,11510,A,,Intermediate,CHEMBL629742,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14424,11510,A,,Intermediate,CHEMBL629743,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14425,11510,A,,Intermediate,CHEMBL629744,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14426,11510,A,,Intermediate,CHEMBL629745,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14427,11510,A,,Intermediate,CHEMBL629746,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14428,11510,A,,Intermediate,CHEMBL629747,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14429,11510,A,,Intermediate,CHEMBL629748,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14430,11510,A,,Intermediate,CHEMBL629749,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14431,11510,A,,Intermediate,CHEMBL629750,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14432,11510,A,,Intermediate,CHEMBL629751,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14433,11510,A,,Intermediate,CHEMBL629752,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14434,11510,A,,Intermediate,CHEMBL629753,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14435,11510,A,,Intermediate,CHEMBL629754,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14436,11510,A,,Intermediate,CHEMBL629755,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14437,11510,A,,Intermediate,CHEMBL629756,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14438,11510,A,,Intermediate,CHEMBL629757,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14439,11510,A,,Intermediate,CHEMBL629758,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14440,11510,A,,Intermediate,CHEMBL629759,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14441,11510,A,,Intermediate,CHEMBL629760,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14442,11510,A,,Intermediate,CHEMBL876443,,,50597,,1,,N,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,,,1,,BAO_0000218
14443,8310,A,,Intermediate,CHEMBL629761,,,50588,,1,,N,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,1,,BAO_0000218
14444,8310,A,,Intermediate,CHEMBL629762,,,50588,,1,,N,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,1,,BAO_0000218
14445,8310,A,,Intermediate,CHEMBL629763,,,50594,,1,,N,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14446,8310,A,,Intermediate,CHEMBL629764,,,50594,,1,,N,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14447,8310,A,,Intermediate,CHEMBL629765,,,50594,,1,,N,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14448,8310,A,,Intermediate,CHEMBL629766,,,50594,,1,,N,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14449,8310,A,,Intermediate,CHEMBL629767,,,50594,,1,,N,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14450,8310,A,,Intermediate,CHEMBL629768,,,50588,,1,,N,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,1,,BAO_0000218
14451,8310,A,,Intermediate,CHEMBL629769,,,50594,,1,,N,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14452,8310,A,,Intermediate,CHEMBL629770,,,50588,,1,,N,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,,,1,,BAO_0000218
14453,8310,A,,Intermediate,CHEMBL629771,,,50588,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Canis lupus familiaris,,,1,,BAO_0000218
14454,8310,A,,Intermediate,CHEMBL629772,,,50594,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14455,8310,A,,Intermediate,CHEMBL629773,,,50594,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14456,8310,A,,Intermediate,CHEMBL625455,,,50594,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14457,8310,A,,Intermediate,CHEMBL625456,,,50594,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14458,8310,A,,Intermediate,CHEMBL625457,,,50594,,1,,N,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Mus musculus,,,1,,BAO_0000218
14459,12582,A,,Intermediate,CHEMBL625458,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14460,12582,A,,Intermediate,CHEMBL625459,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14461,12582,A,,Intermediate,CHEMBL875483,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14462,12582,A,,Intermediate,CHEMBL634779,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14463,12582,A,,Intermediate,CHEMBL625460,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14464,12582,A,,Intermediate,CHEMBL626117,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14465,12582,A,,Intermediate,CHEMBL626118,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14466,12582,A,,Intermediate,CHEMBL628342,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14467,12582,A,,Intermediate,CHEMBL628343,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14468,12582,A,,Intermediate,CHEMBL628344,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14469,12582,A,,Intermediate,CHEMBL628345,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14470,12582,A,,Intermediate,CHEMBL628346,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14471,12582,A,,Intermediate,CHEMBL628347,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14472,12582,A,,Intermediate,CHEMBL628348,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14473,12582,A,,Intermediate,CHEMBL628349,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14474,12582,A,,Intermediate,CHEMBL875611,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14475,12582,A,,Intermediate,CHEMBL628350,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14476,12582,A,,Intermediate,CHEMBL628351,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14477,12582,A,,Intermediate,CHEMBL628352,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14478,12582,A,,Intermediate,CHEMBL628353,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14479,12582,A,,Intermediate,CHEMBL628354,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14480,12582,A,,Intermediate,CHEMBL626667,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14481,12582,A,,Intermediate,CHEMBL626668,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14482,12582,A,,Intermediate,CHEMBL626669,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14483,12582,A,,Intermediate,CHEMBL626670,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14484,12582,A,,Intermediate,CHEMBL626671,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14485,12582,A,,Intermediate,CHEMBL626672,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14486,12582,A,,Intermediate,CHEMBL626673,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14487,12582,A,,Intermediate,CHEMBL626674,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14488,12582,A,,Intermediate,CHEMBL626675,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14489,12582,A,,Intermediate,CHEMBL626676,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14490,12582,A,,Intermediate,CHEMBL626677,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14491,12582,A,,Intermediate,CHEMBL626678,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14492,12582,A,,Intermediate,CHEMBL626679,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14493,12582,A,,Intermediate,CHEMBL875612,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14494,12582,A,,Intermediate,CHEMBL626680,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14495,12582,A,,Intermediate,CHEMBL626681,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14496,12582,A,,Intermediate,CHEMBL626682,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14497,12582,A,,Intermediate,CHEMBL626683,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14498,12582,A,,Intermediate,CHEMBL626684,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14499,12582,A,,Intermediate,CHEMBL626685,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14500,12582,A,,Intermediate,CHEMBL626686,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14501,12582,A,,Intermediate,CHEMBL626687,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14502,12582,A,,Intermediate,CHEMBL624978,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14503,12582,A,,Intermediate,CHEMBL624979,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14504,12582,A,,Intermediate,CHEMBL624980,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14505,12582,A,,Intermediate,CHEMBL624981,,1088.0,50597,,1,,N,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14506,12582,A,,Intermediate,CHEMBL624982,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14507,13257,A,,Autocuration,CHEMBL627564,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,Prostate gland,0,,BAO_0000218
14508,13257,A,,Autocuration,CHEMBL627565,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,Prostate gland,0,,BAO_0000218
14509,13257,A,,Autocuration,CHEMBL627566,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,,0,,BAO_0000218
14510,13257,A,,Autocuration,CHEMBL627567,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,Muscle tissue,0,,BAO_0000218
14511,13257,A,,Autocuration,CHEMBL627568,In vivo,2106.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,Spleen,0,,BAO_0000218
14512,13257,A,,Autocuration,CHEMBL627569,In vivo,2113.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,Kidney,0,,BAO_0000218
14513,13257,A,,Autocuration,CHEMBL627570,In vivo,1255.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,Urinary bladder,0,,BAO_0000218
14514,13257,A,,Autocuration,CHEMBL627571,In vivo,178.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,Blood,0,,BAO_0000218
14515,13257,A,,Autocuration,CHEMBL627572,In vivo,1474.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,Bone element,0,,BAO_0000218
14516,13257,A,,Autocuration,CHEMBL627573,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,,0,,BAO_0000218
14517,13257,A,,Autocuration,CHEMBL627574,In vivo,2113.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,Kidney,0,,BAO_0000218
14518,13257,A,,Autocuration,CHEMBL627575,In vivo,2107.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,Liver,0,,BAO_0000218
14519,13257,A,,Autocuration,CHEMBL627576,In vivo,2048.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,Lung,0,,BAO_0000218
14520,13257,A,,Autocuration,CHEMBL627577,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,Muscle tissue,0,,BAO_0000218
14521,13257,A,,Autocuration,CHEMBL627578,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,Prostate gland,0,,BAO_0000218
14522,13257,A,,Autocuration,CHEMBL627579,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,Prostate gland,0,,BAO_0000218
14523,13257,A,,Autocuration,CHEMBL627580,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,Muscle tissue,0,,BAO_0000218
14524,13257,A,,Autocuration,CHEMBL627581,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,Prostate gland,0,,BAO_0000218
14525,13257,A,,Autocuration,CHEMBL627582,In vivo,,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,,0,,BAO_0000218
14526,13257,A,,Autocuration,CHEMBL627583,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,Muscle tissue,0,,BAO_0000218
14527,13257,A,,Autocuration,CHEMBL627584,In vivo,2106.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,Spleen,0,,BAO_0000218
14528,13257,A,,Autocuration,CHEMBL627585,In vivo,2367.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,Prostate gland,0,,BAO_0000218
14529,13257,A,,Autocuration,CHEMBL627586,In vivo,2385.0,22224,,1,,U,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,Muscle tissue,0,,BAO_0000218
14530,15413,A,,Intermediate,CHEMBL627587,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14531,15413,A,,Intermediate,CHEMBL627588,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14532,15413,A,,Intermediate,CHEMBL628250,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14533,15413,A,,Intermediate,CHEMBL628251,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14534,15413,A,,Intermediate,CHEMBL628252,In vivo,10000000.0,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14535,15413,A,,Intermediate,CHEMBL628253,In vivo,10000000.0,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14536,15413,A,,Intermediate,CHEMBL628254,In vivo,1898.0,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14537,15413,A,,Intermediate,CHEMBL877493,In vivo,1898.0,50597,,1,,N,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14538,15413,A,,Intermediate,CHEMBL628255,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14539,15413,A,,Intermediate,CHEMBL628256,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14540,15413,A,,Intermediate,CHEMBL628257,In vivo,10000000.0,50597,,1,,N,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14541,15413,A,,Intermediate,CHEMBL628258,In vivo,1898.0,50597,,1,,N,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14542,15413,A,,Intermediate,CHEMBL628259,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14543,15413,A,,Intermediate,CHEMBL628429,In vivo,,50597,,1,,N,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,,1,,BAO_0000218
14544,15413,A,,Intermediate,CHEMBL626862,In vivo,10000000.0,50597,,1,,N,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14545,15413,A,,Intermediate,CHEMBL626863,In vivo,1898.0,50597,,1,,N,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14546,15413,A,,Intermediate,CHEMBL625886,In vivo,2037.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
14547,15413,A,,Intermediate,CHEMBL625887,In vivo,2037.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
14548,15413,A,,Intermediate,CHEMBL625888,In vivo,,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Rattus norvegicus,,,1,,BAO_0000218
14549,15413,A,,Intermediate,CHEMBL625889,In vivo,,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,,1,,BAO_0000218
14550,15413,A,,Intermediate,CHEMBL625890,In vivo,10000000.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14551,15413,A,,Intermediate,CHEMBL625891,In vivo,10000000.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14552,15413,A,,Intermediate,CHEMBL625892,In vivo,1898.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14553,15413,A,,Intermediate,CHEMBL625893,In vivo,1898.0,50597,,1,,N,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14554,15413,A,,Intermediate,CHEMBL625894,In vivo,2037.0,50597,,1,,N,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Rattus norvegicus,,Cerebellum,1,,BAO_0000218
14555,15413,A,,Intermediate,CHEMBL625895,In vivo,,50597,,1,,N,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Rattus norvegicus,,,1,,BAO_0000218
14556,12404,A,,Autocuration,CHEMBL625896,,,22224,,1,,U,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,0,,BAO_0000019
14557,568,A,,Autocuration,CHEMBL625897,,,22224,,1,,U,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,,0,,BAO_0000019
14558,568,A,,Autocuration,CHEMBL625898,,,22224,,1,,U,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,0,,BAO_0000019
14559,568,A,,Autocuration,CHEMBL625899,,,22224,,1,,U,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,0,,BAO_0000019
14560,12404,A,,Autocuration,CHEMBL626124,,,22224,,1,,U,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,0,,BAO_0000019
14561,7624,A,,Intermediate,CHEMBL628500,,,50212,,1,,N,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Escherichia coli,,,1,,BAO_0000218
14562,7624,A,,Intermediate,CHEMBL857856,,,50597,,1,,N,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Rattus norvegicus,,,1,,BAO_0000218
14563,7624,A,,Intermediate,CHEMBL628501,,,50597,,1,,N,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Rattus norvegicus,,,1,,BAO_0000218
14564,4643,A,,Autocuration,CHEMBL628502,,,22224,,1,,U,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,,0,,BAO_0000019
14565,11532,A,,Autocuration,CHEMBL628503,,,22224,,1,,U,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,,0,,BAO_0000019
14566,11018,A,,Autocuration,CHEMBL628504,,,22224,,1,,U,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,,0,,BAO_0000019
14567,2276,A,,Autocuration,CHEMBL628505,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,0,,BAO_0000019
14568,2276,A,,Autocuration,CHEMBL874452,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,,0,,BAO_0000019
14569,2276,A,,Autocuration,CHEMBL628506,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,,0,,BAO_0000019
14570,2276,A,,Autocuration,CHEMBL628507,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,0,,BAO_0000019
14571,2276,A,,Autocuration,CHEMBL628508,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,,0,,BAO_0000019
14572,8949,A,,Autocuration,CHEMBL628509,,,22224,,1,,U,Michaelis constant (KM) was evaluated,,,,0,,BAO_0000019
14573,12404,A,,Autocuration,CHEMBL628510,,,22224,,1,,U,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,0,,BAO_0000019
14574,7625,B,,Autocuration,CHEMBL628511,,,22224,,1,,U,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,,0,,BAO_0000019
14575,7625,B,,Autocuration,CHEMBL628512,,,22224,,1,,U,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,,0,,BAO_0000019
14576,7625,B,,Autocuration,CHEMBL628513,,,22224,,1,,U,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,,0,,BAO_0000019
14577,7625,B,,Autocuration,CHEMBL628514,,,22224,,1,,U,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,,0,,BAO_0000019
14578,12908,A,,Autocuration,CHEMBL628515,,,22224,,1,,U,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,,0,,BAO_0000019
14579,10368,A,,Autocuration,CHEMBL628516,,,22224,,1,,U,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,,0,,BAO_0000019
14580,13108,A,,Autocuration,CHEMBL628517,,,22224,,1,,U,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,0,,BAO_0000019
14581,13108,A,,Autocuration,CHEMBL628518,,,22224,,1,,U,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,0,,BAO_0000019
14582,15217,A,,Autocuration,CHEMBL628519,,,22224,,1,,U,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,,0,,BAO_0000019
14583,15217,A,,Autocuration,CHEMBL628520,,,22224,,1,,U,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,,0,,BAO_0000019
14584,10933,A,,Autocuration,CHEMBL628521,,,22224,,1,,U,Binding constant was determined,,,,0,,BAO_0000019
14585,2363,A,,Autocuration,CHEMBL630443,,,22224,,1,,U,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,,0,,BAO_0000019
14586,2363,A,,Autocuration,CHEMBL630444,,,22224,,1,,U,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,,0,,BAO_0000019
14587,2276,A,,Autocuration,CHEMBL857732,,,22224,,1,,U,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,,0,,BAO_0000019
14588,14915,P,,Autocuration,CHEMBL630445,,,22224,,1,,U,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,,0,,BAO_0000100
14589,8847,A,,Autocuration,CHEMBL630446,,,22224,,1,,U,Catalytic rate constant of the compound,,,,0,,BAO_0000019
14590,15357,B,,Autocuration,CHEMBL630447,,,22224,,1,,U,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,,0,,BAO_0000019
14591,2869,A,,Autocuration,CHEMBL630448,,,22224,,1,,U,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,,0,,BAO_0000019
14592,3484,A,,Autocuration,CHEMBL630449,,,22224,,1,,U,Catalytic rate constant against phospholipase A2 was determined,,,,0,,BAO_0000019
14593,1373,A,,Autocuration,CHEMBL630450,,,22224,,1,,U,"Compound was evaluated for catalytic constant, Kcat",,,,0,,BAO_0000019
14594,8142,A,,Autocuration,CHEMBL630451,,,22224,,1,,U,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,,0,,BAO_0000019
14595,14131,A,,Autocuration,CHEMBL630452,,,22224,,1,,U,Kcat calculated from 0.693/T1/2,,,,0,,BAO_0000019
14596,17269,A,,Autocuration,CHEMBL630453,,,22224,,1,,U,Kcat was determined,,,,0,,BAO_0000019
14597,3485,A,,Autocuration,CHEMBL630454,,,22224,,1,,U,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,,0,,BAO_0000019
14598,3485,A,,Autocuration,CHEMBL630455,,,22224,,1,,U,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,,0,,BAO_0000019
14599,3485,A,,Autocuration,CHEMBL631487,,,22224,,1,,U,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,,0,,BAO_0000019
14600,5962,A,,Autocuration,CHEMBL631488,,,22224,,1,,U,Kcat value was determined,,,,0,,BAO_0000019
14601,3133,A,,Autocuration,CHEMBL876440,,,22224,,1,,U,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,,0,,BAO_0000019
14602,3133,A,,Autocuration,CHEMBL631489,,,22224,,1,,U,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,,0,,BAO_0000019
14603,2276,A,,Autocuration,CHEMBL857742,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,0,,BAO_0000019
14604,2276,A,,Autocuration,CHEMBL631490,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,0,,BAO_0000019
14605,2276,A,,Autocuration,CHEMBL631491,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,,0,,BAO_0000019
14606,2276,A,,Autocuration,CHEMBL631492,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,0,,BAO_0000019
14607,2276,A,,Autocuration,CHEMBL631493,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,0,,BAO_0000019
14608,4892,A,,Autocuration,CHEMBL631494,,,22224,,1,,U,Kinetic parameter for rate of conversion to PABA was determined,,,,0,,BAO_0000019
14609,3133,A,,Autocuration,CHEMBL631495,,,22224,,1,,U,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,0,,BAO_0000019
14610,11488,A,,Intermediate,CHEMBL631496,,1988.0,50597,,1,,N,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,,Feces,1,,BAO_0000218
14611,11488,A,,Intermediate,CHEMBL631497,,1088.0,50597,,1,,N,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,Urine,1,,BAO_0000218
14612,11488,A,,Intermediate,CHEMBL631498,,1088.0,50597,,1,,N,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,Urine,1,,BAO_0000218
14613,11488,A,,Intermediate,CHEMBL629776,,1088.0,50597,,1,,N,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,,Urine,1,,BAO_0000218
14614,11488,A,,Intermediate,CHEMBL629777,,1088.0,50597,,1,,N,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,,Urine,1,,BAO_0000218
14615,11488,A,,Intermediate,CHEMBL629778,,1088.0,50597,,1,,N,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,,Urine,1,,BAO_0000218
14616,11488,A,,Intermediate,CHEMBL630456,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14617,11488,A,,Intermediate,CHEMBL630457,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14618,11488,A,,Intermediate,CHEMBL630458,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14619,11488,A,,Intermediate,CHEMBL630459,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14620,11488,A,,Intermediate,CHEMBL630460,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14621,11488,A,,Intermediate,CHEMBL876550,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14622,11488,A,,Intermediate,CHEMBL630461,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14623,11488,A,,Intermediate,CHEMBL630462,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14624,11488,A,,Intermediate,CHEMBL630463,,,50597,,1,,N,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14625,11488,A,,Intermediate,CHEMBL630464,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14626,11488,A,,Intermediate,CHEMBL630465,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14627,11488,A,,Intermediate,CHEMBL630466,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14628,11488,A,,Intermediate,CHEMBL630467,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14629,11488,A,,Intermediate,CHEMBL630633,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14630,11488,A,,Intermediate,CHEMBL630634,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14631,11488,A,,Intermediate,CHEMBL630635,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14632,11488,A,,Intermediate,CHEMBL630636,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14633,11488,A,,Intermediate,CHEMBL630637,,,50597,,1,,N,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Rattus norvegicus,,,1,,BAO_0000218
14634,7132,A,,Intermediate,CHEMBL630638,,1988.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14635,7132,A,,Intermediate,CHEMBL630639,,1988.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14636,7132,A,,Intermediate,CHEMBL630640,,1988.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14637,7132,A,,Intermediate,CHEMBL876551,,1988.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14638,7132,A,,Intermediate,CHEMBL630641,,1088.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14639,7132,A,,Intermediate,CHEMBL630642,,1088.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14640,7132,A,,Intermediate,CHEMBL630643,,1088.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14641,7132,A,,Intermediate,CHEMBL630644,,1088.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14642,7132,A,,Intermediate,CHEMBL630645,,1088.0,50592,,1,,N,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14643,7132,A,,Intermediate,CHEMBL625599,,1988.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14644,7132,A,,Intermediate,CHEMBL625600,,1988.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14645,7132,A,,Intermediate,CHEMBL625601,,1988.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14646,7132,A,,Intermediate,CHEMBL625602,,1988.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,,Feces,1,,BAO_0000218
14647,7132,A,,Intermediate,CHEMBL627470,,1088.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14648,7132,A,,Intermediate,CHEMBL627471,,1088.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14649,7132,A,,Intermediate,CHEMBL627472,,1088.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14650,7132,A,,Intermediate,CHEMBL627473,,1088.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14651,7132,A,,Intermediate,CHEMBL627474,,1088.0,50592,,1,,N,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,,Urine,1,,BAO_0000218
14652,13925,A,,Intermediate,CHEMBL627475,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Blood,1,,BAO_0000218
14653,13925,A,,Intermediate,CHEMBL627476,In vivo,178.0,50597,,1,,N,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Blood,1,,BAO_0000218
14654,12582,A,,Intermediate,CHEMBL627477,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14655,12582,A,,Intermediate,CHEMBL627478,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14656,12582,A,,Intermediate,CHEMBL627479,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14657,12582,A,,Intermediate,CHEMBL627480,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14658,12582,A,,Intermediate,CHEMBL627481,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14659,12582,A,,Intermediate,CHEMBL627482,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14660,12582,A,,Intermediate,CHEMBL627483,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14661,12582,A,,Intermediate,CHEMBL875636,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14662,12582,A,,Intermediate,CHEMBL625764,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14663,12582,A,,Intermediate,CHEMBL625765,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14664,12582,A,,Intermediate,CHEMBL625766,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14665,12582,A,,Intermediate,CHEMBL625767,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14666,12582,A,,Intermediate,CHEMBL625768,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14667,12582,A,,Intermediate,CHEMBL625769,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14668,12582,A,,Intermediate,CHEMBL625770,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14669,12582,A,,Intermediate,CHEMBL625771,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14670,12582,A,,Intermediate,CHEMBL625772,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14671,12582,A,,Intermediate,CHEMBL625773,,1088.0,50588,,1,,N,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,,Urine,1,,BAO_0000218
14672,12582,A,,Intermediate,CHEMBL625774,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14673,12582,A,,Intermediate,CHEMBL625775,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14674,12582,A,,Intermediate,CHEMBL625776,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14675,12582,A,,Intermediate,CHEMBL625777,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14676,12582,A,,Intermediate,CHEMBL625778,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14677,12582,A,,Intermediate,CHEMBL625779,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14678,12582,A,,Intermediate,CHEMBL625780,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14679,12582,A,,Intermediate,CHEMBL625781,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14680,12582,A,,Intermediate,CHEMBL875637,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14681,12582,A,,Intermediate,CHEMBL626473,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14682,12582,A,,Intermediate,CHEMBL626474,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14683,12582,A,,Intermediate,CHEMBL626475,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14684,12582,A,,Intermediate,CHEMBL626476,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14685,12582,A,,Intermediate,CHEMBL634397,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14686,12582,A,,Intermediate,CHEMBL626477,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14687,12582,A,,Intermediate,CHEMBL631069,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14688,12582,A,,Intermediate,CHEMBL631070,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14689,12582,A,,Intermediate,CHEMBL631071,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14690,12582,A,,Intermediate,CHEMBL631072,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14691,12582,A,,Intermediate,CHEMBL631073,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14692,12582,A,,Intermediate,CHEMBL631074,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14693,12582,A,,Intermediate,CHEMBL631075,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14694,12582,A,,Intermediate,CHEMBL631725,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14695,12582,A,,Intermediate,CHEMBL631726,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14696,12582,A,,Intermediate,CHEMBL631727,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14697,12582,A,,Intermediate,CHEMBL631728,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14698,12582,A,,Intermediate,CHEMBL631729,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14699,12582,A,,Intermediate,CHEMBL631730,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14700,12582,A,,Intermediate,CHEMBL631731,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14701,12582,A,,Intermediate,CHEMBL631910,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14702,15413,A,,Intermediate,CHEMBL631911,In vivo,10000000.0,50597,,1,,N,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Rattus norvegicus,,Hippocampus,1,,BAO_0000218
14703,15413,A,,Intermediate,CHEMBL631912,In vivo,1898.0,50597,,1,,N,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14704,15413,A,,Intermediate,CHEMBL631913,In vivo,1898.0,50597,,1,,N,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Rattus norvegicus,,Hypothalamus,1,,BAO_0000218
14705,12017,A,,Intermediate,CHEMBL631914,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14706,12017,A,,Intermediate,CHEMBL631915,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14707,12017,A,,Intermediate,CHEMBL875778,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Blood,1,,BAO_0000218
14708,12017,A,,Intermediate,CHEMBL631916,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14709,12017,A,,Intermediate,CHEMBL631917,In vivo,178.0,50597,,1,,N,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14710,12017,A,,Intermediate,CHEMBL631918,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14711,12017,A,,Intermediate,CHEMBL631919,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14712,12017,A,,Intermediate,CHEMBL631920,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Blood,1,,BAO_0000218
14713,12017,A,,Intermediate,CHEMBL631921,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14714,12017,A,,Intermediate,CHEMBL631922,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Blood,1,,BAO_0000218
14715,12017,A,,Intermediate,CHEMBL631923,In vivo,178.0,50597,,1,,N,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Blood,1,,BAO_0000218
14716,12017,A,,Intermediate,CHEMBL631924,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14717,12017,A,,Intermediate,CHEMBL630234,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14718,12017,A,,Intermediate,CHEMBL630235,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,1,,BAO_0000218
14719,12017,A,,Intermediate,CHEMBL630236,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14720,12017,A,,Intermediate,CHEMBL630237,In vivo,,50597,,1,,N,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14721,12017,A,,Intermediate,CHEMBL630238,In vivo,,50597,,1,,N,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14722,12017,A,,Intermediate,CHEMBL630239,In vivo,,50597,,1,,N,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14723,12017,A,,Intermediate,CHEMBL630303,In vivo,,50597,,1,,N,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,,1,,BAO_0000218
14724,12017,A,,Intermediate,CHEMBL630304,In vivo,,50597,,1,,N,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14725,12017,A,,Intermediate,CHEMBL630305,In vivo,,50597,,1,,N,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,,1,,BAO_0000218
14726,12017,A,,Intermediate,CHEMBL630306,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14727,12017,A,,Intermediate,CHEMBL630307,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14728,12017,A,,Intermediate,CHEMBL630308,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Kidney,1,,BAO_0000218
14729,12017,A,,Intermediate,CHEMBL630309,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14730,12017,A,,Intermediate,CHEMBL629309,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14731,12017,A,,Intermediate,CHEMBL629993,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14732,12017,A,,Intermediate,CHEMBL629994,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14733,12017,A,,Intermediate,CHEMBL629995,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Kidney,1,,BAO_0000218
14734,12017,A,,Intermediate,CHEMBL631993,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14735,12017,A,,Intermediate,CHEMBL631994,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14736,12017,A,,Intermediate,CHEMBL631995,In vivo,2113.0,50597,,1,,N,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Kidney,1,,BAO_0000218
14737,12017,A,,Intermediate,CHEMBL631996,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Liver,1,,BAO_0000218
14738,12017,A,,Intermediate,CHEMBL631997,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14739,12017,A,,Intermediate,CHEMBL631998,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14740,12017,A,,Intermediate,CHEMBL631999,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14741,12017,A,,Intermediate,CHEMBL632000,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Liver,1,,BAO_0000218
14742,12017,A,,Intermediate,CHEMBL632001,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14743,12017,A,,Intermediate,CHEMBL874424,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14744,12017,A,,Intermediate,CHEMBL632002,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14745,12017,A,,Intermediate,CHEMBL632003,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14746,3133,A,,Autocuration,CHEMBL632004,,,22224,,1,,U,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,0,,BAO_0000019
14747,2742,A,,Autocuration,CHEMBL632005,,,22224,,1,,U,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,,0,,BAO_0000019
14748,2742,A,,Autocuration,CHEMBL632006,,,22224,,1,,U,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,,0,,BAO_0000019
14749,2742,A,,Autocuration,CHEMBL632007,,,22224,,1,,U,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,,0,,BAO_0000019
14750,2742,A,,Autocuration,CHEMBL632008,,,22224,,1,,U,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,,0,,BAO_0000019
14751,2742,A,,Autocuration,CHEMBL632009,,,22224,,1,,U,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,,0,,BAO_0000019
14752,2742,A,,Autocuration,CHEMBL632010,,,22224,,1,,U,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,,0,,BAO_0000019
14753,2742,A,,Autocuration,CHEMBL857750,,,22224,,1,,U,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,,0,,BAO_0000019
14754,2742,A,,Autocuration,CHEMBL632011,,,22224,,1,,U,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,,0,,BAO_0000019
14755,2276,A,,Autocuration,CHEMBL632012,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,0,,BAO_0000019
14756,2276,A,,Autocuration,CHEMBL632013,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,0,,BAO_0000019
14757,2276,A,,Autocuration,CHEMBL632014,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,,0,,BAO_0000019
14758,2276,A,,Autocuration,CHEMBL629622,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,0,,BAO_0000019
14759,2276,A,,Autocuration,CHEMBL629623,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,0,,BAO_0000019
14760,2276,A,,Autocuration,CHEMBL629624,,,22224,,1,,U,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,,0,,BAO_0000019
14761,17269,A,,Autocuration,CHEMBL629625,,,22224,,1,,U,Ratio of Kcat to that of Km was determined,,,,0,,BAO_0000019
14762,2276,A,,Autocuration,CHEMBL629626,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,0,,BAO_0000019
14763,2276,A,,Autocuration,CHEMBL629627,,,22224,,1,,U,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,0,,BAO_0000019
14764,15917,A,,Autocuration,CHEMBL629628,,,22224,,1,,U,"Compound was evaluated for constant, Kd",,,,0,,BAO_0000019
14765,10933,A,,Autocuration,CHEMBL629629,,,22224,,1,,U,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,,0,,BAO_0000019
14766,10933,A,,Autocuration,CHEMBL629630,,,22224,,1,,U,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,,0,,BAO_0000019
14767,14293,A,,Autocuration,CHEMBL856030,,,22224,,1,,U,Dissociation Constant of compound determined,,,,0,,BAO_0000019
14768,6698,B,,Autocuration,CHEMBL629631,,,22224,,1,,U,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,,0,,BAO_0000019
14769,6698,B,,Autocuration,CHEMBL629632,,,22224,,1,,U,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,,0,,BAO_0000019
14770,4318,P,,Autocuration,CHEMBL629633,,,22224,,1,,U,Dissociation constant of compound with Fructose was determined,,,,0,,BAO_0000100
14771,4318,P,,Autocuration,CHEMBL629634,,,22224,,1,,U,Dissociation constant of compound with Fructose was determined; Not determined,,,,0,,BAO_0000100
14772,4318,P,,Autocuration,CHEMBL629635,,,22224,,1,,U,Dissociation constant of compound with Lactulose was determined,,,,0,,BAO_0000100
14773,4318,P,,Autocuration,CHEMBL629636,,,22224,,1,,U,Dissociation constant of compound with Lactulose was determined; Not determined,,,,0,,BAO_0000100
14774,14959,P,,Autocuration,CHEMBL629637,,,22224,,1,,U,Dissociation constant of the Compound,,,,0,,BAO_0000100
14775,5913,P,,Autocuration,CHEMBL629638,,,22224,,1,,U,Dissociation constant by non-linear regression analysis,,,,0,,BAO_0000100
14776,14218,P,,Autocuration,CHEMBL629639,,,22224,,1,,U,Dissociation constant was determined,,,,0,,BAO_0000100
14777,10689,P,,Autocuration,CHEMBL629640,,,22224,,1,,U,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,,0,,BAO_0000100
14778,13925,P,,Autocuration,CHEMBL629641,,,22224,,1,,U,Dissociation constant was determined,,,,0,,BAO_0000100
14779,16359,P,,Autocuration,CHEMBL631344,,,22224,,1,,U,Dissociation constant was determined,,,,0,,BAO_0000100
14780,10944,A,,Intermediate,CHEMBL631345,,2385.0,50597,,1,,N,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14781,11080,A,,Autocuration,CHEMBL631346,,,22224,,1,,U,The dissociation constant determined by fluorescence displacement assay,,,,0,,BAO_0000019
14782,17805,A,,Autocuration,CHEMBL631524,,,22224,,1,,U,kd value surface plasmon resonance (SPR) method,,,,0,,BAO_0000019
14783,10944,A,,Intermediate,CHEMBL631525,,2385.0,50597,,1,,N,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14784,16645,F,,Autocuration,CHEMBL631526,,,22224,,1,,U,First dissociation constant of the binding of compound to V30M TTR,,,,0,,BAO_0000019
14785,16645,F,,Autocuration,CHEMBL631527,,,22224,,1,,U,Second dissociation constant of the binding of compound to V30M TTR,,,,0,,BAO_0000019
14786,7793,A,,Autocuration,CHEMBL631528,,,22224,,1,,U,"Compound was evaluated for equilibrium constant, Ke",,,,0,,BAO_0000019
14787,12199,A,,Autocuration,CHEMBL631529,,1898.0,22224,,1,,U,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,Hypothalamus,0,,BAO_0000019
14788,12199,A,,Autocuration,CHEMBL631530,,1898.0,22224,,1,,U,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,Hypothalamus,0,,BAO_0000019
14789,9680,A,,Autocuration,CHEMBL631531,,,22224,,1,,U,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,,0,,BAO_0000019
14790,9680,A,,Autocuration,CHEMBL631532,,,22224,,1,,U,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,,0,,BAO_0000019
14791,9680,A,,Autocuration,CHEMBL631533,,,22224,,1,,U,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,,0,,BAO_0000019
14792,13758,A,,Intermediate,CHEMBL876552,,,50594,,1,,N,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,1,,BAO_0000218
14793,13758,A,,Intermediate,CHEMBL631534,,,50594,,1,,N,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,,,1,,BAO_0000218
14794,13758,A,,Intermediate,CHEMBL631535,,,50594,,1,,N,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,1,,BAO_0000218
14795,13758,A,,Intermediate,CHEMBL631536,,,50594,,1,,N,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,1,,BAO_0000218
14796,13758,A,,Intermediate,CHEMBL631537,,,50594,,1,,N,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Mus musculus,,,1,,BAO_0000218
14797,13758,A,,Intermediate,CHEMBL631538,,,50594,,1,,N,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,,,1,,BAO_0000218
14798,13758,A,,Intermediate,CHEMBL631539,,,50594,,1,,N,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Mus musculus,,,1,,BAO_0000218
14799,13758,A,,Intermediate,CHEMBL631540,,,50594,,1,,N,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,,,1,,BAO_0000218
14800,14393,A,,Intermediate,CHEMBL625637,,,50597,,1,,N,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
14801,14393,A,,Intermediate,CHEMBL625638,,,50597,,1,,N,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,,,1,,BAO_0000218
14802,15078,A,,Intermediate,CHEMBL625639,,,50597,,1,,N,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,,,1,,BAO_0000218
14803,13925,A,,Intermediate,CHEMBL625640,In vivo,955.0,50597,,1,,N,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Brain,1,,BAO_0000218
14804,13925,A,,Intermediate,CHEMBL625641,In vivo,955.0,50597,,1,,N,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Brain,1,,BAO_0000218
14805,13925,A,,Intermediate,CHEMBL625642,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Heart,1,,BAO_0000218
14806,13925,A,,Intermediate,CHEMBL625643,In vivo,948.0,50597,,1,,N,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Heart,1,,BAO_0000218
14807,13925,A,,Intermediate,CHEMBL625644,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
14808,13925,A,,Intermediate,CHEMBL625645,In vivo,2113.0,50597,,1,,N,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Kidney,1,,BAO_0000218
14809,13925,A,,Intermediate,CHEMBL625646,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Liver,1,,BAO_0000218
14810,13925,A,,Intermediate,CHEMBL625647,In vivo,2107.0,50597,,1,,N,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Liver,1,,BAO_0000218
14811,13925,A,,Intermediate,CHEMBL625648,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Lung,1,,BAO_0000218
14812,13925,A,,Intermediate,CHEMBL625649,In vivo,2048.0,50597,,1,,N,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Lung,1,,BAO_0000218
14813,13925,A,,Intermediate,CHEMBL625650,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14814,13925,A,,Intermediate,CHEMBL625651,In vivo,2385.0,50597,,1,,N,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14815,13925,A,,Intermediate,CHEMBL625652,In vivo,14.0,50597,,1,,N,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
14816,13925,A,,Intermediate,CHEMBL625653,In vivo,14.0,50597,,1,,N,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Zone of skin,1,,BAO_0000218
14817,13925,A,,Intermediate,CHEMBL625654,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Spleen,1,,BAO_0000218
14818,13925,A,,Intermediate,CHEMBL625655,In vivo,2106.0,50597,,1,,N,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,,Spleen,1,,BAO_0000218
14819,9712,A,,Intermediate,CHEMBL625656,In vivo,178.0,50597,,1,,N,Biodistribution of Compound in rat blood after 15 minutes of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
14820,9712,A,,Intermediate,CHEMBL625657,In vivo,178.0,50597,,1,,N,Biodistribution of Compound in rat blood after 2 minutes of administration,Rattus norvegicus,,Blood,1,,BAO_0000218
14821,9712,A,,Intermediate,CHEMBL625658,In vivo,955.0,50597,,1,,N,Biodistribution of Compound in rat brain after 15 minutes of administration,Rattus norvegicus,,Brain,1,,BAO_0000218
14822,9712,A,,Intermediate,CHEMBL625659,In vivo,955.0,50597,,1,,N,Biodistribution of Compound in rat brain after 2 minutes of administration,Rattus norvegicus,,Brain,1,,BAO_0000218
14823,9712,A,,Intermediate,CHEMBL625660,In vivo,948.0,50597,,1,,N,Biodistribution of Compound in rat heart after 15 minutes of administration,Rattus norvegicus,,Heart,1,,BAO_0000218
14824,9712,A,,Intermediate,CHEMBL625661,In vivo,948.0,50597,,1,,N,Biodistribution of Compound in rat heart after 2 minutes of administration,Rattus norvegicus,,Heart,1,,BAO_0000218
14825,9712,A,,Intermediate,CHEMBL625662,In vivo,2107.0,50597,,1,,N,Biodistribution of Compound in rat liver after 15 minutes of administration,Rattus norvegicus,,Liver,1,,BAO_0000218
14826,9712,A,,Intermediate,CHEMBL625663,In vivo,2107.0,50597,,1,,N,Biodistribution of Compound in rat liver after 2 minutes of administration,Rattus norvegicus,,Liver,1,,BAO_0000218
14827,9712,A,,Intermediate,CHEMBL875621,In vivo,2048.0,50597,,1,,N,Biodistribution of Compound in rat lung after 15 minutes of administration,Rattus norvegicus,,Lung,1,,BAO_0000218
14828,9712,A,,Intermediate,CHEMBL628382,In vivo,2048.0,50597,,1,,N,Biodistribution of Compound in rat lung after 2 minutes of administration,Rattus norvegicus,,Lung,1,,BAO_0000218
14829,9712,A,,Intermediate,CHEMBL628383,In vivo,2385.0,50597,,1,,N,Biodistribution of Compound in rat muscle after 15 minutes of administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14830,9712,A,,Intermediate,CHEMBL628384,In vivo,2385.0,50597,,1,,N,Biodistribution of Compound in rat muscle after 2 minutes of administration,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14831,13925,A,,Intermediate,CHEMBL628385,,,50597,,1,,N,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Rattus norvegicus,,,1,,BAO_0000218
14832,13925,A,,Intermediate,CHEMBL875753,,,50597,,1,,N,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Rattus norvegicus,,,1,,BAO_0000218
14833,13925,A,,Intermediate,CHEMBL628386,,,50597,,1,,N,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Rattus norvegicus,,,1,,BAO_0000218
14834,6941,A,,Intermediate,CHEMBL628387,,,50597,,1,,N,Organ distribution in rat blood 2 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14835,6941,A,,Intermediate,CHEMBL628388,,,50597,,1,,N,Organ distribution in rat blood 2 hr after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14836,6941,A,,Intermediate,CHEMBL628389,,,50597,,1,,N,Organ distribution in rat blood 30 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14837,6941,A,,Intermediate,CHEMBL632756,,,50597,,1,,N,Organ distribution in rat blood 30 min after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14838,6941,A,,Intermediate,CHEMBL628390,,,50597,,1,,N,Organ distribution in rat brain 2 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14839,6941,A,,Intermediate,CHEMBL631811,,,50597,,1,,N,Organ distribution in rat brain 2 hr after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14840,6941,A,,Intermediate,CHEMBL631812,,,50597,,1,,N,Organ distribution in rat brain 30 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14841,6941,A,,Intermediate,CHEMBL631813,,,50597,,1,,N,Organ distribution in rat heart 2 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14842,6941,A,,Intermediate,CHEMBL631814,,,50597,,1,,N,Organ distribution in rat heart 2 hr after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14843,6941,A,,Intermediate,CHEMBL631815,,,50597,,1,,N,Organ distribution in rat heart 30 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14844,6941,A,,Intermediate,CHEMBL631816,,,50597,,1,,N,Organ distribution in rat kidney 2 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14845,6941,A,,Intermediate,CHEMBL875758,,,50597,,1,,N,Organ distribution in rat kidney 2 hr after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14846,6941,A,,Intermediate,CHEMBL631817,,,50597,,1,,N,Organ distribution in rat kidney 30 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14847,6941,A,,Intermediate,CHEMBL631818,,2107.0,50597,,1,,N,Organ distribution in rat liver 2 minutes after intravenous injection,Rattus norvegicus,,Liver,1,,BAO_0000218
14848,6941,A,,Intermediate,CHEMBL631819,,2107.0,50597,,1,,N,Organ distribution in rat liver 2 hr after intravenous injection,Rattus norvegicus,,Liver,1,,BAO_0000218
14849,6941,A,,Intermediate,CHEMBL631820,,2107.0,50597,,1,,N,Organ distribution in rat liver 30 minutes after intravenous injection,Rattus norvegicus,,Liver,1,,BAO_0000218
14850,6941,A,,Intermediate,CHEMBL631821,,,50597,,1,,N,Organ distribution in rat lung 2 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14851,6941,A,,Intermediate,CHEMBL631822,,,50597,,1,,N,Organ distribution in rat lung 2 hr after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14852,6941,A,,Intermediate,CHEMBL631823,,,50597,,1,,N,Organ distribution in rat lung 30 minutes after intravenous injection,Rattus norvegicus,,,1,,BAO_0000218
14853,6941,A,,Intermediate,CHEMBL631824,,2385.0,50597,,1,,N,Organ distribution in rat muscle 2 minutes after intravenous injection,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14854,6941,A,,Intermediate,CHEMBL631825,,2385.0,50597,,1,,N,Organ distribution in rat muscle 2 hr after intravenous injection,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14855,6941,A,,Intermediate,CHEMBL631826,,2385.0,50597,,1,,N,Organ distribution in rat muscle 30 minutes after intravenous injection,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14856,14439,A,,Intermediate,CHEMBL631827,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,1,,BAO_0000218
14857,14439,A,,Intermediate,CHEMBL631828,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,1,,BAO_0000218
14858,14439,A,,Intermediate,CHEMBL631829,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,1,,BAO_0000218
14859,12582,A,,Intermediate,CHEMBL875759,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14860,12582,A,,Intermediate,CHEMBL631830,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14861,12582,A,,Intermediate,CHEMBL631831,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14862,12582,A,,Intermediate,CHEMBL631832,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14863,12582,A,,Intermediate,CHEMBL631833,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14864,12582,A,,Intermediate,CHEMBL631834,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14865,12582,A,,Intermediate,CHEMBL631835,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14866,12582,A,,Intermediate,CHEMBL631836,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14867,12582,A,,Intermediate,CHEMBL631837,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14868,12582,A,,Intermediate,CHEMBL631838,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14869,12582,A,,Intermediate,CHEMBL631839,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14870,12582,A,,Intermediate,CHEMBL631840,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14871,12582,A,,Intermediate,CHEMBL631841,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14872,12582,A,,Intermediate,CHEMBL631842,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14873,12582,A,,Intermediate,CHEMBL631843,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14874,12582,A,,Intermediate,CHEMBL631844,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14875,12582,A,,Intermediate,CHEMBL631845,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14876,12582,A,,Intermediate,CHEMBL631846,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14877,12582,A,,Intermediate,CHEMBL875760,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14878,12582,A,,Intermediate,CHEMBL632199,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14879,12582,A,,Intermediate,CHEMBL631847,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14880,12582,A,,Intermediate,CHEMBL631848,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14881,12582,A,,Intermediate,CHEMBL628707,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14882,12582,A,,Intermediate,CHEMBL628708,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14883,12582,A,,Intermediate,CHEMBL628709,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14884,12582,A,,Intermediate,CHEMBL628710,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14885,12582,A,,Intermediate,CHEMBL628711,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14886,12582,A,,Intermediate,CHEMBL628712,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14887,12582,A,,Intermediate,CHEMBL628713,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14888,12582,A,,Intermediate,CHEMBL628714,,1088.0,50597,,1,,N,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,,Urine,1,,BAO_0000218
14889,7415,A,,Intermediate,CHEMBL628715,,,50597,,1,,N,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Rattus norvegicus,,,1,,BAO_0000218
14890,7313,A,,Autocuration,CHEMBL629179,,,22224,,1,,U,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,,0,,BAO_0000019
14891,7313,A,,Autocuration,CHEMBL629180,,,22224,,1,,U,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,,0,,BAO_0000019
14892,7313,A,,Autocuration,CHEMBL875108,,,22224,,1,,U,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,,0,,BAO_0000019
14893,7570,A,,Autocuration,CHEMBL629181,,1235.0,22224,,1,,U,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14894,7570,A,,Autocuration,CHEMBL629182,,1235.0,22224,,1,,U,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14895,7570,A,,Autocuration,CHEMBL629183,,,22224,,1,,U,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,,0,,BAO_0000019
14896,7570,A,,Autocuration,CHEMBL629184,,,22224,,1,,U,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14897,7570,A,,Autocuration,CHEMBL629185,,1235.0,22224,,1,,U,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14898,7570,A,,Autocuration,CHEMBL629186,,1235.0,22224,,1,,U,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14899,7570,A,,Autocuration,CHEMBL629187,,,22224,,1,,U,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14900,7570,A,,Autocuration,CHEMBL629887,,,22224,,1,,U,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,0,,BAO_0000019
14901,7570,A,,Autocuration,CHEMBL629888,,,22224,,1,,U,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14902,7570,A,,Autocuration,CHEMBL629889,,,22224,,1,,U,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14903,7570,A,,Autocuration,CHEMBL629890,,1235.0,22224,,1,,U,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14904,7570,A,,Autocuration,CHEMBL629891,,,22224,,1,,U,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14905,7570,A,,Autocuration,CHEMBL629892,,,22224,,1,,U,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,,0,,BAO_0000019
14906,7570,A,,Autocuration,CHEMBL629893,,1235.0,22224,,1,,U,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,Adrenal cortex,0,,BAO_0000019
14907,7570,A,,Autocuration,CHEMBL629894,,,22224,,1,,U,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,,0,,BAO_0000019
14908,7570,A,,Autocuration,CHEMBL629895,,,22224,,1,,U,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,0,,BAO_0000019
14909,14122,A,,Autocuration,CHEMBL875109,In vivo,,22224,,1,,U,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,,,0,,BAO_0000218
14910,16449,A,,Autocuration,CHEMBL629896,In vivo,,22224,,1,,U,Absolute bioavailability in male cynomolgus monkeys,Macaca fascicularis,,,0,,BAO_0000218
14911,16449,A,,Autocuration,CHEMBL629897,In vivo,,22224,,1,,U,Absolute bioavailability in maleSprague-Dawley rats,Rattus norvegicus,,,0,,BAO_0000218
14912,12017,A,,Intermediate,CHEMBL629898,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Liver,1,,BAO_0000218
14913,12017,A,,Intermediate,CHEMBL630057,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14914,12017,A,,Intermediate,CHEMBL630058,In vivo,2107.0,50597,,1,,N,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Liver,1,,BAO_0000218
14915,12017,A,,Intermediate,CHEMBL630059,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14916,12017,A,,Intermediate,CHEMBL630060,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14917,12017,A,,Intermediate,CHEMBL630061,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Lung,1,,BAO_0000218
14918,12017,A,,Intermediate,CHEMBL630062,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14919,12017,A,,Intermediate,CHEMBL630063,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14920,12017,A,,Intermediate,CHEMBL630064,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14921,12017,A,,Intermediate,CHEMBL630065,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14922,12017,A,,Intermediate,CHEMBL630066,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Lung,1,,BAO_0000218
14923,12017,A,,Intermediate,CHEMBL630067,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14924,12017,A,,Intermediate,CHEMBL630068,In vivo,2048.0,50597,,1,,N,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Lung,1,,BAO_0000218
14925,12017,A,,Intermediate,CHEMBL631113,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14926,12017,A,,Intermediate,CHEMBL631114,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14927,12017,A,,Intermediate,CHEMBL631115,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14928,12017,A,,Intermediate,CHEMBL631116,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14929,12017,A,,Intermediate,CHEMBL630528,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14930,12017,A,,Intermediate,CHEMBL630529,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14931,12017,A,,Intermediate,CHEMBL630530,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14932,12017,A,,Intermediate,CHEMBL630531,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14933,12017,A,,Intermediate,CHEMBL630532,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14934,12017,A,,Intermediate,CHEMBL630533,In vivo,2385.0,50597,,1,,N,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Muscle tissue,1,,BAO_0000218
14935,15045,A,,Intermediate,CHEMBL630534,In vivo,178.0,50594,,1,,N,Biodistribution in normal mice blood after 120 hr,Mus musculus,,Blood,1,,BAO_0000218
14936,15045,A,,Intermediate,CHEMBL630535,In vivo,178.0,50594,,1,,N,Biodistribution in normal mice blood after 24 hr,Mus musculus,,Blood,1,,BAO_0000218
14937,15045,A,,Intermediate,CHEMBL630536,In vivo,178.0,50594,,1,,N,Biodistribution in normal mice blood after 4 hr,Mus musculus,,Blood,1,,BAO_0000218
14938,15045,A,,Intermediate,CHEMBL630537,In vivo,10000001.0,50594,,1,,N,Biodistribution in normal mice bone after 120 hr,Mus musculus,,Bone,1,,BAO_0000218
14939,15045,A,,Intermediate,CHEMBL630538,In vivo,10000001.0,50594,,1,,N,Biodistribution in normal mice bone after 24 hr,Mus musculus,,Bone,1,,BAO_0000218
14940,15045,A,,Intermediate,CHEMBL630539,In vivo,10000001.0,50594,,1,,N,Biodistribution in normal mice bone after 4 hr,Mus musculus,,Bone,1,,BAO_0000218
14941,15045,A,,Intermediate,CHEMBL630540,In vivo,948.0,50594,,1,,N,Biodistribution in normal mice heart after 120 hr,Mus musculus,,Heart,1,,BAO_0000218
14942,15045,A,,Intermediate,CHEMBL630541,In vivo,948.0,50594,,1,,N,Biodistribution in normal mice heart after 24 hr,Mus musculus,,Heart,1,,BAO_0000218
14943,15045,A,,Intermediate,CHEMBL630542,In vivo,948.0,50594,,1,,N,Biodistribution in normal mice heart after 4 hr,Mus musculus,,Heart,1,,BAO_0000218
14944,15045,A,,Intermediate,CHEMBL630543,In vivo,2113.0,50594,,1,,N,Biodistribution in normal mice kidney after 120 hr,Mus musculus,,Kidney,1,,BAO_0000218
14945,15045,A,,Intermediate,CHEMBL630544,In vivo,2113.0,50594,,1,,N,Biodistribution in normal mice kidney after 24 hr,Mus musculus,,Kidney,1,,BAO_0000218
14946,15045,A,,Intermediate,CHEMBL630545,In vivo,2113.0,50594,,1,,N,Biodistribution in normal mice kidney after 4 hr,Mus musculus,,Kidney,1,,BAO_0000218
14947,15045,A,,Intermediate,CHEMBL630546,In vivo,2107.0,50594,,1,,N,Biodistribution in normal mice liver after 120 hr,Mus musculus,,Liver,1,,BAO_0000218
14948,15045,A,,Intermediate,CHEMBL630547,In vivo,2107.0,50594,,1,,N,Biodistribution in normal mice liver after 24 hr,Mus musculus,,Liver,1,,BAO_0000218
14949,15045,A,,Intermediate,CHEMBL630548,In vivo,2107.0,50594,,1,,N,Biodistribution in normal mice liver after 4 hr,Mus musculus,,Liver,1,,BAO_0000218
14950,15045,A,,Intermediate,CHEMBL630549,In vivo,2106.0,50594,,1,,N,Biodistribution in normal mice spleen after 120 hr,Mus musculus,,Spleen,1,,BAO_0000218
14951,15045,A,,Intermediate,CHEMBL630550,In vivo,2106.0,50594,,1,,N,Biodistribution in normal mice spleen after 24 hr,Mus musculus,,Spleen,1,,BAO_0000218
14952,15045,A,,Intermediate,CHEMBL876426,In vivo,2106.0,50594,,1,,N,Biodistribution in normal mice spleen after 4 hr,Mus musculus,,Spleen,1,,BAO_0000218
14953,12017,A,,Intermediate,CHEMBL630551,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14954,12017,A,,Intermediate,CHEMBL630552,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14955,12017,A,,Intermediate,CHEMBL630553,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Spleen,1,,BAO_0000218
14956,12017,A,,Intermediate,CHEMBL630554,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14957,12017,A,,Intermediate,CHEMBL630555,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14958,12017,A,,Intermediate,CHEMBL630556,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14959,12017,A,,Intermediate,CHEMBL630557,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14960,12017,A,,Intermediate,CHEMBL630558,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,,Spleen,1,,BAO_0000218
14961,12017,A,,Intermediate,CHEMBL630559,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14962,12017,A,,Intermediate,CHEMBL630560,In vivo,2106.0,50597,,1,,N,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Spleen,1,,BAO_0000218
14963,12017,A,,Intermediate,CHEMBL876427,In vivo,2046.0,50597,,1,,N,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,,Thyroid gland,1,,BAO_0000218
14964,14941,A,,Intermediate,CHEMBL630561,,,50597,,1,,N,The Kel values in female wistar rats.,Rattus norvegicus,,,1,,BAO_0000218
14965,4646,A,,Autocuration,CHEMBL630562,,,22224,,1,,U,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,,0,,BAO_0000019
14966,8847,A,,Autocuration,CHEMBL630563,,,22224,,1,,U,Hydrolysis rate constant of the compound,,,,0,,BAO_0000019
14967,11778,P,,Autocuration,CHEMBL629673,,,22229,,1,,U,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,,0,,BAO_0000100
14968,2363,A,,Autocuration,CHEMBL629674,,,22224,,1,,U,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,,0,,BAO_0000019
14969,2363,A,,Autocuration,CHEMBL629675,,,22224,,1,,U,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,,0,,BAO_0000019
14970,2363,A,,Autocuration,CHEMBL629676,,,22224,,1,,U,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,,0,,BAO_0000019
14971,2363,A,,Autocuration,CHEMBL629677,,,22224,,1,,U,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,,0,,BAO_0000019
14972,8371,A,,Autocuration,CHEMBL629678,,,22224,,1,,U,Apparent inactivation rate constant was evaluated,,,,0,,BAO_0000019
14973,14883,A,,Autocuration,CHEMBL629679,,,22224,,1,,U,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,,0,,BAO_0000019
14974,14883,A,,Autocuration,CHEMBL629680,,,22224,,1,,U,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,,0,,BAO_0000019
14975,4643,A,,Autocuration,CHEMBL629681,,,22224,,1,,U,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,,0,,BAO_0000019
14976,3519,A,,Autocuration,CHEMBL629682,,,22224,,1,,U,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,,0,,BAO_0000019
14977,10600,A,,Autocuration,CHEMBL629683,,,22224,,1,,U,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,,0,,BAO_0000019
14978,8501,F,,Autocuration,CHEMBL629684,,,22224,,1,,U,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,,0,,BAO_0000019
14979,8505,P,,Autocuration,CHEMBL629685,,,22224,,1,,U,Dissociation constant was determined,,,,0,,BAO_0000100
14980,9778,P,,Autocuration,CHEMBL629686,,,22224,,1,,U,Dissociation constant was determined,,,,0,,BAO_0000100
14981,9778,P,,Autocuration,CHEMBL872932,,,22224,,1,,U,Dissociation constant at pH 7.4,,,,0,,BAO_0000100
14982,9778,P,,Autocuration,CHEMBL629687,,,22224,,1,,U,Dissociation constant in presence of 1 mM dithiothreitol,,,,0,,BAO_0000100
14983,13007,A,,Autocuration,CHEMBL872931,,,22224,,1,,U,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,0,,BAO_0000019
14984,13007,A,,Autocuration,CHEMBL628151,,,22224,,1,,U,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,0,,BAO_0000019
14985,13007,A,,Autocuration,CHEMBL628152,,,22224,,1,,U,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,0,,BAO_0000019
14986,13007,A,,Autocuration,CHEMBL628153,,,22224,,1,,U,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,0,,BAO_0000019
14987,11482,A,,Autocuration,CHEMBL628154,,,22224,,1,,U,Kinetic constant for aromatization of androstenedione,,,,0,,BAO_0000019
14988,11482,A,,Autocuration,CHEMBL628155,,,22224,,1,,U,Kinetic constant for aromatization of testosterone,,,,0,,BAO_0000019
14989,2303,A,,Autocuration,CHEMBL628156,,,22224,,1,,U,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,,0,,BAO_0000019
14990,11964,A,,Autocuration,CHEMBL628157,,,22224,,1,,U,Local inhibition constant was determined,,,,0,,BAO_0000019
14991,3140,A,,Intermediate,CHEMBL857533,,,50347,,1,,N,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Saccharomyces cerevisiae,,,1,,BAO_0000218
14992,10650,P,,Autocuration,CHEMBL628158,,,22224,,1,,U,Dissociation constant value of the compound,,,,0,,BAO_0000100
14993,4667,A,,Autocuration,CHEMBL628159,,964.0,22224,,1,,U,In vitro permeability through cornea without epithelium,,,Cornea,0,,BAO_0000019
14994,4667,A,,Autocuration,CHEMBL875616,,964.0,22224,,1,,U,In vitro permeability through intact cornea,,,Cornea,0,,BAO_0000019
14995,9199,A,,Intermediate,CHEMBL628160,,964.0,50592,,1,,N,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Oryctolagus cuniculus,,Cornea,1,,BAO_0000218
14996,11966,A,,Autocuration,CHEMBL628161,,,22224,,1,,U,Rate of enzyme inactivation for the compound was determined,,,,0,,BAO_0000019
14997,4667,A,,Autocuration,CHEMBL628162,,964.0,22224,,1,,U,In vitro permeability through cornea without epithelium,,,Cornea,0,,BAO_0000019
14998,4667,A,,Autocuration,CHEMBL628163,,964.0,22224,,1,,U,In vitro permeability through intact cornea,,,Cornea,0,,BAO_0000019
14999,8354,A,,Autocuration,CHEMBL628164,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15000,8354,A,,Autocuration,CHEMBL628165,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15001,8354,A,,Autocuration,CHEMBL628166,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15002,8354,A,,Autocuration,CHEMBL628167,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15003,8354,A,,Autocuration,CHEMBL628168,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15004,8354,A,,Autocuration,CHEMBL628169,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15005,8354,A,,Autocuration,CHEMBL628170,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15006,8354,A,,Autocuration,CHEMBL628171,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15007,8354,A,,Autocuration,CHEMBL627434,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15008,8354,A,,Autocuration,CHEMBL627435,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15009,8354,A,,Autocuration,CHEMBL628110,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15010,8354,A,,Autocuration,CHEMBL628111,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15011,8354,A,,Autocuration,CHEMBL628112,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15012,8354,A,,Autocuration,CHEMBL628260,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15013,8354,A,,Autocuration,CHEMBL628261,,,22224,,1,,U,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,0,,BAO_0000019
15014,14439,A,,Intermediate,CHEMBL628262,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,1,,BAO_0000218
15015,14439,A,,Intermediate,CHEMBL628263,In vivo,,50587,,1,,N,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Homo sapiens,,,1,,BAO_0000218
15016,14439,A,,Intermediate,CHEMBL628264,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,1,,BAO_0000218
15017,14439,A,,Intermediate,CHEMBL628265,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,1,,BAO_0000218
15018,14439,A,,Intermediate,CHEMBL628266,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,1,,BAO_0000218
15019,14439,A,,Intermediate,CHEMBL628267,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,1,,BAO_0000218
15020,14439,A,,Intermediate,CHEMBL628268,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Mus musculus,,,1,,BAO_0000218
15021,14439,A,,Intermediate,CHEMBL628269,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Mus musculus,,,1,,BAO_0000218
15022,14439,A,,Intermediate,CHEMBL628270,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Mus musculus,,,1,,BAO_0000218
15023,14439,A,,Intermediate,CHEMBL628271,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Mus musculus,,,1,,BAO_0000218
15024,14439,A,,Intermediate,CHEMBL628272,In vivo,,50594,,1,,N,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Mus musculus,,,1,,BAO_0000218
